advertisement

Topcon

List of abstracts related to

90166 Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial
Rossetti L; Iester M; Tranchina L; Ottobelli L; Coco G; Calcatelli E; Ancona C; Cirafici P; Cirafici P; Manni G
Journal of Glaucoma 2020; 29: 513-520

Listed by Classification


11.14 Investigational drugs; pharmacological experiments (2500 abstracts found)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Sakata R
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Olander KW
Journal of Glaucoma 2021; 30: 473-480 (IGR: 22-2)


94934 Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal-tension glaucoma: the randomized phase II study
Ha A
Acta Ophthalmologica 2022; 100: e470-e477 (IGR: 22-2)


94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Naik M
Clinical Ophthalmology 2021; 15: 2683-2692 (IGR: 22-2)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Fujishiro T
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


94934 Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal-tension glaucoma: the randomized phase II study
Kim YK
Acta Ophthalmologica 2022; 100: e470-e477 (IGR: 22-2)


94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Kapur M
Clinical Ophthalmology 2021; 15: 2683-2692 (IGR: 22-2)


94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Sato MA
Journal of Glaucoma 2021; 30: 473-480 (IGR: 22-2)


94934 Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal-tension glaucoma: the randomized phase II study
Jeoung JW
Acta Ophthalmologica 2022; 100: e470-e477 (IGR: 22-2)


94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Gupta V
Clinical Ophthalmology 2021; 15: 2683-2692 (IGR: 22-2)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Saito H
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Abrams MA; Jerkins GW
Journal of Glaucoma 2021; 30: 473-480 (IGR: 22-2)


94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Sethi H
Clinical Ophthalmology 2021; 15: 2683-2692 (IGR: 22-2)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Nakamura N
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


94934 Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal-tension glaucoma: the randomized phase II study
Satyal S
Acta Ophthalmologica 2022; 100: e470-e477 (IGR: 22-2)


94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Srivastava K
Clinical Ophthalmology 2021; 15: 2683-2692 (IGR: 22-2)


94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Lu F
Journal of Glaucoma 2021; 30: 473-480 (IGR: 22-2)


94934 Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal-tension glaucoma: the randomized phase II study
Kim J
Acta Ophthalmologica 2022; 100: e470-e477 (IGR: 22-2)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Honjo M; Shirato S
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Dinh P
Journal of Glaucoma 2021; 30: 473-480 (IGR: 22-2)


94934 Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal-tension glaucoma: the randomized phase II study
Kim S
Acta Ophthalmologica 2022; 100: e470-e477 (IGR: 22-2)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Miyamoto E
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


94934 Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal-tension glaucoma: the randomized phase II study
Park KH
Acta Ophthalmologica 2022; 100: e470-e477 (IGR: 22-2)


94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Odani-Kawabata N; Chabi A
Journal of Glaucoma 2021; 30: 473-480 (IGR: 22-2)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Yamada Y
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


94605 A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Shams NK
Journal of Glaucoma 2021; 30: 473-480 (IGR: 22-2)


94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Aihara M
Japanese Journal of Ophthalmology 2021; 65: 591-597 (IGR: 22-2)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Riva I
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92695 Responsiveness to ripasudil may be a potential outcome marker for selective laser trabeculoplasty in patients with primary open-angle glaucoma
Baba T
Scientific reports 2021; 11: 5812 (IGR: 22-1)


92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Zaman F
Current Medical Research and Opinion 2021; 37: 1011-1020 (IGR: 22-1)


92662 Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension
Batra M
European Journal of Ophthalmology 2021; 0: 11206721211008783 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Amankwa CE
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée A
Biomedicines 2021; 9: (IGR: 22-1)


92720 Netarsudil-related Eyelid Wound Dehiscence
Kim HM
Journal of Glaucoma 2021; 30: 206-208 (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Rozpędek-Kamińska W
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Tan C
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée A
Biomedicines 2021; 9: (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Li G
eLife 2021; 10: (IGR: 22-1)


92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Cao T
Neuroimmunomodulation 2021; 0: 1-10 (IGR: 22-1)


92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Roddy GW
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)


92635 Rhopressa-induced corneal edema: a case report
Chu MJ
Journal of Medical Case Reports 2021; 15: 182 (IGR: 22-1)


92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Araie M
Advances in Therapy 2021; 38: 1757-1775 (IGR: 22-1)


92784 The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery
Fujimoto H
Translational vision science & technology 2021; 10: 18 (IGR: 22-1)


92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
MacIver S
Clinical and Experimental Optometry 2021; 104: 350-366 (IGR: 22-1)


92055 Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
Al-Humimat G
Journal of experimental pharmacology 2021; 13: 197-212 (IGR: 22-1)


92762 Effectiveness and Tolerability of Netarsudil in Combination with Other Ocular Hypotensive Agents
Prager AJ
Ophthalmology. Glaucoma 2021; 4: 597-603 (IGR: 22-1)


92458 MiR-137 promotes cell growth and inhibits extracellular matrix protein expression in HO-induced human trabecular meshwork cells by targeting Src
Wang L
Neuroscience Letters 2021; 755: 135902 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
van der Merwe Y
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Mehta AA
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92458 MiR-137 promotes cell growth and inhibits extracellular matrix protein expression in HO-induced human trabecular meshwork cells by targeting Src
Tian Y
Neuroscience Letters 2021; 755: 135902 (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Kanu LN
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Micheletti E
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92762 Effectiveness and Tolerability of Netarsudil in Combination with Other Ocular Hypotensive Agents
Tang M
Ophthalmology. Glaucoma 2021; 4: 597-603 (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Jia F
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Chowdhury UR
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)


92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
Stout N
Clinical and Experimental Optometry 2021; 104: 350-366 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Murphy MC
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92055 Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
Marashdeh I
Journal of experimental pharmacology 2021; 13: 197-212 (IGR: 22-1)


92695 Responsiveness to ripasudil may be a potential outcome marker for selective laser trabeculoplasty in patients with primary open-angle glaucoma
Hirooka K
Scientific reports 2021; 11: 5812 (IGR: 22-1)


92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Wang J
Neuroimmunomodulation 2021; 0: 1-10 (IGR: 22-1)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Micheletti E
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92662 Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension
Gupta S
European Journal of Ophthalmology 2021; 0: 11206721211008783 (IGR: 22-1)


92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Sugiyama K
Advances in Therapy 2021; 38: 1757-1775 (IGR: 22-1)


92784 The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery
Setoguchi Y
Translational vision science & technology 2021; 10: 18 (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Galita G
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92635 Rhopressa-induced corneal edema: a case report
Song M
Journal of Medical Case Reports 2021; 15: 182 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Gondi SR
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée JN
Biomedicines 2021; 9: (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Lee C
eLife 2021; 10: (IGR: 22-1)


92720 Netarsudil-related Eyelid Wound Dehiscence
Tran AQ
Journal of Glaucoma 2021; 30: 206-208 (IGR: 22-1)


92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Gieser SC
Current Medical Research and Opinion 2021; 37: 1011-1020 (IGR: 22-1)


92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Vallée JN
Biomedicines 2021; 9: (IGR: 22-1)


92635 Rhopressa-induced corneal edema: a case report
Palmares T
Journal of Medical Case Reports 2021; 15: 182 (IGR: 22-1)


92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Lecarpentier Y
Biomedicines 2021; 9: (IGR: 22-1)


92784 The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery
Kiryu J
Translational vision science & technology 2021; 10: 18 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Dibas A
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Fausto R
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92762 Effectiveness and Tolerability of Netarsudil in Combination with Other Ocular Hypotensive Agents
Pleet AL
Ophthalmology. Glaucoma 2021; 4: 597-603 (IGR: 22-1)


92662 Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension
Nair AB
European Journal of Ophthalmology 2021; 0: 11206721211008783 (IGR: 22-1)


92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
Ricci O
Clinical and Experimental Optometry 2021; 104: 350-366 (IGR: 22-1)


92720 Netarsudil-related Eyelid Wound Dehiscence
Yang C
Journal of Glaucoma 2021; 30: 206-208 (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Zhang P
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92055 Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
Daradkeh D
Journal of experimental pharmacology 2021; 13: 197-212 (IGR: 22-1)


92458 MiR-137 promotes cell growth and inhibits extracellular matrix protein expression in HO-induced human trabecular meshwork cells by targeting Src
Cao Y
Neuroscience Letters 2021; 755: 135902 (IGR: 22-1)


92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Aso K
Advances in Therapy 2021; 38: 1757-1775 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Sims JR
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Schwartz GF
Current Medical Research and Opinion 2021; 37: 1011-1020 (IGR: 22-1)


92360 Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Lecarpentier Y
Biomedicines 2021; 9: (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Read AT
eLife 2021; 10: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Sood-Mendiratta S
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Wu Y
Neuroimmunomodulation 2021; 0: 1-10 (IGR: 22-1)


92695 Responsiveness to ripasudil may be a potential outcome marker for selective laser trabeculoplasty in patients with primary open-angle glaucoma
Nii H
Scientific reports 2021; 11: 5812 (IGR: 22-1)


92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Monson KJ
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Siwecka N
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92720 Netarsudil-related Eyelid Wound Dehiscence
Dagi Glass LR
Journal of Glaucoma 2021; 30: 206-208 (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Carroll SL
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Weston C
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92055 Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
Kooner K
Journal of experimental pharmacology 2021; 13: 197-212 (IGR: 22-1)


92635 Rhopressa-induced corneal edema: a case report
Song A
Journal of Medical Case Reports 2021; 15: 182 (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Sun X
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Kanemoto K
Advances in Therapy 2021; 38: 1757-1775 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Faiq MA
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Quinones R
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Fautsch MP
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)


92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Swan C
Current Medical Research and Opinion 2021; 37: 1011-1020 (IGR: 22-1)


92762 Effectiveness and Tolerability of Netarsudil in Combination with Other Ocular Hypotensive Agents
Petito LC
Ophthalmology. Glaucoma 2021; 4: 597-603 (IGR: 22-1)


92695 Responsiveness to ripasudil may be a potential outcome marker for selective laser trabeculoplasty in patients with primary open-angle glaucoma
Kiuchi Y
Scientific reports 2021; 11: 5812 (IGR: 22-1)


92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Wang L
Neuroimmunomodulation 2021; 0: 1-10 (IGR: 22-1)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Bruttini C
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92458 MiR-137 promotes cell growth and inhibits extracellular matrix protein expression in HO-induced human trabecular meshwork cells by targeting Src
Ma Q
Neuroscience Letters 2021; 755: 135902 (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Wang K
eLife 2021; 10: (IGR: 22-1)


92662 Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension
Dhanawat M; Sandal S
European Journal of Ophthalmology 2021; 0: 11206721211008783 (IGR: 22-1)


92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Kothapalli K
Advances in Therapy 2021; 38: 1757-1775 (IGR: 22-1)


92310 Antiglaucoma Potential of β-Glucogallin Is Mediated by Modulating Mitochondrial Responses in Experimentally Induced Glaucoma
Zhang H
Neuroimmunomodulation 2021; 0: 1-10 (IGR: 22-1)


92458 MiR-137 promotes cell growth and inhibits extracellular matrix protein expression in HO-induced human trabecular meshwork cells by targeting Src
Zhao S
Neuroscience Letters 2021; 755: 135902 (IGR: 22-1)


92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Williams JM
Current Medical Research and Opinion 2021; 37: 1011-1020 (IGR: 22-1)


92762 Effectiveness and Tolerability of Netarsudil in Combination with Other Ocular Hypotensive Agents
Tanna AP
Ophthalmology. Glaucoma 2021; 4: 597-603 (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Ha J
eLife 2021; 10: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Yang XL
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Hawkins A
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Qiao Y
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Diehl JA
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92635 Rhopressa-induced corneal edema: a case report
Song J
Journal of Medical Case Reports 2021; 15: 182 (IGR: 22-1)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
De Angelis G
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Funk A
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Ho LC
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Chen X
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Kuhn M
eLife 2021; 10: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Lehrer RA
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Kucharska E
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Ceccuzzi R
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92662 Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension
Morsy MA
European Journal of Ophthalmology 2021; 0: 11206721211008783 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Nguyen T
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Kopczynski C; Senchyna M
Advances in Therapy 2021; 38: 1757-1775 (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Malhotra K
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92335 Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy
Quaranta L
European Journal of Ophthalmology 2021; 0: 1120672121999344 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Nguyen KT
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Navarro I
eLife 2021; 10: (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Pytel D
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Conner IP
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Wang Y
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Papas R
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92099 Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Hollander DA
Advances in Therapy 2021; 38: 1757-1775 (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Cui J
eLife 2021; 10: (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Chen J
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Ellis DZ
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Yu Y
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92303 The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
Majsterek I
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Lei Y
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)


92580 Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma
Acharya S
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Hillman D
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Leung CK
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Young K
eLife 2021; 10: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Wollstein G
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Gorijavolu R
eLife 2021; 10: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Wilensky JT
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Sulchek T
eLife 2021; 10: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Schuman JS
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Aref AA; Vajaranant TS
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Kopczynski C
eLife 2021; 10: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Chan KC
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Edward DP
European Journal of Ophthalmology 2021; 0: 1120672121998913 (IGR: 22-1)


92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Farsiu S; Samples J; Challa P; Ethier CR; Stamer WD
eLife 2021; 10: (IGR: 22-1)


91192 Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
Ono K
International Ophthalmology 2021; 41: 605-611 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Singh IP
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Zhang Y
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Manabe K
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91139 ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM)
Ota C
Scientific reports 2020; 10: 20292 (IGR: 21-4)


91635 Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review
Gonzalez LE
Annals of Pharmacotherapy 2020; 0: 1060028020971215 (IGR: 21-4)


91117 Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Wang Y
Clinics 2020; 75: e1874 (IGR: 21-4)


91371 Trabodenoson on trabecular meshwork rejuvenation: a comprehensive review of clinical data
Qiu TG
Expert Opinion on Investigational Drugs 2021; 30: 227-236 (IGR: 21-4)


91775 Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles
Kamiya T
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 104-111 (IGR: 21-4)


91467 A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
Peace JH
Ophthalmology and therapy 2021; 10: 89-100 (IGR: 21-4)


91292 Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil
Chen H
Journal of Glaucoma 2020; 29: e124-e126 (IGR: 21-4)


91403 Intraocular pressure-lowering effect of mycelia extract in a glaucoma rat model
Horng CT
International journal of medical sciences 2021; 18: 1007-1014 (IGR: 21-4)


91674 Rho kinase inhibitors as new local therapy option in primary open angle glaucoma
Erb C
Ophthalmologe 2021; 118: 449-460 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Lorenzo-Soler L
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


91050 The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
Jayanetti V
Journal of experimental pharmacology 2020; 12: 539-548 (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Harasymowycz P
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


91664 Effects of Ripasudil on Open-Angle Glaucoma after Circumferential Suture Trabeculotomy Ab Interno
Sato T
Journal of clinical medicine 2021; 10: (IGR: 21-4)


91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Passani A
Journal of clinical medicine 2020; 9: (IGR: 21-4)


91117 Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Liao Y
Clinics 2020; 75: e1874 (IGR: 21-4)


91664 Effects of Ripasudil on Open-Angle Glaucoma after Circumferential Suture Trabeculotomy Ab Interno
Kawaji T
Journal of clinical medicine 2021; 10: (IGR: 21-4)


91050 The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
Sandhu S
Journal of experimental pharmacology 2020; 12: 539-548 (IGR: 21-4)


91674 Rho kinase inhibitors as new local therapy option in primary open angle glaucoma
Konieczka K
Ophthalmologe 2021; 118: 449-460 (IGR: 21-4)


91192 Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
Sakemi F
International Ophthalmology 2021; 41: 605-611 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Olafsdottir OB
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Posarelli C
Journal of clinical medicine 2020; 9: (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Wu N
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91635 Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review
Boylan PM
Annals of Pharmacotherapy 2020; 0: 1060028020971215 (IGR: 21-4)


91139 ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM)
Ida Y
Scientific reports 2020; 10: 20292 (IGR: 21-4)


91292 Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil
McMillin JC
Journal of Glaucoma 2020; 29: e124-e126 (IGR: 21-4)


91403 Intraocular pressure-lowering effect of mycelia extract in a glaucoma rat model
Yang YL
International journal of medical sciences 2021; 18: 1007-1014 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Kaidzu S
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Royer C
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Fechtner RD
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91775 Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles
Omae T
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 104-111 (IGR: 21-4)


91467 A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
McKee HJ
Ophthalmology and therapy 2021; 10: 89-100 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Tsutsui A
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Garhöfer G
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


91775 Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles
Nakabayashi S
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 104-111 (IGR: 21-4)


91467 A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
Kopczynski CC
Ophthalmology and therapy 2021; 10: 89-100 (IGR: 21-4)


91292 Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil
Frankfort BJ
Journal of Glaucoma 2020; 29: e124-e126 (IGR: 21-4)


91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Sframeli AT
Journal of clinical medicine 2020; 9: (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Myers JS
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Tsutsui A
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91139 ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM)
Ohguro H
Scientific reports 2020; 10: 20292 (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Cui AX
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


91117 Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Nie X
Clinics 2020; 75: e1874 (IGR: 21-4)


91192 Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
Marumoto T
International Ophthalmology 2021; 41: 605-611 (IGR: 21-4)


91403 Intraocular pressure-lowering effect of mycelia extract in a glaucoma rat model
Chen CC
International journal of medical sciences 2021; 18: 1007-1014 (IGR: 21-4)


91050 The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
Lusthaus JA
Journal of experimental pharmacology 2020; 12: 539-548 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Li Q
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Jansook P
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


91403 Intraocular pressure-lowering effect of mycelia extract in a glaucoma rat model
Huang YS
International journal of medical sciences 2021; 18: 1007-1014 (IGR: 21-4)


91775 Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles
Takahashi K
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 104-111 (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Barbeau M
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Hu X
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Kim T
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Mochiji M
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Perciballi L
Journal of clinical medicine 2020; 9: (IGR: 21-4)


91139 ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM)
Hikage F
Scientific reports 2020; 10: 20292 (IGR: 21-4)


91292 Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil
Al-Mohtaseb Z
Journal of Glaucoma 2020; 29: e124-e126 (IGR: 21-4)


91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Pellegrini M
Journal of clinical medicine 2020; 9: (IGR: 21-4)


91403 Intraocular pressure-lowering effect of mycelia extract in a glaucoma rat model
Chen C
International journal of medical sciences 2021; 18: 1007-1014 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Wang L
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Jobin-Gervais K
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Matsuoka Y
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91775 Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles
Tanner A
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 104-111 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Usner DW
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Kristinsdottir IM
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Takagi Y
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Mathurin K
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Guidi G
Journal of clinical medicine 2020; 9: (IGR: 21-4)


91403 Intraocular pressure-lowering effect of mycelia extract in a glaucoma rat model
Chen FA
International journal of medical sciences 2021; 18: 1007-1014 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Sun JG
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
McKee H
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Tan A
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


91775 Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles
Yoshida A
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 104-111 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Sheng H
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Loftsson T
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Figus M
Journal of clinical medicine 2020; 9: (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Lachaine J
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Wang Z
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Miyamoto E
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Sun XH
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Tanito M
Journal of clinical biochemistry and nutrition 2021; 68: 67-72 (IGR: 21-4)


91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Stefansson E
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Lewis RA
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Beauchemin C
British Journal of Ophthalmology 2022; 106: 640-647 (IGR: 21-4)


90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Heah T; Kopczynski CC
Journal of Glaucoma 2020; 29: 878-884 (IGR: 21-4)


89975 A comprehensive map of disease networks and molecular drug discoveries for glaucoma
Wang H
Scientific reports 2020; 10: 9719 (IGR: 21-3)


90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Aihara M
American Journal of Ophthalmology 2020; 220: 53-63 (IGR: 21-3)


89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Cesar ALA
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Aihara M
Japanese Journal of Ophthalmology 2020; 64: 398-406 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Rossi GCM
Scientific reports 2020; 10: 10468 (IGR: 21-3)


89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)


90747 Tissue plasminogen activator attenuates outflow facility reduction in mouse model of juvenile open angle glaucoma
Gindina S
Experimental Eye Research 2020; 199: 108179 (IGR: 21-3)


90673 AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery
Cheng WS
Molecules 2020; 25: (IGR: 21-3)


89941 Current and new pharmacotherapeutic approaches for glaucoma
Shalaby WS
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)


90747 Tissue plasminogen activator attenuates outflow facility reduction in mouse model of juvenile open angle glaucoma
Hu Y
Experimental Eye Research 2020; 199: 108179 (IGR: 21-3)


90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Ropo A
Japanese Journal of Ophthalmology 2020; 64: 398-406 (IGR: 21-3)


89941 Current and new pharmacotherapeutic approaches for glaucoma
Shankar V
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)


89975 A comprehensive map of disease networks and molecular drug discoveries for glaucoma
Deng Y
Scientific reports 2020; 10: 9719 (IGR: 21-3)


90673 AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery
Chen CL
Molecules 2020; 25: (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Navarro LC
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Scudeller L
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Lu F; Kawata H
American Journal of Ophthalmology 2020; 220: 53-63 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Lumini C
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90747 Tissue plasminogen activator attenuates outflow facility reduction in mouse model of juvenile open angle glaucoma
Barron AO
Experimental Eye Research 2020; 199: 108179 (IGR: 21-3)


89941 Current and new pharmacotherapeutic approaches for glaucoma
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)


89975 A comprehensive map of disease networks and molecular drug discoveries for glaucoma
Wan L
Scientific reports 2020; 10: 9719 (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Castilho RO
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Lu F
Japanese Journal of Ophthalmology 2020; 64: 398-406 (IGR: 21-3)


90673 AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery
Chen JT
Molecules 2020; 25: (IGR: 21-3)


90747 Tissue plasminogen activator attenuates outflow facility reduction in mouse model of juvenile open angle glaucoma
Qureshi Z
Experimental Eye Research 2020; 199: 108179 (IGR: 21-3)


90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Iwata A
American Journal of Ophthalmology 2020; 220: 53-63 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Bettio F
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90673 AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery
Lin LT
Molecules 2020; 25: (IGR: 21-3)


90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Kawata H
Japanese Journal of Ophthalmology 2020; 64: 398-406 (IGR: 21-3)


89941 Current and new pharmacotherapeutic approaches for glaucoma
Katz LJ
Expert Opinion in Pharmacotherapy 2020; 21: 2027-2040 (IGR: 21-3)


89975 A comprehensive map of disease networks and molecular drug discoveries for glaucoma
Huang L
Scientific reports 2020; 10: 9719 (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Goulart GAC
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Foureaux G
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90673 AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery
Pao SI
Molecules 2020; 25: (IGR: 21-3)


90747 Tissue plasminogen activator attenuates outflow facility reduction in mouse model of juvenile open angle glaucoma
Danias J
Experimental Eye Research 2020; 199: 108179 (IGR: 21-3)


90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Iwata A
Japanese Journal of Ophthalmology 2020; 64: 398-406 (IGR: 21-3)


90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Odani-Kawabata N
American Journal of Ophthalmology 2020; 220: 53-63 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Picasso E
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Ferreira AJ
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90673 AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery
Chen YH
Molecules 2020; 25: (IGR: 21-3)


90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Odani-Kawabata N
Japanese Journal of Ophthalmology 2020; 64: 398-406 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Ruberto G
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Shams NK
American Journal of Ophthalmology 2020; 220: 53-63 (IGR: 21-3)


90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Shams N
Japanese Journal of Ophthalmology 2020; 64: 398-406 (IGR: 21-3)


90673 AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery
Lu DW
Molecules 2020; 25: (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Cronemberger S
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Briola A
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Gomes Faraco AA
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Mirabile A
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Paviglianiti A
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Pasinetti GM; Bianchi PE
Scientific reports 2020; 10: 10468 (IGR: 21-3)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Cao K
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Roy Chowdhury U
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Ishida T
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Kudgus RA
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Fang Y
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Rinkoski TA; Holman BH
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Shinohara K; Li X
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Bahler CK; Hann CR
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Nagaoka N
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Reid JM
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Ohno-Matsui K; Yoshida T
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Dosa PI; Fautsch MP
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Caruso C
International Ophthalmology 2019; 0: (IGR: 21-1)


84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Mehran NA
Eye 2020; 34: 72-88 (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Yagi-Yaguchi Y
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Hommer N
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


85112 Secondary Neuroprotection in Glaucoma Through the Concepts of Complementary Drug Therapy
Erb C
Klinische Monatsblätter für Augenheilkunde 2020; 237: 163-174 (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Nemoto E
International journal of molecular sciences 2019; 21: (IGR: 21-1)


85085 Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Montero-Oleas N
BMC complementary medicine and therapies 2020; 20: 12 (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Rocha LR
Aging Cell 2020; 19: e13089 (IGR: 21-1)


85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Wisely CE
Advances in Therapy 2020; 37: 1114-1123 (IGR: 21-1)


84522 Once Daily Pregabalin Eye Drops for Management of Glaucoma
Ibrahim MM
ACS nano 2019; 13: 13728-13744 (IGR: 21-1)


85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Chen W
Frontiers in pharmacology 2020; 11: 302 (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Yamamoto K
Scientific reports 2019; 9: 19288 (IGR: 21-1)


85225 Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis
Park CW
EXCLI journal 2020; 19: 187-200 (IGR: 21-1)


85224 Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Martin P
Clinical Ophthalmology 2020; 14: 885-896 (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Tan J
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Sanz-González SM
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129 (IGR: 21-1)


85224 Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Cohen A
Clinical Ophthalmology 2020; 14: 885-896 (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Kojima T
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


84522 Once Daily Pregabalin Eye Drops for Management of Glaucoma
Maria DN
ACS nano 2019; 13: 13728-13744 (IGR: 21-1)


85225 Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis
Han CT
EXCLI journal 2020; 19: 187-200 (IGR: 21-1)


85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Raga-Cervera J
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129 (IGR: 21-1)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Pacente L
International Ophthalmology 2019; 0: (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Kokubun T
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Wang X
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


85085 Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Arevalo-Rodriguez I
BMC complementary medicine and therapies 2020; 20: 12 (IGR: 21-1)


84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Sinha S
Eye 2020; 34: 72-88 (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Kojima S
International journal of molecular sciences 2019; 21: (IGR: 21-1)


85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Sheng H
Advances in Therapy 2020; 37: 1114-1123 (IGR: 21-1)


85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Yang X
Frontiers in pharmacology 2020; 11: 302 (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Kallab M
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Nguyen Huu VA
Aging Cell 2020; 19: e13089 (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Szegedi S
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


85085 Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Nuñez-González S
BMC complementary medicine and therapies 2020; 20: 12 (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Cai S
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Heah T
Advances in Therapy 2020; 37: 1114-1123 (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Sato K
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84489 New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Razeghinejad R
Eye 2020; 34: 72-88 (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Higa K
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


84522 Once Daily Pregabalin Eye Drops for Management of Glaucoma
Mishra SR
ACS nano 2019; 13: 13728-13744 (IGR: 21-1)


85225 Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis
Sakaguchi Y
EXCLI journal 2020; 19: 187-200 (IGR: 21-1)


85224 Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Uddin S
Clinical Ophthalmology 2020; 14: 885-896 (IGR: 21-1)


85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Aguirre Lipperheide M
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129 (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Palomino La Torre C
Aging Cell 2020; 19: e13089 (IGR: 21-1)


85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Fang J
Frontiers in pharmacology 2020; 11: 302 (IGR: 21-1)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Troiano P
International Ophthalmology 2019; 0: (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Sugiyama T
International journal of molecular sciences 2019; 21: (IGR: 21-1)


85224 Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Epelbaum L
Clinical Ophthalmology 2020; 14: 885-896 (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Jin D
International journal of molecular sciences 2019; 21: (IGR: 21-1)


85225 Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis
Lee J
EXCLI journal 2020; 19: 187-200 (IGR: 21-1)


85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Zhang Y
Frontiers in pharmacology 2020; 11: 302 (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
He F
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Akaishi T
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Ostacolo C
International Ophthalmology 2019; 0: (IGR: 21-1)


85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Zanón-Moreno V
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129 (IGR: 21-1)


85085 Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Viteri-García A
BMC complementary medicine and therapies 2020; 20: 12 (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Puchner S
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


84522 Once Daily Pregabalin Eye Drops for Management of Glaucoma
Guragain D
ACS nano 2019; 13: 13728-13744 (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Xu Q
Aging Cell 2020; 19: e13089 (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Dogru M
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


85019 Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
Kim T
Advances in Therapy 2020; 37: 1114-1123 (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Takai S
International journal of molecular sciences 2019; 21: (IGR: 21-1)


85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Zhu W
Frontiers in pharmacology 2020; 11: 302 (IGR: 21-1)


85225 Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis
Youn HY
EXCLI journal 2020; 19: 187-200 (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Stjepanek K
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Chiner V
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129 (IGR: 21-1)


85224 Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Josiah S
Clinical Ophthalmology 2020; 14: 885-896 (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Jabari M
Aging Cell 2020; 19: e13089 (IGR: 21-1)


85224 Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Josiah S
Clinical Ophthalmology 2020; 14: 885-896 (IGR: 21-1)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
D'Andrea L
International Ophthalmology 2019; 0: (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Zhang D
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


85085 Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Simancas-Racines D
BMC complementary medicine and therapies 2020; 20: 12 (IGR: 21-1)


84522 Once Daily Pregabalin Eye Drops for Management of Glaucoma
Wang X
ACS nano 2019; 13: 13728-13744 (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shimazaki A
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Ibrahim OM
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Li D
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Ramírez AI
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129 (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Krawczyk M
Aging Cell 2020; 19: e13089 (IGR: 21-1)


84522 Once Daily Pregabalin Eye Drops for Management of Glaucoma
Jablonski MM
ACS nano 2019; 13: 13728-13744 (IGR: 21-1)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Bartollino S
International Ophthalmology 2019; 0: (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Bauer M
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Bartollino S
International Ophthalmology 2019; 0: (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Shimizu T
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Nakamura M
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Maeda M
International journal of molecular sciences 2019; 21: (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Weinreb RN
Aging Cell 2020; 19: e13089 (IGR: 21-1)


84662 Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients
Costagliola C
International Ophthalmology 2019; 0: (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Werkmeister RM
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Zhu X
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Tsubota K
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Kohmoto R
International journal of molecular sciences 2019; 21: (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shiga Y
Scientific reports 2019; 9: 19288 (IGR: 21-1)


85017 Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients
Pinazo-Durán MD
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 120-129 (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Tsuda S
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84802 Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
Skowronska-Krawczyk D
Aging Cell 2020; 19: e13089 (IGR: 21-1)


84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Shimazaki J
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Ueki M
International journal of molecular sciences 2019; 21: (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Zhou L
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Schmetterer L
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Fan N
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Omodaka K
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Oku H
International journal of molecular sciences 2019; 21: (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Abensperg-Traun M; Garhöfer G
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Saya H
Scientific reports 2019; 9: 19288 (IGR: 21-1)


84885 C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
Liu X
Molecular therapy. Methods & clinical development 2020; 17: 143-155 (IGR: 21-1)


84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Ikeda T
International journal of molecular sciences 2019; 21: (IGR: 21-1)


84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Nakazawa T
Scientific reports 2019; 9: 19288 (IGR: 21-1)


85010 The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects-A Randomized Clinical Trial
Schmidl D
Clinical Pharmacology and Therapeutics 2020; 0: (IGR: 21-1)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Sinha S
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82273 Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595
Bonardi A
Expert Opinion on Therapeutic Patents 2019; 29: 753-759 (IGR: 20-4)


82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 781-792 (IGR: 20-4)


82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Lanza M
Frontiers in pharmacology 2019; 10: 1117 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Savinainen A
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Quaranta L
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Mittal N
International Journal of Biological Macromolecules 2019; 139: 1252-1262 (IGR: 20-4)


82535 Rho-kinase inhibitors in the management of glaucoma
Berrino E
Expert Opinion on Therapeutic Patents 2019; 29: 817-827 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Guo Y
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82315 Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018)
Angeli A
Expert Opinion on Therapeutic Patents 2019; 29: 793-803 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Savinainen A
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Chițu I
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82309 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension
Heo JH
Journal of managed care & specialty pharmacy 2019; 25: 1001-1010 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Uchida T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


82614 Sustained scleral stiffening in rats after a single genipin treatment
Hannon BG
Journal of the Royal Society, Interface / the Royal Society 2019; 16: 20190427 (IGR: 20-4)


82430 Latanoprost uptake and release from commercial contact lenses
Horne RR
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Krishnan A
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Ha JY
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)


82163 Novel therapies for glaucoma: a patent review (2013-2019)
Guglielmi P
Expert Opinion on Therapeutic Patents 2019; 29: 769-780 (IGR: 20-4)


82244 Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice
Millar JC
Experimental Eye Research 2019; 188: 107763 (IGR: 20-4)


82222 Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery
Sheppard JD
Clinical Ophthalmology 2019; 13: 1279-1288 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Fernández-Albarral JA
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Fakhraie G
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82877 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Aillegas NA
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Choi KJ
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Prusakiewicz JJ
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82430 Latanoprost uptake and release from commercial contact lenses
Rich JT
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Voinea LM
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82222 Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery
Singh IP
Clinical Ophthalmology 2019; 13: 1279-1288 (IGR: 20-4)


82163 Novel therapies for glaucoma: a patent review (2013-2019)
Carradori S
Expert Opinion on Therapeutic Patents 2019; 29: 769-780 (IGR: 20-4)


82273 Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 753-759 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Lee D
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Lu F
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Na YJ
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Mirghorbani M
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Altamimi ASA
Expert Opinion on Therapeutic Patents 2019; 29: 781-792 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Mehrabian Z
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Kaur G
International Journal of Biological Macromolecules 2019; 139: 1252-1262 (IGR: 20-4)


82535 Rho-kinase inhibitors in the management of glaucoma
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 817-827 (IGR: 20-4)


82244 Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice
Savinainen A
Experimental Eye Research 2019; 188: 107763 (IGR: 20-4)


82309 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension
Rascati KL
Journal of managed care & specialty pharmacy 2019; 25: 1001-1010 (IGR: 20-4)


82315 Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018)
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 793-803 (IGR: 20-4)


82877 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Tártara LI
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-4)


82614 Sustained scleral stiffening in rats after a single genipin treatment
Schwaner SA
Journal of the Royal Society, Interface / the Royal Society 2019; 16: 20190427 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Kocab AJ
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82244 Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice
Savinainen A
Experimental Eye Research 2019; 188: 107763 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Ramírez AI
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Sung MS
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)


82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Gironi Carnevale UA
Frontiers in pharmacology 2019; 10: 1117 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Ueta T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Riva I
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Johnson MA
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82309 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension
Wilson JP
Journal of managed care & specialty pharmacy 2019; 25: 1001-1010 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Biagioli E
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82244 Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice
Josiah S
Experimental Eye Research 2019; 188: 107763 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Kolomeyer NN
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Park SW
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Honjo M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


82614 Sustained scleral stiffening in rats after a single genipin treatment
Boazak EM
Journal of the Royal Society, Interface / the Royal Society 2019; 16: 20190427 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Oswald J
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Katz LJ
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82244 Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice
Josiah S
Experimental Eye Research 2019; 188: 107763 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Kolomeyer NN
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82877 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Caballero G
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Kawata H
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Mele L
Frontiers in pharmacology 2019; 10: 1117 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Jung WH
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
de Hoz R
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Carta F
Expert Opinion on Therapeutic Patents 2019; 29: 781-792 (IGR: 20-4)


82430 Latanoprost uptake and release from commercial contact lenses
Bradley MW
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Zacks DN
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Istrate S
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82163 Novel therapies for glaucoma: a patent review (2013-2019)
Campestre C
Expert Opinion on Therapeutic Patents 2019; 29: 769-780 (IGR: 20-4)


82244 Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice
Pang IH
Experimental Eye Research 2019; 188: 107763 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Marshak-Rothstein A
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Mollazadeh A
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82309 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension
Lawson KA
Journal of managed care & specialty pharmacy 2019; 25: 1001-1010 (IGR: 20-4)


82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Bifani Sconocchia M
Frontiers in pharmacology 2019; 10: 1117 (IGR: 20-4)


82877 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Campana V
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-4)


82430 Latanoprost uptake and release from commercial contact lenses
Pitt WG
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
López-Villarín N
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82163 Novel therapies for glaucoma: a patent review (2013-2019)
Poce G
Expert Opinion on Therapeutic Patents 2019; 29: 769-780 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Park SB
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Myers JS
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Tanaka Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Vrapciu A
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Albers DS
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Spencer E
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82614 Sustained scleral stiffening in rats after a single genipin treatment
Gerberich BG
Journal of the Royal Society, Interface / the Royal Society 2019; 16: 20190427 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Ciuluvică RC
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Kang S
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Lou Z
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Gregory-Ksander M
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82309 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension
Richards KM
Journal of managed care & specialty pharmacy 2019; 25: 1001-1010 (IGR: 20-4)


82877 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Allemandi DA
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-4)


82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Bartollino S
Frontiers in pharmacology 2019; 10: 1117 (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Vahedian Z
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Rulli E
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82614 Sustained scleral stiffening in rats after a single genipin treatment
Winger EJ
Journal of the Royal Society, Interface / the Royal Society 2019; 16: 20190427 (IGR: 20-4)


82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Razeghinejad R
Expert Opinion in Pharmacotherapy 2020; 21: 39-45 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Salobrar-García E
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Bartollino S
Frontiers in pharmacology 2019; 10: 1117 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Yamamura K
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Rich CC
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82877 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Palma SD
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-4)


82614 Sustained scleral stiffening in rats after a single genipin treatment
Prausnitz MR
Journal of the Royal Society, Interface / the Royal Society 2019; 16: 20190427 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Cohen ML
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Nam HJ
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Odani-Kawabata N
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Baumgartner RA
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
López-Cuenca I
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Costagliola C
Frontiers in pharmacology 2019; 10: 1117 (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Zarei R
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Tudosescu R
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Poli D
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82309 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension
Nair R
Journal of managed care & specialty pharmacy 2019; 25: 1001-1010 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Licastro E
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Eslami Y
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Shams NK
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550 (IGR: 20-4)


82614 Sustained scleral stiffening in rats after a single genipin treatment
Ethier CR
Journal of the Royal Society, Interface / the Royal Society 2019; 16: 20190427 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Legramandi L
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Rashidzadeh H
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Bernstein SL
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Ahn JH; Kim KY
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Mohammadi M
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol

Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Josiah S
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Inarejos-García AM
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Josiah S
Experimental Eye Research 2019; 189: 107836 (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Hamzeh N
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Almodóvar P; Pinazo-Durán MD
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Masoomi A
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Ramírez JM; Salazar JJ
International journal of molecular sciences 2019; 20: (IGR: 20-4)


81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Angel Aillegas N
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-3)


80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M
Journal of Glaucoma 2019; 28: 375-385 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Fan KR
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Ekicier Acar S
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


80720 Causative glaucoma treatment: promising targets and delivery systems
Mietzner R
Drug Discovery Today 2019; 24: 1606-1613 (IGR: 20-3)


81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Coman IC
Romanian journal of ophthalmology 2019; 63: 135-141 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Sarıcaoğlu MS
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Al Hammoud M
Romanian journal of ophthalmology 2019; 63: 135-141 (IGR: 20-3)


81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Tártara LI
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-3)


80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Lu F
Journal of Glaucoma 2019; 28: 375-385 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Baskaran M
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80720 Causative glaucoma treatment: promising targets and delivery systems
Breunig M
Drug Discovery Today 2019; 24: 1606-1613 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Tudosescu R
Romanian journal of ophthalmology 2019; 63: 135-141 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Nongpiur ME
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Kawata H
Journal of Glaucoma 2019; 28: 375-385 (IGR: 20-3)


81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Caballero G
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Çolak A
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Htoon HM
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Campana V
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Aktaş Z
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Iancu R
Romanian journal of ophthalmology 2019; 63: 135-141 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Iwata A
Journal of Glaucoma 2019; 28: 375-385 (IGR: 20-3)


81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Barac C
Romanian journal of ophthalmology 2019; 63: 135-141 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Clark KL; Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Liu K
Journal of Glaucoma 2019; 28: 375-385 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
De Leon JMS
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Allemandi DA
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Sepici Dinçel A
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Odani-Kawabata N
Journal of Glaucoma 2019; 28: 375-385 (IGR: 20-3)


81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Popa CA
Romanian journal of ophthalmology 2019; 63: 135-141 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Stamer WD
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Palma SD
Pharmacological Reports 2019; 71: 794-797 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Perera SA; Belkin M
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Tao G
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Shams NK
Journal of Glaucoma 2019; 28: 375-385 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Fan S
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Aung T
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Toris CB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277 (IGR: 20-3)


79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Dang Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109 (IGR: 20-2)


79393 Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval
Duggan S
Drugs 2018; 78: 1925-1929 (IGR: 20-2)


79787 Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
Martucci A
Neural Regeneration Research 2019; 14: 197-200 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Kang X
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Hu C
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Lin C
Eye 2019; 33: 777-784 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kahook MY
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Fingeret M
Clinical and Experimental Optometry 2019; 102: 541-550 (IGR: 20-2)


79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Sun J
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Shen Y
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wu F
Eye 2019; 33: 777-784 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Serle JB
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Gaddie IB
Clinical and Experimental Optometry 2019; 102: 541-550 (IGR: 20-2)


79787 Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
Nucci C
Neural Regeneration Research 2019; 14: 197-200 (IGR: 20-2)


79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Wang C; Shah P
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109 (IGR: 20-2)


79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Zhang Y
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Mah FS
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Zhao H
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Zheng T
Eye 2019; 33: 777-784 (IGR: 20-2)


80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Bloomenstein M
Clinical and Experimental Optometry 2019; 102: 541-550 (IGR: 20-2)


79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Chen J
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wang X
Eye 2019; 33: 777-784 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kim T
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Waxman S
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Wang Z
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Chen Y
Eye 2019; 33: 777-784 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Raizman MB
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Guan W
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Loewen RT
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109 (IGR: 20-2)


79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Lei Y
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wu X
Eye 2019; 33: 777-784 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Ge R
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Heah T
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Loewen NA
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109 (IGR: 20-2)


79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Sun X
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Wang R
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Deng Y
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Ramirez-Davis N
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Tai X
Journal of Southern Medical University 2018; 38: 1389-1394 (IGR: 20-2)


79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kopczynski CC; Usner DW; Novack GD;
American Journal of Ophthalmology 2019; 200: 130-137 (IGR: 20-2)


78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Matsou A
Expert Opinion on Investigational Drugs 2018; 27: 777-785 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Weinreb RN
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79132 Rho-kinase (ROCK) Inhibitors- A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Abbhi V
Current Medicinal Chemistry 2018; 0: (IGR: 20-1)


78351 Glaucoma Drugs in the Pipeline
Kaufman PL
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)


78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Moshirfar M
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111 (IGR: 20-1)


79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Ashwinbalaji S
Scientific reports 2018; 8: 15472 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Pitha I
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Komizo T
Japanese Journal of Ophthalmology 2019; 63: 40-45 (IGR: 20-1)


78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Parker L
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111 (IGR: 20-1)


79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Ono T
Japanese Journal of Ophthalmology 2019; 63: 40-45 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Oglesby E
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Anastasopoulos E
Expert Opinion on Investigational Drugs 2018; 27: 777-785 (IGR: 20-1)


79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Senthilkumari S
Scientific reports 2018; 8: 15472 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Liebmann JM
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79132 Rho-kinase (ROCK) Inhibitors- A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Piplani P
Current Medicinal Chemistry 2018; 0: (IGR: 20-1)


78351 Glaucoma Drugs in the Pipeline
Mohr ME
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Chow A
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Gowripriya C
Scientific reports 2018; 8: 15472 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Cioffi GA
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Birdsong OC
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111 (IGR: 20-1)


79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Yagi A
Japanese Journal of Ophthalmology 2019; 63: 40-45 (IGR: 20-1)


78351 Glaucoma Drugs in the Pipeline
Riccomini SP
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)


79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Krishnadas S
Scientific reports 2018; 8: 15472 (IGR: 20-1)


79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Miyata K
Japanese Journal of Ophthalmology 2019; 63: 40-45 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Kimball E
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78351 Glaucoma Drugs in the Pipeline
Rasmussen CA
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Goldberg I
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Kimball E
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Ronquillo YC
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111 (IGR: 20-1)


79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Gabelt BAT
Scientific reports 2018; 8: 15472 (IGR: 20-1)


79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Aihara M
Japanese Journal of Ophthalmology 2019; 63: 40-45 (IGR: 20-1)


78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Hofstedt D
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Pease ME
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Brandt JD
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Schaub J
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Kaufman PL
Scientific reports 2018; 8: 15472 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Johnson CA
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Shah TJ
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Schaub J
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Zangwill LM
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Quigley H
Translational vision science & technology 2018; 7: 6 (IGR: 20-1)


79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Muthukkaruppan V
Scientific reports 2018; 8: 15472 (IGR: 20-1)


78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Gomez AT; Hoopes PCS
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Schneider S; Badger H; Bejanian M
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78293 Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension
Kopczynski CC
Drugs of Today 2018; 54: 467-478 (IGR: 19-4)


78168 Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
Mahalingam K
Indian Journal of Ophthalmology 2018; 66: 1104-1108 (IGR: 19-4)


78256 Old and New Drug Classes Expanding To Include Glaucoma Treatments
Kish T
P and T 2018; 43: 489-502 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Iwamura R
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78148 Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision
Sharif NA
Neural Regeneration Research 2018; 13: 1145-1150 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Fuwa M
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78116 Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
Tanna AP
Ophthalmology 2018; 125: 1741-1756 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Jacob TF
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Iwamura R
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78116 Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
Johnson M
Ophthalmology 2018; 125: 1741-1756 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Singh V
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78168 Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
Chaurasia AK
Indian Journal of Ophthalmology 2018; 66: 1104-1108 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Tanaka M
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78293 Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension
Heah T
Drugs of Today 2018; 54: 467-478 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Toris CB
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Okanari E
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Dixit M
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78168 Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
Gowtham L
Indian Journal of Ophthalmology 2018; 66: 1104-1108 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Fan S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Ginsburg-Shmuel T
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Kirihara T
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Taniguchi T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78168 Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
Gupta S
Indian Journal of Ophthalmology 2018; 66: 1104-1108 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Odani-Kawabata N
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Ichikawa M
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Fonseca B
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78168 Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
Somarajan BI; Velpandian T
Indian Journal of Ophthalmology 2018; 66: 1104-1108 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Pintor J
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Shams N
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Odani-Kawabata N
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Youdim MBH
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Iwamura R
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Yoneda K
Journal of Medicinal Chemistry 2018; 61: 6869-6891 (IGR: 19-4)


78168 Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
Sihota R
Indian Journal of Ophthalmology 2018; 66: 1104-1108 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Iwamura R; Yoneda K
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78168 Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
Gupta V
Indian Journal of Ophthalmology 2018; 66: 1104-1108 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Major DT; Weinreb O
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Matsugi T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


78127 A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Fischer B
Purinergic signalling 2018; 14: 271-284 (IGR: 19-4)


78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Shams NK; Zhang JZ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537 (IGR: 19-4)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Prasanna G
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Stacy R
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Impagnatiello F
British Journal of Pharmacology 2019; 176: 1079-1089 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Gu L
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Stack T
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)


77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Miller S
Pharmaceuticals (Basel, Switzerland) 2018; 11: (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Zhang QL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


77175 Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil
Inoue K
Japanese Journal of Ophthalmology 2018; 62: 508-516 (IGR: 19-3)


77101 Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Hoy SM
Drugs 2018; 78: 773-780 (IGR: 19-3)


76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Hampel U
International Ophthalmology 2019; 39: 847-851 (IGR: 19-3)


76503 Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma
Honjo M
Japanese Journal of Ophthalmology 2018; 62: 109-126 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Dibas A
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Stacy R
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76551 Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
Kusuhara S
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 809-814 (IGR: 19-3)


76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Kazemi A
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386 (IGR: 19-3)


77039 The nitric oxide-guanylate cyclase pathway and glaucoma
Wareham LK
Nitric oxide : biology and chemistry 2018; 77: 75-87 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Wang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Kulkarni S
Pharmaceuticals (Basel, Switzerland) 2018; 11: (IGR: 19-3)


77175 Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil
Ishida K
Japanese Journal of Ophthalmology 2018; 62: 508-516 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Ferrara L
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77039 The nitric oxide-guanylate cyclase pathway and glaucoma
Buys ES
Nitric oxide : biology and chemistry 2018; 77: 75-87 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Millar C
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Träger K
International Ophthalmology 2019; 39: 847-851 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Kwong JMK
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76503 Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma
Tanihara H
Japanese Journal of Ophthalmology 2018; 62: 109-126 (IGR: 19-3)


76551 Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
Katsuyama A
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 809-814 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Huttner K
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
McLaren JW
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386 (IGR: 19-3)


76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Vahabikashi A
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)


76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Bastia E
British Journal of Pharmacology 2019; 176: 1079-1089 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Adams C
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Yadegari D
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Johnson M
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)


76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Kopczynski CC
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386 (IGR: 19-3)


77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Ciesielski A
Pharmaceuticals (Basel, Switzerland) 2018; 11: (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Watts J
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Almirante N
British Journal of Pharmacology 2019; 176: 1079-1089 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Jiang Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76551 Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
Matsumiya W
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 809-814 (IGR: 19-3)


77039 The nitric oxide-guanylate cyclase pathway and glaucoma
Sappington RM
Nitric oxide : biology and chemistry 2018; 77: 75-87 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Al-Farra A
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Adams C
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Liu H
International Ophthalmology 2019; 39: 847-851 (IGR: 19-3)


77175 Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil
Tomita G
Japanese Journal of Ophthalmology 2018; 62: 508-516 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Peace J
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Yorio T
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Yu F
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76551 Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
Nakamura M
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 809-814 (IGR: 19-3)


76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Teister J
International Ophthalmology 2019; 39: 847-851 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Ehara T
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
A-Tuya
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Scott E
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)


76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Heah TG
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386 (IGR: 19-3)


76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Brambilla S
British Journal of Pharmacology 2019; 176: 1079-1089 (IGR: 19-3)


77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Nikas SP
Pharmaceuticals (Basel, Switzerland) 2018; 11: (IGR: 19-3)


76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Duquesroix B
British Journal of Pharmacology 2019; 176: 1079-1089 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Dongmei
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Li B
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Novack GD
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386 (IGR: 19-3)


77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Mackie K
Pharmaceuticals (Basel, Switzerland) 2018; 11: (IGR: 19-3)


76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Grus F
International Ophthalmology 2019; 39: 847-851 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Wirta D
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Caprioli J
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Sit AJ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Walters T
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Piri N
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Yang L
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Kothe AC
British Journal of Pharmacology 2019; 176: 1079-1089 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Li LL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Makriyannis A
Pharmaceuticals (Basel, Switzerland) 2018; 11: (IGR: 19-3)


76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Prokosch-Willing V
International Ophthalmology 2019; 39: 847-851 (IGR: 19-3)


76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Bergamini MVW
British Journal of Pharmacology 2019; 176: 1079-1089 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Xiang C
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Lu ZJ
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Sall K
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Straiker A
Pharmaceuticals (Basel, Switzerland) 2018; 11: (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Seaman J
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Chang H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Ng CTH
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Zhang TZ
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Ni X
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Kim S
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Prasanna G
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Towler C; Topley T
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Mogi M; Adams C; Adams C
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
McAllister C
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Yan JH
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Ghosh M; Newton R; Newton R
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Wald M; He Y
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Stacy R; Stacy R; Rice DS
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Newton R; Newton R
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Mogi M
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716 (IGR: 19-3)


77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Kolega R; Grosskreutz C
American Journal of Ophthalmology 2018; 192: 113-123 (IGR: 19-3)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Giannaccini M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Weinreb RN
Journal of Glaucoma 2018; 27: 7-15 (IGR: 19-2)


75286 Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits
Loma P
Journal of optometry 2018; 11: 69-74 (IGR: 19-2)


75045 Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Williams PA
Journal of Glaucoma 2017; 26: 1161-1168 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Serle JB
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Kim J
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
Yu AK
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Pfeiffer N
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Kudisch M
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
Datta S
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Voykov B
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Liebmann JM
Journal of Glaucoma 2018; 27: 7-15 (IGR: 19-2)


75286 Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits
Guzman-Aranguez A
Journal of optometry 2018; 11: 69-74 (IGR: 19-2)


75045 Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Harder JM
Journal of Glaucoma 2017; 26: 1161-1168 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Katz LJ
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Usai A
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Martin KR
Journal of Glaucoma 2018; 27: 7-15 (IGR: 19-2)


75045 Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
John SWM
Journal of Glaucoma 2017; 26: 1161-1168 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
McLaurin E
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Renieri G
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75286 Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits
de Lara MJP
Journal of optometry 2018; 11: 69-74 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
da Silva NRK
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
McMackin MZ
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Chiellini F
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Heah T
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Asada H
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75286 Beta2 adrenergic receptor silencing change intraocular pressure in New Zealand rabbits
Pintor J
Journal of optometry 2018; 11: 69-74 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Bell K
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
Cortopassi GA
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Guadagni V
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Kaufman PL
Journal of Glaucoma 2018; 27: 7-15 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Andreazzoli M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Vittitow JL
Journal of Glaucoma 2018; 27: 7-15 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Ramirez-Davis N
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Aya-Shibuya E
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Richter P; Weigel M
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Usner DW
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Bloomer MM
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Ori M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Thieme H
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Novack GD
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Pasqualetti M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Mudumba S
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Dente L
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Kopczynski CC
American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Bhisitkul RB
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Wilhelm B
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Raffa V
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Desai TA
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Lorenz K
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


75444 Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

American Journal of Ophthalmology 2018; 186: 116-127 (IGR: 19-2)


75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Feindor M; Wosikowski K; Janicot M; Päckert D; Römmich R; Mala C; Fettes P; Leo E
PLoS ONE 2017; 12: e0188899 (IGR: 19-2)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Nakamura O
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74106 The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
Cavet ME
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 52-60 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Do YJ
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Yasuda M
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Jain A
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74421 Novel therapeutics in glaucoma management
Bucolo C
Current Neuropharmacology 2017; 0: (IGR: 19-1)


74704 Baicalin alleviates oxidative stress damage in trabecular meshwork cells in vitro
Gong L
Naunyn-Schmiedeberg's archives of pharmacology 2018; 391: 51-58 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Seong H
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Leopold SA
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74773 Impact of Topically Administered Steroids, Antibiotics, and Sodium Hyaluronate on Bleb-Related Infection Onset: The Japan Glaucoma Society Survey of Bleb-Related Infection Report 4
Sagara H
Journal of Ophthalmology 2017; 2017: 7062565 (IGR: 19-1)


74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Kawaguchi I
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Blanco R
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Liu H
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74834 Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation
Gong Y
Oncotarget 2017; 8: 105126-105136 (IGR: 19-1)


74473 Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway
O'Callaghan J
Expert Opinion on Therapeutic Targets 2017; 21: 1037-1050 (IGR: 19-1)


74426 Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis
Nuzzi R
Frontiers in neuroscience 2017; 11: 494 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Wan P
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74710 The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats
Uchida T
Investigative Ophthalmology and Visual Science 2017; 58: 5584-5593 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Gao FJ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74124 ROCK inhibitors for the treatment of ocular diseases
Nourinia R
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
He S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74342 Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma
Inoue T
Expert Opinion in Pharmacotherapy 2017; 18: 1669-1673 (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Mysona BA
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Liu X
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703 (IGR: 19-1)


74658 Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model
Wang JW
International Journal of Ophthalmology 2017; 10: 1483-1489 (IGR: 19-1)


74342 Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma
Tanihara H
Expert Opinion in Pharmacotherapy 2017; 18: 1669-1673 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Zhang SH
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Stankowska DL
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Anders F
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Sul JW
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74426 Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis
Tridico F
Frontiers in neuroscience 2017; 11: 494 (IGR: 19-1)


74658 Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model
Liu YM
International Journal of Ophthalmology 2017; 10: 1483-1489 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Martínez-Navarrete G
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74710 The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats
Honjo M
Investigative Ophthalmology and Visual Science 2017; 58: 5584-5593 (IGR: 19-1)


74704 Baicalin alleviates oxidative stress damage in trabecular meshwork cells in vitro
Zhu J
Naunyn-Schmiedeberg's archives of pharmacology 2018; 391: 51-58 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Ryu J
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Takayama K
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Zhao J
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Zeilbeck LF
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Yang Y
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703 (IGR: 19-1)


74473 Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway
Cassidy PS
Expert Opinion on Therapeutic Targets 2017; 21: 1037-1050 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Moritoh S
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Zode G
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74421 Novel therapeutics in glaucoma management
Platania CBM
Current Neuropharmacology 2017; 0: (IGR: 19-1)


74106 The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
DeCory HH
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 52-60 (IGR: 19-1)


74773 Impact of Topically Administered Steroids, Antibiotics, and Sodium Hyaluronate on Bleb-Related Infection Onset: The Japan Glaucoma Society Survey of Bleb-Related Infection Report 4
Yamamoto T
Journal of Ophthalmology 2017; 2017: 7062565 (IGR: 19-1)


74834 Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation
Yin JY
Oncotarget 2017; 8: 105126-105136 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Su W
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74124 ROCK inhibitors for the treatment of ocular diseases
Nakao S
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)


74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Kobayashi A
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)


74710 The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats
Yamagishi R
Investigative Ophthalmology and Visual Science 2017; 58: 5584-5593 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Thanos S
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74834 Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation
Tong BD
Oncotarget 2017; 8: 105126-105136 (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Smith S
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Kasetti RB
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74124 ROCK inhibitors for the treatment of ocular diseases
Zandi S
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)


74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Kanda T
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Ellis DZ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Higashide T
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)


74421 Novel therapeutics in glaucoma management
Drago F
Current Neuropharmacology 2017; 0: (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Zhang Y
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74658 Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model
Zhao XF
International Journal of Ophthalmology 2017; 10: 1483-1489 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Xu P
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Jang KH
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Sato K
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Guo X
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703 (IGR: 19-1)


74773 Impact of Topically Administered Steroids, Antibiotics, and Sodium Hyaluronate on Bleb-Related Infection Onset: The Japan Glaucoma Society Survey of Bleb-Related Infection Report 4
Imaizumi K
Journal of Ophthalmology 2017; 2017: 7062565 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Weber G
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Yoo WS
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74473 Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway
Humphries P
Expert Opinion on Therapeutic Targets 2017; 21: 1037-1050 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Valiente-Soriano FJ
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Seitz R
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Avilés-Trigueros M
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Liu L
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Yang BQ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Maekawa S
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Bollinger KE
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74124 ROCK inhibitors for the treatment of ocular diseases
Safi S
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kang NS
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74773 Impact of Topically Administered Steroids, Antibiotics, and Sodium Hyaluronate on Bleb-Related Infection Onset: The Japan Glaucoma Society Survey of Bleb-Related Infection Report 4
Sekiryu T
Journal of Ophthalmology 2017; 2017: 7062565 (IGR: 19-1)


74834 Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation
Zeng JX
Oncotarget 2017; 8: 105126-105136 (IGR: 19-1)


74658 Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model
Zhang H
International Journal of Ophthalmology 2017; 10: 1483-1489 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Kim SJ
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Takeji Y
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Ran FA
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74421 Novel therapeutics in glaucoma management
Reibaldi M
Current Neuropharmacology 2017; 0: (IGR: 19-1)


74710 The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats
Aihara M
Investigative Ophthalmology and Visual Science 2017; 58: 5584-5593 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Mann C
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Li Z
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Krishnamoorthy RR
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Taguchi M
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Deng C
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Sakurai K
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Yorio T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Yan W
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Pérez-Rico C
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Murayama N
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74421 Novel therapeutics in glaucoma management
Bonfiglio V
Current Neuropharmacology 2017; 0: (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Bösl MR
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74124 ROCK inhibitors for the treatment of ocular diseases
Hafezi-Moghadam A
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)


74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Wu K
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703 (IGR: 19-1)


74834 Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation
Xiong W
Oncotarget 2017; 8: 105126-105136 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Han YS
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Someya H
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Liu A
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kim YH
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Zhang R
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74421 Novel therapeutics in glaucoma management
Avitabile T
Current Neuropharmacology 2017; 0: (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Cheng Y
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74124 ROCK inhibitors for the treatment of ocular diseases
Ahmadieh H
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kim YG
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Zhuo Y
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Yu M
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703 (IGR: 19-1)


74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Kawaguchi C
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Park JM
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Himori N
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Sharma TP
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Jägle H
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Takeuchi M
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Serrano-Puebla A
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Grus FH
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Kang SS
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Omodaka K
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74421 Novel therapeutics in glaucoma management
Uva M
Current Neuropharmacology 2017; 0: (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Bugge K
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Pfeiffer N
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kim E
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Sugiyama K
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Boya P
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Zhou XJ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Fuchshofer R
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Searby CC
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Sogon T
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74535 Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3
Seo SW
Current Eye Research 2017; 42: 1650-1658 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Tamm ER
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Prokosch-Willing V
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Huang WJ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Fernández E
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Wang M
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Nakazawa T
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Vidal-Sanz M
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Ohlmann A
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Fingert JH
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Chen JY
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Zhang F
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
de la Villa P
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Sun XH
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74512 CRISPR-Cas9-based treatment of myocilin-associated glaucoma
Clark AF; Sheffield VC
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: 11199-11204 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Wu JH
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


72668 Peeking into Sigma-1 Receptor Functions Through the Retina
Mavlyutov TA
Adv Exp Med Biol 2017; 964: 285-297 (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Adelli GR
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Nakano Y
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72682 Grooved Glaucoma Drainage Devices That Continuously Deliver Cyclosporine A Decrease Postsurgical Scar Formation in Rabbit Eyes
Dai Z
Investigative Ophthalmology and Visual Science 2017; 58: 1692-1701 (IGR: 18-4)


72730 Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
Andrés-Guerrero V
Advances in Therapy 2017; 34: 1049-1069 (IGR: 18-4)


72716 Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients
Haug NA
Addictive behaviors 2017; 72: 14-20 (IGR: 18-4)


72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Matsumura R
Clinical Drug Investigation 2017; 37: 535-539 (IGR: 18-4)


72748 Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma
Lu LJ
The Yale journal of biology and medicine 2017; 90: 111-118 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Mysona B
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Yu-Wai-Man C
Scientific reports 2017; 7: 518 (IGR: 18-4)


73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Natesan S
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Lin CW
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72791 Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera
Campbell IC
Journal of the Royal Society, Interface / the Royal Society 2017; 14: (IGR: 18-4)


72713 An introduction to DARC technology
Ahmad SS
Saudi Journal of Ophthalmology 2017; 31: 38-41 (IGR: 18-4)


72748 Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma
Tsai JC
The Yale journal of biology and medicine 2017; 90: 111-118 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Spencer-Dene B
Scientific reports 2017; 7: 518 (IGR: 18-4)


72791 Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera
Hannon BG
Journal of the Royal Society, Interface / the Royal Society 2017; 14: (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Shimazawa M
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72682 Grooved Glaucoma Drainage Devices That Continuously Deliver Cyclosporine A Decrease Postsurgical Scar Formation in Rabbit Eyes
Yu X
Investigative Ophthalmology and Visual Science 2017; 58: 1692-1701 (IGR: 18-4)


73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Pandian S
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Sherman B
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72730 Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
García-Feijoo J
Advances in Therapy 2017; 34: 1049-1069 (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Bhagav P
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Inoue T
Clinical Drug Investigation 2017; 37: 535-539 (IGR: 18-4)


72668 Peeking into Sigma-1 Receptor Functions Through the Retina
Guo LW
Adv Exp Med Biol 2017; 964: 285-297 (IGR: 18-4)


72716 Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients
Padula CB
Addictive behaviors 2017; 72: 14-20 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Kansara N
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Matsumura A
Clinical Drug Investigation 2017; 37: 535-539 (IGR: 18-4)


72791 Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera
Read AT
Journal of the Royal Society, Interface / the Royal Society 2017; 14: (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Ojino K
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Zhao J
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Taskar P
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


72682 Grooved Glaucoma Drainage Devices That Continuously Deliver Cyclosporine A Decrease Postsurgical Scar Formation in Rabbit Eyes
Sun J
Investigative Ophthalmology and Visual Science 2017; 58: 1692-1701 (IGR: 18-4)


72716 Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients
Sottile JE
Addictive behaviors 2017; 72: 14-20 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Moore LA
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72748 Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma
Liu J
The Yale journal of biology and medicine 2017; 90: 111-118 (IGR: 18-4)


73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Ponnusamy C
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)


72730 Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
Konstas AG
Advances in Therapy 2017; 34: 1049-1069 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Lee RM
Scientific reports 2017; 7: 518 (IGR: 18-4)


72728 Efficacy of Ripasudil as a Second-line Medication in Addition to a Prostaglandin Analog in Patients with Exfoliation Glaucoma: A Pilot Study
Tanihara H
Clinical Drug Investigation 2017; 37: 535-539 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Bollinger K
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


72716 Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients
Vandrey R
Addictive behaviors 2017; 72: 14-20 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Hutchings K
Scientific reports 2017; 7: 518 (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Hingorani T
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Palanichamy R
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)


72791 Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera
Sherwood JM
Journal of the Royal Society, Interface / the Royal Society 2017; 14: (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Izawa H
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72682 Grooved Glaucoma Drainage Devices That Continuously Deliver Cyclosporine A Decrease Postsurgical Scar Formation in Rabbit Eyes
Sun X
Investigative Ophthalmology and Visual Science 2017; 58: 1692-1701 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Laethem CL
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72716 Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients
Heinz AJ
Addictive behaviors 2017; 72: 14-20 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Lu DW
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72791 Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera
Schwaner SA
Journal of the Royal Society, Interface / the Royal Society 2017; 14: (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Lisabeth EM
Scientific reports 2017; 7: 518 (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Pettaway S
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Takeuchi H
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Muthusamy S
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Pattabiraman PP
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Kandasamy R
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)


72791 Quantification of the efficacy of collagen cross-linking agents to induce stiffening of rat sclera
Ethier CR
Journal of the Royal Society, Interface / the Royal Society 2017; 14: (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Gul W
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


72716 Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients
Bonn-Miller MO
Addictive behaviors 2017; 72: 14-20 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Treisman R
Scientific reports 2017; 7: 518 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Inoue Y; Tsuruma K
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Rao PV
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Elsohly MA
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Bailly M
Scientific reports 2017; 7: 518 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
deLong MA
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Larsen SD
Scientific reports 2017; 7: 518 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Hara H
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Repka MA; Majumdar S
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Neubig RR
Scientific reports 2017; 7: 518 (IGR: 18-4)


73280 Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Kopczynski CC
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 40-51 (IGR: 18-4)


72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Khaw PT
Scientific reports 2017; 7: 518 (IGR: 18-4)


71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Patil A
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)


71590 Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery
Suh W
J Korean Med Sci 2017; 32: 666-671 (IGR: 18-3)


71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Maria DN
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Lambert WS
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Luo X
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71257 Open-Angle Glaucoma: Drug Development Pipeline during the Last 20 Years (1995-2015)
Vicente A
Ophthalmic Research 2017; 57: 201-207 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Liu XF
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Chandrawati R
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71291 The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling
Peng J
Biochemical and Biophysical Research Communications 2017; 484: 474-479 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Yu Y
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71257 Open-Angle Glaucoma: Drug Development Pipeline during the Last 20 Years (1995-2015)
Prud'homme S
Ophthalmic Research 2017; 57: 201-207 (IGR: 18-3)


71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Singh S
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)


71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Abd-Elgawad AH
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Hao JL
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71291 The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling
Zhou H
Biochemical and Biophysical Research Communications 2017; 484: 474-479 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Chang JY
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71590 Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery
Han KE
J Korean Med Sci 2017; 32: 666-671 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Carlson BJ
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Reina-Torres E
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71590 Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery
Han JR
J Korean Med Sci 2017; 32: 666-671 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Xiang Z
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Formichella CR
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71291 The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling
Kuang G
Biochemical and Biophysical Research Communications 2017; 484: 474-479 (IGR: 18-3)


71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Opere C
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)


71257 Open-Angle Glaucoma: Drug Development Pipeline during the Last 20 Years (1995-2015)
Ferreira J
Ophthalmic Research 2017; 57: 201-207 (IGR: 18-3)


71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Soliman OA
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Xie T
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71257 Open-Angle Glaucoma: Drug Development Pipeline during the Last 20 Years (1995-2015)
Abegão Pinto L
Ophthalmic Research 2017; 57: 201-207 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Mukhtar NJ
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Dash A
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Jumeaux C
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
El-Dahan MS
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)


71291 The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling
Xie L
Biochemical and Biophysical Research Communications 2017; 484: 474-479 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Wu H
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Sappington RM
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Jablonski MM
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Zhang W
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Ahlem C
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71257 Open-Angle Glaucoma: Drug Development Pipeline during the Last 20 Years (1995-2015)
Stalmans I
Ophthalmic Research 2017; 57: 201-207 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Sherwood JM
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Ramakrishna S
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71291 The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling
Tian T; Liu R
Biochemical and Biophysical Research Communications 2017; 484: 474-479 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Stamer WD
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Calkins DJ
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Wang Y
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Malik TH
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Zelikin AN
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Lu CW
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
So KF
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Zhou DD
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Zhang Z
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Overby DR; Stevens MM
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Xu Y
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Kimura A
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70557 Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma
Fonseca B
Purinergic signalling 2017; 13: 171-177 (IGR: 18-2)


70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Miller Ellis E
British Journal of Ophthalmology 2017; 101: 796-800 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Terao E
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70838 The arguments for and against cannabinoids application in glaucomatous retinopathy
Panahi Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2017; 86: 620-627 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Blangetti M
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70151 Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research
Rao PV
Experimental Eye Research 2017; 158: 23-32 (IGR: 18-2)


70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Cai X
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748 (IGR: 18-2)


70044 Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma
Lusthaus JA
Expert Opinion on Investigational Drugs 2016; 25: 1201-1208 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Sakamoto K
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Laties A
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Chao HM
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Ishimaru Y
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70538 Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
Ren R
Investigative Ophthalmology and Visual Science 2016; 57: 6197-6209 (IGR: 18-2)


70513 New classes of glaucoma medications
Schehlein EM
Current Opinions in Ophthalmology 2017; 28: 161-168 (IGR: 18-2)


70072 Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Skaat A
Journal of Glaucoma 2016; 25: e807-e814 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Van Bergen T
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Harris A
Journal of Glaucoma 2016; 25: e826-e833 (IGR: 18-2)


70466 Critical evaluation of latanoprostene bunod in the treatment of glaucoma
Garcia GA
Clinical Ophthalmology 2016; 10: 2035-2050 (IGR: 18-2)


69863 Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-an
Babizhayev MA
BBA clinical 2016; 6: 49-68 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Nakakura S
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70151 Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research
Pattabiraman PP
Experimental Eye Research 2017; 158: 23-32 (IGR: 18-2)


70513 New classes of glaucoma medications
Novack GD
Current Opinions in Ophthalmology 2017; 28: 161-168 (IGR: 18-2)


70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Yang Y
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748 (IGR: 18-2)


70557 Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma
Martínez-Águila A
Purinergic signalling 2017; 13: 171-177 (IGR: 18-2)


69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Rich CC
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554 (IGR: 18-2)


70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Berlin MS
British Journal of Ophthalmology 2017; 101: 796-800 (IGR: 18-2)


69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Ward CL
Journal of Glaucoma 2016; 25: e826-e833 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Rolando B
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70538 Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
Li G
Investigative Ophthalmology and Visual Science 2016; 57: 6197-6209 (IGR: 18-2)


70072 Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Jasien JV
Journal of Glaucoma 2016; 25: e807-e814 (IGR: 18-2)


70466 Critical evaluation of latanoprostene bunod in the treatment of glaucoma
Ngai P
Clinical Ophthalmology 2016; 10: 2035-2050 (IGR: 18-2)


70044 Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma
Goldberg I
Expert Opinion on Investigational Drugs 2016; 25: 1201-1208 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Namekata K
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70838 The arguments for and against cannabinoids application in glaucomatous retinopathy
Manayi A
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2017; 86: 620-627 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Sumino A
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Murakami Y
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Zahn G
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Hu L
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Sawada S
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Rowe-Rendleman CL
Journal of Glaucoma 2016; 25: e826-e833 (IGR: 18-2)


70072 Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Ritch R
Journal of Glaucoma 2016; 25: e807-e814 (IGR: 18-2)


70538 Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
Le TD
Investigative Ophthalmology and Visual Science 2016; 57: 6197-6209 (IGR: 18-2)


69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Stoltz R
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Guo X
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70513 New classes of glaucoma medications
Robin AL
Current Opinions in Ophthalmology 2017; 28: 161-168 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Kajioka D
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70838 The arguments for and against cannabinoids application in glaucomatous retinopathy
Nikan M
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2017; 86: 620-627 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Cheng JM
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70466 Critical evaluation of latanoprostene bunod in the treatment of glaucoma
Mosaed S
Clinical Ophthalmology 2016; 10: 2035-2050 (IGR: 18-2)


70557 Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma
de Lara MJ
Purinergic signalling 2017; 13: 171-177 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Fujisawa Y
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Caldirola P
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Ward CL
British Journal of Ophthalmology 2017; 101: 796-800 (IGR: 18-2)


70151 Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research
Kopczynski C
Experimental Eye Research 2017; 158: 23-32 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Chegaev K
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Chen P
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Shibagaki F
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Fsadni M
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


70466 Critical evaluation of latanoprostene bunod in the treatment of glaucoma
Lin KY
Clinical Ophthalmology 2016; 10: 2035-2050 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Liu XQ
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70538 Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
Kopczynski C
Investigative Ophthalmology and Visual Science 2016; 57: 6197-6209 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Harada C
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Ushikubo H
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Humbert V
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554 (IGR: 18-2)


70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Sharpe JA
British Journal of Ophthalmology 2017; 101: 796-800 (IGR: 18-2)


69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Ouchi T
Journal of Glaucoma 2016; 25: e826-e833 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Guglielmo S
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70557 Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma
Pintor J
Purinergic signalling 2017; 13: 171-177 (IGR: 18-2)


70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Ye Y
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Fujio Y
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70838 The arguments for and against cannabinoids application in glaucomatous retinopathy
Vazirian M
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2017; 86: 620-627 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Matsuya K
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Brickman C
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Mori A
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Liu JH
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70538 Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
Stamer WD
Investigative Ophthalmology and Visual Science 2016; 57: 6197-6209 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Caram-Lelham N
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Wood A
Journal of Glaucoma 2016; 25: e826-e833 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Harada T
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Liu X
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Lazzarato L
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Yamamuro A
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Jamil A
British Journal of Ophthalmology 2017; 101: 796-800 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Yoshioka Y
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70538 Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
Gong H
Investigative Ophthalmology and Visual Science 2016; 57: 6197-6209 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Pan WH
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Durante M
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Wu K
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748 (IGR: 18-2)


70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Harris A
British Journal of Ophthalmology 2017; 101: 796-800 (IGR: 18-2)


69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Fujii A
Journal of Glaucoma 2016; 25: e826-e833 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Kobayashi Y
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Vandewalle E
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
McVicar W
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Nakahara T
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Moons L
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Maeda S
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Ishii K
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70180 Tetramethylpyrazine Attenuates Transdifferentiation of TGF-β2-Treated Human Tenon's Fibroblasts
Yu M
Investigative Ophthalmology and Visual Science 2016; 57: 4740-4748 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Masini E
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Serle JB
Journal of Glaucoma 2016; 25: e826-e833 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Tabuchi H
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Zhang XM
Chinese medicine 2016; 11: 39 (IGR: 18-2)


69659 A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Baumgartner RA
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 548-554 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Yoneda T
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Almirante N
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70625 Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery
Stalmans I
Investigative Ophthalmology and Visual Science 2016; 57: 6428-6439 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Bastia E
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Fukushima A
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Impagnatiello F
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Kiuchi Y
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)


70839 New furoxan derivatives for the treatment of ocular hypertension
Fruttero R; Gasco A
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483 (IGR: 18-2)


68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Medeiros FA
American Journal of Ophthalmology 2016; 168: 250-259 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Shaw PX
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Mao WM
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)


69300 The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts
Futakuchi A
Experimental Eye Research 2016; 149: 107-115 (IGR: 18-1)


69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Liu JH
American Journal of Ophthalmology 2016; 169: 249-257 (IGR: 18-1)


69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Sato S
Advances in Therapy 2016; 33: 1628-1634 (IGR: 18-1)


69132 Revisiting the role of erythropoietin for treatment of ocular disorders
Shirley Ding SL
Eye 2016; 30: 1293-1309 (IGR: 18-1)


69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Kawase K
Advances in Therapy 2016; 33: 1612-1627 (IGR: 18-1)


69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Hirooka K
Advances in Therapy 2016; 33: 1628-1634 (IGR: 18-1)


69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Vittitow JL
Advances in Therapy 2016; 33: 1612-1627 (IGR: 18-1)


69300 The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts
Inoue T
Experimental Eye Research 2016; 149: 107-115 (IGR: 18-1)


68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Martin KR
American Journal of Ophthalmology 2016; 168: 250-259 (IGR: 18-1)


69132 Revisiting the role of erythropoietin for treatment of ocular disorders
Leow SN
Eye 2016; 30: 1293-1309 (IGR: 18-1)


69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Liu Y
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)


69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Slight JR
American Journal of Ophthalmology 2016; 169: 249-257 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Sang A
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Nitta E
Advances in Therapy 2016; 33: 1628-1634 (IGR: 18-1)


69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Vittitow JL
American Journal of Ophthalmology 2016; 169: 249-257 (IGR: 18-1)


69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Weinreb RN
Advances in Therapy 2016; 33: 1612-1627 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Wang Y
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69300 The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts
Fujimoto T
Experimental Eye Research 2016; 149: 107-115 (IGR: 18-1)


68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Peace J
American Journal of Ophthalmology 2016; 168: 250-259 (IGR: 18-1)


69132 Revisiting the role of erythropoietin for treatment of ocular disorders
Munisvaradass R
Eye 2016; 30: 1293-1309 (IGR: 18-1)


69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Wordinger YH
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)


69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Araie M
Advances in Therapy 2016; 33: 1612-1627 (IGR: 18-1)


69300 The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts
Inoue-Mochita M
Experimental Eye Research 2016; 149: 107-115 (IGR: 18-1)


69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Scassellati Sforzolini B
American Journal of Ophthalmology 2016; 169: 249-257 (IGR: 18-1)


68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Scassellati Sforzolini B
American Journal of Ophthalmology 2016; 168: 250-259 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Ho D
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69132 Revisiting the role of erythropoietin for treatment of ocular disorders
Koh EH
Eye 2016; 30: 1293-1309 (IGR: 18-1)


69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Clark AF
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)


69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Ukegawa K
Advances in Therapy 2016; 33: 1628-1634 (IGR: 18-1)


69132 Revisiting the role of erythropoietin for treatment of ocular disorders
Bastion ML
Eye 2016; 30: 1293-1309 (IGR: 18-1)


69268 Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma
Pang IH
Chinese Journal of Ophthalmology 2016; 52: 471-475 (IGR: 18-1)


69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study

Advances in Therapy 2016; 33: 1612-1627 (IGR: 18-1)


68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Vittitow JL
American Journal of Ophthalmology 2016; 168: 250-259 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Douglas C
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69300 The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts
Kawai M
Experimental Eye Research 2016; 149: 107-115 (IGR: 18-1)


69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Weinreb RN
American Journal of Ophthalmology 2016; 169: 249-257 (IGR: 18-1)


69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Tsujikawa A
Advances in Therapy 2016; 33: 1628-1634 (IGR: 18-1)


69132 Revisiting the role of erythropoietin for treatment of ocular disorders
Then KY
Eye 2016; 30: 1293-1309 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Dia L
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69300 The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts
Tanihara H
Experimental Eye Research 2016; 149: 107-115 (IGR: 18-1)


68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Weinreb RN
American Journal of Ophthalmology 2016; 168: 250-259 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Goldberg JL
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69132 Revisiting the role of erythropoietin for treatment of ocular disorders
Kumar S; Mok PL
Eye 2016; 30: 1293-1309 (IGR: 18-1)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Liu X
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Sturdivant JM
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


67460 Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantation
Jung KI
Drug design, development and therapy 2016; 10: 1477-1488 (IGR: 17-4)


66700 Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery
Occhiutto ML
Investigative Ophthalmology and Visual Science 2016; 57: 971-978 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Unlu M
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


66840 Cannabinoids for treatment of glaucoma
Novack GD
Current Opinions in Ophthalmology 2016; 27: 146-150 (IGR: 17-4)


67316 Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice
Martínez-Águila A
Journal of Pharmacology and Experimental Therapeutics 2016; 357: 293-299 (IGR: 17-4)


66794 Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study
Weinreb RN
Ophthalmology 2016; 123: 965-973 (IGR: 17-4)


67559 Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats
Resende AP
Ophthalmic Research 2016; 56: 104-110 (IGR: 17-4)


67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Myers JS
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562 (IGR: 17-4)


67476 ATP sensitive potassium channel openers: A new class of ocular hypotensive agents
Roy Chowdhury U
Experimental Eye Research 2017; 158: 85-93 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Li G
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Sall KN
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562 (IGR: 17-4)


67316 Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice
Fonseca B
Journal of Pharmacology and Experimental Therapeutics 2016; 357: 293-299 (IGR: 17-4)


66700 Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery
Freitas FR
Investigative Ophthalmology and Visual Science 2016; 57: 971-978 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Mukherjee D
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67559 Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats
São Braz B
Ophthalmic Research 2016; 56: 104-110 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Huang P
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67476 ATP sensitive potassium channel openers: A new class of ocular hypotensive agents
Dosa PI
Experimental Eye Research 2017; 158: 85-93 (IGR: 17-4)


67460 Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantation
Park CK
Drug design, development and therapy 2016; 10: 1477-1488 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Aktas Z
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


66794 Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study
Scassellati Sforzolini B
Ophthalmology 2016; 123: 965-973 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Royalty SM
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


67476 ATP sensitive potassium channel openers: A new class of ocular hypotensive agents
Fautsch MP
Experimental Eye Research 2017; 158: 85-93 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Gocun PU
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
DuBiner H
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Wang J
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Lin CW
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Navarro I
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67316 Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice
Pérez de Lara MJ
Journal of Pharmacology and Experimental Therapeutics 2016; 357: 293-299 (IGR: 17-4)


66700 Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery
Lima PP
Investigative Ophthalmology and Visual Science 2016; 57: 971-978 (IGR: 17-4)


67559 Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats
Delgado E
Ophthalmic Research 2016; 56: 104-110 (IGR: 17-4)


66794 Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study
Vittitow J
Ophthalmology 2016; 123: 965-973 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Moore LA
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


66794 Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study
Liebmann J
Ophthalmology 2016; 123: 965-973 (IGR: 17-4)


66700 Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery
Maranhão RC
Investigative Ophthalmology and Visual Science 2016; 57: 971-978 (IGR: 17-4)


67316 Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice
Pintor J
Journal of Pharmacology and Experimental Therapeutics 2016; 357: 293-299 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Ilhan SO
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Yang Z
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Ashpole NE
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Slomowitz N
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Sherwood JM
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


66700 Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery
Costa VP
Investigative Ophthalmology and Visual Science 2016; 57: 971-978 (IGR: 17-4)


67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
McVicar W
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Huang S
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Hasanreisoglu M
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Yingling JD
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Luo X
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Hasanreisoglu B
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Rich CC
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Chang J
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Laethem CL
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Overby DR
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Sherman B
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Qi J
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Baumgartner RA
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Yuan F
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Shen X
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Heintzelman GR
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Gonzalez P
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
Kopczynski CC
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


66716 The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Zhong Y
Investigative Ophthalmology and Visual Science 2016; 57: 776-786 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Kopczynski CC
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


67164 Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma
deLong MA
Bioorganic and Medicinal Chemistry Letters 2016; 26: 2475-2480 (IGR: 17-4)


67545 Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes
Farsiu S; Stamer WD
European Journal of Pharmacology 2016; 787: 20-31 (IGR: 17-4)


66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Liu Y
Molecular Vision 2015; 21: 1368-1377 (IGR: 17-3)


65831 New drugs and preparations for open-angle glaucoma in adults

Drug and therapeutics bulletin 2015; 53: 141-144 (IGR: 17-3)


66221 Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
Kokona D
Neural plasticity 2016; 2016: 8373020 (IGR: 17-3)


65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Roberti G
International journal of molecular sciences 2015; 16: 28401-28417 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Li CP
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Suto F
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970 (IGR: 17-3)


66220 The Endocannabinoid System as a Therapeutic Target in Glaucoma
Cairns EA
Neural plasticity 2016; 2016: 9364091 (IGR: 17-3)


66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Acharya S
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494 (IGR: 17-3)


65985 Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Roy Chowdhury U
PLoS ONE 2015; 10: e0141783 (IGR: 17-3)


65926 Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease
Cairns EA
Journal of basic and clinical physiology and pharmacology 2016; 27: 253-265 (IGR: 17-3)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Germano RA
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Pakravan M
American Journal of Therapeutics 2017; 24: e676-e680 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Madeira MH
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Yin S
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Keppel Hesselink JM
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
May JA
Journal of Medicinal Chemistry 2015; 58: 8818-8833 (IGR: 17-3)


66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Kaneko Y
Scientific reports 2016; 6: 19640 (IGR: 17-3)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Finzi S
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


65985 Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Bahler CK
PLoS ONE 2015; 10: e0141783 (IGR: 17-3)


65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Rowe-Rendleman CL
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Boia R
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Wang ZF
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Costagliola C
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
Sharif NA
Journal of Medicinal Chemistry 2015; 58: 8818-8833 (IGR: 17-3)


65926 Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease
Toguri JT
Journal of basic and clinical physiology and pharmacology 2016; 27: 253-265 (IGR: 17-3)


66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Kimura K
Molecular Vision 2015; 21: 1368-1377 (IGR: 17-3)


66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Rogers P
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494 (IGR: 17-3)


65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Tanga L
International journal of molecular sciences 2015; 16: 28401-28417 (IGR: 17-3)


66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Ohta M
Scientific reports 2016; 6: 19640 (IGR: 17-3)


66221 Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
Georgiou PC
Neural plasticity 2016; 2016: 8373020 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Qiu GZ
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Beni AN
American Journal of Therapeutics 2017; 24: e676-e680 (IGR: 17-3)


66220 The Endocannabinoid System as a Therapeutic Target in Glaucoma
Baldridge WH
Neural plasticity 2016; 2016: 9364091 (IGR: 17-3)


65926 Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease
Porter RF
Journal of basic and clinical physiology and pharmacology 2016; 27: 253-265 (IGR: 17-3)


66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Krishnamoorthy RR
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494 (IGR: 17-3)


66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Ghahari E
American Journal of Therapeutics 2017; 24: e676-e680 (IGR: 17-3)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Challa P
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Michelessi M
International journal of molecular sciences 2015; 16: 28401-28417 (IGR: 17-3)


65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
McLaughlin MA
Journal of Medicinal Chemistry 2015; 58: 8818-8833 (IGR: 17-3)


66221 Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
Kounenidakis M
Neural plasticity 2016; 2016: 8373020 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Duan JG
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Fakhry J
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Orita T
Molecular Vision 2015; 21: 1368-1377 (IGR: 17-3)


66220 The Endocannabinoid System as a Therapeutic Target in Glaucoma
Kelly ME
Neural plasticity 2016; 2016: 9364091 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Liu B
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Inoue T
Scientific reports 2016; 6: 19640 (IGR: 17-3)


65985 Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Holman BH
PLoS ONE 2015; 10: e0141783 (IGR: 17-3)


65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Ouchi T
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Elvas F
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Mizuno K
Scientific reports 2016; 6: 19640 (IGR: 17-3)


65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
Chen HH
Journal of Medicinal Chemistry 2015; 58: 8818-8833 (IGR: 17-3)


65985 Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Dosa PI
PLoS ONE 2015; 10: e0141783 (IGR: 17-3)


66221 Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
Kiagiadaki F
Neural plasticity 2016; 2016: 8373020 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Ji L
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Kopsky DJ
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Susanna Junior R
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Chen JL
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Quaranta L
International journal of molecular sciences 2015; 16: 28401-28417 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Martins T
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Varshochian R
American Journal of Therapeutics 2017; 24: e676-e680 (IGR: 17-3)


65926 Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease
Szczesniak AM
Journal of basic and clinical physiology and pharmacology 2016; 27: 253-265 (IGR: 17-3)


66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Suzuki K
Molecular Vision 2015; 21: 1368-1377 (IGR: 17-3)


66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Stankowska DL
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494 (IGR: 17-3)


65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Jamil A
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970 (IGR: 17-3)


66221 Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
Thermos K
Neural plasticity 2016; 2016: 8373020 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Lu XJ
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Yazdani S
American Journal of Therapeutics 2017; 24: e676-e680 (IGR: 17-3)


66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Isobe T
Scientific reports 2016; 6: 19640 (IGR: 17-3)


66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Dias HV
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494 (IGR: 17-3)


65985 Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Fautsch MP
PLoS ONE 2015; 10: e0141783 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Fu HT
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
Severns BS
Journal of Medicinal Chemistry 2015; 58: 8818-8833 (IGR: 17-3)


65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Wood A
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Cunha RA
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Parisi V
International journal of molecular sciences 2015; 16: 28401-28417 (IGR: 17-3)


65926 Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease
Kelly ME
Journal of basic and clinical physiology and pharmacology 2016; 27: 253-265 (IGR: 17-3)


66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Teranishi S
Molecular Vision 2015; 21: 1368-1377 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Ambrósio AF
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Esfandiari H
American Journal of Therapeutics 2017; 24: e676-e680 (IGR: 17-3)


66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Mori T
Molecular Vision 2015; 21: 1368-1377 (IGR: 17-3)


65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Ward CL
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970 (IGR: 17-3)


66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Tanabe S
Scientific reports 2016; 6: 19640 (IGR: 17-3)


65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
Kelly CR
Journal of Medicinal Chemistry 2015; 58: 8818-8833 (IGR: 17-3)


66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Yorio T
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494 (IGR: 17-3)


65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Manni G
International journal of molecular sciences 2015; 16: 28401-28417 (IGR: 17-3)


66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Sonoda KH
Molecular Vision 2015; 21: 1368-1377 (IGR: 17-3)


65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Oddone F
International journal of molecular sciences 2015; 16: 28401-28417 (IGR: 17-3)


66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Tanihara H
Scientific reports 2016; 6: 19640 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Santiago AR
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Ahmadieh H
American Journal of Therapeutics 2017; 24: e676-e680 (IGR: 17-3)


65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
Holt WF; Young R; Glennon RA; Hellberg MR; Dean TR
Journal of Medicinal Chemistry 2015; 58: 8818-8833 (IGR: 17-3)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Aksar AT
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Shen C
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61527 Therapeutic potential of cannabis-related drugs
Alexander SP
Progress in neuro-psychopharmacology & biological psychiatry 2016; 64: 157-166 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Li Y
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61299 Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study
Majeed M
Saudi Journal of Ophthalmology 2015; 29: 197-200 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Noro T
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61781 The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model
Eren K
Current Eye Research 2015; 0: 1-10 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Tanihara H
JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Saini M
Eye 2015; 29: 808-814 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Foureaux G
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Marshall J
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Van de Velde S
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61784 Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
Belendiuk KA
Addiction science & clinical practice 2015; 10: 10 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Hill LJ
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting PF
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Noro T
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Madeira MH
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Kaja S
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Lin HC
JAMA ophthalmology 2015; 133: 915-923 (IGR: 17-1)


61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Tokuda N
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Can N
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Parisi V
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Szumny D
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Lewis RA
British Journal of Ophthalmology 2016; 100: 339-344 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Yang Z
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Russo R
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Wei J
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Catak O
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Wolff RF
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Centofanti M
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Yuksel N
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Jiang H
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Payne AJ
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Levy B
British Journal of Ophthalmology 2016; 100: 339-344 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Huang P
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Wong KY
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Kitaoka Y
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)


61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Dhiman R
Eye 2015; 29: 808-814 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
De Groef L
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Adornetto A
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Sozański T
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61784 Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
Baldini LL
Addiction science & clinical practice 2015; 10: 10 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Elvas F
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Liu X
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Namekata K
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61781 The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model
Turgut B
Current Eye Research 2015; 0: 1-10 (IGR: 17-1)


61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Stein JD
JAMA ophthalmology 2015; 133: 915-923 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Mead B
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61299 Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study
Nagabhushanam K
Saudi Journal of Ophthalmology 2015; 29: 197-200 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Inoue T
JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Franca JR
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Chen L
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Namekata K
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Nan B
JAMA ophthalmology 2015; 133: 915-923 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Kimura A
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Matsuzawa A
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)


61299 Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study
Natarajan S
Saudi Journal of Ophthalmology 2015; 29: 197-200 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Stalmans I
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61784 Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
Bonn-Miller MO
Addiction science & clinical practice 2015; 10: 10 (IGR: 17-1)


61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Tesavibul N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)


61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Ramirez N
British Journal of Ophthalmology 2016; 100: 339-344 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Gok M
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Yamamoto T
JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Deshpande S
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Dada T
Eye 2015; 29: 808-814 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Jiang L
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Gao H
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Rupasinghe CN
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Turgut B
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Liu X
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Nogueira JC
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Cavaliere F
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Kucharska AZ
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Boia R
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Azuchi Y
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Huang S
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Blanch RJ
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61781 The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model
Akin MM
Current Eye Research 2015; 0: 1-10 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Ziccardi L
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Naumchuk Y
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Dziewiszek W
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Kuwayama Y
JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Tandon R
Eye 2015; 29: 808-814 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Gonçalves FQ
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Tanga L
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Kimura A
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Guo X
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Demir T
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Varano GP
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
C Kopczynski C
British Journal of Ophthalmology 2016; 100: 339-344 (IGR: 17-1)


61781 The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model
Demir T
Current Eye Research 2015; 0: 1-10 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Fulgêncio Gde O
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Huang S
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Cekmen M
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Huang P
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61299 Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study
Vaidyanathan P
Saudi Journal of Ophthalmology 2015; 29: 197-200 (IGR: 17-1)


61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Miyamoto J
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Lai TY
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Wang G
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Tiwari R
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Childers D
JAMA ophthalmology 2015; 133: 915-923 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Ahmed Z
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Levy D
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Moons L
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Di Nisio M
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Thewthong M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Zaidi DH
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Van Hove I
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Usner DW
British Journal of Ophthalmology 2016; 100: 339-344 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Duffy S
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Rusciano D
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Newman-Casey PA
JAMA ophthalmology 2015; 133: 915-923 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Cunha RA
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Sakae S
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Zhong Y
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Deng L
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Abe H
JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Ilhan N
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61299 Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study
Karri SK
Saudi Journal of Ophthalmology 2015; 29: 197-200 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Guo X
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
De Cogan F
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Azuchi Y
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Michelessi M
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Vanathi M
Eye 2015; 29: 808-814 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Zhao X
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Ribeiro TG
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Caglar Y
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Piórecki N; Magdalan J
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Jin Z
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Munemasa Y
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Kuloglu T
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Morrone LA
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Suganami H
JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Roberti G
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Castilho RO
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Thompson DA
JAMA ophthalmology 2015; 133: 915-923 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Harada C
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Novack GD
British Journal of Ophthalmology 2016; 100: 339-344 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Hernandez AV
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Morgan-Warren PJ
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Berberoglu ED
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Altman AM
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61299 Efficacy and safety of 1% forskolin eye drops in open angle glaucoma - An open label study
Jose JA
Saudi Journal of Ophthalmology 2015; 29: 197-200 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Harada C
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Ambrósio AF
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Mohamed S
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Santiago AR
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Nakano T
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Richards JE
JAMA ophthalmology 2015; 133: 915-923 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Sinkler C
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Nawazish S
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Chlebda-Sieragowska E
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Keurentjes JC
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Corasaniti MT
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Manni G
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Yoshida MI
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension

British Journal of Ophthalmology 2016; 100: 339-344 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Xu S
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Araie M
JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Nakano T
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Ozercan IH
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Takagi H
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Bagetta G
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Fuscaldi LL
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Ghuman JK
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Tsuneoka H
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Shen X
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Leadbeater W
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Kupczynski R
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Liu J
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials

JAMA ophthalmology 2015; 133: 755-761 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Lang S
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Tsuneoka H
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Luo X
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Scott RA
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Gerdes BC
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Harada T
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Misso K
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Nucci C
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Szeląg A
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Harada T
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Fernandes SO
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Lee I
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Ryder S
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


60986 Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure
Szumny A
Evidence-based Complementary and Alternative Medicine 2015; 2015: 939402 (IGR: 17-1)


61406 Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
Zhong Y
Scientific reports 2015; 5: 11294 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Cardoso VN
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Berry M
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Moore MA
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Parang K
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61016 Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork
Logan A
Investigative Ophthalmology and Visual Science 2015; 56: 3743-3757 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Koulen P
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Cronemberger S
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Schmidlkofer S
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Spaller MR
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Faraco AA
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Hüttemann M
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61345 Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Westwood M; Kleijnen J
JAMA (Journal of the American Medical Association) 2015; 313: 2456-2473 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Goebel DJ
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61540 Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
Ferreira AJ
PLoS ONE 2015; 10: e0133149 (IGR: 17-1)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Iomdina EN
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Valiente-Soriano FJ
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Wang X
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Weinreb RN
British Journal of Ophthalmology 2015; 99: 738-745 (IGR: 16-4)


60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Nagai N
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Tanihara H
Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Lindsey JD
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Bozdag M
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Loma P
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)


60296 Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Pescosolido N
Ophthalmic and Physiological Optics 2015; 35: 201-205 (IGR: 16-4)


60621 Effect of AR-13324 on Episcleral Venous Pressure in Dutch Belted Rabbits
Kiel JW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 146-151 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Sakamoto K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Pirhan D
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Chen YS
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Raber S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Ferreira JD
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Yanagisawa M
Cell Death and Disease 2015; 6: e1693 (IGR: 16-4)


60295 Novel potential treatment modalities for ocular hypertension: focus on Angiotensin and bradykinin system axes
Sharif NA
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 131-145 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Stein JD
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60162 Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes
Wang RF
Journal of Glaucoma 2015; 24: 51-54 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Harrison BA
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60786 Options for prolonging the hypotensive effect of trabeculectomy

Vestnik Oftalmologii 2015; 131: 75-78, 80-81 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Parsons CG
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
White AJ
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Endo K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Inoue T
Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Duong-Polk KX
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Ong T
British Journal of Ophthalmology 2015; 99: 738-745 (IGR: 16-4)


60621 Effect of AR-13324 on Episcleral Venous Pressure in Dutch Belted Rabbits
Kopczynski CC
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 146-151 (IGR: 16-4)


60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Mandema JW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197 (IGR: 16-4)


60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Aida T
Cell Death and Disease 2015; 6: e1693 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Yüksel N
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Chahud F
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Talwar N
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Yoshioka C
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Khoroshilova-Maslova IP
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Lin J
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Guzman-Aranguez A
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Heller JP
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Nadal-Nicolás FM
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Ruitenberg M
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Green CR
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60296 Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Gatto V
Ophthalmic and Physiological Optics 2015; 35: 201-205 (IGR: 16-4)


60162 Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes
Williamson JE
Journal of Glaucoma 2015; 24: 51-54 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Almstead ZY
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Carta F
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Freitag CE
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Danesh-Meyer HV
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Perez De Lara MJ
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Leung J
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60162 Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes
Kopczynski C
Journal of Glaucoma 2015; 24: 51-54 (IGR: 16-4)


60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Takeda T
Cell Death and Disease 2015; 6: e1693 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Arzeno A
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Ramalho LN
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Yamamoto T
Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Salinas-Navarro M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Vullo D
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Scassellati Sforzolini B
British Journal of Ophthalmology 2015; 99: 738-745 (IGR: 16-4)


60296 Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Stefanucci A
Ophthalmic and Physiological Optics 2015; 35: 201-205 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Suzuki T
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Mano Y
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Robustova OV
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Hammond D
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Li H
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Emre E
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Burgoon H
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Kang JH
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Jiménez-López M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60296 Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Rusciano D
Ophthalmic and Physiological Optics 2015; 35: 201-205 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Okereke OI
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Kuwayama Y
Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Tnabe W
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Cengiz A
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Rupenthal ID
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Choi JY
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Tassoni A
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60162 Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes
Serle JB
Journal of Glaucoma 2015; 24: 51-54 (IGR: 16-4)


60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Namekata K
Cell Death and Disease 2015; 6: e1693 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Sroka-Saidi K
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Gardyan M
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Fujimura K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Vittitow JL
British Journal of Ophthalmology 2015; 99: 738-745 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Akdemir A
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Leung CK
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Averina OA
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Modulo CM
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Pintor J
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)


60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Nickens DJ
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Isik S
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Martin KR
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Bernal-Garro JM
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Russ H
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Singh K
British Journal of Ophthalmology 2015; 99: 738-745 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Wiggs JL
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Boccio J
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Abe H
Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Weinreb RN
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Kovaleva NA
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Kürşat Yıldız D
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Goodwin NC
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Ito Y
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)


60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Harada T
Cell Death and Disease 2015; 6: e1693 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Kurauchi Y
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Vieira LC
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Okamoto N
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Aliev G
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Mori A
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Lanzi C
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Pasquale LR
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Frieden E
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Healy J
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Suganami H
Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Villegas-Pérez MP
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Rammes G
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Reinach PS
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Shinagawa R
Cell Death and Disease 2015; 6: e1693 (IGR: 16-4)


60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Kaufman PL
British Journal of Ophthalmology 2015; 99: 738-745 (IGR: 16-4)


60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Tanaka K
Cell Death and Disease 2015; 6: e1693 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Reddy VP
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Scozzafava A
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Liu Y
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Shimomura Y
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Rodrigues MD
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Nakahara T
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

British Journal of Ophthalmology 2015; 99: 738-745 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Agudo-Barriuso M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Bhargava A
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Araie M
Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Maynard G
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Masini E
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Cunha AS
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Ishii K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Zamyatnin AA
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Mabon R
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Vidal-Sanz M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study

Acta Ophthalmologica 2015; 93: e254-e260 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Marinelli B
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Paula JS
Current Eye Research 2014; 0: 1-7 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Skulachev MV
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Supuran CT
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Tsai JC
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Senin II
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Samala L
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Strittmatter SM
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Skulachev VP
Front Biosci 2015; 20: 892-901 (IGR: 16-4)


60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Zhang Y; Stouch TR; Whitlock NA; Gopinathan S; McKnight B; Wang S; Patel N; Wilson AG; Hamman BD; Rice DS; Rawlins DB
ACS Medicinal Chemistry Letters 2015; 6: 84-88 (IGR: 16-4)


58916 Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma
Salt TE; Nizari S; Cordeiro MF; Russ H; Danysz W
Neurotoxicity research 2014; 26: 440-446 (IGR: 16-3)


58772 Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma
Semba K; Namekata K; Guo X; Harada C; Harada T; Mitamura Y
Cell Death and Disease 2014; 5: e1333 (IGR: 16-3)


58506 Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits
Isobe T; Mizuno K; Kaneko Y; Ohta M; Koide T; Tanabe S
Current Eye Research 2014; 39: 813-822 (IGR: 16-3)


58860 Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma
Parisi V; Centofanti M; Gandolfi S; Marangoni D; Rossetti L; Tanga L; Tardini M; Traina S; Ungaro N; Vetrugno M; Falsini B
Journal of Glaucoma 2014; 23: 391-404 (IGR: 16-3)


59314 Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep
Candia OA; Gerometta RM; Danias J
Experimental Eye Research 2014; 128: 114-116 (IGR: 16-3)


59438 Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress
Hong S; Iizuka Y; Lee T; Kim CY; Seong GJ
Molecular Vision 2014; 20: 1456-1462 (IGR: 16-3)


59266 The Novel Rho Kinase (ROCK) Inhibitor K-115: A New Candidate Drug for Neuroprotective Treatment in Glaucoma
Yamamoto K; Maruyama K; Himori N; Omodaka K; Yokoyama Y; Shiga Y; Morin R; Nakazawa T
Investigative Ophthalmology and Visual Science 2014; 55: 7126-7136 (IGR: 16-3)


59294 Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosis
Cheng H; Ding Y; Yu R; Chen J; Wu C
PLoS ONE 2014; 9: e108090 (IGR: 16-3)


58505 Nerve growth factor modulation of retinal ganglion cell physiology
Roberti G; Mantelli F; Macchi I; Massaro-Giordano M; Centofanti M
Journal of Cellular Physiology 2014; 229: 1130-1133 (IGR: 16-3)


59530 Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model
Ishikawa M; Yoshitomi T; Zorumski CF; Izumi Y
Investigative Ophthalmology and Visual Science 2014; 0: (IGR: 16-3)


59535 Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush
Mac Nair CE; Fernandes KA; Schlamp CL; Libby RT; Nickells RW
Journal of Neuroinflammation 2014; 11: 194 (IGR: 16-3)


59389 Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models
Nagai N; Yoshioka C; Mano Y; Ito Y; Okamoto N; Shimomura Y
Current Eye Research 2014; 0: 1-11 (IGR: 16-3)


58752 Dock GEFs and their therapeutic potential: neuroprotection and axon regeneration
Namekata K; Kimura A; Kawamura K; Harada C; Harada T
Progress in Retinal and Eye Research 2014; 43: 1-16 (IGR: 16-3)


59231 Double-masked, Randomized, Dose-Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure
Bacharach J; Dubiner HB; Levy B; Kopczynski CC; Novack GD;
Ophthalmology 2015; 122: 302-307 (IGR: 16-3)


59385 Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes
Quinteros D; Vicario-de-la-Torre M; Andrés-Guerrero V; Palma S; Allemandi D; Herrero-Vanrell R; Molina-Martínez IT
PLoS ONE 2014; 9: e110344 (IGR: 16-3)


59157 Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma
Rasmussen CA; Kaufman PL; Ritch R; Haque R; Brazzell RK; Vittitow JL
Translational vision science & technology 2014; 3: 1 (IGR: 16-3)


59332 Application of Retinalamin for the treatment of glaucomatous optic neuropathy
Makashova NV; Vasil'eva AE; Morozova NE; Ronzina IA
Vestnik Oftalmologii 2014; 130: 71-76, 78-80 (IGR: 16-3)


59443 A Class of 4-Sulfamoylphenyl-ω-aminoalkyl Ethers with Effective Carbonic Anhydrase Inhibitory Action and Antiglaucoma Effects
Bozdag M; Pinard M; Carta F; Masini E; Scozzafava A; McKenna R; Supuran CT
Journal of Medicinal Chemistry 2014; 57: 9673-9686 (IGR: 16-3)


59343 Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients
Helin-Toiviainen M; Rönkkö S; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
Acta Ophthalmologica 2015; 93: 165-171 (IGR: 16-3)


59335 Preclinical pharmacology, ocular tolerability and ocular hypotensive efficacy of a novel non-peptide bradykinin mimetic small molecule
Sharif NA; Li L; Katoli P; Xu S; Veltman J; Li B; Scott D; Wax M; Gallar J; Acosta C; Belmonte C
Experimental Eye Research 2014; 128: 170-180 (IGR: 16-3)


59536 Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
Giacoppo S; Mandolino G; Galuppo M; Bramanti P; Mazzon E
Molecules 2014; 19: 18781-18816 (IGR: 16-3)


58815 Reduction of conjunctival fibrosis after trabeculectomy using topical α-lipoic acid in rabbit eyes
Ekinci M; Cagatay HH; Ceylan E; Keles S; Koban Y; Gokce G; Huseyinoğlu U; Ozcan E; Oba ME
Journal of Glaucoma 2014; 23: 372-379 (IGR: 16-3)


59364 The ocular hypotensive effect of saffron extract in primary open angle glaucoma: a pilot study
Jabbarpoor Bonyadi MH; Yazdani S; Saadat S
BMC complementary and alternative medicine 2014; 14: 399 (IGR: 16-3)


57497 Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents
Chegaev K; Lazzarato L; Tamboli Y; Boschi D; Blangetti M; Scozzafava A; Carta F; Masini E; Fruttero R; Supuran CT; Gasco A
Bio-organic and Medicinal Chemistry 2014; 22: 3913-3921 (IGR: 16-2)


57130 CSM Enhances the Filtration Bleb Survival in Rabbit Model of Experimental Glaucoma Surgery
Ma J; Li X; Zhang W; Huang L; Chen M; Xi L; Zhang Z; Duan L; Quan D; Ge J
Current Eye Research 2014; 39: 982-988 (IGR: 16-2)


57159 The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment
Sekeroglu MA; Hekimoglu E; Petricli IS; Tasci Y; Dolen I; Arslan U
International urogynecology journal 2014; 25: 1479-1482 (IGR: 16-2)


57022 Investigation of ocular events associated with taprenepag isopropyl, a topical EP2 agonist in development for treatment of glaucoma
Yanochko GM; Affolter T; Eighmy JJ; Evans MG; Khoh-Reiter S; Lee D; Miller PE; Shiue MH; Trajkovic D; Jessen BA
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 429-439 (IGR: 16-2)


57305 A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy
Roberti G; Tanga L; Parisi V; Sampalmieri M; Centofanti M; Manni G
Indian Journal of Ophthalmology 2014; 62: 549-553 (IGR: 16-2)


57150 Critical neuroprotective roles of heme oxygenase-1 induction against axonal injury-induced retinal ganglion cell death
Himori N; Maruyama K; Yamamoto K; Yasuda M; Ryu M; Omodaka K; Shiga Y; Tanaka Y; Nakazawa T
Journal of Neuroscience Research 2014; 92: 1134-1142 (IGR: 16-2)


57024 Taurine: the comeback of a neutraceutical in the prevention of retinal degenerations
Froger N; Moutsimilli L; Cadetti L; Jammoul F; Wang QP; Fan Y; Gaucher D; Rosolen SG; Neveux N; Cynober L; Sahel JA; Picaud S
Progress in Retinal and Eye Research 2014; 41: 44-63 (IGR: 16-2)


57202 Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up
Costagliola C; Romano MR; dell'Omo R; Russo A; Mastropasqua R; Semeraro F
Journal of medicinal food 2014; 17: 949-954 (IGR: 16-2)


57115 Identification of the ghrelin-GHSR 1 system and its influence in the modulation of induced ocular hypertension in rabbit and rat eyes
Rocha-Sousa A; Pereira-Silva P; Tavares-Silva M; Azevedo-Pinto S; Rodrigues-Araújo J; Pinho S; Avelino A; Falcão-Reis F; Leite-Moreira A
Peptides 2014; 57: 59-66 (IGR: 16-2)


57146 Intracameral triamcinolone acetonide in glaucoma surgery: a prospective randomized controlled trial
Koval MS; Moster MR; Freidl KB; Waisbourd M; Jain SG; Ichhpujani P; Myers JS; Pro MJ
American Journal of Ophthalmology 2014; 158: 395-401.e2 (IGR: 16-2)


57154 Impact of trastuzumab on wound healing in experimental glaucoma surgery
Turgut B; Eren K; Akin MM; Bilir Can N; Demir T
Clinical and Experimental Ophthalmology 2015; 43: 67-76 (IGR: 16-2)


56422 Investigation of the Rho-kinase Gene Polymorphism in Primary Open-angle Glaucoma
Demiryürek S; Okumus S; Bozgeyik I; Oztuzcu S; Coskun E; Mat E; Durucu E; Tatar MG; Erbagci I; Gürler B; Demiryürek AT
Ophthalmic Genetics 2015; 0: 4-jan (IGR: 16-1)


56432 Aquaporins: important but elusive drug targets
Verkman AS; Anderson MO; Papadopoulos MC
Nature Reviews Drug Discovery 2014; 13: 259-277 (IGR: 16-1)


55998 Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial
Guo X; Kong X; Huang R; Jin L; Ding X; He M; Liu X; Patel MC; Congdon NG
Investigative Ophthalmology and Visual Science 2014; 55: 110-116 (IGR: 16-1)


56445 Cyclosporine a protects RGC-5 cells from excitotoxic cell death
Schultheiss M; Schnichels S; Mlynczak T; Dipl-Ing JH; Bartz-Schmidt KU; Szurman P; Spitzer MS
Journal of Glaucoma 2014; 23: 219-224 (IGR: 16-1)


56122 Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transection
Levkovitch-Verbin H; Waserzoog Y; Vander S; Makarovsky D; Ilia P
The International Journal of Neuroscience 2014; 124: 755-761 (IGR: 16-1)


56239 Neuroprotective properties of citicoline: facts, doubts and unresolved issues
Grieb P
CNS Drugs 2014; 28: 185-193 (IGR: 16-1)


56525 In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma
Chen HH; Namil A; Severns B; Ward J; Kelly C; Drace C; McLaughlin MA; Yacoub S; Li B; Patil R; Sharif N; Hellberg MR; Rusinko A; Pang IH; Combrink KD
Bioorganic and Medicinal Chemistry Letters 2014; 24: 1875-1879 (IGR: 16-1)


56207 AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia
Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
Investigative Ophthalmology and Visual Science 2014; 55: 1006-1016 (IGR: 16-1)


56471 Resveratrol and the eye: activity and molecular mechanisms
Bola C; Bartlett H; Eperjesi F
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 699-713 (IGR: 16-1)


56655 An emerging treatment option for glaucoma: Rho kinase inhibitors
Wang SK; Chang RT
Clinical Ophthalmology 2014; 8: 883-890 (IGR: 16-1)


55315 Anti-connective tissue growth factor antibody treatment reduces extracellular matrix production in trabecular meshwork and lamina cribrosa cells
Wallace DM; Clark AF; Lipson KE; Andrews D; Crean JK; O'brien CJ
Investigative Ophthalmology and Visual Science 2013; 54: 7836-7848 (IGR: 15-4)


55283 Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome
Johnson TV; Dekorver NW; Levasseur VA; Osborne A; Tassoni A; Lorber B; Heller JP; Villasmil R; Bull ND; Martin KR; Tomarev SI
Brain 2014; 137: 503-519 (IGR: 15-4)


55282 Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator
Gerometta R; Kumar S; Shah S; Alvarez L; Candia O; Danias J
Investigative Ophthalmology and Visual Science 2013; 54: 7903-7909 (IGR: 15-4)


55441 Calcium channels and their blockers in intraocular pressure and glaucoma
Mayama C
European Journal of Pharmacology 2014; 739: 96-105 (IGR: 15-4)


55687 γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway
Wilding C; Bell K; Beck S; Funke S; Pfeiffer N; Grus FH
PLoS ONE 2014; 9: e90737 (IGR: 15-4)


55481 Curcumin: therapeutical potential in ophthalmology
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Medica 2014; 80: 249-254 (IGR: 15-4)


55709 The effectiveness of endonasal electrophoresis of neuroprotective agents used in the rehabilitative treatment of the patients presenting with primary open angle glaucoma
Nazarova GA; Konchugova TV; Iurova OV; Sichinava NV; Turova EA; Rassulova MA; Morozova NE
Voprosy kurortologii, fizioterapii, i lechebno? fizichesko? kultury 2013; 0: 27-30 (IGR: 15-4)


55169 Rho-kinase inhibitors offer a new approach in the treatment of glaucoma
Challa P; Arnold JJ
Expert Opinion on Investigational Drugs 2014; 23: 81-95 (IGR: 15-4)


55428 Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma
Rao PV
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 181-190 (IGR: 15-4)


55376 Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis
Suzuki K; Teranishi S; Sagara T; Yoshino H; Nakayama M; Enoki M; Nuno Y; Hirano S; Wakuta M; Takahashi N; Tokuhisa K; Kondo Y; Shiraishi R; Ishida Y; Sonoda KH;
Journal of Glaucoma 2015; 24: e145-e150 (IGR: 15-4)


55192 Inhibition of placental growth factor improves surgical outcome of glaucoma surgery
Van Bergen T; Jonckx B; Hollanders K; Sijnave D; Van de Velde S; Vandewalle E; Moons L; Stassen JM; Stalmans I
Journal of cellular and molecular medicine 2013; 17: 1632-1643 (IGR: 15-4)


55343 Interferon-alpha and interferon-gamma modulate Fas-mediated apoptosis in mitomycin-C-resistant human Tenon's fibroblasts
Wang XY; Crowston JG; White AJ; Zoellner H; Healey PR
Clinical and Experimental Ophthalmology 2014; 42: 529-538 (IGR: 15-4)


55435 RNA Interference Targeting Connective Tissue Growth Factor Inhibits the Transforming Growth Factor- β 2 Induced Proliferation in Human Tenon Capsule Fibroblasts
Jing J; Li P; Li T; Sun Y; Guan H
Journal of Ophthalmology 2013; 2013: 354798 (IGR: 15-4)


55431 Effect of poly(DL-lactide-co-glycolide) on scar formation after glaucoma filtration surgery
DU LQ; Yang HL; Wu XY; Wang SG; Li Y
Chinese Medical Journal 2013; 126: 4528-4535 (IGR: 15-4)


54709 In Vitro and In Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma
Martí,nez T; Gonzá,lez MV; Roehl I; Wright N; Pañ,eda C; Jimé,nez AI
Molecular Therapy 2014; 22: 81-91 (IGR: 15-3)


54424 17β-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma
Prokai-Tatrai K; Xin H; Nguyen V; Szarka S; Blazics B; Prokai L; Koulen P
Molecular pharmaceutics 2013; 10: 3253-3261 (IGR: 15-3)


54397 Neuroprotective Effects of Bis(7)-tacrine in a Rat Model of Pressure-Induced Retinal Ischemia
Li JB; Lu ZG; Xu L; Wang Q; Zhang ZH; Fang JH
Cell biochemistry and biophysics 2014; 68: 275-282 (IGR: 15-3)


54418 VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro
Beazley-Long N; Hua J; Jehle T; Hulse RP; Dersch R; Lehrling C; Bevan H; Qiu Y; Lagrè,ze WA; Wynick D; Churchill AJ; Kehoe P; Harper SJ; Bates DO; Donaldson LF
American Journal of Pathology 2013; 183: 918-929 (IGR: 15-3)


54508 Lycium barbarum (wolfberry) reduces secondary degeneration and oxidative stress, and inhibits JNK pathway in retina after partial optic nerve transection
Li H; Liang Y; Chiu K; Yuan Q; Lin B; Chang RC; So KF
PLoS ONE 2013; 8: e68881 (IGR: 15-3)


54722 Leptin as a neuroprotective agent in glaucoma
Gupta A
Medical Hypotheses 2013; 81: 797-802 (IGR: 15-3)


54395 Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Araie M;
American Journal of Ophthalmology 2013; 156: 731-736 (IGR: 15-3)


54599 Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline
Platania CB; Leggio GM; Drago F; Salomone S; Bucolo C
Biochemical Pharmacology 2013; 86: 1347-1356 (IGR: 15-3)


54664 Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II
Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
International Journal of Pharmaceutics 2013; 456: 499-507 (IGR: 15-3)


54348 Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles
Turturro S; Sunoqrot S; Ying H; Hong S; Yue BY
Molecular pharmaceutics 2013; 10: 3023-3032 (IGR: 15-3)


54406 The Effects of Remifentanil and Esmolol on Increase in Intraocular Pressure Due to Laryngoscopy and Tracheal Intubation: A Double-Blind, Randomized Clinical Trial
Tuzcu K; Tuzcu EA; Karcioglu M; Davarci I; Coskun M; Ilhan O; Daglioglu MC; Turhanoglu S
Journal of Glaucoma 2015; 24: 372-376 (IGR: 15-3)


53973 Ethyl pyruvate treatment mitigates oxidative stress damage in cultured trabecular meshwork cells
Famili A; Ammar DA; Kahook MY
Molecular Vision 2013; 19: 1304-1309 (IGR: 15-2)


53825 Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells
Thomasy SM; Morgan JT; Wood JA; Murphy CJ; Russell P
Experimental Eye Research 2013; 113: 66-73 (IGR: 15-2)


53533 Synthesis and biological evaluation of urea derivatives as highly potent and selective rho kinase inhibitors
Yin Y; Lin L; Ruiz C; Khan S; Cameron MD; Grant W; Pocas J; Eid N; Park H; Schröter T; Lograsso PV; Feng Y
Journal of Medicinal Chemistry 2013; 56: 3568-3581 (IGR: 15-2)


53708 Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio
Kernt M; Arend N; Buerger A; Mann T; Haritoglou C; Ulbig MW; Kampik A; Hirneiss C
Journal of Glaucoma 2013; 22: 404-412 (IGR: 15-2)


53856 An Effective Prodrug Strategy to Selectively Enhance Ocular Exposure of a Cannabinoid Receptor (CB1/2) Agonist
Mainolfi N; Powers J; Amin J; Long D; Lee W; McLaughlin ME; Jaffee B; Brain CT; Elliott J; Sivak JM
Journal of Medicinal Chemistry 2013; 0: (IGR: 15-2)


53523 Targeting the A3 adenosine receptor for glaucoma treatment (review)
Fishman P; Cohen S; Bar-Yehuda S
Molecular medicine reports 2013; 7: 1723-1725 (IGR: 15-2)


54004 Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension
Sandalon S; Könnecke B; Levkovitch-Verbin H; Simons M; Hein K; Sättler MB; Bähr M; Ofri R
Experimental Eye Research 2013; 115: 47-56 (IGR: 15-2)


53977 Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice
Howell GR; Soto I; Ryan M; Graham LC; Smith RS; John SW
Journal of Neuroinflammation 2013; 10: 76 (IGR: 15-2)


53903 Intravitreal cidofovir injection for the management of chronic glaucoma in dogs
Low MC; Landis ML; Peiffer RL
Veterinary Ophthalmology 2014; 17: 201-206 (IGR: 15-2)


53780 Effect of intranasal budesonide irrigations on intraocular pressure
Seiberling KA; Chang DF; Nyirady J; Park F; Church CA
International forum of allergy & rhinology 2013; 3: 704-707 (IGR: 15-2)


53500 Effects of thailanstatins on glucocorticoid response in trabecular meshwork and steroid-induced glaucoma
Jain A; Liu X; Wordinger RJ; Yorio T; Cheng YQ; Clark AF
Investigative Ophthalmology and Visual Science 2013; 54: 3137-3142 (IGR: 15-2)


53933 Nerve growth factor: basic studies and possible therapeutic applications
Manni L; Rocco ML; Bianchi P; Soligo M; Guaragna M; Barbaro SP; Aloe L
Growth Factors 2013; 31: 115-122 (IGR: 15-2)


53472 Dynamic mobilization of PGC-1α mediates mitochondrial biogenesis for the protection of RGC-5 cells by resveratrol during serum deprivation
Chen S; Fan Q; Li A; Liao D; Ge J; Laties AM; Zhang X
Apoptosis 2013; 18: 786-799 (IGR: 15-2)


53695 Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo
Carta F; Akdemir A; Scozzafava A; Masini E; Supuran CT
Journal of Medicinal Chemistry 2013; 56: 4691-4700 (IGR: 15-2)


53778 Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Investigative Ophthalmology and Visual Science 2013; 54: 4296-4306 (IGR: 15-2)


53553 Randomized, Double-Masked, Placebo-Controlled Study to Assess the Ocular Safety of Mirabegron in Healthy Volunteers
Novack GD; Lewis RA; Vogel R; Sheth N; Swearingen D; Rasmussen S; Hantsbarger G; Martin NE
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 674-680 (IGR: 15-2)


54058 Effect of 0.004% travoprost and 2% carteolol on intraocular pressure in patients with ocular hypertension after laser peripheral iridotomy or trabeculectomy in primary angle-closure glaucoma
Yao BQ; Pang YY; Li YX
Chinese Journal of Ophthalmology 2013; 49: 340-344 (IGR: 15-2)


53948 Phase 1 Clinical Trials of a Selective Rho Kinase Inhibitor, K-115
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Araie M;
JAMA ophthalmology 2013; 0: 1-8 (IGR: 15-2)


53559 Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma
Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
Journal of Pharmacology and Experimental Therapeutics 2013; 346: 138-145 (IGR: 15-2)


54052 Role of dopaminergic receptors in glaucomatous disease modulation
Pescosolido N; Parisi F; Russo P; Buomprisco G; Nebbioso M
BioMed research international 2013; 2013: 193048 (IGR: 15-2)


53924 Rho-associated kinase inhibitors: A novel glaucoma therapy
Inoue T; Tanihara H
Progress in Retinal and Eye Research 2013; 37: 1-12 (IGR: 15-2)


52969 Protective effects of a compound isolated from Alnus japonica on oxidative stress-induced death in transformed retinal ganglion cells
Jo H; Choi SJ; Jung SH
Food and Chemical Toxicology 2013; 56: 425-435 (IGR: 15-1)


53096 The role of transforming growth factor β in glaucoma and the therapeutic implications
Prendes MA; Harris A; Wirostko BM; Gerber AL; Siesky B
British Journal of Ophthalmology 2013; 97: 680-686 (IGR: 15-1)


52709 Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model
Abdul Y; Akhter N; Husain S
Investigative Ophthalmology and Visual Science 2013; 54: 1816-1828 (IGR: 15-1)


53246 Stanniocalcin-1 protects retinal ganglion cells by inhibiting apoptosis and oxidative damage
Kim SJ; Ko JH; Yun JH; Kim JA; Kim TE; Lee HJ; Kim SH; Park KH; Oh JY
PLoS ONE 2013; 8: e63749 (IGR: 15-1)


52941 Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism
Lavine JA; Sang Y; Wang S; Ip MS; Sheibani N
JAMA ophthalmology 2013; 131: 376-382 (IGR: 15-1)


53207 Inhibition of histone deacetylases 1 and 3 protects injured retinal ganglion cells
Chindasub P; Lindsey JD; Duong-Polk K; Leung CK; Weinreb RN
Investigative Ophthalmology and Visual Science 2013; 54: 96-102 (IGR: 15-1)


52789 The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches
Cheong SL; Federico S; Venkatesan G; Mandel AL; Shao YM; Moro S; Spalluto G; Pastorin G
Medicinal Research Reviews 2013; 33: 235-335 (IGR: 15-1)


52537 The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate
Arnold JJ; Hansen MS; Gorman GS; Inoue T; Rao V; Spellen S; Hunsinger RN; Chapleau CA; Pozzo-Miller L; Stamer WD; Challa P
Investigative Ophthalmology and Visual Science 2013; 54: 1118-1126 (IGR: 15-1)


53035 Identification of PDE6D as a molecular target of anecortave acetate via a methotrexate-anchored yeast three-hybrid screen
Shepard AR; Conrow RE; Pang IH; Jacobson N; Rezwan M; Rutschmann K; Auerbach D; Sriramaratnam R; Cornish VW
ACS Chemical Biology 2013; 8: 549-558 (IGR: 15-1)


52837 Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs
Fischer KM; Ward DA; Hendrix DV
American Journal of Veterinary Research 2013; 74: 275-280 (IGR: 15-1)


53128 Oxidative stress and potential applications of free radical scavengers in glaucoma
Aslan M; Dogan S; Kucuksayan E
Redox report : communications in free radical research 2013; 18: 76-87 (IGR: 15-1)


52750 Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X
Stamer WD; Hoffman EA; Kurali E; Krauss AH
Investigative Ophthalmology and Visual Science 2013; 54: 2100-2107 (IGR: 15-1)


52528 Protective effects of the compounds isolated from the seed of Psoralea corylifolia on oxidative stress-induced retinal damage
Kim KA; Shim SH; Ahn HR; Jung SH
Toxicology and applied pharmacology 2013; 269: 109-120 (IGR: 15-1)


51647 Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism
Suntharalingam A; Abisambra JF; O'Leary JC; Koren J; Zhang B; Joe MK; Blair LJ; Hill SE; Jinwal UK; Cockman M; Duerfeldt AS; Tomarev S; Blagg BS; Lieberman RL; Dickey CA
Journal of Biological Chemistry 2012; 287: 40661-40669 (IGR: 14-4)


51658 The activity of lowering intraocular pressure of cassiae seed extract in a DBA/2J mouse glaucoma model
Horng CT; Tsai ML; Chien ST; Kao WT; Tsai MK; Chang TH; Chen FA
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 48-54 (IGR: 14-4)


51996 Melatonin analogue agomelatine reduces rabbit's intraocular pressure in normotensive and hypertensive conditions
Martínez-Águila A; Fonseca B; Bergua A; Pintor J
European Journal of Pharmacology 2013; 701: 213-217 (IGR: 14-4)


51640 Comparison of single versus multiple injections of the protein saratin for prolonging bleb survival in a rabbit model
Min J; Lukowski ZL; Levine MA; Meyers CA; Beattie AR; Schultz GS; Samuelson DA; Sherwood MB
Investigative Ophthalmology and Visual Science 2012; 53: 7625-7630 (IGR: 14-4)


52046 A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma
Long DD; Frieman B; Hegde SS; Hill CM; Jiang L; Kintz S; Marquess DG; Purkey H; Shaw JP; Steinfeld T; Wilson MS; Wrench K
Bioorganic and Medicinal Chemistry Letters 2013; 23: 939-943 (IGR: 14-4)


51739 Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension
Mi XS; Feng Q; Lo AC; Chang RC; Lin B; Chung SK; So KF
PLoS ONE 2012; 7: e45469 (IGR: 14-4)


51754 Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
Pertwee RG
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2012; 367: 3353-3363 (IGR: 14-4)


51990 Poloxamine micellar solubilization of α-tocopherol for topical ocular treatment
Ribeiro A; Sandez-Macho I; Casas M; Alvarez-Pérez S; Alvarez-Lorenzo C; Concheiro A
Colloids and surfaces. B, Biointerfaces 2013; 103: 550-557 (IGR: 14-4)


52002 Effects of roscovitine, a cell cycling-dependent kinase inhibitor, on intraocular pressure of rabbit and retinal ganglion cell damage
Kasai H; Imamura T; Tsuruma K; Takahashi Y; Kurasawa T; Hirata H; Shimazawa M; Hara H
Neuroscience Letters 2013; 535: 95-99 (IGR: 14-4)


51668 Effects of black currant anthocyanins on intraocular pressure in healthy volunteers and patients with glaucoma
Ohguro H; Ohguro I; Yagi S
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 61-67 (IGR: 14-4)


51626 The effects of transforming growth factor-β2 on the expression of follistatin and activin A in normal and glaucomatous human trabecular meshwork cells and tissues
Fitzgerald AM; Benz C; Clark AF; Wordinger RJ
Investigative Ophthalmology and Visual Science 2012; 53: 7358-7369 (IGR: 14-4)


52099 Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Sericin into Timolol Maleate Eye Drops
Nagai N; Ito Y; Okamoto N; Shimomura Y
Journal of oleo science 2013; 62: 159-166 (IGR: 14-4)


51235 Melatonin: an underappreciated player in retinal physiology and pathophysiology
Tosini G; Baba K; Hwang CK; Iuvone PM
Experimental Eye Research 2012; 103: 82-89 (IGR: 14-3)


51142 Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro
Wang ZY; Mo XF; Jiang XH; Rong XF; Miao HM
Acta physiologica Sinica 2012; 64: 417-424 (IGR: 14-3)


51340 8-Hydroxycalamenene isolated from the rhizomes of Reynoutria elliptica exerts neuroprotective effects both in vitro and in vivo
Jo H; Lee HJ; Kim CY; Son JK; Jung SH
Food and Chemical Toxicology 2012; 51: 231-241 (IGR: 14-3)


51298 The influence of water soluble antioxidant agent (mexidol) on optic nerve and blood flow velocity in ocular and orbital arteries in patients with primary open-angle glaucoma
Volchegorskiĭ IA; Tur EV; Soliannikova OV; Rykun VS; Berdnikova EV; Sumina MS; Dmitrienko VN
Vestnik Oftalmologii 2012; 128: 35-38, 41 (IGR: 14-3)


51245 Protective effects of the β3-adrenoceptor agonist CL316243 against N-methyl-D-aspartate-induced retinal neurotoxicity
Oikawa F; Nakahara T; Akanuma K; Ueda K; Mori A; Sakamoto K; Ishii K
Naunyn-Schmiedeberg's archives of pharmacology 2012; 385: 1077-1081 (IGR: 14-3)


51375 Oxidative stress in the closed-eyelid test: management of glaucoma
Pescosolido N; Malagola R; Scarsella G; Lenarduzzi F; Dapoto L; Nebbioso M
European review for medical and pharmacological sciences 2012; 16: 1453-1457 (IGR: 14-3)


51163 Modeling of LIM-Kinase 2 Inhibitory Activity of Pyrrolopyrimidine Analogues: Useful in Treatment of Ocular Hypertension and Glaucoma
Singh G; Gupta MK; Kumar V; Prabhakar YS
Medicinal Chemistry 2013; 9: 402-409 (IGR: 14-3)


50884 Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets
Nakagawa S; Usui T; Yokoo S; Omichi S; Kimakura M; Mori Y; Miyata K; Aihara M; Amano S; Araie M
Investigative Ophthalmology and Visual Science 2012; 53: 5154-5160 (IGR: 14-3)


51152 Autotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressure
Iyer P; Lalane R; Morris C; Challa P; Vann R; Rao PV
PLoS ONE 2012; 7: e42627 (IGR: 14-3)


50283 Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment
Colligris B; Crooke A; Huete F; Pintor J
Recent patents on endocrine, metabolic & immune drug discovery 2012; 6: 89-98 (IGR: 14-2)


50494 CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension
Denoyer A; Godefroy D; Cé,lé,rier I; Frugier J; Degardin J; Harrison JK; Brignole-Baudouin F; Picaud S; Baleux F; Sahel JA; Rostè,ne W; Baudouin C
PLoS ONE 2012; 7: e37873 (IGR: 14-2)


50499 Effect of diinosine polyphosphates on intraocular pressure in normotensive rabbits
Guzman-Aranguez A; Dí,ez LM; Martí,n-Gil A; Gualix J; Miras-Portugal MT; Pintor J
Experimental Eye Research 2012; 101: 49-55 (IGR: 14-2)


50553 Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues
Crooke A; Colligris B; Pintor J
Current Medicinal Chemistry 2012; 19: 3508-3522 (IGR: 14-2)


50578 Is low dose of Estrogen beneficial for prevention of glaucoma?
Wei X; Cai SP; Zhang X; Li X; Chen X; Liu X
Medical Hypotheses 2012; 79: 377-380 (IGR: 14-2)


50539 Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang K; Zhang L; Weinreb RN
Nature Reviews Drug Discovery 2012; 11: 541-559 (IGR: 14-2)


50585 Oral Administration of Forskolin and Rutin Contributes to Intraocular Pressure Control in Primary Open Angle Glaucoma Patients Under Maximum Tolerated Medical Therapy
Vetrugno M; Uva MG; Russo V; Iester M; Ciancaglini M; Brusini P; Centofanti M; Rossetti LM
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 536-541 (IGR: 14-2)


50214 Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy
Ribeiro A; Sosnik A; Chiappetta DA; Veiga F; Concheiro A; Alvarez-Lorenzo C
Journal of the Royal Society, Interface / the Royal Society 2012; 9: 2059-2069 (IGR: 14-2)


50603 Curcuminoids in Neurodegenerative Diseases
Kim DS; Kim JY; Han Y
Recent Patents on CNS Drug Discovery 2012; 7: 184-204 (IGR: 14-2)


49014 Preventive effects of omega-3 and omega-6 Fatty acids on peroxide mediated oxidative stress responses in primary human trabecular meshwork cells
Tourtas T; Birke MT; Kruse FE; Welge-Lü,ssen UC; Birke K
PLoS ONE 2012; 7: e31340 (IGR: 14-1)


49000 Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14)
Osborne NN; Ji D; Majid AS; Del Soldata P; Sparatore A
Neurochemistry International 2012; 60: 365-378 (IGR: 14-1)


48816 Guanylate cyclase activators, cell volume changes and IOP reduction
Ellis DZ
Cellular Physiology and Biochemistry 2011; 28: 1145-1154 (IGR: 14-1)


49030 Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma
Zode GS; Bugge KE; Mohan K; Grozdanic SD; Peters JC; Koehn DR; Anderson MG; Kardon RH; Stone EM; Sheffield VC
Investigative Ophthalmology and Visual Science 2012; 53: 1557-1565 (IGR: 14-1)


48840 1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates
Kutuzova GD; Gabelt BT; Kiland JA; Hennes-Beann EA; Kaufman PL; DeLuca HF
Archives of Biochemistry and Biophysics 2012; 518: 53-60 (IGR: 14-1)


49142 Norrin: Molecular and functional properties of an angiogenic and neuroprotective growth factor
Ohlmann A; Tamm ER
Progress in Retinal and Eye Research 2012; 31: 243-257 (IGR: 14-1)


48967 Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo
Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Masini E; Supuran CT
Journal of Medicinal Chemistry 2012; 55: 1721-1730 (IGR: 14-1)


48812 Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes
Wang RF; Podos SM; Serle JB; Baltatu OC
Experimental Eye Research 2012; 94: 146-149 (IGR: 14-1)


49004 Pregnenolone sulfate decreases intraocular pressure and changes expression of sigma receptor in a model of chronic ocular hypertension
Sun X; Cheng F; Meng B; Yang B; Song W; Yuan H
Molecular Biology Reports 2012; 39: 6607-6614 (IGR: 14-1)


49359 Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction
Kurihara T; Ozawa Y; Ishida S; Okano H; Tsubota K
International Journal of Inflammation 2012; 2012: 581695 (IGR: 14-1)


48814 Dopamine-₃ receptor modulates intraocular pressure: implications for glaucoma
Bucolo C; Leggio GM; Maltese A; Castorina A; D'Agata V; Drago F
Biochemical Pharmacology 2012; 83: 680-686 (IGR: 14-1)


48525 A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties Mechanism of action and preliminary pharmacology
Fabrizi F; Mincione F; Somma T; Scozzafava G; Galassi F; Masini E; Impagnatiello F; Supuran CT
Journal of Enzyme Inhibition and Medicinal Chemistry 2012; 27: 138-147 (IGR: 14-1)


48529 Palmitoylethanolamide effects on intraocular pressure after Nd:YAG laser iridotomy: an experimental clinical study
Pescosolido N; Librando A; Puzzono M; Nebbioso M
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 629-635 (IGR: 14-1)


48532 A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits
Altinsoy A; Dilekö,z E; Kul O; Ilhan SÖ,; Tunccan OG; Seven I; Bagriacik EU; Sarioglu Y; Or M; Ercan ZS
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 545-552 (IGR: 14-1)


48620 Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy
Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
Journal of Pharmaceutical Sciences 2012; 101: 616-626 (IGR: 14-1)


49130 Two-Year Randomized, Placebo-Controlled Study of Black Currant Anthocyanins on Visual Field in Glaucoma
Ohguro H; Ohguro I; Katai M; Tanaka S
Ophthalmologica 2012; 228: 26-35 (IGR: 14-1)


49109 Effect of tetrandrine on bax, bcl-2 and TGF-β2 mRNA expressions in cultured human Tenon's capsule fibroblasts
Li D; Sun M; Li Q; Yang F; Lin S; Wu K
Journal of Southern Medical University 2012; 32: 97-100 (IGR: 14-1)


48825 Clinical study on interferon treatment of early scarring in filtering bleb
Wang WH; Zhang JL; Huang Y; Huang JX; Jiang JH
Eye Science 2011; 26: 197-200 (IGR: 14-1)


49053 Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery
Arslan S; Aydemir O; Gü,ler M; DaÄŸlı AF
Current Eye Research 2012; 37: 228-233 (IGR: 14-1)


47577 Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma
Zode GS; Kuehn MH; Nishimura DY; Searby CC; Mohan K; Grozdanic SD; Bugge K; Anderson MG; Clark AF; Stone EM
Journal of Clinical Investigation 2011; 121: 3542-3553 (IGR: 13-4)


48136 Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease
Bakalash S; Pham M; Koronyo Y; Salumbides BC; Kramerov A; Seidenberg H; Berel D; Black KL; Koronyo-Hamaoui M
Investigative Ophthalmology and Visual Science 2011; 52: 9033-9046 (IGR: 13-4)


47581 Indirect sympatholytic actions at (beta)-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists
Hudson BD; Beazley M; Szczesniak A-M; Straiker A; Kelly MEM
Journal of Pharmacology and Experimental Therapeutics 2011; 339: 757-767 (IGR: 13-4)


48001 Effect of recombinant human erythropoietin on bcl-2 protein expression in the retina in a rabbit model of acute high intraocular pressure
Wang JM; Song YP; Sun NX; Hui N; Zhao SP; Hu K
Journal of Southern Medical University 2010; 30: 552-554 (IGR: 13-4)


47924 Tafluprost for glaucoma
Papadia M; Bagnis A; Scotto R; Traverso CE
Expert Opinion in Pharmacotherapy 2011; 12: 2393-2401 (IGR: 13-4)


47679 The role of neurotrophins and mimetics in the treatment of ocular diseases
Bai Y; Ge J; Saragovi HU; Zhuo Y
Drugs of the Future 2011; 36: 123-131 (IGR: 13-4)


48421 Simvastatin upregulates Bcl-2 expression and protects retinal neurons from early ischemia/reperfusion injury in the rat retina
Ko ML; Chen CF; Peng PH; Peng YH
Experimental Eye Research 2011; 93: 580-585 (IGR: 13-4)


48338 Down-regulation of matrix metalloproteinase-9 by pyrrolidine dithiocarbamate prevented retinal ganglion cell death after transection of optic nerve in rats
Sun MH; Chen KJ; Tsao YP; Kao LY; Han WH; Lin KK; Pang JH
Current Eye Research 2011; 36: 1053-1063 (IGR: 13-4)


48260 Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model
Thaler S; Fiedorowicz M; Grieb P; Wypych Z; Knap N; Borowik T; Zawada K; Kaminski J; Wozniak M; Rejdak R
Acta Ophthalmologica 2011; 89: 555-560 (IGR: 13-4)


47600 Cannabinoids and their possible use in the treatment of glaucoma
Aldana BZ; Rodriguez IM; Pineda NT
Revista Cubana de Farmacia 2011; 45: 439-448 (IGR: 13-4)


47596 Effect of Ketorolac Add-On Treatment on Intra-Ocular Pressure in Glaucoma Patients Receiving Prostaglandin Analogues
Turan-Vural E; Torun-Acar B; Acar S
Ophthalmologica 2011; (IGR: 13-4)


47896 Adenosine receptor targeting in health and disease
Gessi S; Merighi S; Fazzi D; Stefanelli A; Varani K; Borea PA
Expert Opinion on Investigational Drugs 2011; 20: 1591-1609 (IGR: 13-4)


47824 Pharmacokinetics of pirfenidone after topical administration in rabbit eye
Sun G; Lin X; Zhong H; Yang Y; Qiu X; Ye C; Wu K; Yu M
Molecular Vision 2011; 17: 2191-2196 (IGR: 13-4)


47678 Novel therapeutic approaches for glaucoma
Rasmussen CA; Kaufman PL
Drugs of the Future 2011; 36: 287-300 (IGR: 13-4)


48329 Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats
Tokushige H; Waki M; Takayama Y; Tanihara H
Current Eye Research 2011; 36: 964-970 (IGR: 13-4)


47664 Ocular and systemic distribution of ino-8875, a selective adenosine A1 receptor agonist, in rabbits by quantitative whole body autoradiography (QWBA) and tissue analysis
Prescott E; Struble C; Denissen J; Kim N
Drug Metabolism Reviews 2011; 43: 78-79 (IGR: 13-4)


48242 Efficacy and tolerability of topical 0 0.5% flunarizine in patients with open-angle glaucoma or ocular hypertension-a pilot study
Mansouri K; Silva SE; Shaarawy T
Journal of Glaucoma 2011; 20: 519-522 (IGR: 13-4)


48283 Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2? agonist, in preclinical models
Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
Experimental Eye Research 2011; 93: 250-255 (IGR: 13-4)


48323 Similar hydrodynamic and morphological changes in the aqueous humor outflow pathway after washout and Y27632 treatment in monkey eyes
Lu Z; Zhang Y; Freddo TF; Gong H
Experimental Eye Research 2011; 93: 397-404 (IGR: 13-4)


47580 Effect of ion pairing on in vitro transcorneal permeability of a (Delta)(9)-tetrahydrocannabinol prodrug: Potential in glaucoma therapy
Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
Journal of Pharmaceutical Sciences 2011; (IGR: 13-4)


48334 Evaluation of Sustained Release of PLC-Loaded Prednisolone Acetate Microfilm on Postoperative Inflammation in an Experimental Model of Glaucoma Filtration Surgery
Ang M; Yan P; Zhen M; Foo S; Venkatraman SS; Wong TT
Current Eye Research 2011; 36: 1123-1128 (IGR: 13-4)


47803 Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model
Lukowski ZL; Min J; Beattie AR; Meyers CA; Levine MA; Stoller G; Schultz GS; Samuelson DA; Sherwood MB
Journal of Glaucoma 2011; (IGR: 13-4)


47123 Oral administration of an association of forskolin, rutin and vitamins B1 and B2 potentiates the hypotonising effects of pharmacological treatments in POAG patients
Pescosolido N; Librando A
Clinica Terapeutica 2010; 161: 81-85 (IGR: 13-3)


46864 Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits
Song Z; Gong Y; Liu H; Ren Q; Sun X
Molecular Vision 2011; 17: 2056-2064 (IGR: 13-3)


46998 Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes
Pirie CG; Maranda LS; Pizzirani S
Veterinary Ophthalmology 2011; 14: 71-79 (IGR: 13-3)


46956 Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea
Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
Journal of oleo science 2010; 59: 423-430 (IGR: 13-3)


46688 A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension
Schachar RA; Raber S; Courtney R; Zhang M
Current Eye Research 2011; 36: 809-817 (IGR: 13-3)


47128 Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors
Almasieh M; Zhou Y; Kelly ME; Casanova C; Di Polo A
Cell Death and Disease 2010; 1: 27 (IGR: 13-3)


46464 Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients with Glaucoma and Ocular Hypertension
Williams RD; Novack GD; Van Haarlem T; Kopczynski C
American Journal of Ophthalmology 2011; (IGR: 13-3)


46716 Cannabinoid applications in glaucoma
Pinar-Sueiro S; Rodriguez-Puertas R; Vecino E
Archivos de la Sociedad Española de Oftalmologia 2011; 86: 16-23 (IGR: 13-3)


46757 Manganese porphyrin reduces retinal injury induced by ocular hypertension
Dogan S; Baranowska K; Walankiewicz M; Yargicoglu P; Unal M; Spasojevic I; Haberle IB; Aslan M
Free Radical Biology and-Medicine 2010; 49: S176-S177 (IGR: 13-3)


46613 Ocular hypotensive effect of oral palmitoyl-ethanolamide: A clinical trial
Gagliano C; Ortisi E; Pulvirenti L; Reibaldi M; Scollo D; Amato R; Avitabile T; Longo A
Investigative Ophthalmology and Visual Science 2011; 52: 6096-6100 (IGR: 13-3)


46906 Novel ocular antihypertensive compounds in clinical trials
Chen J; Runyan SA; Robinson MR
Clinical Ophthalmology 2011; 5: 667-677 (IGR: 13-3)


47065 Local Ocular Renin-Angiotensin System - A Target for Glaucoma Therapy?
Vaajanen A; Vapaatalo H
Basic and Clinical Pharmacology and Toxicology 2011; (IGR: 13-3)


46750 Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: Challenges of dual combination therapy with N-acetylcarnosine lubricant eye d
Babizhayev MA
Fundamental and Clinical Pharmacology 2011; (IGR: 13-3)


46546 Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries
Watabe H; Abe S; Yoshitomi T
Japanese Journal of Ophthalmology 2011; (IGR: 13-3)


46668 Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martinez IT; Young MJ; Herrero-Vanrell R
Journal of Controlled Release 2011; (IGR: 13-3)


46997 Evaluation of the ocular penetration of topical alpha-luminol (Galavit((registered trademark))/GVT((registered trademark)))
da Silva EG; Gionfriddo JR; Hudachek SF; Gustafson DL; Olea-Popelka FJ; Scofield VL; Powell CC; Hill AE
Veterinary Ophthalmology 2011; 14: 180-185 (IGR: 13-3)


47018 Can topical ketorolac 0.5% improve the function of Ahmed glaucoma drainage devices?
Scott GR; Weizer JS; Moroi SE; Bruno CA; Musch DC; Niziol LM; Lee PP; Stein JD
Ophthalmic Surgery Lasers and Imaging 2011; 42: 190-195 (IGR: 13-3)


46446 Monoclonal antibodies in ophthalmology
Biswas NR; Das GK; Dubey AK
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2010; 12: 264-271 (IGR: 13-3)


45634 Real-time measurements of nicotinamide adenine dinucleotide in live human trabecular meshwork cells: Effects of acute oxidative stress
Masihzadeh O; Ammar DA; Lei TC; Gibson EA; Kahook MY
Experimental Eye Research 2011; (IGR: 13-2)


46301 Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death
Gregory MS; Hackett CG; Abernathy EF; Lee KS; Saff RR; Hohlbaum AM; Moody KL; Hobson MW; Jones A; Kolovou P
PLoS ONE 2011; 6: e17659 (IGR: 13-2)


46168 Current and emerging medical therapies in the treatment of glaucoma
Bagnis A; Papadia M; Scotto R; Traverso CE
Expert Opinion on Emerging Drugs 2011; 16: 293-307 (IGR: 13-2)


46112 Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
Duncan RS; Xin H; Goad DL; Chapman KD; Koulen P
Clinical Ophthalmology 2011; 5: 543-548 (IGR: 13-2)


45491 Rasagiline-induced Delay of Retinal Ganglion Cell Death in Experimental Glaucoma in Rats
Levkovitch-Verbin H; Vander S; Melamed S
Journal of Glaucoma 2011; 20: 273-277 (IGR: 13-2)


45733 A selective inhibitor of Drp1, Mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina
Park SW; Kim K-Y; Lindsey JD; Dai Y; Heo H; Nguyen DH; Ellisman MH; Weinreb RN; Ju W-K
Investigative Ophthalmology and Visual Science 2011; 52: 2837-2843 (IGR: 13-2)


46102 Closed gateways- Can neuroprotectants shield the retina in glaucoma?
Velpandian T
Drugs in R&D 2010; 10: 93-96 (IGR: 13-2)


46103 Visual field protective effect of erigeron breviscapus (vant.) hand. mazz. extract on glaucoma with controlled intraocular pressure: A randomized, double-blind, clinical trial
Zhong Y; Xiang M; Ye W; Cheng Y; Jiang Y
Drugs in R&D 2010; 10: 75-82 (IGR: 13-2)


45658 Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits
Alarma-Estrany P; Guzman-Aranguez A; Huete F; Peral A; Plourde Jr R; Pelaez T; Yerxa B; Pintor J
Journal of Pharmacology and Experimental Therapeutics 2011; 337: 703-709 (IGR: 13-2)


46317 Asymmetric synthesis of potent chroman-based Rho kinase (ROCK-II) inhibitors
Chen YT; Vojkovsky T; Fang X; Pocas JR; Grant W; Handy AMW; Schroter T; LoGrasso P; Bannister TD; Feng Y
MedChemComm 2011; 2: 73-75 (IGR: 13-2)


45942 Biological activity of quinoxaline derivatives
Deepika Y; Nath PS; Sachin K; Shewta S
International Journal of Current Pharmaceutical Review and Research 2011; 2: 33-46 (IGR: 13-2)


45630 A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs
Impagnatiello F; Borghi V; Gale DC; Batugo M; Guzzetta M; Brambilla S; Carreiro ST; Chong WKM; Prasanna G; Chiroli V
Experimental Eye Research 2011; (IGR: 13-2)


45627 Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating Prostaglandin F2(alpha) agonist, in preclinical models
Krauss AHP; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WKM; Carreiro ST; Ongini E
Experimental Eye Research 2011; (IGR: 13-2)


45922 Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action
Mincione F; Benedini F; Biondi S; Cecchi A; Temperini C; Formicola G; Pacileo I; Scozzafava A; Masini E; Supuran CT
Bioorganic and Medicinal Chemistry Letters 2011; 21: 3216-3221 (IGR: 13-2)


45628 Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma
Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D
Experimental Eye Research 2011; (IGR: 13-2)


46130 (alpha)2C-adrenoceptor modulators: A patent review
Quaglia W; Del Bello F; Giannella M; Piergentili A; Pigini M
Expert Opinion on Therapeutic Patents 2011; 21: 455-481 (IGR: 13-2)


45687 Combined treatment in patients with unstabilized glaucoma
Shtilerman AL; Mikhal'skii EA; Lysiak IV
Vestnik Oftalmologii 2010; 126: 28-31 (IGR: 13-2)


46063 Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension
Sun H; Wang Y; Pang I-H; Shen J; Tang X; Li Y; Liu C; Li B
Molecular Vision 2011; 17: 864-875 (IGR: 13-2)


45642 Functional and morphological effects of (beta)-estradiol in eyes with N-methyl-d-Aspartate-induced retinal neurotoxicity in rats
Yamashita H; Yamada-Nakayama C; Sugihara K; Tsuji S; Sakurai T; Ban Y; Tsutsumi S; Sato Y
Experimental Eye Research 2011; (IGR: 13-2)


45734 The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes
Andres-Guerrero V; Molina-Martinez IT; Pera A; de las Heras B; Pintor J; Herrero-Vanrell R
Investigative Ophthalmology and Visual Science 2011; 52: 1507-1515 (IGR: 13-2)


46186 Enhanced Solubility, Stability, and Transcorneal Permeability of Delta-8-Tetrahydrocannabinol in the Presence of Cyclodextrins
Hippalgaonkar K; Gul W; Elsohly MA; Repka MA; Majumdar S
AAPS PharmSciTech 2011; (IGR: 13-2)


45947 Inhibition of TGF beta 2 shRNA on human Tenon's capsular fibroblasts
Luo W; Sun L; Li J-M
Chinese Ophthalmic Research 2010; 28: 1150-1153 (IGR: 13-2)


45945 Inhibition effect of P27 tumor suppressor gene transfection on human Tenon's fibroblast cells
Sun L; Luo W; Li J-M
Chinese Ophthalmic Research 2010; 28: 1119-1123 (IGR: 13-2)


45944 Effects of huoxuehuayu prescription on retina with acute intraocular hypertension
Zhang C; Wang D-B; Fang J; Shang W-W
Chinese Ophthalmic Research 2010; 28: 1129-1133 (IGR: 13-2)


28116 Cationic nano-copolymers mediated IKK(beta) targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery
Ye H; Qian Y; Lin M; Duan Y; Sun X; Zhuo Y; Ge J
Molecular Vision 2010; 16: 2502-2510 (IGR: 13-1)


27917 The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents
McKee CT; Wood JA; Shah NM; Fischer ME; Reilly CM; Murphy CJ; Russell P
Biomaterials 2011; 32: 2417-2423 (IGR: 13-1)


27850 Endothelin antagonism as an active principle for glaucoma therapy
Rosenthal R; Fromm M
British Journal of Pharmacology 2011; 162: 806-816 (IGR: 13-1)


27706 Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats
Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK
Experimental Eye Research 2011; 92: 112-119 (IGR: 13-1)


27688 Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension
Huang P; Xu Y; Wei R; Li H; Tang Y; Liu J; Zhang SS; Zhang C
Journal of Glaucoma 2011; 20: 183-188 (IGR: 13-1)


27676 Alpha-Crystallin Promotes Rat Retinal Neurite Growth on Myelin Substrates in vitro
Wang YH; Wang DW; Wu N; Wang Y; Yin ZQ
Ophthalmic Research 2010; 45: 164-168 (IGR: 13-1)


27958 Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes
Wang R-F; Podos SM; Serle JB; Baltatu OC
Current Eye Research 2011; 36: 41-46 (IGR: 13-1)


27741 Cytokine-Dependent ELAM-1 Induction and Concomitant Intraocular Pressure Regulation in Porcine Anterior Eye Perfusion Culture
Birke MT; Birke K; Lütjen-Drecoll E; Schlötzer-Schrehardt U; Hammer CH
Investigative Ophthalmology and Visual Science 2011; 52: 468-475 (IGR: 13-1)


27960 Effect of avosentan (SPP-301) in porcine ciliary arteries
Konieczka K; Meyer P; Schoetzau A; Neutzner A; Mozaffarieh M; Flammer J
Current Eye Research 2011; 36: 118-124 (IGR: 13-1)


28157 Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up
Allegri P; Mastromarino A; Neri P
Clinical Ophthalmology 2010; 4: 1201-1206 (IGR: 13-1)


28205 Pharmacotherapies for glaucoma
Toris CB
Current Molecular Medicine 2010; 10: 824-840 (IGR: 13-1)


28149 Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
Pozarowska D
Clinical Ophthalmology 2010; 4: 1229-1236 (IGR: 13-1)


28150 Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension
Schnober D; Hofmann G; Maier H; Scherzer M-L; Ogundele AB; Jasek MC
Clinical Ophthalmology 2010; 4: 1459-1463 (IGR: 13-1)


27999 Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline
Levkovitch-Verbin H; Spierer O; Vander S; Dardik R
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; 1-9 (IGR: 13-1)


28068 Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma
Colafrancesco V; Parisi V; Sposato V; Rossi S; Russo MA; Coassin M; Lambiase A; Aloe L
Journal of Glaucoma 2011; 20: 100-108 (IGR: 13-1)


27938 Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina
Teuchner B; Dimmer A; Troger J; Fischer-Colbrie R; Schmid E; Kieselbach G; Dietrich H; Bechrakis N
Regulatory Peptides 2010; 165: 123-127 (IGR: 13-1)


28019 Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse
Endo K; Nakamachi T; Seki T; Kagami N; Wada Y; Nakamura K; Kishimoto K; Hori M; Tsuchikawa D; Shinntani N
Journal of Molecular Neuroscience 2011; 43: 22-29 (IGR: 13-1)


28048 Neuro-protective effects of yiyanming solution on visual function of glaucoma patient
Wang Y; Qiu B; Zhang C-X; Ou Y; Pang L; Li Z-P
Chinese Ophthalmic Research 2010; 28: 1087-1090 (IGR: 13-1)


28035 Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors
Fang X; Chen YT; Sessions EH; Chowdhury S; Vojkovsky T; Yin Y; Pocas JR; Grant W; Schroter T; Lin L
Bioorganic and Medicinal Chemistry Letters 2011; 21:1844-1848 (IGR: 13-1)


28165 Use of calcium channel blockers for glaucoma
Araie M; Mayama C
Progress in Retinal and Eye Research 2011; 30: 54-71 (IGR: 13-1)


27758 Quercetin Induces the Expression of Peroxiredoxins 3 and 5 via the Nrf2/NRF1 Transcription Pathway
Miyamoto N; Izumi H; Miyamoto R; Kondo H; Tawara A; Sasaguri Y; Kohno K
Investigative Ophthalmology and Visual Science 2011; 52: 1055-1063 (IGR: 13-1)


28181 Emerging drugs for ocular hypertension
Lee AJ; Goldberg I
Expert Opinion on Emerging Drugs 2011; 16: 137-161 (IGR: 13-1)


28222 Role of nitric oxide in the regulation of intraocular pressure: A possibility for glaucoma treatment
Vapaatalo H; Kotikoski H; Oksala O
Expert Review of Ophthalmology 2010; 5: 751-758 (IGR: 13-1)


28185 Future possibilities in glaucoma therapy
Wierzbowska J; Robaszkiewicz J; Figurska M; Stankiewicz A
Case Reports and Clinical Practice Review 2010; 16: 252-259 (IGR: 13-1)


27737 Effects of Fasudil, a Rho-Associated Protein Kinase Inhibitor, on Optic Nerve Head Blood Flow in Rabbits
Sugiyama T; Shibata M; Kajiura S; Okuno T; Tonari M; Oku H; IkedaT
Investigative Ophthalmology and Visual Science 2011; 52: 64-69 (IGR: 13-1)


28215 Potential for serotonergic agents to treat elevated intraocular pressure and glaucoma: Focus on 5-HT(2) receptor agonists
Sharif NA; May JA
Expert Review of Ophthalmology 2011; 6: 105-120 (IGR: 13-1)


28227 Prevention of filtering surgery failure by subconjunctival injection of a novel peptide hydrogel into rabbit eyes
Liang L; Xu XD; Zhang XZ; Feng M; Peng C; Jiang FG
Biomedical Materials 2010; 5: 045008) (IGR: 13-1)


28229 Therapeutic potential of new hydrogen sulfide-releasing hybrids
Sparatore A; Santus G; Giustarini D; Rossi R; Del Soldato P
Expert Review of Clinical Pharmacology 2011; 4: 109-121 (IGR: 13-1)


27957 A potential new therapeutic system for glaucoma: Solid lipid nanoparticles containing methazolamide
Li R; Jiang S; Liu D; Bi X; Wang F; Zhang Q; Xu Q
Journal of Microencapsulation 2011; 28: 134-141 (IGR: 13-1)


28209 Ophthalmic drug-loaded N,O-carboxymethyl chitosan hydrogels: Synthesis, in vitro and in vivo evaluation
Yang L-Q; Lan Y-Q; Guo H; Cheng L-Z; Fan J-Z; Cai X; Zhang L-M; Chen R-F; Zhou H-S
Acta Pharmacologica Sinica 2010; 31: 1625-1634 (IGR: 13-1)


27265 Sulbutiamine counteracts trophic factor deprivation induced apoptotic cell death in transformed retinal ganglion cells
Kang KD; Abdul Majid AS; Kim K-A; Kang K; Ahn HR; Nho CW; Jung SH
Neurochemical Research 2010; 35: 1828-1839 (IGR: 12-4)


27496 Topical administration of adrenergic receptor pharmaceutics and nerve growth factor
Steinle JJ
Clinical Ophthalmology 2010; 4: 605-610 (IGR: 12-4)


27222 Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide
Kasmoullar R; Bulbul M; Arslan BS; Goke B
European Journal of Medicinal Chemistry 2010; 45: 4769-4773 (IGR: 12-4)


26972 Intravitreal Injections of Neurotrophic Factors Secreting Mesenchymal Stem Cells Are Neuroprotective in Rat Eyes following Optic Nerve Transection.
Levkovitch-Verbin H; Sadan O; Vander S; Rosner M; Barhum Y; Melamed E; Offen D; Melamed S
Investigative Ophthalmology and Visual Science 2010; 51: 6394-6400 (IGR: 12-4)


27635 Calcium channel blockers: Their use in normal tension glaucoma
Mozaffarieh M; Konieczka K; Flammer J
Expert Review of Ophthalmology 2010; 5: 617-625 (IGR: 12-4)


27492 Mirtogenol((registered trademark)) potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects
Steigerwalt Jr RD; Belcaro G; Morazzoni P; Bombardelli E; Burki C; Schonlau F
Clinical Ophthalmology 2010; 4: 471-476 (IGR: 12-4)


27577 An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma
Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
Investigative ophthalmology & visual science 2010; 51: 4722-4731 (IGR: 12-4)


26983 TRPC6 channel protects retinal ganglion cells in a rat model of retinal ischemia/reperfusion-induced cell death.
Wang X; Teng L; Li A; Ge J; Laties AM; Zhang X
Investigative Ophthalmology and Visual Science 2010; 51: 5751-5758 (IGR: 12-4)


27070 Neuroprotection by acetoacetate and ?-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid.
Thaler S; Choragiewicz TJ; Rejdak R; Fiedorowicz M; Turski WA; Tulidowicz-Bielak M; Zrenner E; Schuettauf F; Zarnowski T
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1729-1735 (IGR: 12-4)


27274 Hypotensive action of naturally occurring diterpenes: A therapeutic promise for the treatment of hypertension
Tirapelli CR; Ambrosio SR; De Oliveira AM; Tostes RC
Fitoterapia 2010; 81: 690-702 (IGR: 12-4)


27319 Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-(beta)-cyclodextrin in rabbit
Ito Y; Nagai N; Shimomura Y
Biological & Pharmaceutical Bulletin 2010; 33: 1574-1578 (IGR: 12-4)


27275 Therapeutic targets for glaucoma
Sorbera LA; Aravamudan J; Dulsat C; Rosa E
Drugs of the Future 2010; 35: 585-592 (IGR: 12-4)


27365 Effect of topically applied moxonidine on intraocular pressure and blood pressure
Zhang Q; Sun N-X; Liu J
Chinese Ophthalmic Research 2010; 28: 611-615 (IGR: 12-4)


27220 Isoquercitrin is the most effective antioxidant in the plant Thuja orientalis and able to counteract oxidative-induced damage to a transformed cell line (RGC-5 cells)
Jung SH; Kim BJ; Lee EH; Osborne NN
Neurochemistry International 2010; 57: 713-721 (IGR: 12-4)


27650 Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action
Sharif NA
Current Drug Targets 2010; 11: 978-993 (IGR: 12-4)


27410 Efficacy and tolerability of topical 0.05% flunarizine in patients with open-angle glaucoma or ocular hypertension-a pilot study
Mansouri K; Silva SE; Shaarawy T
Journal of Glaucoma 2010; (IGR: 12-4)


27029 Sodium orthovanadate effect on outflow facility and intraocular pressure in live monkeys.
Tan JC; Kiland JA; Gonzalez JM; Gabelt BT; Peters DM; Kaufman PL
Experimental Eye Research 2010; 91: 486-490 (IGR: 12-4)


26974 Potentiation of Bortezomib-Induced Apoptosis by TGF-{beta} in Cultured Human Tenon's Fibroblasts: Contribution of the PI3K/Akt Signaling Pathway.
Chung EJ; Moon SW; Jung SA; Cho YJ; Kim SW; Lee JH
Investigative Ophthalmology and Visual Science 2010; 51: 6232-6237 (IGR: 12-4)


27033 The effect of adjuvant dimethylenastron, a mitotic Kinesin eg5 inhibitor, in experimental glaucoma filtration surgery.
Lüke J; Nassar K; Lüke M; Tura A; Merz H; Giannis A; Grisanti S
Current Eye Research 2010; 35: 1090-1098 (IGR: 12-4)


27572 Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis
Klocek MS; Sassani JW; Donahue RN; McLaughlin PJ; Zagon IS
Investigative ophthalmology & visual science 2010; 51: 5054-5061 (IGR: 12-4)


26425 Cyclooxygenase-2 and tissue inhibitor of matrix metalloproteinases-1 confer the antimigratory effect of cannabinoids on human trabecular meshwork cells
Ramer R; Hinz B
Biochemical Pharmacology 2010; 80: 846-857 (IGR: 12-3)


26369 In vitro effects of antivascular endothelial growth factors on cultured human trabecular meshwork cells
Kahook MY; Ammar DA
Journal of Glaucoma 2010; 19: 437-441 (IGR: 12-3)


26446 The calcineurin inhibitor, FK506, does not alter glutamate transport in the ischaemic mouse retina
Holcombe DJ; Gole GA; Barnett NL
Experimental Eye Research 2010; 91: 315-319 (IGR: 12-3)


26382 Dietary deficiency of vitamin E aggravates retinal ganglion cell death in experimental glaucoma of rats
Ko ML; Peng PH; Hsu SY; Chen CF
Current Eye Research 2010; 35: 842-849 (IGR: 12-3)


26332 The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Acta Ophthalmologica 2010; 88: 553-557 (IGR: 12-3)


26315 Neuroprotective effects of C-type natriuretic peptide on rat retinal ganglion cells
Ma J; Yu W; Wang Y; Cao G; Cai S; Chen X; Yan N; Yuan Y; Zeng H; Fleenor DL
Investigative Ophthalmology and Visual Science 2010; 51: 3544-3553 (IGR: 12-3)


26391 Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1
Sun MH; Pang JH; Chen SL; Han WH; Ho TC; Chen KJ; Kao LY; Lin KK; Tsao YP
Investigative Ophthalmology and Visual Science 2010; 51: 4798-4808 (IGR: 12-3)


26869 Protective effects of nerve regeneration factor and brain-derived neurotrophic factor on retinal ganglion cells in a rabbit model of acute hyper-intraocular pressure
Huang Z; Guan H; Ding F; Gu X
Neural Regeneration Research 2010; 5: 445-449 (IGR: 12-3)


26777 Gene delivery of erythropoietin protects retinal ganglion cells in DBA/2J glaucomatous mice
Sullivan TA; Geisert EE; Rex TS
Molecular Therapy 2010; 18: S171 (IGR: 12-3)


26880 Pharmacology of pre-versus postsynaptic A(2)-adrenoceptors
Hein L; Gilsbach R; Haubold M; Albarran-Juarez J; Schneider J
Basic and Clinical Pharmacology and Toxicology 2010; 107: 42-43 (IGR: 12-3)


26825 Effect of Latrunculin-B on rabbit uveoscleral outflow
Li W-G; He X-Z
International Journal of Ophthalmology 2010; 10: 1277-1280 (IGR: 12-3)


26878 Focused Conference Group: P02 - Transmembrane transport: Perspectives for disease and drug discovery calcium signal passway-based on to research the neuroprotection of effective components of traditional chinese medicine
Zhang Y; Lai X; Zhang J
Basic and Clinical Pharmacology and Toxicology 2010; 107: 687 (IGR: 12-3)


26439 Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits
Mehta A; Iyer L; Parmar S; Shah G; Goyal R
Canadian Journal of Physiology and Pharmacology 2010; 88: 595-600 (IGR: 12-3)


26829 Protective effect of Ginaton and fleabane on retinal ganglion cells
Wang M-L; Fei Z-G; Li H; He M-N
International Journal of Ophthalmology 2010; 10: 850-852 (IGR: 12-3)


26771 An overview of satavaptan: A selective V2 receptor antagonist
Farah J; Daifallah S; Zmily H; Ghali JK
Therapy 2010; 7: 409-422 (IGR: 12-3)


26752 Association for research in vision and ophthalmology (ARVO) - 2010 annual meeting. for sight: The future of eye and vision research - Part 2
Hookes L
Idrugs 2010; 13: 430-432 (IGR: 12-3)


26460 Tetrahydroisoquinoline derivatives as highly selective and potent rho kinase inhibitors
Fang X; Yin Y; Chen YT; Yao L; Wang B; Cameron MD; Lin L; Khan S; Ruiz C; Schroter T
Journal of Medicinal Chemistry 2010; 53: 5727-5737 (IGR: 12-3)


26751 Association for research in vision and ophthalmology (ARVO) - 2010 annual meeting. for sight: The future of eye and vision research - Part 1
Hookes L
Idrugs 2010; 13: 427-429 (IGR: 12-3)


26905 Discovery of potent and selective urea-based ROCK inhibitors and their effects on intraocular pressure in rats
Yin Y; Cameron MD; Lin L; Khan S; Schroter T; Grant W; Pocas J; Chen YT; Schurer S; Pachori A
ACS Medicinal Chemistry Letters 2010; 1: 175-179 (IGR: 12-3)


26623 Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucoma
Davis RL; Kahraman M; Prins TJ; Beaver Y; Cook TG; Cramp J; Cayanan CS; Gardiner EMM; McLaughlin MA; Clark AF
Bioorganic and Medicinal Chemistry Letters 2010; 20: 3361-3366 (IGR: 12-3)


26775 Numerical simulations of ethacrynic acid transport from precorneal region to trabecular meshwork
Lin CW; Yuan F
Annals of Biomedical Engineering 2010; 38: 935-944 (IGR: 12-3)


26049 Effects of recombinant human erythropoietin on hypoxia inducible factor-1alpha expression in the retina of rabbits with acute high intraocular pressure
Wang JM; Song YP; Sun NX; Hui N; Zhao SP; Hu K
Journal of Southern Medical University 2009; 29: 271-273 (IGR: 12-2)


25750 Melatonin: A novel neuroprotectant for the treatment of glaucoma
Belforte NA; Moreno MC; de Zavalia N; Sande PH; Chianelli MS; Keller Sarmiento MI; Rosenstein RE
Journal of Pineal Research 2010; 48: 353-364 (IGR: 12-2)


25948 Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage
Fang JH; Wang XH; Xu ZR; Jiang FG
BMC Neuroscience 2010; 11: 31 (IGR: 12-2)


26055 Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye
Hoyle CHV; Pintor JJ
Acta Physiologica 2010; 199: 205-210 (IGR: 12-2)


25830 Copolymer-1 immunization reduces damage in retinal ganglion cells under high intraocular pressure through altering the expression of retinal neurotrophins
Yang B; Shan L; Song W; Xiao Z; Shi L; Yuan H
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 11-19 (IGR: 12-2)


25839 A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma
Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WKM; Gale DC; Kucera DJ
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 125-131 (IGR: 12-2)


25994 Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones
Burns JN; Orwig SD; Harris JL; Watkins JD; Vollrath D; Lieberman RL
ACS Chemical Biology 2010; 5: 477-487 (IGR: 12-2)


25768 Interaction of endocannabinoid receptors with biological membranes
Dainese E; Oddi S; Maccarrone M
Current Medicinal Chemistry 2010; 17: 1487-1499 (IGR: 12-2)


25658 2-MeS-(beta),(gamma)-CCl(2)-ATP is a potent agent for reducing intraocular pressure
Eliahu S; Martin-Gil A; Perez De Lara MJ; Pintor J; Camden J; Weisman GA; Lecka J; Sevigny J; Fischer B
Journal of Medicinal Chemistry 2010; 53: 3305-3319 (IGR: 12-2)


25834 Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN((registered trademark)) or TRAVATAN((registered trademark))
Faulkner R; Sharif NA; Orr S; Sall K; DuBiner H; Whitson JT; Moster M; Craven ER; Curtis M; Pailliotet C
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 147-156 (IGR: 12-2)


25648 Advances in eicosanoid research, novel therapeutic implications
Haeggstrom JZ; Rinaldo-Matthis A; Wheelock CE; Wetterholm A
Biochemical and Biophysical Research Communications 2010; 396: 135-139 (IGR: 12-2)


25987 Effect of the Age Cross-Link Breaker Alagebrium on Anterior Segment Physiology, Morphology, and Ocular Age and Rage
Kiland JA; Gabelt BT; Tezel G; Lutjen-Drecoll E; Kaufman PL
Transactions of the American Ophthalmological Society 2009; 107: 146-158 (IGR: 12-2)


26277 Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits
Loftsson T; Thorisdóttir S; Fridriksdóttir H; Stefánsson E
Acta Ophthalmologica 2010; 88: 337-341 (IGR: 12-2)


26057 Design and application of locally delivered agonists of the adenosine A(2A) receptor
Mantell S; Jones R; Trevethick M
Expert Review of Clinical Pharmacology 2010; 3: 55-72 (IGR: 12-2)


26030 Effects of bushenhuoxue on protecting the visual function of rat with chronic intraocular hypertension
Mao X; Li X
International Journal of Ophthalmology 2010; 10: 238-240 (IGR: 12-2)


25737 New developments in glaucoma medical treatment
Munoz-Negrete FJ; Perez-Lopez M; Won Kim HR; Rebolleda G
Archivos de la Sociedad Española de Oftalmologia 2009; 84: 491-500 (IGR: 12-2)


25817 Intraocular hypotensive effect and action on aqueous humor dynamics of (alpha)-ergocryptine in ocular normotensive and in (alpha)-chymotrypsin-induced ocular hypertensive rabbits
Puras G; Garcia VB; Rivera G
Revista Mexicana de Ciencias Farmaceuticas 2009; 40: 22-29 (IGR: 12-2)


25783 The development of benzimidazoles as selective rho kinase inhibitors
Sessions EH; Smolinski M; Wang B; Frackowiak B; Chowdhury S; Yin Y; Chen YT; Ruiz C; Lin L; Pocas J
Bioorganic and Medicinal Chemistry Letters 2010; 20: 1939-1943 (IGR: 12-2)


25828 A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of tafluprost compared with latanoprost
Traverso CE; Ropo A; Papadia M; Uusitalo H
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 97-104 (IGR: 12-2)


25785 Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation
Vernier W; Chong W; Rewolinski D; Greasley S; Pauly T; Shaw M; Dinh D; Ferre RA; Nukui S; Ornelas M
Bio-organic and Medicinal Chemistry 2010; 18: 3307-3319 (IGR: 12-2)


25832 A pilot study for the effects of donepezil therapy on cerebral and optic nerve head blood flow, visual field defect in normal-tension glaucoma
Yoshida Y; Sugiyama T; Utsunomiya K; Ogura Y; Ikeda T
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 187-192 (IGR: 12-2)


25674 Methazolamide calcium phosphate nanoparticles in an ocular delivery system
Chen R; Qian Y; Li R; Zhang Q; Liu D; Wang M; Xu Q
Yakugaku Zasshi 2010; 130: 419-424 (IGR: 12-2)


25761 Preparation and evaluation of a contact lens vehicle for puerarin delivery
Xu J; Li X; Sun F
Journal of Biomaterials Science, Polymer Edition 2010; 21: 271-288 (IGR: 12-2)


25918 Diclofenac prevents temporal increase of intraocular pressure after uneventful cataract surgery with longer operation time
Shimura M; Nakazawa T; Yasuda K; Shiono T; Nishida K
Clinical Ophthalmology 2009; 3: 95-101 (IGR: 12-2)


25021 Effects of chemical inhibition of N-WASP, a critical regulator of actin polymerization on aqueous humor outflow through the conventional pathway
Inoue T; Pattabiraman PP; Epstein DL; Vasantha Rao P
Experimental Eye Research 2010; 90: 360-367 (IGR: 12-1)


25217 Episcleral Venous Pressure Responses to Topical Nitroprusside and N-Nitro-L-arginine Methyl Ester
Zamora DO; Kiel JW
Investigative Ophthalmology and Visual Science 2010; 51: 1614-1620 (IGR: 12-1)


25584 Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma
Chiu K; Yeung S -C; So K -F; Chang R C -C
Cellular and Molecular Immunology 2010; 7: 61-68 (IGR: 12-1)


25148 ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture
Osborne NN; Ji D; Abdul Majid AS; Fawcett RJ; Sparatore A; Del Soldato P
Investigative Ophthalmology and Visual Science 2010; 51: 284-294 (IGR: 12-1)


25077 Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species
Wang Z; Do CW; Avila MY; Peterson-Yantorno K; Stone RA; Gao ZG; Joshi B; Besada P; Jeong LS; Jacobson KA
Experimental Eye Research 2010; 90: 146-154 (IGR: 12-1)


25187 Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids
Pfeffer BA; DeWitt CA; Salvador-Silva M; Cavet ME; López FJ; Ward KW
Investigative Ophthalmology and Visual Science 2010; 51: 437-446 (IGR: 12-1)


25583 Effects of qingguangan on retinal structure and apoptosis in rabbit eyes with acute ocular hypertension
Dong C -X; Peng J; Peng Q -H; Zeng Z -C
International Journal of Ophthalmology 2010; 10: 51-54 (IGR: 12-1)


25543 Effect of orally administered zingiber officinale on the intra ocular pressure of experimental rabbits
Akpalaba R U E; Agu G C; Adeleke O O; Asonye C C
International Journal of Health Research 2009; 2: 273-278 (IGR: 12-1)


25572 Experimental study on the protective effects of qingguangan granule on optic nerve axons in rabbit eyes with acute ocular hypertension
Zhao H -B; Peng Q -H; Wu Q -L; Zeng Z -C
International Journal of Ophthalmology 2009; 9: 2318-2321 (IGR: 12-1)


25393 The effect of forskolin ophthalmic inserts on intraocular pressure in rabbit eyes
Wagh V D; Wagh K V; Inamdar B; Samanta M K
International Journal of Pharmacy and Pharmaceutical Sciences 2009; 146-155 (IGR: 12-1)


25180 Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury
Weber AJ; Viswanáthan S; Ramanathan C; Harman CD
Investigative Ophthalmology and Visual Science 2010; 51: 327-334 (IGR: 12-1)


25570 Experimental study about the effect of qingguangan suspel on the structure and function of lamina cribrosa in rabbit eye with chronic hypertension
Li X -J; Peng Q -H; Zeng Z -C; Li J -C
International Journal of Ophthalmology 2009; 9: 2310-2314 (IGR: 12-1)


25202 The effect of oral magnesium therapy on visual field and ocular blood flow in normotensive glaucoma
Aydin B; Onol M; Hondur A; Kaya MG; Ozdemir H; Cengel A; Hasanreisoglu B
European Journal of Ophthalmology 2010; 20: 131-135 (IGR: 12-1)


25513 Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
Holland E J; Djalilian A R; Sanderson J P
Cornea 2009; 28: 1139-1143 (IGR: 12-1)


25158 Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity
Seki M; Soussou W; Manabe S; Lipton SA
Investigative Ophthalmology and Visual Science 2010; 51: 1198-1207 (IGR: 12-1)


25022 Triamcinolone attenuates macrophage/microglia accumulation associated with NMDA-induced RGC death and facilitates survival of Müller stem cell grafts
Singhal S; Lawrence JM; Salt TE; Khaw PT; Limb GA
Experimental Eye Research 2010; 90: 308-315 (IGR: 12-1)


25168 Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the toll-like receptor 2 agonist Pam3Cys
Hauk TG; Leibinger M; Müller A; Andreadaki A; Knippschild U; Fischer D
Investigative Ophthalmology and Visual Science 2010; 51: 459-464 (IGR: 12-1)


25179 Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells
Biermann J; Grieshaber P; Goebel U; Martin G; Thanos S; Di Giovanni S; Lagrèze WA
Investigative Ophthalmology and Visual Science 2010; 51: 526-534 (IGR: 12-1)


25367 NBCe1 (Slc4A4) functional dimer assembly
Chang M; Holmes H L; Ranatunga W K; Chen A; Romero M F
FASEB Journal 2009; 23: S1 (IGR: 12-1)


25351 Nucleoside-based adenosine A(3) receptor antagonists as drug candidates
Tosh D K; Jacobson K A; Jeong L S
Drugs of the Future 2009; 34: 43-52 (IGR: 12-1)


25392 Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex
Yenikaya C; Sari M; Bulbul M; Ilkimen H; Celik H; Buyukgungor O
Bio-organic and Medicinal Chemistry 2010; 18: 930-938 (IGR: 12-1)


25282 The possibility of selective Rho-associated kinase (ROCK) inhibitors as a medical treatment for glaucoma
Honjo M
Nippon Ganka Gakkai Zasshi 2009; 113: 1071-1081 (IGR: 12-1)


25142 Future target molecules in antiglaucoma therapy: tgf-Beta may have a role to play
Agarwal R; Agarwal P
Ophthalmic Research 2010; 3: 1-10 (IGR: 12-1)


25390 Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma
Steele R M; Benedini F; Biondi S; Borghi V; Carzaniga L; Impagnatiello F; Miglietta D; Chong W K M; Rajapakse R; Cecchi A
Bioorganic and Medicinal Chemistry Letters 2009; 19: 6565-6570 (IGR: 12-1)


25420 Comparative study of topical application of timolol and verapamil in patients with glaucoma within 6 months
Shayegan M R; Boloorian A A; Kianoush S
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 551-553 (IGR: 12-1)


25345 Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine
Selt M; Bartlett C A; Harvey A R; Dunlop S A; Fitzgerald M
Brain Research Bulletin 2010; 81: 467-471 (IGR: 12-1)


25388 3D-QSAR and docking studies on transforming growth factor (TGF)-(beta) receptor 1 antagonists
Geldenhuys W J; Nakamura H
Bioorganic and Medicinal Chemistry Letters 2010; 20: 1918-1923 (IGR: 12-1)


25389 2,3-Diaminopyrazines as rho kinase inhibitors
Henderson A J; Hadden M; Guo C; Douglas N; Decornez H; Hellberg M R; Rusinko A; McLaughlin M; Sharif N; Drace C
Bioorganic and Medicinal Chemistry Letters 2010; 20: 1137-1140 (IGR: 12-1)


25540 Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists.
Gerra G; Zaimovic A; Gerra M L; Ciccocioppo R; Cippitelli A; Serpelloni G; Somaini L
Recent Patents on CNS Drug Discovery 2010; 5: 46-52 (IGR: 12-1)


25258 Characterization of a novel non-steroidal glucocorticoid receptor antagonist
Li Q -Y; Zhang M; Hallis T M; DeRosier T A; Yue J -M; Ye Y; Mais D E; Wang M -W
Biochemical and Biophysical Research Communications 2010; 391: 1531-1536 (IGR: 12-1)


25512 Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy
Gupta S; Samanta M K; Raichur A M
AAPS PharmSciTech 2010; 1-14 (IGR: 12-1)


25093 Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery
Fakhraie G; Lopes JF; Spaeth GL; Almodin J; Ichhpujani P; Moster MR
Clinical and Experimental Ophthalmology 2009; 37: 842-848 (IGR: 12-1)


25453 Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube
Tsui I; Airiani S; Wen A; El-Sawy T; Fine H F; Maris Jr P J G
Clinical Ophthalmology 2009; 3: 91-93 (IGR: 12-1)


25044 Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices
Choritz L; Grub J; Wegner M; Pfeiffer N; Thieme H
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 197-206 (IGR: 12-1)


25398 Inhibitory effect of tetrandrine on the apoptosis of cultured human Tenon's capsule fibroblasts
Li D; Yang L; Lin S; Kaili W
Chinese Ophthalmic Research 2010; 28: 1-4 (IGR: 12-1)


25401 The prevention effect of pyrrolidine dithiocarbamate against scarring of filtering bleb in rats
Li X; Ma J; Wang N
Chinese Ophthalmic Research 2009; 27: 858-862 (IGR: 12-1)


25049 Antifibrotic effects of tocotrienols on human Tenon's fibroblasts
Tappeiner C; Meyenberg A; Goldblum D; Mojon D; Zingg JM; Nesaretnam K; Kilchenmann M; Frueh BE
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 65-71 (IGR: 12-1)


24941 Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma
Yang H; Hirooka K; Fukuda K; Shiraga F
Investigative Ophthalmology and Visual Science 2009; 50: 5800-5804 (IGR: 11-4)


24835 Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models
Prasanna G; Fortner J; Xiang C; Zhang E; Carreiro S; Anderson S; Sartnurak S; Wu G; Gukasyan H; Niesman M
Experimental Eye Research 2009; 89: 608-617 (IGR: 11-4)


24950 Effect of systemic moxaverine on ocular blood flow in humans
Resch H; Weigert G; Karl K; Pemp B; Garhofer G; Schmetterer L
Acta Ophthalmologica 2009; 87: 731-735 (IGR: 11-4)


24626 Evaluation of a new lead for acetylcholinesterase inhibition
Khorana N; Markmee S; Ingkaninan K; Ruchirawat S; Kitbunnadaj R; Pullagurla MR
Medicinal Chemistry Research 2009; 18: 231-241 (IGR: 11-4)


24832 Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine
Fitzgerald M; Payne SC; Bartlett CA; Evill L; Harvey AR; Dunlop SA
Investigative Ophthalmology and Visual Science 2009; 50: 5456-5462 (IGR: 11-4)


24522 Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells
Koriyama Y; Ohno M; Kimura T; Kato S
Brain Research 2009; 1296: 187-195 (IGR: 11-4)


24669 Endocannabinoid system: Emerging role from neurodevelopment to neurodegeneration
Basavarajappa BS; Nixon RA; Arancio O
Mini Reviews in Medicinal Chemistry 2009; 9: 448-462 (IGR: 11-4)


24715 Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications
Galal AM; Slade D; Gul W; El-Alfy AT; Ferreira D; Elsohly MA
Recent Patents on CNS Drug Discovery 2009; 4: 112-136 (IGR: 11-4)


24538 Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma
Harrison BA; Whitlock NA; Voronkov MV; Almstead ZY; Gu K-J; Mabon R; Gardyan M; Hamman BD; Allen J; Gopinathan S
Journal of Medicinal Chemistry 2009; 52: 6515-6518 (IGR: 11-4)


24756 Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects
Garhofer G; Resch H; Wolzt M; Schmetterer L
Basic and Clinical Pharmacology and Toxicology 2009; 105 42 (IGR: 11-4)


24551 Intraocular pressure-lowering activity of topical application of Aegle marmelos fruit extract in experimental animal models
Agarwal R; Gupta SK; Srivastava S; Saxena R; Agrawal SS
Ophthalmic Research 2009; 42: 112-116 (IGR: 11-4)


24671 Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
Hahmann C; Schroeter T
Cellular and Molecular Life Sciences 2009; 1-7 (IGR: 11-4)


24676 (alpha)-Luminol prevents decreases in glutamate, glutathione, and glutamine synthetase in the retinas of glaucomatous DBA/2J mice
Gionfriddo JR; Freeman KS; Groth A; Scofield VL; Alyahya K; Madl JE
Veterinary Ophthalmology 2009; 12: 325-332 (IGR: 11-4)


24770 BMP-7: Therapeutic target for ocular fibrotic disorders
Wang J-Y; Han G-g; Wang J; Mei H-F; Yang A-H
Bioscience Hypotheses 2009; 2: 413-416 (IGR: 11-4)


24755 Mitochondria-targeted rechargeable antioxidant SkQ1 prevents senescence in mammals
Skulachev V
FEBS Journal 2009; 276 35-36 (IGR: 11-4)


24119 Effects of platelet-derived growth factor on aqueous humor dynamics
Syriani E; Cuesto G; Abad E; Pelaez T; Gual A; Pintor J; Morales M; Gasull X
Investigative Ophthalmology and Visual Science 2009; 50: 3833-3839 (IGR: 11-3)


24068 Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow
Woodward DF; Nilsson SF; Toris CB; Kharlamb AB; Nieves AL; Krauss AH
Investigative Ophthalmology and Visual Science 2009; 50: 3320-3328 (IGR: 11-3)


24164 Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body
Ooi YH; Oh DJ; Rhee DJ
Investigative Ophthalmology and Visual Science 2009; 50: 4237-4243 (IGR: 11-3)


24112 Cyclic mechanical stress and trabecular meshwork cell contractility
Ramos RF; Sumida GM; Stamer WD
Investigative Ophthalmology and Visual Science 2009; 50: 3826-3832 (IGR: 11-3)


24443 Effect of serum containing qingguang'an grains on pressurized human trabecular cells activity
Peng Q-H; Zeng Z-C; Li B; Zhuo Y-H
International Journal of Ophthalmology 2009; 9: 839-842 (IGR: 11-3)


24011 Correction of the disease phenotype of myocilin-causing glaucoma by a natural osmolyte
Jia LY; Gong B; Pang CP; Huang Y; Lam DS; Wang N; Yam GH
Investigative Ophthalmology and Visual Science 2009; 50: 3743-3749 (IGR: 11-3)


24485 Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor
Baba K; Pozdeyev N; Mazzoni F; Contreras-Alcantara S; Liu C; Kasamatsu M; Martinez-Merlos T; Strettoi E; Iuvone PM; Tosini G
Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 15043-15048 (IGR: 11-3)


24156 Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram
Falsini B; Marangoni D; Salgarello T; Stifano G; Montrone L; Di Landro S; Guccione L; Balestrazzi E; Colotto A
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1223-1233 (IGR: 11-3)


24387 Both systemic and local application of Granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy
Frank T; Schlachetzki JCM; Goricke B; Meuer K; Rohde G; Dietz GPH; Bahr M; Schneider A; Weishaupt JH
BMC Neuroscience 2009; 10: 49 (IGR: 11-3)


24268 Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma
Fu Q-L; Li X; Yip HK; Shao Z; Wu W; Mi S; So K-F
Neuroscience 2009; 162: 375-382 (IGR: 11-3)


24490 Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma
Lambiasea A; Aloe L; Centofanti M; Parisi V; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 13469-13474 (IGR: 11-3)


24517 Pyroglutamic Acid Promotes Survival of Retinal Ganglion Cells after Optic Nerve Injury
Oono S; Kurimoto T; Nakazawa T; Miyoshi T; Okamoto N; Kashimoto R; Tagami Y; Ito Y; Mimura O
Current Eye Research 2009; 34: 598-605 (IGR: 11-3)


24080 Expression of prostaglandin PGE2 receptors under conditions of aging and stress and the protective effect of the EP2 agonist butaprost on retinal ischemia
Osborne NN; Li GY; Ji D; Andrade da Costa BL; Fawcett RJ; Kang KD; Rittenhouse KD
Investigative Ophthalmology and Visual Science 2009; 50: 3238-3248 (IGR: 11-3)


24343 Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits
Arnold JJ; Choksi Y; Chen X; Shimazaki A; Hatten J; Toone EJ; Epstein DL; Challa P
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 179-186 (IGR: 11-3)


24203 Agmatine as retinal protection from ischemia-reperfusion injury in guinea pigs
Dastan A; Kocer I; Erdogan F; Ates O; KIzIltunc A
Japanese Journal of Ophthalmology 2009; 53: 219-224 (IGR: 11-3)


24304 The effect of H-1152 on IOP and trabecular meshwork structure in rabbit
Wang Y; Sun J; Cai S; Qiu J; Yu M; Cao G; Liu X; Li X
Chinese Ophthalmic Research 2009; 27: 453-456 (IGR: 11-3)


24238 Therapeutic applications of glycosidic carbonic anhydrase inhibitors
Winum J-Y; Poulsen S-A; Supuran CT
Medicinal Research Reviews 2009; 29: 419-435 (IGR: 11-3)


24122 Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro
Lin X; Yu M; Wu K; Yuan H; Zhong H
Investigative Ophthalmology and Visual Science 2009; 50: 3763-3770 (IGR: 11-3)


23667 Effect of moxonidine on the uveoscleral outflow: role of alpha2-adrenoceptors or i1 imidazoline receptors
Yang J; Sun N; Xiong Q; Yang R
Current Eye Research 2009; 34: 287-296 (IGR: 11-2)


23581 Pathophysiology of cyclooxygenase inhibition in animal models
Radi ZA
Toxicologic Pathology 2009; 37: 34-46 (IGR: 11-2)


23881 alpha-Crystallin Downregulates the Expression of TNF-alpha and iNOS by Activated Rat Retinal Microglia in vitro and in vivo
Wu N; Wang YH; Zhao HS; Liu DN; Ying X; Yin ZQ; Wang Y
Ophthalmic Research 2009; 42: 21-28 (IGR: 11-2)


23658 17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat
Russo R; Cavaliere F; Watanabe C; Nucci C; Bagetta G; Corasaniti MT; Sakurada S; Morrone LA
Progress in Brain Research 2008; 173:- 583-590 (IGR: 11-2)


23716 Histological protection by cilnidipine, a dual L/N-type Ca(2+) channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina
Sakamoto K; Kawakami T; Shimada M; Yamaguchi A; Kuwagata M; Saito M; Nakahara T; Ishii K
Experimental Eye Research 2009; 88: 974-982 (IGR: 11-2)


23429 Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining
Zhuang J; Li F; Liu X; Liu Z; Lin J; Ge Y; Kaminski JM; Summers JB; Wang Z; Ge J
Biochemical and Biophysical Research Communications 2009; 380: 650-654 (IGR: 11-2)


23492 New prostaglandin derivative for glaucoma treatment
Perrino E; Uliva C; Lanzi C; Soldato PD; Masini E; Sparatore A
Bioorganic and Medicinal Chemistry Letters 2009; 19: 1639-1642 (IGR: 11-2)


23590 Safety of intravitreally administered recombinant erythropoietin (an AOS thesis)
Tsai JC
Transactions of the American Ophthalmological Society 2008; 106:- 459-472 (IGR: 11-2)


23526 Alpha-tocopherol: Looking beyond an antioxidant
Engin KN
Molecular Vision 2009; 15:- 855-860 (IGR: 11-2)


23825 Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells
Laengle UW; Markstein R; Cazaubon C; Roman D
Japanese Journal of Ophthalmology 2009; 53: 159-163 (IGR: 11-2)


23605 New treatments for ocular hypertension
Mediero A; Alarma-Estrany P; Pintor J
Auton Neuroscience 2009; 147:-2 14-19 (IGR: 11-2)


23569 LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders
Megson IL; Leslie SJ
Current Opinion in Investigational Drugs 2009; 10: 276-285 (IGR: 11-2)


23541 The aging eye and the role of L-carnitine and its derivatives
Pescosolido N; Imperatrice B; Karavitis P
Drugs in R&D 2008; 9 Suppl 1:- 3-14 (IGR: 11-2)


23793 Effects of some ophthalmic medications on pupil size: a literature review
Novitskaya ES; Dean SJ; Moore JE; Moore TC; Nagendran S; Sharma A
Canadian Journal of Ophthalmology 2009; 44: 193-197 (IGR: 11-2)


23666 The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes
Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
Current Eye Research 2009; 34: 282-286 (IGR: 11-2)


23872 Dietary Tocopherol Supplementation after Trabeculectomy and Phacotrabeculectomy: Double-Blind Randomized Placebo-Controlled Trial
Goldblum D; Meyenberg A; Mojon D; Tappeiner C; Frueh BE
Ophthalmologica 2009; 223: 226-230 (IGR: 11-2)


23957 SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism
Xiao YQ; Liu K; Shen JF; Xu GT; Ye W
Investigative Ophthalmology and Visual Science 2009; 50: 1698-1706 (IGR: 11-2)


23823 Seprafilm as a new antifibrotic agent following trabeculectomy in rabbit eyes
Tsurumaru N; Arai M; Teruya K; Sueda J; Yamakawa R
Japanese Journal of Ophthalmology 2009; 53: 164-170 (IGR: 11-2)


23792 Diphenhydramine as a topical ocular anesthetic
Suffridge PJ; Wiggins MN; Landes RD; Harper RA
Canadian Journal of Ophthalmology 2009; 44: 181-184 (IGR: 11-2)


22717 Suppression of injury-induced conjunctiva scarring by peroxisome proliferator-activated receptor γ gene transfer in mice
Yamanaka O; Miyazaki K; Kitano A; Saika S; Nakajima Y; Ikeda K
Investigative Ophthalmology and Visual Science 2009; 50: 187-193 (IGR: 11-1)


23358 Rho-kinase, but not protein kinase C, is involved in generation of the spontaneous tone in the resting phase of the isolated pig iris sphincter muscle
Okano M; Uchikawa Y; Tanaka N; Mutoh J; Ohkura M; Hisa H; Yamamoto R
Current Eye Research 2009; 34: 177-183 (IGR: 11-1)


22778 Study on the influence of the treatment with some newly synthesized antiglaucoma prostamides on the hematological parameters on rats
Udeanu DI; Mihele D; Cocu F; Caraene G; Vulturescu V; Iova D
Farmacia 2008; 56: 669-674 (IGR: 11-1)


22905 Effect of WIN55, 212-2 on lowing rabbit IOP
Liu H; Wang W; Zhao J
Chinese Ophthalmic Research 2008; 26: 929-931 (IGR: 11-1)


22619 The effect of the Rho-associated protein kinase inhibitor, HA-1077, in the rabbit ocular hypertension model induced by water loading
Fukunaga T; Ikesugi K; Nishio M; Sugimoto M; Sasoh M; Hidaka H; Uji Y
Current Eye Research 2009; 34: 42-47 (IGR: 11-1)


22610 A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits
Stagni E; Privitera MG; Bucolo C; Leggio GM; Motterlini R; Drago F
British Journal of Ophthalmology 2009; 93: 254-257 (IGR: 11-1)


22816 Effect of vasoactive drugs on visual functions and ocular hemodynamics in patients with primary open-angle glaucoma
Makashova NV; Kiseleva TN; Ronzina IA; Vasil'eva AE
Vestnik Oftalmologii 2008; 124: 55-59 (IGR: 11-1)


22936 Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: Critical role of p38 MAPK activation
El-Remessy AB; Tang Y; Zhu G; Matragoon S; Khalifa Y; Liu EK; Liu J-Y; Hanson E; Mian S; Fatteh N
Molecular Vision 2008; 14: 2190-2203 (IGR: 11-1)


23362 GABA agonists fail to protect the retina from ischemia-reperfusion injury
Traustason S; Eysteinsson T; Agnarsson BA; Stefánsson E
Experimental Eye Research 2009; 88: 361-366 (IGR: 11-1)


22558 Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma
Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J; Alcon Anecortave Acetate for IOP Research Team
Archives of Ophthalmology 2009; 127: 173-178 (IGR: 11-1)


22523 Adjunctive use of tafluprost with timolol provides additive effects for reduction of intraocular pressure in patients with glaucoma
Egorov E; Ropo A; on behalf of the Investigators
European Journal of Ophthalmology 2009; 19: 214-222 (IGR: 11-1)


22897 Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: Synthesis and biological activity
Feng Z; Hellberg MR; Sharif NA; McLaughlin MA; Williams GW; Scott D; Wallace T
Bio-organic and Medicinal Chemistry 2009; 17: 576-584 (IGR: 11-1)


22896 Chroman-3-amides as potent Rho kinase inhibitors
Chen YT; Bannister TD; Weiser A; Griffin E; Lin L; Ruiz C; Cameron MD; Schurer S; Duckett D; Schroter T
Bioorganic and Medicinal Chemistry Letters 2008; 18: 6406-6409 (IGR: 11-1)


22921 The pleiotropic effects of ethacrynic acid
Somberg JC; Molnar J
American Journal of Therapeutics 2009; 16: 102-104 (IGR: 11-1)


23004 Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals
Neroev VV; Archipova MM; Bakeeva LE; Fursova AZ; Grigorian EN; Grishanova AY; Iomdina EN; Ivashchenko ZN; Katargina LA; Khoroshilova-Maslova IP
Biochemistry. Biokhimiia 2008; 73: 1317-1328 (IGR: 11-1)


22796 Possibilities of applying cannabinoids' in the treatment of glaucoma
Nadolska K; Gos R
Klinika Oczna 2008; 110:-9 314-317 (IGR: 11-1)


23365 Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT
Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
Experimental Eye Research 2009; 88: 504-511 (IGR: 11-1)


21832 Aqueous humor outflow effects of 2-arachidonylglycerol
Njie YF; He F; Qiao Z; Song ZH
Experimental Eye Research 2008; 87: 106-114 (IGR: 10-3)


21619 Expression of caspase-9 affected by AG on retina of rats with chronic IOP elevation
Nie Q-Z; Sha Q; Wang Y-S; Gui D-M; Liu Z-L; Gao D-W
International Journal of Ophthalmology 2008; 8: 1299-1303 (IGR: 10-3)


21829 Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries
Dong Y; Watabe H; Su G; Ishikawa H; Sato N; Yoshitomi T
Experimental Eye Research 2008; 87: 251-256 (IGR: 10-3)


21497 The mechanisms by which latanoprost free acid inhibits human carbonic anhydrase I and II
Sugimoto A; Ikeda H; Tsukamoto H; Kihira K; Takeda C; Hirose J; Hata T; Baba E; Ono Y
Biological & Pharmaceutical Bulletin 2008; 31: 796-801 (IGR: 10-3)


21668 Neuroprotection in glaucoma using calpain-1 inhibitors: Regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therepeutics
Govindarajan B; Laird J; Sherman R; Salomon RG; Bhattacharya SK
CNS and Neurological Disorders - Drug Targets 2008; 7: 295-304 (IGR: 10-3)


21816 Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats
Tsai RK; Chang CH; Wang HZ
Experimental Eye Research 2008; 87: 242-250 (IGR: 10-3)


21434 Oculohypotensive effects of Foeniculum vulgare in experimental models of glaucoma
Agarwal R; Gupta SK; Agrawal SS; Srivastava S; Saxena R
Indian Journal of Physiology and Pharmacology 2008; 52: 77-83 (IGR: 10-3)


21727 Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork
Renieri G; Choritz L; Rosenthal R; Meissner S; Pfeiffer N; Thieme H
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 1107-1115 (IGR: 10-3)


21842 Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies
Stewart WC; Jenkins JN
Eye 2008; 22: 985-988 (IGR: 10-3)


21618 Effect of endogenous AEA on the morphology and cytoskeleton of bovine trabecular meshwork cells cultured in vitro
Sun S-L; Zhang D-X; Guo B-X
International Journal of Ophthalmology 2008; 8: 1346-1349 (IGR: 10-3)


21495 Adverse effects of medical cannabinoids: A systematic review
Wang T; Collet J-P; Shapiro S; Ware MA
Canadian Medical Association Journal 2008; 178: 1669-1678 (IGR: 10-3)


21622 Effect of AEA on proliferation, adherence and immigration in cultured bovine trabecular cells
Yang X-G; Zhang D-X; Liu S-W; Chen L; Sun S-L
International Journal of Ophthalmology 2008; 8: 1343-1345 (IGR: 10-3)


21571 Scope and limitations of the co-drug approach to topical drug delivery
Lau WM; White AW; Gallagher SJ; Donaldson M; McNaughton G; Heard CM
Current Pharmaceutical Design 2008; 14: 794-802 (IGR: 10-3)


21780 Lovastatin inhibits TGF-β-induced myofibroblast transdifferentiation in human tenon fibroblasts
Meyer-Ter-Vehn T; Katzenberger B; Han H; Grehn F; Schlunck G
Investigative Ophthalmology and Visual Science 2008; 49: 3955-3960 (IGR: 10-3)


21287 Effect of cannabinoid (WIN55, 212-2) on glutamic acid concentration in vitreous body of chronic glaucoma rabbit model
Zhao J-H; Wang W-H
International Journal of Ophthalmology 2008; 8: 726-728 (IGR: 10-2)


21029 Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Investigative Ophthalmology and Visual Science 2008; 49: 1437-1446 (IGR: 10-2)


21254 Neuroprotection of progesterone on retinal ganglion cells in chronic ocular hypertension model rats
Xu S-L; Yin Y; Gu G-Z; Gao Z-Z
Journal of Jilin University Medicine Edition 2008; 34: 226-229 (IGR: 10-2)


21292 Studies on corneal permeation and oculo-hypotensive effect of benazepril in chronic and acute models of glaucoma
Sharma S; Pathak D; Goyal R
Iranian Journal of Pharmacology and Therapeutics 2006; 5: 145-149 (IGR: 10-2)


21045 Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro
Zhang B; Rusciano D; Osborne NN
Brain Research 2008; 1198: 141-152 (IGR: 10-2)


20477 Hypotensive effect of UDP on intraocular pressure in rabbits
Markovskaya A; Crooke A; Guzman-Aranguez AI; Peral A; Ziganshin AU; Pintor J
European Journal of Pharmacology 2008; 579: 93-97 (IGR: 10-1)


20655 Cannabinoids in health and disease
Kogan NM; Mechoulam R
Dialogues in Clinical Neuroscience 2007; 9: 413-430 (IGR: 10-1)


20653 Cannabis sativa in the light of scientific research
Szulakowska A; Milnerowicz H
Advances in Clinical and Experimental Medicine 2007; 16: 807-815 (IGR: 10-1)


20522 Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension
Fu Q-L; Wu W; Wang H; Li X; Lee VWH; So K-F
Cellular and molecular neurobiology 2008; 28: 317-329 (IGR: 10-1)


20456 Effects of the topically applied calcium-channel blocker flunarizine on intraocular pressure in clinically normal dogs
Greller AL; Hoffman AR; Liu C; Ying G-S; Vudathala DK; Acland GM; Komaromy AM
American Journal of Veterinary Research 2008; 69: 273-278 (IGR: 10-1)


20473 Rabbit's intraocular pressure after instillation of timolol and aminoacid lysine, arginine, glycine or taurine mixture.
Olah Z; Veselovsky J
Bratisl Lek Listy 2007; 108: 283-286 (IGR: 10-1)


20615 Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action
Oltmanns MH; Samudre SS; Castillo IG; Hosseini A; Lichtman AH; Allen RC; Lattanzio Jr FA; Williams PB
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 104-115 (IGR: 10-1)


20766 Intraocular Pressure-Lowering Effects and Safety of Topical Administration of a Selective ROCK Inhibitor, SNJ-1656, in Healthy Volunteers
Tanihara H; Inatani M; Honjo M; Tokushige H; Azuma J; Araie M
Archives of Ophthalmology 2008; 126: 309-315 (IGR: 10-1)


20602 Curative effect of acupuncture separation combined with injection of recombinant human Interferon αZb around Bulbar conjunctiva on encapsulated filtering bled
Wang Y; Shao-Lin X; Cheng Z
Chinese Journal of Biologicals 2007; 20: 457-458 (IGR: 10-1)


20596 Effect of TGF-β1 on proliferation of Tenon capsule fibroblasts and expression of heat shock protein 47
Pan R; Chen X; Li M; Liu D
Chinese Ophthalmic Research 2007; 25: 933-936 (IGR: 10-1)


20686 Interpretation of uniocular and binocular trials of glaucoma medications: An observational case series
Leffler CT; Amini L
BMC Ophthalmology 2007; 7: 17 (IGR: 10-1)


19804 Aquaporins as targets for drug discovery
Frigeri A; Nicchia GP; Svelto M
Current Pharmaceutical Design 2007; 13: 2421-2427 (IGR: 9-4)


20069 Promotion of neurite outgrowth and protective effect of erythropoietin on the retinal neurons of rats
Zhong Y; Yao H; Deng L; Cheng Y; Zhou X
Graefe's Archive for Clinical and Experimental Ophthalmology 2007; 245: 1859-1867 (IGR: 9-4)


19706 Pitavastatin: Protection against neuronal retinal damage induced by ischemia-reperfusion injury in rats
Kawaji T; Inomata Y; Takano A; Sagara N; Inatani M; Fukushima M; Tanihara H; Honjo M
Current Eye Research 2007; 32: 991-997 (IGR: 9-4)


19833 Effects of ZX-5 and its optical isomers on ocular blood flow in rabbits and retinal function recovery in rats
Peng J; Zou Y-H; Jiang W; Zhang Y-H; Ji X-B; Shen Z-L; Peng S-X; Chiou GCY
International Journal of Ophthalmology 2007; 7: 1197-1201 (IGR: 9-4)


19785 Characterization of the effects of anti-aging medicine Fructus lycii on β-amyloid peptide neurotoxicity
Yu MS; Lai CS; Ho YS; Zee SY; So KF; Yuen WH; Chang RC
International Journal of Molecular Medicine 2007; 20: 261-268 (IGR: 9-4)


19828 Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT
Alarma-Estrany P; Crooke A; Peral A; Pintor J
Auton Neuroscience 2007; 137: 63-66 (IGR: 9-4)


20037 Dinucleoside polyphosphates in the eye: from physiology to therapeutics
Guzmán-Aranguez A; Crooke A; Peral A; Hoyle CH; Pintor J
Progress in Retinal and Eye Research 2007; 26: 674-687 (IGR: 9-4)


20065 Potential role of rho-associated protein kinase inhibitor y-27632 in glaucoma filtration surgery
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Investigative Ophthalmology and Visual Science 2007; 48: 5549-5557 (IGR: 9-4)


20077 Effects of latanoprost, timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist on LTC4 release after rat mast cell activation
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Clinical and Experimental Ophthalmology 2007; 35: 645-650 (IGR: 9-4)


19835 Hypericin's effects on retinal glutamate in acute ocular hypertension of rabbits
Li L-L; Jiang F-G; Li S
International Journal of Ophthalmology 2007; 7: 1308-1310 (IGR: 9-4)


20080 A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and α-chymotrypsin-induced ocular hypertensive rabbits
Puras G; Santafé J; Segarra J; Garrido M; Melena J
Graefe's Archive for Clinical and Experimental Ophthalmology 2007; 245: 1559-1567 (IGR: 9-4)


19705 Effects of MISA A on actin cytoskeleton of cultured HTM cells and intraocular pressure of rats and glaucomatous monkeys
Wang H; Liu X; Guo L; Gabelt BT; Lee P-Y; Podos SM; Kaufman PL; Wang N
Current Eye Research 2007; 32: 843-850 (IGR: 9-4)


20043 A phase III study of subconjunctival human anti-transforming growth factor β2 monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy
CAT-152 0102 Trabeculectomy Study Group; Khaw P; Grehn F; Holló G; Overton B; Wilson R; Vogel R; Smith Z
Ophthalmology 2007; 114: 1822-1830 (IGR: 9-4)


20042 Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor β2, CAT-152
CAT-152 Trabeculectomy Study Group; Grehn F; Holló G; Khaw P; Overton B; au; Wilson R; Vogel R; Smith Z
Ophthalmology 2007; 114: 1831-1838 (IGR: 9-4)


19342 Effect of hypericin on retinal glutamate levels in chronic ocular hypertension rabbits
Li S; Jiang F
Chinese Ophthalmic Research 2007; 25: 370-372 (IGR: 9-3)


19246 Hypotensive effect of profilin on rabbit intraocular pressure
Morales M; Gomez-Cabrero A; Peral A; Gasull X; Pintor J
European Journal of Pharmacology 2007; 567: 145-148 (IGR: 9-3)


19295 Survival and axonal regeneration of off-center retinal ganglion cells of adult cats are promoted with an anti-glaucoma drug, nipradilol, but not BDNF and CNTF
Yata T; Nakamura M; Sagawa H; Tokita Y; Terasaki H; Watanabe M
Neuroscience 2007; 148: 53-64 (IGR: 9-3)


19523 Effects of dopamine on retinal and choroidal blood flow parameters in humans
Huemer KH; Zawinka C; Garhöfer G; Golestani E; Litschauer B; Dorner GT; Schmetterer L
British Journal of Ophthalmology 2007; 91: 1194-1198 (IGR: 9-3)


19413 The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents
Mincione F; Scozzafava A; Supuran CT
Current Topics in Medicinal Chemistry 2007; 7: 849-854 (IGR: 9-3)


19476 Clinical evaluation of the neuroprotective effect of alpha-tocopherol against glaucomatous damage
Engin KN; Engin G; Kucuksahin H; Oncu M; Guvener B
European Journal of Ophthalmology 2007; 17: 528-533 (IGR: 9-3)


19343 Effect of nerve regeneration factor on expression of inducible-nitric oxide synthase in retina with experimental intraocular hypertension
Guan H; Huang Z; Ding F; Gu X
Chinese Ophthalmic Research 2007; 25: 325-328 (IGR: 9-3)


19383 Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation
Lipton SA
Current Drug Targets 2007; 8: 621-632 (IGR: 9-3)


19266 Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders
Lipton SA; Gu Z; Nakamura T
International review of neurobiology 2007; 82: 1-27 (IGR: 9-3)


19557 Erythropoietin: A candidate neuroprotective agent in the treatment of glaucoma
Tsai JC; Song BJ; Wu L; Forbes M
Journal of Glaucoma 2007; 16: 567-571 (IGR: 9-3)


19392 Fixed-combination and emerging glaucoma therapies
Woodward DF; Chen J
Expert Opinion on Emerging Drugs 2007; 12: 313-327 (IGR: 9-3)


19341 Effects of low dose of latrunculin-A on actin cytoskeleton and extracellular matrix protein TSP-1 in dexamethasone-induced bovine TMCs
Cao J; Zhang D
Chinese Ophthalmic Research 2007; 25: 502-505 (IGR: 9-3)


19424 Research progress on application of ET-1 on eyes
Cao W-J; Zhou Y-H
International Journal of Ophthalmology 2007; 7: 782-783 (IGR: 9-3)


19333 Novel benzodifuran analogs as potent 5-HT(2A) receptor agonists with ocular hypotensive activity
Feng Z; Mohapatra S; Klimko PG; Hellberg MR; May JA; Kelly C; Williams G; McLaughlin MA; Sharif NA
Bioorganic and Medicinal Chemistry Letters 2007; 17: 2998-3002 (IGR: 9-3)


19421 The protective function of erythropoietin to the rat retina after acute intraocular hypertension
Guo Y; Wang W-H
International Journal of Ophthalmology 2007; 7: 688-691 (IGR: 9-3)


19431 Protective effect on visual functions of long-term use of trimetazidine in treatment of primary open angle glaucoma and degenerative myopia
Nowak MS; Wybor K; Gos R; Zeman-Miecznik A; Waszczykowska A; Pastuszka M; Klysik A; Gajdowska A
Archives of Medical Science 2007; 3: 152-156 (IGR: 9-3)


19359 Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits
Privitera MG; Potenza M; Bucolo C; Leggio GM; Drago F
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 232-239 (IGR: 9-3)


19376 Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma
Rao VP; Epstein DL
BioDrugs 2007; 21: 167-177 (IGR: 9-3)


19434 Therapeutic potential of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the treatment of retinal and eye diseases
Schmeer C; Kretz A; Isenmann S
CNS and Neurological Disorders - Drug Targets 2007; 6: 282-287 (IGR: 9-3)


19634 Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys
Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
Investigative Ophthalmology and Visual Science 2007; 48: 3216-3222 (IGR: 9-3)


19411 Metal binding functions in the design of carbonic anhydrase inhibitors
Winum J-Y; Scozzafava A; Montero J-L; Supuran CT
Current Topics in Medicinal Chemistry 2007; 7: 835-848 (IGR: 9-3)


18202 Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Investigative Ophthalmology and Visual Science 2007; 48: 1683-1690 (IGR: 9-2)


17455 Analysis of human carbonic anhydrase II: Docking reliability and receptor-based 3D-QSAR study
Tuccinardi T; Nuti E; Ortore G; Supuran CT; Rossello A; Martinelli A
Journal of Chemical Information and Modeling 2007; 47: 515-525 (IGR: 9-2)


17633 Implication of cannabinoids in neurological diseases
Alsasua del Valle A
Cellular and molecular neurobiology 2006; 26: 579-591 (IGR: 9-2)


17567 Structure-activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II
Feng Y; Cameron MD; Frackowiak B; Griffin E; Lin L; Ruiz C; Schroter T; LoGrasso P
Bioorganic and Medicinal Chemistry Letters 2007; 17: 2355-2360 (IGR: 9-2)


17568 Carbonic anhydrase inhibitors: Binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties
Fiore AD; Scozzafava A; Winum J-Y; Montero J-L; Pedone C; Supuran CT; De Simone G
Bioorganic and Medicinal Chemistry Letters 2007; 17: 1726-1731 (IGR: 9-2)


17648 Synthesis and ocular hypotensive activity of magnolol
Huang W-H; Lin I-H; Tan K-I; Chiang C-H; Lee A-R
Chinese Pharmaceutical Journal 2006; 58: 115-122 (IGR: 9-2)


17622 New ocular therapeutics: a view from the patenting perspective
Mucke HA
Idrugs 2007; 10: 37-41 (IGR: 9-2)


18096 The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice
Ota T; Aihara M; Saeki T; Narumiya S; Araie M
British Journal of Ophthalmology 2007; 91: 673-676 (IGR: 9-2)


17608 Pigment epithelium-derived factor protects retinal ganglion cells
Pang I-H; Zeng H; Fleenor DL; Clark AF
BMC Neuroscience 2007; 8: 11 (IGR: 9-2)


17529 AL-34662: A potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist
Sharif NA; McLaughlin MA; Kelly CR
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 1-13 (IGR: 9-2)


18169 The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro
Tura A; Grisanti S; Petermeier K; Henke-Fahle S
Investigative Ophthalmology and Visual Science 2007; 48: 2152-2161 (IGR: 9-2)


17601 Experimental study of TGF-β(2) antisense oligodeoxynucleotide as an anti-scarring agent in glaucoma surgery
Li J-Y; Fu P; Yang Q
International Journal of Ophthalmology 2007; 7: 10-14 (IGR: 9-2)


16815 Morphine-stimulated nitric oxide release in rabbit aqueous humor
Dortch-Carnes J; Russell K
Experimental Eye Research 2007; 84: 185-190 (IGR: 9-1)


16945 Neuroprotective and intraocular pressure-lowering effects of (-)delta-tetrahydrocannabinol in a rat model of glaucoma
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Research 2007; 39: 69-75 (IGR: 9-1)


17167 The function of the selective inhibitors of cycloxygenase 2
Luan Y; Xu W
Mini Reviews in Medicinal Chemistry 2006; 6: 1375-1381 (IGR: 9-1)


17078 New perspectives in ocular pharmacology: Nucleotides as therapeutic agents
Pintor J
Anales de la Real Academia Nacional de Farmacia 2006; 72: 519-538 (IGR: 9-1)


16859 Dronabinol and retinal hemodynamics in humans
Plange N; Arend KO; Kaup M; Doehmen B; Adams H; Hendricks S; Cordes A; Huth J; Sponsel WE; Remky A
American Journal of Ophthalmology 2007; 143: 173-174 (IGR: 9-1)


16958 Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Investigative Ophthalmology and Visual Science 2007; 48: 1212-1218 (IGR: 9-1)


15272 Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat
Schuettauf F; Rejdak R; Thaler S; Bolz S; Lehaci C; Mankowska A; Zarnowski T; Junemann A; Zagorski Z; Zrenner E
Experimental Eye Research 2006; 83: 1128-1134 (IGR: 8-4)


15264 Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells
Schlieve CR; Tam A; Nilsson BL; Lieven CJ; Raines RT; Levin LA
Experimental Eye Research 2006; 83: 1252-1259 (IGR: 8-4)


15253 Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma
Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
American Journal of Ophthalmology 2006; 142: 1054-1056 (IGR: 8-4)


14489 The effect of glycine with timoptol on the rabbit IOP physiological values
Veselovsky J; Olah Z; Vesela A; Gressnerova S
?eska a Slovenska Oftalmologie 2006; 62: 247-254 (IGR: 8-4)


15120 Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid
Heiduschka P; Thanos S
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1512-1521 (IGR: 8-4)


15054 Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide
Dortch Carnes J; Russell KR
Pharmacology 2006; 77: 17-24 (IGR: 8-4)


15205 A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model
Galassi F; Masini E; Giambene B; Fabrizi F; Uliva C; Bolla M; Ongini E
British Journal of Ophthalmology 2006; 90: 1414-1419 (IGR: 8-4)


15265 Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-α release in vitro from activated rat mast cells
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Experimental Eye Research 2006; 83: 1335-1339 (IGR: 8-4)


14782 Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbo nyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester
Oka T; Walkup RD; Tamada Y; Nakajima E; Tochigi A; Shearer TR; Azuma M
Neuroscience 2006; 141: 2139-2145 (IGR: 8-4)


14718 Ocular hypotensive effects of an intratracheally delivered liposomal Δ9-tetrahydrocannabinol preparation in rats
Szczesniak A-M; Kelly MEM; Whynot S; Shek PN; Hung O
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 160-167 (IGR: 8-4)


15202 Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study
Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
Journal of Glaucoma 2006; 15: 349-353 (IGR: 8-4)


15263 Short-term exposure to transforming growth factor β induces long-term fibrotic responses
Wormstone IM; Anderson IK; Eldred JA; Dawes LJ; Duncan G
Experimental Eye Research 2006; 83: 1238-1245 (IGR: 8-4)


14143 Effects of endothelin-1 and flunarizine on human trabecular meshwork cell contraction
Cellini M; Versura P; Zamparini E; Bendo E; Campos EC
Experimental Biology and Medicine (Maywood, N.J.) 2006; 231: 1081-1084 (IGR: 8-3)


14171 Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits
Bonfiglio V; Bucolo C; Camillieri G; Drago F
European Journal of Pharmacology 2006; 534: 227-232 (IGR: 8-3)


13898 Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes
Ethier CR; Read AT; Chan DW
Investigative Ophthalmology and Visual Science 2006; 47: 1991-1998 (IGR: 8-2)


13899 Chronic topical administration of WIN-55-212-2 maintains a reduction in IOP in a rat glaucoma model without adverse effects
Hosseini A; Lattanzio FA; Williams PB; Tibbs D; Samudre SS; Allen RC
Experimental Eye Research 2006; 82: 753-759 (IGR: 8-2)


13900 Effects of antiglaucoma drugs GLC756, a novel dopamine D2 agonist and D1 antagonist, and timolol on endotoxin-induced TNF-α release in serum of rats
Laengle UW; Markstein R; Schneider V; Roman D
European Journal of Ophthalmology 2006; 16: 401-406 (IGR: 8-2)


13897 Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility
Njie YF; Kumar A; Qiao Z; Zhong L; Song ZH
Investigative Ophthalmology and Visual Science 2006; 47: 1999-2005 (IGR: 8-2)


13590 The pharmacology of cannabinoid receptors and their ligands: An overview
Pertwee RG
International Journal of Obesity 2006; 30: S13-S18 (IGR: 8-2)


13626 R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells
Rosch S; Ramer R; Brune K; Hinz B
Journal of Pharmacology and Experimental Therapeutics 2006; 316: 1219-1228 (IGR: 8-2)


13567 Reduction of the physiologic IOP value after instilation of the mixture of the 2 amino acids (L-lysine and L-arginine) in Timoptol - Experiment on rabbits
Veselovsky J; Olah Z; Vesela A; Gressnerova S
?eska a Slovenska Oftalmologie 2006; 62: 3-10 (IGR: 8-2)


13364 Effects of latanoprost and GLC756, a novel dopamine D2 agonist and D1 antagonist, on cultured normal human dermal fibroblasts
Laengle UW; Markstein R; Pralet D; Greiner B; Roman D
European Journal of Ophthalmology 2006; 16: 67-72 (IGR: 8-1)


13361 Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells
Koga T; Awai M; Tsutsui J; Yue BY; Tanihara H
Experimental Eye Research 2006; 82: 362-370 (IGR: 8-1)


13320 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity
May JA; Dantanarayana AP; Zinke PW; McLaughlin MA; Sharif NA
Journal of Medicinal Chemistry 2006; 49: 318-328 (IGR: 8-1)


13311 Effects of novel ethacrynic acid derivatives on human trabecular meshwork cell shape, actin cytoskeletal organization, and transcellular fluid flow
Rao PV; Shimazaki A; Ichikawa M; Alvarado JA; Epstein DL
Biological & Pharmaceutical Bulletin 2005; 28: 2189-2196 (IGR: 8-1)


13359 Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys
Sabanay I; Tian B; Gabelt BT; Geiger B; Kaufman PL
Experimental Eye Research 2006; 82: 236-246 (IGR: 8-1)


13488 Increased glutamate uptake and GLAST expression by cyclic AMP in retinal glial cells
Sakai T; Yoshitoshi T; Nagai Y; Kitahara K
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 359-363 (IGR: 8-1)


13299 Development of specific Rho-kinase inhibitors and their clinical application
Tamura M; Nakao H; Yoshizaki H; Shiratsuchi M; Shigyo H; Yamada H; Ozawa T; Totsuka J; Hidaka H
Biochimica et Biophysica Acta Proteins and Proteomics 2005; 1754: 245-252 (IGR: 8-1)


13527 Endothelin Antagonism: Effects of FP Receptor Agonists Prostaglandin F2α and Fluprostenol on Trabecular Meshwork Contractility
Thieme H; Schimmat C; Munzer G; Boxberger M; Fromm M; Pfeiffer N; Rosenthal R
Investigative Ophthalmology and Visual Science 2006; 47: 938-945 (IGR: 8-1)


13027 Aqueous humor dynamics in monkeys after topical R-DOI
Gabelt BT; Okka M; Dean TR; Kaufman PL
Investigative Ophthalmology and Visual Science 2005; 46: 4691-4696 (IGR: 7-3)


12594 Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D2 receptor agonist and D1 receptor antagonist, on endotoxin-induced-uveitis and -arthritis in rats
Laengle UW; Court M; Markstein R; Germann PG; Nogues V; Roman D
Experimental and Toxicologic Pathology 2005; 57: 127-134 (IGR: 7-3)


13176 Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats
Lambiase A; Tirassa P; Micera A; Aloe L; Bonini S
Investigative Ophthalmology and Visual Science 2005; 46: 3800-3806 (IGR: 7-3)


12593 Ocular pharmacology of bicyclic hexahydroaporphines
Ohia SE; Zhan GL; Leday AM; Opere CA; Kulkarni KH; Harris LC; Roche VF
Methods and Findings in Experimental and Clinical Pharmacology 2005; 27: 87-93 (IGR: 7-3)


12590 Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow
Rao PV; Deng P; Maddala R; Epstein DL; Li C-Y; Shimokawa H
Molecular Vision 2005; 11: 288-297 (IGR: 7-3)


12589 Effects of dinucleoside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility
Soto D; Pintor J; Peral A; Gual A; Gasull X
Journal of Pharmacology and Experimental Therapeutics 2005; 314: 1042-1051 (IGR: 7-3)


13180 Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes
Zhang M; Rao PV
Investigative Ophthalmology and Visual Science 2005; 46: 4130-4138 (IGR: 7-3)


12520 CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility
Zhong L; Geng L; Njie Y; Feng W; Song ZH
Investigative Ophthalmology and Visual Science 2005; 46: 1988-1992 (IGR: 7-2)


12348 Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes
Wang RF; Podos SM; Mittag TW; Yokoyoma T
Experimental Eye Research 2005; 80: 629-632 (IGR: 7-2)


12299 The rabbit IOP and pupil values after application of aminoacid L-lysine and antiglaucomatic Timoptol mixture
Veselovsky J; Olah Z; Gressnerova S; Vesela A
?eska a Slovenska Oftalmologie 2005; 61: 88-95 (IGR: 7-2)


12148 Preparation and characterization of demeclocycline liposomal formulations and assessment of their intraocular pressure-lowering effects
Afouna MI; Khattab IS; Reddy IK
Journal of Toxicology – Cutaneous and Ocular Toxiclogy 2005; 24: 111-124 (IGR: 7-2)


12163 Finding of endocannabinoids in human eye tissues: implications for glaucoma
Chen J; Matias I; Dinh T; Lu T; Venezia S; Nieves A; Woodward DF; Di-Marzo V
Biochemical and Biophysical Research Communications 2005; 330: 1062-1067 (IGR: 7-2)


12169 Novel antiglaucoma prodrugs and codrugs of ethacrynic acid
Cynkowska G; Cynkowski T; Al-Ghananeem AA; Guo H; Ashton P; Crooks PA
Bioorganic and Medicinal Chemistry Letters 2005; 15: 3524-3527 (IGR: 7-2)


12192 Ocular hypotensive effect of bunazosin hydrochloride as the third concomitant topical medication
Hashimoto T; Kara T; Kubota S; Kubota M; Tsuru T
Japanese Journal of Clinical Ophthalmology 2005; 59: 359-362 (IGR: 7-2)


12354 Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats
Laengle UW; Markstein R; Schneider V; Greiner B; Roman D
Experimental Eye Research 2005; 80: 847-852 (IGR: 7-2)


12242 Contribution of ROCK in contraction of trabecular meshwork: Proposed mechanism for regulating aqueous outflow in monkey and human eyes
Nakajima E; Nakajima T; Minagawa Y; Shearer TR; Azuma MM
Journal of Pharmaceutical Sciences 2005; 94: 701-708 (IGR: 7-2)


12245 Synthesis, hydrolysis, and intraocular pressure lowering effects of fadolmidine prodrugs
Niemi R; Huuskonen J; Laine K; Jarvinen T
International Journal of Pharmaceutics 2005; 13: 121-127 (IGR: 7-2)


12247 Effects of latrunculin B on outflow facility, intraocular pressure, corneal thickness, and miotic and accommodative responses to pilocarpine in monkeys
Okka M; Tian B; Kaufman PL
Transactions of the American Ophthalmological Society 2004; 102: 251-259 (IGR: 7-2)


12249 Synthesis and ocular effects of imidazole nitrolic acids
Oresmaa L; Kotikoski H; Haukka M; Salminen J; Oksala O; Pohjala E; Moilanen E; Vapaatalo H; Vainiotalo P; Aulaskari P
Journal of Medicinal Chemistry 2005; 48: 4231-4236 (IGR: 7-2)


12353 Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork
Rosenthal R; Choritz L; Schlott S; Bechrakis NE; Jaroszewski J; Wiederholt M; Thieme H
Experimental Eye Research 2005; 80: 837-845 (IGR: 7-2)


12277 Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye
Shahidullah M; Yap M; To CH
British Journal of Pharmacology 2005; 145: 84-92 (IGR: 7-2)


12282 Additive effect of bunazosin hydrochloride on intraocular pressure and disc circulation in patients of normal-tension glaucoma treated by latanoprost
Shimizu M; Kon No-S; Maeda S; Matsumoto H; Ohtsuka K
Japanese Journal of Clinical Ophthalmology 2005; 59: 283-287 (IGR: 7-2)


11965 Fadolmidine-induced ocular hypotension in normotensive rabbits
Savolainen J; Niemi R; Mantyla A; Huuskonen J; Jarvinen T
Journal of Pharmacy and Pharmacology 2005; 57: 191-195 (IGR: 7-1)


12105 The anandamide membrane transporter and the therapeutic implications of its inhibition
Battista N; Gasperi V; Fezza F; Maccarrone M
Therapy 2005; 2: 141-150 (IGR: 7-1)


11770 β-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane
Glennon RA; Bondarev ML; Khorana N; Young R; May JA; Hellberg MR; McLaughlin MA; Sharif NA
Journal of Medicinal Chemistry 2004; 47: 6034-6041 (IGR: 7-1)


11917 The rabbit's IOP after instillation of antiglaucomatic COSOPT and aminoacid L-argininin. HCL mixture in the conjunctival sac
Olah Z; Veselovsky J; Gressnerova S; Vesela A
?eska a Slovenska Oftalmologie 2005; 61: 3-12 (IGR: 7-1)


11934 Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma
Pintor J
Current Opinion in Investigational Drugs 2005; 6: 76-80 (IGR: 7-1)


11976 Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes
Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 489-508 (IGR: 7-1)


12005 Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys
Tian B; Kaufman PL
Experimental Eye Research 2005; 80: 215-225 (IGR: 7-1)


11294 Effects of adenosine on optic nerve head circulation in rabbits
Hirao M; Oku H; Goto W; Sugiyama T; Kobayashi T; Ikeda T
Experimental Eye Research 2004; 79: 729-735 (IGR: 6-3)


11336 Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium
Fidzinski P; Salvador Silva M; Choritz L; Geibel J; Coca Prados M
American Journal of Physiology and Cell Physiology 2004; 287: C655-663 (IGR: 6-3)


11476 Effects of topically instilled bunazosin, an α1-adrenoceptor antagonist, on constrictions induced by phenylephrine and ET-1 in rabbit retinal arteries
Ichikawa M; Okada Y; Asai Y; Hara H; Ishii K; Araie M
Investigative Ophthalmology and Visual Science 2004; 45: 4041-4048 (IGR: 6-3)


11439 Effect of low-dose latrunculin B on anterior segment physiologic features in themonkey eye
Okka M; Tian B; Kaufman PL
Archives of Ophthalmology 2004; 122: 1482-1488 (IGR: 6-3)


11265 Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes
Serle JB; Wang RF; Peterson WM; Plourde R; Yerxa BR
Journal of Glaucoma 2004; 13: 385-388 (IGR: 6-3)


11557 The mechanism of ocular hypotensive effect of CS-088, angiotensin II type I receptor blocker, in pigmented rabbit - Investigation of central ocular hypotensive effect
Yoshida M; Ueda T; Noda T; Shimada S; Koide R; Shi Yu G; Hisamitsu T; Oguchi K
Journal of the Showa Medical Association 2004; 64: 199-205 (IGR: 6-3)


10587 The effect of verapamil on expression of transforming growth factor-β in bovine trabecular meshwork cells
Chen F; Wei H; Zeng Y; Lu Y; Zhang Y
Chinese Ophthalmic Research 2004; 22: 156-160 (IGR: 6-2)


10641 H-7 effect on outflow facility after trabecular obstruction following long-term echothiophate treatment in monkeys
Gabelt BT; Hennes EA; Seeman JL; Tian B; Kaufman PL
Investigative Ophthalmology and Visual Science 2004; 45: 2732-6 (IGR: 6-2)


10532 Effects of bunazosin hydrochloride on ciliary muscle constriction and matrix metalloproteinase activities
Akaishi T; Takagi Y; Matsugi T; Ishida N; Hara H; Kashiwagi K
Journal of Glaucoma 2004; 13: 312-8 (IGR: 6-2)


10550 Pharmacologic disruption of Schlemm's canal cells and outflow facility in anterior segments of human eyes
Bahler CK; Hann CR; Fautsch MP; Johnson DH
Investigative Ophthalmology and Visual Science 2004; 45: 2246-54 (IGR: 6-2)


10578 The inhibitory effect of tranilast on transforming growth factor-β2 expression in cultured human trabecular meshwork cells
Cao Y; Da BH; Wei HR
Chinese Journal of Ophthalmology 2004; 40: 254-7 (IGR: 6-2)


10595 SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms
Costagliola C; Parmeggiani F; Sebastiani A
CNS Drugs 2004; 18: 475-484 (IGR: 6-2)


10710 Role of adenosine in intraocular pressure
Konno T
Nippon yakurigaku zasshi 2004; 123: 289-294 (IGR: 6-2)


10763 Effect of rilmenidine on intraocular pressure in rabbits, interaction with efaroxan and rauwolscine
Misiuk Hojlo M; Szalinski M; Merwid Lad A; Trocha M; Piesniewska M
Klinika Oczna 2004; 106: 7-10 (IGR: 6-2)


10795 Structure-activity relationships of adenosine A3 receptor ligands: New potential therapy for the treatment of glaucoma
Okamura T; Kurogi Y; Hashimoto K; Sato S; Nishikawa H; Kiryu K; Nagao Y
Bioorganic and Medicinal Chemistry Letters 2004; 14: 3775-3779 (IGR: 6-2)


10811 Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility
Potter DE; Russell KR; Manhiani M
Journal of Pharmacology and Experimental Therapeutics 2004; 309: 548-53 (IGR: 6-2)


10875 Effects of Topical H-7 on Outflow Facility, Intraocular Pressure, and Corneal Thickness in Monkeys
Tian B; Wang R-F; Podos SM; Kaufman PL
Archives of Ophthalmology 2004; 122: 1171-1177 (IGR: 6-2)


10878 Cannabinoids and glaucoma
Tomida I; Pertwee RG; Azuara-Blanco A
British Journal of Ophthalmology 2004; 88: 708-13 (IGR: 6-2)


10893 Intraocular pressure in rabbits after administration of 10% L-arginine HCl in 2% Trusopt
Veselovsky J; Olah Z; Vesela A; Gressnerova S
?eska a Slovenska Oftalmologie 2004; 60: 81-8 (IGR: 6-2)


10892 The amino acid 10% L-arginin.HCl combined with 0.5% timoptol and with 2% trusopt: Effectivity check and comparison with the single compounds - Experiment on rabbits
Veselovsky J; Olah Z; Vesela A; Gressnerova S
?eska a Slovenska Oftalmologie 2004; 60: 163-170 (IGR: 6-2)


10106 PD128,907 induces ocular hypotension in rabbits: involvement of D2/D3 dopamine receptors and brain natriuretic peptide
Chu E; Socci R; Chu TC
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 15-23 (IGR: 6-1)


10108 The fall and rise of active chloride transport: implications for regulation of intraocular pressure
Civan MM
Journal of Experimental Zoology Part A Comp Experimental Biology 2003; 300: 5-13 (IGR: 6-1)


10111 Efficacy of bunazosin hydrochloride 0.01% as adjunctive therapy of latanoprost or timolol
Kobayashi H; Kobayashi K; Okinami S
Journal of Glaucoma 2004; 13: 73-80 (IGR: 6-1)


10477 Effects of 2-alkynyladenosine derivatives on intraocular pressure in rabbits
Konno T; Ohnuma SY; Uemoto K; Uchibori T; Nagai A; Kogi K; Endo K; Hosokawa T; Nakahata N
European Journal of Pharmacology 2004; 486: 307-316 (IGR: 6-1)


10107 Adenosine tetraphosphate, Ap4, a physiological regulator of intraocular pressure in normotensive rabbit eyes
Pintor J; Pelaez T; Peral A
Journal of Pharmacology and Experimental Therapeutics 2004; 308: 468-473 (IGR: 6-1)


10511 Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment
Wang Y; Challa P; Epstein DL; Yuan F
Biomaterials 2004; 25: 4279-4285 (IGR: 6-1)


10105 Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
Journal of Medicinal Chemistry 2004; 47: 550-557 (IGR: 6-1)


9945 Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma
Flach AJ; Anderson DR; Spaeth GL; Cantor LB
Transactions of the American Ophthalmological Society 2002; 100: 215-224 (IGR: 5-3)


9946 A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole
May JA; Chen HH; Rusinko A; Lynch VM; Sharif NA; McLaughlin MA
Journal of Medicinal Chemistry 2003; 46: 4188-4195 (IGR: 5-3)


9944 4-Aminopyridine transiently increases intraocular pressure in rabbits
Socci RR; Chu E; Bayorh MA; Chu TC
Pharmacology 2003; 69: 108-114 (IGR: 5-3)


9948 A combination of timoptol and L-arginine HCl: a regulator of intraocular pressure in rabbits
Veselovsky J; Olah Z; Vesela A; Gressnerova S
?eska a Slovenska Oftalmologie 2003; 59: 295-302 (IGR: 5-3)


8874 Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits
Kotikoski H; Vapaatalo H; Oksala O
Current Eye Research 2003; 26: 119-123 (IGR: 5-2)


8937 Omega conotoxin: a subtype specific calcium channel ligand with therapeutic potential in glaucoma?
Chu TC; Potter DE
Research Communications in Pharmacology and Toxicology 2001; 6: 263-275 (IGR: 5-2)


8933 Pharmacokinetic profile of topical flunarizine in rabbit eye and plasma
Maltese A; Bucolo C
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 171-179 (IGR: 5-2)


8934 Evaluation of the ocular hypotensive response of serotonin 5 HT1A and 5 HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys
May JA; McLaughlin MA; Sharif NA; Hellberg MR; Dean TR
Journal of Pharmacology and Experimental Therapeutics 2003; 306: 301-309 (IGR: 5-2)


8932 Effects of adenosine on intraocular pressure, optic nerve head blood flow, and choroidal blood flow in healthy humans
Polska E; Ehrlich P; Luksch A; Fuchsjager-Mayrl G; Schmetterer L
Investigative Ophthalmology and Visual Science 2003; 44: 3110-3114 (IGR: 5-2)


8939 Inhibition of 11β hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension
Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
Quarterly Journal of Medicine 2003; 96: 481-490 (IGR: 5-2)


8935 A novel D2 dopaminergic and α2 adrenoceptor receptor agonist induces substantial and prolonged IOP decrease in normotensive rabbits
Savolainen J; Rautio J; Razzetti R; Jarvinen T
Journal of Pharmacy and Pharmacology 2003; 55: 789-794 (IGR: 5-2)


8385 Effects of ion transport and channel-blocking drugs on aqueous humor formation in isolated bovine eye
Shahidullah M; Wilson WS; Yap M; To CH
Investigative Ophthalmology and Visual Science 2003; 44: 1185-1191 (IGR: 5-1)


8525 Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys
Chien FY; Wang RF; Mittag TW; Podos SM
Archives of Ophthalmology 2003; 121: 87-90 (IGR: 5-1)


8526 Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury
Zalish M; Lavie V
Vision Research 2003; 43: 237-242 (IGR: 5-1)


8419 Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit
Wang N; Orr-Urtreger A; Chapman J; Rabinowitz R; Nachman R; Korczyn AD
Journal of Physiology 2002; 542: 347-354 (IGR: 5-1)


8532 Effects of olprinone hydrochloride on intraocular pressure and ocular blood flow in patients after cardiac surgery under cardiopulmonary bypass
Goto K; Hasegawa A; Shingu C; Hayano Y; Yoshitake S; Noguchi T
Japanese Journal of Anesthesiology 2002; 51: 1212-1216 (IGR: 5-1)


8678 Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation
Ishii K; Matsuo H; Fukaya Y; Tanaka S; Sakaki H; Waki M; Araie M
Investigative Ophthalmology and Visual Science 2003; 44: 1169-1177 (IGR: 5-1)


8531 Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure
Pintor J; Peral A; Pelaez T; Martin S; Hoyle CH
Journal of Pharmacology and Experimental Therapeutics 2003; 304: 342-348 (IGR: 5-1)


8298 Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites
Campana G; Bucolo C; Murari G; Spampinato S
Journal of Pharmacology and Experimental Therapeutics 2002; 303: 1086-1094 (IGR: 4-3)


8060 Endothelin-A receptor antagonist BQ-485 protects against intraocular pressure spike induced by laser trabeculoplasty in the rabbit
Holló G; Kóthy P; Lakatos P; Vargha P
Ophthalmologica 2002; 216: 459-462 (IGR: 4-3)


8339 Cannabinoids in the treatment of glaucoma
Jarvinen T; Pate DW; Laine K
Pharmacology and Therapeutics 2002; 95: 203-220 (IGR: 4-3)


8301 Topically administered CB2-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits
Laine K; Jarvinen K; Jarvinen T
Life Sciences 2003; 72: 837-842 (IGR: 4-3)


8059 Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid
Laine K; Jarvinen K; Mechoulam R; Breuer A; Jarvinen T
Investigative Ophthalmology and Visual Science 2002; 43(10): 3216-3222 (IGR: 4-3)


8062 The influence of nitric synthase inhibitor (L-NAME) on the intraocular pressure in endotoxin induced uveitis in rats
Szymaniec S; Misiuk-Hojlo M
Klinika Oczna 2002; 104: 87-88 (IGR: 4-3)


8330 Nipradilol inhibits apoptosis by preventing the activation of caspase-3 via S-nitrosylation and the cGMP-dependent pathway
Tomita H; Nakazawa T; Sugano E; Abe T; Tamai M
European Journal of Pharmacology 2002; 452: 263-268 (IGR: 4-3)


3452 Aquaporin deletion in mice reduces intraocular pressure and aqueous fluid production
Zhang D; Vetrivel L; Verkman AS
Journal of General Physiology 2002; 119: 561-569 (IGR: 4-2)


3591 Inhibitors of NHE-1 Na+/H+ exchange reduce mouse intraocular pressure
Avila MY; Seidler RW; Stone RA; Civan MM
Investigative Ophthalmology and Visual Science 2002; 43: 1897-1902 (IGR: 4-2)


3592 Adenylyl cyclase activity mediated by β-adrenoceptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells
Crider JY; Sharif NA
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 221-230 (IGR: 4-2)


3593 A myosin light chain kinase inhibitor, ML-9, lowers the intraocular pressure in rabbit eyes
Honjo M; Inatani M; Kido N; Sawamura T; Yue BY; Honda Y; Tanihara H
Experimental Eye Research 2002; 75: 135-142 (IGR: 4-2)


3594 The effects of several vasopressin receptor antagonists on normal intraocular pressure and the intraocular distribution of vasopressin receptor subtypes
Naito A; Kurasawa T; Ohtake Y; Toyoda Y; Ezure Y; Koike K; Shigenobu K
Biological & Pharmaceutical Bulletin 2002; 25: 251-255 (IGR: 4-2)


3595 Chronic cannabis use in the Compassionate Investigational New Drug program: an examination of benefits and adverse effects of legal clinical cannabis
Russo E; Mathre ML; Byrne A; Velin R; Bach PJ; Sanchez Ramos J; Kirlin KA
Journal of Cannabis Therapeutics 2002; 2: 3-57 (IGR: 4-2)


6600 Aqueous humor adrenomedullin levels differ in patients with different types of glaucoma
Evereklioglu C; Doganay S; Er H; Yurekli M
Japanese Journal of Ophthalmology 2002; 46: 203-208 (IGR: 4-1)


6847 Relaxing effect of CEDO 8956 and hydralazine HCl in cultured smooth muscle cells versus pericytes: a preliminary study
Haefliger IO; Pedrini M; Anderson DR
Klinische Monatsblätter für Augenheilkunde 2002; 219: 277-280 (IGR: 4-1)


6858 Nitric oxide is proangiogenic in the retina and choroid
Ando A; Yang A; Mori K; Yamada H; Yamada E; Takahashi K; Saikia J; Kim M; Melia M; Fishman M
Journal of Cellular Physiology 2002; 191: 116-124 (IGR: 4-1)


6859 Soft cannabinoid analogues as potential anti-glaucoma agents
Buchwald A; Derendorf H; Ji F; Nagaraja NY; Wu WM; Bodor N
Pharmazie 2002; 57: 108-114 (IGR: 4-1)


6860 Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: Role of cyclic GMP
Kotikoski H; Alajuuma P; Moilanen E; Salmenpera P; Oksala O; Laippala P; Vapaatalo H
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 11-23 (IGR: 4-1)


6861 Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides
Laine K; Jarvinen K; Pate DW; Urtti A; Jarvinen T
Investigative Ophthalmology and Visual Science 2002; 43: 393-397 (IGR: 4-1)


6862 Forskolin upregulation of NOS I protein expression in porcine ciliary processes: a new aspect of aqueous humor regulation
Liu R; Flammer J; Haefliger IO
Klinische Monatsblätter für Augenheilkunde 2002; 219: 281-283 (IGR: 4-1)


6863 Potentiation of sympathetic neurotransmission in bovine isolated irides by isoprostanes
Opere CA; Awe SO; Harris LC; Leday AM; Ohia SE
Free Radical Research 2001; 35: 257-264 (IGR: 4-1)


6864 Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate)
Pang IH; Moll H; McLaughlin M; Knepper PA; De Santis L; Epstein DL; Clark AF
Experimental Eye Research 2001; 73: 815-825 (IGR: 4-1)


6865 The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with α-chymotrypsin-induced ocular hypertension
Puras G; Santafe J; Segarra J; Garrido M; Melena J
Graefe's Archive for Clinical and Experimental Ophthalmology 2002; 240: 322-328 (IGR: 4-1)


6866 Flufenamic acid enhances current through maxi-K channels in the trabecular meshwork of the eye
Stumpff F; Boxberger M; Thieme H; Strauss O; Wiederholt M
Current Eye Research 2001; 22: 427-437 (IGR: 4-1)


6867 Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase
Waki M; Yoshida Y; Oka T; Azuma M
Current Eye Research 2001; 22: 470-474 (IGR: 4-1)


6868 Effects of two forskolin analogues on the elevation of ocular pressure in human
Yang W; Li X; Chen Z; Nie L; Li L; Lie W
Chinese Ophthalmic Research 2001; 19: 556-559 (IGR: 4-1)


18333 Activation of p42/p44 mitogen-activated protein kinase and contraction by prostaglandin F2α, ionomycin, and thapsigargin in cat iris sphincter smooth muscle: inhibition by PD98059, KN-93, and isoproterenol
Ansari HR; Husain S; Abdel-Latif AA
Journal of Pharmacology and Experimental Therapeutics 2001; 299: 178-186 (IGR: 3-3)


18332 Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes
Maihöfner C; Schlötzer-Schrehardt U; Gübring H; Zeilhofer HU; Naumann GOH; Pahl A; Mardin CY; Tamm ER; Brune K
Investigative Ophthalmology and Visual Science 2001; 42: 2616-2624 (IGR: 3-3)


18331 Assessment of the intraocular pressure-lowering activity of bicyclic derivatives of 1-substituted benzyloctahydroisoquinoline
Saha SL; Igbo IN; Opere CA; Zhan GL; Taniyama J; Ohia SE; Roche VF
Journal of Ocular Pharmacology and Therapeutics 2001; 17: 413-420 (IGR: 3-3)


18330 Effects of the marine macrolides swinholide A and jasplakinolide on outflow facility in monkeys
Tian B; Kiland JA; Kaufman PL
Investigative Ophthalmology and Visual Science 2001; 42: 3187-3192 (IGR: 3-3)


6321 Effect of H-7 on cultured human trabecular meshwork cells
Liu X; Cai S; Glasser A; Volberg T; Polansky JR; Fauss DJ; Brandt CR; Geiger B; Kaufman PL
Molecular Vision 2001; 7: 145-153 (IGR: 3-2)


6332 Nitric oxide attenuates α2-adrenergic receptors by ADP-ribosylation of GIα in ciliary epithelium
Moroi SE; Sitaramayya A
Investigative Ophthalmology and Visual Science 2001; 42: 2056-2062 (IGR: 3-2)


6363 Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: evidence for a dual mechanism of action
Crosson CE
Investigative Ophthalmology and Visual Science 2001; 42: 1837-1840 (IGR: 3-2)


6368 Intraocular pressure-lowering activity and in vivo disposition of dipivalyl terbutalone in rabbits
Reddy IK; Vaithiyalingam SR; Khan MA; Bodor NS
Drug Development and Industrial Pharmacy 2001; 27: 137-141 (IGR: 3-2)


6516 Cationic ferritin changes outflow facility in human eyes whereas anionic ferritin does not
Ethier CR; Chan DWH
Investigative Ophthalmology and Visual Science 2001; 42: 1795-1802 (IGR: 3-2)


6517 Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes
Honjo M; Inatani M; Kido N; Sawamura T; Yue BYJT; Honda Y; Tanihara H
Archives of Ophthalmology 2001; 119: 1171-1178 (IGR: 3-2)


19152 Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility
Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BYJT; Narumiya S; Honda Y
Investigative Ophthalmology and Visual Science 2001; 42: 137-144 (IGR: 3-1)


19153 The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies
Porcella A; Maxia C; Gessa GL; Pani L
European Journal of Neuroscience 2001; 13: 409-412 (IGR: 3-1)


19154 Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632
Rao PV; Deng PF; Kumar J; Epstein DL
Investigative Ophthalmology and Visual Science 2001; 42: 1029-1037 (IGR: 3-1)


19155 The changes on free radical and catalase in ocular tissue of rabbits undergoing acute ocular hypertension status
Weirong S; Qingkang M; Yanyan L
Chinese Ophthalmic Research 2001; 19: 104-106 (IGR: 3-1)


15661 Mechanism related to reduction of intraocular pressure by melanocortins in rabbits
Naveh N; Kaplan-Messas A; Marshall J
British Journal of Ophthalmology 2000; 84: 1411-1414 (IGR: 2-3)


15660 Effect of ifenprodil on aqueous humor dynamics and optic nerve head circulation in rabbits
Muta K; Tamaki Y; Araie M; Matsubara M
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 241-250 (IGR: 2-3)


15920 Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid
Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 217-230 (IGR: 2-3)


15788 Ocular effects associated with the chronic administration of the adenosine A(1) agonist cyclohexyladenosine
Crosson CE; Niazi Z
Current Eye Research 2000; 21: 808-813 (IGR: 2-3)


15773 In vitro and ex vivo hydrolysis rates of ethacrynate esters and their relationship to intraocular pressure in the rabbit eye
Deshpande G; Schoenwald RD; Barfknecht CF; Duffel MW
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 539-556 (IGR: 2-3)


15779 Effect of CO2 pneumoperitoneum on early cellular markers of retinal ischemia in rabbits with alpha-chymotrypsin-induced glaucoma
Lentschener C; Fredi-Reygrobellet D; Bouaziz H; Mazoit JX; Niessen F; Benhamou D
Surgical Endoscopy 2000; 14: 1057-1061 (IGR: 2-3)


16004 Suppressing effect of isoforskolin and forskolin on ocular hypertension in rabbits
Li X; Nie L; Yang W
Chinese Journal of Ophthalmology 2000; 36: 292 (IGR: 2-3)


15748 The ocular pharmacokinetics of ketanserin and its metabolite, ketanserinol, in albino rabbits
Schoenwald RD; Zhu J
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 481-495 (IGR: 2-3)


15769 Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A
Thieme H; Nuskovski M; Nass JU; Pleyer U; Strauss O; Wiederholt M
Investigative Ophthalmology and Visual Science 2000; 41: 4240-4246 (IGR: 2-3)


15892 ML-7, chelerythrine and phorbol ester increase outflow facility in the monkey eye
Tian B; Brumback LC; Kaufman PL
Experimental Eye Research 2000; 71: 551-556 (IGR: 2-3)


5982 H-7 effects on the structure and fluid conductance of monkey trabecular meshwork
Sabanay I; Gabelt BT; Tian B; Kaufman PL; Geiger B
Archives of Ophthalmology 2000; 118: 955-962 (IGR: 2-2)


5991 The role of NaKCl cotransport in blood-to-aqueous chloride fluxes across rabbit ciliary epithelium
Crook RB; Takahashi K; Mead A; Dunn JJ; Sears ML
Investigative Ophthalmology and Visual Science 2000; 41: 2574-2583 (IGR: 2-2)


6212 Effect of latrunculin-A on morphology and actin-associated adhesions of cultured human trabecular meshwork cells
Cai S; Liu X; Glasser A; Volberg T; Filla M; Geiger B; Polansky JR; Kaufman PL
Molecular Vision 2000; 6: 132-143 (IGR: 2-2)


6213 The effect of L-arginine on intraocular pressure in the human eye
Chuman H; Chuman T; Nao-i N; Sawada A
Current Eye Research 2000; 20: 511-516 (IGR: 2-2)


6214 Effect of fluoxetine on intraocular pressure in the rabbit
Costagliola C; Mastropasqua L; Capone D; Verolino M; Ciancaglini M; Pisanti N
Experimental Eye Research 2000; 70: 551-555 (IGR: 2-2)


6215 Effect of SR121463, a selective non-peptide vasopressin V sub(2) receptor antagonist, in a rabbit model of ocular hypertension
Lacheretz F; Barbier A; Serradeil-Le Gal C; Elena PP; Maffrand JP; Le Fur G
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 203-216 (IGR: 2-2)


6216 Latrunculins' effects on intraocular pressure, aqueous humor flow, and corneal endothelium
Peterson JA; Tian B; McLaren JW; Hubbard WC; Geiger B; Kaufman PL
Investigative Ophthalmology and Visual Science 2000; 41: 1749-1758 (IGR: 2-2)


5626 Influence of muscarinic agonists and tyrosine kinase inhibitors on L-type Ca(2+)Channels in human and bovine trabecular meshwork cells
Steinhausen K; Stumpff F; Strauss O; Thieme H; Wiederholt M
Experimental Eye Research 2000; 70: 285-293 (IGR: 2-1)


5630 Effect of latrunculin-B on outflow facility in monkeys
Peterson JA; Tian B; Geiger B; Kaufman PL
Experimental Eye Research 2000; 70: 307-313 (IGR: 2-1)


5837 Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina
Birgbauer E; Cowan CA; Sretavan DW; Henkemeyer M
Development 2000; 127: 1231-1241 (IGR: 2-1)


5838 Acetylsalicylic acid does not reduce the intraocular pressure variation in ocular hypertension or glaucoma
Linden C; Alm A
Experimental Eye Research 2000; 70: 281-283 (IGR: 2-1)


5839 Laboratory investigation: A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits
Naveh N; Weissman C; Muchtar S; Benita S; Mechoulam R
Graefe's Archive for Clinical and Experimental Ophthalmology 2000; 238: 334-338 (IGR: 2-1)


5840 Expression of adenylate cyclase subtypes II and IV in the human outflow pathway
Zhang X; Wang N; Schroeder A; Erickson KA
Investigative Ophthalmology and Visual Science 2000; 41: 998-1005 (IGR: 2-1)


15544 Advances in glaucoma diagnosis and therapy for the next millennium: new drugs for trabecular and uveoscleral outflow
Kaufman PL; Gabelt B; Tian B; Liu X
Seminars in Ophthalmology 1999; 14: 130-143 (IGR: 1-3)


15546 Atriopeptin, sodium azide and cyclic GMP reduce secretion of aqueous humour and inhibit intracellular calcium release in bovine cultured ciliary epithelium
Shahidullah M; Wilson WS
British Journal of Pharmacology 1999; 127: 1438-1446 (IGR: 1-3)


15547 Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2
Song ZH; Slowey CA
Journal of Pharmacology and Experimental Therapeutics 2000; 292: 136-139 (IGR: 1-3)


15548 Ocular effects of adrenomedullin
Taniguchi T; Kawase K; Gu Z-B; Kimura M; Okano Y; Kawakami H; Tsuji A; Kitazawa Y
Experimental Eye Research 1999; 69: 467-474 (IGR: 1-3)


15549 Biphasic intraocular pressure response to calcitonin gene-related peptide
Taniguchi T; Nakai Y; Karim Z; Gu Z-B; Kawase K; Kitazawa Y
Current Eye Research 1999; 5: 432-438 (IGR: 1-3)


15550 The effects of protein kinase C on trabecular meshwork and ciliary muscle contractility
Thieme H; Nass JU; Nuskovski M; Bechrakis NE; Stumpff F; Strauss O; Wiederholt M
Investigative Ophthalmology and Visual Science 1999; 40: 3254-3261 (IGR: 1-3)


5191 Stimulation of maxi-K channels in trabecular meshwork by tyrosine kinase inhibitors.
Stumpff F; Que Y; Boxberger M; Strauss O; Wiederholt M
Investigative Ophthalmology and Visual Science 1999; 40: 1404-1417 (IGR: 1-2)


5231 The effect of topical dihydroergocristine on the intraocular pressure in alpha-chymotrypsin-induced ocular hypertensive rabbits.
Melena J; Santafe J; Segarra J
Methods and Findings in Experimental and Clinical Pharmacology 1998; 20: 861-867 (IGR: 1-2)


5235 Ocular hypotensive effect of ramiprilat in chronic and acute models of glaucoma in rabbits
Shah GB; Harma S; Mehta AA; Goyal RK
Indian Journal of Pharmacology 1999; 31: 110-115 (IGR: 1-2)


5290 Sympathetic vasoconstriction in the rat anterior choroid is mediated by alpha1-adrenoceptors
Kawarai M; Koss MC
European Journal of Pharmacology 1999; 363: 35-40 (IGR: 1-2)


5456 Sigma1 recognition sites in rabbit iris-ciliary body: topical sigma1-site agonists lower intraocular pressure.
Bucolo C; Campana G; Di Toro R; Cacciaguerra S; Spampinato S
Journal of Pharmacology and Experimental Therapeutics 1999; 289: 1362-1369 (IGR: 1-2)


5457 Effects of ethacrynic acid on Schlemm's canal inner wall and outflow facility in human eyes.
Ethier CR; Coloma FM
Investigative Ophthalmology and Visual Science 1999; 40: 1599-1607 (IGR: 1-2)


5458 Enthacrynic and acid effects on inner wall pores in living monkeys.
Ethier CR; Croft MA; Coloma FM; Gangnon RE; Ladd W; Kaufman PL
Investigative Ophthalmology and Visual Science 1999; 40: 1382-1391 (IGR: 1-2)


5459 Effects of adenosinergic agents on the vascular resistance and on the optic nerve response in the perfused cat eye.
Kaelin-Lang A; Jurklies B; Niemeyer G
Vision Research 1999; 39: 1059-1068 (IGR: 1-2)


5460 Effects of ethacrynic acid on intraocular pressure of anesthetized rats.
Searles RV; Johnson M; Shikher V; Balaban CD; Severs WB
Proceedings of the Society for Experimental Biology and Medicine 1999; 220: 184-188 (IGR: 1-2)


5461 Safety and ocular hypotensive efficacy of a single dose of metoclopramide or droperidol in healthy subjects
Shu Lang Liao; Por Tying Hung; Yi Chun Chen; Wei Lun Lan
Journal of Ocular Pharmacology and Therapeutics 1999; 15: 117-121 (IGR: 1-2)


5462 8OH-DPAT-Induced ocular hypotension: Sites and mechanisms of action
Teh-Ching Chu; Miller J; Ogidigben; Potter DE
Experimental Eye Research 1999; 69: 227-238 (IGR: 1-2)


5463 Combined effects of H-7 and cytochalasin B on outflow facility in monkeys
Tian B; Gabelt BT; Geiger B; Kaufman PL
Experimental Eye Research 1999; 66: 649-655 (IGR: 1-2)



11.8 Neuroprotection (4882 abstracts found)


94820 Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma
Sayyad Z
Neurochemistry International 2021; 148: 105075 (IGR: 22-2)


94394 Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
Vernazza S
International journal of molecular sciences 2021; 22: (IGR: 22-2)


94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Belforte N
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)


94240 ATP and Adenosine in the Retina and Retinal Diseases
Ye SS
Frontiers in pharmacology 2021; 12: 654445 (IGR: 22-2)


94583 Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy
Limoli PG
Stem cell research & therapy 2021; 12: 275 (IGR: 22-2)


94829 Tackling retinal ganglion cell apoptosis in glaucoma: role of adenosine receptors
Agarwal P
Expert Opinion on Therapeutic Targets 2021; 25: 585-596 (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Pahlitzsch M
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


94583 Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy
Limoli PG
Stem cell research & therapy 2021; 12: 275 (IGR: 22-2)


94921 Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Cordeiro MF
Progress in Retinal and Eye Research 2021; 0: 100976 (IGR: 22-2)


94673 Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models
Webster SE
Experimental Eye Research 2021; 210: 108717 (IGR: 22-2)


94852 Neuroprotection in Glaucoma: NAD/NADH Redox State as a Potential Biomarker and Therapeutic Target
Petriti B
Cells 2021; 10: (IGR: 22-2)


94992 miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage
Mead B
Cells 2021; 10: (IGR: 22-2)


94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Risner ML
Molecular Neurodegeneration 2021; 16: 36 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Cen LP
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94492 Stem Cell-Based Regeneration and Restoration for Retinal Ganglion Cell: Recent Advancements and Current Challenges
Zhang J
Biomolecules 2021; 11: (IGR: 22-2)


94824 Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma towards Multi-Target Strategies for Broader Treatment Effects
Tezel G
Cells 2021; 10: (IGR: 22-2)


94630 Neuroprotection of the Inner Retina Also Prevents Secondary Outer Retinal Pathology in a Mouse Model of Glaucoma
Kumar S
Investigative Ophthalmology and Visual Science 2021; 62: 35 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Xu K
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


94992 miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage
Kerr A
Cells 2021; 10: (IGR: 22-2)


94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Agostinone J
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Fritsche-Guenther R
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


94673 Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models
Sklar NC
Experimental Eye Research 2021; 210: 108717 (IGR: 22-2)


94921 Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Hill D
Progress in Retinal and Eye Research 2021; 0: 100976 (IGR: 22-2)


94492 Stem Cell-Based Regeneration and Restoration for Retinal Ganglion Cell: Recent Advancements and Current Challenges
Wu S
Biomolecules 2021; 11: (IGR: 22-2)


94829 Tackling retinal ganglion cell apoptosis in glaucoma: role of adenosine receptors
Agarwal R
Expert Opinion on Therapeutic Targets 2021; 25: 585-596 (IGR: 22-2)


94921 Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Hill D
Progress in Retinal and Eye Research 2021; 0: 100976 (IGR: 22-2)


94240 ATP and Adenosine in the Retina and Retinal Diseases
Tang Y
Frontiers in pharmacology 2021; 12: 654445 (IGR: 22-2)


94820 Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma
Vishwakarma S
Neurochemistry International 2021; 148: 105075 (IGR: 22-2)


94583 Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy
Limoli C
Stem cell research & therapy 2021; 12: 275 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Li S
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


94630 Neuroprotection of the Inner Retina Also Prevents Secondary Outer Retinal Pathology in a Mouse Model of Glaucoma
Ramakrishnan H
Investigative Ophthalmology and Visual Science 2021; 62: 35 (IGR: 22-2)


94394 Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
Oddone F
International journal of molecular sciences 2021; 22: (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Ng TK
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94852 Neuroprotection in Glaucoma: NAD/NADH Redox State as a Potential Biomarker and Therapeutic Target
Williams PA
Cells 2021; 10: (IGR: 22-2)


94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Pasini S
Molecular Neurodegeneration 2021; 16: 36 (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Pompös I
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


94673 Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models
Spitsbergen JB
Experimental Eye Research 2021; 210: 108717 (IGR: 22-2)


94921 Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Patel R
Progress in Retinal and Eye Research 2021; 0: 100976 (IGR: 22-2)


94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
McGrady NR
Molecular Neurodegeneration 2021; 16: 36 (IGR: 22-2)


94394 Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
Tirendi S
International journal of molecular sciences 2021; 22: (IGR: 22-2)


94240 ATP and Adenosine in the Retina and Retinal Diseases
Song JT
Frontiers in pharmacology 2021; 12: 654445 (IGR: 22-2)


94820 Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma
Dave TV
Neurochemistry International 2021; 148: 105075 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Yang Q
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


94583 Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy
Vingolo EM
Stem cell research & therapy 2021; 12: 275 (IGR: 22-2)


94630 Neuroprotection of the Inner Retina Also Prevents Secondary Outer Retinal Pathology in a Mouse Model of Glaucoma
Viswanathan S
Investigative Ophthalmology and Visual Science 2021; 62: 35 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Liang JJ
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94852 Neuroprotection in Glaucoma: NAD/NADH Redox State as a Potential Biomarker and Therapeutic Target
Lascaratos G
Cells 2021; 10: (IGR: 22-2)


94492 Stem Cell-Based Regeneration and Restoration for Retinal Ganglion Cell: Recent Advancements and Current Challenges
Jin ZB
Biomolecules 2021; 11: (IGR: 22-2)


94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Alarcon-Martinez L
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)


94992 miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage
Nakaya N
Cells 2021; 10: (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Xu C
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94583 Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy
Franzone F
Stem cell research & therapy 2021; 12: 275 (IGR: 22-2)


94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
D'Alessandro KB
Molecular Neurodegeneration 2021; 16: 36 (IGR: 22-2)


94820 Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma
Naik MN
Neurochemistry International 2021; 148: 105075 (IGR: 22-2)


94492 Stem Cell-Based Regeneration and Restoration for Retinal Ganglion Cell: Recent Advancements and Current Challenges
Wang N
Biomolecules 2021; 11: (IGR: 22-2)


94852 Neuroprotection in Glaucoma: NAD/NADH Redox State as a Potential Biomarker and Therapeutic Target
Chau KY
Cells 2021; 10: (IGR: 22-2)


94921 Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Corazza P
Progress in Retinal and Eye Research 2021; 0: 100976 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Zhou Z
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


94630 Neuroprotection of the Inner Retina Also Prevents Secondary Outer Retinal Pathology in a Mouse Model of Glaucoma
Akopian A
Investigative Ophthalmology and Visual Science 2021; 62: 35 (IGR: 22-2)


94992 miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage
Tomarev SI
Cells 2021; 10: (IGR: 22-2)


94394 Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
Bassi AM
International journal of molecular sciences 2021; 22: (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Pohlmann D
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Villafranca-Baughman D
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)


94673 Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models
Stanchfield ML
Experimental Eye Research 2021; 210: 108717 (IGR: 22-2)


94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Dotigny F
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)


94630 Neuroprotection of the Inner Retina Also Prevents Secondary Outer Retinal Pathology in a Mouse Model of Glaucoma
Bloomfield SA
Investigative Ophthalmology and Visual Science 2021; 62: 35 (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Maier AB
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


94583 Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy
Nebbioso M
Stem cell research & therapy 2021; 12: 275 (IGR: 22-2)


94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Yao V
Molecular Neurodegeneration 2021; 16: 36 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Zhuang X
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94852 Neuroprotection in Glaucoma: NAD/NADH Redox State as a Potential Biomarker and Therapeutic Target
Garway-Heath DF
Cells 2021; 10: (IGR: 22-2)


94673 Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models
Webster MK
Experimental Eye Research 2021; 210: 108717 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Fu M
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


94820 Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma
Radha V
Neurochemistry International 2021; 148: 105075 (IGR: 22-2)


94921 Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Maddison J
Progress in Retinal and Eye Research 2021; 0: 100976 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Yang X
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


94820 Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma
Kaur I
Neurochemistry International 2021; 148: 105075 (IGR: 22-2)


94673 Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models
Linn DM
Experimental Eye Research 2021; 210: 108717 (IGR: 22-2)


94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Cooper ML
Molecular Neurodegeneration 2021; 16: 36 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Liu YF
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Cueva Vargas JL
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Winterhalter S
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


94921 Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Younis S
Progress in Retinal and Eye Research 2021; 0: 100976 (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Erb C
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Hao K
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Chen SL
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Di Polo A
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)


94820 Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma
Swarup G
Neurochemistry International 2021; 148: 105075 (IGR: 22-2)


94807 Neuroprotection by Wld depends on retinal ganglion cell type and age in glaucoma
Calkins DJ
Molecular Neurodegeneration 2021; 16: 36 (IGR: 22-2)


94673 Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models
Otteson DC; Linn CL
Experimental Eye Research 2021; 210: 108717 (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Liu Y
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Xu Y
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94850 Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma
Rübsam A
Clinical Ophthalmology 2021; 15: 2505-2517 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Yang Q
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


94741 MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway in glaucoma
Ji H
Journal of Gene Medicine 2021; 0: e3378 (IGR: 22-2)


95416 Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury
Yuan XL; Qin YJ; Chan SO; Chen H; Zhang M; Schally AV; Pang CP
Proceedings of the National Academy of Sciences of the United States of America 2021; 118: (IGR: 22-2)


92710 Estrogen Protects Optic Nerve Head Astrocytes Against Oxidative Stress by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser and the Formation of Tau Protein Aggregates
Means JC
Cellular and molecular neurobiology 2021; 41: 449-458 (IGR: 22-1)


92774 Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
Lafuente M
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92727 Carboxymethylated chitosan alleviated oxidative stress injury in retinal ganglion cells via IncRNA-THOR/IGF2BP1 axis
Wu X
Genes & genomics 2021; 43: 643-651 (IGR: 22-1)


92022 Transneuronal Degeneration in the Brain During Glaucoma
You M
Frontiers in aging neuroscience 2021; 13: 643685 (IGR: 22-1)


92118 Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
Al Hussein Al Awamlh S
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
González Fleitas MF
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


92065 Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
García-Bermúdez MY
Frontiers in neurology 2021; 12: 624983 (IGR: 22-1)


92132 New solutions for old challenges in glaucoma treatment: is taurine an option to consider?
Iezhitsa I
Neural Regeneration Research 2021; 16: 967-971 (IGR: 22-1)


91980 The role of citicoline in glaucoma
Jünemann AGM
Ophthalmologe 2021; 118: 439-448 (IGR: 22-1)


92793 Neuroinflammatory Mechanisms of Mitochondrial Dysfunction and Neurodegeneration in Glaucoma
Duarte JN
Journal of Ophthalmology 2021; 2021: 4581909 (IGR: 22-1)


92114 Protection of retinal ganglion cells in glaucoma: Current status and future
Shen J
Experimental Eye Research 2021; 205: 108506 (IGR: 22-1)


92498 The role of PGS/PCL scaffolds in promoting differentiation of human embryonic stem cells into retinal ganglion cells
Behtaj S
Acta biomaterialia 2021; 126: 238-248 (IGR: 22-1)


92634 Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions
Rhee J
Biomolecules 2021; 11: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
van der Merwe Y
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Oddone F
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Tribble JR
Redox biology 2021; 43: 101988 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Yu H
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92660 Improving the Power of Glaucoma Neuroprotection Trials Using Existing Visual Field Data
Montesano G
American Journal of Ophthalmology 2021; 229: 127-136 (IGR: 22-1)


92022 Transneuronal Degeneration in the Brain During Glaucoma
You M
Frontiers in aging neuroscience 2021; 13: 643685 (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Hvozda Arana AG
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92634 Use of Gene Therapy in Retinal Ganglion Cell Neuroprotection: Current Concepts and Future Directions
Shih KC
Biomolecules 2021; 11: (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Rossetti L
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Murphy MC
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92660 Improving the Power of Glaucoma Neuroprotection Trials Using Existing Visual Field Data
Quigley HA
American Journal of Ophthalmology 2021; 229: 127-136 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Zhong H
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Otmani A
Redox biology 2021; 43: 101988 (IGR: 22-1)


92710 Estrogen Protects Optic Nerve Head Astrocytes Against Oxidative Stress by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser and the Formation of Tau Protein Aggregates
Lopez AA
Cellular and molecular neurobiology 2021; 41: 449-458 (IGR: 22-1)


92022 Transneuronal Degeneration in the Brain During Glaucoma
Rong R
Frontiers in aging neuroscience 2021; 13: 643685 (IGR: 22-1)


92118 Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
Wareham LK
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Otmani A
Redox biology 2021; 43: 101988 (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
Devouassoux J
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Lasagni Vitar RM
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92727 Carboxymethylated chitosan alleviated oxidative stress injury in retinal ganglion cells via IncRNA-THOR/IGF2BP1 axis
Liu Y
Genes & genomics 2021; 43: 643-651 (IGR: 22-1)


92065 Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
Freude KK
Frontiers in neurology 2021; 12: 624983 (IGR: 22-1)


92132 New solutions for old challenges in glaucoma treatment: is taurine an option to consider?
Agarwal R
Neural Regeneration Research 2021; 16: 967-971 (IGR: 22-1)


92498 The role of PGS/PCL scaffolds in promoting differentiation of human embryonic stem cells into retinal ganglion cells
Karamali F
Acta biomaterialia 2021; 126: 238-248 (IGR: 22-1)


91980 The role of citicoline in glaucoma
Grieb P
Ophthalmologe 2021; 118: 439-448 (IGR: 22-1)


92774 Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
Rodríguez González-Herrero ME
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92114 Protection of retinal ganglion cells in glaucoma: Current status and future
Wang Y
Experimental Eye Research 2021; 205: 108506 (IGR: 22-1)


92065 Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
Mouhammad ZA
Frontiers in neurology 2021; 12: 624983 (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Reides CG
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
Aranda ML
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


91980 The role of citicoline in glaucoma
Rejdak R
Ophthalmologe 2021; 118: 439-448 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Li N
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92498 The role of PGS/PCL scaffolds in promoting differentiation of human embryonic stem cells into retinal ganglion cells
Najafian S
Acta biomaterialia 2021; 126: 238-248 (IGR: 22-1)


92114 Protection of retinal ganglion cells in glaucoma: Current status and future
Yao K
Experimental Eye Research 2021; 205: 108506 (IGR: 22-1)


92727 Carboxymethylated chitosan alleviated oxidative stress injury in retinal ganglion cells via IncRNA-THOR/IGF2BP1 axis
Ji Y
Genes & genomics 2021; 43: 643-651 (IGR: 22-1)


92660 Improving the Power of Glaucoma Neuroprotection Trials Using Existing Visual Field Data
Crabb DP
American Journal of Ophthalmology 2021; 229: 127-136 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Sims JR
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Parravano M
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92710 Estrogen Protects Optic Nerve Head Astrocytes Against Oxidative Stress by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser and the Formation of Tau Protein Aggregates
Koulen P
Cellular and molecular neurobiology 2021; 41: 449-458 (IGR: 22-1)


92774 Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
Romeo Villadóniga S
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Sun S
Redox biology 2021; 43: 101988 (IGR: 22-1)


92022 Transneuronal Degeneration in the Brain During Glaucoma
Zeng Z
Frontiers in aging neuroscience 2021; 13: 643685 (IGR: 22-1)


92118 Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
Risner ML; Calkins DJ
International journal of molecular sciences 2021; 22: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Faiq MA
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Sbardella D
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
Dieguez HH
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


92022 Transneuronal Degeneration in the Brain During Glaucoma
Xia X
Frontiers in aging neuroscience 2021; 13: 643685 (IGR: 22-1)


92065 Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
Van Wijngaarden P
Frontiers in neurology 2021; 12: 624983 (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Calabró V
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Chen K
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92774 Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
Domingo JC
Antioxidants (Basel, Switzerland) 2021; 10: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Ellis SA
Redox biology 2021; 43: 101988 (IGR: 22-1)


92498 The role of PGS/PCL scaffolds in promoting differentiation of human embryonic stem cells into retinal ganglion cells
Masaeli E
Acta biomaterialia 2021; 126: 238-248 (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Sbardella D
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92022 Transneuronal Degeneration in the Brain During Glaucoma
Ji D
Frontiers in aging neuroscience 2021; 13: 643685 (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Marchini T
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92498 The role of PGS/PCL scaffolds in promoting differentiation of human embryonic stem cells into retinal ganglion cells
Esfahani MN
Acta biomaterialia 2021; 126: 238-248 (IGR: 22-1)


92065 Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
Martin KK
Frontiers in neurology 2021; 12: 624983 (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Cimaglia G
Redox biology 2021; 43: 101988 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Yang XL
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Coletta M
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Chen J
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
Calanni JS
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Vohra R
Redox biology 2021; 43: 101988 (IGR: 22-1)


92498 The role of PGS/PCL scaffolds in promoting differentiation of human embryonic stem cells into retinal ganglion cells
Rybachuk M
Acta biomaterialia 2021; 126: 238-248 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Sun J
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92065 Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
Kolko M
Frontiers in neurology 2021; 12: 624983 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Ho LC
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Lerner SF
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Ziccardi L
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
Iaquinandi A; Sande PH
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Conner IP
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Evelson PA
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Roberti G
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Xu L
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Jöe M
Redox biology 2021; 43: 101988 (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Carnevale C
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Lardner E
Redox biology 2021; 43: 101988 (IGR: 22-1)


92123 Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Ferreira SM
Archives of Biochemistry and Biophysics 2021; 701: 108815 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Wang J
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Yu Y
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
Dorfman D
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Carnevale C
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Lardner E
Redox biology 2021; 43: 101988 (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Romano D
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Leung CK
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Zhang M
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Venkataraman AP
Redox biology 2021; 43: 101988 (IGR: 22-1)


92295 Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats
Rosenstein RE
Molecular Neurobiology 2021; 58: 3653-3664 (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Manni G
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Liu X
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Wollstein G
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Domínguez-Vicent A
Redox biology 2021; 43: 101988 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Schuman JS
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Parisi V
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Kokkali E; Kokkali E
Redox biology 2021; 43: 101988 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Deng L; Huang P
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92669 Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control
Chan KC
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; 0: (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Rho S; Jóhannesson G
Redox biology 2021; 43: 101988 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Huang S; Shen X
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Burgess RW
Redox biology 2021; 43: 101988 (IGR: 22-1)


92749 Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
Zhong Y
FASEB Journal 2021; 35: e21405 (IGR: 22-1)


92681 Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Fuerst PG; Brautaset R; Kolko M; Morgan JE; Crowston JG; Votruba M; Williams PA
Redox biology 2021; 43: 101988 (IGR: 22-1)


90971 Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2/HO-1 pathway
Li Y
Journal of chemical neuroanatomy 2020; 110: 101876 (IGR: 21-4)


91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Adornetto A
Nutrients 2020; 12: (IGR: 21-4)


91082 Coenzyme Q and its role in glaucoma
Ahmad SS
Saudi Journal of Ophthalmology 2020; 34: 45-49 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Lu Y
Nature 2020; 588: 124-129 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Harder JM
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91772 Potential neuroprotective biomolecules in ophthalmology
Afarid M
International Ophthalmology 2021; 41: 1103-1109 (IGR: 21-4)


91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
Lani-Louzada R
Current Gene Therapy 2021; 0: (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Kasetti RB
Nature communications 2020; 11: 5594 (IGR: 21-4)


91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Dal Monte M
International journal of molecular sciences 2020; 21: (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752 (IGR: 21-4)


91724 Ad- and AAV8-mediated gene therapy in a murine model with retinal ischemia/reperfusion injuries
Luo J
Molecular therapy. Methods & clinical development 2021; 20: 551-558 (IGR: 21-4)


90871 Glaucoma and Antioxidants: Review and Update
Garcia-Medina JJ
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Yao K
Experimental Eye Research 2021; 203: 108388 (IGR: 21-4)


91696 Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension
Naguib S
Redox biology 2021; 0: 101883 (IGR: 21-4)


91483 Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma
Yu P
Annals of translational medicine 2021; 9: 332 (IGR: 21-4)


91006 Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma
Fotesko K
Cellular and molecular neurobiology 2022; 42: 41-57 (IGR: 21-4)


91848 A lab-on-a-chip model of glaucoma
Nafian F
Brain and behavior 2020; 10: e01799 (IGR: 21-4)


91304 Regulation of distinct caspase-8 functions in retinal ganglion cells and astroglia in experimental glaucoma
Yang X
Neurobiology of Disease 2021; 150: 105258 (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Sterling JK
Cell reports 2020; 33: 108271 (IGR: 21-4)


91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Edwards G
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752 (IGR: 21-4)


91452 Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
Hasegawa T
Scientific reports 2020; 10: 21653 (IGR: 21-4)


91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Vilela CAP
Documenta Ophthalmologica 2021; 143: 33-38 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Zhang Y
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Tribble JR
Cells 2021; 10: (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Zhang KY
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Guymer C
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91724 Ad- and AAV8-mediated gene therapy in a murine model with retinal ischemia/reperfusion injuries
Wang S
Molecular therapy. Methods & clinical development 2021; 20: 551-558 (IGR: 21-4)


91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Zhao Y
Experimental Eye Research 2021; 203: 108388 (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Moore SM
Scientific reports 2020; 10: 21752 (IGR: 21-4)


91696 Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension
Backstrom JR
Redox biology 2021; 0: 101883 (IGR: 21-4)


91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Messias A
Documenta Ophthalmologica 2021; 143: 33-38 (IGR: 21-4)


91452 Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
Ikeda HO
Scientific reports 2020; 10: 21653 (IGR: 21-4)


91006 Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma
Thomsen BSV
Cellular and molecular neurobiology 2022; 42: 41-57 (IGR: 21-4)


91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
Dias MS
Current Gene Therapy 2021; 0: (IGR: 21-4)


91304 Regulation of distinct caspase-8 functions in retinal ganglion cells and astroglia in experimental glaucoma
Zeng Q
Neurobiology of Disease 2021; 150: 105258 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Wu N
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Patel PD
Nature communications 2020; 11: 5594 (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Tuffy C
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Brommer B
Nature 2020; 588: 124-129 (IGR: 21-4)


91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Cammalleri M
International journal of molecular sciences 2020; 21: (IGR: 21-4)


91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Hui F
Cells 2021; 10: (IGR: 21-4)


91483 Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma
Dong WP
Annals of translational medicine 2021; 9: 332 (IGR: 21-4)


90971 Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2/HO-1 pathway
Wang Q
Journal of chemical neuroanatomy 2020; 110: 101876 (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Adetunji MO
Cell reports 2020; 33: 108271 (IGR: 21-4)


91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Rombolà L
Nutrients 2020; 12: (IGR: 21-4)


91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Lee Y
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91848 A lab-on-a-chip model of glaucoma
Kamali Doust Azad B
Brain and behavior 2020; 10: e01799 (IGR: 21-4)


90871 Glaucoma and Antioxidants: Review and Update
Rubio-Velazquez E
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91772 Potential neuroprotective biomolecules in ophthalmology
Sanie-Jahromi F
International Ophthalmology 2021; 41: 1103-1109 (IGR: 21-4)


90871 Glaucoma and Antioxidants: Review and Update
Lopez-Bernal MD
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Zangwill LM
Scientific reports 2020; 10: 21752 (IGR: 21-4)


91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Morrone LA
Nutrients 2020; 12: (IGR: 21-4)


91006 Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma
Kolko M
Cellular and molecular neurobiology 2022; 42: 41-57 (IGR: 21-4)


91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Jin P
Experimental Eye Research 2021; 203: 108388 (IGR: 21-4)


91483 Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma
Tang YB
Annals of translational medicine 2021; 9: 332 (IGR: 21-4)


91848 A lab-on-a-chip model of glaucoma
Yazdani S
Brain and behavior 2020; 10: e01799 (IGR: 21-4)


91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Jöe M
Cells 2021; 10: (IGR: 21-4)


90971 Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2/HO-1 pathway
Chu C
Journal of chemical neuroanatomy 2020; 110: 101876 (IGR: 21-4)


91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Amato R
International journal of molecular sciences 2020; 21: (IGR: 21-4)


91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Kim M
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
Linden R
Current Gene Therapy 2021; 0: (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Li Q
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91452 Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
Iwai S
Scientific reports 2020; 10: 21653 (IGR: 21-4)


91724 Ad- and AAV8-mediated gene therapy in a murine model with retinal ischemia/reperfusion injuries
Zhou Z
Molecular therapy. Methods & clinical development 2021; 20: 551-558 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Tian X
Nature 2020; 588: 124-129 (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Mertz JL
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


91696 Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension
Gil M
Redox biology 2021; 0: 101883 (IGR: 21-4)


91304 Regulation of distinct caspase-8 functions in retinal ganglion cells and astroglia in experimental glaucoma
Tezel G
Neurobiology of Disease 2021; 150: 105258 (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Guttha S
Cell reports 2020; 33: 108271 (IGR: 21-4)


91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Calado RT
Documenta Ophthalmologica 2021; 143: 33-38 (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Maddineni P
Nature communications 2020; 11: 5594 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Wood JPM
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Lou X
Experimental Eye Research 2021; 203: 108388 (IGR: 21-4)


91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Siqueira RC
Documenta Ophthalmologica 2021; 143: 33-38 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Hu X
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Quillen S
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


91483 Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma
Chen HZ
Annals of translational medicine 2021; 9: 332 (IGR: 21-4)


91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Pezzino S
International journal of molecular sciences 2020; 21: (IGR: 21-4)


91724 Ad- and AAV8-mediated gene therapy in a murine model with retinal ischemia/reperfusion injuries
Zhao Y
Molecular therapy. Methods & clinical development 2021; 20: 551-558 (IGR: 21-4)


90971 Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2/HO-1 pathway
Liu S
Journal of chemical neuroanatomy 2020; 110: 101876 (IGR: 21-4)


91848 A lab-on-a-chip model of glaucoma
Rasaee MJ
Brain and behavior 2020; 10: e01799 (IGR: 21-4)


90871 Glaucoma and Antioxidants: Review and Update
Cobo-Martinez A
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Bhanvadia S
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91452 Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
Sasaoka N
Scientific reports 2020; 10: 21653 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Daskalaki E
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Nucci C
Nutrients 2020; 12: (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Bargoud AR
Cell reports 2020; 33: 108271 (IGR: 21-4)


91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
de Toledo Ribas V
Current Gene Therapy 2021; 0: (IGR: 21-4)


91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Bell K
Cells 2021; 10: (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Patil S
Nature communications 2020; 11: 5594 (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Proudfoot JA
Scientific reports 2020; 10: 21752 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Krishnan A
Nature 2020; 588: 124-129 (IGR: 21-4)


91696 Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension
Calkins DJ
Redox biology 2021; 0: 101883 (IGR: 21-4)


91006 Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma
Vohra R
Cellular and molecular neurobiology 2022; 42: 41-57 (IGR: 21-4)


91452 Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
Kakizuka A
Scientific reports 2020; 10: 21653 (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Uyhazi KE
Cell reports 2020; 33: 108271 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Wang L
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
Petrs-Silva H
Current Gene Therapy 2021; 0: (IGR: 21-4)


91848 A lab-on-a-chip model of glaucoma
Daftarian N
Brain and behavior 2020; 10: e01799 (IGR: 21-4)


91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Corsaro R
International journal of molecular sciences 2020; 21: (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Kiehlbauch C
Nature communications 2020; 11: 5594 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Meer M
Nature 2020; 588: 124-129 (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Wechsler L
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Chidlow G
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Silva MJL
Documenta Ophthalmologica 2021; 143: 33-38 (IGR: 21-4)


91696 Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension
Rex TS
Redox biology 2021; 0: 101883 (IGR: 21-4)


91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Corasaniti MT
Nutrients 2020; 12: (IGR: 21-4)


91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
Petrs-Silva H
Current Gene Therapy 2021; 0: (IGR: 21-4)


91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Chrysostomou V
Cells 2021; 10: (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Weinreb RN
Scientific reports 2020; 10: 21752 (IGR: 21-4)


91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Luo Z
Experimental Eye Research 2021; 203: 108388 (IGR: 21-4)


91483 Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma
Cui YY
Annals of translational medicine 2021; 9: 332 (IGR: 21-4)


90871 Glaucoma and Antioxidants: Review and Update
Zanon-Moreno V
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Kim KY
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91483 Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma
Bian XL
Annals of translational medicine 2021; 9: 332 (IGR: 21-4)


91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Crowston JG
Cells 2021; 10: (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Ross AG
Cell reports 2020; 33: 108271 (IGR: 21-4)


90871 Glaucoma and Antioxidants: Review and Update
Pinazo-Duran MD
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Sun JG
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Ju WK
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Wang C
Nature 2020; 588: 124-129 (IGR: 21-4)


91452 Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
Tsujikawa A
Scientific reports 2020; 10: 21653 (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Millar JC
Nature communications 2020; 11: 5594 (IGR: 21-4)


91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Covas DT
Documenta Ophthalmologica 2021; 143: 33-38 (IGR: 21-4)


91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Zhang H
Experimental Eye Research 2021; 203: 108388 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Zhang C
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Bagetta G
Nutrients 2020; 12: (IGR: 21-4)


91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Bagnoli P
International journal of molecular sciences 2020; 21: (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Quigley HA
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Skowronska-Krawczyk D
Scientific reports 2020; 10: 21752 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Vera DL
Nature 2020; 588: 124-129 (IGR: 21-4)


91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Williams PA
Cells 2021; 10: (IGR: 21-4)


91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Baxter SL
Scientific reports 2020; 10: 21752 (IGR: 21-4)


91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Russo R
Nutrients 2020; 12: (IGR: 21-4)


91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Li F
Experimental Eye Research 2021; 203: 108388 (IGR: 21-4)


91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Paula JS
Documenta Ophthalmologica 2021; 143: 33-38 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Wang Z
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Dunaief JL
Cell reports 2020; 33: 108271 (IGR: 21-4)


90871 Glaucoma and Antioxidants: Review and Update
Del-Rio-Vellosillo M
Antioxidants (Basel, Switzerland) 2020; 9: (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Zack DJ
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Balasubramanian R
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Rusciano D
International journal of molecular sciences 2020; 21: (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Searby CC
Nature communications 2020; 11: 5594 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Cardozo BH
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Cui QN
Cell reports 2020; 33: 108271 (IGR: 21-4)


91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Johnson TV
Stem cell reports 2021; 16: 149-167 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Zeng Q
Nature 2020; 588: 124-129 (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Raghunathan V
Nature communications 2020; 11: 5594 (IGR: 21-4)


91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Sun XH
Experimental Eye Research 2021; 204: 108449 (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Sheffield VC
Nature communications 2020; 11: 5594 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Foxworth NE
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Yu D
Nature 2020; 588: 124-129 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Deering KE
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Zode GS
Nature communications 2020; 11: 5594 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Bonkowski MS
Nature 2020; 588: 124-129 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Ouellette TB
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Yang JH; Zhou S
Nature 2020; 588: 124-129 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Montgomery C; Wheelock CE
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Hoffmann EM; Karg MM
Nature 2020; 588: 124-129 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Casson RJ
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Schultz MB
Nature 2020; 588: 124-129 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Williams PA
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Kane AE
Nature 2020; 588: 124-129 (IGR: 21-4)


90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
John SWM
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627 (IGR: 21-4)


90866 Reprogramming to recover youthful epigenetic information and restore vision
Davidsohn N; Korobkina E; Chwalek K; Rajman LA; Church GM; Hochedlinger K; Gladyshev VN; Horvath S; Levine ME; Gregory-Ksander MS; Ksander BR; He Z; Sinclair DA
Nature 2020; 588: 124-129 (IGR: 21-4)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Mirzaei M
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Fachim HA
Journal of biochemical and molecular toxicology 2020; 34: e22578 (IGR: 21-3)


90487 Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model
Hvozda Arana AG
Experimental Eye Research 2020; 200: 108225 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Guttenplan KA
Cell reports 2020; 31: 107776 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Xu LJ
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90727 Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
Wójcik-Gryciuk A
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90399 CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma
Maddineni P
Molecular Neurodegeneration 2020; 15: 48 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Wang F
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90557 miR-708 and miR-335-3p Inhibit the Apoptosis of Retinal Ganglion Cells Through Suppressing Autophagy
Zhang Q
Journal of Molecular Neuroscience 2021; 71: 284-292 (IGR: 21-3)


90486 The Neurovascular Unit in Glaucomatous Neurodegeneration
Wareham LK
Frontiers in cell and developmental biology 2020; 8: 452 (IGR: 21-3)


90515 MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma
Harun-Or-Rashid M
Neurobiology of Disease 2020; 141: 104944 (IGR: 21-3)


90024 Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
Artero-Castro A
Progress in Neurobiology 2020; 193: 101817 (IGR: 21-3)


90220 Can neuroprotection effectively manage primary open-angle glaucoma? a protocol of systematic review and meta-analysis
Qi YX
Medicine 2020; 99: e20380 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Abbasi M
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90484 Common aspects between glaucoma and brain neurodegeneration
Saccà SC
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2020; 786: 108323 (IGR: 21-3)


90139 Betalain exerts a protective effect against glaucoma is majorly through the association of inflammatory cytokines
Wang J
AMB Express 2020; 10: 125 (IGR: 21-3)


90478 Association of Ultrapure Citicoline, Homotaurine and Vitamin E in the Management of Normotensive Glaucoma: A Case Report
Verdina T
Case Reports in Ophthalmology 2020; 11: 222-228 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
VanderWall KB
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Kikuchi K
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Reinehr S
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Quillen S
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90540 Ocular Hypertension Drives Remodeling of AMPA Receptors in Select Populations of Retinal Ganglion Cells
Sladek AL
Frontiers in synaptic neuroscience 2020; 12: 30 (IGR: 21-3)


90467 Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma
Yang X
Journal of Neuroinflammation 2020; 17: 252 (IGR: 21-3)


90651 The Expression and Role of Hypoxia-induced Factor-1α in Human Tenon's Capsule Fibroblasts under Hypoxia
Qin X
Current Eye Research 2020; 0: 1-9 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Rossi GCM
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90509 Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Benning L
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90365 Neuroprotection: A versatile approach to combat glaucoma
Naik S
European Journal of Pharmacology 2020; 881: 173208 (IGR: 21-3)


90128 Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
Cooper ML
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 18810-18821 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
VanderWall KB
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90461 High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina
Harper MM
Current Eye Research 2020; 0: 1-7 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Hui F
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Choi SH
Redox biology 2020; 37: 101703 (IGR: 21-3)


90600 Transcorneal Electrical Stimulation Reduces Neurodegenerative Process in a Mouse Model of Glaucoma
Jassim AH
Annals of Biomedical Engineering 2021; 49: 858-870 (IGR: 21-3)


90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Romano GL
Biochemical Pharmacology 2020; 180: 114199 (IGR: 21-3)


90656 On the Generation and Regeneration of Retinal Ganglion Cells
Oliveira-Valença VM
Frontiers in cell and developmental biology 2020; 8: 581136 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Froger N
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90662 The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography
Tanaka-Gonome T
Biochemistry and biophysics reports 2020; 23: 100777 (IGR: 21-3)


90555 Functional analysis of mesencephalic astrocyte-derived neurotrophic factor in retinal ganglion cells under oxidative stress
Ko JA
Cell biochemistry and function 2021; 39: 98-106 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Schaub J
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90662 The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography
Xie Y
Biochemistry and biophysics reports 2020; 23: 100777 (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Dong Z
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90656 On the Generation and Regeneration of Retinal Ganglion Cells
Bosco A
Frontiers in cell and developmental biology 2020; 8: 581136 (IGR: 21-3)


90139 Betalain exerts a protective effect against glaucoma is majorly through the association of inflammatory cytokines
Zhang D
AMB Express 2020; 10: 125 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Matonti F
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Stafford BK
Cell reports 2020; 31: 107776 (IGR: 21-3)


90461 High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina
Boese EA
Current Eye Research 2020; 0: 1-7 (IGR: 21-3)


90727 Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
Gajewska-Woźniak O
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Gupta VK
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90557 miR-708 and miR-335-3p Inhibit the Apoptosis of Retinal Ganglion Cells Through Suppressing Autophagy
He C
Journal of Molecular Neuroscience 2021; 71: 284-292 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Schaub J
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90467 Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma
Zeng Q
Journal of Neuroinflammation 2020; 17: 252 (IGR: 21-3)


90024 Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
Rodriguez-Jimenez FJ
Progress in Neurobiology 2020; 193: 101817 (IGR: 21-3)


90399 CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma
Kasetti RB
Molecular Neurodegeneration 2020; 15: 48 (IGR: 21-3)


90555 Functional analysis of mesencephalic astrocyte-derived neurotrophic factor in retinal ganglion cells under oxidative stress
Komatsu K
Cell biochemistry and function 2021; 39: 98-106 (IGR: 21-3)


90486 The Neurovascular Unit in Glaucomatous Neurodegeneration
Calkins DJ
Frontiers in cell and developmental biology 2020; 8: 452 (IGR: 21-3)


90128 Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
Pasini S
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 18810-18821 (IGR: 21-3)


90220 Can neuroprotection effectively manage primary open-angle glaucoma? a protocol of systematic review and meta-analysis
Zhang J
Medicine 2020; 99: e20380 (IGR: 21-3)


90600 Transcorneal Electrical Stimulation Reduces Neurodegenerative Process in a Mouse Model of Glaucoma
Cavanaugh M
Annals of Biomedical Engineering 2021; 49: 858-870 (IGR: 21-3)


90509 Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Reinehr S
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90365 Neuroprotection: A versatile approach to combat glaucoma
Pandey A
European Journal of Pharmacology 2020; 881: 173208 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Huang KC
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90515 MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma
Pappenhagen N
Neurobiology of Disease 2020; 141: 104944 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Gupta VK
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90478 Association of Ultrapure Citicoline, Homotaurine and Vitamin E in the Management of Normotensive Glaucoma: A Case Report
Passarelli N
Case Reports in Ophthalmology 2020; 11: 222-228 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Ma F
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90484 Common aspects between glaucoma and brain neurodegeneration
Paluan F
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2020; 786: 108323 (IGR: 21-3)


90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Amato R
Biochemical Pharmacology 2020; 180: 114199 (IGR: 21-3)


90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Guizzo R
Journal of biochemical and molecular toxicology 2020; 34: e22578 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Kim KY
Redox biology 2020; 37: 101703 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Buschhorn V
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90487 Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model
Lasagni Vitar RM
Experimental Eye Research 2020; 200: 108225 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Scudeller L
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Gao F
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90540 Ocular Hypertension Drives Remodeling of AMPA Receptors in Select Populations of Retinal Ganglion Cells
Nawy S
Frontiers in synaptic neuroscience 2020; 12: 30 (IGR: 21-3)


90651 The Expression and Role of Hypoxia-induced Factor-1α in Human Tenon's Capsule Fibroblasts under Hypoxia
Wu K
Current Eye Research 2020; 0: 1-9 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Tang J
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Mueller-Buehl AM
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90509 Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Grotegut P
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90128 Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
Lambert WS
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 18810-18821 (IGR: 21-3)


90461 High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina
Kardon RH
Current Eye Research 2020; 0: 1-7 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Roubeix C
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90467 Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma
Barış M
Journal of Neuroinflammation 2020; 17: 252 (IGR: 21-3)


90515 MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma
Zubricky R
Neurobiology of Disease 2020; 141: 104944 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Chitranshi N
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Perkins GA
Redox biology 2020; 37: 101703 (IGR: 21-3)


90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Lazzara F
Biochemical Pharmacology 2020; 180: 114199 (IGR: 21-3)


90478 Association of Ultrapure Citicoline, Homotaurine and Vitamin E in the Management of Normotensive Glaucoma: A Case Report
Carlini A
Case Reports in Ophthalmology 2020; 11: 222-228 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Song Y
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Lumini C
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90487 Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model
Reides CG
Experimental Eye Research 2020; 200: 108225 (IGR: 21-3)


90600 Transcorneal Electrical Stimulation Reduces Neurodegenerative Process in a Mouse Model of Glaucoma
Shah JS
Annals of Biomedical Engineering 2021; 49: 858-870 (IGR: 21-3)


90365 Neuroprotection: A versatile approach to combat glaucoma
Lewis SA
European Journal of Pharmacology 2020; 881: 173208 (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Shinmei Y
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Williams PA
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90656 On the Generation and Regeneration of Retinal Ganglion Cells
Vetter ML
Frontiers in cell and developmental biology 2020; 8: 581136 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Chitranshi N
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90651 The Expression and Role of Hypoxia-induced Factor-1α in Human Tenon's Capsule Fibroblasts under Hypoxia
Zuo C
Current Eye Research 2020; 0: 1-9 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Cheng S
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90557 miR-708 and miR-335-3p Inhibit the Apoptosis of Retinal Ganglion Cells Through Suppressing Autophagy
Li R
Journal of Molecular Neuroscience 2021; 71: 284-292 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Quigley H
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
El-Danaf RN
Cell reports 2020; 31: 107776 (IGR: 21-3)


90139 Betalain exerts a protective effect against glaucoma is majorly through the association of inflammatory cytokines
Cao C
AMB Express 2020; 10: 125 (IGR: 21-3)


90024 Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
Jendelova P
Progress in Neurobiology 2020; 193: 101817 (IGR: 21-3)


90662 The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography
Yamauchi K
Biochemistry and biophysics reports 2020; 23: 100777 (IGR: 21-3)


90555 Functional analysis of mesencephalic astrocyte-derived neurotrophic factor in retinal ganglion cells under oxidative stress
Okumichi H
Cell biochemistry and function 2021; 39: 98-106 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Pan Y
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Cheng S
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90484 Common aspects between glaucoma and brain neurodegeneration
Gandolfi S
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2020; 786: 108323 (IGR: 21-3)


90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Cunha AOS
Journal of biochemical and molecular toxicology 2020; 34: e22578 (IGR: 21-3)


90399 CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma
Patel PD
Molecular Neurodegeneration 2020; 15: 48 (IGR: 21-3)


90727 Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
Kordecka K
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90220 Can neuroprotection effectively manage primary open-angle glaucoma? a protocol of systematic review and meta-analysis
Su XJ
Medicine 2020; 99: e20380 (IGR: 21-3)


90557 miR-708 and miR-335-3p Inhibit the Apoptosis of Retinal Ganglion Cells Through Suppressing Autophagy
Ke Y
Journal of Molecular Neuroscience 2021; 71: 284-292 (IGR: 21-3)


90600 Transcorneal Electrical Stimulation Reduces Neurodegenerative Process in a Mouse Model of Glaucoma
Willits R
Annals of Biomedical Engineering 2021; 49: 858-870 (IGR: 21-3)


90024 Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
VanderWall KB
Progress in Neurobiology 2020; 193: 101817 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Pease M
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Pereira AC
Journal of biochemical and molecular toxicology 2020; 34: e22578 (IGR: 21-3)


90651 The Expression and Role of Hypoxia-induced Factor-1α in Human Tenon's Capsule Fibroblasts under Hypoxia
Lin M
Current Eye Research 2020; 0: 1-9 (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Murata M
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90555 Functional analysis of mesencephalic astrocyte-derived neurotrophic factor in retinal ganglion cells under oxidative stress
Kiuchi Y
Cell biochemistry and function 2021; 39: 98-106 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Adler DI
Cell reports 2020; 31: 107776 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Phan S
Redox biology 2020; 37: 101703 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Lavekar SS
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Li N
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Goldmann T
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90365 Neuroprotection: A versatile approach to combat glaucoma
Rao BSS
European Journal of Pharmacology 2020; 881: 173208 (IGR: 21-3)


90662 The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography
Maeda-Monai N
Biochemistry and biophysics reports 2020; 23: 100777 (IGR: 21-3)


90461 High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina
Ledolter J
Current Eye Research 2020; 0: 1-7 (IGR: 21-3)


90727 Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
Boguszewski PM
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
McGuinness MB
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Gupta VB
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90484 Common aspects between glaucoma and brain neurodegeneration
Manni G
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2020; 786: 108323 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Bettio F
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Porciatti V
Biochemical Pharmacology 2020; 180: 114199 (IGR: 21-3)


90656 On the Generation and Regeneration of Retinal Ganglion Cells
Silveira MS
Frontiers in cell and developmental biology 2020; 8: 581136 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Forster V
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90128 Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
D'Alessandro KB
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 18810-18821 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Deng L
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90024 Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
VanderWall KB
Progress in Neurobiology 2020; 193: 101817 (IGR: 21-3)


90487 Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model
Lerner SF
Experimental Eye Research 2020; 200: 108225 (IGR: 21-3)


90509 Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Kuehn S
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90139 Betalain exerts a protective effect against glaucoma is majorly through the association of inflammatory cytokines
Yao J
AMB Express 2020; 10: 125 (IGR: 21-3)


90515 MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma
Coughlin L
Neurobiology of Disease 2020; 141: 104944 (IGR: 21-3)


90399 CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma
Millar JC
Molecular Neurodegeneration 2020; 15: 48 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Zhou ZX
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90467 Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma
Tezel G
Journal of Neuroinflammation 2020; 17: 252 (IGR: 21-3)


90478 Association of Ultrapure Citicoline, Homotaurine and Vitamin E in the Management of Normotensive Glaucoma: A Case Report
Chemello F
Case Reports in Ophthalmology 2020; 11: 222-228 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Mirzaei M
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90484 Common aspects between glaucoma and brain neurodegeneration
Cutolo CA
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2020; 786: 108323 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Picasso E
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90365 Neuroprotection: A versatile approach to combat glaucoma
Mutalik S
European Journal of Pharmacology 2020; 881: 173208 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Hadoux X
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Li F
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Grus FH
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90600 Transcorneal Electrical Stimulation Reduces Neurodegenerative Process in a Mouse Model of Glaucoma
Inman DM
Annals of Biomedical Engineering 2021; 49: 858-870 (IGR: 21-3)


90662 The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography
Tanabu R
Biochemistry and biophysics reports 2020; 23: 100777 (IGR: 21-3)


90509 Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Stute G
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90461 High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina
Kuehn MH
Current Eye Research 2020; 0: 1-7 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Ivkovic I
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Fligor CM
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90515 MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma
Jassim AH
Neurobiology of Disease 2020; 141: 104944 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Pushpitha K
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Chou TH
Biochemical Pharmacology 2020; 180: 114199 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Münch AE
Cell reports 2020; 31: 107776 (IGR: 21-3)


90024 Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
Meyer JS
Progress in Neurobiology 2020; 193: 101817 (IGR: 21-3)


90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Dos Anjos LC
Journal of biochemical and molecular toxicology 2020; 34: e22578 (IGR: 21-3)


90487 Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model
Ferreira SM
Experimental Eye Research 2020; 200: 108225 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Edwards G
Redox biology 2020; 37: 101703 (IGR: 21-3)


90399 CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma
Kiehlbauch C
Molecular Neurodegeneration 2020; 15: 48 (IGR: 21-3)


90557 miR-708 and miR-335-3p Inhibit the Apoptosis of Retinal Ganglion Cells Through Suppressing Autophagy
Sun K
Journal of Molecular Neuroscience 2021; 71: 284-292 (IGR: 21-3)


90727 Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
Waleszczyk W
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Kanda A
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90478 Association of Ultrapure Citicoline, Homotaurine and Vitamin E in the Management of Normotensive Glaucoma: A Case Report
Mastropasqua R
Case Reports in Ophthalmology 2020; 11: 222-228 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Li X
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Korneva A
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90128 Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
Yao V
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 18810-18821 (IGR: 21-3)


90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Drago F
Biochemical Pharmacology 2020; 180: 114199 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Casson RJ
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Allsop AR
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90484 Common aspects between glaucoma and brain neurodegeneration
Izzotti A
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2020; 786: 108323 (IGR: 21-3)


90509 Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Dick HB
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90399 CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma
Clark AF
Molecular Neurodegeneration 2020; 15: 48 (IGR: 21-3)


90128 Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
Risner ML
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 18810-18821 (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Noda K
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Wolfrum U
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Miao Y
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90727 Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
Skup M
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Pang Y
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Kimball E
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Mortari MR
Journal of biochemical and molecular toxicology 2020; 34: e22578 (IGR: 21-3)


90515 MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma
Inman DM
Neurobiology of Disease 2020; 141: 104944 (IGR: 21-3)


90478 Association of Ultrapure Citicoline, Homotaurine and Vitamin E in the Management of Normotensive Glaucoma: A Case Report
Cavallini GM
Case Reports in Ophthalmology 2020; 11: 222-228 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Xia Y
Redox biology 2020; 37: 101703 (IGR: 21-3)


90116 Astrocyte responses to experimental glaucoma in mouse optic nerve head
Kimball E
PLoS ONE 2020; 15: e0238104 (IGR: 21-3)


90662 The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography
Kudo T
Biochemistry and biophysics reports 2020; 23: 100777 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Brunel N
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Dheer Y
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90557 miR-708 and miR-335-3p Inhibit the Apoptosis of Retinal Ganglion Cells Through Suppressing Autophagy
Wang J
Journal of Molecular Neuroscience 2021; 71: 284-292 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Abbasi M
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Ruberto G
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90024 Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
Erceg S
Progress in Neurobiology 2020; 193: 101817 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Weigel MK
Cell reports 2020; 31: 107776 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Lentsch KA
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Niu WR
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Coote M
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90787 Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Dos Santos WF
Journal of biochemical and molecular toxicology 2020; 34: e22578 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Kim J
Redox biology 2020; 37: 101703 (IGR: 21-3)


90333 P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Bucolo C
Biochemical Pharmacology 2020; 180: 114199 (IGR: 21-3)


90128 Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
Calkins DJ
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 18810-18821 (IGR: 21-3)


90662 The protective effect of astaxanthin on the ganglion cell complex in glutamate/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography
Nakazawa M
Biochemistry and biophysics reports 2020; 23: 100777 (IGR: 21-3)


90509 Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
Joachim SC
International journal of molecular sciences 2020; 21: (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Hu P
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Chick JM
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90399 CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma
Zode GS
Molecular Neurodegeneration 2020; 15: 48 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Garthwaite L
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Briola A
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Dick HB
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Huberman AD
Cell reports 2020; 31: 107776 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Baudouin C
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Harada T
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Skowronska-Krawczyk D
Redox biology 2020; 37: 101703 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Shao A
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Zaw T
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Sahel JA
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90590 Occurrence of Retinal Ganglion Cell Loss via Autophagy and Apoptotic Pathways in an Autoimmune Glaucoma Model
Joachim SC
Current Eye Research 2020; 45: 1124-1135 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Mirabile A
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Trounce IA
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Yuan F
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90614 Cytoprotective Effect of Astaxanthin in a Model of Normal Intraocular Pressure Glaucoma
Ishida S
Journal of Ophthalmology 2020; 2020: 9539681 (IGR: 21-3)


90788 Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Liddelow SA
Cell reports 2020; 31: 107776 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Rajput R
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Dang P
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Deng C
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Paviglianiti A
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Parton RG
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Zhang C
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Sun XH
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


89907 VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons
Picaud S
Scientific reports 2020; 10: 12409 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Martin KR
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Weinreb RN
Redox biology 2020; 37: 101703 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Wu Y
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Pasinetti GM
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
McKay MJ
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Tseng HC
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90856 Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma
Wang Z
Neuropharmacology 2020; 178: 108228 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
You Y
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Ellisman MH
Redox biology 2020; 37: 101703 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Van Wijngaarden P
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90749 Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model
Zhang X
European Journal of Pharmacology 2020; 884: 173369 (IGR: 21-3)


90545 Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Crowston JG
Clinical and Experimental Ophthalmology 2020; 48: 903-914 (IGR: 21-3)


90309 Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram
Bianchi PE
Scientific reports 2020; 10: 10468 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Salekdeh GH
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Miller YI
Redox biology 2020; 37: 101703 (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Cummins TR
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90639 Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation
Graham SL
Molecular Neurobiology 2020; 57: 3759-3784 (IGR: 21-3)


90645 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Ju WK
Redox biology 2020; 37: 101703 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Gupta VB
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


90611 Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids
Meyer JS
Stem cell reports 2020; 15: 52-66 (IGR: 21-3)


90079 Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes
Haynes PA; Graham SL
Journal of Cellular Biochemistry 2020; 0: (IGR: 21-3)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Bell K
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86834 Reprogramming Müller Glia to Regenerate Retinal Neurons
Lahne M
Annual review of vision science 2020; 6: 171-193 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Cao K
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86641 Neuroprotection in glaucoma-electrophysiology
Lešták J
Experimental and therapeutic medicine 2020; 19: 2401-2405 (IGR: 21-2)


86475 Neuroprotective effect of Qinggan Lishui formula on retinal ganglion cell apoptosis in a microbead-induced rat chronic glaucoma model
Zhang C
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine 2018; 38: 175-181 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Guo L
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Hasegawa T
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Chen H
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86819 A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma
Cammalleri M
Nutrients 2020; 12: (IGR: 21-2)


86415 The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific
Yang N
Cells 2020; 9: (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Wang H
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
López ES
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)


86392 Magnesium acetyltaurate protects against endothelin-1 induced RGC loss by reducing neuroinflammation in Sprague dawley rats
Nor Arfuzir NN
Experimental Eye Research 2020; 194: 107996 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Choi SH
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Sato K
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Sabel BA
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Nahomi RB
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86290 Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model
Li Q
Neuropharmacology 2020; 170: 108016 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Wang X
Science translational medicine 2020; 12: (IGR: 21-2)


86745 Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review
Holappa M
Annals of Medicine 2020; 52: 191-206 (IGR: 21-2)


86858 Hydrogen Sulfide and -Synuclein Are Involved and Interlinked in the Aging Glaucomatous Retina
Liu H
Journal of Ophthalmology 2020; 2020: 8642135 (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Nakano Y
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86501 Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Gandolfi S
Nutrients 2020; 12: (IGR: 21-2)


86200 The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA receptors in rat glaucoma models
Ishikawa M
Autophagy 2020; 0: 1-18 (IGR: 21-2)


86144 Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma
Cui QN
Experimental Eye Research 2020; 193: 107961 (IGR: 21-2)


86516 BDNF improves axon transportation and rescues visual function in a rodent model of acute elevation of intraocular pressure
Du R
Science China Life Sciences 2020; 63: 1-10 (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
Chaphalkar RM
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Wang Q
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Lu Y
Nature 2020; 588: 124-129 (IGR: 21-2)


86620 Reversibility of visual field defects through induction of brain plasticity: vision restoration, recovery and rehabilitation using alternating current stimulation
Sabel BA
Neural Regeneration Research 2020; 15: 1799-1806 (IGR: 21-2)


86372 Individualized Visual Reality Training Improves Visual Acuity and Visual Field Defects in Patients with Glaucoma: A Preliminary Study Report
Li B
Cyberpsychology, behavior and social networking 2020; 23: 179-184 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Mueller-Buehl AM
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Edwards G
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86670 Sestrin2 overexpression alleviates hydrogen peroxide-induced apoptosis and oxidative stress in retinal ganglion cells by enhancing Nrf2 activation via Keap1 downregulation
Fan Y
Chemico-biological interactions 2020; 324: 109086 (IGR: 21-2)


86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Machado ALL
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
Stankowska DL
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86200 The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA receptors in rat glaucoma models
Takaseki S
Autophagy 2020; 0: 1-18 (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Ikeda HO
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Hirooka K
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86745 Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review
Vapaatalo H
Annals of Medicine 2020; 52: 191-206 (IGR: 21-2)


86372 Individualized Visual Reality Training Improves Visual Acuity and Visual Field Defects in Patients with Glaucoma: A Preliminary Study Report
Chu H
Cyberpsychology, behavior and social networking 2020; 23: 179-184 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Ishida T
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Nam MH
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86290 Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model
Jin R
Neuropharmacology 2020; 170: 108016 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Rosignol I
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Kim KY
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86620 Reversibility of visual field defects through induction of brain plasticity: vision restoration, recovery and rehabilitation using alternating current stimulation
Gao Y
Neural Regeneration Research 2020; 15: 1799-1806 (IGR: 21-2)


86858 Hydrogen Sulfide and -Synuclein Are Involved and Interlinked in the Aging Glaucomatous Retina
Mercieca K
Journal of Ophthalmology 2020; 2020: 8642135 (IGR: 21-2)


86670 Sestrin2 overexpression alleviates hydrogen peroxide-induced apoptosis and oxidative stress in retinal ganglion cells by enhancing Nrf2 activation via Keap1 downregulation
Xing Y
Chemico-biological interactions 2020; 324: 109086 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Davis BM
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86516 BDNF improves axon transportation and rescues visual function in a rodent model of acute elevation of intraocular pressure
Wang X
Science China Life Sciences 2020; 63: 1-10 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Brommer B
Nature 2020; 588: 124-129 (IGR: 21-2)


86475 Neuroprotective effect of Qinggan Lishui formula on retinal ganglion cell apoptosis in a microbead-induced rat chronic glaucoma model
Zhang Y
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine 2018; 38: 175-181 (IGR: 21-2)


86144 Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma
Bargoud AR
Experimental Eye Research 2020; 193: 107961 (IGR: 21-2)


86392 Magnesium acetyltaurate protects against endothelin-1 induced RGC loss by reducing neuroinflammation in Sprague dawley rats
Agarwal R
Experimental Eye Research 2020; 194: 107996 (IGR: 21-2)


86415 The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific
Young BK
Cells 2020; 9: (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Zhuang P
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Perkins GA
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Thut G
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Song X
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86834 Reprogramming Müller Glia to Regenerate Retinal Neurons
Nagashima M
Annual review of vision science 2020; 6: 171-193 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Doepper H
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86641 Neuroprotection in glaucoma-electrophysiology
Fůs M
Experimental and therapeutic medicine 2020; 19: 2401-2405 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Rosignol I
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Deng Y
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86819 A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma
Dal Monte M
Nutrients 2020; 12: (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Lou N
Science translational medicine 2020; 12: (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Mochida S
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86501 Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Marchini G
Nutrients 2020; 12: (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Gan X
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86516 BDNF improves axon transportation and rescues visual function in a rodent model of acute elevation of intraocular pressure
He S
Science China Life Sciences 2020; 63: 1-10 (IGR: 21-2)


86415 The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific
Wang P
Cells 2020; 9: (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Huang H
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Haueisen J
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86144 Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma
Ross AG
Experimental Eye Research 2020; 193: 107961 (IGR: 21-2)


86200 The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA receptors in rat glaucoma models
Yoshitomi T
Autophagy 2020; 0: 1-18 (IGR: 21-2)


86475 Neuroprotective effect of Qinggan Lishui formula on retinal ganglion cell apoptosis in a microbead-induced rat chronic glaucoma model
Chen Y
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine 2018; 38: 175-181 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Eberhardt A
Science translational medicine 2020; 12: (IGR: 21-2)


86501 Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Caporossi A
Nutrients 2020; 12: (IGR: 21-2)


86290 Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model
Zhang S
Neuropharmacology 2020; 170: 108016 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Sierra-Filardi E
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
He S
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86620 Reversibility of visual field defects through induction of brain plasticity: vision restoration, recovery and rehabilitation using alternating current stimulation
Antal A
Neural Regeneration Research 2020; 15: 1799-1806 (IGR: 21-2)


86372 Individualized Visual Reality Training Improves Visual Acuity and Visual Field Defects in Patients with Glaucoma: A Preliminary Study Report
Yan L
Cyberpsychology, behavior and social networking 2020; 23: 179-184 (IGR: 21-2)


86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Vidal LB
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Grauthoff S
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86392 Magnesium acetyltaurate protects against endothelin-1 induced RGC loss by reducing neuroinflammation in Sprague dawley rats
Iezhitsa I
Experimental Eye Research 2020; 194: 107996 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Sierra-Filardi E
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Perkins GA
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86834 Reprogramming Müller Glia to Regenerate Retinal Neurons
Hyde DR
Annual review of vision science 2020; 6: 171-193 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Tian X
Nature 2020; 588: 124-129 (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Gotoh N
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86620 Reversibility of visual field defects through induction of brain plasticity: vision restoration, recovery and rehabilitation using alternating current stimulation
Antal A
Neural Regeneration Research 2020; 15: 1799-1806 (IGR: 21-2)


86858 Hydrogen Sulfide and -Synuclein Are Involved and Interlinked in the Aging Glaucomatous Retina
Anders F
Journal of Ophthalmology 2020; 2020: 8642135 (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tomimoto D
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86670 Sestrin2 overexpression alleviates hydrogen peroxide-induced apoptosis and oxidative stress in retinal ganglion cells by enhancing Nrf2 activation via Keap1 downregulation
Xiong L
Chemico-biological interactions 2020; 324: 109086 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Ravindran N
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Rankenberg J
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86819 A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma
Amato R
Nutrients 2020; 12: (IGR: 21-2)


86745 Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review
Vaajanen A
Annals of Medicine 2020; 52: 191-206 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Kim KY
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Li M
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Fang Y
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Chiba Y
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Rakete S
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Wang X
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86392 Magnesium acetyltaurate protects against endothelin-1 induced RGC loss by reducing neuroinflammation in Sprague dawley rats
Agarwal P
Experimental Eye Research 2020; 194: 107996 (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Konuma T
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Ueno M
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Kiebler T
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86144 Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma
Song Y
Experimental Eye Research 2020; 193: 107961 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Rodriguez-Muela N
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86834 Reprogramming Müller Glia to Regenerate Retinal Neurons
Hitchcock PF
Annual review of vision science 2020; 6: 171-193 (IGR: 21-2)


86819 A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma
Bagnoli P
Nutrients 2020; 12: (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Li L
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
Kodati B
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Shinohara K
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Iida K
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Krishnan A
Nature 2020; 588: 124-129 (IGR: 21-2)


86670 Sestrin2 overexpression alleviates hydrogen peroxide-induced apoptosis and oxidative stress in retinal ganglion cells by enhancing Nrf2 activation via Keap1 downregulation
Wang J
Chemico-biological interactions 2020; 324: 109086 (IGR: 21-2)


86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
González-Pizarro R
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)


86475 Neuroprotective effect of Qinggan Lishui formula on retinal ganglion cell apoptosis in a microbead-induced rat chronic glaucoma model
Li F
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine 2018; 38: 175-181 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Kong Y
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86290 Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model
Sun X
Neuropharmacology 2020; 170: 108016 (IGR: 21-2)


86415 The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific
Tian N
Cells 2020; 9: (IGR: 21-2)


86200 The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA receptors in rat glaucoma models
Covey DF
Autophagy 2020; 0: 1-18 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Phan S
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86501 Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Scuderi G
Nutrients 2020; 12: (IGR: 21-2)


86372 Individualized Visual Reality Training Improves Visual Acuity and Visual Field Defects in Patients with Glaucoma: A Preliminary Study Report
Wiederhold BK
Cyberpsychology, behavior and social networking 2020; 23: 179-184 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Li Y
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Yang Y
Science translational medicine 2020; 12: (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Henrich-Noack P
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86858 Hydrogen Sulfide and -Synuclein Are Involved and Interlinked in the Aging Glaucomatous Retina
Prokosch V
Journal of Ophthalmology 2020; 2020: 8642135 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Galvao J
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Meer M
Nature 2020; 588: 124-129 (IGR: 21-2)


86290 Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model
Wu J
Neuropharmacology 2020; 170: 108016 (IGR: 21-2)


86819 A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma
Rusciano D
Nutrients 2020; 12: (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Herrmann CS
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Edwards G
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
Phillips N
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Iwai S
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86200 The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA receptors in rat glaucoma models
Zorumski CF
Autophagy 2020; 0: 1-18 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Lee Y
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Kusk P
Science translational medicine 2020; 12: (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Li X
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Ojima D
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Huang W
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86501 Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Tomasso L
Nutrients 2020; 12: (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Kiyota N
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86372 Individualized Visual Reality Training Improves Visual Acuity and Visual Field Defects in Patients with Glaucoma: A Preliminary Study Report
Wiederhold M
Cyberpsychology, behavior and social networking 2020; 23: 179-184 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Kapoor N
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Liu L
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Peters L
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Schmelter C
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Silva AD
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Houck JA
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86392 Magnesium acetyltaurate protects against endothelin-1 induced RGC loss by reducing neuroinflammation in Sprague dawley rats
Ismail NM
Experimental Eye Research 2020; 194: 107996 (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Tao Y
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86475 Neuroprotective effect of Qinggan Lishui formula on retinal ganglion cell apoptosis in a microbead-induced rat chronic glaucoma model
Wang Z
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine 2018; 38: 175-181 (IGR: 21-2)


86144 Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma
Dunaief JL
Experimental Eye Research 2020; 193: 107961 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Xia Y
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Xu Q
Science translational medicine 2020; 12: (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tsuda S
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Hurst J
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Choi SH
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Wang C
Nature 2020; 588: 124-129 (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Nakano N
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Cecconi F
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Johnson GC
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Xiya X
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86372 Individualized Visual Reality Training Improves Visual Acuity and Visual Field Defects in Patients with Glaucoma: A Preliminary Study Report
Lu Y
Cyberpsychology, behavior and social networking 2020; 23: 179-184 (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Hossain MR
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86501 Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Brunoro A
Nutrients 2020; 12: (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Lu L
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Nagaoka N
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Hunold A
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Haamedi N
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Souto EB
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)


86200 The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs/GABA receptors in rat glaucoma models
Izumi Y
Autophagy 2020; 0: 1-18 (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
Prah J
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Webber HC
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Kuehn S
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Dalal R
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Shamsher E
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Kammer T
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Liu H
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Wei L
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Ohno-Matsui K
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Förstera B
Science translational medicine 2020; 12: (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Kim J
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Kakizuka A
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Shiga Y
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Takahashi H
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Grus F
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
Yang S
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Vera DL
Nature 2020; 588: 124-129 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Liu Y
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Stankowska DL
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Zhao Y
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Bartz-Schmidt KU
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Zeng Q
Nature 2020; 588: 124-129 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Matteo B
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Pantcheva MB
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Peng S
Science translational medicine 2020; 12: (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Yamamoto T
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Siew L
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86454 Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
Yoshida T
Investigative Ophthalmology and Visual Science 2020; 61: 13 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Skowronska-Krawczyk D
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Skowronska-Krawczyk D
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Luong V
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86807 Age related retinal Ganglion cell susceptibility in context of autophagy deficiency
Boya P
Cell death discovery 2020; 6: 21 (IGR: 21-2)


86307 Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
Krishnamoorthy RR
Scientific reports 2020; 10: 3571 (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Omodaka K
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Su L
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86364 Effect of VCP modulators on gene expression profiles of retinal ganglion cells in an acute injury mouse model
Tsujikawa A
Scientific reports 2020; 10: 4251 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Luo J
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Fligor CM
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Fico E
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Chang D
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Weinreb RN
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
MacLean PS
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Weinreb RN
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Kiuchi Y
Cell Death and Disease 2020; 11: 166 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Shi M
Science translational medicine 2020; 12: (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Yu D
Nature 2020; 588: 124-129 (IGR: 21-2)


86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Nakazawa T
Experimental Eye Research 2020; 193: 107997 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Dick HB
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Sergeeva EG
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Ladrón-de-Guevara A
Science translational medicine 2020; 12: (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Zou B
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Waleszczyk W
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86507 The role of TLR4/NF-κB signaling pathway in activated microglia of rats with chronic high intraocular pressure and vitro scratch injury-induced microglia
Sha Q
International immunopharmacology 2020; 83: 106395 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Joachim SC
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Bonkowski MS
Nature 2020; 588: 124-129 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Zangwill L
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Chang KC
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86373 Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
Nagaraj RH
International journal of molecular sciences 2020; 21: (IGR: 21-2)


86285 Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration
Cordeiro MF
Scientific reports 2020; 10: 3375 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Ellisman MH
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Strack S
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Miller YI
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Antal A
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Hong Y
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Delle C
Science translational medicine 2020; 12: (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Yang JH
Nature 2020; 588: 124-129 (IGR: 21-2)


86209 Oxidative stress-induced retinal damage is prevented by mild hypothermia in an ex vivo model of cultivated porcine retinas
Schnichels S
Clinical and Experimental Ophthalmology 2020; 48: 666-681 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Nahmou M
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86214 Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review
Antal A
Clinical Neurophysiology 2020; 131: 887-911 (IGR: 21-2)


86757 Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells
Ju WK
Cell Death and Disease 2020; 11: 254 (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Cao Y
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Sigurdsson B
Science translational medicine 2020; 12: (IGR: 21-2)


86864 AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
Ju WK
Redox biology 2020; 2020;Epub ahead of print (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Kreymerman A
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Zhou S
Nature 2020; 588: 124-129 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Sun Y
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Hoffmann EM
Nature 2020; 588: 124-129 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Xavier ALR
Science translational medicine 2020; 12: (IGR: 21-2)


86717 NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma
Liu Y; Chi W
Molecular Neurodegeneration 2020; 15: 26 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Meyer JS
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Karg MM
Nature 2020; 588: 124-129 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Ertürk A; Libby RT
Science translational medicine 2020; 12: (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Schultz MB
Nature 2020; 588: 124-129 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Goldberg JL
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Kane AE
Nature 2020; 588: 124-129 (IGR: 21-2)


86728 Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Hu Y
Journal of Neuroscience 2020; 40: 3896-3914 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Chen L; Thrane AS
Science translational medicine 2020; 12: (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Davidsohn N
Nature 2020; 588: 124-129 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Thrane AS
Science translational medicine 2020; 12: (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Korobkina E
Nature 2020; 588: 124-129 (IGR: 21-2)


86543 An ocular glymphatic clearance system removes β-amyloid from the rodent eye
Nedergaard M
Science translational medicine 2020; 12: (IGR: 21-2)


86863 Reprogramming to recover youthful epigenetic information and restore vision
Chwalek K; Rajman LA; Church GM; Hochedlinger K; Gladyshev VN; Horvath S; Levine ME; Gregory-Ksander MS; Ksander BR; He Z; Sinclair DA
Nature 2020; 588: 124-129 (IGR: 21-2)


84510 Intravitreal S100B Injection Triggers a Time-Dependent Microglia Response in a Pro-Inflammatory Manner in Retina and Optic Nerve
Grotegut P
Molecular Neurobiology 2020; 57: 1186-1202 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Nascimento-Dos-Santos G
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84559 Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons
Risner ML
Experimental Eye Research 2020; 190: 107873 (IGR: 21-1)


84995 Current State of Primary Neuroprotection in Glaucoma
Reinehr S
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149 (IGR: 21-1)


85159 Pathogenic roles of retinal glia in glaucoma
Shinozaki Y
Nippon yakurigaku zasshi 2020; 155: 87-92 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
Zhou RR
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Reinehr S
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84793 Lycium Barbarum Exerts Protection against Glaucoma-Like Injury Via Inhibition of MMP-9 Signaling In Vitro
Xu S
Medical Science Monitor 2019; 25: 9794-9800 (IGR: 21-1)


84628 Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization
Ju WK
Oxidative medicine and cellular longevity 2019; 2019: 8060962 (IGR: 21-1)


85210 The Role of Autophagy in Glaucomatous Optic Neuropathy
Adornetto A
Frontiers in cell and developmental biology 2020; 8: 121 (IGR: 21-1)


84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Zhang X
Experimental Eye Research 2020; 190: 107892 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Nascimento-Dos-Santos G
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


85112 Secondary Neuroprotection in Glaucoma Through the Concepts of Complementary Drug Therapy
Erb C
Klinische Monatsblätter für Augenheilkunde 2020; 237: 163-174 (IGR: 21-1)


84549 Possible therapeutic effect of magnesium in ocular diseases
Ajith TA
Journal of basic and clinical physiology and pharmacology 2019; 31: (IGR: 21-1)


84903 Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser and Formation of Misfolded Protein Aggregates
Means JC
Cellular and molecular neurobiology 2020; 40: 911-926 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Wang AY
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84863 SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice
Luo J
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 335-344 (IGR: 21-1)


85111 Secondary Neuroprotection in Glaucoma from Change in Lifestyle
Rüfer F
Klinische Monatsblätter für Augenheilkunde 2020; 237: 158-162 (IGR: 21-1)


84973 Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma
Yadav KS
Life Sciences 2020; 243: 117303 (IGR: 21-1)


84615 Secondary Neuroprotection in Glaucoma by Reduction of Intraocular Pressure
Unterlauft JD
Klinische Monatsblätter für Augenheilkunde 2020; 237: 150-157 (IGR: 21-1)


84808 Piezo channel plays a part in retinal ganglion cell damage
Morozumi W
Experimental Eye Research 2020; 191: 107900 (IGR: 21-1)


85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Fouda AY
Frontiers in pharmacology 2020; 11: 277 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Wang AY
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84764 TRPC5 regulates axonal outgrowth in developing retinal ganglion cells
Oda M
Laboratory Investigation 2020; 100: 297-310 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Tribble JR
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84736 Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications
Fu L
BioMed research international 2019; 2019: 8397521 (IGR: 21-1)


85110 Recent Research Efforts to Achieve Neuroprotection, Progression and Treatment of Glaucoma
Jacobi A
Klinische Monatsblätter für Augenheilkunde 2020; 237: 133-139 (IGR: 21-1)


84973 Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma
Yadav KS
Life Sciences 2020; 243: 117303 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Gomes SC
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Vasalauskaite A
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84736 Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications
Kwok SS
BioMed research international 2019; 2019: 8397521 (IGR: 21-1)


84808 Piezo channel plays a part in retinal ganglion cell damage
Inagaki S
Experimental Eye Research 2020; 191: 107900 (IGR: 21-1)


85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Eldahshan W
Frontiers in pharmacology 2020; 11: 277 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Lee PY
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


85110 Recent Research Efforts to Achieve Neuroprotection, Progression and Treatment of Glaucoma
van Zyl T
Klinische Monatsblätter für Augenheilkunde 2020; 237: 133-139 (IGR: 21-1)


84973 Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma
Sharma S
Life Sciences 2020; 243: 117303 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
Li HB
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84510 Intravitreal S100B Injection Triggers a Time-Dependent Microglia Response in a Pro-Inflammatory Manner in Retina and Optic Nerve
Kuehn S
Molecular Neurobiology 2020; 57: 1186-1202 (IGR: 21-1)


84764 TRPC5 regulates axonal outgrowth in developing retinal ganglion cells
Yamamoto H
Laboratory Investigation 2020; 100: 297-310 (IGR: 21-1)


84559 Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons
McGrady NR
Experimental Eye Research 2020; 190: 107873 (IGR: 21-1)


84628 Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization
Shim MS
Oxidative medicine and cellular longevity 2019; 2019: 8060962 (IGR: 21-1)


85210 The Role of Autophagy in Glaucomatous Optic Neuropathy
Parisi V
Frontiers in cell and developmental biology 2020; 8: 121 (IGR: 21-1)


84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Zhang R
Experimental Eye Research 2020; 190: 107892 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
de-Souza-Ferreira E
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84793 Lycium Barbarum Exerts Protection against Glaucoma-Like Injury Via Inhibition of MMP-9 Signaling In Vitro
Liu S
Medical Science Monitor 2019; 25: 9794-9800 (IGR: 21-1)


84863 SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice
He T
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 335-344 (IGR: 21-1)


84995 Current State of Primary Neuroprotection in Glaucoma
Grotegut P
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149 (IGR: 21-1)


84903 Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser and Formation of Misfolded Protein Aggregates
Lopez AA
Cellular and molecular neurobiology 2020; 40: 911-926 (IGR: 21-1)


85159 Pathogenic roles of retinal glia in glaucoma
Koizumi S
Nippon yakurigaku zasshi 2020; 155: 87-92 (IGR: 21-1)


84903 Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser and Formation of Misfolded Protein Aggregates
Koulen P
Cellular and molecular neurobiology 2020; 40: 911-926 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
You QS
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84736 Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications
Chan YK
BioMed research international 2019; 2019: 8397521 (IGR: 21-1)


84764 TRPC5 regulates axonal outgrowth in developing retinal ganglion cells
Matsumoto H
Laboratory Investigation 2020; 100: 297-310 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Gassel CJ
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84559 Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons
Pasini S
Experimental Eye Research 2020; 190: 107873 (IGR: 21-1)


85210 The Role of Autophagy in Glaucomatous Optic Neuropathy
Morrone LA
Frontiers in cell and developmental biology 2020; 8: 121 (IGR: 21-1)


84995 Current State of Primary Neuroprotection in Glaucoma
Tsai T
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Redmond T
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84973 Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma
Londhe VY
Life Sciences 2020; 243: 117303 (IGR: 21-1)


84793 Lycium Barbarum Exerts Protection against Glaucoma-Like Injury Via Inhibition of MMP-9 Signaling In Vitro
Yan G
Medical Science Monitor 2019; 25: 9794-9800 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Bui BV
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84808 Piezo channel plays a part in retinal ganglion cell damage
Iwata Y
Experimental Eye Research 2020; 191: 107900 (IGR: 21-1)


84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Chen J
Experimental Eye Research 2020; 190: 107892 (IGR: 21-1)


85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Narayanan SP
Frontiers in pharmacology 2020; 11: 277 (IGR: 21-1)


84510 Intravitreal S100B Injection Triggers a Time-Dependent Microglia Response in a Pro-Inflammatory Manner in Retina and Optic Nerve
Meißner W
Molecular Neurobiology 2020; 57: 1186-1202 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Lani R
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84628 Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization
Kim KY
Oxidative medicine and cellular longevity 2019; 2019: 8060962 (IGR: 21-1)


84863 SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice
Yang J
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 335-344 (IGR: 21-1)


84628 Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization
Park TL
Oxidative medicine and cellular longevity 2019; 2019: 8060962 (IGR: 21-1)


84808 Piezo channel plays a part in retinal ganglion cell damage
Nakamura S
Experimental Eye Research 2020; 191: 107900 (IGR: 21-1)


85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Caldwell RW
Frontiers in pharmacology 2020; 11: 277 (IGR: 21-1)


84863 SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice
Yang N
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 335-344 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Jobling AI
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Faria CC
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84995 Current State of Primary Neuroprotection in Glaucoma
Wagner N
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149 (IGR: 21-1)


84764 TRPC5 regulates axonal outgrowth in developing retinal ganglion cells
Ishizaki Y
Laboratory Investigation 2020; 100: 297-310 (IGR: 21-1)


84510 Intravitreal S100B Injection Triggers a Time-Dependent Microglia Response in a Pro-Inflammatory Manner in Retina and Optic Nerve
Dick HB
Molecular Neurobiology 2020; 57: 1186-1202 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Asaad MA
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Young RD
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
Rong R
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


85210 The Role of Autophagy in Glaucomatous Optic Neuropathy
Corasaniti MT
Frontiers in cell and developmental biology 2020; 8: 121 (IGR: 21-1)


84736 Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications
Ming Lai JS
BioMed research international 2019; 2019: 8397521 (IGR: 21-1)


84559 Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons
Lambert WS
Experimental Eye Research 2020; 190: 107873 (IGR: 21-1)


84701 Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model
Wu J
Experimental Eye Research 2020; 190: 107892 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Araújo VG
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


85210 The Role of Autophagy in Glaucomatous Optic Neuropathy
Bagetta G
Frontiers in cell and developmental biology 2020; 8: 121 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Greferath U
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84559 Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons
Calkins DJ
Experimental Eye Research 2020; 190: 107873 (IGR: 21-1)


84863 SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice
Li Z
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 335-344 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Araújo VG
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84764 TRPC5 regulates axonal outgrowth in developing retinal ganglion cells
Shibasaki K
Laboratory Investigation 2020; 100: 297-310 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Hassan S
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84736 Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications
Pan W
BioMed research international 2019; 2019: 8397521 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
You ML
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84995 Current State of Primary Neuroprotection in Glaucoma
Joachim SC
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149 (IGR: 21-1)


85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Caldwell RB
Frontiers in pharmacology 2020; 11: 277 (IGR: 21-1)


84628 Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization
Ahn S
Oxidative medicine and cellular longevity 2019; 2019: 8060962 (IGR: 21-1)


84510 Intravitreal S100B Injection Triggers a Time-Dependent Microglia Response in a Pro-Inflammatory Manner in Retina and Optic Nerve
Joachim SC
Molecular Neurobiology 2020; 57: 1186-1202 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Stute G
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84808 Piezo channel plays a part in retinal ganglion cell damage
Hara H
Experimental Eye Research 2020; 191: 107900 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Teixeira-Pinheiro LC
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Brandli A
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84628 Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization
Edwards G
Oxidative medicine and cellular longevity 2019; 2019: 8060962 (IGR: 21-1)


84736 Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications
Nie L
BioMed research international 2019; 2019: 8397521 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Schargus M
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84863 SIRT1 is required for the neuroprotection of resveratrol on retinal ganglion cells after retinal ischemia-reperfusion injury in mice
Xing Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 335-344 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
Xiong K
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84808 Piezo channel plays a part in retinal ganglion cell damage
Shimazawa M
Experimental Eye Research 2020; 191: 107900 (IGR: 21-1)


85210 The Role of Autophagy in Glaucomatous Optic Neuropathy
Tonin P
Frontiers in cell and developmental biology 2020; 8: 121 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Fautsch MP
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84628 Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization
Weinreb RN
Oxidative medicine and cellular longevity 2019; 2019: 8060962 (IGR: 21-1)


85210 The Role of Autophagy in Glaucomatous Optic Neuropathy
Russo R
Frontiers in cell and developmental biology 2020; 8: 121 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Sengpiel F
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84736 Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications
Shih KC
BioMed research international 2019; 2019: 8397521 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Dick HB
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Vasconcelos T
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Dixon MA
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
Huang JF
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Joachim SC
Frontiers in pharmacology 2019; 10: 1381 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Williams PA
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Gonçalo T
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Findlay Q
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
Xia XB
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Gonçalo T; Santiago MF
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84852 Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Morgan JE
Brain communications 2019; 1: fcz035 (IGR: 21-1)


84393 Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis
Ji D
Human Genetics and Therapeutics 2019; 30: 1505-1519 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Fletcher EL
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Linden R
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


84756 Potential mechanisms of retinal ganglion cell type-specific vulnerability in glaucoma
Vessey KA
Clinical and Experimental Optometry 2020; 103: 562-571 (IGR: 21-1)


84974 Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina
Galina A; Petrs-Silva H; Petrs-Silva H
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686 (IGR: 21-1)


81992 The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model
Huang J
FASEB Journal 2019; 33: 11194-11209 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Choi KJ
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82820 The effects of intravitreal H S application on apoptosis in the retina and cornea in experimental glaucoma model
Erisgin Z
International journal of experimental pathology 2019; 100: 330-336 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Qin X
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82707 Potential Impact of DARC Technology in Neuroprotective Therapies
Pahlitzsch M
Klinische Monatsblätter für Augenheilkunde 2020; 237: 140-142 (IGR: 20-4)


81949 Neuroprotective Effect of Ginkgo Biloba Extract Against Hypoxic Retinal Ganglion Cell Degeneration and
Cho HK
Journal of medicinal food 2019; 22: 771-778 (IGR: 20-4)


82655 DDIT3 (CHOP) contributes to retinal ganglion cell somal loss but not axonal degeneration in DBA/2J mice
Marola OJ
Cell death discovery 2019; 5: 140 (IGR: 20-4)


82800 Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal Neuroinflammation via Toll-Like Receptor 4 Pathway
Ji S
Stem cells international 2019; 2019: 9274585 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Cheng Z
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Chițu I
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Fernández-Albarral JA
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Guo Y
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82799 Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma
Fischer RA
Frontiers in neuroscience 2019; 13: 1139 (IGR: 20-4)


82633 Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma
Thomson BR
eLife 2019; 8: (IGR: 20-4)


81958 Human retinal ganglion cell axon regeneration by recapitulating developmental mechanisms: effects of recruitment of the mTOR pathway
Teotia P
Development 2019; 146: (IGR: 20-4)


82619 Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model
Zhou X
Experimental Eye Research 2019; 189: 107833 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Juźwik CA
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82336 Neuroprotection in Glaucoma: Towards Clinical Trials and Precision Medicine
Khatib TZ
Current Eye Research 2020; 45: 327-338 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Stankowska DL
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Krishnan A
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82563 Enriched environment provides neuroprotection against experimental glaucoma
González Fleitas MF
Journal of Neurochemistry 2020; 152: 103-121 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Uchida T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


82660 Role of Heat Shock Proteins in Glaucoma
Tsai T
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Yang Y
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82347 Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats
Claes M
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Buchanan RA
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82459 Immune Mediated Degeneration and Possible Protection in Glaucoma
Tsai T
Frontiers in neuroscience 2019; 13: 931 (IGR: 20-4)


82001 Axon injury signaling and compartmentalized injury response in glaucoma
Syc-Mazurek SB
Progress in Retinal and Eye Research 2019; 73: 100769 (IGR: 20-4)


82700 Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin
Gábriel R
Frontiers in neuroscience 2019; 13: 1031 (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Honda S
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Huang S
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82151 IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases
Wooff Y
Frontiers in immunology 2019; 10: 1618 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Quaranta L
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Ueta T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


81958 Human retinal ganglion cell axon regeneration by recapitulating developmental mechanisms: effects of recruitment of the mTOR pathway
Van Hook MJ
Development 2019; 146: (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Foley KE
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Nam MH
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82660 Role of Heat Shock Proteins in Glaucoma
Grotegut P
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Huang P
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Namekata K
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


82459 Immune Mediated Degeneration and Possible Protection in Glaucoma
Reinehr S
Frontiers in neuroscience 2019; 13: 931 (IGR: 20-4)


82700 Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin
Pöstyéni E
Frontiers in neuroscience 2019; 13: 1031 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Ramírez AI
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Mehrabian Z
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82655 DDIT3 (CHOP) contributes to retinal ganglion cell somal loss but not axonal degeneration in DBA/2J mice
Syc-Mazurek SB
Cell death discovery 2019; 5: 140 (IGR: 20-4)


82151 IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases
Man SM
Frontiers in immunology 2019; 10: 1618 (IGR: 20-4)


81992 The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model
Zhao Q
FASEB Journal 2019; 33: 11194-11209 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Li N
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Na YJ
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
S Drake S
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Riva I
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82820 The effects of intravitreal H S application on apoptosis in the retina and cornea in experimental glaucoma model
Ozer MA
International journal of experimental pathology 2019; 100: 330-336 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Xu C
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Kocab AJ
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Zhang T
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82563 Enriched environment provides neuroprotection against experimental glaucoma
Devouassoux JD
Journal of Neurochemistry 2020; 152: 103-121 (IGR: 20-4)


81949 Neuroprotective Effect of Ginkgo Biloba Extract Against Hypoxic Retinal Ganglion Cell Degeneration and
Kim S
Journal of medicinal food 2019; 22: 771-778 (IGR: 20-4)


82633 Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma
Carota IA
eLife 2019; 8: (IGR: 20-4)


82336 Neuroprotection in Glaucoma: Towards Clinical Trials and Precision Medicine
Martin KR
Current Eye Research 2020; 45: 327-338 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Voinea LM
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82799 Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma
Risner ML
Frontiers in neuroscience 2019; 13: 1139 (IGR: 20-4)


82619 Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model
Zhang T
Experimental Eye Research 2019; 189: 107833 (IGR: 20-4)


82800 Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal Neuroinflammation via Toll-Like Receptor 4 Pathway
Xiao J
Stem cells international 2019; 2019: 9274585 (IGR: 20-4)


82347 Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats
De Groef L
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82001 Axon injury signaling and compartmentalized injury response in glaucoma
Libby RT
Progress in Retinal and Eye Research 2019; 73: 100769 (IGR: 20-4)


82700 Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin
Dénes V
Frontiers in neuroscience 2019; 13: 1031 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Johnson MA
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Yu H
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82151 IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases
Aggio-Bruce R
Frontiers in immunology 2019; 10: 1618 (IGR: 20-4)


82799 Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma
Roux AL
Frontiers in neuroscience 2019; 13: 1139 (IGR: 20-4)


82633 Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma
Souma T
eLife 2019; 8: (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Chen Y
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82459 Immune Mediated Degeneration and Possible Protection in Glaucoma
Maliha AM
Frontiers in neuroscience 2019; 13: 931 (IGR: 20-4)


82619 Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model
Wu J
Experimental Eye Research 2019; 189: 107833 (IGR: 20-4)


82347 Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats
Moons L
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Pepper KW
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
de Hoz R
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82563 Enriched environment provides neuroprotection against experimental glaucoma
Aranda ML
Journal of Neurochemistry 2020; 152: 103-121 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Honjo M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Nahomi RB
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82660 Role of Heat Shock Proteins in Glaucoma
Reinehr S
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82820 The effects of intravitreal H S application on apoptosis in the retina and cornea in experimental glaucoma model
Tosun M
International journal of experimental pathology 2019; 100: 330-336 (IGR: 20-4)


81949 Neuroprotective Effect of Ginkgo Biloba Extract Against Hypoxic Retinal Ganglion Cell Degeneration and
Lee EJ
Journal of medicinal food 2019; 22: 771-778 (IGR: 20-4)


82800 Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal Neuroinflammation via Toll-Like Receptor 4 Pathway
Liu J
Stem cells international 2019; 2019: 9274585 (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Kimura A
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


81992 The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model
Li M
FASEB Journal 2019; 33: 11194-11209 (IGR: 20-4)


81958 Human retinal ganglion cell axon regeneration by recapitulating developmental mechanisms: effects of recruitment of the mTOR pathway
Fischer D
Development 2019; 146: (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Istrate S
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82655 DDIT3 (CHOP) contributes to retinal ganglion cell somal loss but not axonal degeneration in DBA/2J mice
Libby RT
Cell death discovery 2019; 5: 140 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Zhang M
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Jung WH
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Biagioli E
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Zacks DN
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Zheng J
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Zhang Y
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Marshak-Rothstein A
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82563 Enriched environment provides neuroprotection against experimental glaucoma
Calanni JS
Journal of Neurochemistry 2020; 152: 103-121 (IGR: 20-4)


81949 Neuroprotective Effect of Ginkgo Biloba Extract Against Hypoxic Retinal Ganglion Cell Degeneration and
Kee C
Journal of medicinal food 2019; 22: 771-778 (IGR: 20-4)


82151 IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases
Natoli R
Frontiers in immunology 2019; 10: 1618 (IGR: 20-4)


81992 The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model
Duan Q
FASEB Journal 2019; 33: 11194-11209 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Chaphalkar RM
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Lin S
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Ding W
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Vrapciu A
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82633 Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma
Soman S
eLife 2019; 8: (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Liang JJ
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Lin Z
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82799 Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma
Wareham LK
Frontiers in neuroscience 2019; 13: 1139 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Albers DS
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Park SB
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
López-Villarín N
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82800 Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal Neuroinflammation via Toll-Like Receptor 4 Pathway
Tang S
Stem cells international 2019; 2019: 9274585 (IGR: 20-4)


82820 The effects of intravitreal H S application on apoptosis in the retina and cornea in experimental glaucoma model
Ozen S
International journal of experimental pathology 2019; 100: 330-336 (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Guo X
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Paradis-Isler N
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


81958 Human retinal ganglion cell axon regeneration by recapitulating developmental mechanisms: effects of recruitment of the mTOR pathway
Ahmad I
Development 2019; 146: (IGR: 20-4)


82660 Role of Heat Shock Proteins in Glaucoma
Joachim SC
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Reagan AM
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82459 Immune Mediated Degeneration and Possible Protection in Glaucoma
Joachim SC
Frontiers in neuroscience 2019; 13: 931 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Ciuluvică RC
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82563 Enriched environment provides neuroprotection against experimental glaucoma
Chianelli MS
Journal of Neurochemistry 2020; 152: 103-121 (IGR: 20-4)


82799 Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma
Sappington RM
Frontiers in neuroscience 2019; 13: 1139 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Salobrar-García E
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82633 Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma
Vestweber D
eLife 2019; 8: (IGR: 20-4)


82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Gregory-Ksander M
Journal of Neuroinflammation 2019; 16: 184 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Sylvester A
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Kang S
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Rulli E
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Harada C
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Wang Y
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Xu Y
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82820 The effects of intravitreal H S application on apoptosis in the retina and cornea in experimental glaucoma model
Takir S
International journal of experimental pathology 2019; 100: 330-336 (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Keezer KJ
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Liu X
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82151 IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases
Fernando N
Frontiers in immunology 2019; 10: 1618 (IGR: 20-4)


81992 The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model
Zhao Y
FASEB Journal 2019; 33: 11194-11209 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Nandi SK
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Rich CC
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Zhu J
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Amar-Zifkin A
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Shen X
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Murakami A
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Chen SL
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Li Y
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Baumgartner RA
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Nam HJ
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


81992 The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model
Zhang H
FASEB Journal 2019; 33: 11194-11209 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Poli D
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Xiao D
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Tudosescu R
Romanian journal of ophthalmology 2019; 63: 222-230 (IGR: 20-4)


82633 Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma
Quaggin SE
eLife 2019; 8: (IGR: 20-4)


82563 Enriched environment provides neuroprotection against experimental glaucoma
Dorfman D
Journal of Neurochemistry 2020; 152: 103-121 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
López-Cuenca I
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Hewes AA
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Fudala R
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Huang S
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Legramandi L
Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Douglas C
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Diemler CA
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82563 Enriched environment provides neuroprotection against experimental glaucoma
Rosenstein RE
Journal of Neurochemistry 2020; 152: 103-121 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Licastro E
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Matsuda A
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Zhu L
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Bernstein SL
Translational vision science & technology 2019; 8: 47 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Krishnamoorthy RR
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Cui W
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Ahn JH
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Guo L
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Inarejos-García AM
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82354 Survival of Alpha and Intrinsically Photosensitive Retinal Ganglion Cells in NMDA-Induced Neurotoxicity and a Mouse Model of Normal Tension Glaucoma
Harada T
Investigative Ophthalmology and Visual Science 2019; 60: 3696-3707 (IGR: 20-4)


82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol

Advances in Therapy 2019; 36: 2506-2514 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Murray M
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Kim KY
Biochemical Pharmacology 2019; 169: 113632 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Zhang T
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Preuss C
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82639 Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma
Zhong Y
Investigative Ophthalmology and Visual Science 2019; 60: 4346-4359 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Morquette B
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


81980 Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Nagaraj RH
Cell death discovery 2019; 5: 112 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Yang Q
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82093 Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Zhou F
Experimental Cell Research 2019; 383: 111509 (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Moore CS
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Cen LP
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Almodóvar P
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Lin Y
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Soto I; John SWM
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Pang CP
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82686 Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway
Cai X
Nanoscale 2019; 11: 20667-20675 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Pinazo-Durán MD
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82102 microRNA dysregulation in neurodegenerative diseases: A systematic review
Fournier AE
Progress in Neurobiology 2019; 182: 101664 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Ramírez JM
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82130 Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
Howell GR
Investigative Ophthalmology and Visual Science 2019; 60: 3283-3296 (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Sun XH
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Salazar JJ
International journal of molecular sciences 2019; 20: (IGR: 20-4)


82152 Green Tea Extract Ameliorates Ischemia-Induced Retinal Ganglion Cell Degeneration in Rats
Ng TK
Oxidative medicine and cellular longevity 2019; 2019: 8407206 (IGR: 20-4)


80532 Mitochondrial Uncoupling Protein 2 Knock-out Promotes Mitophagy to Decrease Retinal Ganglion Cell Death in a Mouse Model of Glaucoma
Hass DT
Journal of Neuroscience 2019; 39: 3582-3596 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Chan KC
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


81171 Increased levels of synaptic proteins involved in synaptic plasticity after chronic intraocular pressure elevation and modulation by brain-derived neurotrophic factor in a glaucoma animal model
Park HL
Disease models & mechanisms 2019; 12: (IGR: 20-3)


81265 Comparative lipid profiling dataset of the inflammation-induced optic nerve regeneration
Trzeciecka A
Data in brief 2019; 24: 103950 (IGR: 20-3)


80722 Cell Autonomous Neuroprotection by the Mitochondrial Uncoupling Protein 2 in a Mouse Model of Glaucoma
Hass DT
Frontiers in neuroscience 2019; 13: 201 (IGR: 20-3)


80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Jia Y
Molecular medicine reports 2019; 19: 4863-4871 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Laspas P
Scientific reports 2019; 9: 5222 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Wu X
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


81200 Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
Schlüter A
Molecular Neurobiology 2019; 56: 8018-8034 (IGR: 20-3)


80643 Lactate-Mediated Protection of Retinal Ganglion Cells
Vohra R
Journal of Molecular Biology 2019; 431: 1878-1888 (IGR: 20-3)


81372 Multipotent stem cell-derived retinal ganglion cells in 3D culture as tools for neurotrophic factor gene delivery system development
Chen DW
Nanomedicine: Nanotechnology, Biology, and Medicine 2019; 21: 102045 (IGR: 20-3)


80532 Mitochondrial Uncoupling Protein 2 Knock-out Promotes Mitophagy to Decrease Retinal Ganglion Cell Death in a Mouse Model of Glaucoma
Hass DT
Journal of Neuroscience 2019; 39: 3582-3596 (IGR: 20-3)


81450 Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment
Bariş M
Current ophthalmology reports 2019; 7: 160-169 (IGR: 20-3)


80993 Chlorogenic acid relieved oxidative stress injury in retinal ganglion cells through IncRNA-TUG1/Nrf2
Gong W
Cell cycle (Georgetown, Tex.) 2019; 18: 1549-1559 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Sheng L
Marine drugs 2019; 17: (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Ekicier Acar S
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


80565 Early Optic Nerve Head Glial Proliferation and Jak-Stat Pathway Activation in Chronic Experimental Glaucoma
Lozano DC
Investigative Ophthalmology and Visual Science 2019; 60: 921-932 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Eastlake K
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80912 Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma-induced optic atrophy
Chen Q
Journal of Cellular Biochemistry 2019; 120: 13133-13140 (IGR: 20-3)


80632 Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma
Wang C
Cell cycle (Georgetown, Tex.) 2019; 18: 932-948 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
He JN
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


81414 Quercetin Enhances Inhibitory Synaptic Inputs and Reduces Excitatory Synaptic Inputs to OFF- and ON-Type Retinal Ganglion Cells in a Chronic Glaucoma Rat Model
Zhou X
Frontiers in neuroscience 2019; 13: 672 (IGR: 20-3)


81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Li X
International Journal of Molecular Medicine 2019; 44: 503-512 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Fan KR
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


81300 Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma
Daniel S
Experimental Eye Research 2019; 185: 107703 (IGR: 20-3)


81068 Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
Pérez de Lara MJ
Brain Research Bulletin 2019; 150: 61-74 (IGR: 20-3)


80722 Cell Autonomous Neuroprotection by the Mitochondrial Uncoupling Protein 2 in a Mouse Model of Glaucoma
Hass DT
Frontiers in neuroscience 2019; 13: 201 (IGR: 20-3)


81353 Cholinergic nervous system and glaucoma: From basic science to clinical applications
Faiq MA
Progress in Retinal and Eye Research 2019; 72: 100767 (IGR: 20-3)


81139 5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model
Zhou X
Frontiers in cellular neuroscience 2019; 13: 167 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Wu J
Scientific reports 2019; 9: 9057 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Reinehr S
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
He JN
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Dai C
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


81372 Multipotent stem cell-derived retinal ganglion cells in 3D culture as tools for neurotrophic factor gene delivery system development
Narsineni L
Nanomedicine: Nanotechnology, Biology, and Medicine 2019; 21: 102045 (IGR: 20-3)


81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Wang Q
International Journal of Molecular Medicine 2019; 44: 503-512 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Zhutdieva MB
Scientific reports 2019; 9: 5222 (IGR: 20-3)


80912 Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma-induced optic atrophy
Xi X
Journal of Cellular Biochemistry 2019; 120: 13133-13140 (IGR: 20-3)


81139 5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model
Li G
Frontiers in cellular neuroscience 2019; 13: 167 (IGR: 20-3)


81414 Quercetin Enhances Inhibitory Synaptic Inputs and Reduces Excitatory Synaptic Inputs to OFF- and ON-Type Retinal Ganglion Cells in a Chronic Glaucoma Rat Model
Li G
Frontiers in neuroscience 2019; 13: 672 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Baskaran M
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Wang W
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Zhang SD
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Xie J
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


81068 Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
Avilés-Trigueros M
Brain Research Bulletin 2019; 150: 61-74 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Mak HK
Scientific reports 2019; 9: 9057 (IGR: 20-3)


81200 Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
Aksan B
Molecular Neurobiology 2019; 56: 8018-8034 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Lu B
Marine drugs 2019; 17: (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Sarıcaoğlu MS
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


81171 Increased levels of synaptic proteins involved in synaptic plasticity after chronic intraocular pressure elevation and modulation by brain-derived neurotrophic factor in a glaucoma animal model
Kim SW
Disease models & mechanisms 2019; 12: (IGR: 20-3)


80643 Lactate-Mediated Protection of Retinal Ganglion Cells
Aldana BI
Journal of Molecular Biology 2019; 431: 1878-1888 (IGR: 20-3)


80722 Cell Autonomous Neuroprotection by the Mitochondrial Uncoupling Protein 2 in a Mouse Model of Glaucoma
Barnstable CJ
Frontiers in neuroscience 2019; 13: 201 (IGR: 20-3)


81300 Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma
Meyer KJ
Experimental Eye Research 2019; 185: 107703 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Mak HK
Scientific reports 2019; 9: 9057 (IGR: 20-3)


80532 Mitochondrial Uncoupling Protein 2 Knock-out Promotes Mitophagy to Decrease Retinal Ganglion Cell Death in a Mouse Model of Glaucoma
Barnstable CJ
Journal of Neuroscience 2019; 39: 3582-3596 (IGR: 20-3)


81450 Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment
Tezel G
Current ophthalmology reports 2019; 7: 160-169 (IGR: 20-3)


81265 Comparative lipid profiling dataset of the inflammation-induced optic nerve regeneration
Stark DT
Data in brief 2019; 24: 103950 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Koch D
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


81353 Cholinergic nervous system and glaucoma: From basic science to clinical applications
Wollstein G
Progress in Retinal and Eye Research 2019; 72: 100767 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Yu Y
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80632 Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma
Ren YL
Cell cycle (Georgetown, Tex.) 2019; 18: 932-948 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Pang Y
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


80565 Early Optic Nerve Head Glial Proliferation and Jak-Stat Pathway Activation in Chronic Experimental Glaucoma
Choe TE
Investigative Ophthalmology and Visual Science 2019; 60: 921-932 (IGR: 20-3)


80993 Chlorogenic acid relieved oxidative stress injury in retinal ganglion cells through IncRNA-TUG1/Nrf2
Li J
Cell cycle (Georgetown, Tex.) 2019; 18: 1549-1559 (IGR: 20-3)


80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Jiang S
Molecular medicine reports 2019; 19: 4863-4871 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Nongpiur ME
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Çolak A
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Ng SH
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80632 Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma
Zhai J
Cell cycle (Georgetown, Tex.) 2019; 18: 932-948 (IGR: 20-3)


80643 Lactate-Mediated Protection of Retinal Ganglion Cells
Bulli G
Journal of Molecular Biology 2019; 431: 1878-1888 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Chan YK
Scientific reports 2019; 9: 9057 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Zhang Z
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


80565 Early Optic Nerve Head Glial Proliferation and Jak-Stat Pathway Activation in Chronic Experimental Glaucoma
Cepurna WO
Investigative Ophthalmology and Visual Science 2019; 60: 921-932 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Chen H
Marine drugs 2019; 17: (IGR: 20-3)


81300 Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma
Clark AF
Experimental Eye Research 2019; 185: 107703 (IGR: 20-3)


80912 Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma-induced optic atrophy
Zeng Y
Journal of Cellular Biochemistry 2019; 120: 13133-13140 (IGR: 20-3)


81353 Cholinergic nervous system and glaucoma: From basic science to clinical applications
Schuman JS
Progress in Retinal and Eye Research 2019; 72: 100767 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Dai J
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


81068 Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
Guzmán-Aránguez A
Brain Research Bulletin 2019; 150: 61-74 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Weiss M
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Chen C
Molecular medicine reports 2019; 19: 4863-4871 (IGR: 20-3)


81372 Multipotent stem cell-derived retinal ganglion cells in 3D culture as tools for neurotrophic factor gene delivery system development
Foldvari M
Nanomedicine: Nanotechnology, Biology, and Medicine 2019; 21: 102045 (IGR: 20-3)


81171 Increased levels of synaptic proteins involved in synaptic plasticity after chronic intraocular pressure elevation and modulation by brain-derived neurotrophic factor in a glaucoma animal model
Kim JH
Disease models & mechanisms 2019; 12: (IGR: 20-3)


81265 Comparative lipid profiling dataset of the inflammation-induced optic nerve regeneration
Kwong JMK
Data in brief 2019; 24: 103950 (IGR: 20-3)


81139 5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model
Zhang S
Frontiers in cellular neuroscience 2019; 13: 167 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Jayaram H
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80993 Chlorogenic acid relieved oxidative stress injury in retinal ganglion cells through IncRNA-TUG1/Nrf2
Zhu G
Cell cycle (Georgetown, Tex.) 2019; 18: 1549-1559 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Qu Y
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Brochhausen C
Scientific reports 2019; 9: 5222 (IGR: 20-3)


81414 Quercetin Enhances Inhibitory Synaptic Inputs and Reduces Excitatory Synaptic Inputs to OFF- and ON-Type Retinal Ganglion Cells in a Chronic Glaucoma Rat Model
Yang B
Frontiers in neuroscience 2019; 13: 672 (IGR: 20-3)


81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Ren Y
International Journal of Molecular Medicine 2019; 44: 503-512 (IGR: 20-3)


81200 Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
Fioravanti R
Molecular Neurobiology 2019; 56: 8018-8034 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Du Y
Marine drugs 2019; 17: (IGR: 20-3)


81300 Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma
Anderson MG
Experimental Eye Research 2019; 185: 107703 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Murray-Dunning C
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Wang HL
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


81068 Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
Valiente-Soriano FJ
Brain Research Bulletin 2019; 150: 61-74 (IGR: 20-3)


81353 Cholinergic nervous system and glaucoma: From basic science to clinical applications
Chan KC
Progress in Retinal and Eye Research 2019; 72: 100767 (IGR: 20-3)


80912 Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma-induced optic atrophy
He Z
Journal of Cellular Biochemistry 2019; 120: 13133-13140 (IGR: 20-3)


80993 Chlorogenic acid relieved oxidative stress injury in retinal ganglion cells through IncRNA-TUG1/Nrf2
Wang Y
Cell cycle (Georgetown, Tex.) 2019; 18: 1549-1559 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Mak HK
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80632 Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma
Zhou XY
Cell cycle (Georgetown, Tex.) 2019; 18: 932-948 (IGR: 20-3)


81139 5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model
Wu J
Frontiers in cellular neuroscience 2019; 13: 167 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Froemel F
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


81414 Quercetin Enhances Inhibitory Synaptic Inputs and Reduces Excitatory Synaptic Inputs to OFF- and ON-Type Retinal Ganglion Cells in a Chronic Glaucoma Rat Model
Wu J
Frontiers in neuroscience 2019; 13: 672 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Li X
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Wang X
International Journal of Molecular Medicine 2019; 44: 503-512 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Musayeva A
Scientific reports 2019; 9: 5222 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Htoon HM
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Li D
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Mak HK
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Lin C
Scientific reports 2019; 9: 9057 (IGR: 20-3)


80565 Early Optic Nerve Head Glial Proliferation and Jak-Stat Pathway Activation in Chronic Experimental Glaucoma
Morrison JC
Investigative Ophthalmology and Visual Science 2019; 60: 921-932 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Aktaş Z
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


81200 Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
Valente S
Molecular Neurobiology 2019; 56: 8018-8034 (IGR: 20-3)


80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Lu G
Molecular medicine reports 2019; 19: 4863-4871 (IGR: 20-3)


81265 Comparative lipid profiling dataset of the inflammation-induced optic nerve regeneration
Piqueras M
Data in brief 2019; 24: 103950 (IGR: 20-3)


81171 Increased levels of synaptic proteins involved in synaptic plasticity after chronic intraocular pressure elevation and modulation by brain-derived neurotrophic factor in a glaucoma animal model
Park CK
Disease models & mechanisms 2019; 12: (IGR: 20-3)


80643 Lactate-Mediated Protection of Retinal Ganglion Cells
Skytt DM
Journal of Molecular Biology 2019; 431: 1878-1888 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Voss C
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


80993 Chlorogenic acid relieved oxidative stress injury in retinal ganglion cells through IncRNA-TUG1/Nrf2
Zheng G
Cell cycle (Georgetown, Tex.) 2019; 18: 1549-1559 (IGR: 20-3)


80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Sepici Dinçel A
European Journal of Ophthalmology 2019; 0: 1120672119833271 (IGR: 20-3)


81300 Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma
McDowell CM
Experimental Eye Research 2019; 185: 107703 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Zadeh JK
Scientific reports 2019; 9: 5222 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Tham CC
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Khaw PT
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Carr AJF
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Xie Y
Molecular medicine reports 2019; 19: 4863-4871 (IGR: 20-3)


81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Cheng H
International Journal of Molecular Medicine 2019; 44: 503-512 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Chen C
Marine drugs 2019; 17: (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
De Leon JMS
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80565 Early Optic Nerve Head Glial Proliferation and Jak-Stat Pathway Activation in Chronic Experimental Glaucoma
Johnson EC
Investigative Ophthalmology and Visual Science 2019; 60: 921-932 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Yip YWY
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


81068 Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
de la Villa P
Brain Research Bulletin 2019; 150: 61-74 (IGR: 20-3)


81200 Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
Mai A
Molecular Neurobiology 2019; 56: 8018-8034 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Kong C
Scientific reports 2019; 9: 9057 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Voss C
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


80643 Lactate-Mediated Protection of Retinal Ganglion Cells
Waagepetersen H
Journal of Molecular Biology 2019; 431: 1878-1888 (IGR: 20-3)


80912 Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma-induced optic atrophy
Zhao J
Journal of Cellular Biochemistry 2019; 120: 13133-13140 (IGR: 20-3)


80632 Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma
Wu J
Cell cycle (Georgetown, Tex.) 2019; 18: 932-948 (IGR: 20-3)


81265 Comparative lipid profiling dataset of the inflammation-induced optic nerve regeneration
Bhattacharya SK
Data in brief 2019; 24: 103950 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Wang C
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Yin Z
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Cai W
Marine drugs 2019; 17: (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Dick HB
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Sun X
Molecular medicine reports 2019; 19: 4863-4871 (IGR: 20-3)


81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Yang H
International Journal of Molecular Medicine 2019; 44: 503-512 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Perera SA
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


81068 Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
Vidal-Sanz M
Brain Research Bulletin 2019; 150: 61-74 (IGR: 20-3)


81265 Comparative lipid profiling dataset of the inflammation-induced optic nerve regeneration
Caprioli J
Data in brief 2019; 24: 103950 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Leung CKS
Scientific reports 2019; 9: 9057 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Lei Y
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


81200 Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
Mauceri D
Molecular Neurobiology 2019; 56: 8018-8034 (IGR: 20-3)


80912 Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma-induced optic atrophy
Li Y
Journal of Cellular Biochemistry 2019; 120: 13133-13140 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Pfeiffer N
Scientific reports 2019; 9: 5222 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Pang CP
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


80643 Lactate-Mediated Protection of Retinal Ganglion Cells
Bergersen LH
Journal of Molecular Biology 2019; 431: 1878-1888 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Ramsden CM
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80993 Chlorogenic acid relieved oxidative stress injury in retinal ganglion cells through IncRNA-TUG1/Nrf2
Kan Q
Cell cycle (Georgetown, Tex.) 2019; 18: 1549-1559 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
van der Merwe Y
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


81224 Tetramethylpyrazine protects retinal ganglion cells against H2O2‑induced damage via the microRNA‑182/mitochondrial pathway
Wang B
International Journal of Molecular Medicine 2019; 44: 503-512 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Huo S
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


80643 Lactate-Mediated Protection of Retinal Ganglion Cells
Kolko M
Journal of Molecular Biology 2019; 431: 1878-1888 (IGR: 20-3)


80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Chu WK
Molecular Neurobiology 2019; 56: 6586-6593 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Yang Y
Marine drugs 2019; 17: (IGR: 20-3)


80997 Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death
Huang L
Molecular medicine reports 2019; 19: 4863-4871 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Xia N
Scientific reports 2019; 9: 5222 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Li A
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Fuchshofer R
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Ren T
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Belkin M
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


81068 Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
Pintor J
Brain Research Bulletin 2019; 150: 61-74 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Vugler A
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


81319 An in vitro pressure model towards studying the response of primary retinal ganglion cells to elevated hydrostatic pressures
Shum HC
Scientific reports 2019; 9: 9057 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Yung JSY
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Li H
Scientific reports 2019; 9: 5222 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Yu L
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Gore K
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


81174 Loss of retinal ganglion cells in a new genetic mouse model for primary open-angle glaucoma
Joachim SC
Journal of cellular and molecular medicine 2019; 23: 5497-5507 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Collins A
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Aung T
Acta Ophthalmologica 2019; 97: e827-e832 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Tian X
Marine drugs 2019; 17: (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Clemo N
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Huang Z
Marine drugs 2019; 17: (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Biswas S
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Raisman G
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


80529 Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model
Ye J
Acta biochimica et biophysica Sinica 2019; 51: 411-421 (IGR: 20-3)


80732 The M muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice
Wess J; Gericke A
Scientific reports 2019; 9: 5222 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Cao X
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Stewart M
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Chi W
Marine drugs 2019; 17: (IGR: 20-3)


80488 Transplantation of cultured olfactory mucosal cells rescues optic nerve axons in a rat glaucoma model
Li Y
Brain Research 2019; 1714: 45-51 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Chau Y
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Lin S
Marine drugs 2019; 17: (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Coffey P
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


81229 Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma
Leung CKS
Acta biomaterialia 2019; 94: 219-231 (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Khaw PT
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Yan G; Yin W
Marine drugs 2019; 17: (IGR: 20-3)


80950 Phenotypic and Functional Characterization of Müller Glia Isolated from Induced Pluripotent Stem Cell-Derived Retinal Organoids: Improvement of Retinal Ganglion Cell Function upon Transplantation
Limb GA
Stem cells translational medicine 2019; 8: 775-784 (IGR: 20-3)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Dheer Y
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79876 Loss of foxc1 in zebrafish reduces optic nerve size and cell number in the retinal ganglion cell layer
Umali J
Vision Research 2019; 156: 66-72 (IGR: 20-2)


79752 The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration
Pietrucha-Dutczak M
Frontiers in neuroscience 2018; 12: 834 (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Arranz-Romera A
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


80079 Evidence of Hypoxic Glial Cells in a Model of Ocular Hypertension
Jassim AH
Investigative Ophthalmology and Visual Science 2019; 60: 1-15 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Lauzi J
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79925 Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells
Aires ID
GLIA 2019; 67: 896-914 (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Tehrani S
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


80037 Mild Intraocular Pressure Elevation in Mice Reveals Distinct Retinal Ganglion Cell Functional Thresholds and Pressure-Dependent Properties
Tao X
Journal of Neuroscience 2019; 39: 1881-1891 (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Sano H
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


80072 Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences
Del Valle Bessone C
Life Sciences 2019; 218: 233-240 (IGR: 20-2)


79748 Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
Zhou X
Journal of Neuroscience 2019; 39: 1484-1504 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Williams PA
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79396 Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma
Tribble JR
Molecular brain 2018; 11: 69 (IGR: 20-2)


80000 Activation of Nrf2/HO-1 pathway protects retinal ganglion cells from a rat chronic ocular hypertension model of glaucoma
Wang X
International Ophthalmology 2019; 39: 2303-2312 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Lin C
Eye 2019; 33: 777-784 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Geeraerts E
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79787 Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
Martucci A
Neural Regeneration Research 2019; 14: 197-200 (IGR: 20-2)


79941 Differentiation of retinal ganglion cells from induced pluripotent stem cells: a review
Ji SL
International Journal of Ophthalmology 2019; 12: 152-160 (IGR: 20-2)


79463 Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma
Harun-Or-Rashid M
Journal of Neuroinflammation 2018; 15: 313 (IGR: 20-2)


79818 MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway
Zhang LQ
Journal of Cellular Physiology 2019; 234: 8873-8887 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Sun HJ
Molecules 2019; 24: (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Yuan H
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79701 Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension
Zhou L
Experimental Eye Research 2019; 180: 77-85 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Yu J
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


79762 Neuroinflammation as a target for glaucoma therapy
Adornetto A
Neural Regeneration Research 2019; 14: 391-394 (IGR: 20-2)


79319 Molecular mechanisms of neuroretinoprotection in primary open-angle glaucoma
Gabdrakhmanova AF
Vestnik Oftalmologii 2018; 134: 54-60 (IGR: 20-2)


80000 Activation of Nrf2/HO-1 pathway protects retinal ganglion cells from a rat chronic ocular hypertension model of glaucoma
Yuan ZL
International Ophthalmology 2019; 39: 2303-2312 (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Namekata K
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wu F
Eye 2019; 33: 777-784 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Sun W
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


79748 Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
Zhang R
Journal of Neuroscience 2019; 39: 1484-1504 (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Davis BM
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79941 Differentiation of retinal ganglion cells from induced pluripotent stem cells: a review
Tang SB
International Journal of Ophthalmology 2019; 12: 152-160 (IGR: 20-2)


79762 Neuroinflammation as a target for glaucoma therapy
Russo R
Neural Regeneration Research 2019; 14: 391-394 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Chitranshi N
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79701 Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension
Chen W
Experimental Eye Research 2019; 180: 77-85 (IGR: 20-2)


79876 Loss of foxc1 in zebrafish reduces optic nerve size and cell number in the retinal ganglion cell layer
Hawkey-Noble A
Vision Research 2019; 156: 66-72 (IGR: 20-2)


80079 Evidence of Hypoxic Glial Cells in a Model of Ocular Hypertension
Inman DM
Investigative Ophthalmology and Visual Science 2019; 60: 1-15 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Anders F
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79319 Molecular mechanisms of neuroretinoprotection in primary open-angle glaucoma
Aznabaeva LF
Vestnik Oftalmologii 2018; 134: 54-60 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Xue DD
Molecules 2019; 24: (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Braine CE
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Claes M
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79396 Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma
Williams PA
Molecular brain 2018; 11: 69 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Li H
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79787 Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
Nucci C
Neural Regeneration Research 2019; 14: 197-200 (IGR: 20-2)


79925 Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells
Boia R
GLIA 2019; 67: 896-914 (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Davis L
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


79752 The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration
Amadio M
Frontiers in neuroscience 2018; 12: 834 (IGR: 20-2)


79818 MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway
Cui H
Journal of Cellular Physiology 2019; 234: 8873-8887 (IGR: 20-2)


79463 Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma
Inman DM
Journal of Neuroinflammation 2018; 15: 313 (IGR: 20-2)


80037 Mild Intraocular Pressure Elevation in Mice Reveals Distinct Retinal Ganglion Cell Functional Thresholds and Pressure-Dependent Properties
Sabharwal J
Journal of Neuroscience 2019; 39: 1881-1891 (IGR: 20-2)


80072 Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences
Fajreldines HD
Life Sciences 2019; 218: 233-240 (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Cepurna WO
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


79701 Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension
Lin D
Experimental Eye Research 2019; 180: 77-85 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Gupta V
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Yu P
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Lu BZ
Molecules 2019; 24: (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Kimura A
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Song Y
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Bravo-Osuna I
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


80072 Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences
de Barboza GED
Life Sciences 2019; 218: 233-240 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Liu H
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79762 Neuroinflammation as a target for glaucoma therapy
Parisi V
Neural Regeneration Research 2019; 14: 391-394 (IGR: 20-2)


80037 Mild Intraocular Pressure Elevation in Mice Reveals Distinct Retinal Ganglion Cell Functional Thresholds and Pressure-Dependent Properties
Seilheimer RL
Journal of Neuroscience 2019; 39: 1881-1891 (IGR: 20-2)


79876 Loss of foxc1 in zebrafish reduces optic nerve size and cell number in the retinal ganglion cell layer
French CR
Vision Research 2019; 156: 66-72 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Kizhatil K
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79319 Molecular mechanisms of neuroretinoprotection in primary open-angle glaucoma
Abizgil'dina GS
Vestnik Oftalmologii 2018; 134: 54-60 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Zheng T
Eye 2019; 33: 777-784 (IGR: 20-2)


79925 Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells
Rodrigues-Neves AC
GLIA 2019; 67: 896-914 (IGR: 20-2)


79752 The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration
Govoni S
Frontiers in neuroscience 2018; 12: 834 (IGR: 20-2)


79748 Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
Zhang S
Journal of Neuroscience 2019; 39: 1484-1504 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Dekeyster E
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79818 MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway
Yu YB
Journal of Cellular Physiology 2019; 234: 8873-8887 (IGR: 20-2)


79396 Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma
Caterson B
Molecular brain 2018; 11: 69 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Foxworth NE
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79319 Molecular mechanisms of neuroretinoprotection in primary open-angle glaucoma
Kurbanov SA
Vestnik Oftalmologii 2018; 134: 54-60 (IGR: 20-2)


79701 Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension
Hu W
Experimental Eye Research 2019; 180: 77-85 (IGR: 20-2)


79818 MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway
Shi HQ
Journal of Cellular Physiology 2019; 234: 8873-8887 (IGR: 20-2)


79752 The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration
Lewin-Kowalik J
Frontiers in neuroscience 2018; 12: 834 (IGR: 20-2)


79925 Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells
Madeira MH
GLIA 2019; 67: 896-914 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Fan Q
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Delf RK
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


80072 Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences
Tolosa de Talamoni NG
Life Sciences 2019; 218: 233-240 (IGR: 20-2)


79748 Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
Wu J
Journal of Neuroscience 2019; 39: 1484-1504 (IGR: 20-2)


79396 Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma
Sengpiel F
Molecular brain 2018; 11: 69 (IGR: 20-2)


80037 Mild Intraocular Pressure Elevation in Mice Reveals Distinct Retinal Ganglion Cell Functional Thresholds and Pressure-Dependent Properties
Wu SM
Journal of Neuroscience 2019; 39: 1881-1891 (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Esteban-Pérez S
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Pfeiffer N
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Salinas-Navarro M
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Sharma S
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Shitara H
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wang X
Eye 2019; 33: 777-784 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Liu J
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Li Y; Sheng LX
Molecules 2019; 24: (IGR: 20-2)


79818 MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway
Zhou Y
Journal of Cellular Physiology 2019; 234: 8873-8887 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Pushpitha K
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
De Groef L
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Xue F
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


80072 Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences
Allemandi DA
Life Sciences 2019; 218: 233-240 (IGR: 20-2)


79748 Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
Sun X
Journal of Neuroscience 2019; 39: 1484-1504 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Tolman NG
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Zhang X
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


80037 Mild Intraocular Pressure Elevation in Mice Reveals Distinct Retinal Ganglion Cell Functional Thresholds and Pressure-Dependent Properties
Frankfort BJ
Journal of Neuroscience 2019; 39: 1881-1891 (IGR: 20-2)


79701 Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension
Tang Z
Experimental Eye Research 2019; 180: 77-85 (IGR: 20-2)


79925 Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells
Marques C
GLIA 2019; 67: 896-914 (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Guo X
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


79752 The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration
Smedowski A
Frontiers in neuroscience 2018; 12: 834 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Chen Y
Eye 2019; 33: 777-784 (IGR: 20-2)


79396 Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma
Morgan JE
Molecular brain 2018; 11: 69 (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Lozano DC
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Molina-Martínez IT
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Grus F
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Gong K
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Van den Haute C
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Huang W
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Thanos S
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79925 Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells
Ambrósio AF
GLIA 2019; 67: 896-914 (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Shamsher E
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Zhu Z
Molecules 2019; 24: (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Choe TE
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wu X
Eye 2019; 33: 777-784 (IGR: 20-2)


79818 MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway
Liu MJ
Journal of Cellular Physiology 2019; 234: 8873-8887 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Abbasi M
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Harder JM
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


80072 Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences
Carpentieri AR
Life Sciences 2019; 218: 233-240 (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Harada C
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


80072 Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences
Quinteros DA
Life Sciences 2019; 218: 233-240 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Scheyltjens I
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Johnson EC
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Mirzaei M
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Zhou YW
Molecules 2019; 24: (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Ravindran N
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Yang X
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Mitamura Y
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Shen J
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Arnhold S
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Scott RA
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79925 Blockade of microglial adenosine A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells
Santiago AR
GLIA 2019; 67: 896-914 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Cui Y
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Sousa GL
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Guo L
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79859 Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma
Harada T
Cell Death and Disease 2019; 10: 75 (IGR: 20-2)


79932 Optic Nerve Head Astrocytes Display Axon-Dependent and -Independent Reactivity in Response to Acutely Elevated Intraocular Pressure
Morrison JC
Investigative Ophthalmology and Visual Science 2019; 60: 312-321 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
You Y
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79948 SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1
Kang Q
Chemico-biological interactions 2019; 300: 151-158 (IGR: 20-2)


79911 Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
Prokosch V
PLoS ONE 2019; 14: e0207190 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Baekelandt V
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Zhang JX
Molecules 2019; 24: (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Cordeiro MF
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79415 Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury
Zhou W
BMC Ophthalmology 2018; 18: 300 (IGR: 20-2)


79843 Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Graham SL
Experimental Neurology 2019; 314: 111-125 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Arckens L
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Panitch A
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Lin GJ
Molecules 2019; 24: (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
Howell GR
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79955 Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model
Moons L
Journal of Neuroscience 2019; 39: 2313-2325 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Lin SZ
Molecules 2019; 24: (IGR: 20-2)


79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Herrero-Vanrell R
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Yan GM
Molecules 2019; 24: (IGR: 20-2)


79921 Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma
John SWM
Molecular Neurodegeneration 2019; 14: 6 (IGR: 20-2)


79989 A Novel Synthetic Steroid of 2β,3α,5α-Trihydroxy-androst-6-one Alleviates the Loss of Rat Retinal Ganglion Cells Caused by Acute Intraocular Hypertension via Inhibiting the Inflammatory Activation of Microglia
Chen YP; Yin W
Molecules 2019; 24: (IGR: 20-2)


78448 Intraocular miR-211 exacerbates pressure-induced cell death in retinal ganglion cells via direct repression of FRS2 signaling
Yang J
Biochemical and Biophysical Research Communications 2018; 503: 2984-2992 (IGR: 20-1)


79132 Rho-kinase (ROCK) Inhibitors- A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Abbhi V
Current Medicinal Chemistry 2018; 0: (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Chen H
Nature communications 2018; 9: 3914 (IGR: 20-1)


78410 Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model
Ishikawa M
Scientific reports 2018; 8: 12851 (IGR: 20-1)


79276 Retinal Ganglion Cell Replacement: Current Status and Challenges Ahead
Miltner AM
Developmental Dynamics 2019; 248: 118-128 (IGR: 20-1)


79124 Antiapoptotic effect of taurine against NMDA-induced retinal excitotoxicity in rats
Lambuk L
Neurotoxicology 2019; 70: 62-71 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Liu ST
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78482 Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration
Ju WK
Biochemical and Biophysical Research Communications 2018; 503: 2639-2645 (IGR: 20-1)


79125 Microtubule Imaging Reveals Cytoskeletal Deficit Predisposing the Retinal Ganglion Cell Axons to Atrophy in DBA/2J
Sharoukhov D
Investigative Ophthalmology and Visual Science 2018; 59: 5292-5300 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Chen H
Nature communications 2018; 9: 3209 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Li L
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Kuehn S
Frontiers in cellular neuroscience 2018; 12: 312 (IGR: 20-1)


79090 Cyanin Chloride Inhibits Hyperbaric Pressure-Induced Decrease of Intracellular Glutamate-Aspartate Transporter in Rat Retinal Müller Cells
Chen X
Journal of Ophthalmology 2018; 2018: 6128470 (IGR: 20-1)


78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Hu X
Frontiers in molecular neuroscience 2018; 11: 350 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Wareham LK
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Chitranshi N
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78886 Pronounced synergistic neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse
Flachsbarth K
Experimental Eye Research 2018; 176: 258-265 (IGR: 20-1)


78812 Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies
Rabesandratana O
Frontiers in neuroscience 2018; 12: 651 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Bosco A
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78960 Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma
Nie XG
American Journal of Physiology and Cell Physiology 2018; 315: C839-C849 (IGR: 20-1)


79211 Etidronate protects chronic ocular hypertension induced retinal oxidative stress and promotes retinal ganglion cells growth through IGF-1 signaling pathway
Su J
European Journal of Pharmacology 2018; 841: 75-81 (IGR: 20-1)


79100 Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in a Genetic DBA/2J Mouse Model of Glaucoma
Mead B
Investigative Ophthalmology and Visual Science 2018; 59: 5473-5480 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Weinreb RN
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79137 Reactive Oxygen Species-Mediated Damage of Retinal Neurons: Drug Development Targets for Therapies of Chronic Neurodegeneration of the Retina
Rohowetz LJ
International journal of molecular sciences 2018; 19: (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Zhong SM
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


79211 Etidronate protects chronic ocular hypertension induced retinal oxidative stress and promotes retinal ganglion cells growth through IGF-1 signaling pathway
Huang M
European Journal of Pharmacology 2018; 841: 75-81 (IGR: 20-1)


79100 Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in a Genetic DBA/2J Mouse Model of Glaucoma
Ahmed Z
Investigative Ophthalmology and Visual Science 2018; 59: 5473-5480 (IGR: 20-1)


78960 Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma
Fan DS
American Journal of Physiology and Cell Physiology 2018; 315: C839-C849 (IGR: 20-1)


79090 Cyanin Chloride Inhibits Hyperbaric Pressure-Induced Decrease of Intracellular Glutamate-Aspartate Transporter in Rat Retinal Müller Cells
Wang Y
Journal of Ophthalmology 2018; 2018: 6128470 (IGR: 20-1)


79137 Reactive Oxygen Species-Mediated Damage of Retinal Neurons: Drug Development Targets for Therapies of Chronic Neurodegeneration of the Retina
Kraus JG
International journal of molecular sciences 2018; 19: (IGR: 20-1)


78812 Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies
Goureau O
Frontiers in neuroscience 2018; 12: 651 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Cho KS
Nature communications 2018; 9: 3914 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Dheer Y
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78448 Intraocular miR-211 exacerbates pressure-induced cell death in retinal ganglion cells via direct repression of FRS2 signaling
Wang N
Biochemical and Biophysical Research Communications 2018; 503: 2984-2992 (IGR: 20-1)


78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Dai Y
Frontiers in molecular neuroscience 2018; 11: 350 (IGR: 20-1)


78886 Pronounced synergistic neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse
Jankowiak W
Experimental Eye Research 2018; 176: 258-265 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Dordea AC
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


79276 Retinal Ganglion Cell Replacement: Current Status and Challenges Ahead
La Torre A
Developmental Dynamics 2019; 248: 118-128 (IGR: 20-1)


79124 Antiapoptotic effect of taurine against NMDA-induced retinal excitotoxicity in rats
Iezhitsa I
Neurotoxicology 2019; 70: 62-71 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Cho KS
Nature communications 2018; 9: 3209 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Anderson SR
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Liebmann JM
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79125 Microtubule Imaging Reveals Cytoskeletal Deficit Predisposing the Retinal Ganglion Cell Axons to Atrophy in DBA/2J
Bucinca-Cupallari F
Investigative Ophthalmology and Visual Science 2018; 59: 5292-5300 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Xu L
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78410 Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model
Yoshitomi T
Scientific reports 2018; 8: 12851 (IGR: 20-1)


78482 Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration
Shim MS
Biochemical and Biophysical Research Communications 2018; 503: 2639-2645 (IGR: 20-1)


79132 Rho-kinase (ROCK) Inhibitors- A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Piplani P
Current Medicinal Chemistry 2018; 0: (IGR: 20-1)


78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Meißner W
Frontiers in cellular neuroscience 2018; 12: 312 (IGR: 20-1)


78812 Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies
Orieux G
Frontiers in neuroscience 2018; 12: 651 (IGR: 20-1)


78960 Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma
Huang YX
American Journal of Physiology and Cell Physiology 2018; 315: C839-C849 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Cioffi GA
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78482 Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration
Kim KY
Biochemical and Biophysical Research Communications 2018; 503: 2639-2645 (IGR: 20-1)


78886 Pronounced synergistic neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse
Kruszewski K
Experimental Eye Research 2018; 176: 258-265 (IGR: 20-1)


78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Grotegut P
Frontiers in cellular neuroscience 2018; 12: 312 (IGR: 20-1)


79100 Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in a Genetic DBA/2J Mouse Model of Glaucoma
Tomarev S
Investigative Ophthalmology and Visual Science 2018; 59: 5473-5480 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Vu THK
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Vu THK
Nature communications 2018; 9: 3209 (IGR: 20-1)


79137 Reactive Oxygen Species-Mediated Damage of Retinal Neurons: Drug Development Targets for Therapies of Chronic Neurodegeneration of the Retina
Koulen P
International journal of molecular sciences 2018; 19: (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Mirzaei M
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


79124 Antiapoptotic effect of taurine against NMDA-induced retinal excitotoxicity in rats
Agarwal R
Neurotoxicology 2019; 70: 62-71 (IGR: 20-1)


78410 Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model
Covey DF
Scientific reports 2018; 8: 12851 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Vu THK
Nature communications 2018; 9: 3914 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Li XY
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Schleifer G
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Vu THK
Nature communications 2018; 9: 3209 (IGR: 20-1)


78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Zhang R
Frontiers in molecular neuroscience 2018; 11: 350 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Chen W
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Breen KT
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78448 Intraocular miR-211 exacerbates pressure-induced cell death in retinal ganglion cells via direct repression of FRS2 signaling
Luo X
Biochemical and Biophysical Research Communications 2018; 503: 2984-2992 (IGR: 20-1)


79090 Cyanin Chloride Inhibits Hyperbaric Pressure-Induced Decrease of Intracellular Glutamate-Aspartate Transporter in Rat Retinal Müller Cells
Han F
Journal of Ophthalmology 2018; 2018: 6128470 (IGR: 20-1)


79125 Microtubule Imaging Reveals Cytoskeletal Deficit Predisposing the Retinal Ganglion Cell Axons to Atrophy in DBA/2J
Lim H
Investigative Ophthalmology and Visual Science 2018; 59: 5292-5300 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Gao F
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Shen CH
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Shen CH
Nature communications 2018; 9: 3209 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Wu Y
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Shang K
Frontiers in molecular neuroscience 2018; 11: 350 (IGR: 20-1)


78960 Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma
He YY
American Journal of Physiology and Cell Physiology 2018; 315: C839-C849 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Shen CH
Nature communications 2018; 9: 3914 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Yao V
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Shen CH
Nature communications 2018; 9: 3209 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Romero CO
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Goldberg I
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78482 Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration
Bu JH
Biochemical and Biophysical Research Communications 2018; 503: 2639-2645 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Li X
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78886 Pronounced synergistic neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse
Helbing S
Experimental Eye Research 2018; 176: 258-265 (IGR: 20-1)


78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Theiss C
Frontiers in cellular neuroscience 2018; 12: 312 (IGR: 20-1)


79090 Cyanin Chloride Inhibits Hyperbaric Pressure-Induced Decrease of Intracellular Glutamate-Aspartate Transporter in Rat Retinal Müller Cells
Ke M
Journal of Ophthalmology 2018; 2018: 6128470 (IGR: 20-1)


79124 Antiapoptotic effect of taurine against NMDA-induced retinal excitotoxicity in rats
Bakar NS
Neurotoxicology 2019; 70: 62-71 (IGR: 20-1)


78410 Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model
Zorumski CF
Scientific reports 2018; 8: 12851 (IGR: 20-1)


78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Sun X
Frontiers in molecular neuroscience 2018; 11: 350 (IGR: 20-1)


78482 Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration
Park TL
Biochemical and Biophysical Research Communications 2018; 503: 2639-2645 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Li F
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Batten A
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Kaur M
Nature communications 2018; 9: 3914 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Salekdeh GH
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


79124 Antiapoptotic effect of taurine against NMDA-induced retinal excitotoxicity in rats
Agarwal P
Neurotoxicology 2019; 70: 62-71 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Xia Q
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78410 Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model
Izumi Y
Scientific reports 2018; 8: 12851 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Kaur M
Nature communications 2018; 9: 3209 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Steele MR
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78960 Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma
Dong BL
American Journal of Physiology and Cell Physiology 2018; 315: C839-C849 (IGR: 20-1)


78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Dick HB
Frontiers in cellular neuroscience 2018; 12: 312 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Brandt JD
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78886 Pronounced synergistic neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse
Bartsch S
Experimental Eye Research 2018; 176: 258-265 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Zheng L
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Chen G
Nature communications 2018; 9: 3914 (IGR: 20-1)


79124 Antiapoptotic effect of taurine against NMDA-induced retinal excitotoxicity in rats
Ismail NM
Neurotoxicology 2019; 70: 62-71 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Abbasi M
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Fei F
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Chen G
Nature communications 2018; 9: 3209 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Chiodo VA
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Johnson CA
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Zhang ML
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78960 Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma
Gao F
American Journal of Physiology and Cell Physiology 2018; 315: C839-C849 (IGR: 20-1)


78482 Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration
Ahn S
Biochemical and Biophysical Research Communications 2018; 503: 2639-2645 (IGR: 20-1)


78886 Pronounced synergistic neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse
Bartsch U
Experimental Eye Research 2018; 176: 258-265 (IGR: 20-1)


78801 Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve
Joachim SC
Frontiers in cellular neuroscience 2018; 12: 312 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Mertz J
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Zangwill LM
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Boye SL
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Mathew R
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Mathew R
Nature communications 2018; 9: 3209 (IGR: 20-1)


78482 Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration
Weinreb RN
Biochemical and Biophysical Research Communications 2018; 503: 2639-2645 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Zhu K
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Duan Q
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
McHam ML
Nature communications 2018; 9: 3209 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Zhang H
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Hauswirth WW
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
McHam ML
Nature communications 2018; 9: 3914 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Schneider S
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
McHam ML
Nature communications 2018; 9: 3209 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Sun XH
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Gregory-Ksander M
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Vander Wall R
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
McHam ML
Nature communications 2018; 9: 3914 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Pasquale LR
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Tomlinson S
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Wang X
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fazelat A
Nature communications 2018; 9: 3914 (IGR: 20-1)


79150 Reduced Annexin A1 Secretion by ABCA1 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model
Zhao Y
Frontiers in cellular neuroscience 2018; 12: 347 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fazelat A
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fazelat A
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fazelat A
Nature communications 2018; 9: 3209 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
You Y
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Badger H
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Vetter ML
Molecular Therapy 2018; 26: 2379-2396 (IGR: 20-1)


78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Bejanian M
Ophthalmology 2018; 125: 1874-1885 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Miao Y
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Lashkari K
Nature communications 2018; 9: 3914 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Buys ES
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Graham SL
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Lashkari K; Au NPB
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Au NPB
Nature communications 2018; 9: 3914 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Yang XL
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78908 Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration
Sappington RM
Neurobiology of Disease 2019; 121: 65-75 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Au NPB
Nature communications 2018; 9: 3209 (IGR: 20-1)


79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Gupta V
Molecular Therapy 2019; 27: 424-441 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Au NPB
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Tse JKY
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Tse JKY
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Tse JKY
Nature communications 2018; 9: 3209 (IGR: 20-1)


79171 EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model
Wang Z
Acta neuropathologica communications 2018; 6: 111 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Tse JKY; Li Y
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Li Y
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Yu H
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Yu H; Yang L
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Yang L; Stein-Streilein J
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Stein-Streilein J
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Stein-Streilein J
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Stein-Streilein J
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Ma CHE
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Ma CHE
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Ma CHE
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Ma CHE
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Woolf CJ
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Woolf CJ
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Woolf CJ
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Woolf CJ
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Whary MT
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Whary MT
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Whary MT
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Whary MT; Jager MJ
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Jager MJ
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fox JG
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fox JG
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fox JG
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Fox JG; Chen J
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Chen J
Nature communications 2018; 9: 3209 (IGR: 20-1)


78885 Author Correction: Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Chen DF
Nature communications 2018; 9: 3914 (IGR: 20-1)


78502 Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma
Chen DF
Nature communications 2018; 9: 3209 (IGR: 20-1)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Huang W
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


78276 Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival
Takasago Y
Journal of the renin-angiotensin-aldosterone system : JRAAS 2018; 19: 1470320318795001 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Harder JM
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


78226 Subtype-specific response of retinal ganglion cells to optic nerve crush
Daniel S
Cell death discovery 2018; 5: 7 (IGR: 19-4)


77930 Neuroprotection in glaucoma: recent advances and clinical translation
Guymer C
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-4)


77984 Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury
Agostinone J
Brain 2018; 141: 1963-1980 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Luo H
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


77917 Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
Zhang X
Life Sciences 2018; 207: 234-245 (IGR: 19-4)


78249 Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
Jafri AJA
Molecular Vision 2018; 24: 495-508 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Campos E
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Anders F
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


77900 7,8,3'-Trihydroxyflavone ameliorate oxidative stress in vivo and promotes neurite regeneration in vitro in rat retinal ganglion cells
Han W
European Journal of Pharmacology 2018; 833: 283-289 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Davis BM
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78295 Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model
Hirt J
Cell death discovery 2018; 5: 14 (IGR: 19-4)


77950 Real-Time Imaging of Retinal Ganglion Cell Apoptosis
Yap TE
Cells 2018; 7: (IGR: 19-4)


78023 Nogo-A inactivation improves visual plasticity and recovery after retinal injury
Mdzomba JB
Cell Death and Disease 2018; 9: 727 (IGR: 19-4)


78147 The Role of Axon Transport in Neuroprotection and Regeneration
Shah SH
Developmental neurobiology 2018; 0: (IGR: 19-4)


77930 Neuroprotection in glaucoma: recent advances and clinical translation
Wood JP
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Gao F
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Williams PA
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Zhuang J
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


78023 Nogo-A inactivation improves visual plasticity and recovery after retinal injury
Jordi N
Cell Death and Disease 2018; 9: 727 (IGR: 19-4)


78147 The Role of Axon Transport in Neuroprotection and Regeneration
Goldberg JL
Developmental neurobiology 2018; 0: (IGR: 19-4)


77950 Real-Time Imaging of Retinal Ganglion Cell Apoptosis
Donna P
Cells 2018; 7: (IGR: 19-4)


78249 Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
Agarwal R
Molecular Vision 2018; 24: 495-508 (IGR: 19-4)


77900 7,8,3'-Trihydroxyflavone ameliorate oxidative stress in vivo and promotes neurite regeneration in vitro in rat retinal ganglion cells
Zhu Y
European Journal of Pharmacology 2018; 833: 283-289 (IGR: 19-4)


78276 Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival
Hirooka K
Journal of the renin-angiotensin-aldosterone system : JRAAS 2018; 19: 1470320318795001 (IGR: 19-4)


77917 Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
Feng Y
Life Sciences 2018; 207: 234-245 (IGR: 19-4)


78295 Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model
Porter K
Cell death discovery 2018; 5: 14 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Mann C
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Pahlitzsch M
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78226 Subtype-specific response of retinal ganglion cells to optic nerve crush
Clark AF
Cell death discovery 2018; 5: 7 (IGR: 19-4)


77984 Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury
Alarcon-Martinez L
Brain 2018; 141: 1963-1980 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Versura P
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Hu P
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


78023 Nogo-A inactivation improves visual plasticity and recovery after retinal injury
Rodriguez L
Cell Death and Disease 2018; 9: 727 (IGR: 19-4)


78295 Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model
Dixon A
Cell death discovery 2018; 5: 14 (IGR: 19-4)


78226 Subtype-specific response of retinal ganglion cells to optic nerve crush
McDowell CM
Cell death discovery 2018; 5: 7 (IGR: 19-4)


77984 Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury
Gamlin C
Brain 2018; 141: 1963-1980 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Giannaccare G
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78249 Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
Iezhitsa I
Molecular Vision 2018; 24: 495-508 (IGR: 19-4)


77950 Real-Time Imaging of Retinal Ganglion Cell Apoptosis
Almonte MT
Cells 2018; 7: (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Hu F
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


77900 7,8,3'-Trihydroxyflavone ameliorate oxidative stress in vivo and promotes neurite regeneration in vitro in rat retinal ganglion cells
Chen B
European Journal of Pharmacology 2018; 833: 283-289 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Guo L
Scientific reports 2018; 8: 11066 (IGR: 19-4)


77930 Neuroprotection in glaucoma: recent advances and clinical translation
Chidlow G
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-4)


78276 Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival
Nakano Y
Journal of the renin-angiotensin-aldosterone system : JRAAS 2018; 19: 1470320318795001 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Liu A
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


77917 Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
Wang Y
Life Sciences 2018; 207: 234-245 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Soto I
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


78249 Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
Agarwal P
Molecular Vision 2018; 24: 495-508 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Teister J
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


78276 Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival
Kobayashi M
Journal of the renin-angiotensin-aldosterone system : JRAAS 2018; 19: 1470320318795001 (IGR: 19-4)


77950 Real-Time Imaging of Retinal Ganglion Cell Apoptosis
Cordeiro MF
Cells 2018; 7: (IGR: 19-4)


77917 Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
Wang J
Life Sciences 2018; 207: 234-245 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Terzi A
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


77930 Neuroprotection in glaucoma: recent advances and clinical translation
Casson RJ
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-4)


78023 Nogo-A inactivation improves visual plasticity and recovery after retinal injury
Joly S
Cell Death and Disease 2018; 9: 727 (IGR: 19-4)


77984 Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury
Yu WQ
Brain 2018; 141: 1963-1980 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Balendra S
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78295 Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model
McKinnon S
Cell death discovery 2018; 5: 14 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Ye W
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Foxworth NE
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


77900 7,8,3'-Trihydroxyflavone ameliorate oxidative stress in vivo and promotes neurite regeneration in vitro in rat retinal ganglion cells
Liu S
European Journal of Pharmacology 2018; 833: 283-289 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Huang J
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


78295 Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model
Liton PB
Cell death discovery 2018; 5: 14 (IGR: 19-4)


77900 7,8,3'-Trihydroxyflavone ameliorate oxidative stress in vivo and promotes neurite regeneration in vitro in rat retinal ganglion cells
Dang Y
European Journal of Pharmacology 2018; 833: 283-289 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Shah P
Scientific reports 2018; 8: 11066 (IGR: 19-4)


77917 Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
Xiang D
Life Sciences 2018; 207: 234-245 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Bisti S
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Wang M
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Funke S
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


78276 Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival
Ono A
Journal of the renin-angiotensin-aldosterone system : JRAAS 2018; 19: 1470320318795001 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Chen S
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Fernandes KA
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


78023 Nogo-A inactivation improves visual plasticity and recovery after retinal injury
Bretzner F
Cell Death and Disease 2018; 9: 727 (IGR: 19-4)


77984 Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury
Wong ROL
Brain 2018; 141: 1963-1980 (IGR: 19-4)


78249 Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
Spasov A
Molecular Vision 2018; 24: 495-508 (IGR: 19-4)


77984 Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury
Di Polo A
Brain 2018; 141: 1963-1980 (IGR: 19-4)


78249 Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
Ozerov A
Molecular Vision 2018; 24: 495-508 (IGR: 19-4)


78023 Nogo-A inactivation improves visual plasticity and recovery after retinal injury
Pernet V
Cell Death and Disease 2018; 9: 727 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Thanos S
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Di Marco S
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Freeburg NF
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Pang Y
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Xu P
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


77917 Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
Niu W
Life Sciences 2018; 207: 234-245 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Ravindran N
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Grus F
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Malaguarnera G
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Li N
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Libby RT
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


77917 Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model
Yuan F
Life Sciences 2018; 207: 234-245 (IGR: 19-4)


78249 Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress
Ismail NM
Molecular Vision 2018; 24: 495-508 (IGR: 19-4)


78281 Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report
Buzzi M
Case reports in ophthalmological medicine 2018; 2018: 2381296 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Zhang R
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


77929 Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
John SWM
Cell Death and Disease 2018; 9: 705 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Chen J
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Sisa C
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Pfeiffer N
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Deng C
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Sun X
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


78074 Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages
Prokosch V
Current Eye Research 2018; 43: 1267-1273 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Shamsher E
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78240 Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury
Zhang X
Investigative Ophthalmology and Visual Science 2018; 59: 3879-3888 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Hamze H
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Zhang S
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Noor A
Scientific reports 2018; 8: 11066 (IGR: 19-4)


78244 Asiatic Acid Prevents Retinal Ganglion Cell Apoptosis in a Rat Model of Glaucoma
Wu J
Frontiers in neuroscience 2018; 12: 489 (IGR: 19-4)


78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Sornsute A; Somavarapu S; Cordeiro MF
Scientific reports 2018; 8: 11066 (IGR: 19-4)


76640 Structural endpoints for glaucoma studies
Popa-Cherechenau A
Ophthalmologe 2018; 0: (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Wang JJ
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Sun W
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Zhang QL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Wang JJ
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76456 MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma
Li R
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 100: 1-7 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Wu HJ
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76557 Neuroprotective agents in the management of glaucoma
Nucci C
Eye 2018; 32: 938-945 (IGR: 19-3)


77256 Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP
Cheng HH
Neural Regeneration Research 2018; 13: 923-929 (IGR: 19-3)


76913 A Proteomics Approach to Identify Candidate Proteins Secreted by Müller Glia that Protect Ganglion Cells in the Retina
Ruzafa N
Proteomics 2018; 18: e1700321 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
de Hoz R
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Nakashima KI
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


76596 Time- and dose-related effects of amyloid beta1-40 on retina and optic nerve morphology in rats
Mohd Lazaldin MA
The International Journal of Neuroscience 2018; 0: 1-14 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Navneet S
Experimental Eye Research 2018; 0: (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Inagaki S
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76544 Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma
Risner ML
Proceedings of the National Academy of Sciences of the United States of America 2018; 115: E2393-E2402 (IGR: 19-3)


76574 Neuroprotective strategies for retinal disease
Pardue MT
Progress in Retinal and Eye Research 2018; 65: 50-76 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Harun-Or-Rashid M
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


76960 Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects
Chitranshi N
Current Neuropharmacology 2018; 0: (IGR: 19-3)


76454 Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse
Struebing FL
Experimental Eye Research 2018; 169: 61-67 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Akaiwa K
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
Fu L
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Dibas A
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


77067 Astrocyte remodeling without gliosis precedes optic nerve Axonopathy
Cooper ML
Acta neuropathologica communications 2018; 6: 38 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Nor Arfuzir NN
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Gu L
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Huang W
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Fernandes KA
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Shan K
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76557 Neuroprotective agents in the management of glaucoma
Martucci A
Eye 2018; 32: 938-945 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Millar C
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Li XY
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76574 Neuroprotective strategies for retinal disease
Allen RS
Progress in Retinal and Eye Research 2018; 65: 50-76 (IGR: 19-3)


76960 Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects
Dheer Y
Current Neuropharmacology 2018; 0: (IGR: 19-3)


77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Li YN
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
Fung FK
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Pappenhagen N
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


77067 Astrocyte remodeling without gliosis precedes optic nerve Axonopathy
Collyer JW
Acta neuropathologica communications 2018; 6: 38 (IGR: 19-3)


77256 Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP
Ye H
Neural Regeneration Research 2018; 13: 923-929 (IGR: 19-3)


76913 A Proteomics Approach to Identify Candidate Proteins Secreted by Müller Glia that Protect Ganglion Cells in the Retina
Pereiro X
Proteomics 2018; 18: e1700321 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Ramírez AI
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76640 Structural endpoints for glaucoma studies
Schmidl D
Ophthalmologe 2018; 0: (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Mitchell KL
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Iwao K
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Agarwal R
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Namekata K
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


76454 Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse
King R
Experimental Eye Research 2018; 169: 61-67 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Wang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Cui X
Experimental Eye Research 2018; 0: (IGR: 19-3)


76544 Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma
Pasini S
Proceedings of the National Academy of Sciences of the United States of America 2018; 115: E2393-E2402 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Shan K
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Liu C
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76596 Time- and dose-related effects of amyloid beta1-40 on retina and optic nerve morphology in rats
Iezhitsa I
The International Journal of Neuroscience 2018; 0: 1-14 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Kwong JMK
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Hu F
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Kawase K
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76456 MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma
Jin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 100: 1-7 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
González-Martín R
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
Lo AC
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Shan K
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Liu BH
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76640 Structural endpoints for glaucoma studies
Garhöfer G
Ophthalmologe 2018; 0: (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Inoue T
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Al-Farra A
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


76456 MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma
Li Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 100: 1-7 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Yadegari D
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Qian WJ
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Patel A
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Shan K
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Liu BH
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


77256 Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP
Peng RP
Neural Regeneration Research 2018; 13: 923-929 (IGR: 19-3)


76913 A Proteomics Approach to Identify Candidate Proteins Secreted by Müller Glia that Protect Ganglion Cells in the Retina
Lepper MF
Proteomics 2018; 18: e1700321 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Palmer PG
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


76596 Time- and dose-related effects of amyloid beta1-40 on retina and optic nerve morphology in rats
Agarwal R
The International Journal of Neuroscience 2018; 0: 1-14 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Funato M
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76557 Neuroprotective agents in the management of glaucoma
Giannini C
Eye 2018; 32: 938-945 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Iezhitsa I
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Azuchi Y
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


76960 Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects
Abbasi M
Current Neuropharmacology 2018; 0: (IGR: 19-3)


76454 Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse
Li Y
Experimental Eye Research 2018; 169: 61-67 (IGR: 19-3)


77067 Astrocyte remodeling without gliosis precedes optic nerve Axonopathy
Calkins DJ
Acta neuropathologica communications 2018; 6: 38 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Wang M
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Ye JF
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Jiang Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Zhao J
Experimental Eye Research 2018; 0: (IGR: 19-3)


76544 Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma
Cooper ML
Proceedings of the National Academy of Sciences of the United States of America 2018; 115: E2393-E2402 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Smith MA
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Liu BH
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76596 Time- and dose-related effects of amyloid beta1-40 on retina and optic nerve morphology in rats
Bakar NS
The International Journal of Neuroscience 2018; 0: 1-14 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Gao F
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
A-Tuya
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Sano H
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Seki J
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Wang J
Experimental Eye Research 2018; 0: (IGR: 19-3)


76544 Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma
Lambert WS
Proceedings of the National Academy of Sciences of the United States of America 2018; 115: E2393-E2402 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Agarwal P
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
Chan YK
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Haga A
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Yu F
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Li Q
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76456 MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma
Sun X
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 100: 1-7 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Ajoy D
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76960 Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects
You Y
Current Neuropharmacology 2018; 0: (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Marola OJ
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Liu BH
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Guan YQ
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)


76454 Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse
Cooke Bailey JN
Experimental Eye Research 2018; 169: 61-67 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Liu C
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76640 Structural endpoints for glaucoma studies
Schmetterer L
Ophthalmologe 2018; 0: (IGR: 19-3)


76557 Neuroprotective agents in the management of glaucoma
Morrone LA
Eye 2018; 32: 938-945 (IGR: 19-3)


77256 Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP
Deng J
Neural Regeneration Research 2018; 13: 923-929 (IGR: 19-3)


76913 A Proteomics Approach to Identify Candidate Proteins Secreted by Müller Glia that Protect Ganglion Cells in the Retina
Hauck SM
Proteomics 2018; 18: e1700321 (IGR: 19-3)


76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Yorio T
Current Eye Research 2018; 43: 921-933 (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Shrager P
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Tsutsumi T
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Sidek S
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


76454 Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse

Experimental Eye Research 2018; 169: 61-67 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Guo X
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


76456 MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma
Zhu H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 100: 1-7 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Caprioli J
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


76960 Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects
Graham SL
Current Neuropharmacology 2018; 0: (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Li XM
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76596 Time- and dose-related effects of amyloid beta1-40 on retina and optic nerve morphology in rats
Agarwal P
The International Journal of Neuroscience 2018; 0: 1-14 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Rojas B
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Li SJ
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Wang SY
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76544 Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma
Calkins DJ
Proceedings of the National Academy of Sciences of the United States of America 2018; 115: E2393-E2402 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Kaidery NA
Experimental Eye Research 2018; 0: (IGR: 19-3)


76557 Neuroprotective agents in the management of glaucoma
Bagetta G
Eye 2018; 32: 938-945 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Zhou RM
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Li XM
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Kawase C
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Xu P
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
So KF
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


77256 Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP
Ding Y
Neural Regeneration Research 2018; 13: 923-929 (IGR: 19-3)


76913 A Proteomics Approach to Identify Candidate Proteins Secreted by Müller Glia that Protect Ganglion Cells in the Retina
Vecino E
Proteomics 2018; 18: e1700321 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Zhou RM
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Gevorgyan V
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Dongmei
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76960 Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects
Gupta V
Current Neuropharmacology 2018; 0: (IGR: 19-3)


76454 Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse
Wiggs JL
Experimental Eye Research 2018; 169: 61-67 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Li XM
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Zack DJ
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Wilson GN
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Spasov A
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Ji M
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76557 Neuroprotective agents in the management of glaucoma
Mancino R
Eye 2018; 32: 938-945 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Salobrar-Garcia E
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Zhang SJ
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76596 Time- and dose-related effects of amyloid beta1-40 on retina and optic nerve morphology in rats
Mohd Ismail N
The International Journal of Neuroscience 2018; 0: 1-14 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Ohuchi K
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Xing C
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Li LL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76456 MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma
Cui H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 100: 1-7 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
Wong IY
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Li XM
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Thomas B
Experimental Eye Research 2018; 0: (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Mochita MI
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Kimura A
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Piri N
Neuroscience Letters 2018; 670: 89-93 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
Shih KC
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Kameyama T
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Zhou RM
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Bollinger KE
Experimental Eye Research 2018; 0: (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Valiente-Soriano FJ
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Lu ZJ
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76454 Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse
Geisert EE
Experimental Eye Research 2018; 169: 61-67 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Sun X
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Zhou RM
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Harada C
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Dong R
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Ozerov A
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Dong R
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Ma YY
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Libby RT
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Crish SD
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Fujimoto T
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Yoon Y
Experimental Eye Research 2018; 0: (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Dong R
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76673 Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
Welsbie DS
Experimental Eye Research 2018; 171: 54-61 (IGR: 19-3)


77097 Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration
Inman DM
Journal of Neuroscience 2018; 38: 5122-5139 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Mitamura Y
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Gao F
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Chang H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Zhang S
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Avilés-Trigueros M
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76583 Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells
Tanihara H
Experimental Eye Research 2018; 170: 160-168 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Dong R
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Ando S
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76964 Effect of Magnesium Acetyltaurate and Taurine on Endothelin1-Induced Retinal Nitrosative Stress in Rats
Mohd Ismail N
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


77249 Transcorneal Electrical Stimulation Inhibits Retinal Microglial Activation and Enhances Retinal Ganglion Cell Survival After Acute Ocular Hypertensive Injury
Lai JS
Translational vision science & technology 2018; 7: 7 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Zhang SJ
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Villegas-Pérez MP
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76970 Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma
Harada T
Investigative Ophthalmology and Visual Science 2018; 59: 2080-2089 (IGR: 19-3)


76833 Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models
Wu J
Experimental Eye Research 2018; 172: 112-122 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Sun XH
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Sato A
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Zhang SH
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76838 Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Smith SB
Experimental Eye Research 2018; 0: (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Yan B
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Zhang TZ
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500 (IGR: 19-3)


77297 Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
Yan B; Sun XH
Theranostics 2018; 8: 3408-3415 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Wang X
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Wu JH
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Vidal-Sanz M
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Morozumi W
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Yan B
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Nakamura S
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


77068 Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
Yan B
Cell Death and Disease 2018; 9: 540 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Miao Y
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Triviño A
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Shimazawa M
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Ramírez JM
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Yang XL
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Iejima D
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


76675 Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension
Salazar JJ
Experimental Eye Research 2018; 171: 12-29 (IGR: 19-3)


76632 Dopamine D1 receptor-mediated upregulation of BK currents modifies Müller cell gliosis in a rat chronic ocular hypertension model
Wang Z
GLIA 2018; 66: 1507-1519 (IGR: 19-3)


77200 Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma
Iwata T; Yamamoto T; Kaneko H; Hara H
Investigative Ophthalmology and Visual Science 2018; 59: 2293-2304 (IGR: 19-3)


75473 Effects of intravitreous sodium hydrosulfide on intraocular pressure and retinopathy in ocular hypertensive rats
Özer MA
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2018; 93: 8-14 (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Luo H
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Giannaccini M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Livne-Bar I
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Sánchez-López E
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75253 Candidate proteins from predegenerated nerve exert time-specific protection of retinal ganglion cells in glaucoma
Pietrucha-Dutczak M
Scientific reports 2017; 7: 14540 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Zhu K
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75550 Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Kalogerou M
Experimental Eye Research 2018; 167: 128-139 (IGR: 19-2)


75636 PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection
Husain S
Investigative Ophthalmology and Visual Science 2017; 58: 6489-6499 (IGR: 19-2)


75045 Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Williams PA
Journal of Glaucoma 2017; 26: 1161-1168 (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
Yu AK
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Marangoz D
International Ophthalmology 2017; 0: (IGR: 19-2)


75241 Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
Wang S
Neuroscience Letters 2018; 662: 368-373 (IGR: 19-2)


75411 In Vitro and In Vivo Methods for Studying Retinal Ganglion Cell Survival and Optic Nerve Regeneration
Yin Y
Methods in molecular biology (Clifton, N.J.) 2018; 1695: 187-205 (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Anders F
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75454 P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model
Dong L
Molecular medicine reports 2018; 17: 2289-2296 (IGR: 19-2)


75503 Monitoring Neurodegeneration in Glaucoma: Therapeutic Implications
Ban N
Trends in molecular medicine 2018; 24: 7-17 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Egea MA
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75411 In Vitro and In Vivo Methods for Studying Retinal Ganglion Cell Survival and Optic Nerve Regeneration
Benowitz LI
Methods in molecular biology (Clifton, N.J.) 2018; 1695: 187-205 (IGR: 19-2)


75550 Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Kolovos P
Experimental Eye Research 2018; 167: 128-139 (IGR: 19-2)


75503 Monitoring Neurodegeneration in Glaucoma: Therapeutic Implications
Siegfried CJ
Trends in molecular medicine 2018; 24: 7-17 (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Wei J
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Zhou M
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Guzel E
International Ophthalmology 2017; 0: (IGR: 19-2)


75454 P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model
Hu Y
Molecular medicine reports 2018; 17: 2289-2296 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Zhang ML
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Liu A
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75045 Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Harder JM
Journal of Glaucoma 2017; 26: 1161-1168 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Usai A
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75636 PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection
Ahmad A
Investigative Ophthalmology and Visual Science 2017; 58: 6489-6499 (IGR: 19-2)


75241 Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
Gu D
Neuroscience Letters 2018; 662: 368-373 (IGR: 19-2)


75473 Effects of intravitreous sodium hydrosulfide on intraocular pressure and retinopathy in ocular hypertensive rats
Erişgin Z
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2018; 93: 8-14 (IGR: 19-2)


75253 Candidate proteins from predegenerated nerve exert time-specific protection of retinal ganglion cells in glaucoma
Smedowski A
Scientific reports 2017; 7: 14540 (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
Datta S
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75241 Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
Zhang P
Neuroscience Letters 2018; 662: 368-373 (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Liu HH
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Liu ST
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75045 Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
John SWM
Journal of Glaucoma 2017; 26: 1161-1168 (IGR: 19-2)


75253 Candidate proteins from predegenerated nerve exert time-specific protection of retinal ganglion cells in glaucoma
Liu X
Scientific reports 2017; 7: 14540 (IGR: 19-2)


75636 PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection
Singh S
Investigative Ophthalmology and Visual Science 2017; 58: 6489-6499 (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Eyuboglu S
International Ophthalmology 2017; 0: (IGR: 19-2)


75454 P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model
Zhou L
Molecular medicine reports 2018; 17: 2289-2296 (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Ji K
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Davis BM
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
McMackin MZ
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75503 Monitoring Neurodegeneration in Glaucoma: Therapeutic Implications
Apte RS
Trends in molecular medicine 2018; 24: 7-17 (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Mann C
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Chiellini F
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75473 Effects of intravitreous sodium hydrosulfide on intraocular pressure and retinopathy in ocular hypertensive rats
Özen S
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2018; 93: 8-14 (IGR: 19-2)


75550 Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Prokopiou E
Experimental Eye Research 2018; 167: 128-139 (IGR: 19-2)


75253 Candidate proteins from predegenerated nerve exert time-specific protection of retinal ganglion cells in glaucoma
Matuszek I
Scientific reports 2017; 7: 14540 (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Teister J
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75170 Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules
Cortopassi GA
Human Molecular Genetics 2017; 26: 4929-4936 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Guadagni V
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75636 PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection
Peterseim C
Investigative Ophthalmology and Visual Science 2017; 58: 6489-6499 (IGR: 19-2)


75473 Effects of intravitreous sodium hydrosulfide on intraocular pressure and retinopathy in ocular hypertensive rats
Tekelioğlu Y
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2018; 93: 8-14 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Li XY
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75550 Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Papagregoriou G
Experimental Eye Research 2018; 167: 128-139 (IGR: 19-2)


75241 Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
Chen J
Neuroscience Letters 2018; 662: 368-373 (IGR: 19-2)


75454 P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model
Cheng X
Molecular medicine reports 2018; 17: 2289-2296 (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Alqawlaq S
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Zhuang J
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Gumusel A
International Ophthalmology 2017; 0: (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Guo L
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Dang W
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Andreazzoli M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Espina M
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Lauzi J
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75550 Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Deltas C
Experimental Eye Research 2018; 167: 128-139 (IGR: 19-2)


75241 Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
Li Y
Neuroscience Letters 2018; 662: 368-373 (IGR: 19-2)


75473 Effects of intravitreous sodium hydrosulfide on intraocular pressure and retinopathy in ocular hypertensive rats
Takır S
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2018; 93: 8-14 (IGR: 19-2)


75636 PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection
Abdul Y
Investigative Ophthalmology and Visual Science 2017; 58: 6489-6499 (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Seckin I
International Ophthalmology 2017; 0: (IGR: 19-2)


75253 Candidate proteins from predegenerated nerve exert time-specific protection of retinal ganglion cells in glaucoma
Varjosalo M
Scientific reports 2017; 7: 14540 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Zhong SM
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Won GJ
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75550 Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Malas S
Experimental Eye Research 2018; 167: 128-139 (IGR: 19-2)


75636 PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection
Nutaitis MJ
Investigative Ophthalmology and Visual Science 2017; 58: 6489-6499 (IGR: 19-2)


75241 Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
Xiao H
Neuroscience Letters 2018; 662: 368-373 (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Ciftci F
International Ophthalmology 2017; 0: (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Fu S
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75253 Candidate proteins from predegenerated nerve exert time-specific protection of retinal ganglion cells in glaucoma
Lewin-Kowalik J
Scientific reports 2017; 7: 14540 (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Tuccitto A
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Silva AM
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Ori M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Li F
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Thanos S
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Yilmaz B
International Ophthalmology 2017; 0: (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Xu GZ
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Gronert K
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Calpena AC
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Pasqualetti M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75241 Melanopsin-expressing retinal ganglion cells are relatively resistant to excitotoxicity induced by N-methyl-d-aspartate
Zhou G
Neuroscience Letters 2018; 662: 368-373 (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Grus FH
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Sun T
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75550 Omega-3 fatty acids protect retinal neurons in the DBA/2J hereditary glaucoma mouse model
Georgiou T
Experimental Eye Research 2018; 167: 128-139 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Wang Z
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Dente L
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Souto EMB
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Pfeiffer N
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75338 Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells
Yalvac I
International Ophthalmology 2017; 0: (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Flanagan JG
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75539 Expression of Sirtuins in the Retinal Neurons of Mice, Rats, and Humans
Zhang X
Frontiers in aging neuroscience 2017; 9: 366 (IGR: 19-2)


75298 The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
Prokosch V
International journal of molecular sciences 2017; 18: (IGR: 19-2)


75251 Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury
Sivak JM
Journal of Clinical Investigation 2017; 127: 4403-4414 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Ravindran N
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Raffa V
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)


75484 Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model
Miao Y
Investigative Ophthalmology and Visual Science 2017; 58: 6113-6122 (IGR: 19-2)


75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Ettcheto M; Camins A; García ML; Cordeiro MF
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)


74122 Modeling Glaucoma: Retinal Ganglion Cells Generated from Induced Pluripotent Stem Cells of Patients with SIX6 Risk Allele Show Developmental Abnormalities
Teotia P
Stem Cells 2017; 35: 2239-2252 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Leopold SA
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Van Houcke J
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Blanco R
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Smedowski A
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Liberatore F
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74539 Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection
Lawlor M
Survey of Ophthalmology 2018; 63: 296-306 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Gao FJ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74158 Evaluation of heat shock protein (HSP-72) expression in retinal ganglion cells of rats with glaucoma
Wang GH
Experimental and therapeutic medicine 2017; 14: 1577-1581 (IGR: 19-1)


74452 A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells
Wang J
PLoS ONE 2017; 12: e0185390 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Wan P
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74499 Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
Syc-Mazurek SB
Molecular Neurodegeneration 2017; 12: 71 (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Mysona BA
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Renner M
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Do YJ
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
He S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74526 Intraocular Injection of ES Cell-Derived Neural Progenitors Improve Visual Function in Retinal Ganglion Cell-Depleted Mouse Models
Divya MS
Frontiers in cellular neuroscience 2017; 11: 295 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Yang TC
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Zhang L
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Yan F
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74614 Neuroprotective Effects of Human Mesenchymal Stem Cells and Platelet-Derived Growth Factor on Human Retinal Ganglion Cells
Osborne A
Stem Cells 2018; 36: 65-78 (IGR: 19-1)


74752 Perspectives of Stem Cell-Based Therapy for Age-Related Retinal Degenerative Diseases
Holan V
Cell transplantation 2017; 26: 1538-1541 (IGR: 19-1)


74750 Tenascins in Retinal and Optic Nerve Neurodegeneration
Reinhard J
Frontiers in integrative neuroscience 2017; 11: 30 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Liu H
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Nakamura O
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74375 Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA
Takahama S
Investigative Ophthalmology and Visual Science 2017; 58: 4703-4711 (IGR: 19-1)


74499 Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
Fernandes KA
Molecular Neurodegeneration 2017; 12: 71 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Stankowska DL
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74158 Evaluation of heat shock protein (HSP-72) expression in retinal ganglion cells of rats with glaucoma
Xing YQ
Experimental and therapeutic medicine 2017; 14: 1577-1581 (IGR: 19-1)


74752 Perspectives of Stem Cell-Based Therapy for Age-Related Retinal Degenerative Diseases
Hermankova B
Cell transplantation 2017; 26: 1538-1541 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Martínez-Navarrete G
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Stute G
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74375 Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA
Adetunji MO
Investigative Ophthalmology and Visual Science 2017; 58: 4703-4711 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Liu X
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Zhao J
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74750 Tenascins in Retinal and Optic Nerve Neurodegeneration
Roll L
Frontiers in integrative neuroscience 2017; 11: 30 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Chuang JH
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74526 Intraocular Injection of ES Cell-Derived Neural Progenitors Improve Visual Function in Retinal Ganglion Cell-Depleted Mouse Models
Rasheed VA
Frontiers in cellular neuroscience 2017; 11: 295 (IGR: 19-1)


74452 A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells
Ma HY
PLoS ONE 2017; 12: e0185390 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Zeilbeck LF
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Sul JW
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Moritoh S
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Su W
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Bollaerts I
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Bucci D
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Guo S
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Zhang SH
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74122 Modeling Glaucoma: Retinal Ganglion Cells Generated from Induced Pluripotent Stem Cells of Patients with SIX6 Risk Allele Show Developmental Abnormalities
Van Hook MJ
Stem Cells 2017; 35: 2239-2252 (IGR: 19-1)


74539 Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection
Danesh-Meyer H
Survey of Ophthalmology 2018; 63: 296-306 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Xu J
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Anders F
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74614 Neuroprotective Effects of Human Mesenchymal Stem Cells and Platelet-Derived Growth Factor on Human Retinal Ganglion Cells
Sanderson J
Stem Cells 2018; 36: 65-78 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Podracka L
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74452 A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells
Krishnamoorthy RR
PLoS ONE 2017; 12: e0185390 (IGR: 19-1)


74499 Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
Wilson MP
Molecular Neurodegeneration 2017; 12: 71 (IGR: 19-1)


74539 Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection
Levin LA
Survey of Ophthalmology 2018; 63: 296-306 (IGR: 19-1)


74614 Neuroprotective Effects of Human Mesenchymal Stem Cells and Platelet-Derived Growth Factor on Human Retinal Ganglion Cells
Martin KR
Stem Cells 2018; 36: 65-78 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Jang KH
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Liu R
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Geeraerts E
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Ellis DZ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74526 Intraocular Injection of ES Cell-Derived Neural Progenitors Improve Visual Function in Retinal Ganglion Cell-Depleted Mouse Models
Schmidt T
Frontiers in cellular neuroscience 2017; 11: 295 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Chai Y
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Alzureiqi M
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Xu P
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Zhang Y
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74122 Modeling Glaucoma: Retinal Ganglion Cells Generated from Induced Pluripotent Stem Cells of Patients with SIX6 Risk Allele Show Developmental Abnormalities
Wichman CS
Stem Cells 2017; 35: 2239-2252 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Mascio G
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74752 Perspectives of Stem Cell-Based Therapy for Age-Related Retinal Degenerative Diseases
Kossl J
Cell transplantation 2017; 26: 1538-1541 (IGR: 19-1)


74750 Tenascins in Retinal and Optic Nerve Neurodegeneration
Faissner A
Frontiers in integrative neuroscience 2017; 11: 30 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Thanos S
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74375 Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA
Zhao T
Investigative Ophthalmology and Visual Science 2017; 58: 4703-4711 (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Smith S
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Sato K
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Weber G
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Valiente-Soriano FJ
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Buddhakosai W
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Seitz R
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Akhtar S
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Avilés-Trigueros M
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Zhang L
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74591 Relationship between Sigma-1 receptor and BDNF in the visual system
Bollinger KE
Experimental Eye Research 2017; 167: 25-30 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Reinhard J
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74539 Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection
Davagnanam I
Survey of Ophthalmology 2018; 63: 296-306 (IGR: 19-1)


74375 Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA
Chen S
Investigative Ophthalmology and Visual Science 2017; 58: 4703-4711 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Maekawa S
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Chen W
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Davis B
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Mann C
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74452 A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells
Yorio T
PLoS ONE 2017; 12: e0185390 (IGR: 19-1)


74499 Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
Shrager P
Molecular Neurodegeneration 2017; 12: 71 (IGR: 19-1)


74526 Intraocular Injection of ES Cell-Derived Neural Progenitors Improve Visual Function in Retinal Ganglion Cell-Depleted Mouse Models
Lalitha S
Frontiers in cellular neuroscience 2017; 11: 295 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Li Z
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Krishnamoorthy RR
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Madonna M
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Wu WJ
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kang NS
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74122 Modeling Glaucoma: Retinal Ganglion Cells Generated from Induced Pluripotent Stem Cells of Patients with SIX6 Risk Allele Show Developmental Abnormalities
Allingham RR
Stem Cells 2017; 35: 2239-2252 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Yang BQ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Beckers A
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74526 Intraocular Injection of ES Cell-Derived Neural Progenitors Improve Visual Function in Retinal Ganglion Cell-Depleted Mouse Models
Hattar S
Frontiers in cellular neuroscience 2017; 11: 295 (IGR: 19-1)


74182 Targets of Neuroprotection in Glaucoma
Yorio T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Lee CJ
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74499 Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
Libby RT
Molecular Neurodegeneration 2017; 12: 71 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Pérez-Rico C
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kim YH
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Liu K
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Liu A
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Murayama N
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Bösl MR
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Di Pietro P
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Chen Q
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Zhang R
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Wiemann S
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74122 Modeling Glaucoma: Retinal Ganglion Cells Generated from Induced Pluripotent Stem Cells of Patients with SIX6 Risk Allele Show Developmental Abnormalities
Hauser MA
Stem Cells 2017; 35: 2239-2252 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Trzeciecka A
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74539 Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection
De Vita E
Survey of Ophthalmology 2018; 63: 296-306 (IGR: 19-1)


74375 Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA
Li W
Investigative Ophthalmology and Visual Science 2017; 58: 4703-4711 (IGR: 19-1)


74452 A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells
He S
PLoS ONE 2017; 12: e0185390 (IGR: 19-1)


74159 Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/Ho-1 pathway
Deng C; Zhuo Y
Clinical Science 2017; 131: 2363-2375 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Beneventano M
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74122 Modeling Glaucoma: Retinal Ganglion Cells Generated from Induced Pluripotent Stem Cells of Patients with SIX6 Risk Allele Show Developmental Abnormalities
Ahmad I
Stem Cells 2017; 35: 2239-2252 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Grus FH
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Himori N
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74375 Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA
Tomarev SI
Investigative Ophthalmology and Visual Science 2017; 58: 4703-4711 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Van Hove I
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Pietrucha-Dutczak M
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74539 Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection
Plant GT
Survey of Ophthalmology 2018; 63: 296-306 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Chen WS
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Jägle H
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Serrano-Puebla A
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Schmid H
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kim YG
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74526 Intraocular Injection of ES Cell-Derived Neural Progenitors Improve Visual Function in Retinal Ganglion Cell-Depleted Mouse Models
James J
Frontiers in cellular neuroscience 2017; 11: 295 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Hu W
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Lu Q
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Cheng Y
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74145 A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model
Kim E
Experimental Cell Research 2017; 359: 30-38 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Puliti AM
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Omodaka K
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Wang N
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Pfeiffer N
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Yang YP
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Lemmens K
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Zhou XJ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Boya P
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Zhou L
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Fuchshofer R
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Lewin-Kowalik J
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Faissner A
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74543 Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo
Prokosch-Willing V
Investigative Ophthalmology and Visual Science 2017; 58: 5129-5141 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Li MC
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Sogon T
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Huang WJ
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Tamm ER
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Dick HB
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Zhang R
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Fernández E
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74790 Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Li S
Journal of Vision Exp 2017; 0: (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Battaglia G
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Urtti A
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
De Groef L
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Bruno V
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Wang M
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74393 Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes
Moons L
Neurobiology of Aging 2017; 60: 1-10 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Ruponen M
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74672 Bilberry extract administration prevents retinal ganglion cell death in mice via the regulation of chaperone molecules under conditions of endoplasmic reticulum stress
Nakazawa T
Clinical Ophthalmology 2017; 11: 1825-1834 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
Vidal-Sanz M
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Peng CH
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74703 Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Ohlmann A
Scientific reports 2017; 7: 14274 (IGR: 19-1)


74318 Optic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Joachim SC
Frontiers in cellular neuroscience 2017; 11: 254 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Xu H
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Chen JY
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Nicoletti F
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Kaarniranta K
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74194 The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss
de la Villa P
Experimental Eye Research 2017; 164: 37-45 (IGR: 19-1)


74432 Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold
Chen SJ
International journal of molecular sciences 2017; 18: (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Lin D; Li X
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Varjosalo M
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Sun XH
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74396 Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Romano MR
Neuroscience 2017; 363: 142-149 (IGR: 19-1)


74447 Quercetin Declines Apoptosis, Ameliorates Mitochondrial Function and Improves Retinal Ganglion Cell Survival and Function in In Vivo Model of Glaucoma in Rat and Retinal Ganglion Cell Culture In Vitro
Wu JH
Frontiers in molecular neuroscience 2017; 10: 285 (IGR: 19-1)


74316 Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway
Tang Z
Scientific reports 2017; 7: 10716 (IGR: 19-1)


74749 Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure
Amadio M
Biochimica et Biophysica Acta 2018; 1864: 296-306 (IGR: 19-1)


72631 Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection
Criscuolo C
Frontiers in cellular neuroscience 2017; 11: 53 (IGR: 18-4)


72887 P16INK4a upregulation mediated by TBK1 induces retinal ganglion cell senescence in ischemic injury
Li LU
Cell Death and Disease 2017; 8: e2752 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Davis BM
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


72868 Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries
Sun D
Journal of Experimental Medicine 2017; 214: 1411-1430 (IGR: 18-4)


72944 GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma
Williams PA
Journal of Neuroinflammation 2017; 14: 93 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Anders F
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Vidal-Sanz M
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72602 Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis
Kimura A
Oxidative medicine and cellular longevity 2017; 2017: 2817252 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Mysona B
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


73035 Nicotinamide and WLD(S) Act Together to Prevent Neurodegeneration in Glaucoma
Williams PA
Frontiers in neuroscience 2017; 11: 232 (IGR: 18-4)


73051 The advances in research on precisely inducing retinal ganglion cells from stem cells
Li KJ
Chinese Journal of Ophthalmology 2017; 53: 381-385 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Zhao Y
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Ban N
JCI insight 2017; 2: (IGR: 18-4)


72863 A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria
Kimball EC
Experimental Eye Research 2017; 160: 106-115 (IGR: 18-4)


72593 Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush Model
Maciulaitiene R
Medical Science Monitor 2017; 23: 1173-1179 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Harder JM
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72668 Peeking into Sigma-1 Receptor Functions Through the Retina
Mavlyutov TA
Adv Exp Med Biol 2017; 964: 285-297 (IGR: 18-4)


73574 A short term high-fat high-sucrose diet in mice impairs optic nerve recovery after injury and this is not reversed by exercise
Chrysostomou V
Experimental Eye Research 2017; 162: 104-109 (IGR: 18-4)


73057 Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma
Bordone MP
Journal of Neurochemistry 2017; 142: 323-337 (IGR: 18-4)


72713 An introduction to DARC technology
Ahmad SS
Saudi Journal of Ophthalmology 2017; 31: 38-41 (IGR: 18-4)


73013 Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury
Fujita K
Molecular therapy. Methods & clinical development 2017; 5: 130-141 (IGR: 18-4)


73522 Modulation of the immune system for the treatment of glaucoma
Bell K
Current Neuropharmacology 2017; 0: (IGR: 18-4)


72886 Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration
Ryul Ahn H
Scientific reports 2017; 7: 46449 (IGR: 18-4)


73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Zhou X
Scientific reports 2017; 7: 1734 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Chang KC
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72630 Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection
Cheng L
Frontiers in cellular neuroscience 2017; 11: 20 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Nakano Y
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72602 Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis
Namekata K
Oxidative medicine and cellular longevity 2017; 2017: 2817252 (IGR: 18-4)


72886 Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration
Kim KA
Scientific reports 2017; 7: 46449 (IGR: 18-4)


73051 The advances in research on precisely inducing retinal ganglion cells from stem cells
Zhu MY
Chinese Journal of Ophthalmology 2017; 53: 381-385 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Braine CE
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72631 Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection
Fabiani C
Frontiers in cellular neuroscience 2017; 11: 53 (IGR: 18-4)


73522 Modulation of the immune system for the treatment of glaucoma
Und Hohenstein-Blaul NVT
Current Neuropharmacology 2017; 0: (IGR: 18-4)


72887 P16INK4a upregulation mediated by TBK1 induces retinal ganglion cell senescence in ischemic injury
Zhao Y
Cell Death and Disease 2017; 8: e2752 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Galindo-Romero C
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72593 Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush Model
Pakuliene G
Medical Science Monitor 2017; 23: 1173-1179 (IGR: 18-4)


72668 Peeking into Sigma-1 Receptor Functions Through the Retina
Guo LW
Adv Exp Med Biol 2017; 964: 285-297 (IGR: 18-4)


73574 A short term high-fat high-sucrose diet in mice impairs optic nerve recovery after injury and this is not reversed by exercise
Van Wijngaarden P
Experimental Eye Research 2017; 162: 104-109 (IGR: 18-4)


72944 GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma
Braine CE
Journal of Neuroinflammation 2017; 14: 93 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Siegfried CJ
JCI insight 2017; 2: (IGR: 18-4)


73057 Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma
González Fleitas MF
Journal of Neurochemistry 2017; 142: 323-337 (IGR: 18-4)


72863 A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria
Pease ME
Experimental Eye Research 2017; 160: 106-115 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Tian K
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


73013 Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury
Nishiguchi KM
Molecular therapy. Methods & clinical development 2017; 5: 130-141 (IGR: 18-4)


72868 Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries
Moore S
Journal of Experimental Medicine 2017; 214: 1411-1430 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Teister J
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Hertz J
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72630 Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection
Yu H
Frontiers in cellular neuroscience 2017; 11: 20 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Kansara N
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


73035 Nicotinamide and WLD(S) Act Together to Prevent Neurodegeneration in Glaucoma
Harder JM
Frontiers in neuroscience 2017; 11: 232 (IGR: 18-4)


73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Cheng Y
Scientific reports 2017; 7: 1734 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Shimazawa M
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Li X
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


72863 A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria
Steinhart MR
Experimental Eye Research 2017; 160: 106-115 (IGR: 18-4)


72593 Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush Model
Kaja S
Medical Science Monitor 2017; 23: 1173-1179 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Ojino K
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


73035 Nicotinamide and WLD(S) Act Together to Prevent Neurodegeneration in Glaucoma
Foxworth NE
Frontiers in neuroscience 2017; 11: 232 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Zhao J
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


73574 A short term high-fat high-sucrose diet in mice impairs optic nerve recovery after injury and this is not reversed by exercise
Steinberg GR
Experimental Eye Research 2017; 162: 104-109 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Valiente-Soriano FJ
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


73057 Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma
Pasquini LA
Journal of Neurochemistry 2017; 142: 323-337 (IGR: 18-4)


73013 Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury
Shiga Y
Molecular therapy. Methods & clinical development 2017; 5: 130-141 (IGR: 18-4)


72630 Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection
Yan N
Frontiers in cellular neuroscience 2017; 11: 20 (IGR: 18-4)


72886 Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration
Kang SW
Scientific reports 2017; 7: 46449 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Zhang X
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Zhang R
Scientific reports 2017; 7: 1734 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Lin JB
JCI insight 2017; 2: (IGR: 18-4)


73522 Modulation of the immune system for the treatment of glaucoma
Teister J
Current Neuropharmacology 2017; 0: (IGR: 18-4)


72887 P16INK4a upregulation mediated by TBK1 induces retinal ganglion cell senescence in ischemic injury
Zhang H
Cell Death and Disease 2017; 8: e2752 (IGR: 18-4)


72602 Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis
Guo X
Oxidative medicine and cellular longevity 2017; 2017: 2817252 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Liu A
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


73051 The advances in research on precisely inducing retinal ganglion cells from stem cells
Ge J
Chinese Journal of Ophthalmology 2017; 53: 381-385 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Gong J
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Pahlitzsch M
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


72868 Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries
Jakobs TC
Journal of Experimental Medicine 2017; 214: 1411-1430 (IGR: 18-4)


72631 Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection
Cerri E
Frontiers in cellular neuroscience 2017; 11: 53 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Williams PA
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72944 GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma
Foxworth NE
Journal of Neuroinflammation 2017; 14: 93 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Li L
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


73574 A short term high-fat high-sucrose diet in mice impairs optic nerve recovery after injury and this is not reversed by exercise
Crowston JG
Experimental Eye Research 2017; 162: 104-109 (IGR: 18-4)


72630 Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection
Lai K
Frontiers in cellular neuroscience 2017; 11: 20 (IGR: 18-4)


73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Li G
Scientific reports 2017; 7: 1734 (IGR: 18-4)


73013 Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury
Nakazawa T
Molecular therapy. Methods & clinical development 2017; 5: 130-141 (IGR: 18-4)


73522 Modulation of the immune system for the treatment of glaucoma
Grus FH
Current Neuropharmacology 2017; 0: (IGR: 18-4)


72593 Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush Model
Pauza DH
Medical Science Monitor 2017; 23: 1173-1179 (IGR: 18-4)


72863 A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria
Oglesby EN
Experimental Eye Research 2017; 160: 106-115 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Brenton J
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


72886 Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration
Lee JY
Scientific reports 2017; 7: 46449 (IGR: 18-4)


73057 Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma
Bosco A
Journal of Neurochemistry 2017; 142: 323-337 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Izawa H
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72602 Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis
Noro T
Oxidative medicine and cellular longevity 2017; 2017: 2817252 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Zhu X
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72631 Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection
Domenici L
Frontiers in cellular neuroscience 2017; 11: 53 (IGR: 18-4)


73035 Nicotinamide and WLD(S) Act Together to Prevent Neurodegeneration in Glaucoma
Cardozo BH
Frontiers in neuroscience 2017; 11: 232 (IGR: 18-4)


72944 GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma
Cochran KE
Journal of Neuroinflammation 2017; 14: 93 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Shui YB
JCI insight 2017; 2: (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Jin XL
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Funke S
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Nadal-Nicolás FM
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72669 The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma
Bollinger K
Adv Exp Med Biol 2017; 964: 299-307 (IGR: 18-4)


72886 Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration
Kim TJ
Scientific reports 2017; 7: 46449 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Chen L
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


72630 Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection
Xiang M
Frontiers in cellular neuroscience 2017; 11: 20 (IGR: 18-4)


73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Yang B
Scientific reports 2017; 7: 1734 (IGR: 18-4)


72593 Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush Model
Kalesnykas G
Medical Science Monitor 2017; 23: 1173-1179 (IGR: 18-4)


72863 A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria
Pitha I
Experimental Eye Research 2017; 160: 106-115 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Ravindran N
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Macnicoll KH
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Grus FH
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Takeuchi H
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72944 GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma
John SWM
Journal of Neuroinflammation 2017; 14: 93 (IGR: 18-4)


73035 Nicotinamide and WLD(S) Act Together to Prevent Neurodegeneration in Glaucoma
Cochran KE
Frontiers in neuroscience 2017; 11: 232 (IGR: 18-4)


72602 Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis
Harada C
Oxidative medicine and cellular longevity 2017; 2017: 2817252 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Ortin-Martinez A
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


73057 Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma
Sande PH
Journal of Neurochemistry 2017; 142: 323-337 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Sein J
JCI insight 2017; 2: (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Shaw P
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Thanos S
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Butt G
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


73035 Nicotinamide and WLD(S) Act Together to Prevent Neurodegeneration in Glaucoma
John SWM
Frontiers in neuroscience 2017; 11: 232 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Sousa GL
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Zheng L
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Pita-Thomas W
JCI insight 2017; 2: (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Inoue Y
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72593 Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush Model
Januleviciene I
Medical Science Monitor 2017; 23: 1173-1179 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Rovere G
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Zhang S
Scientific reports 2017; 7: 1734 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Derosa BA
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


73057 Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma
Rosenstein RE
Journal of Neurochemistry 2017; 142: 323-337 (IGR: 18-4)


72886 Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration
Jung SH
Scientific reports 2017; 7: 46449 (IGR: 18-4)


72602 Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis
Harada T
Oxidative medicine and cellular longevity 2017; 2017: 2817252 (IGR: 18-4)


72863 A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria
Nguyen C
Experimental Eye Research 2017; 160: 106-115 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Li JY
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


73057 Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma
Dorfman D
Journal of Neurochemistry 2017; 142: 323-337 (IGR: 18-4)


72863 A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria
Quigley HA
Experimental Eye Research 2017; 160: 106-115 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
von Pein HD
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Tsuruma K
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Wu J
Scientific reports 2017; 7: 1734 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Chen Z
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Buchanan RA
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Sene A
JCI insight 2017; 2: (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Malaguarnera G
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Salinas-Navarro M
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Santeford A
JCI insight 2017; 2: (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Smith RS
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72679 Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice
Hara H
Journal of Pharmacological Sciences 2017; 133: 176-183 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Pfeiffer N
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Lucas-Ruiz F
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Shi J
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Normando EM
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Venugopalan P
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Guo L
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Sanchez-Migallon MC
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Valenzuela DA
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Gordon M
JCI insight 2017; 2: (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Libby RT
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Prokosch V
PLoS ONE 2017; 12: e0175451 (IGR: 18-4)


72807 Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
Zhang H
Biochimica et Biophysica Acta 2017; 1863: 1350-1358 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
Howell GR
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Sobrado-Calvo P
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Patel RD
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


73163 Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
Cordeiro MF
Mitochondrion 2017; 36: 114-123 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Lamb R
JCI insight 2017; 2: (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Aviles-Trigueros M
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Dong Z
JCI insight 2017; 2: (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Russano KR
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72945 Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective
John SWM
Proceedings of the National Academy of Sciences of the United States of America 2017; 114: E3839-E3848 (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Villegas-Pérez MP
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Kelly SC
JCI insight 2017; 2: (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Alshamekh SA
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Cavalli V
JCI insight 2017; 2: (IGR: 18-4)


73040 Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension
Agudo-Barriuso M
Frontiers in neuroscience 2017; 11: 235 (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Sun C
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Yoshino J
JCI insight 2017; 2: (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Tenerelli K; Li C
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


72990 GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients
Apte RS
JCI insight 2017; 2: (IGR: 18-4)


72852 Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development
Velmeshev D; Cheng Y; Boyce TM; Dreyfuss A; Uddin MS; Muller KJ; Dykxhoorn DM; Goldberg JL
Journal of Neuroscience 2017; 37: 4967-4981 (IGR: 18-4)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Zhao L
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Mesentier-Louro LA
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71235 Targeting retinal ganglion cell recovery
Crowston JG
Eye 2017; 31: 196-198 (IGR: 18-3)


71241 BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells
Maes ME
Progress in Retinal and Eye Research 2017; 57: 1-25 (IGR: 18-3)


71607 Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma
McGrady NR
BMC Neuroscience 2017; 18: 27 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Liu XF
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71349 Neuroprotection for treatment of glaucoma in adults
Sena DF
Cochrane Database of Systematic Reviews 2017; 1: CD006539 (IGR: 18-3)


71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Chesnokova NB
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)


71634 Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells
Chen M
Molecular medicine reports 2017; 15: 2179-2185 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Lambert WS
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71497 Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms
Mead B
Stem cells translational medicine 2017; 6: 1273-1285 (IGR: 18-3)


71275 Protecting retinal ganglion cells
Khatib TZ
Eye 2017; 31: 218-224 (IGR: 18-3)


71545 Biomechanical aspects of axonal damage in glaucoma: A brief review
Stowell C
Experimental Eye Research 2017; 157: 13-19 (IGR: 18-3)


71512 Transplantation of lineage-negative stem cells in pterygopalatine artery ligation induced retinal ischemia-reperfusion injury in mice
Minhas G
Molecular and Cellular Biochemistry 2017; 429: 123-136 (IGR: 18-3)


71414 The challenge of regenerative therapies for the optic nerve in glaucoma
Calkins DJ
Experimental Eye Research 2017; 157: 28-33 (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
García-Caballero C
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Li S
Oncotarget 2017; 8: 2816-2824 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Luo X
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Hao JL
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71349 Neuroprotection for treatment of glaucoma in adults
Lindsley K
Cochrane Database of Systematic Reviews 2017; 1: CD006539 (IGR: 18-3)


71235 Targeting retinal ganglion cell recovery
Fahy ET
Eye 2017; 31: 196-198 (IGR: 18-3)


71512 Transplantation of lineage-negative stem cells in pterygopalatine artery ligation induced retinal ischemia-reperfusion injury in mice
Prabhakar S
Molecular and Cellular Biochemistry 2017; 429: 123-136 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Carlson BJ
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71545 Biomechanical aspects of axonal damage in glaucoma: A brief review
Burgoyne CF
Experimental Eye Research 2017; 157: 13-19 (IGR: 18-3)


71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Shao M
Oncotarget 2017; 8: 2816-2824 (IGR: 18-3)


71241 BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells
Schlamp CL
Progress in Retinal and Eye Research 2017; 57: 1-25 (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Prieto-Calvo E
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71414 The challenge of regenerative therapies for the optic nerve in glaucoma
Pekny M
Experimental Eye Research 2017; 157: 28-33 (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Ethier CR
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Yu Y
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Beznos OV
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)


71607 Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma
Minton AZ
BMC Neuroscience 2017; 18: 27 (IGR: 18-3)


71497 Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms
Tomarev S
Stem cells translational medicine 2017; 6: 1273-1285 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
De Nicolò S
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71275 Protecting retinal ganglion cells
Martin KR
Eye 2017; 31: 218-224 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Chen G
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71634 Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells
Liu B
Molecular medicine reports 2017; 15: 2179-2185 (IGR: 18-3)


71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Tang B
Oncotarget 2017; 8: 2816-2824 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Xiang Z
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Lozinskaya NA
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Li J
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71512 Transplantation of lineage-negative stem cells in pterygopalatine artery ligation induced retinal ischemia-reperfusion injury in mice
Morishita R
Molecular and Cellular Biochemistry 2017; 429: 123-136 (IGR: 18-3)


71607 Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma
Stankowska DL
BMC Neuroscience 2017; 18: 27 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Rosso P
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Xie T
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71634 Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells
Ma J
Molecular medicine reports 2017; 15: 2179-2185 (IGR: 18-3)


71241 BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells
Nickells RW
Progress in Retinal and Eye Research 2017; 57: 1-25 (IGR: 18-3)


71235 Targeting retinal ganglion cell recovery
Fry L
Eye 2017; 31: 196-198 (IGR: 18-3)


71545 Biomechanical aspects of axonal damage in glaucoma: A brief review
Tamm ER
Experimental Eye Research 2017; 157: 13-19 (IGR: 18-3)


71414 The challenge of regenerative therapies for the optic nerve in glaucoma
Cooper ML
Experimental Eye Research 2017; 157: 28-33 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Formichella CR
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Checa-Casalengua P
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review

Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Sappington RM
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71607 Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma
He S
BMC Neuroscience 2017; 18: 27 (IGR: 18-3)


71545 Biomechanical aspects of axonal damage in glaucoma: A brief review
Ethier CR
Experimental Eye Research 2017; 157: 13-19 (IGR: 18-3)


71414 The challenge of regenerative therapies for the optic nerve in glaucoma
Benowitz L
Experimental Eye Research 2017; 157: 28-33 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Wu H
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71634 Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells
Ge J
Molecular medicine reports 2017; 15: 2179-2185 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
De Vitis LA
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
García-Martín E
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Mukhtar NJ
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Zhang A
Oncotarget 2017; 8: 2816-2824 (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Burgoyne C
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Volkova MS
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)


71512 Transplantation of lineage-negative stem cells in pterygopalatine artery ligation induced retinal ischemia-reperfusion injury in mice
Shimamura M
Molecular and Cellular Biochemistry 2017; 429: 123-136 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Fu Y
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71235 Targeting retinal ganglion cell recovery
Trounce IA
Eye 2017; 31: 196-198 (IGR: 18-3)


71634 Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells
Wang K
Molecular medicine reports 2017; 15: 2179-2185 (IGR: 18-3)


71545 Biomechanical aspects of axonal damage in glaucoma: A brief review

Experimental Eye Research 2017; 157: 13-19 (IGR: 18-3)


71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Cao W
Oncotarget 2017; 8: 2816-2824 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Ramakrishna S
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71235 Targeting retinal ganglion cell recovery
Van Wijngaarden P
Eye 2017; 31: 196-198 (IGR: 18-3)


71414 The challenge of regenerative therapies for the optic nerve in glaucoma

Experimental Eye Research 2017; 157: 28-33 (IGR: 18-3)


71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Zaryanova EV
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Mavlyutov TA
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Ahlem C
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Polo-Llorens V
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Zhang W
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71512 Transplantation of lineage-negative stem cells in pterygopalatine artery ligation induced retinal ischemia-reperfusion injury in mice
Bansal R
Molecular and Cellular Biochemistry 2017; 429: 123-136 (IGR: 18-3)


71607 Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma
Jefferies HB
BMC Neuroscience 2017; 18: 27 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Castoldi V
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71512 Transplantation of lineage-negative stem cells in pterygopalatine artery ligation induced retinal ischemia-reperfusion injury in mice
Anand A
Molecular and Cellular Biochemistry 2017; 429: 123-136 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Wang Y
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Zefirov NA
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Yao A
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71607 Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma
Krishnamoorthy RR
BMC Neuroscience 2017; 18: 27 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Malik TH
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Tamm ER
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71235 Targeting retinal ganglion cell recovery
Petrou S
Eye 2017; 31: 196-198 (IGR: 18-3)


71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Sun X
Oncotarget 2017; 8: 2816-2824 (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
García-Feijoo J
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Leocani L
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71547 Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
Calkins DJ
Frontiers in neuroscience 2017; 11: 45 (IGR: 18-3)


71617 Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma
Grigoryev AV
Biomeditsinskaia khimiia 2017; 63: 75-80 (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Molina-Martínez IT
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Lu CW
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Mendez-Otero R
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
So KF
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Stowell C
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71235 Targeting retinal ganglion cell recovery
Chrysostomou V
Eye 2017; 31: 196-198 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Nickells RW
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Zhang Z
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Santiago MF
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Bravo-Osuna I
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Dowling JE
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Gong S
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71645 Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review
Zhou DD
Frontiers in pharmacology 2017; 8: 66 (IGR: 18-3)


71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Guo LW
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)


71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Herrero-Vanrell R
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Tirassa P
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Downs C
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71425 Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity
Xu Y
Journal of Neurochemistry 2017; 141: 373-386 (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Ellisman MH
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Rama P
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Fisher S
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


71243 Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells
Lambiase A
International journal of molecular sciences 2017; 18: (IGR: 18-3)


71544 Biological aspects of axonal damage in glaucoma: A brief review
Fortune B; Fruttiger M; Jakobs T; Lewis G; Mitchell CH; Morrison J; Sharma SC; Sigal I; Sofroniew M; Wang L; Wiggs J; Wu S; Masland RH
Experimental Eye Research 2017; 157: 5-12 (IGR: 18-3)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Xu Y
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70673 Role of cyclic AMP in the eye of glaucoma
Shim MS
BMB reports 2017; 50: 60-70 (IGR: 18-2)


70047 In vitro bioassay model for screening non-viral neurotrophic factor gene delivery systems for glaucoma treatment
Chen DW
Drug delivery and translational research 2016; 6: 676-685 (IGR: 18-2)


70709 Alteration of Neurotrophic Factors After Transplantation of Bone Marrow Derived Lin-ve Stem Cell in NMDA-Induced Mouse Model of Retinal Degeneration
Jindal N
Journal of Cellular Biochemistry 2017; 118: 1699-1711 (IGR: 18-2)


70733 Neuroprotection for glaucoma: Requirements for clinical translation
Levin LA
Experimental Eye Research 2017; 157: 34-37 (IGR: 18-2)


70574 Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma
Wilson GN
Frontiers in neuroscience 2016; 10: 494 (IGR: 18-2)


70775 Why autophagy is good for retinal ganglion cells?
Boya P
Eye 2017; 31: 185-190 (IGR: 18-2)


70646 Neuro-rejuvenation for neuronal function
Liu Y
Neural Regeneration Research 2016; 11: 1560-1563 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Wang X
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Xue B
Experimental Eye Research 2016; 153: 42-50 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Ishimaru Y
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Tsutsumi T
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Bell K
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70614 Visual light effects on mitochondria: The potential implications in relation to glaucoma
Osborne NN
Mitochondrion 2017; 36: 29-35 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Sakamoto K
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Bagli E
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)


70601 Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
Araújo DS
Experimental Eye Research 2016; 154: 116-125 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Zhou YS
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70748 Expression and signaling of NGF in the healthy and injured retina
Garcia TB
Cytokine & growth factor reviews 2017; 34: 43-57 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Chao HM
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70413 Reversal of functional loss in a rat model of chronic intraocular pressure elevation
Liu HH
Ophthalmic and Physiological Optics 2017; 37: 71-81 (IGR: 18-2)


70136 Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Phatak NR
Molecular Vision 2016; 22: 1048-1061 (IGR: 18-2)


70098 Autophagy in the eye: Development, degeneration, and aging
Boya P
Progress in Retinal and Eye Research 2016; 55: 206-245 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Lambuk L
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70584 cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Olivares-González L
PLoS ONE 2016; 11: e0166717 (IGR: 18-2)


70559 Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
Krishnan A
Journal of immunology 2016; 197: 4626-4638 (IGR: 18-2)


70244 24(S)-Hydroxycholesterol protects the ex vivo rat retina from injury by elevated hydrostatic pressure
Ishikawa M
Scientific reports 2016; 6: 33886 (IGR: 18-2)


70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Lv B
Journal of Glaucoma 2016; 25: e792-e801 (IGR: 18-2)


70714 Lutein Attenuates Both Apoptosis and Autophagy upon Cobalt (II) Chloride-Induced Hypoxia in Rat Műller Cells
Fung FK
PLoS ONE 2016; 11: e0167828 (IGR: 18-2)


70157 TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
Ishikawa M
Neuropharmacology 2016; 111: 142-159 (IGR: 18-2)


70376 Translational Pharmacology in Glaucoma Neuroprotection
Levin LA
Handb Exp Pharmacol 2017; 242: 209-230 (IGR: 18-2)


70234 Is glaucoma a mitochondrial neurodegenerative disease
Zhang Z
Chinese Journal of Ophthalmology 2016; 52: 714-717 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Guo X
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Teotia P
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Dong Z
Heliyon 2016; 2: e00191 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Huang S
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Yamamoto K
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Kimura A
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70125 Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension
Ou Y
Journal of Neuroscience 2016; 36: 9240-9252 (IGR: 18-2)


70706 Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective
Lim JC
Frontiers in cellular neuroscience 2016; 10: 270 (IGR: 18-2)


70695 Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway
Yan P
Metabolic brain disease 2017; 32: 453-460 (IGR: 18-2)


70042 Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma
Wang ZF
Acta physiologica Sinica 2016; 68: 483-491 (IGR: 18-2)


70705 Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Breen KT
Frontiers in neuroscience 2016; 10: 526 (IGR: 18-2)


70158 The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Ozaki T
Biochemical and Biophysical Research Communications 2016; 478: 1700-1705 (IGR: 18-2)


70125 Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension
Jo RE
Journal of Neuroscience 2016; 36: 9240-9252 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Wilding C
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Shinmei Y
Heliyon 2016; 2: e00191 (IGR: 18-2)


70706 Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective
Lu W
Frontiers in cellular neuroscience 2016; 10: 270 (IGR: 18-2)


70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Xie Y
Experimental Eye Research 2016; 153: 42-50 (IGR: 18-2)


70584 cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Martínez-Fernández de la Cáma
PLoS ONE 2016; 11: e0166717 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Yang B
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70695 Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway
Tang S
Metabolic brain disease 2017; 32: 453-460 (IGR: 18-2)


70244 24(S)-Hydroxycholesterol protects the ex vivo rat retina from injury by elevated hydrostatic pressure
Yoshitomi T
Scientific reports 2016; 6: 33886 (IGR: 18-2)


70136 Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Stankowska DL
Molecular Vision 2016; 22: 1048-1061 (IGR: 18-2)


70157 TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
Yoshitomi T
Neuropharmacology 2016; 111: 142-159 (IGR: 18-2)


70098 Autophagy in the eye: Development, degeneration, and aging
Esteban-Martínez L
Progress in Retinal and Eye Research 2016; 55: 206-245 (IGR: 18-2)


70733 Neuroprotection for glaucoma: Requirements for clinical translation
Crowe ME
Experimental Eye Research 2017; 157: 34-37 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Huang P
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70673 Role of cyclic AMP in the eye of glaucoma
Kim KY
BMB reports 2017; 50: 60-70 (IGR: 18-2)


70413 Reversal of functional loss in a rat model of chronic intraocular pressure elevation
He Z
Ophthalmic and Physiological Optics 2017; 37: 71-81 (IGR: 18-2)


70047 In vitro bioassay model for screening non-viral neurotrophic factor gene delivery systems for glaucoma treatment
Foldvari M
Drug delivery and translational research 2016; 6: 676-685 (IGR: 18-2)


70559 Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
Fei F
Journal of immunology 2016; 197: 4626-4638 (IGR: 18-2)


70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Huo F
Journal of Glaucoma 2016; 25: e792-e801 (IGR: 18-2)


70714 Lutein Attenuates Both Apoptosis and Autophagy upon Cobalt (II) Chloride-Induced Hypoxia in Rat Műller Cells
Law BY
PLoS ONE 2016; 11: e0167828 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Jafri AJ
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Sumino A
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70234 Is glaucoma a mitochondrial neurodegenerative disease
Ma JM
Chinese Journal of Ophthalmology 2016; 52: 714-717 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Kimura A
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Chopra DA
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70158 The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Yamashita T
Biochemical and Biophysical Research Communications 2016; 478: 1700-1705 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Sato K
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Namekata K
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70042 Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma
Yang XL
Acta physiologica Sinica 2016; 68: 483-491 (IGR: 18-2)


70705 Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Anderson SR
Frontiers in neuroscience 2016; 10: 526 (IGR: 18-2)


70748 Expression and signaling of NGF in the healthy and injured retina
Hollborn M
Cytokine & growth factor reviews 2017; 34: 43-57 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Hu L
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70709 Alteration of Neurotrophic Factors After Transplantation of Bone Marrow Derived Lin-ve Stem Cell in NMDA-Induced Mouse Model of Retinal Degeneration
Banik A
Journal of Cellular Biochemistry 2017; 118: 1699-1711 (IGR: 18-2)


70614 Visual light effects on mitochondria: The potential implications in relation to glaucoma
Núñez-Álvarez C
Mitochondrion 2017; 36: 29-35 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Murakami Y
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Goussia A
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Iwao K
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


70646 Neuro-rejuvenation for neuronal function
Lee RK
Neural Regeneration Research 2016; 11: 1560-1563 (IGR: 18-2)


70601 Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
Miya-Coreixas VS
Experimental Eye Research 2016; 154: 116-125 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Xu J
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Su J
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70574 Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma
Smith MA
Frontiers in neuroscience 2016; 10: 494 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Kajioka D
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70584 cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Hervás D
PLoS ONE 2016; 11: e0166717 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Dong Y
Heliyon 2016; 2: e00191 (IGR: 18-2)


70234 Is glaucoma a mitochondrial neurodegenerative disease
Wang NL
Chinese Journal of Ophthalmology 2016; 52: 714-717 (IGR: 18-2)


70614 Visual light effects on mitochondria: The potential implications in relation to glaucoma
del Olmo-Aguado S
Mitochondrion 2017; 36: 29-35 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Dravid SM
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70705 Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Steele MR
Frontiers in neuroscience 2016; 10: 526 (IGR: 18-2)


70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Dang X
Journal of Glaucoma 2016; 25: e792-e801 (IGR: 18-2)


70157 TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
Covey DF
Neuropharmacology 2016; 111: 142-159 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Guo X
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70125 Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension
Ullian EM
Journal of Neuroscience 2016; 36: 9240-9252 (IGR: 18-2)


70574 Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma
Inman DM
Frontiers in neuroscience 2016; 10: 494 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Arfuzir NN
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Yukita M
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Cheng JM
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70244 24(S)-Hydroxycholesterol protects the ex vivo rat retina from injury by elevated hydrostatic pressure
Zorumski CF
Scientific reports 2016; 6: 33886 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Azuchi Y
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Hayashi H
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


70695 Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway
Zhang H
Metabolic brain disease 2017; 32: 453-460 (IGR: 18-2)


70709 Alteration of Neurotrophic Factors After Transplantation of Bone Marrow Derived Lin-ve Stem Cell in NMDA-Induced Mouse Model of Retinal Degeneration
Prabhakar S
Journal of Cellular Biochemistry 2017; 118: 1699-1711 (IGR: 18-2)


70673 Role of cyclic AMP in the eye of glaucoma
Ju WK
BMB reports 2017; 50: 60-70 (IGR: 18-2)


70706 Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective
Beckel JM
Frontiers in cellular neuroscience 2016; 10: 270 (IGR: 18-2)


70601 Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
Pandolfo P
Experimental Eye Research 2016; 154: 116-125 (IGR: 18-2)


70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Moschos MM
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Peng J
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Liu X
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70098 Autophagy in the eye: Development, degeneration, and aging
Serrano-Puebla A
Progress in Retinal and Eye Research 2016; 55: 206-245 (IGR: 18-2)


70413 Reversal of functional loss in a rat model of chronic intraocular pressure elevation
Nguyen CT
Ophthalmic and Physiological Optics 2017; 37: 71-81 (IGR: 18-2)


70136 Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Krishnamoorthy RR
Molecular Vision 2016; 22: 1048-1061 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Funke S
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Ding J
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70733 Neuroprotection for glaucoma: Requirements for clinical translation
Quigley HA
Experimental Eye Research 2017; 157: 34-37 (IGR: 18-2)


70158 The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Tomita H
Biochemical and Biophysical Research Communications 2016; 478: 1700-1705 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Hu Y
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70559 Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
Jones A
Journal of immunology 2016; 197: 4626-4638 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Sawada S
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70714 Lutein Attenuates Both Apoptosis and Autophagy upon Cobalt (II) Chloride-Induced Hypoxia in Rat Műller Cells
Lo AC
PLoS ONE 2016; 11: e0167828 (IGR: 18-2)


70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Xue Y
Experimental Eye Research 2016; 153: 42-50 (IGR: 18-2)


70748 Expression and signaling of NGF in the healthy and injured retina
Bringmann A
Cytokine & growth factor reviews 2017; 34: 43-57 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Kirihara T
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


70413 Reversal of functional loss in a rat model of chronic intraocular pressure elevation
Vingrys AJ
Ophthalmic and Physiological Optics 2017; 37: 71-81 (IGR: 18-2)


70559 Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
Busto P
Journal of immunology 2016; 197: 4626-4638 (IGR: 18-2)


70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Agnantis N
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)


70601 Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
Calaza KC
Experimental Eye Research 2016; 154: 116-125 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Akiyama G
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Liu XQ
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Xu Z
Journal of Glaucoma 2016; 25: e792-e801 (IGR: 18-2)


70709 Alteration of Neurotrophic Factors After Transplantation of Bone Marrow Derived Lin-ve Stem Cell in NMDA-Induced Mouse Model of Retinal Degeneration
Vaiphie K
Journal of Cellular Biochemistry 2017; 118: 1699-1711 (IGR: 18-2)


70158 The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Sugano E
Biochemical and Biophysical Research Communications 2016; 478: 1700-1705 (IGR: 18-2)


70125 Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension
Wong RO
Journal of Neuroscience 2016; 36: 9240-9252 (IGR: 18-2)


70706 Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective
Mitchell CH
Frontiers in cellular neuroscience 2016; 10: 270 (IGR: 18-2)


70574 Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma
Dengler-Crish CM
Frontiers in neuroscience 2016; 10: 494 (IGR: 18-2)


70157 TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
Zorumski CF
Neuropharmacology 2016; 111: 142-159 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Harada C
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70584 cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Marín MP
PLoS ONE 2016; 11: e0166717 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Lu L
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Perumal N
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Inafuku S
Heliyon 2016; 2: e00191 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Han S
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70614 Visual light effects on mitochondria: The potential implications in relation to glaucoma
Merrayo-Lloves J
Mitochondrion 2017; 36: 29-35 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Ushikubo H
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70733 Neuroprotection for glaucoma: Requirements for clinical translation

Experimental Eye Research 2017; 157: 34-37 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Lin Z
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Yasuda M
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Iezhitsa I
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Shibagaki F
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70695 Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway
Guo Y
Metabolic brain disease 2017; 32: 453-460 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Li P
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70705 Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Calkins DJ
Frontiers in neuroscience 2016; 10: 526 (IGR: 18-2)


70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Hu N
Experimental Eye Research 2016; 153: 42-50 (IGR: 18-2)


70244 24(S)-Hydroxycholesterol protects the ex vivo rat retina from injury by elevated hydrostatic pressure
Izumi Y
Scientific reports 2016; 6: 33886 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Van Hook MJ
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70098 Autophagy in the eye: Development, degeneration, and aging
Gómez-Sintes R
Progress in Retinal and Eye Research 2016; 55: 206-245 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Liu JH
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Mori A
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Wang J
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Agarwal R
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Yamamuro A
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70705 Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Bosco A
Frontiers in neuroscience 2016; 10: 526 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Ma W
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Harada T
Histology and Histopathology 2017; 32: 215-221 (IGR: 18-2)


70709 Alteration of Neurotrophic Factors After Transplantation of Bone Marrow Derived Lin-ve Stem Cell in NMDA-Induced Mouse Model of Retinal Degeneration
Anand A
Journal of Cellular Biochemistry 2017; 118: 1699-1711 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Qiu F
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70695 Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway
Zeng Z
Metabolic brain disease 2017; 32: 453-460 (IGR: 18-2)


70098 Autophagy in the eye: Development, degeneration, and aging
Villarejo-Zori B
Progress in Retinal and Eye Research 2016; 55: 206-245 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Lu X
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Fukuhara J
Heliyon 2016; 2: e00191 (IGR: 18-2)


70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Chen T
Journal of Glaucoma 2016; 25: e792-e801 (IGR: 18-2)


70559 Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
Marshak-Rothstein A
Journal of immunology 2016; 197: 4626-4638 (IGR: 18-2)


70413 Reversal of functional loss in a rat model of chronic intraocular pressure elevation
Bui BV
Ophthalmic and Physiological Optics 2017; 37: 71-81 (IGR: 18-2)


70125 Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension
Della Santina L
Journal of Neuroscience 2016; 36: 9240-9252 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Noro T
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Wen XJ
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70574 Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma
Crish SD
Frontiers in neuroscience 2016; 10: 494 (IGR: 18-2)


70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Zhang G
Experimental Eye Research 2016; 153: 42-50 (IGR: 18-2)


70158 The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Ishiguro S
Biochemical and Biophysical Research Communications 2016; 478: 1700-1705 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Kawaji T
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


70584 cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Lahoz A
PLoS ONE 2016; 11: e0166717 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Omodaka K
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Beck S
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Kitsos G
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)


70157 TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
Izumi Y
Neuropharmacology 2016; 111: 142-159 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Rozali KN
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Harada C
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Liu Y
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Luo H
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70559 Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
Ksander BR
Journal of immunology 2016; 197: 4626-4638 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Wang J
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Ando R
Heliyon 2016; 2: e00191 (IGR: 18-2)


70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Guan H
Experimental Eye Research 2016; 153: 42-50 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Ryu M
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


70705 Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Vetter ML
Frontiers in neuroscience 2016; 10: 526 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Yoshioka Y
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Inoue T
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Wolters D
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Morrison J
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Nakahara T
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


70695 Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway
Wen Q
Metabolic brain disease 2017; 32: 453-460 (IGR: 18-2)


70584 cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Millán JM
PLoS ONE 2016; 11: e0166717 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Pan WH
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Zhang T
Journal of Glaucoma 2016; 25: e792-e801 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Xu S
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70146 Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice
Ishii K
European Journal of Pharmacology 2016; 791: 213-220 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Holz-Müller J
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Namekata K
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Guo L
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Rizzino A
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70584 cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants
Rodrigo R
PLoS ONE 2016; 11: e0166717 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Chen KZ
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Ji M
Experimental Eye Research 2016; 153: 42-50 (IGR: 18-2)


70195 Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase
Zhang XM
Chinese medicine 2016; 11: 39 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Kitaichi N
Heliyon 2016; 2: e00191 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Hughes G
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Hino S
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Yang X
Journal of Glaucoma 2016; 25: e792-e801 (IGR: 18-2)


70559 Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma
Gregory-Ksander M
Journal of immunology 2016; 197: 4626-4638 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Agarwal P
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70884 Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF-α expression in mice
Maeda S
Journal of Pharmacological Sciences 2017; 133: 34-41 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Xu F
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Fujita K; Nishiguchi KM
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Pfeiffer N
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Liu JQ
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Meng Z
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Nakao M
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Yu S
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Ahmad I
Stem Cells 2017; 35: 572-585 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Kanda A
Heliyon 2016; 2: e00191 (IGR: 18-2)


70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Harada T
Scientific reports 2016; 6: 33950 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Leung CK
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Bakar NS
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Tanihara H
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Tanaka K
Heliyon 2016; 2: e00191 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Machida S
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Huang J
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Yin Y
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Wang Y
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Zhong Y
Neuroscience 2017; 341: 27-41 (IGR: 18-2)


69967 Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture
Grus FH
Journal of Neurochemistry 2016; 139: 256-269 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Kutty MK; Yusof AP
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Nakazawa T
Journal of Neurochemistry 2017; 140: 495-508 (IGR: 18-2)


70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Liang X
Oncotarget 2016; 7: 72503-72517 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Noda K
Heliyon 2016; 2: e00191 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Wang Y
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70140 Research progress of stem cells on glaucomatous optic nerve injury
Peng QH
International Journal of Ophthalmology 2016; 9: 1226-1229 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Krasilnikova A
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Li J
Drug design, development and therapy 2016; 10: 3449-3457 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Harada T; Chin S
Heliyon 2016; 2: e00191 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Spasov A; Ozerov A
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Ishida S
Heliyon 2016; 2: e00191 (IGR: 18-2)


70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Ismail NM
Neurotoxicity research 2017; 31: 31-45 (IGR: 18-2)


68932 The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling
Cueva Vargas JL
Neurobiology of Disease 2016; 93: 156-171 (IGR: 18-1)


69134 Brain-derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells
Binley KE
European Journal of Neuroscience 2016; 44: 2028-2039 (IGR: 18-1)


69167 Down-regulation of semaphorin 3F in rat retinal ganglion cells in response to optic nerve crush
Ko JA
Cell biochemistry and function 2016; 34: 378-384 (IGR: 18-1)


69190 Who's lost first? Susceptibility of retinal ganglion cell types in experimental glaucoma
Della Santina L
Experimental Eye Research 2017; 158: 43-50 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Yang L
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69147 Retinal Macroglial Responses in Health and Disease
de Hoz R
BioMed research international 2016; 2016: 2954721 (IGR: 18-1)


69481 Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies
Davis BM
Cell death discovery 2016; 2: 16031 (IGR: 18-1)


69098 Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Madeira MH
Scientific reports 2016; 6: 27532 (IGR: 18-1)


69338 Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension
Feng L
Investigative Ophthalmology and Visual Science 2016; 57: 3793-3802 (IGR: 18-1)


69399 Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit
Staubli U
Vision Research 2016; 127: 35-48 (IGR: 18-1)


69140 Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
Lopez Sanchez MI
Pharmacology and Therapeutics 2016; 165: 132-152 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Reinehr S
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69427 Targeting mitochondrial function to treat optic neuropathy
Gueven N
Mitochondrion 2017; 36: 7-14 (IGR: 18-1)


69469 Increased Frataxin Levels Protect Retinal Ganglion Cells After Acute Ischemia/Reperfusion in the Mouse Retina In Vivo
Schultz R
Investigative Ophthalmology and Visual Science 2016; 57: 4115-4124 (IGR: 18-1)


69436 The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy
Foldvari M
Neural Regeneration Research 2016; 11: 875-877 (IGR: 18-1)


69104 Dental Pulp Stem Cells: A Novel Cell Therapy for Retinal and Central Nervous System Repair
Mead B
Stem Cells 2017; 35: 61-67 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Bae S
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69009 Blue Light Action on Mitochondria Leads to Cell Death by Necroptosis
del Olmo-Aguado S
Neurochemical Research 2016; 41: 2324-2335 (IGR: 18-1)


69135 Effects of Chronic and Acute Intraocular Pressure Elevation on Scotopic and Photopic Contrast Sensitivity in Mice
van der Heijden ME
Investigative Ophthalmology and Visual Science 2016; 57: 3077-3087 (IGR: 18-1)


69014 Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
Montgomery CL
Lipids 2016; 51: 857-866 (IGR: 18-1)


69296 Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27
Casola C
Investigative Ophthalmology and Visual Science 2016; 57: 3626-3639 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Wang Y
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69124 Red Light Treatment in an Axotomy Model of Neurodegeneration
Beirne K
Photochemistry and photobiology 2016; 92: 624-631 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Gupta V
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Deng F
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Shaw PX
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69150 Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma
Keller KE
Experimental Eye Research 2017; 158: 154-160 (IGR: 18-1)


69381 A mouse retinal explant model for use in studying neuroprotection in glaucoma
Pattamatta U
Experimental Eye Research 2016; 151: 38-44 (IGR: 18-1)


69411 Signaling Networks of Retinal Ganglion Cell Formation and the Potential Application of Stem Cell-Based Therapy in Retinal Degenerative Diseases
Wu N
Human Genetics and Therapeutics 2016; 27: 609-620 (IGR: 18-1)


69072 Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma
Chidlow G
Journal of Glaucoma 2016; 25: 681-691 (IGR: 18-1)


69296 Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27
Reinehr S
Investigative Ophthalmology and Visual Science 2016; 57: 3626-3639 (IGR: 18-1)


69140 Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
Crowston JG
Pharmacology and Therapeutics 2016; 165: 132-152 (IGR: 18-1)


69481 Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies
Guo L
Cell death discovery 2016; 2: 16031 (IGR: 18-1)


69098 Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Ortin-Martinez A
Scientific reports 2016; 6: 27532 (IGR: 18-1)


69104 Dental Pulp Stem Cells: A Novel Cell Therapy for Retinal and Central Nervous System Repair
Logan A
Stem Cells 2017; 35: 61-67 (IGR: 18-1)


69150 Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma
Wirtz MK
Experimental Eye Research 2017; 158: 154-160 (IGR: 18-1)


69381 A mouse retinal explant model for use in studying neuroprotection in glaucoma
McPherson Z
Experimental Eye Research 2016; 151: 38-44 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Chen M
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69436 The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy
Chen DW
Neural Regeneration Research 2016; 11: 875-877 (IGR: 18-1)


68932 The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling
Belforte N
Neurobiology of Disease 2016; 93: 156-171 (IGR: 18-1)


69167 Down-regulation of semaphorin 3F in rat retinal ganglion cells in response to optic nerve crush
Minamoto A
Cell biochemistry and function 2016; 34: 378-384 (IGR: 18-1)


69009 Blue Light Action on Mitochondria Leads to Cell Death by Necroptosis
Núñez-Álv
Neurochemical Research 2016; 41: 2324-2335 (IGR: 18-1)


69190 Who's lost first? Susceptibility of retinal ganglion cell types in experimental glaucoma
Ou Y
Experimental Eye Research 2017; 158: 43-50 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Li S
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69124 Red Light Treatment in an Axotomy Model of Neurodegeneration
Rozanowska M
Photochemistry and photobiology 2016; 92: 624-631 (IGR: 18-1)


69411 Signaling Networks of Retinal Ganglion Cell Formation and the Potential Application of Stem Cell-Based Therapy in Retinal Degenerative Diseases
Wang Y
Human Genetics and Therapeutics 2016; 27: 609-620 (IGR: 18-1)


69147 Retinal Macroglial Responses in Health and Disease
Rojas B
BioMed research international 2016; 2016: 2954721 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Jeoung JW
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69399 Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit
Rangel-Diaz N
Vision Research 2016; 127: 35-48 (IGR: 18-1)


69469 Increased Frataxin Levels Protect Retinal Ganglion Cells After Acute Ischemia/Reperfusion in the Mouse Retina In Vivo
Witte OW
Investigative Ophthalmology and Visual Science 2016; 57: 4115-4124 (IGR: 18-1)


69072 Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma
Ebneter A
Journal of Glaucoma 2016; 25: 681-691 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Lopez D
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Sang A
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69135 Effects of Chronic and Acute Intraocular Pressure Elevation on Scotopic and Photopic Contrast Sensitivity in Mice
Shah P
Investigative Ophthalmology and Visual Science 2016; 57: 3077-3087 (IGR: 18-1)


69427 Targeting mitochondrial function to treat optic neuropathy
Nadikudi M
Mitochondrion 2017; 36: 7-14 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Gupta VB
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69338 Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension
Chen H
Investigative Ophthalmology and Visual Science 2016; 57: 3793-3802 (IGR: 18-1)


69134 Brain-derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells
Ng WS
European Journal of Neuroscience 2016; 44: 2028-2039 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Reinhard J
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69014 Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
Keereetaweep J
Lipids 2016; 51: 857-866 (IGR: 18-1)


69481 Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies
Brenton J
Cell death discovery 2016; 2: 16031 (IGR: 18-1)


69338 Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension
Yi J
Investigative Ophthalmology and Visual Science 2016; 57: 3793-3802 (IGR: 18-1)


69124 Red Light Treatment in an Axotomy Model of Neurodegeneration
Votruba M
Photochemistry and photobiology 2016; 92: 624-631 (IGR: 18-1)


69399 Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit
Alcantara M
Vision Research 2016; 127: 35-48 (IGR: 18-1)


69427 Targeting mitochondrial function to treat optic neuropathy
Daniel A
Mitochondrion 2017; 36: 7-14 (IGR: 18-1)


69014 Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
Johnson HM
Lipids 2016; 51: 857-866 (IGR: 18-1)


69072 Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma
Wood JP
Journal of Glaucoma 2016; 25: 681-691 (IGR: 18-1)


69296 Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27
Kuehn S
Investigative Ophthalmology and Visual Science 2016; 57: 3626-3639 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Jeun M
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69134 Brain-derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells
Barde YA
European Journal of Neuroscience 2016; 44: 2028-2039 (IGR: 18-1)


69135 Effects of Chronic and Acute Intraocular Pressure Elevation on Scotopic and Photopic Contrast Sensitivity in Mice
Cowan CS
Investigative Ophthalmology and Visual Science 2016; 57: 3077-3087 (IGR: 18-1)


69147 Retinal Macroglial Responses in Health and Disease
Ramírez AI
BioMed research international 2016; 2016: 2954721 (IGR: 18-1)


69104 Dental Pulp Stem Cells: A Novel Cell Therapy for Retinal and Central Nervous System Repair
Berry M
Stem Cells 2017; 35: 61-67 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Wang Y
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69381 A mouse retinal explant model for use in studying neuroprotection in glaucoma
White A
Experimental Eye Research 2016; 151: 38-44 (IGR: 18-1)


68932 The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling
Di Polo A
Neurobiology of Disease 2016; 93: 156-171 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Gandej M
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Chitranshi N
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Miao L
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69098 Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Nadal-Nícolas F
Scientific reports 2016; 6: 27532 (IGR: 18-1)


69167 Down-regulation of semaphorin 3F in rat retinal ganglion cells in response to optic nerve crush
Sugimoto Y
Cell biochemistry and function 2016; 34: 378-384 (IGR: 18-1)


69411 Signaling Networks of Retinal Ganglion Cell Formation and the Potential Application of Stem Cell-Based Therapy in Retinal Degenerative Diseases
Yang L
Human Genetics and Therapeutics 2016; 27: 609-620 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Liu Y
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Davey PG
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69009 Blue Light Action on Mitochondria Leads to Cell Death by Necroptosis
Osborne NN
Neurochemical Research 2016; 41: 2324-2335 (IGR: 18-1)


69140 Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
Mackey DA
Pharmacology and Therapeutics 2016; 165: 132-152 (IGR: 18-1)


69469 Increased Frataxin Levels Protect Retinal Ganglion Cells After Acute Ischemia/Reperfusion in the Mouse Retina In Vivo
Schmeer C
Investigative Ophthalmology and Visual Science 2016; 57: 4115-4124 (IGR: 18-1)


69098 Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Ambrósio AF
Scientific reports 2016; 6: 27532 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Cameron DJ
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69411 Signaling Networks of Retinal Ganglion Cell Formation and the Potential Application of Stem Cell-Based Therapy in Retinal Degenerative Diseases
Cho KS
Human Genetics and Therapeutics 2016; 27: 609-620 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Gangoda S
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69399 Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit
Li YX
Vision Research 2016; 127: 35-48 (IGR: 18-1)


69296 Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27
Stute G
Investigative Ophthalmology and Visual Science 2016; 57: 3626-3639 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Jang JT
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69135 Effects of Chronic and Acute Intraocular Pressure Elevation on Scotopic and Photopic Contrast Sensitivity in Mice
Yang Z
Investigative Ophthalmology and Visual Science 2016; 57: 3077-3087 (IGR: 18-1)


69014 Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
Grillo SL
Lipids 2016; 51: 857-866 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Hu H
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69072 Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma
Casson RJ
Journal of Glaucoma 2016; 25: 681-691 (IGR: 18-1)


69338 Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension
Troy JB
Investigative Ophthalmology and Visual Science 2016; 57: 3793-3802 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Ho D
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69134 Brain-derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells
Song B
European Journal of Neuroscience 2016; 44: 2028-2039 (IGR: 18-1)


69167 Down-regulation of semaphorin 3F in rat retinal ganglion cells in response to optic nerve crush
Kiuchi Y
Cell biochemistry and function 2016; 34: 378-384 (IGR: 18-1)


69140 Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
Trounce IA
Pharmacology and Therapeutics 2016; 165: 132-152 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Kuehn S
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69427 Targeting mitochondrial function to treat optic neuropathy
Chhetri J
Mitochondrion 2017; 36: 7-14 (IGR: 18-1)


69481 Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies
Langley L
Cell death discovery 2016; 2: 16031 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Huang H
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69104 Dental Pulp Stem Cells: A Novel Cell Therapy for Retinal and Central Nervous System Repair
Leadbeater W
Stem Cells 2017; 35: 61-67 (IGR: 18-1)


69147 Retinal Macroglial Responses in Health and Disease
Salazar JJ
BioMed research international 2016; 2016: 2954721 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Douglas C
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Liang F
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Noristani R
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69134 Brain-derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells
Morgan JE
European Journal of Neuroscience 2016; 44: 2028-2039 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Nguyen K
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69135 Effects of Chronic and Acute Intraocular Pressure Elevation on Scotopic and Photopic Contrast Sensitivity in Mice
Wu SM
Investigative Ophthalmology and Visual Science 2016; 57: 3077-3087 (IGR: 18-1)


69104 Dental Pulp Stem Cells: A Novel Cell Therapy for Retinal and Central Nervous System Repair
Scheven BA
Stem Cells 2017; 35: 61-67 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Xiong Y
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Vander Wall R
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69098 Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Vidal-Sanz M
Scientific reports 2016; 6: 27532 (IGR: 18-1)


69481 Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies
Normando EM
Cell death discovery 2016; 2: 16031 (IGR: 18-1)


69296 Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27
Spiess BM
Investigative Ophthalmology and Visual Science 2016; 57: 3626-3639 (IGR: 18-1)


69399 Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit
Yang JY
Vision Research 2016; 127: 35-48 (IGR: 18-1)


69147 Retinal Macroglial Responses in Health and Disease
Gallego BI
BioMed research international 2016; 2016: 2954721 (IGR: 18-1)


69338 Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension
Zhang HF
Investigative Ophthalmology and Visual Science 2016; 57: 3793-3802 (IGR: 18-1)


69014 Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
Chapman KD
Lipids 2016; 51: 857-866 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Park JH; Kim YJ
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69014 Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma
Koulen P
Lipids 2016; 51: 857-866 (IGR: 18-1)


69399 Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit
Zhang KM
Vision Research 2016; 127: 35-48 (IGR: 18-1)


69338 Long-Term Protection of Retinal Ganglion Cells and Visual Function by Brain-Derived Neurotrophic Factor in Mice With Ocular Hypertension
Liu X
Investigative Ophthalmology and Visual Science 2016; 57: 3793-3802 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Dia L
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Abbasi M
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Tran J
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Teng X
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69481 Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies
Cordeiro MF
Cell death discovery 2016; 2: 16031 (IGR: 18-1)


69296 Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27
Dick HB
Investigative Ophthalmology and Visual Science 2016; 57: 3626-3639 (IGR: 18-1)


69098 Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Agudo-Barriuso M
Scientific reports 2016; 6: 27532 (IGR: 18-1)


69147 Retinal Macroglial Responses in Health and Disease
Triviño A
BioMed research international 2016; 2016: 2954721 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Faissner A
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69135 Effects of Chronic and Acute Intraocular Pressure Elevation on Scotopic and Photopic Contrast Sensitivity in Mice
Frankfort BJ
Investigative Ophthalmology and Visual Science 2016; 57: 3077-3087 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Xu C
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69296 Specific Inner Retinal Layer Cell Damage in an Autoimmune Glaucoma Model Is Induced by GDNF With or Without HSP27
Joachim SC
Investigative Ophthalmology and Visual Science 2016; 57: 3626-3639 (IGR: 18-1)


69147 Retinal Macroglial Responses in Health and Disease
Ramírez JM
BioMed research international 2016; 2016: 2954721 (IGR: 18-1)


69373 Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury
Goldberg JL
Experimental Eye Research 2017; 158: 33-42 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Dick HB
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Xu L
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Marquez E
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69098 Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
Santiago AR
Scientific reports 2016; 6: 27532 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Lee K
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69399 Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit
Foster AC
Vision Research 2016; 127: 35-48 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Golzan M; Dheer Y
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Li K
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Kim M
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Liu Y
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69178 Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model
Joachim SC
Frontiers in cellular neuroscience 2016; 10: 140 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Wang Q
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Bi X
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Xiao W
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Lee J
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Zhuang J
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Shah T
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69145 Stage-specific differentiation of iPSCs toward retinal ganglion cell lineage
Ge J
Molecular Vision 2016; 22: 536-547 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Avolio A
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


68969 Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell degeneration induced by retinal ischemia/reperfusion injury
Baudry M
Neurobiology of Disease 2016; 93: 121-128 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Ridder WH
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Hwang HM; Paek SH
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Chung R
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Ferguson TA
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69148 Magnetically softened iron oxide (MSIO) nanofluid and its application to thermally-induced heat shock proteins for ocular neuroprotection
Park KH
Biomaterials 2016; 101: 165-175 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Chen DF
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Martins R
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Kaufman RJ
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


69202 One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Graham S
Cellular and Molecular Life Sciences 2016; 73: 4279-4297 (IGR: 18-1)


69022 Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules
Hu Y
Journal of Neuroscience 2016; 36: 5891-5903 (IGR: 18-1)


67309 Targeting the complement system for the management of retinal inflammatory and degenerative diseases
Xu H
European Journal of Pharmacology 2016; 787: 94-104 (IGR: 17-4)


66638 Imipramine protects retinal ganglion cells from oxidative stress through the tyrosine kinase receptor B signaling pathway
Han ML
Neural Regeneration Research 2016; 11: 476-479 (IGR: 17-4)


66722 Red light of the visual spectrum attenuates cell death in culture and retinal ganglion cell death in situ
del Olmo-Aguado S
Acta Ophthalmologica 2016; 94: e481-e491 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Mead B
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67276 Axonal transport along retinal ganglion cells is grossly intact during reduced function post-injury
Fahy ET
Experimental Eye Research 2016; 146: 289-292 (IGR: 17-4)


67127 Antioxidant Treatment Limits Neuroinflammation in Experimental Glaucoma
Yang X
Investigative Ophthalmology and Visual Science 2016; 57: 2344-2354 (IGR: 17-4)


66714 Platelet-Derived Growth Factor Preserves Retinal Synapses in a Rat Model of Ocular Hypertension
Chong RS
Investigative Ophthalmology and Visual Science 2016; 57: 842-852 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Unlu M
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Nucci C
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


66806 Involvement of AMPA Receptor and Its Flip and Flop Isoforms in Retinal Ganglion Cell Death Following Oxygen/Glucose Deprivation
Park YH
Investigative Ophthalmology and Visual Science 2016; 57: 508-526 (IGR: 17-4)


67486 Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways
Mac Nair CE
Journal of Neuroinflammation 2016; 13: 93 (IGR: 17-4)


66837 Transplanted neurons integrate into adult retinas and respond to light
Venugopalan P
Nature communications 2016; 7: 10472 (IGR: 17-4)


67537 Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Osborne NN
European Journal of Pharmacology 2016; 787: 127-133 (IGR: 17-4)


67538 Autoimmune aspects in glaucoma
von Thun Und Hohenstein-Blaul N
European Journal of Pharmacology 2016; 787: 105-118 (IGR: 17-4)


67168 Inhibition on Apoptosis Induced by Elevated Hydrostatic Pressure in Retinal Ganglion Cell-5 via Laminin Upregulating β1-integrin/Focal Adhesion Kinase/Protein Kinase B Signaling Pathway
Li Y
Chinese Medical Journal 2016; 129: 976-983 (IGR: 17-4)


67566 Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma
Smith MA
Journal of Comparative Neurology 2016; 524: 3503-3517 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Lv B
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Gupta VK
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67191 Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity
Smedowski A
Scientific reports 2016; 6: 23187 (IGR: 17-4)


67507 Neurodegeneration beyond the primary visual pathways in a population with a high incidence of normal-pressure glaucoma
Boucard CC
Ophthalmic and Physiological Optics 2016; 36: 344-353 (IGR: 17-4)


67120 Brain derived neurotrophic factor keeps pattern electroretinogram from dropping after superior colliculus lesion in mice
Yang BB
International Journal of Ophthalmology 2016; 9: 369-372 (IGR: 17-4)


67283 Effects of optineurin mutants on SH-SY5Y cell survival
Zhu M
Molecular and Cellular Neurosciences 2016; 74: 18-24 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Yan L
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Russo R
European Journal of Pharmacology 2016; 787: 134-142 (IGR: 17-4)


67208 Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival
Piri N
Progress in Retinal and Eye Research 2016; 52: 22-46 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Williams PA
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


67234 Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
Ohlemacher SK
Stem Cells 2016; 34: 1553-1562 (IGR: 17-4)


67600 Cigarette Smoke Extract Causes Injury in Primary Retinal Ganglion Cells via Apoptosis and Autophagy
Lee K
Current Eye Research 2016; 0: 1-6 (IGR: 17-4)


67307 The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected
Takır S
Experimental Eye Research 2016; 145: 401-411 (IGR: 17-4)


67537 Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Núñez-Álvarez C
European Journal of Pharmacology 2016; 787: 127-133 (IGR: 17-4)


67283 Effects of optineurin mutants on SH-SY5Y cell survival
Li A
Molecular and Cellular Neurosciences 2016; 74: 18-24 (IGR: 17-4)


67168 Inhibition on Apoptosis Induced by Elevated Hydrostatic Pressure in Retinal Ganglion Cell-5 via Laminin Upregulating β1-integrin/Focal Adhesion Kinase/Protein Kinase B Signaling Pathway
Chen YM
Chinese Medical Journal 2016; 129: 976-983 (IGR: 17-4)


67307 The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected
Gürel-Gürevin E
Experimental Eye Research 2016; 145: 401-411 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Russo R
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Varano GP
European Journal of Pharmacology 2016; 787: 134-142 (IGR: 17-4)


67566 Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma
Xia CZ
Journal of Comparative Neurology 2016; 524: 3503-3517 (IGR: 17-4)


66806 Involvement of AMPA Receptor and Its Flip and Flop Isoforms in Retinal Ganglion Cell Death Following Oxygen/Glucose Deprivation
Broyles HV
Investigative Ophthalmology and Visual Science 2016; 57: 508-526 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Chitranshi N
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67208 Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival
Kwong JM
Progress in Retinal and Eye Research 2016; 52: 22-46 (IGR: 17-4)


67486 Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways
Schlamp CL
Journal of Neuroinflammation 2016; 13: 93 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Huo F
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Tribble JR
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


67234 Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
Sridhar A
Stem Cells 2016; 34: 1553-1562 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Aktas Z
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


66837 Transplanted neurons integrate into adult retinas and respond to light
Wang Y
Nature communications 2016; 7: 10472 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Hill LJ
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67600 Cigarette Smoke Extract Causes Injury in Primary Retinal Ganglion Cells via Apoptosis and Autophagy
Hong S
Current Eye Research 2016; 0: 1-6 (IGR: 17-4)


66638 Imipramine protects retinal ganglion cells from oxidative stress through the tyrosine kinase receptor B signaling pathway
Liu GH
Neural Regeneration Research 2016; 11: 476-479 (IGR: 17-4)


67309 Targeting the complement system for the management of retinal inflammatory and degenerative diseases
Chen M
European Journal of Pharmacology 2016; 787: 94-104 (IGR: 17-4)


66722 Red light of the visual spectrum attenuates cell death in culture and retinal ganglion cell death in situ
Núñez-Álvarez C
Acta Ophthalmologica 2016; 94: e481-e491 (IGR: 17-4)


67507 Neurodegeneration beyond the primary visual pathways in a population with a high incidence of normal-pressure glaucoma
Hanekamp S
Ophthalmic and Physiological Optics 2016; 36: 344-353 (IGR: 17-4)


67538 Autoimmune aspects in glaucoma
Bell K
European Journal of Pharmacology 2016; 787: 105-118 (IGR: 17-4)


67127 Antioxidant Treatment Limits Neuroinflammation in Experimental Glaucoma
Hondur G
Investigative Ophthalmology and Visual Science 2016; 57: 2344-2354 (IGR: 17-4)


66714 Platelet-Derived Growth Factor Preserves Retinal Synapses in a Rat Model of Ocular Hypertension
Osborne A
Investigative Ophthalmology and Visual Science 2016; 57: 842-852 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Zhao B
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67191 Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity
Liu X
Scientific reports 2016; 6: 23187 (IGR: 17-4)


67276 Axonal transport along retinal ganglion cells is grossly intact during reduced function post-injury
Chrysostomou V
Experimental Eye Research 2016; 146: 289-292 (IGR: 17-4)


67120 Brain derived neurotrophic factor keeps pattern electroretinogram from dropping after superior colliculus lesion in mice
Yang X
International Journal of Ophthalmology 2016; 9: 369-372 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Gocun PU
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67566 Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma
Dengler-Crish CM
Journal of Comparative Neurology 2016; 524: 3503-3517 (IGR: 17-4)


66837 Transplanted neurons integrate into adult retinas and respond to light
Nguyen T
Nature communications 2016; 7: 10472 (IGR: 17-4)


67191 Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity
Pietrucha-Dutczak M
Scientific reports 2016; 6: 23187 (IGR: 17-4)


67507 Neurodegeneration beyond the primary visual pathways in a population with a high incidence of normal-pressure glaucoma
Ćurčić-Blake B
Ophthalmic and Physiological Optics 2016; 36: 344-353 (IGR: 17-4)


67538 Autoimmune aspects in glaucoma
Pfeiffer N
European Journal of Pharmacology 2016; 787: 105-118 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Zhu Z
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


66722 Red light of the visual spectrum attenuates cell death in culture and retinal ganglion cell death in situ
Osborne NN
Acta Ophthalmologica 2016; 94: e481-e491 (IGR: 17-4)


67600 Cigarette Smoke Extract Causes Injury in Primary Retinal Ganglion Cells via Apoptosis and Autophagy
Seong GJ
Current Eye Research 2016; 0: 1-6 (IGR: 17-4)


67276 Axonal transport along retinal ganglion cells is grossly intact during reduced function post-injury
Abbott CJ
Experimental Eye Research 2016; 146: 289-292 (IGR: 17-4)


67120 Brain derived neurotrophic factor keeps pattern electroretinogram from dropping after superior colliculus lesion in mice
Ding HY
International Journal of Ophthalmology 2016; 9: 369-372 (IGR: 17-4)


67127 Antioxidant Treatment Limits Neuroinflammation in Experimental Glaucoma
Tezel G
Investigative Ophthalmology and Visual Science 2016; 57: 2344-2354 (IGR: 17-4)


67168 Inhibition on Apoptosis Induced by Elevated Hydrostatic Pressure in Retinal Ganglion Cell-5 via Laminin Upregulating β1-integrin/Focal Adhesion Kinase/Protein Kinase B Signaling Pathway
Sun MM
Chinese Medical Journal 2016; 129: 976-983 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Liu X
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Adornetto A
European Journal of Pharmacology 2016; 787: 134-142 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Gupta VB
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67208 Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival
Gu L
Progress in Retinal and Eye Research 2016; 52: 22-46 (IGR: 17-4)


67307 The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected
Toprak A
Experimental Eye Research 2016; 145: 401-411 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Martucci A
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


66714 Platelet-Derived Growth Factor Preserves Retinal Synapses in a Rat Model of Ocular Hypertension
Conceição R
Investigative Ophthalmology and Visual Science 2016; 57: 842-852 (IGR: 17-4)


67537 Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Joglar B
European Journal of Pharmacology 2016; 787: 127-133 (IGR: 17-4)


66806 Involvement of AMPA Receptor and Its Flip and Flop Isoforms in Retinal Ganglion Cell Death Following Oxygen/Glucose Deprivation
He S
Investigative Ophthalmology and Visual Science 2016; 57: 508-526 (IGR: 17-4)


67486 Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways
Montgomery AD
Journal of Neuroinflammation 2016; 13: 93 (IGR: 17-4)


67283 Effects of optineurin mutants on SH-SY5Y cell survival
Chen J
Molecular and Cellular Neurosciences 2016; 74: 18-24 (IGR: 17-4)


66638 Imipramine protects retinal ganglion cells from oxidative stress through the tyrosine kinase receptor B signaling pathway
Guo J
Neural Regeneration Research 2016; 11: 476-479 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Blanch RJ
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67234 Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
Xiao Y
Stem Cells 2016; 34: 1553-1562 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Pepper KW
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


67208 Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival
Caprioli J
Progress in Retinal and Eye Research 2016; 52: 22-46 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Cross SD
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


67486 Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways
Shestopalov VI
Journal of Neuroinflammation 2016; 13: 93 (IGR: 17-4)


67600 Cigarette Smoke Extract Causes Injury in Primary Retinal Ganglion Cells via Apoptosis and Autophagy
Kim CY
Current Eye Research 2016; 0: 1-6 (IGR: 17-4)


66837 Transplanted neurons integrate into adult retinas and respond to light
Huang A
Nature communications 2016; 7: 10472 (IGR: 17-4)


67537 Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
del Olmo-Aguado S
European Journal of Pharmacology 2016; 787: 127-133 (IGR: 17-4)


66638 Imipramine protects retinal ganglion cells from oxidative stress through the tyrosine kinase receptor B signaling pathway
Yu SJ
Neural Regeneration Research 2016; 11: 476-479 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Giannini C
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


67234 Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
Hochstetler AE
Stem Cells 2016; 34: 1553-1562 (IGR: 17-4)


67507 Neurodegeneration beyond the primary visual pathways in a population with a high incidence of normal-pressure glaucoma
Ida M
Ophthalmic and Physiological Optics 2016; 36: 344-353 (IGR: 17-4)


67538 Autoimmune aspects in glaucoma
Grus FH
European Journal of Pharmacology 2016; 787: 105-118 (IGR: 17-4)


67307 The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected
Demirci-Tansel C
Experimental Eye Research 2016; 145: 401-411 (IGR: 17-4)


66714 Platelet-Derived Growth Factor Preserves Retinal Synapses in a Rat Model of Ocular Hypertension
Martin KR
Investigative Ophthalmology and Visual Science 2016; 57: 842-852 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Xu Z
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


67283 Effects of optineurin mutants on SH-SY5Y cell survival
Zhang S
Molecular and Cellular Neurosciences 2016; 74: 18-24 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Ward K
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67276 Axonal transport along retinal ganglion cells is grossly intact during reduced function post-injury
Van Wijngaarden P
Experimental Eye Research 2016; 146: 289-292 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Ilhan SO
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67168 Inhibition on Apoptosis Induced by Elevated Hydrostatic Pressure in Retinal Ganglion Cell-5 via Laminin Upregulating β1-integrin/Focal Adhesion Kinase/Protein Kinase B Signaling Pathway
Guo XD
Chinese Medical Journal 2016; 129: 976-983 (IGR: 17-4)


67566 Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma
Fening KM
Journal of Comparative Neurology 2016; 524: 3503-3517 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Li X
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Nucci C
European Journal of Pharmacology 2016; 787: 134-142 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Golzan M
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67191 Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity
Matuszek I
Scientific reports 2016; 6: 23187 (IGR: 17-4)


66806 Involvement of AMPA Receptor and Its Flip and Flop Isoforms in Retinal Ganglion Cell Death Following Oxygen/Glucose Deprivation
McGrady NR
Investigative Ophthalmology and Visual Science 2016; 57: 508-526 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Zeng C
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Corasaniti MT
European Journal of Pharmacology 2016; 787: 134-142 (IGR: 17-4)


66806 Involvement of AMPA Receptor and Its Flip and Flop Isoforms in Retinal Ganglion Cell Death Following Oxygen/Glucose Deprivation
Li L
Investigative Ophthalmology and Visual Science 2016; 57: 508-526 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Dang X
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Logan A
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67234 Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
Sarfarazi M
Stem Cells 2016; 34: 1553-1562 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Morgan BP
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


67507 Neurodegeneration beyond the primary visual pathways in a population with a high incidence of normal-pressure glaucoma
Yoshida M
Ophthalmic and Physiological Optics 2016; 36: 344-353 (IGR: 17-4)


67276 Axonal transport along retinal ganglion cells is grossly intact during reduced function post-injury
Crowston JG
Experimental Eye Research 2016; 146: 289-292 (IGR: 17-4)


67283 Effects of optineurin mutants on SH-SY5Y cell survival
Wu J
Molecular and Cellular Neurosciences 2016; 74: 18-24 (IGR: 17-4)


67307 The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected
Uydeş-Doğan BS
Experimental Eye Research 2016; 145: 401-411 (IGR: 17-4)


67168 Inhibition on Apoptosis Induced by Elevated Hydrostatic Pressure in Retinal Ganglion Cell-5 via Laminin Upregulating β1-integrin/Focal Adhesion Kinase/Protein Kinase B Signaling Pathway
Wang YC
Chinese Medical Journal 2016; 129: 976-983 (IGR: 17-4)


66638 Imipramine protects retinal ganglion cells from oxidative stress through the tyrosine kinase receptor B signaling pathway
Huang J
Neural Regeneration Research 2016; 11: 476-479 (IGR: 17-4)


67191 Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity
Varjosalo M
Scientific reports 2016; 6: 23187 (IGR: 17-4)


67486 Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways
Nickells RW
Journal of Neuroinflammation 2016; 13: 93 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Dheer Y
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


66837 Transplanted neurons integrate into adult retinas and respond to light
Muller KJ
Nature communications 2016; 7: 10472 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Hasanreisoglu M
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Garaci F
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


67566 Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma
Inman DM
Journal of Comparative Neurology 2016; 524: 3503-3517 (IGR: 17-4)


67122 Neuroprotective effect of systemic and/or intravitreal rosuvastatin administration in rat glaucoma model
Hasanreisoglu B
International Journal of Ophthalmology 2016; 9: 340-347 (IGR: 17-4)


67168 Inhibition on Apoptosis Induced by Elevated Hydrostatic Pressure in Retinal Ganglion Cell-5 via Laminin Upregulating β1-integrin/Focal Adhesion Kinase/Protein Kinase B Signaling Pathway
Zhang ZZ
Chinese Medical Journal 2016; 129: 976-983 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Shi H
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Bagetta G
European Journal of Pharmacology 2016; 787: 134-142 (IGR: 17-4)


66806 Involvement of AMPA Receptor and Its Flip and Flop Isoforms in Retinal Ganglion Cell Death Following Oxygen/Glucose Deprivation
Yorio T
Investigative Ophthalmology and Visual Science 2016; 57: 508-526 (IGR: 17-4)


66837 Transplanted neurons integrate into adult retinas and respond to light
Goldberg JL
Nature communications 2016; 7: 10472 (IGR: 17-4)


67191 Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity
Lewin-Kowalik J
Scientific reports 2016; 6: 23187 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Floris R
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Berry M
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67566 Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma
Schofield BR
Journal of Comparative Neurology 2016; 524: 3503-3517 (IGR: 17-4)


67234 Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
Cummins TR
Stem Cells 2016; 34: 1553-1562 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Chen T
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Morgan JE
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Wall RV
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67507 Neurodegeneration beyond the primary visual pathways in a population with a high incidence of normal-pressure glaucoma
Cornelissen FW
Ophthalmic and Physiological Optics 2016; 36: 344-353 (IGR: 17-4)


67234 Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration
Meyer JS
Stem Cells 2016; 34: 1553-1562 (IGR: 17-4)


67566 Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma
Crish SD
Journal of Comparative Neurology 2016; 524: 3503-3517 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Leadbeater W
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Xu X
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Morrone LA
European Journal of Pharmacology 2016; 787: 134-142 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Georgevsky D
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
John SW
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Bagetta G
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Zhang T
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Morrone LA
European Journal of Pharmacology 2016; 787: 119-126 (IGR: 17-4)


67547 Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
Yang X
Neurochemical Research 2016; 41: 1949-1957 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
King AE
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Lin T
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67595 Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Howell GR
Molecular Neurodegeneration 2016; 11: 26 (IGR: 17-4)


66761 Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Scheven BA
Cytotherapy 2016; 18: 487-496 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Vickers JC
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Dai L
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Chung R
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


67326 Aligned Nanofibers from Polypyrrole/Graphene as Electrodes for Regeneration of Optic Nerve via Electrical Stimulation
Liu Y
ACS applied materials & interfaces 2016; 8: 6834-6840 (IGR: 17-4)


67468 Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Graham S
Neuroscience Letters 2016; 623: 52-56 (IGR: 17-4)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Germano RA
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Kolko M
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65943 Müller cell-mediated neurite outgrowth of the retinal ganglion cells via P2Y6 receptor signals
Taguchi M
Journal of Neurochemistry 2015; 0: (IGR: 17-3)


65802 Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-κB
Lv B
International Journal of Molecular Medicine 2016; 37: 225-232 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Madeira MH
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Keppel Hesselink JM
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


66377 Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma
Cooper ML
Experimental Eye Research 2016; 150: 22-33 (IGR: 17-3)


66330 Glaucoma -state of the art and perspectives on treatment
Wójcik-Gryciuk A
Restorative Neurology and Neuroscience 2015; 34: 107-123 (IGR: 17-3)


66518 Neuroprotective Strategies in Glaucoma
Gossman CA
Current Pharmaceutical Design 2016; 0: (IGR: 17-3)


66320 Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension
Wostyn P
Clinical and Experimental Optometry 2016; 99: 213-218 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Yin S
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


66577 Targeting mitochondrial function to protect against vision loss
Chhetri J
Expert Opinion on Therapeutic Targets 2016; 0: 1-16 (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Fujita K
Scientific reports 2015; 5: 18141 (IGR: 17-3)


66273 Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells
Schmitt HM
Neuroscience Letters 2016; 625: 11-15 (IGR: 17-3)


65793 Decreased Energy Capacity and Increased Autophagic Activity in Optic Nerve Axons With Defective Anterograde Transport
Kleesattel D
Investigative Ophthalmology and Visual Science 2015; 56: 8215-8227 (IGR: 17-3)


66549 Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains
De Groef L
Experimental Eye Research 2016; 145: 235-247 (IGR: 17-3)


66258 Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma
Lindner E
Molecular Vision 2015; 21: 1340-1344 (IGR: 17-3)


65876 Integrative properties of retinal ganglion cell electrical responsiveness depend on neurotrophic support and genotype in the mouse
Chou TH
Experimental Eye Research 2015; 145: 68-74 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Li CP
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


66457 Production of Retinal Cells from Confluent Human iPS Cells
Reichman S
Methods in molecular biology (Clifton, N.J.) 2016; 1357: 339-351 (IGR: 17-3)


65889 Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma
Yang F
Drug design, development and therapy 2015; 9: 6095-6107 (IGR: 17-3)


66597 Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model
Noristani R
Journal of Molecular Neuroscience 2016; 58: 470-482 (IGR: 17-3)


65854 Current perspective of neuroprotection and glaucoma
Tian K
Clinical Ophthalmology 2015; 9: 2109-2118 (IGR: 17-3)


66384 Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma
Berry RH
PLoS ONE 2015; 10: e0144341 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Sluch VM
Scientific reports 2015; 5: 16595 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Dekeyster E
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


66356 Multipronged Approach to Identify and Validate a Novel Upstream Regulator of Sncg in Mouse Retinal Ganglion Cells
Chintalapudi SR
FEBS Journal 2016; 283: 678-693 (IGR: 17-3)


66411 Therapeutic Approach of Nanotechnology for Oxidative Stress Induced Ocular Neurodegenerative Diseases
Mitra RN
Adv Exp Med Biol 2016; 854: 463-469 (IGR: 17-3)


66320 Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension
De Groot V
Clinical and Experimental Optometry 2016; 99: 213-218 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Davis CH
Scientific reports 2015; 5: 16595 (IGR: 17-3)


66577 Targeting mitochondrial function to protect against vision loss
Gueven N
Expert Opinion on Therapeutic Targets 2016; 0: 1-16 (IGR: 17-3)


66549 Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains
Dekeyster E
Experimental Eye Research 2016; 145: 235-247 (IGR: 17-3)


66597 Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model
Kuehn S
Journal of Molecular Neuroscience 2016; 58: 470-482 (IGR: 17-3)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Finzi S
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


66258 Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma
Glatz W
Molecular Vision 2015; 21: 1340-1344 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Qiu GZ
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


66457 Production of Retinal Cells from Confluent Human iPS Cells
Goureau O
Methods in molecular biology (Clifton, N.J.) 2016; 1357: 339-351 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Boia R
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Costagliola C
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


66377 Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma
Crish SD
Experimental Eye Research 2016; 150: 22-33 (IGR: 17-3)


65854 Current perspective of neuroprotection and glaucoma
Shibata-Germanos S
Clinical Ophthalmology 2015; 9: 2109-2118 (IGR: 17-3)


66411 Therapeutic Approach of Nanotechnology for Oxidative Stress Induced Ocular Neurodegenerative Diseases
Conley SM
Adv Exp Med Biol 2016; 854: 463-469 (IGR: 17-3)


66330 Glaucoma -state of the art and perspectives on treatment
Skup M
Restorative Neurology and Neuroscience 2015; 34: 107-123 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Vosborg F
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Geeraerts E
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


66356 Multipronged Approach to Identify and Validate a Novel Upstream Regulator of Sncg in Mouse Retinal Ganglion Cells
Morales-Tirado VM
FEBS Journal 2016; 283: 678-693 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Wang ZF
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


66273 Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells
Schlamp CL
Neuroscience Letters 2016; 625: 11-15 (IGR: 17-3)


65793 Decreased Energy Capacity and Increased Autophagic Activity in Optic Nerve Axons With Defective Anterograde Transport
Crish SD
Investigative Ophthalmology and Visual Science 2015; 56: 8215-8227 (IGR: 17-3)


65943 Müller cell-mediated neurite outgrowth of the retinal ganglion cells via P2Y6 receptor signals
Shinozaki Y
Journal of Neurochemistry 2015; 0: (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Nishiguchi KM
Scientific reports 2015; 5: 18141 (IGR: 17-3)


66384 Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma
Qu J
PLoS ONE 2015; 10: e0144341 (IGR: 17-3)


65876 Integrative properties of retinal ganglion cell electrical responsiveness depend on neurotrophic support and genotype in the mouse
Feuer WJ
Experimental Eye Research 2015; 145: 68-74 (IGR: 17-3)


66518 Neuroprotective Strategies in Glaucoma
Christie J
Current Pharmaceutical Design 2016; 0: (IGR: 17-3)


65802 Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-κB
Chen T
International Journal of Molecular Medicine 2016; 37: 225-232 (IGR: 17-3)


65889 Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma
Wang D
Drug design, development and therapy 2015; 9: 6095-6107 (IGR: 17-3)


66273 Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells
Nickells RW
Neuroscience Letters 2016; 625: 11-15 (IGR: 17-3)


65854 Current perspective of neuroprotection and glaucoma
Pahlitzsch M
Clinical Ophthalmology 2015; 9: 2109-2118 (IGR: 17-3)


65793 Decreased Energy Capacity and Increased Autophagic Activity in Optic Nerve Axons With Defective Anterograde Transport
Inman DM
Investigative Ophthalmology and Visual Science 2015; 56: 8215-8227 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Liu B
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Duan JG
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


66258 Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma
Schwab C
Molecular Vision 2015; 21: 1340-1344 (IGR: 17-3)


66411 Therapeutic Approach of Nanotechnology for Oxidative Stress Induced Ocular Neurodegenerative Diseases
Naash MI
Adv Exp Med Biol 2016; 854: 463-469 (IGR: 17-3)


65889 Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma
Wu L
Drug design, development and therapy 2015; 9: 6095-6107 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Henriksen UL
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Elvas F
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Buyens T
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


66377 Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma
Inman DM
Experimental Eye Research 2016; 150: 22-33 (IGR: 17-3)


65876 Integrative properties of retinal ganglion cell electrical responsiveness depend on neurotrophic support and genotype in the mouse
Schwartz O
Experimental Eye Research 2015; 145: 68-74 (IGR: 17-3)


65943 Müller cell-mediated neurite outgrowth of the retinal ganglion cells via P2Y6 receptor signals
Kashiwagi K
Journal of Neurochemistry 2015; 0: (IGR: 17-3)


65802 Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-κB
Xu Z
International Journal of Molecular Medicine 2016; 37: 225-232 (IGR: 17-3)


66597 Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model
Stute G
Journal of Molecular Neuroscience 2016; 58: 470-482 (IGR: 17-3)


66356 Multipronged Approach to Identify and Validate a Novel Upstream Regulator of Sncg in Mouse Retinal Ganglion Cells
Williams RW
FEBS Journal 2016; 283: 678-693 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Ranganathan V
Scientific reports 2015; 5: 16595 (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Yokoyama Y
Scientific reports 2015; 5: 18141 (IGR: 17-3)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Challa P
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


66384 Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma
John SW
PLoS ONE 2015; 10: e0144341 (IGR: 17-3)


66518 Neuroprotective Strategies in Glaucoma
Webster MK
Current Pharmaceutical Design 2016; 0: (IGR: 17-3)


66320 Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension
Van Dam D
Clinical and Experimental Optometry 2016; 99: 213-218 (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Fakhry J
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


66330 Glaucoma -state of the art and perspectives on treatment
Waleszczyk WJ
Restorative Neurology and Neuroscience 2015; 34: 107-123 (IGR: 17-3)


66549 Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains
Geeraerts E
Experimental Eye Research 2016; 145: 235-247 (IGR: 17-3)


66597 Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model
Reinehr S
Journal of Molecular Neuroscience 2016; 58: 470-482 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Van den Haute C
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


65876 Integrative properties of retinal ganglion cell electrical responsiveness depend on neurotrophic support and genotype in the mouse
Rojas MJ
Experimental Eye Research 2015; 145: 68-74 (IGR: 17-3)


66356 Multipronged Approach to Identify and Validate a Novel Upstream Regulator of Sncg in Mouse Retinal Ganglion Cells
Jablonski MM
FEBS Journal 2016; 283: 678-693 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Kerr JM
Scientific reports 2015; 5: 16595 (IGR: 17-3)


65854 Current perspective of neuroprotection and glaucoma
Cordeiro MF
Clinical Ophthalmology 2015; 9: 2109-2118 (IGR: 17-3)


66384 Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma
Howell GR
PLoS ONE 2015; 10: e0144341 (IGR: 17-3)


66258 Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma
El-Shabrawi Y
Molecular Vision 2015; 21: 1340-1344 (IGR: 17-3)


65889 Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma
Li Y
Drug design, development and therapy 2015; 9: 6095-6107 (IGR: 17-3)


65943 Müller cell-mediated neurite outgrowth of the retinal ganglion cells via P2Y6 receptor signals
Shigetomi E
Journal of Neurochemistry 2015; 0: (IGR: 17-3)


65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Kopsky DJ
Journal of Ophthalmology 2015; 2015: 430596 (IGR: 17-3)


66549 Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains
Lefevere E
Experimental Eye Research 2016; 145: 235-247 (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Tomiyama Y
Scientific reports 2015; 5: 18141 (IGR: 17-3)


65820 Rho kinase inhibitors for glaucoma treatment - Review
Susanna Junior R
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391 (IGR: 17-3)


66377 Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma
Horner PJ
Experimental Eye Research 2016; 150: 22-33 (IGR: 17-3)


66518 Neuroprotective Strategies in Glaucoma
Linn DM
Current Pharmaceutical Design 2016; 0: (IGR: 17-3)


65802 Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-κB
Huo F
International Journal of Molecular Medicine 2016; 37: 225-232 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Martins T
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66320 Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension
Audenaert K
Clinical and Experimental Optometry 2016; 99: 213-218 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Chen JL
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Ji L
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Hasan-Olive MM
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


66377 Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma
Calkins DJ
Experimental Eye Research 2016; 150: 22-33 (IGR: 17-3)


66384 Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma
Jakobs TC
PLoS ONE 2015; 10: e0144341 (IGR: 17-3)


66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Fu HT
Neurological Sciences 2016; 37: 755-762 (IGR: 17-3)


66597 Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model
Stellbogen M
Journal of Molecular Neuroscience 2016; 58: 470-482 (IGR: 17-3)


66320 Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension
Killer HE
Clinical and Experimental Optometry 2016; 99: 213-218 (IGR: 17-3)


65943 Müller cell-mediated neurite outgrowth of the retinal ganglion cells via P2Y6 receptor signals
Robaye B
Journal of Neurochemistry 2015; 0: (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Tsuda S
Scientific reports 2015; 5: 18141 (IGR: 17-3)


66549 Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains
Stalmans I
Experimental Eye Research 2016; 145: 235-247 (IGR: 17-3)


66518 Neuroprotective Strategies in Glaucoma
Linn CL
Current Pharmaceutical Design 2016; 0: (IGR: 17-3)


66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Lu XJ
International Journal of Ophthalmology 2015; 8: 1101-1106 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Diget EH
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65802 Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-κB
Wei Y
International Journal of Molecular Medicine 2016; 37: 225-232 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Baekelandt V
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


65876 Integrative properties of retinal ganglion cell electrical responsiveness depend on neurotrophic support and genotype in the mouse
Roebber JK
Experimental Eye Research 2015; 145: 68-74 (IGR: 17-3)


66258 Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma
Mossböck G
Molecular Vision 2015; 21: 1340-1344 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Krick K
Scientific reports 2015; 5: 16595 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Cunha RA
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66549 Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains
Salinas-Navarro M
Experimental Eye Research 2016; 145: 235-247 (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Yasuda M
Scientific reports 2015; 5: 18141 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
De Groef L
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


65876 Integrative properties of retinal ganglion cell electrical responsiveness depend on neurotrophic support and genotype in the mouse
Porciatti V
Experimental Eye Research 2015; 145: 68-74 (IGR: 17-3)


65802 Crocin protects retinal ganglion cells against H2O2-induced damage through the mitochondrial pathway and activation of NF-κB
Yang X
International Journal of Molecular Medicine 2016; 37: 225-232 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Ambrósio AF
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66597 Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model
Dick HB
Journal of Molecular Neuroscience 2016; 58: 470-482 (IGR: 17-3)


66320 Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension
De Deyn PP
Clinical and Experimental Optometry 2016; 99: 213-218 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Martin R
Scientific reports 2015; 5: 16595 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Vohra R
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65943 Müller cell-mediated neurite outgrowth of the retinal ganglion cells via P2Y6 receptor signals
Koizumi S
Journal of Neurochemistry 2015; 0: (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Maekawa S
Scientific reports 2015; 5: 18141 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Berlinicke CA
Scientific reports 2015; 5: 16595 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Gurubaran IR
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Salinas-Navarro M
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Santiago AR
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128 (IGR: 17-3)


66549 Differential visual system organization and susceptibility to experimental models of optic neuropathies in three commonly used mouse strains
Moons L
Experimental Eye Research 2016; 145: 235-247 (IGR: 17-3)


66597 Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model
Joachim SC
Journal of Molecular Neuroscience 2016; 58: 470-482 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Gjedde A
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65944 Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Moons L
PLoS ONE 2015; 10: e0142067 (IGR: 17-3)


66352 In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice
Nakazawa T
Scientific reports 2015; 5: 18141 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Marsh-Armstrong N; Diamond JS
Scientific reports 2015; 5: 16595 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Mariga ST; Skytt DM
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Mao HQ
Scientific reports 2015; 5: 16595 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Utheim TP
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


65929 Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Zack DJ
Scientific reports 2015; 5: 16595 (IGR: 17-3)


66343 Lactate Transport and Receptor Actions in Retina: Potential Roles in Retinal Function and Disease
Storm-Mathisen J; Bergersen LH
Neurochemical Research 2016; 41: 1229-1236 (IGR: 17-3)


61314 Impaired Axonal Transport and Glaucoma
Fahy ET
Current Eye Research 2015; 0: 1-11 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Can N
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61391 Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss
Nuschke AC
Experimental Eye Research 2015; 141: 111-124 (IGR: 17-1)


61332 Glia-neuron interactions in the mammalian retina
Vecino E
Progress in Retinal and Eye Research 2016; 51: 1-40 (IGR: 17-1)


61006 Present and New Treatment Strategies in the Management of Glaucoma
Kolko M
Open Ophthalmology Journal 2015; 9: 89-100 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Shen C
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61078 Effect of Müller cells on the survival and neuritogenesis in retinal ganglion cells
Ruzafa N
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 522-526 (IGR: 17-1)


61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Bell K
BMC Ophthalmology 2015; 15: 64 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Ying H
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Li Y
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
Ma J
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61572 Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study
Zhang Z
Acta Ophthalmologica 2016; 94: 266-275 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Madeira MH
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Russo R
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61110 In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma
Bosco A
Journal of Vision Exp 2015; 0: e52731 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Marshall J
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Van de Velde S
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61531 Effect of subconjunctival glucose on retinal ganglion cell survival in experimental retinal ischaemia and contrast sensitivity in human glaucoma
Shibeeb O
Clinical and Experimental Ophthalmology 2016; 44: 24-32 (IGR: 17-1)


61695 Thiol redox homeostasis in neurodegenerative disease
McBean GJ
Redox biology 2015; 5: 186-194 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Kaja S
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61071 Influence of extracellular matrix components on the expression of integrins and regeneration of adult retinal ganglion cells
Vecino E
PLoS ONE 2015; 10: e0125250 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Parisi V
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Schubert T
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61758 Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice
Nusbaum DM
Experimental Eye Research 2015; 136: 38-44 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Lascaratos G
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Aksar AT
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Noro T
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Noro T
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61495 Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors
Mata D
Neuropharmacology 2015; 99: 337-346 (IGR: 17-1)


61389 Autophagy in glaucoma: Crosstalk with apoptosis and its implications
Wang Y
Brain Research Bulletin 2015; 117: 1-9 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Wei J
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Yuksel N
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Chen L
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61071 Influence of extracellular matrix components on the expression of integrins and regeneration of adult retinal ganglion cells
Heller JP
PLoS ONE 2015; 10: e0125250 (IGR: 17-1)


61531 Effect of subconjunctival glucose on retinal ganglion cell survival in experimental retinal ischaemia and contrast sensitivity in human glaucoma
Chidlow G
Clinical and Experimental Ophthalmology 2016; 44: 24-32 (IGR: 17-1)


61572 Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study
Wu S
Acta Ophthalmologica 2016; 94: 266-275 (IGR: 17-1)


61389 Autophagy in glaucoma: Crosstalk with apoptosis and its implications
Huang C
Brain Research Bulletin 2015; 117: 1-9 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Adornetto A
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61110 In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma
Romero CO
Journal of Vision Exp 2015; 0: e52731 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Chau KY
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Jiang H
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Payne AJ
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61758 Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice
Wu SM
Experimental Eye Research 2015; 136: 38-44 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Catak O
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61314 Impaired Axonal Transport and Glaucoma
Chrysostomou V
Current Eye Research 2015; 0: 1-11 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Namekata K
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61495 Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors
Linn DM
Neuropharmacology 2015; 99: 337-346 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Namekata K
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61078 Effect of Müller cells on the survival and neuritogenesis in retinal ganglion cells
Vecino E
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 522-526 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Elvas F
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Wong KY
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61391 Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss
Farrell SR
Experimental Eye Research 2015; 141: 111-124 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
Guo C
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
De Groef L
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Liu X
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61332 Glia-neuron interactions in the mammalian retina
Rodriguez FD
Progress in Retinal and Eye Research 2016; 51: 1-40 (IGR: 17-1)


61695 Thiol redox homeostasis in neurodegenerative disease
Aslan M
Redox biology 2015; 5: 186-194 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Centofanti M
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Wilding C
BMC Ophthalmology 2015; 15: 64 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Turturro S
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Gleiser C
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Naumchuk Y
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61758 Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice
Frankfort BJ
Experimental Eye Research 2015; 136: 38-44 (IGR: 17-1)


61495 Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors
Linn CL
Neuropharmacology 2015; 99: 337-346 (IGR: 17-1)


61695 Thiol redox homeostasis in neurodegenerative disease
Griffiths HR
Redox biology 2015; 5: 186-194 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Gok M
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61572 Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study
Jonas JB
Acta Ophthalmologica 2016; 94: 266-275 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Cavaliere F
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Zhu H
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61332 Glia-neuron interactions in the mammalian retina
Ruzafa N
Progress in Retinal and Eye Research 2016; 51: 1-40 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Stalmans I
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Azuchi Y
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61391 Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss
Levesque JM
Experimental Eye Research 2015; 141: 111-124 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Heiduschka P
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Gao H
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Jiang L
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Nguyen T
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61314 Impaired Axonal Transport and Glaucoma
Crowston JG
Current Eye Research 2015; 0: 1-11 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Boia R
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Funke S
BMC Ophthalmology 2015; 15: 64 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Kimura A
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61389 Autophagy in glaucoma: Crosstalk with apoptosis and its implications
Zhang H
Brain Research Bulletin 2015; 117: 1-9 (IGR: 17-1)


61110 In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma
Ambati BK
Journal of Vision Exp 2015; 0: e52731 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Rupasinghe CN
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61071 Influence of extracellular matrix components on the expression of integrins and regeneration of adult retinal ganglion cells
Veiga-Crespo P
PLoS ONE 2015; 10: e0125250 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Ziccardi L
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61531 Effect of subconjunctival glucose on retinal ganglion cell survival in experimental retinal ischaemia and contrast sensitivity in human glaucoma
Han G
Clinical and Experimental Ophthalmology 2016; 44: 24-32 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Turgut B
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Huang S
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Moons L
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Shen X
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Tanga L
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Gonçalves FQ
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Franz C
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61695 Thiol redox homeostasis in neurodegenerative disease
Torrão RC
Redox biology 2015; 5: 186-194 (IGR: 17-1)


61531 Effect of subconjunctival glucose on retinal ganglion cell survival in experimental retinal ischaemia and contrast sensitivity in human glaucoma
Wood JP
Clinical and Experimental Ophthalmology 2016; 44: 24-32 (IGR: 17-1)


61389 Autophagy in glaucoma: Crosstalk with apoptosis and its implications
Wu R
Brain Research Bulletin 2015; 117: 1-9 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Cekmen M
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Pfeiffer N
BMC Ophthalmology 2015; 15: 64 (IGR: 17-1)


61332 Glia-neuron interactions in the mammalian retina
Pereiro X
Progress in Retinal and Eye Research 2016; 51: 1-40 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Gkotsi D
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
Sun Y
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Demir T
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61572 Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study
Zhang J
Acta Ophthalmologica 2016; 94: 266-275 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Huang P
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61594 Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush
Wang G
Journal of Molecular Neuroscience 2015; 57: 243-248 (IGR: 17-1)


61419 Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
Lai TY
Neuroscience Letters 2015; 600: 132-136 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Kimura A
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Tiwari R
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61071 Influence of extracellular matrix components on the expression of integrins and regeneration of adult retinal ganglion cells
Martin KR
PLoS ONE 2015; 10: e0125250 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Levy D
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61391 Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss
Chauhan BC
Experimental Eye Research 2015; 141: 111-124 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Varano GP
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Guo X
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61110 In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma
Vetter ML
Journal of Vision Exp 2015; 0: e52731 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Guo X
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Zaidi DH
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Nagel-Wolfrum K
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Van Hove I
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Cunha RA
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61071 Influence of extracellular matrix components on the expression of integrins and regeneration of adult retinal ganglion cells
Fawcett JW
PLoS ONE 2015; 10: e0125250 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Azuchi Y
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Zelkha R
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61332 Glia-neuron interactions in the mammalian retina
Sharma SC
Progress in Retinal and Eye Research 2016; 51: 1-40 (IGR: 17-1)


61425 Effect of SCH442416 on glutamate uptake in retinal Müller cells at increased hydrostatic pressure
Zhong Y
Molecular medicine reports 2015; 12: 3993-3998 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Michelessi M
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
Liao T
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61531 Effect of subconjunctival glucose on retinal ganglion cell survival in experimental retinal ischaemia and contrast sensitivity in human glaucoma
Casson RJ
Clinical and Experimental Ophthalmology 2016; 44: 24-32 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Rusciano D
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61726 Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
Caglar Y
International Journal of Ophthalmology 2015; 8: 239-244 (IGR: 17-1)


61325 Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway
Grus FH
BMC Ophthalmology 2015; 15: 64 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Ilhan N
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61572 Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study
Liu K
Acta Ophthalmologica 2016; 94: 266-275 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
King R
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Zhao X
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Sahaboglu A
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Harada C
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Roberti G
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Gout I
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Harada C
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
Beattie U
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Kuloglu T
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61572 Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study
Lu Q
Acta Ophthalmologica 2016; 94: 266-275 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Johnson EC
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Altman AM
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Ambrósio AF
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Morrone LA
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Berberoglu ED
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
López FJ
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61378 Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
Ozercan IH
Drug design, development and therapy 2015; 9: 2819-2829 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Nawazish S
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61089 Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Manni G
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1327-1340 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Kamal D
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Sinkler C
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Nakano T
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Nakano T
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Weisschuh N
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61572 Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study
Wang N
Acta Ophthalmologica 2016; 94: 266-275 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Morrison JC
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61412 Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
Santiago AR
Journal of Neuroinflammation 2015; 12: 115 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Corasaniti MT
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
Chen DF
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Ghuman JK
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Bagetta G
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Eske G
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Tsuneoka H
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Tsuneoka H
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Luthert PJ
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Liu J
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61159 Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene
Yue BY
BMC Cell Biology 2015; 16: 14 (IGR: 17-1)


61292 Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
Nucci C
Molecular Vision 2015; 21: 718-729 (IGR: 17-1)


61802 Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
Harada T
Cell Death and Disease 2015; 6: e1720 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Lee I
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61261 Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma
Harada T
Investigative Ophthalmology and Visual Science 2015; 56: 5012-5019 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Rohbock K
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Gerdes BC
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Schapira AH
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61741 Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
Lashkari K
PLoS ONE 2015; 10: e0125695 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Parang K
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Garway-Heath DF
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Rieger N
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Moore MA
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Spaller MR
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Paquet-Durand F
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61420 Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes
Koulen P
Experimental Eye Research 2015; 138: 159-166 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Wissinger B
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Hüttemann M
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Wolfrum U
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


61346 Inhibition of N-Methyl-D-Aspartate-Induced Retinal Neuronal Death by Polyarginine Peptides is Linked to the Attenuation of Stress-Induced Hyperpolarization of the Inner Mitochondrial Membrane Potential
Goebel DJ
Journal of Biological Chemistry 2015; 290: 22030-22048 (IGR: 17-1)


61167 Deletion of myosin VI causes slow retinal optic neuropathy and age-related macular degeneration (AMD)-relevant retinal phenotype
Hirt B; Singer W; Rüttiger L; Zimmermann U; Knipper M
Cellular and Molecular Life Sciences 2015; 72: 3953-3969 (IGR: 17-1)


60427 Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury
Chen YJ
Investigative Ophthalmology and Visual Science 2015; 56: 1506-1516 (IGR: 16-4)


60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Kimura A
Neuroscience Letters 2015; 588: 108-113 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Stein JD
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Lindsey JD
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60187 Differential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes
Kaja S
Experimental Neurology 2015; 265: 59-68 (IGR: 16-4)


60448 Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types
El-Danaf RN
Journal of Neuroscience 2015; 35: 2329-2343 (IGR: 16-4)


60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Emre E
Cytotherapy 2015; 17: 543-559 (IGR: 16-4)


60245 Discovery of novel inhibitors for the treatment of glaucoma
Cholkar K
Expert Opinion on Drug Discovery 2015; 10: 293-313 (IGR: 16-4)


60085 Glial cell interactions and glaucoma
Chong RS
Current Opinions in Ophthalmology 2015; 26: 73-77 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Januschowski K
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Guo X
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Wang W
Cellular and molecular neurobiology 2015; 35: 633-640 (IGR: 16-4)


60690 Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria
Wong YC
Autophagy 2015; 11: 422-424 (IGR: 16-4)


60365 Differential protection of injured retinal ganglion cell dendrites by brimonidine
Lindsey JD
Investigative Ophthalmology and Visual Science 2015; 56: 1789-1804 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Roozafzoon R
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60825 Study of thioredoxin antioxidative system in lateral geniculate body of chronic intraocular hypertension rat
Chen X
Chinese Journal of Ophthalmology 2015; 51: 120-125 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Chen YS
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Sakamoto K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60064 Retinal microglia: just bystander or target for therapy?
Karlstetter M
Progress in Retinal and Eye Research 2015; 45: 30-57 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Wang X
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Ju WK
GLIA 2015; 63: 736-753 (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Domenici L
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


59912 Opioid receptors: methods for detection and their modes of actions in the eye
Husain S
Methods in molecular biology (Clifton, N.J.) 2015; 1230: 243-251 (IGR: 16-4)


60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
He Y
Neural Regeneration Research 2015; 10: 432-437 (IGR: 16-4)


60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Nowak A
BioMed research international 2015; 2015: 258281 (IGR: 16-4)


60204 Enhanced retinal ganglion cell survival in glaucoma by hypoxic postconditioning after disease onset
Gidday JM
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2015; 12: 502-514 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Valiente-Soriano FJ
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Pirhan D
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Parsons CG
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60186 Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Kimura A
American Journal of Pathology 2015; 185: 756-764 (IGR: 16-4)


60163 Expression of inducible heat shock proteins Hsp27 and Hsp70 in the visual pathway of rats subjected to various models of retinal ganglion cell injury
Chidlow G
PLoS ONE 2014; 9: e114838 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Crowston JG
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Osborne A
PLoS ONE 2015; 10: e0115591 (IGR: 16-4)


60627 Glutathione attenuates nitric oxide-induced retinal lipid and protein changes
Siu AW
Ophthalmic and Physiological Optics 2015; 35: 135-146 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Stankowska DL
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
White AJ
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60242 Activation of autophagy and paraptosis in retinal ganglion cells after retinal ischemia and reperfusion injury in rats
Wei T
Experimental and therapeutic medicine 2015; 9: 476-482 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Parameswaran S
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60142 Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury
Johnson EC
Investigative Ophthalmology and Visual Science 2015; 56: 412-419 (IGR: 16-4)


60671 Neuroprotective therapies for glaucoma
Song W
Drug design, development and therapy 2015; 9: 1469-1479 (IGR: 16-4)


60705 Autophagy in axonal degeneration in glaucomatous optic neuropathy
Munemasa Y
Progress in Retinal and Eye Research 2015; 47: 1-18 (IGR: 16-4)


60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Bosco A
Disease models & mechanisms 2015; 0: (IGR: 16-4)


60534 Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
Sappington RM
Channels (Austin, Tex.) 2015; 9: 102-113 (IGR: 16-4)


60430 Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve
Coughlin L
Investigative Ophthalmology and Visual Science 2015; 56: 1437-1446 (IGR: 16-4)


60689 Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina
Yokota T
Clinical and Experimental Ophthalmology 2015; 43: 568-577 (IGR: 16-4)


60437 Retinal and trabecular degeneration in glaucoma: New insights into pathogenesis and treatment
Denoyer A
Journal Français d'Ophtalmologie 2015; 38: 347-356 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Ortín-Martínez A
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Dong LD
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60408 Retinal Microglia in Glaucoma
Wang JW
Journal of Glaucoma 2016; 25: 459-465 (IGR: 16-4)


60762 GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57
Wilding C
Journal of Pharmacological Sciences 2015; 127: 298-304 (IGR: 16-4)


60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Aldarwesh A
PLoS ONE 2015; 10: e0115591 (IGR: 16-4)


60825 Study of thioredoxin antioxidative system in lateral geniculate body of chronic intraocular hypertension rat
Zhang S
Chinese Journal of Ophthalmology 2015; 51: 120-125 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Gao F
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60430 Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve
Morrison RS
Investigative Ophthalmology and Visual Science 2015; 56: 1437-1446 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Nadal-Nicolás FM
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Yüksel N
Cytotherapy 2015; 17: 543-559 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Kim KY
GLIA 2015; 63: 736-753 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Müller S
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60534 Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
Sidorova T
Channels (Austin, Tex.) 2015; 9: 102-113 (IGR: 16-4)


60408 Retinal Microglia in Glaucoma
Chen SD
Journal of Glaucoma 2016; 25: 459-465 (IGR: 16-4)


60762 GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57
Bell K
Journal of Pharmacological Sciences 2015; 127: 298-304 (IGR: 16-4)


60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
Chen J
Neural Regeneration Research 2015; 10: 432-437 (IGR: 16-4)


60186 Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Namekata K
American Journal of Pathology 2015; 185: 756-764 (IGR: 16-4)


60671 Neuroprotective therapies for glaucoma
Huang P
Drug design, development and therapy 2015; 9: 1469-1479 (IGR: 16-4)


60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Guo X
Neuroscience Letters 2015; 588: 108-113 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Heller JP
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60242 Activation of autophagy and paraptosis in retinal ganglion cells after retinal ischemia and reperfusion injury in rats
Kang Q
Experimental and therapeutic medicine 2015; 9: 476-482 (IGR: 16-4)


60689 Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina
Kamimura N
Clinical and Experimental Ophthalmology 2015; 43: 568-577 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Dravid SM
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Yüksel N
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Ruitenberg M
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Salinas-Navarro M
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60142 Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury
Cepurna WO
Investigative Ophthalmology and Visual Science 2015; 56: 412-419 (IGR: 16-4)


60448 Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types
Huberman AD
Journal of Neuroscience 2015; 35: 2329-2343 (IGR: 16-4)


60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Romero CO
Disease models & mechanisms 2015; 0: (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Minton AZ
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60085 Glial cell interactions and glaucoma
Martin KR
Current Opinions in Ophthalmology 2015; 26: 73-77 (IGR: 16-4)


60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Zhang G
Cellular and molecular neurobiology 2015; 35: 633-640 (IGR: 16-4)


60690 Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria
Holzbaur EL
Autophagy 2015; 11: 422-424 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Green CR
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Lashay A
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Origlia N
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


60427 Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury
Huang YS
Investigative Ophthalmology and Visual Science 2015; 56: 1506-1516 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Namekata K
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Majsterek I
BioMed research international 2015; 2015: 258281 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Kong YX
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60365 Differential protection of injured retinal ganglion cell dendrites by brimonidine
Duong-Polk KX
Investigative Ophthalmology and Visual Science 2015; 56: 1789-1804 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Crabb DP
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60204 Enhanced retinal ganglion cell survival in glaucoma by hypoxic postconditioning after disease onset
Zhang L
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2015; 12: 502-514 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Talwar N
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Duong-Polk KX
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Lin J
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60163 Expression of inducible heat shock proteins Hsp27 and Hsp70 in the visual pathway of rats subjected to various models of retinal ganglion cell injury
Wood JP
PLoS ONE 2014; 9: e114838 (IGR: 16-4)


60187 Differential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes
Payne AJ
Experimental Neurology 2015; 265: 59-68 (IGR: 16-4)


60064 Retinal microglia: just bystander or target for therapy?
Scholz R
Progress in Retinal and Eye Research 2015; 45: 30-57 (IGR: 16-4)


60627 Glutathione attenuates nitric oxide-induced retinal lipid and protein changes
Shan SW
Ophthalmic and Physiological Optics 2015; 35: 135-146 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Endo K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60245 Discovery of novel inhibitors for the treatment of glaucoma
Trinh HM
Expert Opinion on Drug Discovery 2015; 10: 293-313 (IGR: 16-4)


60705 Autophagy in axonal degeneration in glaucomatous optic neuropathy
Kitaoka Y
Progress in Retinal and Eye Research 2015; 47: 1-18 (IGR: 16-4)


60437 Retinal and trabecular degeneration in glaucoma: New insights into pathogenesis and treatment
Roubeix C
Journal Français d'Ophtalmologie 2015; 38: 347-356 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Vasei M
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Rutledge MA
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60163 Expression of inducible heat shock proteins Hsp27 and Hsp70 in the visual pathway of rats subjected to various models of retinal ganglion cell injury
Casson RJ
PLoS ONE 2014; 9: e114838 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Teotia P
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60142 Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury
Choi D
Investigative Ophthalmology and Visual Science 2015; 56: 412-419 (IGR: 16-4)


60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Przybyłowska-Sygut K
BioMed research international 2015; 2015: 258281 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Nadal-Nicolás FM
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Breen KT
Disease models & mechanisms 2015; 0: (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Arzeno A
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Falsini B
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


60187 Differential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes
Patel KR
Experimental Neurology 2015; 265: 59-68 (IGR: 16-4)


60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Rhodes JD
PLoS ONE 2015; 10: e0115591 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Kang JH
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60430 Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve
Horner PJ
Investigative Ophthalmology and Visual Science 2015; 56: 1437-1446 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Krupp C
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Suzuki T
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Gu H
Cellular and molecular neurobiology 2015; 35: 633-640 (IGR: 16-4)


60365 Differential protection of injured retinal ganglion cell dendrites by brimonidine
Hammond D
Investigative Ophthalmology and Visual Science 2015; 56: 1789-1804 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Bunce C
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Duruksu G
Cytotherapy 2015; 17: 543-559 (IGR: 16-4)


60245 Discovery of novel inhibitors for the treatment of glaucoma
Pal D
Expert Opinion on Drug Discovery 2015; 10: 293-313 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Hammond D
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
Zhang SG
Neural Regeneration Research 2015; 10: 432-437 (IGR: 16-4)


60408 Retinal Microglia in Glaucoma
Zhang XL
Journal of Glaucoma 2016; 25: 459-465 (IGR: 16-4)


60762 GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57
Funke S
Journal of Pharmacological Sciences 2015; 127: 298-304 (IGR: 16-4)


60689 Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina
Igarashi T
Clinical and Experimental Ophthalmology 2015; 43: 568-577 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Freitag CE
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60437 Retinal and trabecular degeneration in glaucoma: New insights into pathogenesis and treatment
Sapienza A
Journal Français d'Ophtalmologie 2015; 38: 347-356 (IGR: 16-4)


60825 Study of thioredoxin antioxidative system in lateral geniculate body of chronic intraocular hypertension rat
Wu J
Chinese Journal of Ophthalmology 2015; 51: 120-125 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Wang XH
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Salinas-Navarro M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60427 Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury
Chen JT
Investigative Ophthalmology and Visual Science 2015; 56: 1506-1516 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Leung J
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60186 Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Guo X
American Journal of Pathology 2015; 185: 756-764 (IGR: 16-4)


60064 Retinal microglia: just bystander or target for therapy?
Rutar M
Progress in Retinal and Eye Research 2015; 45: 30-57 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Danesh-Meyer HV
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60534 Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
Ward NJ
Channels (Austin, Tex.) 2015; 9: 102-113 (IGR: 16-4)


60204 Enhanced retinal ganglion cell survival in glaucoma by hypoxic postconditioning after disease onset
Chiang CW
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2015; 12: 502-514 (IGR: 16-4)


60242 Activation of autophagy and paraptosis in retinal ganglion cells after retinal ischemia and reperfusion injury in rats
Ma B
Experimental and therapeutic medicine 2015; 9: 476-482 (IGR: 16-4)


60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Noro T
Neuroscience Letters 2015; 588: 108-113 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Emre E
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60671 Neuroprotective therapies for glaucoma
Zhang C
Drug design, development and therapy 2015; 9: 1469-1479 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Kimura A
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Noh YH
GLIA 2015; 63: 736-753 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Trounce IA
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Rupenthal ID
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Krishnamoorthy RR
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Tassoni A
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60242 Activation of autophagy and paraptosis in retinal ganglion cells after retinal ischemia and reperfusion injury in rats
Gao S
Experimental and therapeutic medicine 2015; 9: 476-482 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Sroka-Saidi K
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Dang TM
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Broadway DC
PLoS ONE 2015; 10: e0115591 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Mueller BH
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60204 Enhanced retinal ganglion cell survival in glaucoma by hypoxic postconditioning after disease onset
Zhu Y
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2015; 12: 502-514 (IGR: 16-4)


60627 Glutathione attenuates nitric oxide-induced retinal lipid and protein changes
Lam HY
Ophthalmic and Physiological Optics 2015; 35: 135-146 (IGR: 16-4)


60689 Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina
Takahashi H
Clinical and Experimental Ophthalmology 2015; 43: 568-577 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Cengiz A
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60437 Retinal and trabecular degeneration in glaucoma: New insights into pathogenesis and treatment
Réaux-Le Goazigo A
Journal Français d'Ophtalmologie 2015; 38: 347-356 (IGR: 16-4)


60534 Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
Chakravarthy R
Channels (Austin, Tex.) 2015; 9: 102-113 (IGR: 16-4)


60427 Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury
Chen YH
Investigative Ophthalmology and Visual Science 2015; 56: 1506-1516 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Jiménez-López M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Jiménez-López M
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Miao Y
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60408 Retinal Microglia in Glaucoma
Jonas JB
Journal of Glaucoma 2016; 25: 459-465 (IGR: 16-4)


60825 Study of thioredoxin antioxidative system in lateral geniculate body of chronic intraocular hypertension rat
Sun X
Chinese Journal of Ophthalmology 2015; 51: 120-125 (IGR: 16-4)


60762 GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57
Beck S
Journal of Pharmacological Sciences 2015; 127: 298-304 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Okereke OI
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Fujimura K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Choi JY
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60187 Differential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes
Naumchuk Y
Experimental Neurology 2015; 265: 59-68 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Lascaratos G
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Harada C
Neuroscience Letters 2015; 588: 108-113 (IGR: 16-4)


60430 Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve
Inman DM
Investigative Ophthalmology and Visual Science 2015; 56: 1437-1446 (IGR: 16-4)


60064 Retinal microglia: just bystander or target for therapy?
Wong WT
Progress in Retinal and Eye Research 2015; 45: 30-57 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Leung CK
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
Yuan YS
Neural Regeneration Research 2015; 10: 432-437 (IGR: 16-4)


60186 Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Noro T
American Journal of Pathology 2015; 185: 756-764 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Hoshijima M
GLIA 2015; 63: 736-753 (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Cerri E
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Ai J
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Pirhan D
Cytotherapy 2015; 17: 543-559 (IGR: 16-4)


60245 Discovery of novel inhibitors for the treatment of glaucoma
Mitra AK
Expert Opinion on Drug Discovery 2015; 10: 293-313 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Spitzer MS
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Liu Y
Cellular and molecular neurobiology 2015; 35: 633-640 (IGR: 16-4)


60142 Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury
Choe TE
Investigative Ophthalmology and Visual Science 2015; 56: 412-419 (IGR: 16-4)


60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Pytel D
BioMed research international 2015; 2015: 258281 (IGR: 16-4)


60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Chagovetz AA
Disease models & mechanisms 2015; 0: (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Noro T
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60365 Differential protection of injured retinal ganglion cell dendrites by brimonidine
Chindasub P
Investigative Ophthalmology and Visual Science 2015; 56: 1789-1804 (IGR: 16-4)


60186 Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Harada C
American Journal of Pathology 2015; 185: 756-764 (IGR: 16-4)


60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Lao J
Cellular and molecular neurobiology 2015; 35: 633-640 (IGR: 16-4)


60242 Activation of autophagy and paraptosis in retinal ganglion cells after retinal ischemia and reperfusion injury in rats
Li X
Experimental and therapeutic medicine 2015; 9: 476-482 (IGR: 16-4)


60064 Retinal microglia: just bystander or target for therapy?
Provis JM
Progress in Retinal and Eye Research 2015; 45: 30-57 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Valiente-Soriano FJ
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Wang SY
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60427 Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury
Tai MC
Investigative Ophthalmology and Visual Science 2015; 56: 1506-1516 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Lukas TJ
GLIA 2015; 63: 736-753 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Azuchi Y
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Weinreb RN
Neurobiology of Aging 2015; 0: (IGR: 16-4)


60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Subaşi C
Cytotherapy 2015; 17: 543-559 (IGR: 16-4)


60187 Differential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes
Koulen P
Experimental Neurology 2015; 265: 59-68 (IGR: 16-4)


60627 Glutathione attenuates nitric oxide-induced retinal lipid and protein changes
Fung MY
Ophthalmic and Physiological Optics 2015; 35: 135-146 (IGR: 16-4)


60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Tanaka K
Neuroscience Letters 2015; 588: 108-113 (IGR: 16-4)


60437 Retinal and trabecular degeneration in glaucoma: New insights into pathogenesis and treatment
Mélik-Parsadaniantz S
Journal Français d'Ophtalmologie 2015; 38: 347-356 (IGR: 16-4)


60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Szymanek K
BioMed research international 2015; 2015: 258281 (IGR: 16-4)


60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Steele MR
Disease models & mechanisms 2015; 0: (IGR: 16-4)


60534 Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
Ho KW
Channels (Austin, Tex.) 2015; 9: 102-113 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Bernal-Garro JM
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Amalfitano F
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Kürşat Yıldız D
Current Eye Research 2015; 0: 1-11 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Hurst J
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Boccio J
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Everitt C
PLoS ONE 2015; 10: e0115591 (IGR: 16-4)


60762 GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57
Pfeiffer N
Journal of Pharmacological Sciences 2015; 127: 298-304 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Kurauchi Y
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60365 Differential protection of injured retinal ganglion cell dendrites by brimonidine
Leung CK
Investigative Ophthalmology and Visual Science 2015; 56: 1789-1804 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Fahy ET
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Khoshzaban A
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Phatak NR
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Martin KR
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Wiggs JL
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
Li Y
Neural Regeneration Research 2015; 10: 432-437 (IGR: 16-4)


60689 Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina
Ohta S
Clinical and Experimental Ophthalmology 2015; 43: 568-577 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Qiu F
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Russ H
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60142 Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury
Morrison JC
Investigative Ophthalmology and Visual Science 2015; 56: 412-419 (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Barloscio D
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
He S
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Ambati BK
Disease models & mechanisms 2015; 0: (IGR: 16-4)


60762 GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57
Grus FH
Journal of Pharmacological Sciences 2015; 127: 298-304 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Mori A
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60064 Retinal microglia: just bystander or target for therapy?
Langmann T
Progress in Retinal and Eye Research 2015; 45: 30-57 (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Fabiani C
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


60689 Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina
Oharazawa H
Clinical and Experimental Ophthalmology 2015; 43: 568-577 (IGR: 16-4)


60437 Retinal and trabecular degeneration in glaucoma: New insights into pathogenesis and treatment
Baudouin C
Journal Français d'Ophtalmologie 2015; 38: 347-356 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Keshel SH
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Rammes G
Neuropharmacology 2015; 92: 158-169 (IGR: 16-4)


60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Szaflik J
BioMed research international 2015; 2015: 258281 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Wu Y
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60627 Glutathione attenuates nitric oxide-induced retinal lipid and protein changes
Li KK
Ophthalmic and Physiological Optics 2015; 35: 135-146 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Frieden E
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60242 Activation of autophagy and paraptosis in retinal ganglion cells after retinal ischemia and reperfusion injury in rats
Liu Y
Experimental and therapeutic medicine 2015; 9: 476-482 (IGR: 16-4)


60534 Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
Calkins DJ
Channels (Austin, Tex.) 2015; 9: 102-113 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Toris C
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60365 Differential protection of injured retinal ganglion cell dendrites by brimonidine
Weinreb RN
Investigative Ophthalmology and Visual Science 2015; 56: 1789-1804 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Anand N
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Semba K
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Pasquale LR
PLoS ONE 2015; 10: e0123682 (IGR: 16-4)


60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Li K
Cellular and molecular neurobiology 2015; 35: 633-640 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
García-Ayuso D
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Namekata K
Neuroscience Letters 2015; 588: 108-113 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Ellisman MH
GLIA 2015; 63: 736-753 (IGR: 16-4)


60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
Lv HB
Neural Regeneration Research 2015; 10: 432-437 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Bui BV
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Sanderson J
PLoS ONE 2015; 10: e0115591 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Villegas-Pérez MP
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60427 Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury
Chen CL
Investigative Ophthalmology and Visual Science 2015; 56: 1506-1516 (IGR: 16-4)


60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Erman G
Cytotherapy 2015; 17: 543-559 (IGR: 16-4)


60186 Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Harada T
American Journal of Pathology 2015; 185: 756-764 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Schultheiss M
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60627 Glutathione attenuates nitric oxide-induced retinal lipid and protein changes
To CH
Ophthalmic and Physiological Optics 2015; 35: 135-146 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Bartz-Schmidt KU
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
Gan JH
Neural Regeneration Research 2015; 10: 432-437 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Agudo-Barriuso M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Harada T
Neuroscience Letters 2015; 588: 108-113 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Morrison J
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Morrison JC
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Vetter ML
Disease models & mechanisms 2015; 0: (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Sansò M
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Barabadi Z
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60427 Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury
Liang CM
Investigative Ophthalmology and Visual Science 2015; 56: 1506-1516 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Li F
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Nakahara T
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Karaöz E
Cytotherapy 2015; 17: 543-559 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Weinreb RN
GLIA 2015; 63: 736-753 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Ma HY
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Harada C
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Azuara-Blanco A
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Bhargava A
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Guan H
Cellular and molecular neurobiology 2015; 35: 633-640 (IGR: 16-4)


60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Szaflik JP
BioMed research international 2015; 2015: 258281 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Bernal-Garro JM
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Vidal-Sanz M
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936 (IGR: 16-4)


60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Ishii K
European Journal of Pharmacology 2015; 756: 52-58 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Maynard G
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Avilés-Trigueros M
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Bourne RR
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Forster MJ
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Szurman P
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Wu J
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Chrysostomou V
Experimental Eye Research 2015; 141: 3-8 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Yoshida H
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Perkins GA
GLIA 2015; 63: 736-753 (IGR: 16-4)


60627 Glutathione attenuates nitric oxide-induced retinal lipid and protein changes
Do CW
Ophthalmic and Physiological Optics 2015; 35: 135-146 (IGR: 16-4)


60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Ahmad I
Stem Cells 2015; 33: 1743-1758 (IGR: 16-4)


60164 Rescue of retinal function by BDNF in a mouse model of glaucoma
Giovannini L
PLoS ONE 2014; 9: e115579 (IGR: 16-4)


60188 Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Bahrami H
Biochemical and Biophysical Research Communications 2015; 457: 154-160 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Tsai JC
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Cheng XL
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Mitamura Y
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60784 Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina
Schnichels S
Journal of Vision Exp 2015; 0: (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Yorio T
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Broadway DC
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Agudo-Barriuso M
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Harada T
Neuroscience Letters 2015; 592: 27-31 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Sun XH
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Cunliffe IA
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60269 Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
Krishnamoorthy RR
Investigative Ophthalmology and Visual Science 2015; 56: 893-907 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Villegas-Pérez MP
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Strittmatter SM
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Diamond JP
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Yang XL
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Vidal-Sanz M
Experimental Eye Research 2015; 132: 17-33 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Fraser SG
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


60748 GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model
Wang Z
Journal of Neuroscience 2015; 35: 5409-5421 (IGR: 16-4)


60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Ho TA; Martin KR; McNaught AI; Negi A; Patel K; Russell RA; Shah A; Spry PG; Suzuki K; White ET; Wormald
Lancet 2015; 385: 1295-1304 (IGR: 16-4)


58764 Correlation between the reduced circulating endothelial progenitor cell counts and elevated intraocular pressure-induced retinal ganglion cell apoptosis
Yao B; Zhao Q; Yan H; Chen F; Liu L
Current Eye Research 2014; 0: 1-10 (IGR: 16-3)


59060 The effect of visual blue light on mitochondrial function associated with retinal ganglions cells
Osborne NN; Núñez-Álvarez C; del Olmo-Aguado S
Experimental Eye Research 2014; 128: 8-14 (IGR: 16-3)


59092 Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells
Lin WJ; Kuang HY
Autophagy 2014; 10: 1692-1701 (IGR: 16-3)


59230 Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice
Flachsbarth K; Kruszewski K; Jung G; Jankowiak W; Riecken K; Wagenfeld L; Richard G; Fehse B; Bartsch U
Investigative Ophthalmology and Visual Science 2014; 55: 7029-7039 (IGR: 16-3)


59037 CD146- and CD105-positive phenotypes of retinal ganglion cells. Are these in situ proofs of neuronal regeneration?
Vrapciu AD; Rusu MC; Voinea LM; Corbu CG
Medical Hypotheses 2014; 83: 497-500 (IGR: 16-3)


59479 Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma
Abu-Hassan DW; Li X; Ryan EI; Acott TS; Kelley MJ
Stem Cells 2015; 33: 751-761 (IGR: 16-3)


59533 Retinal transcriptome profiling at transcription start sites: a cap analysis of gene expression early after axonal injury
Yasuda M; Tanaka Y; Nishiguchi KM; Ryu M; Tsuda S; Maruyama K; Nakazawa T
BMC Genomics 2014; 15: 982 (IGR: 16-3)


58810 Toxicological and pharmacokinetic properties of QPI-1007, a chemically modified synthetic siRNA targeting caspase 2 mRNA, following intravitreal injection
Solano EC; Kornbrust DJ; Beaudry A; Foy JW; Schneider DJ; Thompson JD
Nucleic acid therapeutics 2014; 24: 258-266 (IGR: 16-3)


59532 Downregulation of microRNA-100 protects apoptosis and promotes neuronal growth in retinal ganglion cells
Kong N; Lu X; Li B
BMC molecular biology 2014; 15: 25 (IGR: 16-3)


58967 Oncomodulin/truncated protamine-mediated Nogo-66 receptor small interference RNA delivery promotes axon regeneration in retinal ganglion cells
Cui Z; Kang J; Hu D; Zhou J; Wang Y
Molecules and cells 2014; 37: 613-619 (IGR: 16-3)


58791 Synthetic conantokin peptides potently inhibit N-methyl-D-aspartate receptor-mediated currents of retinal ganglion cells
Huang L; Balsara RD; Castellino FJ
Journal of Neuroscience Research 2014; 92: 1767-1774 (IGR: 16-3)


58952 Enhanced survival of retinal ganglion cells is mediated by Müller glial cell-derived PEDF
Unterlauft JD; Claudepierre T; Schmidt M; Müller K; Yafai Y; Wiedemann P; Reichenbach A; Eichler W
Experimental Eye Research 2014; 127: 206-214 (IGR: 16-3)


58792 Artemin augments survival and axon regeneration in axotomized retinal ganglion cells
Omodaka K; Kurimoto T; Nakamura O; Sato K; Yasuda M; Tanaka Y; Himori N; Yokoyama Y; Nakazawa T
Journal of Neuroscience Research 2014; 92: 1637-1646 (IGR: 16-3)


58769 Protective effects of protocatechuic acid on retinal ganglion cells from oxidative damage induced by H2O2
Wang Z; Pan X; Wang D; Sun H; Han F; Lv C; Zhang X
Neurological Research 2015; 37: 159-166 (IGR: 16-3)


59340 Emerging functions of pannexin 1 in the eye
Kurtenbach S; Zoidl G
Frontiers in cellular neuroscience 2014; 8: 263 (IGR: 16-3)


59043 The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms
Harvey H; Durant S
Experimental Brain Research 2014; 232: 3363-3377 (IGR: 16-3)


59509 Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation
Weitlauf C; Ward NJ; Lambert WS; Sidorova TN; Ho KW; Sappington RM; Calkins DJ
Journal of Neuroscience 2014; 34: 15369-15381 (IGR: 16-3)


58919 Atoh7 promotes retinal Müller cell differentiation into retinal ganglion cells
Song WT; Zeng Q; Xia XB; Xia K; Pan Q
Cytotechnology 2016; 68: 267-277 (IGR: 16-3)


59004 Tumor necrosis factor-alpha mediates activation of NF-κB and JNK signaling cascades in retinal ganglion cells and astrocytes in opposite ways
Dvoriantchikova G; Ivanov D
European Journal of Neuroscience 2014; 40: 3171-3178 (IGR: 16-3)


59386 Regulation of nitric oxide production by δ-opioid receptors during glaucomatous injury
Husain S; Abdul Y; Singh S; Ahmad A; Husain M
PLoS ONE 2014; 9: e110397 (IGR: 16-3)


59500 Recent progress in research on oxidative stress in glaucoma
Zhou X; Liu R; Wu Z
Chinese Journal of Ophthalmology 2014; 50: 634-637 (IGR: 16-3)


58733 The complex role of neuroinflammation in glaucoma
Soto I; Howell GR
Cold Spring Harbor perspectives in medicine 2014; 4: (IGR: 16-3)


58778 Bis(zinc-dipicolylamine), Zn-DPA, a new marker for apoptosis
Kwong JM; Hoang C; Dukes RT; Yee RW; Gray BD; Pak KY; Caprioli J
Investigative Ophthalmology and Visual Science 2014; 55: 4913-4921 (IGR: 16-3)


59183 Astrocyte processes label for filamentous actin and reorient early within the optic nerve head in a rat glaucoma model
Tehrani S; Johnson EC; Cepurna WO; Morrison JC
Investigative Ophthalmology and Visual Science 2014; 55: 6945-6952 (IGR: 16-3)


58916 Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma
Salt TE; Nizari S; Cordeiro MF; Russ H; Danysz W
Neurotoxicity research 2014; 26: 440-446 (IGR: 16-3)


59420 Therapeutic Retrobulbar Inhibition of STAT3 Protects Ischemic Retina Ganglion Cells
Wong M; Li Y; Li S; Zhang S; Li W; Zhang P; Chen C; Barnstable CJ; Zhang SS; Zhang C; Huang P
Molecular Neurobiology 2015; 52: 1364-1377 (IGR: 16-3)


58930 Alterations of the synapse of the inner retinal layers after chronic intraocular pressure elevation in glaucoma animal model
Park HY; Kim JH; Park CK
Molecular brain 2014; 7: 53 (IGR: 16-3)


59139 Nerve fiber layer thinning lags retinal ganglion cell density following crush axonopathy
Munguba GC; Galeb S; Liu Y; Landy DC; Lam D; Camp A; Samad S; Tapia ML; Lee RK
Investigative Ophthalmology and Visual Science 2014; 55: 6505-6513 (IGR: 16-3)


58726 Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model
Wang K; Peng B; Lin B
GLIA 2014; 62: 1943-1954 (IGR: 16-3)


58934 Loss of outer retinal neurons and circuitry alterations in the DBA/2J mouse
Fernández-Sánchez L; de Sevilla Müller LP; Brecha NC; Cuenca N
Investigative Ophthalmology and Visual Science 2014; 55: 6059-6072 (IGR: 16-3)


58819 Effects of a conventional photocoagulator and a 3-ns pulse laser on preconditioning responses and retinal ganglion cell survival after optic nerve crush
Shibeeb O; Wood JP; Casson RJ; Chidlow G
Experimental Eye Research 2014; 127: 77-90 (IGR: 16-3)


58860 Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma
Parisi V; Centofanti M; Gandolfi S; Marangoni D; Rossetti L; Tanga L; Tardini M; Traina S; Ungaro N; Vetrugno M; Falsini B
Journal of Glaucoma 2014; 23: 391-404 (IGR: 16-3)


58999 Estimated rates of retinal ganglion cell loss in glaucomatous eyes with and without optic disc hemorrhages
Gracitelli CP; Tatham AJ; Zangwill LM; Weinreb RN; Liu T; Medeiros FA
PLoS ONE 2014; 9: e105611 (IGR: 16-3)


59079 Morphologic changes in the anterior and posterior subregions of V1 and V2 and the V5/MT+ in patients with primary open-angle glaucoma
Yu L; Yin X; Dai C; Liang M; Wei L; Li C; Zhang J; Xie B; Wang J
Brain Research 2014; 1588: 135-143 (IGR: 16-3)


58773 Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma
Semba K; Namekata K; Kimura A; Harada C; Mitamura Y; Harada T
Cell Death and Disease 2014; 5: e1341 (IGR: 16-3)


59438 Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress
Hong S; Iizuka Y; Lee T; Kim CY; Seong GJ
Molecular Vision 2014; 20: 1456-1462 (IGR: 16-3)


59266 The Novel Rho Kinase (ROCK) Inhibitor K-115: A New Candidate Drug for Neuroprotective Treatment in Glaucoma
Yamamoto K; Maruyama K; Himori N; Omodaka K; Yokoyama Y; Shiga Y; Morin R; Nakazawa T
Investigative Ophthalmology and Visual Science 2014; 55: 7126-7136 (IGR: 16-3)


58744 Presynaptic inhibition by α2 receptor/adenylate cyclase/PDE4 complex at retinal rod bipolar synapse
Dong CJ; Guo Y; Ye Y; Hare WA
Journal of Neuroscience 2014; 34: 9432-9440 (IGR: 16-3)


59294 Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosis
Cheng H; Ding Y; Yu R; Chen J; Wu C
PLoS ONE 2014; 9: e108090 (IGR: 16-3)


58505 Nerve growth factor modulation of retinal ganglion cell physiology
Roberti G; Mantelli F; Macchi I; Massaro-Giordano M; Centofanti M
Journal of Cellular Physiology 2014; 229: 1130-1133 (IGR: 16-3)


58960 Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma
Howell GR; Macnicoll KH; Braine CE; Soto I; MacAlinao DG; Sousa GL; John SW
Neurobiology of Disease 2014; 71: 44-52 (IGR: 16-3)


59247 Extracellular, stem cells and regenerative ophthalmology
Wang Y; Xie T
Journal of Glaucoma 2014; 23: S30-3 (IGR: 16-3)


58928 Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-κB and ERK signaling pathways in BV2 cells
Dang Y; Xu Y; Wu W; Li W; Sun Y; Yang J; Zhu Y; Zhang C
PLoS ONE 2014; 9: e102522 (IGR: 16-3)


59606 The expression of syntaphilin is down-regulated in the optic nerve after axonal injury
Miki A; Kanamori A; Nakamura M; Matsumoto Y; Mizokami J; Negi A
Experimental Eye Research 2014; 129: 38-47 (IGR: 16-3)


59176 The nerve growth factor signaling and its potential as therapeutic target for glaucoma
Wang H; Wang R; Thrimawithana T; Little PJ; Xu J; Feng ZP; Zheng W
BioMed research international 2014; 2014: 759473 (IGR: 16-3)


59129 Heat shock protein 72 confers protection in retinal ganglion cells and lateral geniculate nucleus neurons via blockade of the SAPK/JNK pathway in a chronic ocular-hypertensive rat model
Li N; Li Y; Duan X
Neural Regeneration Research 2014; 9: 1395-1401 (IGR: 16-3)


59162 Protection of pattern electroretinogram and retinal ganglion cells by oncostatin M after optic nerve injury
Xia X; Wen R; Chou TH; Li Y; Wang Z; Porciatti V
PLoS ONE 2014; 9: e108524 (IGR: 16-3)


59365 Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo
Guo L; Davis B; Nizari S; Normando EM; Shi H; Galvao J; Turner L; Shi J; Clements M; Parrinello S; Cordeiro MF
Cell Death and Disease 2014; 5: e1460 (IGR: 16-3)


58609 Preserving neural retina through re-emerging herbal interventions
Anand A; Modgil S; Sharma VL; Shri R; Kaushik S
Journal of Cellular Biochemistry 2014; 115: 1659-1668 (IGR: 16-3)


59499 The option of neuroprotective therapeutics for glaucoma
Xiong S; Xu X
Chinese Journal of Ophthalmology 2014; 50: 630-633 (IGR: 16-3)


59530 Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model
Ishikawa M; Yoshitomi T; Zorumski CF; Izumi Y
Investigative Ophthalmology and Visual Science 2014; 0: (IGR: 16-3)


59065 Retinal ganglion cell polarization using immobilized guidance cues on a tissue-engineered scaffold
Kador KE; Alsehli HS; Zindell AN; Lau LW; Andreopoulos FM; Watson BD; Goldberg JL
Acta biomaterialia 2014; 10: 4939-4946 (IGR: 16-3)


58785 Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases
Cuenca N; Fernández-Sánchez L; Campello L; Maneu V; de la Villa P; Lax P; Pinilla I
Progress in Retinal and Eye Research 2014; 43: 17-75 (IGR: 16-3)


58739 Role of crystallins in ocular neuroprotection and axonal regeneration
Thanos S; Böhm MR; Meyer zu Hörste M; Prokosch-Willing V; Hennig M; Bauer D; Heiligenhaus A
Progress in Retinal and Eye Research 2014; 42: 145-161 (IGR: 16-3)


58961 Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases
Santiago AR; Baptista FI; Santos PF; Cristóvão G; Ambrósio AF; Cunha RA; Gomes CA
Mediators of Inflammation 2014; 2014: 465694 (IGR: 16-3)


59535 Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush
Mac Nair CE; Fernandes KA; Schlamp CL; Libby RT; Nickells RW
Journal of Neuroinflammation 2014; 11: 194 (IGR: 16-3)


59472 Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia
Bond WS; Rex TS
Frontiers in immunology 2014; 5: 523 (IGR: 16-3)


59003 Neuroprotective effect against axonal damage-induced retinal ganglion cell death in apolipoprotein E-deficient mice through the suppression of kainate receptor signaling
Omodaka K; Nishiguchi KM; Yasuda M; Tanaka Y; Sato K; Nakamura O; Maruyama K; Nakazawa T
Brain Research 2014; 1586: 203-212 (IGR: 16-3)


58752 Dock GEFs and their therapeutic potential: neuroprotection and axon regeneration
Namekata K; Kimura A; Kawamura K; Harada C; Harada T
Progress in Retinal and Eye Research 2014; 43: 1-16 (IGR: 16-3)


57514 Distal axonopathy in glaucomatous optic neuropathy
Zhang X; Liu S; Yi J
Chinese Journal of Ophthalmology 2014; 50: 391-394 (IGR: 16-2)


57173 Elevated hydrostatic pressures induce apoptosis and oxidative stress through mitochondrial membrane depolarization in PC12 neuronal cells: A cell culture model of glaucoma
Tök L; Nazıroğlu M; Uğuz AC; Tök O
Journal of receptor and signal transduction research 2014; 34: 410-416 (IGR: 16-2)


57297 DLK-dependent signaling is important for somal but not axonal degeneration of retinal ganglion cells following axonal injury
Fernandes KA; Harder JM; John SW; Shrager P; Libby RT
Neurobiology of Disease 2014; 69: 108-116 (IGR: 16-2)


57301 Targeting mitochondrial dysfunction as in aging and glaucoma
Osborne NN; Alvarez CN; Del Olmo Aguado S
Drug Discovery Today 2014; 19: 1613-1622 (IGR: 16-2)


57466 Retinal ganglion cell death is triggered by paraptosis via reactive oxygen species production: A brief literature review presenting a novel hypothesis in glaucoma pathology
Xu K; Zhang H; Zhao J; Zhu X; Wang Y; Wu R
Molecular medicine reports 2014; 10: 1179-1183 (IGR: 16-2)


57427 Complement activation after induction of ocular hypertension in an animal model
Becker S; Reinehr S; Burkhard Dick H; Joachim SC
Ophthalmologe 2015; 112: 41-48 (IGR: 16-2)


57428 BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma
You Y; Li J; Gupta V; Golzan M; Klistorner A; van den Buuse M; Graham S
Biochimica et Biophysica Acta 2014; 1842: 1567-1578 (IGR: 16-2)


57133 Retinal architecture and mfERG: Optic nerve head component response characteristics in MS
Schnurman ZS; Frohman TC; Beh SC; Conger D; Conger A; Saidha S; Galetta S; Calabresi PA; Green AJ; Balcer LJ; Frohman EM
Neurology 2014; 82: 1888-1896 (IGR: 16-2)


57402 Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy
Wang Y; Yang Q; Guo L; Yin Y; Fan N; Zhou X; Cai SP; Kaufman PL; Liu X
Experimental Eye Research 2014; 125: 128-134 (IGR: 16-2)


57238 IL-6, A1 and A2aR: a crosstalk that modulates BDNF and induces neuroprotection
Perígolo-Vicente R; Ritt K; Gonçalves-de-Albuquerque CF; Castro-Faria-Neto HC; Paes-de-Carvalho R; Giestal-de-Araujo E
Biochemical and Biophysical Research Communications 2014; 449: 477-482 (IGR: 16-2)


57305 A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy
Roberti G; Tanga L; Parisi V; Sampalmieri M; Centofanti M; Manni G
Indian Journal of Ophthalmology 2014; 62: 549-553 (IGR: 16-2)


57150 Critical neuroprotective roles of heme oxygenase-1 induction against axonal injury-induced retinal ganglion cell death
Himori N; Maruyama K; Yamamoto K; Yasuda M; Ryu M; Omodaka K; Shiga Y; Tanaka Y; Nakazawa T
Journal of Neuroscience Research 2014; 92: 1134-1142 (IGR: 16-2)


57024 Taurine: the comeback of a neutraceutical in the prevention of retinal degenerations
Froger N; Moutsimilli L; Cadetti L; Jammoul F; Wang QP; Fan Y; Gaucher D; Rosolen SG; Neveux N; Cynober L; Sahel JA; Picaud S
Progress in Retinal and Eye Research 2014; 41: 44-63 (IGR: 16-2)


57453 Neuroprotective Effect of Curcumin Against Oxidative Damage in BV-2 Microglia and High Intraocular Pressure Animal Model
Yue YK; Mo B; Zhao J; Yu YJ; Liu L; Yue CL; Liu W
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 657-664 (IGR: 16-2)


57059 FTY720 protects retinal ganglion cells in experimental glaucoma
You Y; Gupta VK; Li JC; Al-Adawy N; Klistorner A; Graham SL
Investigative Ophthalmology and Visual Science 2014; 55: 3060-3066 (IGR: 16-2)


56358 Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection
Ward NJ; Ho KW; Lambert WS; Weitlauf C; Calkins DJ
Journal of Neuroscience 2014; 34: 3161-3170 (IGR: 16-1)


56248 Effect of RSCs combined with COP-1 on optic nerve damage in glaucoma rat model
Fu WC; Jiang Y; Zhang L
Asian Pacific journal of tropical medicine 2014; 7: 317-320 (IGR: 16-1)


56393 Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina
Wang M; Wang X; Zhao L; Ma W; Rodriguez IR; Fariss RN; Wong WT
Journal of Neuroscience 2014; 34: 3793-3806 (IGR: 16-1)


56181 Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma
Lee D; Shim MS; Kim KY; Noh YH; Kim H; Kim SY; Weinreb RN; Ju WK
Investigative Ophthalmology and Visual Science 2014; 55: 993-1005 (IGR: 16-1)


56128 A decade of proteomics studies of glaucomatous neurodegeneration
Tezel G
Proteomics - Clinical Applications 2014; 8: 154-167 (IGR: 16-1)


56349 Minocycline upregulates pro-survival genes and downregulates pro-apoptotic genes in experimental glaucoma
Levkovitch-Verbin H; Waserzoog Y; Vander S; Makarovsky D; Piven I
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 761-772 (IGR: 16-1)


56251 Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure
Liu P; Zhang M; Shoeb M; Hogan D; Tang L; Syed MF; Wang CZ; Campbell GA; Ansari NH
Free Radical Biology and-Medicine 2014; 69: 289-299 (IGR: 16-1)


56532 Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma
Zode GS; Sharma AB; Lin X; Searby CC; Bugge K; Kim GH; Clark AF; Sheffield VC
Journal of Clinical Investigation 2014; 124: 1956-1965 (IGR: 16-1)


56138 Hydroxycinnamic acids in Crepidiastrum denticulatum protect oxidative stress-induced retinal damage
Ahn HR; Lee HJ; Kim KA; Kim CY; Nho CW; Jang H; Pan CH; Lee CY; Jung SH
Journal of agricultural and food chemistry 2014; 62: 1310-1323 (IGR: 16-1)


56162 Mitochondrial DNA variant discovery in normal-tension glaucoma patients by next-generation sequencing
Jeoung JW; Seong MW; Park SS; Kim DM; Kim SH; Park KH
Investigative Ophthalmology and Visual Science 2014; 55: 986-992 (IGR: 16-1)


56225 Glucose-induced temporary visual recovery in primary open-angle glaucoma: a double-blind, randomized study
Casson RJ; Han G; Ebneter A; Chidlow G; Glihotra J; Newland H; Wood JP
Ophthalmology 2014; 121: 1203-1211 (IGR: 16-1)


56180 A nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model
Iwamoto K; Birkholz P; Schipper A; Mata D; Linn DM; Linn CL
Investigative Ophthalmology and Visual Science 2014; 55: 1078-1087 (IGR: 16-1)


56445 Cyclosporine a protects RGC-5 cells from excitotoxic cell death
Schultheiss M; Schnichels S; Mlynczak T; Dipl-Ing JH; Bartz-Schmidt KU; Szurman P; Spitzer MS
Journal of Glaucoma 2014; 23: 219-224 (IGR: 16-1)


56519 MMPs in the neuroretina and optic nerve: modulators of glaucoma pathogenesis and repair?
De Groef L; Van Hove I; Dekeyster E; Stalmans I; Moons L
Investigative Ophthalmology and Visual Science 2014; 55: 1953-1964 (IGR: 16-1)


56396 Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury
Kim SY; Shim MS; Kim KY; Weinreb RN; Wheeler LA; Ju WK
Cell Death and Disease 2014; 5: e1105 (IGR: 16-1)


56672 Rapamycin is neuroprotective in a rat chronic hypertensive glaucoma model
Su W; Li Z; Jia Y; Zhuo Y
PLoS ONE 2014; 9: e99719 (IGR: 16-1)


56122 Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transection
Levkovitch-Verbin H; Waserzoog Y; Vander S; Makarovsky D; Ilia P
The International Journal of Neuroscience 2014; 124: 755-761 (IGR: 16-1)


56200 Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina
Payne AJ; Kaja S; Naumchuk Y; Kunjukunju N; Koulen P
International journal of molecular sciences 2014; 15: 1865-1886 (IGR: 16-1)


56340 Comparative quantitative study of astrocytes and capillary distribution in optic nerve laminar regions
Balaratnasingam C; Kang MH; Yu P; Chan G; Morgan WH; Cringle SJ; Yu DY
Experimental Eye Research 2014; 121: 11-22 (IGR: 16-1)


56239 Neuroprotective properties of citicoline: facts, doubts and unresolved issues
Grieb P
CNS Drugs 2014; 28: 185-193 (IGR: 16-1)


56674 Salvia miltiorrhiza extracts protect against retinal injury in a rat glaucoma model
Zhu Q; Su G; Nie L; Wang C; He Y; Liu X
Experimental and therapeutic medicine 2014; 7: 1513-1515 (IGR: 16-1)


56655 An emerging treatment option for glaucoma: Rho kinase inhibitors
Wang SK; Chang RT
Clinical Ophthalmology 2014; 8: 883-890 (IGR: 16-1)


55317 Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma
Hu Y; Tan HB; Wang XM; Rong H; Cui HP; Cui H
Clinical Interventions in Aging 2013; 8: 1467-1470 (IGR: 15-4)


55755 E50K-OPTN-Induced Retinal Cell Death Involves the Rab GTPase-Activating Protein, TBC1D17 Mediated Block in Autophagy
Chalasani ML; Kumari A; Radha V; Swarup G
PLoS ONE 2014; 9: e95758 (IGR: 15-4)


55741 Osteopontin Is Induced by TGF-β2 and Regulates Metabolic Cell Activity in Cultured Human Optic Nerve Head Astrocytes
Neumann C; Garreis F; Paulsen F; Hammer CM; Birke MT; Scholz M
PLoS ONE 2014; 9: e92762 (IGR: 15-4)


55720 Antioxidant therapy for retinal disease
Kiang AS; Humphries MM; Campbell M; Humphries P
Adv Exp Med Biol 2014; 801: 783-789 (IGR: 15-4)


55520 Roles of retinal Müller cells in health and glaucoma
Gao F; Ji M; Wu JH; Wang ZF
Acta physiologica Sinica 2013; 65: 654-663 (IGR: 15-4)


55581 Lipid peroxidation: pathophysiological and pharmacological implications in the eye
Njie-Mbye YF; Kulkarni-Chitnis M; Opere CA; Barrett A; Ohia SE
Frontiers in physiology 2013; 4: 366 (IGR: 15-4)


55680 Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse
Husain S; Abdul Y; Webster C; Chatterjee S; Kesarwani P; Mehrotra S
PLoS ONE 2014; 9: e89392 (IGR: 15-4)


55731 Spink2 modulates apoptotic susceptibility and is a candidate gene in the Rgcs1 QTL that affects retinal ganglion cell death after optic nerve damage
Dietz JA; Maes ME; Huang S; Yandell BS; Schlamp CL; Montgomery AD; Allingham RR; Hauser MA; Nickells RW
PLoS ONE 2014; 9: e93564 (IGR: 15-4)


55693 Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma
Wang AL; Carroll RC; Nawy S
PLoS ONE 2014; 9: e91288 (IGR: 15-4)


55164 Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions
Joachim SC; Mondon C; Gramlich OW; Grus FH; Dick HB
Journal of Molecular Neuroscience 2014; 52: 216-224 (IGR: 15-4)


55230 Autophagy in retinal ganglion cells in a rhesus monkey chronic hypertensive glaucoma model
Deng S; Wang M; Yan Z; Tian Z; Chen H; Yang X; Zhuo Y
PLoS ONE 2013; 8: e77100 (IGR: 15-4)


55740 Quantifying optic nerve axons in a cat glaucoma model by a semi-automated targeted counting method
Teixeira LB; Buhr KA; Bowie O; Duke FD; Nork TM; Dubielzig RR; McLellan GJ
Molecular Vision 2014; 20: 376-385 (IGR: 15-4)


55739 Tetrandrine protects mouse retinal ganglion cells from ischemic injury
Li W; Yang C; Lu J; Huang P; Barnstable CJ; Zhang C; Zhang SS
Drug design, development and therapy 2014; 8: 327-339 (IGR: 15-4)


55621 Organotypic culture of neural retina as a research model of neurodegeneration of ganglion cells
Gancharova OS; Manskikh VN; Zamyatnin AA; Philippov PP
Biochemistry. Biokhimiia 2013; 78: 1280-1286 (IGR: 15-4)


55278 Evaluation of potential topical and systemic neuroprotective agents for ocular hypertension-induced retinal ischemia-reperfusion injury
Chen YI; Lee YJ; Wilkie DA; Lin CT
Veterinary Ophthalmology 2014; 17: 432-442 (IGR: 15-4)


55441 Calcium channels and their blockers in intraocular pressure and glaucoma
Mayama C
European Journal of Pharmacology 2014; 739: 96-105 (IGR: 15-4)


55596 Tumor necrosis factor-induced optic nerve degeneration and axonal protection
Kitaoka Y
Nippon Ganka Gakkai Zasshi 2013; 117: 878-885 (IGR: 15-4)


55216 Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration
Kitaoka Y; Munemasa Y; Kojima K; Hirano A; Ueno S; Takagi H
Cell Death and Disease 2013; 4: e860 (IGR: 15-4)


55719 Nipradilol Promotes Axon Regeneration Through S-Nitrosylation of PTEN in Retinal Ganglion Cells
Koriyama Y; Kamiya M; Arai K; Sugitani K; Ogai K; Kato S
Adv Exp Med Biol 2014; 801: 751-757 (IGR: 15-4)


55687 γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway
Wilding C; Bell K; Beck S; Funke S; Pfeiffer N; Grus FH
PLoS ONE 2014; 9: e90737 (IGR: 15-4)


55475 Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma
Zhu Y; Zhang L; Gidday JM
Molecular Vision 2013; 19: 2360-2372 (IGR: 15-4)


55421 Activation of muscarinic receptors protects against retinal neurons damage and optic nerve degeneration in vitro and in vivo models
Tan PP; Yuan HH; Zhu X; Cui YY; Li H; Feng XM; Qiu Y; Chen HZ; Zhou W
CNS Neuroscience and Therapeutics 2014; 20: 227-236 (IGR: 15-4)


55709 The effectiveness of endonasal electrophoresis of neuroprotective agents used in the rehabilitative treatment of the patients presenting with primary open angle glaucoma
Nazarova GA; Konchugova TV; Iurova OV; Sichinava NV; Turova EA; Rassulova MA; Morozova NE
Voprosy kurortologii, fizioterapii, i lechebno? fizichesko? kultury 2013; 0: 27-30 (IGR: 15-4)


54501 Retinal ganglion cells: Energetics, compartmentation, axonal transport, cytoskeletons and vulnerability
Yu DY; Cringle SJ; Balaratnasingam C; Morgan WH; Yu PK; Su EN
Progress in Retinal and Eye Research 2013; 36: 217-246 (IGR: 15-3)


54710 RNAi screening identifies GSK3β as a regulator of DRP1 and the neuroprotection of lithium chloride against elevated pressure involved in downregulation of DRP1
Wu JH; Zhang SH; Gao FJ; Lei Y; Chen XY; Gao F; Zhang SJ; Sun XH
Neuroscience Letters 2013; 554: 99-104 (IGR: 15-3)


54638 RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride
del Olmo-Aguado S; Nú,ñ,ez-Á,lvarez C; Ji D; Manso AG; Osborne NN
Brain Research Bulletin 2013; 98: 132-144 (IGR: 15-3)


54770 Neurovascular interactions in the retina: physiological and pathological roles
Nakahara T; Mori A; Kurauchi Y; Sakamoto K; Ishii K
Journal of Pharmacological Sciences 2013; 123: 79-84 (IGR: 15-3)


54502 The role of SIRT1 in ocular aging
Mimura T; Kaji Y; Noma H; Funatsu H; Okamoto S
Experimental Eye Research 2013; 116: 17-26 (IGR: 15-3)


54482 Improved retinal ganglion cell survival through retinal microglia suppression by a chinese herb extract, triptolide, in the DBA/2J mouse model of glaucoma
Yang F; Wu L; Guo X; Wang D; Li Y
Ocular Immunology and Inflammation 2013; 21: 378-389 (IGR: 15-3)


54516 NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina
Bai N; Aida T; Yanagisawa M; Katou S; Sakimura K; Mishina M; Tanaka K
Molecular brain 2013; 6: 34 (IGR: 15-3)


54637 Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma
Williams PA; Howell GR; Barbay JM; Braine CE; Sousa GL; John SW; Morgan JE
PLoS ONE 2013; 8: e72282 (IGR: 15-3)


54852 Enhanced expression of NR2B subunits of NMDA receptors in the inherited glaucomatous DBA/2J mouse retina
Dong LD; Chen J; Li F; Gao F; Wu J; Miao Y; Wang Z
Neural plasticity 2013; 2013: 670254 (IGR: 15-3)


54393 Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma
Nitta E; Hirooka K; Tenkumo K; Fujita T; Nishiyama A; Nakamura T; Itano T; Shiraga F
Cell Death and Disease 2013; 4: e711 (IGR: 15-3)


54546 Brimonidine promotes axon growth after optic nerve injury through Erk phosphorylation
Fujita Y; Sato A; Yamashita T
Cell Death and Disease 2013; 4: e763 (IGR: 15-3)


54853 Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions
Ferraris D; Yang Z; Welsbie D
Future medicinal chemistry 2013; 5: 1923-1934 (IGR: 15-3)


54424 17β-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma
Prokai-Tatrai K; Xin H; Nguyen V; Szarka S; Blazics B; Prokai L; Koulen P
Molecular pharmaceutics 2013; 10: 3253-3261 (IGR: 15-3)


54397 Neuroprotective Effects of Bis(7)-tacrine in a Rat Model of Pressure-Induced Retinal Ischemia
Li JB; Lu ZG; Xu L; Wang Q; Zhang ZH; Fang JH
Cell biochemistry and biophysics 2014; 68: 275-282 (IGR: 15-3)


54876 A case for neuroprotection in ophthalmology: developments in translational research
Payne AJ; Kaja S; Sabates NR; Koulen P
Missouri medicine 2013; 110: 429-436 (IGR: 15-3)


54418 VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro
Beazley-Long N; Hua J; Jehle T; Hulse RP; Dersch R; Lehrling C; Bevan H; Qiu Y; Lagrè,ze WA; Wynick D; Churchill AJ; Kehoe P; Harper SJ; Bates DO; Donaldson LF
American Journal of Pathology 2013; 183: 918-929 (IGR: 15-3)


54508 Lycium barbarum (wolfberry) reduces secondary degeneration and oxidative stress, and inhibits JNK pathway in retina after partial optic nerve transection
Li H; Liang Y; Chiu K; Yuan Q; Lin B; Chang RC; So KF
PLoS ONE 2013; 8: e68881 (IGR: 15-3)


54409 Neuroprotection of medical IOP-lowering therapy
Pfeiffer N; Lamparter J; Gericke A; Grus FH; Hoffmann EM; Wahl J
Cell and Tissue Research 2013; 353: 245-251 (IGR: 15-3)


54565 Protection by an oral disubstituted hydroxylamine derivative against loss of retinal ganglion cell differentiation following optic nerve crush
Lindsey JD; Duong-Polk KX; Dai Y; Nguyen DH; Leung CK; Weinreb RN
PLoS ONE 2013; 8: e65966 (IGR: 15-3)


54652 Activation of M1 mAChRs by lesatropane rescues glutamate neurotoxicity in PC12 cells via PKC-mediated phosphorylation of ERK1/2
Ma K; Yang ZH; Yang LM; Chen HZ; Lu Y
Bosnian journal of basic medical sciences 2013; 13: 146-152 (IGR: 15-3)


54722 Leptin as a neuroprotective agent in glaucoma
Gupta A
Medical Hypotheses 2013; 81: 797-802 (IGR: 15-3)


54450 Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy
Dapper JD; Crish SD; Pang IH; Calkins DJ
Neurobiology of Disease 2013; 59: 26-37 (IGR: 15-3)


54446 Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma
Namekata K; Kimura A; Kawamura K; Guo X; Harada C; Tanaka K; Harada T
Cell Death and Differentiation 2013; 20: 1250-1256 (IGR: 15-3)


54674 Sensory stimulation for lowering intraocular pressure, improving blood flow to the optic nerve and neuroprotection in primary open-angle glaucoma
Rom E
Acupuncture in medicine : journal of the British Medical Acupuncture Society 2013; 31: 416-421 (IGR: 15-3)


53832 Potassium ion channels in retinal ganglion cells (Review)
Zhong YS; Wang J; Liu WM; Zhu YH
Molecular medicine reports 2013; 8: 311-319 (IGR: 15-2)


53841 Central nervous system changes in glaucoma
Yücel Y
Journal of Glaucoma 2013; 22: S24-5 (IGR: 15-2)


53786 The potential of stem cell research for the treatment of neuronal damage in glaucoma
Karl MO
Cell and Tissue Research 2013; 353: 311-325 (IGR: 15-2)


53847 Cell-based therapies for retinal degenerative diseases: a thousand strategies
Lewallen M; Xie T
Journal of Glaucoma 2013; 22: S42-5 (IGR: 15-2)


53938 The role of Müller glia and microglia in glaucoma
Seitz R; Ohlmann A; Tamm ER
Cell and Tissue Research 2013; 353: 339-345 (IGR: 15-2)


53698 Reversible reactivity by optic nerve astrocytes
Sun D; Qu J; Jakobs TC
GLIA 2013; 61: 1218-1235 (IGR: 15-2)


53708 Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio
Kernt M; Arend N; Buerger A; Mann T; Haritoglou C; Ulbig MW; Kampik A; Hirneiss C
Journal of Glaucoma 2013; 22: 404-412 (IGR: 15-2)


53828 Melanopsin-expressing retinal ganglion cell loss and behavioral analysis in the Thy1-CFP-DBA/2J mouse model of glaucoma
Zhang Q; Vuong H; Huang X; Wang Y; Brecha NC; Pu M; Gao J
Science China Life Sciences 2013; 56: 720-730 (IGR: 15-2)


53975 Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush
Dai Y; Lindsey JD; Duong-Polk KX; Chindasub P; Leung CK; Weinreb RN
BMC Ophthalmology 2013; 13: 26 (IGR: 15-2)


53923 The challenges of axon survival: Introduction to the special issue on axonal degeneration
Coleman MP
Experimental Neurology 2013; 246: 1-5 (IGR: 15-2)


53919 Canadian Journal of Ophthalmology Lecture: Translational research advances in glaucoma neuroprotection
Tsai JC
Canadian Journal of Ophthalmology 2013; 48: 141-145 (IGR: 15-2)


53933 Nerve growth factor: basic studies and possible therapeutic applications
Manni L; Rocco ML; Bianchi P; Soligo M; Guaragna M; Barbaro SP; Aloe L
Growth Factors 2013; 31: 115-122 (IGR: 15-2)


53738 Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate
Santos-Carvalho A; Elvas F; Alvaro AR; Ambrósio AF; Cavadas C
Cell Death and Disease 2013; 4: e636 (IGR: 15-2)


53740 Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic
Mi S; Blake Pepinsky R; Cadavid D
CNS Drugs 2013; 27: 493-503 (IGR: 15-2)


53743 The cell stress machinery and retinal degeneration
Athanasiou D; Aguilà M; Bevilacqua D; Novoselov SS; Parfitt DA; Cheetham ME
FEBS Letters 2013; 587: 2008-2017 (IGR: 15-2)


53857 A modified chronic ocular hypertension rat model for retinal ganglion cell neuroprotection
Zhong L
Frontiers of medicine 2013; 7: 367-377 (IGR: 15-2)


53804 Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death
Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T
Journal of Neurochemistry 2013; 127: 669-680 (IGR: 15-2)


53792 Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper
Tamm ER; Schmetterer L; Grehn F
Cell and Tissue Research 2013; 353: 347-354 (IGR: 15-2)


53686 Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity
Bai N; Hayashi H; Aida T; Namekata K; Harada T; Mishina M; Tanaka K
Molecular brain 2013; 6: 22 (IGR: 15-2)


54051 Research advances on the usage of traditional Chinese medicine for neuroprotection in glaucoma
Mi XS; Zhong JX; Chang RC; So KF
Journal of integrative medicine 2013; 11: 233-240 (IGR: 15-2)


53472 Dynamic mobilization of PGC-1α mediates mitochondrial biogenesis for the protection of RGC-5 cells by resveratrol during serum deprivation
Chen S; Fan Q; Li A; Liao D; Ge J; Laties AM; Zhang X
Apoptosis 2013; 18: 786-799 (IGR: 15-2)


54025 Adeno-associated virus-mediated expression of growth-associated protein-43 aggravates retinal ganglion cell death in experimental chronic glaucomatous injury
Huang C; Cen LP; Liu L; Leaver SG; Harvey AR; Cui Q; Pang CP; Zhang M
Molecular Vision 2013; 19: 1422-1432 (IGR: 15-2)


53181 The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease
Sivak JM
Investigative Ophthalmology and Visual Science 2013; 54: 871-880 (IGR: 15-1)


53014 M98K-OPTN induces transferrin receptor degradation and RAB12-mediated autophagic death in retinal ganglion cells
Sirohi K; Chalasani ML; Sudhakar C; Kumari A; Radha V; Swarup G
Autophagy 2013; 9: 510-527 (IGR: 15-1)


52791 Involvement of P2X(7) receptors in retinal ganglion cell death after optic nerve crush injury in rats
Kakurai K; Sugiyama T; Kurimoto T; Oku H; Ikeda T
Neuroscience Letters 2013; 534: 237-241 (IGR: 15-1)


52758 P2X7 receptor activation mediates retinal ganglion cell death in a human retina model of ischemic neurodegeneration
Niyadurupola N; Sidaway P; Ma N; Rhodes JD; Broadway DC; Sanderson J
Investigative Ophthalmology and Visual Science 2013; 54: 2163-2170 (IGR: 15-1)


52990 Effect of heat shock protein 72 expression on etoposide-induced cell death of rat retinal ganglion cells
Sohn S; Im JE; Kim TE; Kee C
Korean Journal of Ophthalmology 2013; 27: 48-51 (IGR: 15-1)


52969 Protective effects of a compound isolated from Alnus japonica on oxidative stress-induced death in transformed retinal ganglion cells
Jo H; Choi SJ; Jung SH
Food and Chemical Toxicology 2013; 56: 425-435 (IGR: 15-1)


52638 Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline
Koriyama Y; Nakayama Y; Matsugo S; Kato S
Brain Research 2013; 1499: 145-157 (IGR: 15-1)


52871 Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss
You Y; Gupta VK; Li JC; Klistorner A; Graham SL
Reviews in the neurosciences 2013; 24: 301-321 (IGR: 15-1)


52473 Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders
Jindal V
Molecular Neurobiology 2013; 48: 186-189 (IGR: 15-1)


52708 A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration
Tezel G
Progress in Retinal and Eye Research 2013; 35: 18-43 (IGR: 15-1)


52951 Kinetics of neurodegeneration based on a risk-related biomarker in animal model of glaucoma
Hayashi T; Shimazawa M; Watabe H; Ose T; Inokuchi Y; Ito Y; Yamanaka H; Urayama S; Watanabe Y; Hara H; Onoe H
Molecular Neurodegeneration 2013; 8: 4 (IGR: 15-1)


52709 Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model
Abdul Y; Akhter N; Husain S
Investigative Ophthalmology and Visual Science 2013; 54: 1816-1828 (IGR: 15-1)


52439 Altered Expression of nNOS/NIDD in the Retina of a Glaucoma Model of DBA/2J Mice and the Intervention by nNOS Inhibition
Chen C; Xu Y; Zhu J; Zhang J; Hu N; Guan H
Journal of Molecular Neuroscience 2013; 51: 47-56 (IGR: 15-1)


53129 Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma
Frankfort BJ; Khan AK; Tse DY; Chung I; Pang JJ; Yang Z; Gross RL; Wu SM
Investigative Ophthalmology and Visual Science 2013; 54: 762-770 (IGR: 15-1)


52448 Three-dimensional evaluation of retinal ganglion cell axon regeneration and pathfinding in whole mouse tissue after injury
Luo X; Salgueiro Y; Beckerman SR; Lemmon VP; Tsoulfas P; Park KK
Experimental Neurology 2013; 247: 653-662 (IGR: 15-1)


52788 Differential cell death and Bcl-2 expression in the mouse retina after glutathione decrease by systemic D,L-buthionine sulphoximine administration
Park MH; Kim SY; Moon C; Bae YC; Moon JI
Molecules and cells 2013; 35: 235-242 (IGR: 15-1)


52531 Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location
Feng L; Zhao Y; Yoshida M; Chen H; Yang JF; Kim TS; Cang J; Troy JB; Liu X
Investigative Ophthalmology and Visual Science 2013; 54: 1106-1117 (IGR: 15-1)


53246 Stanniocalcin-1 protects retinal ganglion cells by inhibiting apoptosis and oxidative damage
Kim SJ; Ko JH; Yun JH; Kim JA; Kim TE; Lee HJ; Kim SH; Park KH; Oh JY
PLoS ONE 2013; 8: e63749 (IGR: 15-1)


53249 α-Lipoic Acid Antioxidant Treatment Limits Glaucoma-Related Retinal Ganglion Cell Death and Dysfunction
Inman DM; Lambert WS; Calkins DJ; Horner PJ
PLoS ONE 2013; 8: e65389 (IGR: 15-1)


52968 Tissue engineering the retinal ganglion cell nerve fiber layer
Kador KE; Montero RB; Venugopalan P; Hertz J; Zindell AN; Valenzuela DA; Uddin MS; Lavik EB; Muller KJ; Andreopoulos FM; Goldberg JL
Biomaterials 2013; 34: 4242-4250 (IGR: 15-1)


53207 Inhibition of histone deacetylases 1 and 3 protects injured retinal ganglion cells
Chindasub P; Lindsey JD; Duong-Polk K; Leung CK; Weinreb RN
Investigative Ophthalmology and Visual Science 2013; 54: 96-102 (IGR: 15-1)


53099 Taurine is a crucial factor to preserve retinal ganglion cell survival
Froger N; Jammoul F; Gaucher D; Cadetti L; Lorach H; Degardin J; Pain D; Dubus E; Forster V; Ivkovic I; Simonutti M; Sahel JA; Picaud S
Adv Exp Med Biol 2013; 775: 69-83 (IGR: 15-1)


52412 Challenges in the development of glaucoma neuroprotection therapy
Liu Y; Pang IH
Cell and Tissue Research 2013; 353: 253-260 (IGR: 15-1)


52546 Value of non-IOP lowering therapy for glaucoma
Cybulska-Heinrich A; Mozaffarieh M; Flammer J
Klinische Monatsblätter für Augenheilkunde 2013; 230: 114-119 (IGR: 15-1)


52662 Neuroprotection in glaucoma: present and future
Chen SD; Wang L; Zhang XL
Chinese Medical Journal 2013; 126: 1567-1577 (IGR: 15-1)


52959 Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death
Welsbie DS; Yang Z; Ge Y; Mitchell KL; Zhou X; Martin SE; Berlinicke CA; Hackler L; Fuller J; Fu J; Cao LH; Han B; Auld D; Xue T; Hirai S; Germain L; Simard-Bisson C; Blouin R; Nguyen JV; Davis CH; Enke RA; Boye SL; Merbs SL; Marsh-Armstrong N; Hauswirth
Proceedings of the National Academy of Sciences of the United States of America 2013; 110: 4045-4050 (IGR: 15-1)


52449 Glaucoma and optic nerve repair
Diekmann H; Fischer D
Cell and Tissue Research 2013; 353: 327-337 (IGR: 15-1)


52805 Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1
Zhu Y; Zhang L; Sasaki Y; Milbrandt J; Gidday JM
Investigative Ophthalmology and Visual Science 2013; 54: 25-36 (IGR: 15-1)


52460 Autocrine and paracrine interactions and neuroprotection in glaucoma
Weber AJ
Cell and Tissue Research 2013; 353: 219-230 (IGR: 15-1)


53065 Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection
Munemasa Y; Kitaoka Y
Frontiers in cellular neuroscience 2012; 6: 60 (IGR: 15-1)


53045 Bimatoprost protects retinal neuronal damage via Akt pathway
Takano N; Tsuruma K; Ohno Y; Shimazawa M; Hara H
European Journal of Pharmacology 2013; 702: 56-61 (IGR: 15-1)


53126 Regional pathology in glaucoma--an overlooked link to neuroprotective strategies
Clarke MS
Medical Hypotheses 2013; 80: 756-758 (IGR: 15-1)


52614 VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma
Foxton RH; Finkelstein A; Vijay S; Dahlmann-Noor A; Khaw PT; Morgan JE; Shima DT; Ng YS
American Journal of Pathology 2013; 182: 1379-1390 (IGR: 15-1)


53128 Oxidative stress and potential applications of free radical scavengers in glaucoma
Aslan M; Dogan S; Kucuksayan E
Redox report : communications in free radical research 2013; 18: 76-87 (IGR: 15-1)


51956 Intrinsically photosensitive retinal ganglion cells are resistant to N-methyl-D-aspartic acid excitotoxicity
DeParis S; Caprara C; Grimm C
Molecular Vision 2012; 18: 2814-2827 (IGR: 14-4)


52022 Inactivation of MARCH5 prevents mitochondrial fragmentation and interferes with cell death in a neuronal cell model
Fang L; Hemion C; Goldblum D; Meyer P; Orgül S; Frank S; Flammer J; Neutzner A
PLoS ONE 2012; 7: e52637 (IGR: 14-4)


51957 Calcineurin activation causes retinal ganglion cell degeneration
Qu J; Matsouaka R; Betensky RA; Hyman BT; Grosskreutz CL
Molecular Vision 2012; 18: 2828-2838 (IGR: 14-4)


51677 Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress
Gupta VK; You Y; Li JC; Klistorner A; Graham SL
Journal of Molecular Neuroscience 2013; 49: 96-104 (IGR: 14-4)


51666 Axon pathology in age-related neurodegenerative disorders
Adalbert R; Coleman MP
Neuropathology and Applied Neurobiology 2012; 0: (IGR: 14-4)


51799 Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucoma
Fu CT; Sretavan DW
Journal of Neuroscience 2012; 32: 15859-15876 (IGR: 14-4)


51679 Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury
Lee D; Kim KY; Noh YH; Chai S; Lindsey JD; Ellisman MH; Weinreb RN; Ju WK
PLoS ONE 2012; 7: e47098 (IGR: 14-4)


51712 Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1
Liu XQ; Wu BJ; Pan WH; Zhang XM; Liu JH; Chen MM; Chao FP; Chao HM
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 33-40 (IGR: 14-4)


51769 Taurine provides neuroprotection against retinal ganglion cell degeneration
Froger N; Cadetti L; Lorach H; Martins J; Bemelmans AP; Dubus E; Degardin J; Pain D; Forster V; Chicaud L; Ivkovic I; Simonutti M; Fouquet S; Jammoul F; Léveillard T; Benosman R; Sahel JA; Picaud S
PLoS ONE 2012; 7: e42017 (IGR: 14-4)


51920 Dietary ω-3 Deficiency and IOP Insult Are Additive Risk Factors for Ganglion Cell Dysfunction
Nguyen CT; Vingrys AJ; Bui BV
Journal of Glaucoma 2013; 22: 269-277 (IGR: 14-4)


51739 Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension
Mi XS; Feng Q; Lo AC; Chang RC; Lin B; Chung SK; So KF
PLoS ONE 2012; 7: e45469 (IGR: 14-4)


51878 Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model
Porciatti V; Ventura LM
Journal of Neuro-Ophthalmology 2012; 32: 354-358 (IGR: 14-4)


51730 Immune regulation toward immunomodulation for neuroprotection in glaucoma
Tezel G
Current opinion in pharmacology 2013; 13: 23-31 (IGR: 14-4)


52023 Pharmacological inhibition of caspase-2 protects axotomised retinal ganglion cells from apoptosis in adult rats
Vigneswara V; Berry M; Logan A; Ahmed Z
PLoS ONE 2012; 7: e53473 (IGR: 14-4)


52087 Neuroprotection in glaucoma - delusion, reality or hope?
Dimovska-Jordanova A
Prilozi / Makedonska akademija na naukite i umetnostite, Oddelenie za biološki i medicinski nauki = Contributions / Macedonian Academy of Sciences and Arts, Section of Biological and Medical Sciences 2012; 33: 163-173 (IGR: 14-4)


51971 Neuro-protection of retinal stem cells transplantation combined with copolymer-1 immunization in a rat model of glaucoma
Zhou X; Xia XB; Xiong SQ
Molecular and Cellular Neurosciences 2012; 54: 1-8 (IGR: 14-4)


51846 Towards retinal ganglion cell regeneration
Gao H; Zhang HL; Shou J; Chen L; Shen Y; Tang Q; Huang J; Zhu J
Regenerative Medicine 2012; 7: 865-875 (IGR: 14-4)


51841 Role of interleukin 6-174G>C polymorphism in primary open-angle glaucoma
Zimmermann C; Weger M; Faschinger C; Renner W; Mossböck G
European Journal of Ophthalmology 2012; 23: 183-186 (IGR: 14-4)


51082 Critical pathogenic events underlying progression of neurodegeneration in glaucoma
Calkins DJ
Progress in Retinal and Eye Research 2012; 31: 702-719 (IGR: 14-3)


51173 Olfactomedin 1 interacts with the nogo a receptor complex to regulate axon growth
Nakaya N; Sultana A; Lee HS; Tomarev SI
Journal of Biological Chemistry 2012; 287: 37171-37184 (IGR: 14-3)


50889 Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons
Nixon E; Simpkins JW
Investigative Ophthalmology and Visual Science 2012; 53: 4739-4747 (IGR: 14-3)


51197 TRPC6: an underlying target for human glaucoma
Fan Q; Huang WB; Zhang XL
International Journal of Ophthalmology 2012; 5: 523-526 (IGR: 14-3)


51142 Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro
Wang ZY; Mo XF; Jiang XH; Rong XF; Miao HM
Acta physiologica Sinica 2012; 64: 417-424 (IGR: 14-3)


50860 Methylene blue protects primary rat retinal ganglion cells from cellular senescence
Daudt DR; Mueller B; Park YH; Wen Y; Yorio T
Investigative Ophthalmology and Visual Science 2012; 53: 4657-4667 (IGR: 14-3)


51096 Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress
Gupta VK; You Y; Klistorner A; Graham SL
Biochimica et Biophysica Acta 2012; 1822: 1643-1649 (IGR: 14-3)


51328 Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina
Sims SM; Holmgren L; Cathcart HM; Sappington RM
American journal of neurodegenerative disease 2012; 1: 168-179 (IGR: 14-3)


51300 In vivo imaging of retinal ganglion cell apoptosis
Galvao J; Davis BM; Cordeiro MF
Current opinion in pharmacology 2013; 13: 123-127 (IGR: 14-3)


51025 The Bcl-2 family member BIM has multiple glaucoma-relevant functions in DBA/2J mice
Harder JM; Fernandes KA; Libby RT
Scientific reports 2012; 2: 530 (IGR: 14-3)


51067 A neurobehavioral analysis of the prevention of visual impairment in the DBA/2J mouse model of glaucoma
Wong AA; Brown RE
Investigative Ophthalmology and Visual Science 2012; 53: 5956-5966 (IGR: 14-3)


50979 Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma
Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
PLoS ONE 2012; 7: e40065 (IGR: 14-3)


51153 Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma
Minton AZ; Phatak NR; Stankowska DL; He S; Ma HY; Mueller BH; Jiang M; Luedtke R; Yang S; Brownlee C; Krishnamoorthy RR
PLoS ONE 2012; 7: e43199 (IGR: 14-3)


51056 Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens
Joachim SC; Gramlich OW; Laspas P; Schmid H; Beck S; von Pein HD; Dick HB; Pfeiffer N; Grus FH
PLoS ONE 2012; 7: e40616 (IGR: 14-3)


51311 Effects of Glaucoma on Chrna6 Expression in the Retina
Munguba GC; Geisert EE; Williams RW; Tapia ML; Lam DK; Bhattacharya SK; Lee RK
Current Eye Research 2013; 38: 150-157 (IGR: 14-3)


50844 Regulation of cell death and survival pathways in secondary degeneration of the optic nerve - a long-term study
Vander S; Levkovitch-Verbin H
Current Eye Research 2012; 37: 740-748 (IGR: 14-3)


51218 Early reduction of microglia activation by irradiation in a model of chronic glaucoma
Bosco A; Crish SD; Steele MR; Romero CO; Inman DM; Horner PJ; Calkins DJ; Vetter ML
PLoS ONE 2012; 7: e43602 (IGR: 14-3)


51344 In search of new targets for retinal neuroprotection: is there a role for autophagy?
Russo R; Berliocchi L; Adornetto A; Amantea D; Nucci C; Tassorelli C; Morrone LA; Bagetta G; Corasaniti MT
Current opinion in pharmacology 2013; 13: 72-77 (IGR: 14-3)


51204 Cell transplantation approaches to retinal ganglion cell neuroprotection in glaucoma
Johnson TV; Martin KR
Current opinion in pharmacology 2013; 13: 78-82 (IGR: 14-3)


51296 Markers of Fas-mediated apoptosis in primary open-angle glaucoma and opportunities of their pharmacological correction
Slepova OS; Frolov MA; Morozova NS; Frolov AM; Lovpache DN
Vestnik Oftalmologii 2012; 128: 27-31 (IGR: 14-3)


51245 Protective effects of the β3-adrenoceptor agonist CL316243 against N-methyl-D-aspartate-induced retinal neurotoxicity
Oikawa F; Nakahara T; Akanuma K; Ueda K; Mori A; Sakamoto K; Ishii K
Naunyn-Schmiedeberg's archives of pharmacology 2012; 385: 1077-1081 (IGR: 14-3)


50263 Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy
Nickells RW; Howell GR; Soto I; John SW
Annual review of neuroscience 2012; 35: 153-179 (IGR: 14-2)


50614 Stem cell-based delivery of brain-derived neurotrophic factor gene in the rat retina
Park HY; Kim JH; Sun Kim H; Park CK
Brain Research 2012; 1469: 10-23 (IGR: 14-2)


50358 Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma
Wiggs JL; Yaspan BL; Hauser MA; Kang JH; Allingham RR; Olson LM; Abdrabou W; Fan BJ; Wang DY; Brodeur W; Budenz DL; Caprioli J; Crenshaw A; Crooks K; Delbono E; Doheny KF; Friedman DS; Gaasterland D; Gaasterland T; Laurie C; Lee RK; Lichter PR; Loomis S
PLoS Genetics 2012; 8: e1002654 (IGR: 14-2)


50595 YC-1 targeting of hypoxia-inducible factor-1α reduces RGC-5 cell viability and inhibits cell proliferation
Tsui L; Fong TH; Wang IJ
Molecular Vision 2012; 18: 1594-1603 (IGR: 14-2)


50391 Preclinical models to investigate retinal ischemia: advances and drawbacks
Minhas G; Morishita R; Anand A
Frontiers in neurology 2012; 3: 75 (IGR: 14-2)


50353 An astrocyte-specific proteomic approach to * inflammatory responses in experimental rat glaucoma
Tezel G; Yang X; Luo C; Cai J; Powell DW
Investigative Ophthalmology and Visual Science 2012; 53: 4220-4233 (IGR: 14-2)


50189 Activation of autophagy induces retinal ganglion cell death in a chronic hypertensive glaucoma model
Park HY; Kim JH; Park CK
Cell Death and Disease 2012; 3: e290 (IGR: 14-2)


50470 Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model
Husain S; Abdul Y; Crosson CE
Investigative Ophthalmology and Visual Science 2012; 53: 4289-4298 (IGR: 14-2)


50262 Retinal ganglion cell (RGC) death in glaucomatous beagles is not associated with mutations in p53 and NTF4 genes
Kato K; Sasaki N; Shastry BS
Veterinary Ophthalmology 2012; 15: 8-12 (IGR: 14-2)


50493 A Potential Neuroprotective Role of Apolipoprotein E-containing Lipoproteins through Low Density Lipoprotein Receptor-related Protein 1 in Normal Tension Glaucoma
Hayashi H; Eguchi Y; Fukuchi-Nakaishi Y; Takeya M; Nakagata N; Tanaka K; Vance JE; Tanihara H
Journal of Biological Chemistry 2012; 287: 25395-25406 (IGR: 14-2)


50596 Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action
Shih GC; Calkins DJ
Expert Review of Ophthalmology 2012; 7: 161-175 (IGR: 14-2)


50426 N-Acetylcysteine Protects Against Hypoxia Mimetic-Induced Autophagy by Targeting the HIF-1α Pathway in Retinal Ganglion Cells
Yang L; Tan P; Zhou W; Zhu X; Cui Y; Zhu L; Feng X; Qi H; Zheng J; Gu P; Fan X; Chen H
Cellular and molecular neurobiology 2012; 32: 1275-1285 (IGR: 14-2)


50424 Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors
de Lima S; Koriyama Y; Kurimoto T; Oliveira JT; Yin Y; Li Y; Gilbert HY; Fagiolini M; Martinez AM; Benowitz L
Proceedings of the National Academy of Sciences of the United States of America 2012; 109: 9149-9154 (IGR: 14-2)


50649 Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
Agarwal R; Agarwal P
Indian Journal of Ophthalmology 2012; 60: 255-261 (IGR: 14-2)


50655 Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma
Alqawlaq S; Huzil JT; Ivanova MV; Foldvari M
Nanomedicine 2012; 7: 1067-1083 (IGR: 14-2)


50406 Effect of Ginkgo biloba Extract on Visual Field Progression in Normal Tension Glaucoma
Lee J; Sohn SW; Kee C
Journal of Glaucoma 2013; 22: 780-784 (IGR: 14-2)


50608 Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Husain S; Abdul Y; Potter DE
Current Pharmaceutical Design 2012; 18: 6101-6108 (IGR: 14-2)


48836 Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells
Li H; Ao X; Jia J; Wang Q; Zhang Z
Molecular Vision 2011; 17: 3314-3325 (IGR: 14-1)


49201 Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors
Xia J; Lim JC; Lu W; Beckel JM; Macarak EJ; Laties AM; Mitchell CH
Journal of Physiology 2012; 590: 2285-2304 (IGR: 14-1)


48835 Acid-sensing ion channel 1a is involved in retinal ganglion cell death induced by hypoxia
Tan J; Ye X; Xu Y; Wang H; Sheng M; Wang F
Molecular Vision 2011; 17: 3300-3308 (IGR: 14-1)


49084 JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death
Fernandes KA; Harder JM; Fornarola LB; Freeman RS; Clark AF; Pang IH; John SW; Libby RT
Neurobiology of Disease 2012; 46: 393-401 (IGR: 14-1)


49000 Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14)
Osborne NN; Ji D; Majid AS; Del Soldata P; Sparatore A
Neurochemistry International 2012; 60: 365-378 (IGR: 14-1)


48762 The molecular basis of retinal ganglion cell death in glaucoma
Almasieh M; Wilson AM; Morquette B; Cueva Vargas JL; Di Polo A
Progress in Retinal and Eye Research 2012; 31: 152-181 (IGR: 14-1)


48977 Intrinsic axonal degeneration pathways are critical for glaucomatous damage
Howell GR; Soto I; Libby RT; John SW
Experimental Neurology 2013; 246: 54-61 (IGR: 14-1)


49098 Microglial TIR-domain-containing adapter-inducing interferon-beta (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-kappaB
Lin S; Liang Y; Zhang J; Bian C; Zhou H; Guo Q; Xiong Y; Li S; Su B
Journal of Neuroinflammation 2012; 9: 39 (IGR: 14-1)


49029 Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells
Hu Y; Park KK; Yang L; Wei X; Yang Q; Cho KS; Thielen P; Lee AH; Cartoni R; Glimcher LH; Chen DF; He Z
Neuron 2012; 73: 445-452 (IGR: 14-1)


49303 The electrophysiological properties of voltage-gated potassium channels on cultivated porcine retinal ganglion cells irradiated with continuous near-infrared laser
Xu K; Shao Y; Sun CS; Liang SS; Hao S; Li XY
Chinese Journal of Ophthalmology 2012; 48: 153-158 (IGR: 14-1)


48769 A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics
Nguyen D; Alavi MV; Kim KY; Kang T; Scott RT; Noh YH; Lindsey JD; Wissinger B; Ellisman MH; Weinreb RN; Perkins GA; Ju WK
Cell Death and Disease 2011; 2: e240 (IGR: 14-1)


48807 Estimation of axon counts in a rat model of glaucoma: comparison of fixed-pattern sampling with targeted sampling
Ebneter A; Casson RJ; Wood JP; Chidlow G
Clinical and Experimental Ophthalmology 2012; 40: 626-633 (IGR: 14-1)


49168 Glaucoma-Induced Degeneration of Retinal Ganglion Cells Prevented by Hypoxic Preconditioning: A Model of "Glaucoma Tolerance"
Zhu Y; Zhang L; Schmidt JF; Gidday JM
Molecular Medicine 2012; 18: 697-706 (IGR: 14-1)


48998 Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin
Sullivan TA; Geisert EE; Templeton JP; Rex TS
Experimental Eye Research 2012; 96: 36-41 (IGR: 14-1)


48994 Axonal damage, autophagy and neuronal survival
Rodrí,guez-Muela N; Boya P
Autophagy 2012; 8: 286-288 (IGR: 14-1)


49228 Structure/Function studies and the effects of memantine in monkeys with experimental glaucoma
Gabelt BT; Rasmussen CA; Tektas OY; Kim CB; Peterson JC; Nork TM; Hoeve JN; Lü,tjen-Drecoll E; Kaufman PL
Investigative Ophthalmology and Visual Science 2012; 53: 2368-2376 (IGR: 14-1)


49200 Pigment Epithelium-Derived Factor Released by Müller Glial Cells Exerts Neuroprotective Effects on Retinal Ganglion Cells
Unterlauft JD; Eichler W; Kuhne K; Yang XM; Yafai Y; Wiedemann P; Reichenbach A; Claudepierre T
Neurochemical Research 2012; 37: 1524-1533 (IGR: 14-1)


49179 Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review
Morgan JE
Clinical and Experimental Ophthalmology 2012; 40: 364-368 (IGR: 14-1)


49142 Norrin: Molecular and functional properties of an angiogenic and neuroprotective growth factor
Ohlmann A; Tamm ER
Progress in Retinal and Eye Research 2012; 31: 243-257 (IGR: 14-1)


48913 Clinical trials for glaucoma neuroprotection are not impossible
Quigley HA
Current Opinions in Ophthalmology 2012; 23: 144-154 (IGR: 14-1)


49242 Protecting the retinal neurons from glaucoma: Lowering ocular pressure is not enough
Pascale A; Drago F; Govoni S
Pharmacological Research 2012; 66: 19-32 (IGR: 14-1)


49080 Glaucoma 2.0: Neuroprotection, Neuroregeneration, Neuroenhancement
Chang EE; Goldberg JL
Ophthalmology 2012; 119: 979-986 (IGR: 14-1)


47958 Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes
Harper MM; Grozdanic SD; Blits B; Kuehn MH; Zamzow D; Buss JE; Kardon RH; Sakaguchi DS
Investigative ophthalmology & visual science 2011; 52: 4506-4515 (IGR: 13-4)


48411 Differences between the neurogenic and proliferative abilities of Müller glia with stem cell characteristics and the ciliary epithelium from the adult human eye
Bhatia B; Jayaram H; Singhal S; Jones MF; Limb GA
Experimental Eye Research 2011; 93: 852-861 (IGR: 13-4)


48103 Neurodegenerative and Inflammatory Pathway Components Linked to TNF-?/TNFR1 Signaling in the Glaucomatous Human Retina
Yang X; Luo C; Cai J; Powell DW; Yu D; Kuehn MH; Tezel G
Investigative Ophthalmology and Visual Science 2011; 52: 8442-8454 (IGR: 13-4)


48376 Retinal flavoprotein fluorescence correlates with mitochondrial stress, apoptosis, and chemokine expression
Field MG; Yang D; Bian ZM; Petty HR; Elner VM
Experimental Eye Research 2011; 93: 548-555 (IGR: 13-4)


48415 Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins
Sippl C; Bosserhoff AK; Fischer D; Tamm ER
Experimental Eye Research 2011; 93: 669-680 (IGR: 13-4)


47667 The expression patterns of nogo-A, myelin associated glycoprotein and oligodendrocyte myelin glycoprotein in the retina after ocular hypertension : the expression of myelin proteins in the retina in glaucoma
Liao X-X; Chen D; Shi J; Sun Y-Q; Sun S-J; So K-F; Fu Q-L
Neurochemical Research 2011; 36: 1955-1961 (IGR: 13-4)


47665 Critical role of calpain in axonal damage-induced retinal ganglion cell death
Ryu M; Yasuda M; Shi D; Shanab AY; Watanabe R; Himori N; Omodaka K; Yokoyama Y; Takano J; Saido T
Journal of Neuroscience Research 2011; (IGR: 13-4)


47823 Development of spontaneous neuropathy in NF-(kappa)Bp50-deficient mice by calcineurin-signal involving impaired NF-(kappa)B activation
Nakamura-Yanagidaira T; Takahashi Y; Sano K; Murata T; Hayashi T
Molecular Vision 2011; 17: 2157-2170 (IGR: 13-4)


47679 The role of neurotrophins and mimetics in the treatment of ocular diseases
Bai Y; Ge J; Saragovi HU; Zhuo Y
Drugs of the Future 2011; 36: 123-131 (IGR: 13-4)


48421 Simvastatin upregulates Bcl-2 expression and protects retinal neurons from early ischemia/reperfusion injury in the rat retina
Ko ML; Chen CF; Peng PH; Peng YH
Experimental Eye Research 2011; 93: 580-585 (IGR: 13-4)


48101 Soluble Nogo-66 receptor prevents synaptic dysfunction and rescues retinal ganglion cell loss in chronic glaucoma
Fu QL; Liao XX; Li X; Chen D; Shi J; Wen W; Lee DH; So KF
Investigative Ophthalmology and Visual Science 2011; 52: 8374-8380 (IGR: 13-4)


48105 Enhancement of axonal regeneration of retinal ganglion cells in adult rats by etomidate: involvement of protein kinase C
Xu ZX; Qin SZ; Xu GZ; Hu JM; Ma LT
Investigative Ophthalmology and Visual Science 2011; 52: 8117-8122 (IGR: 13-4)


48418 Neuroprotective effect of transcorneal electrical stimulation on ischemic damage in the rat retina
Wang X; Mo X; Li D; Wang Y; Fang Y; Rong X; Miao H; Shou T
Experimental Eye Research 2011; 93: 753-760 (IGR: 13-4)


48398 Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury
Nakatani M; Shinohara Y; Takii M; Mori H; Asai N; Nishimura S; Furukawa-Hibi Y; Miyamoto Y; Nitta A
Experimental Eye Research 2011; 93: 873-879 (IGR: 13-4)


48377 Neuroprotective effects of prostaglandin analogues on retinal ganglion cell death independent of intraocular pressure reduction
Yamagishi R; Aihara M; Araie M
Experimental Eye Research 2011; 93: 265-270 (IGR: 13-4)


48338 Down-regulation of matrix metalloproteinase-9 by pyrrolidine dithiocarbamate prevented retinal ganglion cell death after transection of optic nerve in rats
Sun MH; Chen KJ; Tsao YP; Kao LY; Han WH; Lin KK; Pang JH
Current Eye Research 2011; 36: 1053-1063 (IGR: 13-4)


48260 Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model
Thaler S; Fiedorowicz M; Grieb P; Wypych Z; Knap N; Borowik T; Zawada K; Kaminski J; Wozniak M; Rejdak R
Acta Ophthalmologica 2011; 89: 555-560 (IGR: 13-4)


47514 Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage
Wei X; Yu Z; Cho K-S; Chen H; Malik MTA; Chen X; Lo EH; Wang X; Chen DF
American Journal of Pathology 2011; 179: 2788-2797 (IGR: 13-4)


48369 Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma
Ebneter A; Chidlow G; Wood JP; Casson RJ
Archives of Ophthalmology 2011; 129: 1337-1344 (IGR: 13-4)


48300 VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina
Teuchner B; Dimmer A; Humpel C; Amberger A; Fischer-Colbrie R; Nemeth J; Waschek JA; Kieselbach G; Kralinger M; Schmid E
Acta Ophthalmologica 2011; 89: 670-675 (IGR: 13-4)


47749 Gene therapy for retinal ganglion cell neuroprotection in glaucoma
Wilson AM; Di Polo A
Gene Therapy 2011; (IGR: 13-4)


46428 Calpain, not caspase, is the causative protease for hypoxic damage in cultured monkey retinal cells
Nakajima E; Hammond KB; Rosales JL; Shearer TR; Azuma M
Investigative Ophthalmology and Visual Science 2011; 52: 7059-7067 (IGR: 13-3)


46391 A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma
Burgoyne CF
Experimental Eye Research 2011; 93: 120-132 (IGR: 13-3)


46706 Hypothesis of optineurin as a new common risk factor in normal-tension glaucoma and Alzheimer's disease
Liu Y-H; Tian T
Medical Hypotheses 2011; (IGR: 13-3)


46434 The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells
Ganapathy PS; White RE; Ha Y; Bozard BR; McNeil PL; Caldwell RW; Kumar S; Black SM; Smith SB
Investigative Ophthalmology and Visual Science 2011; 52: 5515-5524 (IGR: 13-3)


47044 Retinal ganglion cell loss in superoxide dismutase 1 deficiency
Yuki K; Ozawa Y; Yoshida T; Kurihara T; Hirasawa M; Ozeki N; Shiba D; Noda K; Ishida S; Tsubota K
Investigative ophthalmology & visual science 2011; 52: 4143-4150 (IGR: 13-3)


47119 Ischemic tolerance protects the rat retina from glaucomatous damage
Belforte N; Sande PH; de Zavalia N; Fernandez DC; Silberman DM; Chianelli MS; Rosenstein RE
PLoS ONE 2011; 6: 23763 (IGR: 13-3)


46437 During glaucoma, alpha2-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing neuroprotection
Bai Y; Sivori D; Woo SB; Neet KE; Lerner SF; Saragovi HU
Investigative Ophthalmology and Visual Science 2011; 52: 5260-5265 (IGR: 13-3)


46394 Endothelin, astrocytes and glaucoma
Prasanna G; Krishnamoorthy R; Yorio T
Experimental Eye Research 2011; 93: 170-177 (IGR: 13-3)


46550 A cell-permeable phosphine-borane complex delays retinal ganglion cell death after axonal injury through activation of the pro-survival extracellular signal-regulated kinases 1/2 pathway
Almasieh M; Lieven CJ; Levin LA; Di Polo A
Journal of Neurochemistry 2011; 118: 1075-1086 (IGR: 13-3)


46531 Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats
Dogan S; Unal M; Ozturk N; Yargicoglu P; Cort A; Spasojevic I; Batinic-Haberle I; Aslan M
Experimental Eye Research 2011; (IGR: 13-3)


46958 Autophagy promotes survival of retinal ganglion cells after optic nerve axotomy in mice
Rodriguez-Muela N; Germain F; Marino G; Fitze PS; Boya P
Cell Death and Differentiation 2011; (IGR: 13-3)


47112 Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure
Piras A; Gianetto D; Conte D; Bosone A; Vercelli A
PLoS ONE 2011; 6: 22514 (IGR: 13-3)


47121 An optic nerve crush injury murine model to study retinal ganglion cell survival
Tang Z; Zhang S; Lee C; Kumar A; Arjunan P; Li Y; Zhang F; Li X
Journal of Vision Exp 2011; 50 (IGR: 13-3)


47122 Measuring glutamate receptor activation-induced apoptotic cell death in ischemic rat retina using the TUNEL assay
Ju WK; Kim KY
Methods in molecular biology 2011; 740: 149-156 (IGR: 13-3)


46976 Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model
Pinar-Sueiro S; Urcola H; Agurtzane Rivas M; Vecino E
Clinical and Experimental Ophthalmology 2011; (IGR: 13-3)


46614 Opioid receptor activation: Suppression of ischemia/reperfusion-induced production of TNF-(alpha) in the retina
Husain S; Liou GI; Crosson CE
Investigative Ophthalmology and Visual Science 2011; 52: 2577-2583 (IGR: 13-3)


46401 Müller Glia: A Promising Target for Therapeutic Regeneration
Ahmad I; Del Debbio CB; Das AV,Parameswaran S
Investigative Ophthalmology and Visual Science 2011; 52: 5758-5764 (IGR: 13-3)


46353 Caspase inhibitors protect against NMDA-mediated retinal ganglion cell death
Schuettauf F; Stein T; Choragiewicz TJ; Rejdak R; Bolz S; Zurakowski D; Varde MA; Laties AM; Thaler S
Clinical and Experimental Ophthalmology 2011; 39: 545-254 (IGR: 13-3)


47124 Ocular neuroprotection by siRNA targeting caspase-2
Ahmed Z; Kalinski H; Berry M; Almasieh M; Ashush H; Slager N; Brafman A; Spivak I; Prasad N; Mett I
Cell Death and Disease 2011; 2: 173 (IGR: 13-3)


47125 Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma
Calandrella N; De Seta C; Scarsella G; Risuleo G
Cell Death and Disease 2010; 1: 62 (IGR: 13-3)


46379 A novel free radical scavenger rescues retinal cells in vivo
O'Driscoll C; Doonan F; Sanvicens N; Messeguer A; Cotter TG
Experimental Eye Research 2011; 93: 65-74 (IGR: 13-3)


47128 Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors
Almasieh M; Zhou Y; Kelly ME; Casanova C; Di Polo A
Cell Death and Disease 2010; 1: 27 (IGR: 13-3)


46405 Neurotrophic factor delivery as a protective treatment for glaucoma
Johnson TV; Bull ND; Martin KR
Experimental Eye Research 2011; 93: 196-203 (IGR: 13-3)


46400 Current Prospects in Optic Nerve Protection and Regeneration: Sixth ARVO/Pfizer Ophthalmics Research Institute Conference
Limb GA; Martin KR
Investigative Ophthalmology and Visual Science 2011; 52: 5941-5954 (IGR: 13-3)


46775 Activated retinal glia mediated axon regeneration in experimental glaucoma
Lorber B; Guidi A; Fawcett JW; Martin KR
Neurobiology of Disease 2011; (IGR: 13-3)


46698 Edible wild vegetable, Gymnaster koraiensis protects retinal ganglion cells against oxidative stress
Kim K-A; Kang KD; Lee EH; Nho CW; Jung SH
Food and Chemical Toxicology 2011; 49: 2131-2143 (IGR: 13-3)


46601 Thioredoxins 1 and 2 protect retinal ganglion cells from pharmacologically induced oxidative stress, optic nerve transection and ocular hypertension
Munemasa Y; Kwong JMK; Kim SH; Ahn JH; Caprioli J; Piri N
Adv Exp Med Biol 2010; 664: 355-363 (IGR: 13-3)


46757 Manganese porphyrin reduces retinal injury induced by ocular hypertension
Dogan S; Baranowska K; Walankiewicz M; Yargicoglu P; Unal M; Spasojevic I; Haberle IB; Aslan M
Free Radical Biology and-Medicine 2010; 49: S176-S177 (IGR: 13-3)


46668 Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martinez IT; Young MJ; Herrero-Vanrell R
Journal of Controlled Release 2011; (IGR: 13-3)


45928 Elevation of p-NR2A(S1232) by Cdk5/p35 contributes to retinal ganglion cell apoptosis in a rat experimental glaucoma model
Chen J; Miao Y; Wang X-H; Wang Z
Neurobiology of Disease 2011; 43: 455-464 (IGR: 13-2)


46159 Age-dependent rat retinal ganglion cell susceptibility to apoptotic stimuli: Implications for glaucoma
Guerin MB; Donovan M; McKernan DP; O'brien CJ; Cotter TG
Clinical and Experimental Ophthalmology 2011; 39: 243-251 (IGR: 13-2)


45465 Dynamic imaging of axonal transport in living retinal ganglion cells in vitro
Takihara Y; Inatani M; Hayashi H; Adachi N; Iwao K; Inoue T; Iwao M; Tanihara H
Investigative Ophthalmology and Visual Science 2011; 52: 3039-3045 (IGR: 13-2)


46318 Imaging multiple phases of neurodegeneration: A novel approach to assessing cell death in vivo
Cordeiro MF; Guo L; Coxon KM; Duggan J; Nizari S; Normando EM; Sensi SL; Sillito AM; Fitzke FW; Salt TE
Cell Death and Disease 2010; 1: e3 (IGR: 13-2)


46168 Current and emerging medical therapies in the treatment of glaucoma
Bagnis A; Papadia M; Scotto R; Traverso CE
Expert Opinion on Emerging Drugs 2011; 16: 293-307 (IGR: 13-2)


45467 Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies
Bull ND; Johnson TV; Welsapar G; Dekorver NW; Tomarev SI; Martin KR
Investigative Ophthalmology and Visual Science 2011; 52: 3309-3320 (IGR: 13-2)


46158 Translational neuroprotection research in glaucoma: A review of definitions and principles
Casson RJ; Chidlow G; Ebneter A; Wood JP; Crowston J; Goldberg I
Clinical and Experimental Ophthalmology 2011; (IGR: 13-2)


46112 Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
Duncan RS; Xin H; Goad DL; Chapman KD; Koulen P
Clinical Ophthalmology 2011; 5: 543-548 (IGR: 13-2)


46302 Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells
Ganesh BS; Chintala SK
PLoS ONE 2011; 6: e18305 (IGR: 13-2)


46286 REVIEW: An approach for neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in mice
Ito Y; Shimazawa M; Hara H
CNS neuroscience & therapeutics 2010; 16: 169-179 (IGR: 13-2)


45644 Cell non-autonomous functions of homeoproteins in neuroprotection in the brain
Joshi RL; Ibad RT; Rheey J; Castagner F; Prochiantz A; Moya KL
FEBS Letters 2011; 585: 1573-1578 (IGR: 13-2)


45515 Simvastatin improves retinal ganglion cell survival and spatial vision after acute retinal ischemia/reperfusion in mice
Krempler K; Schmeer CW; Isenmann S; Witte OW; Löwel S
Investigative Ophthalmology and Visual Science 2011; 52: 2606-2618 (IGR: 13-2)


45491 Rasagiline-induced Delay of Retinal Ganglion Cell Death in Experimental Glaucoma in Rats
Levkovitch-Verbin H; Vander S; Melamed S
Journal of Glaucoma 2011; 20: 273-277 (IGR: 13-2)


45733 A selective inhibitor of Drp1, Mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina
Park SW; Kim K-Y; Lindsey JD; Dai Y; Heo H; Nguyen DH; Ellisman MH; Weinreb RN; Ju W-K
Investigative Ophthalmology and Visual Science 2011; 52: 2837-2843 (IGR: 13-2)


45559 Brain derived neurotrophic factor maintains Brn3a expression in axotomized rat retinal ganglion cells
Sánchez-Migallón MC; Nadal-Nicolás FM; Jiménez-López M; Sobrado-Calvo P; Vidal-Sanz M; Agudo-Barriuso M
Experimental Eye Research 2011; 92: 260-267 (IGR: 13-2)


45824 Neuroprotection in glaucoma
Vasudevan SK; Gupta V; Crowston JG
Indian Journal of Ophthalmology 2011; 59: 102-113 (IGR: 13-2)


46102 Closed gateways- Can neuroprotectants shield the retina in glaucoma?
Velpandian T
Drugs in R&D 2010; 10: 93-96 (IGR: 13-2)


46060 An immunohistochemical analysis of the neuroprotective effects of memantine, hyperbaric oxygen therapy, and brimonidine after acute ischemia reperfusion injury
Yigit U; Erdenoz S; Uslu U; Oba E; Cumbul A; Cagatay H; Aktas S; Eskicoglu E
Molecular Vision 2011; 17: 1024-1033 (IGR: 13-2)


45476 Neuroprotective effect of intravitreal cell-based glucagon-like peptide-1 production in the optic nerve crush model
Zhang R; Zhang H; Xu L; Ma K; Wallrapp C; Jonas JB
Acta Ophthalmologica 2011; 89: 320-326 (IGR: 13-2)


45812 Latanoprost promotes neurite outgrowth in differentiated RGC-5 cells via the PI3K-Akt-mTOR signaling pathway
Zheng J; Feng X; Hou L; Cui Y; Zhu L; Ma J; Xia Z; Zhou W; Chen H
Cellular and molecular neurobiology 2011; 31: 597-604 (IGR: 13-2)


46103 Visual field protective effect of erigeron breviscapus (vant.) hand. mazz. extract on glaucoma with controlled intraocular pressure: A randomized, double-blind, clinical trial
Zhong Y; Xiang M; Ye W; Cheng Y; Jiang Y
Drugs in R&D 2010; 10: 75-82 (IGR: 13-2)


46241 Retinal ganglion cell gene therapy and visual system repair
Hellstrom M; Harvey AR
Current Gene Therapy 2011; 11: 116-131 (IGR: 13-2)


45967 Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: Neuroprotection against loss of function in two animal models
Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Murakami Y; Yoshida N; Tabata T; Hasegawa M; Tobimatsu S; Sueishi K
Human Genetics and Therapeutics 2011; 22: 559-565 (IGR: 13-2)


45642 Functional and morphological effects of (beta)-estradiol in eyes with N-methyl-d-Aspartate-induced retinal neurotoxicity in rats
Yamashita H; Yamada-Nakayama C; Sugihara K; Tsuji S; Sakurai T; Ban Y; Tsutsumi S; Sato Y
Experimental Eye Research 2011; (IGR: 13-2)


28171 Embryonic stem cells and retinal regeneration
Woronkowicz M; Skopinski P
Central-European Journal of Immunology 2010; 35: 267-272 (IGR: 13-1)


28040 Gap junction protein connexin43 (GJA1) in the human glaucomatous optic nerve head and retina
Kerr NM; Johnson CS; Green CR; Danesh-Meyer HV
Journal of Clinical Neuroscience 2011; 18: 102-108 (IGR: 13-1)


28005 The role of melatonin in glaucoma: Implications concerning pathophysiological relevance and therapeutic potential
Agorastos A; Huber CG
Journal of Pineal Research 2011; 50: 1-7 (IGR: 13-1)


27865 Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions
Liu M; Duggan J; Salt TE; Cordeiro MF
Experimental Eye Research 2011; 92: 244-250 (IGR: 13-1)


27910 The role of the classical complement cascade in synapse loss during development and glaucoma
Rosen AM; Stevens B
Adv Exp Med Biol 2010; 703: 75-93 (IGR: 13-1)


27875 Early microglia activation in a mouse model of chronic glaucoma
Bosco A; Steele MR; Vetter ML
Journal of Comparative Neurology 2011; 519: 599-620 (IGR: 13-1)


27991 Different spatial and temporal protein expressions of repulsive guidance molecule a and neogenin in the rat optic nerve after optic nerve crush with and without lens injury
Schnichels S; Heiduschka P; Julien S
Journal of Neuroscience Research 2011; 89: 490-505 (IGR: 13-1)


27794 The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma
Chidlow G; Ebneter A; Wood JPM; Casson RJ
Acta Neuropathologica 2011; 1-15 (IGR: 13-1)


27706 Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats
Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK
Experimental Eye Research 2011; 92: 112-119 (IGR: 13-1)


27878 Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model
Munemasa Y; Kitaoka Y; Kuribayashi J; Ueno S
Journal of Neurochemistry 2010; 115: 1508-1519 (IGR: 13-1)


27983 Interference of the apoptotic signaling pathway in RGC stress response by SP600125 in moderate ocular hypertensive rats
Liu H; Sun H; Liu C
Chinese Journal of Physiology 2011; 54:2 (IGR: 13-1)


28228 Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
Lambert WS; Ruiz L; Crish SD; Wheeler LA; Calkins DJ
Molecular Neurodegeneration 2011; 6: 4 (IGR: 13-1)


28106 Four steps to optic nerve regeneration
Moore DL; Goldberg JL
Journal of Neuro-Ophthalmology 2010; 30: 347-360 (IGR: 13-1)


28064 Neuroprotection in glaucoma: Recent and future directions
Danesh-Meyer HV
Current Opinions in Ophthalmology 2011; 22: 78-86 (IGR: 13-1)


28208 Stem cell plasticity, neuroprotection and regeneration in human eye diseases
Rodriguez FD; Vecino E
Current Stem Cell Research and Therapy 2011; 6: 73-81 (IGR: 13-1)


27999 Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline
Levkovitch-Verbin H; Spierer O; Vander S; Dardik R
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; 1-9 (IGR: 13-1)


27869 Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice
Quigley HA; Cone FE; Gelman SE; Yang Z; Son JL; Oglesby EN; Pease ME; Zack DJ
Experimental Eye Research 2011; 92:299-305 (IGR: 13-1)


28068 Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma
Colafrancesco V; Parisi V; Sposato V; Rossi S; Russo MA; Coassin M; Lambiase A; Aloe L
Journal of Glaucoma 2011; 20: 100-108 (IGR: 13-1)


27873 Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75(NTR) activity is neurotoxic through a paracrine mechanism
Bai Y; Dergham P; Nedev H; Xu J; Galan A; Rivera JC; ZhiHua S; Mehta HM; Woo SB; Sarunic MV
Journal of Biological Chemistry 2010; 285: 39392-39400 (IGR: 13-1)


27891 Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma
Nguyen JV; Soto I; Kim K-Y; Bushong EA; Oglesby E; Valiente-Soriano FJ; Yang Z; Davis C-HO; Bedont JL; Son JL
Proceedings of the National Academy of Sciences of the United States of America 2011; 108: 1176-1181 (IGR: 13-1)


27963 The wnt signaling pathway protects retinal ganglion cell 5 (RGC-5) cells from elevated pressure
Fragoso MA; Yi H; Nakamura REI; Hackam AS
Cellular and molecular neurobiology 2011; 31: 163-173 (IGR: 13-1)


27938 Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina
Teuchner B; Dimmer A; Troger J; Fischer-Colbrie R; Schmid E; Kieselbach G; Dietrich H; Bechrakis N
Regulatory Peptides 2010; 165: 123-127 (IGR: 13-1)


27985 Neurodegeneration in glaucoma: Progression and calcium-dependent intracellular mechanisms
Crish SD; Calkins DJ
Neuroscience 2011; 176: 1-11 (IGR: 13-1)


27984 Calcium preconditioning triggers neuroprotection in retinal ganglion cells
Brandt SK; Weatherly ME; Ware L; Linn DM; Linn CL
Neuroscience 2011; 172: 387-397 (IGR: 13-1)


28020 Recruitment of monocytes are needed for neuroprotection and repair
Schwartz M
Restorative Neurology and Neuroscience 2010; 28: 610 (IGR: 13-1)


28019 Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse
Endo K; Nakamachi T; Seki T; Kagami N; Wada Y; Nakamura K; Kishimoto K; Hori M; Tsuchikawa D; Shinntani N
Journal of Molecular Neuroscience 2011; 43: 22-29 (IGR: 13-1)


28048 Neuro-protective effects of yiyanming solution on visual function of glaucoma patient
Wang Y; Qiu B; Zhang C-X; Ou Y; Pang L; Li Z-P
Chinese Ophthalmic Research 2010; 28: 1087-1090 (IGR: 13-1)


28229 Therapeutic potential of new hydrogen sulfide-releasing hybrids
Sparatore A; Santus G; Giustarini D; Rossi R; Del Soldato P
Expert Review of Clinical Pharmacology 2011; 4: 109-121 (IGR: 13-1)


27495 Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2
Kernt M; Neubauer AS; Eibl KH; Wolf A; Ulbig MW; Kampik A; Hirneiss C
Clinical Ophthalmology 2010; 4: 591-604 (IGR: 12-4)


27267 CNS Targets Support and Sustain Differentiation of Cultured Neuronal and Retinal Progenitor Cells
Sharma RK; Zhou Q; Netland PA
Neurochemical Research 2010; 1-8 (IGR: 12-4)


27521 ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma
Harada C; Namekata K; Guo X; Yoshida H; Mitamura Y; Matsumoto Y; Tanaka K; Ichijo H; Harada T
Cell Death and Differentiation 2010; 17: 1751-1759 (IGR: 12-4)


27080 In Glaucoma the Upregulated Truncated TrkC.T1 Receptor Isoform in Glia Causes Increased TNF-{alpha} Production, Leading to Retinal Ganglion Cell Death.
Bai Y; Shi Z; Zhuo Y; Liu J; Malakhov A; Ko E; Burgess K; Schaefer H; Esteban PF; Tessarollo L
Investigative Ophthalmology and Visual Science 2010; 51: 6639-6651 (IGR: 12-4)


27232 The Wnt Signaling Pathway Protects Retinal Ganglion Cell 5 (RGC-5) Cells from Elevated Pressure
Fragoso MA; Yi H; Nakamura REI; Hackam AS
Cellular and molecular neurobiology 2010; 1-11 (IGR: 12-4)


27266 Light Effects on Mitochondrial Photosensitizers in Relation to Retinal Degeneration
Osborne NN; Kamalden TA; Majid ASA; del Olmo-Aguado S; Manso AG; Ji D
Neurochemical Research 2010; 1-8 (IGR: 12-4)


27265 Sulbutiamine counteracts trophic factor deprivation induced apoptotic cell death in transformed retinal ganglion cells
Kang KD; Abdul Majid AS; Kim K-A; Kang K; Ahn HR; Nho CW; Jung SH
Neurochemical Research 2010; 35: 1828-1839 (IGR: 12-4)


27360 Current researches on effects of retinal Muller cell on glaucomatous retinal ganglion cells
Xie Y; Wang N-L; Ma J-M
Chinese Ophthalmic Research 2010; 28: 786-790 (IGR: 12-4)


26975 A conditional immortalized mouse muller glial cell line expressing glial and retinal stem cell genes.
Otteson DC; Phillips MJ
Investigative Ophthalmology and Visual Science 2010; 51: 5991-6000 (IGR: 12-4)


27028 Retinal ganglion cell numbers and delayed retinal ganglion cell death in the P23H rat retina.
García-Ayuso D; Salinas-Navarro M; Agudo M; Cuenca N; Pinilla I; Vidal-Sanz M; Villegas-Pérez MP
Experimental Eye Research 2010; 91: 800-810 (IGR: 12-4)


27649 Rapid and noninvasive imaging of retinal ganglion cells in live mouse models of glaucoma
Tosi J; Wang NK; Zhao J; Chou CL; Kasanuki JM; Tsang SH; Nagasaki T
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010; 12: 386-393 (IGR: 12-4)


27646 An approach for neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in Mice
Ito Y; Shimazawa M; Hara H
CNS Neuroscience and Therapeutics 2010; 16: 169-179 (IGR: 12-4)


27030 TRPV1 receptors are involved in protein nitration and Müller cell reaction in the acutely axotomized rat retina.
Leonelli M; Martins DO; Britto LR
Experimental Eye Research 2010; 91: 755-768 (IGR: 12-4)


27063 Morphometric Changes in the Rat Optic Nerve Following Short-term Intermittent Elevations in Intraocular Pressure.
Joos KM; Li C; Sappington RM
Investigative Ophthalmology and Visual Science 2010; 51: 6431-6440 (IGR: 12-4)


27231 Repeated intraocular pressure measurement in awake Lewis Rats does not bias retinal ganglion cell survival
Cuny CS; Joachim SC; Gramlich OW; Gottschling PF; Pfeiffer N; Grus FH
Current Eye Research 2010; 35: 1034-1039 (IGR: 12-4)


27350 Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice
Chi Z; Yasumoto F; Sergeev Y; Minami M; Obazawa M; Kimura I; Takada Y; Iwata T
Human Molecular Genetics 2010; 19: 3806-3815 (IGR: 12-4)


26972 Intravitreal Injections of Neurotrophic Factors Secreting Mesenchymal Stem Cells Are Neuroprotective in Rat Eyes following Optic Nerve Transection.
Levkovitch-Verbin H; Sadan O; Vander S; Rosner M; Barhum Y; Melamed E; Offen D; Melamed S
Investigative Ophthalmology and Visual Science 2010; 51: 6394-6400 (IGR: 12-4)


27061 Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury.
Ebneter A; Casson RJ; Wood JP; Chidlow G
Investigative Ophthalmology and Visual Science 2010; 51: 6448-6460 (IGR: 12-4)


27639 A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma
Marina N; Bull ND; Martin KR
Nature Protocols 2010; 5: 1642-1651 (IGR: 12-4)


27134 Loss of retinal function in aged DBA/2J mice - New insights into retinal neurodegeneration
Heiduschka P; Julien S; Schuettauf F; Schnichels S
Experimental Eye Research 2010; 91: 779-783 (IGR: 12-4)


27233 Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure
Cort A; Ozturk N; Akpinar D; Unal M; Yucel G; Ciftcioglu A; Yargicoglu P; Aslan M
Regulatory Toxicology and Pharmacology 2010; 58: 121-130 (IGR: 12-4)


27362 Expression of hypoxia-inducible factor-1(alpha), inducible nitric oxide synthase and cyclooxygenase-2 in rat retina with chronic high ocular pressure
Gui D-M; Yang Y; Li X; Gao D-W
Chinese Ophthalmic Research 2010; 28: 805-809 (IGR: 12-4)


27259 Nestin, a new marker, expressed in Muller cells following retinal injury
Xue L; Ding P; Xiao L; Hu M; Hu Z
Canadian Journal of Neurological Sciences 2010; 37: 643-649 (IGR: 12-4)


26959 Quantification of the effect of different levels of IOP in the astroglia of the rat retina ipsilateral and contralateral to experimental glaucoma.
Ramírez AI; Salazar JJ; de Hoz R; Rojas B; Gallego BI; Salinas-Navarro M; Alarcón-Martínez L; Ortín-Martínez A; Avilés-Trigueros M; Vidal-Sanz M
Investigative Ophthalmology and Visual Science 2010; 51: 5690-5696 (IGR: 12-4)


27163 Mechanisms of retinal ganglion cell injury in aging and glaucoma
Chrysostomou V; Trounce IA; Crowston JG
Ophthalmic Research 2010; 44: 173-178 (IGR: 12-4)


27175 Engineered superparamagnetic Mn(0.5)Zn(0.5)Fe(2)O(4) nanoparticles as a heat shock protein induction agent for ocular neuroprotection in glaucoma
Jeun M; Jeoung JW; Moon S; Kim YJ; Lee S; Paek SH; Chung K-W; Park KH; Bae S
Biomaterials 2011; 32: 387-394 (IGR: 12-4)


27577 An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma
Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
Investigative ophthalmology & visual science 2010; 51: 4722-4731 (IGR: 12-4)


27545 Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage
Tulsawani R; Kelly LS; Fatma N; Chhunchha B; Kubo E; Kumar A; Singh DP
BMC Neuroscience 2010; 11: 125 (IGR: 12-4)


27326 Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression
Jehle T; Meschede W; Dersch R; Feltgen N; Bach M; Lagreze WA
Ophthalmologe 2010; 107: 347-353 (IGR: 12-4)


27208 Dock3 protects retinal neurones from glutamate neurotoxicity and oxidative stress
Kimura A; Namekata K; Tanaka K; Harada T
Neuroscience Research 2010; 68 (IGR: 12-4)


27633 Neuroprotective agents in glaucoma therapy: Recent developments and future directions
Chua B; Goldberg I
Expert Review of Ophthalmology 2010; 5: 627-636 (IGR: 12-4)


27516 Neuroprotection in glaucoma
Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I
Oftalmologia 2010; 54: 7-10 (IGR: 12-4)


27226 Neuroprotection of Copolymer 1 in glaucoma rats with elevated intraocular pressure
Sun J-F; Wang L
Journal of Shanghai Jiaotong University Medical Science 2009; 29: 1196-1199 (IGR: 12-4)


26983 TRPC6 channel protects retinal ganglion cells in a rat model of retinal ischemia/reperfusion-induced cell death.
Wang X; Teng L; Li A; Ge J; Laties AM; Zhang X
Investigative Ophthalmology and Visual Science 2010; 51: 5751-5758 (IGR: 12-4)


27070 Neuroprotection by acetoacetate and ?-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid.
Thaler S; Choragiewicz TJ; Rejdak R; Fiedorowicz M; Turski WA; Tulidowicz-Bielak M; Zrenner E; Schuettauf F; Zarnowski T
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1729-1735 (IGR: 12-4)


27221 Nerve growth factor eye drops to treat glaucoma
Lambiase A; Mantelli F; Bonini S
Drug News and Perspectives 2010; 23: 361-367 (IGR: 12-4)


27314 HspB1 (Hsp 27) expression and neuroprotection in the retina
O'Reilly AM; Currie RW; Clarke DB
Molecular Neurobiology 2010; 42: 124-132 (IGR: 12-4)


27135 Cellular inhibitor of apoptosis (cIAP1) is down-regulated during Retinal ganglion cell (RGC) maturation
Kisiswa L; Albon J; Morgan JE; Wride MA
Experimental Eye Research 2010; 91: 739-747 (IGR: 12-4)


27573 Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1
Sun MH; Pang JH; Chen SL; Han WH; Ho TC; Chen KJ; Kao LY; Lin KK; Tsao YP
Investigative ophthalmology & visual science 2010; 51: 4798-4808 (IGR: 12-4)


27133 Neuroprotection in glaucoma - Is there a future role?
Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
Experimental Eye Research 2010; 91: 554-566 (IGR: 12-4)


27220 Isoquercitrin is the most effective antioxidant in the plant Thuja orientalis and able to counteract oxidative-induced damage to a transformed cell line (RGC-5 cells)
Jung SH; Kim BJ; Lee EH; Osborne NN
Neurochemistry International 2010; 57: 713-721 (IGR: 12-4)


27518 Future possibilities in glaucoma therapy
Wierzbowska J; Robaszkiewicz J; Figurska M; Stankiewicz A
Medical Science Monitor 2010; 16: 252-259 (IGR: 12-4)


27225 Effect of acupuncture on the expression of Bcl-xl and BDNF of retina in rabbits with chronic intraocular hypertension
Sun H; Zhang H; Lin BS
Zhongguo Zhen Jiu 2010; 30: 661-664 (IGR: 12-4)


26462 Induction of amyloid precursor protein by the neurotoxic peptide, amyloid-beta 25-35, causes retinal ganglion cell death
Tsuruma K; Tanaka Y; Shimazawa M; Hara H
Journal of Neurochemistry 2010; 113: 1545-1554 (IGR: 12-3)


26438 Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve
Dahlmann-Noor A; Vijay S; Jayaram H; Limb A; Khaw PT
Canadian Journal of Ophthalmology 2010; 45: 333-341 (IGR: 12-3)


26686 Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma
Ju W-K; Kim K-Y; Duong-Polk KX; Lindsey JD; Ellisman MH; Weinreb RN
Molecular Vision 2010; 16: 1331-1342 (IGR: 12-3)


26795 Amacrine cell gene expression and survival signaling: differences from neighboring retinal ganglion cells
Kunzevitzky NJ; Almeida MV; Goldberg JL
Investigative Ophthalmology and Visual Science 2010; 51: 3800-3812 (IGR: 12-3)


26364 Mechanisms of retinal ganglion cell injury and defense in glaucoma
Qu J; Wang D; Grosskreutz CL
Experimental Eye Research 2010; 91: 48-53 (IGR: 12-3)


26420 Expression of myocilin mutants sensitizes cells to oxidative stress-induced apoptosis: Implication for glaucoma pathogenesis
Joe MK; Tomarev SI
American Journal of Pathology 2010; 176: 2880-2890 (IGR: 12-3)


26681 Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients
Engin KN; Yemisci B; Yigit U; Agachan A; Coskun C
Molecular Vision 2010; 16: 1260-1271 (IGR: 12-3)


26446 The calcineurin inhibitor, FK506, does not alter glutamate transport in the ischaemic mouse retina
Holcombe DJ; Gole GA; Barnett NL
Experimental Eye Research 2010; 91: 315-319 (IGR: 12-3)


26382 Dietary deficiency of vitamin E aggravates retinal ganglion cell death in experimental glaucoma of rats
Ko ML; Peng PH; Hsu SY; Chen CF
Current Eye Research 2010; 35: 842-849 (IGR: 12-3)


26445 Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve
Levkovitch-Verbin H; Dardik R; Vander S; Melamed S
Experimental Eye Research 2010; 91: 127-134 (IGR: 12-3)


26332 The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Acta Ophthalmologica 2010; 88: 553-557 (IGR: 12-3)


26397 Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo
Hu H; Lu W; Zhang M; Zhang X; Argall AJ; Patel S; Lee GE; Kim YC; Jacobson KA; Laties AM
Experimental Eye Research 2010; 91: 425-432 (IGR: 12-3)


26331 Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury
Biermann J; Lagrèze WA; Dimitriu C; Stoykow C; Goebel U
Investigative Ophthalmology and Visual Science 2010; 51: 3784-3791 (IGR: 12-3)


26315 Neuroprotective effects of C-type natriuretic peptide on rat retinal ganglion cells
Ma J; Yu W; Wang Y; Cao G; Cai S; Chen X; Yan N; Yuan Y; Zeng H; Fleenor DL
Investigative Ophthalmology and Visual Science 2010; 51: 3544-3553 (IGR: 12-3)


26389 An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma
Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
Investigative Ophthalmology and Visual Science 2010; 51: 4722-4731 (IGR: 12-3)


26347 Optic nerve regeneration
Benowitz LI; Yin Y
Archives of Ophthalmology 2010; 128: 1059-1064 (IGR: 12-3)


26391 Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1
Sun MH; Pang JH; Chen SL; Han WH; Ho TC; Chen KJ; Kao LY; Lin KK; Tsao YP
Investigative Ophthalmology and Visual Science 2010; 51: 4798-4808 (IGR: 12-3)


26362 Variations in the rheostat model of apoptosis: what studies of retinal ganglion cell death tell us about the functions of the Bcl2 family proteins
Nickells RW
Experimental Eye Research 2010; 91: 2-8 (IGR: 12-3)


26869 Protective effects of nerve regeneration factor and brain-derived neurotrophic factor on retinal ganglion cells in a rabbit model of acute hyper-intraocular pressure
Huang Z; Guan H; Ding F; Gu X
Neural Regeneration Research 2010; 5: 445-449 (IGR: 12-3)


26561 Exogenous modulation of intrinsic optic nerve neuroprotective activity
Grozdanic SD; Lazic T; Kuehn MH; Harper MM; Kardon RH; Kwon YH; Lavik EB; Sakaguchi DS
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1105-1116 (IGR: 12-3)


26590 Neuroprotective Effect of PACAP Against NMDA-Induced Retinal Damage in the Mouse
Endo K; Nakamachi T; Seki T; Kagami N; Wada Y; Nakamura K; Kishimoto K; Hori M; Tsuchikawa D; Shinntani N
Journal of Molecular Neuroscience 2010; (IGR: 12-3)


26351 Axonal degeneration, regeneration and ganglion cell death in a rodent model of anterior ischemic optic neuropathy (rAION)
Zhang C; Guo Y; Slater BJ; Miller NR; Bernstein SL
Experimental Eye Research 2010; 91: 286-292 (IGR: 12-3)


26463 Neuroprotection against superoxide anion radical by metallocorroles in cellular and murine models of optic neuropathy
Kanamori A; Catrinescu M-M; Mahammed A; Gross Z; Levin LA
Journal of Neurochemistry 2010; 114: 488-498 (IGR: 12-3)


26589 Suppression of Rat Retinal Ganglion Cell Death by PACAP Following Transient Ischemia Induced by High Intraocular Pressure
Seki T; Itoh H; Nakamachi T; Endo K; Wada Y; Nakamura K; Shioda S
Journal of Molecular Neuroscience 2010; (IGR: 12-3)


26878 Focused Conference Group: P02 - Transmembrane transport: Perspectives for disease and drug discovery calcium signal passway-based on to research the neuroprotection of effective components of traditional chinese medicine
Zhang Y; Lai X; Zhang J
Basic and Clinical Pharmacology and Toxicology 2010; 107: 687 (IGR: 12-3)


26829 Protective effect of Ginaton and fleabane on retinal ganglion cells
Wang M-L; Fei Z-G; Li H; He M-N
International Journal of Ophthalmology 2010; 10: 850-852 (IGR: 12-3)


26256 Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma
Osborne NN
Experimental Eye Research 2010; 90: 750-757 (IGR: 12-2)


25666 Distal axonopathy with structural persistence in glaucomatous neurodegeneration
Crish SD; Sappington RM; Inman DM; Horner PJ; Calkins DJ
Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 5196-5201 (IGR: 12-2)


25805 Neuroprotective effect of pigment epithelium-derived factor on retinal ganglion cells of rats with chronic intraocular hypertension
Lu B-J; Gao X-W; Wang R-F; Yan H; Wang B-R
Chinese Ophthalmic Research 2010; 28: 427-431 (IGR: 12-2)


26063 A single nucleotide polymorphism in the bax gene promoter affects transcription and influences retinal ganglion cell death
Semaan SJ; Li Y; Nickells RW
ASN Neuro 2010; 2: 87-101 (IGR: 12-2)


26050 Retinal ganglion cell death in a DBA/2J mouse model of glaucoma: Microglial activation and intraocular pressure
Yang L; Guo X; Li Y; Wu L; Wang D; Tso MOM
Neural Regeneration Research 2010; 5: 273-281 (IGR: 12-2)


25701 Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration
Baltan S; Inman DM; Danilov CA; Morrison RS; Calkins DJ; Horner PJ
Journal of Neuroscience 2010; 30: 5644-5652 (IGR: 12-2)


26010 Recovery of function and plasticity after lesions of the central visual pathway
Gall C; Prilloff S; Sabel BA
Journal fur Neurologie, Neurochirurgie und Psychiatrie 2010; 11: 18-30 (IGR: 12-2)


25980 Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma
Caprioli J; Munemasa Y; Kwong JMK; Piri N
Transactions of the American Ophthalmological Society 2009; 107: 161-165 (IGR: 12-2)


26098 Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice
Panagis L; Zhao X; Ge Y; Ren L; Mittag TW; Danias J
Investigative Ophthalmology and Visual Science 2010; 51: 2024-2034 (IGR: 12-2)


26246 Matrix metalloproteinase-9 expression in retinal ganglion cell layer and effect of topically applied brimonidine tartrate 0.2% therapy on this expression in an endothelin-1-induced optic nerve ischemia model
Aktas Z; Gurelik G; Göçün PU; Akyürek N; Onol M; Hasanreiso?lu B
International Ophthalmology 2010; 30: 253-259 (IGR: 12-2)


25781 LINGO-1 negatively regulates TrkB phosphorylation after ocular hypertension
Fu Q-L; Hu B; Li X; Shao Z; Shi J-B; Wu W; So K-F; Mi S
European Journal of Neuroscience 2010; 31: 1091-1097 (IGR: 12-2)


26128 Susceptibility to N-methyl-D-aspartate toxicity in morphological and functional types of cat retinal ganglion cells
Nakazawa T; Watanabe M; Kudo H; Nishida K; Tamai M
Japanese Journal of Ophthalmology 2010; 54: 156-162 (IGR: 12-2)


25794 Influence of T- and B-cell-deficiency on retinal neurocytes of mice with acute ocular hypertension
Huo Y; Huang P; Zhang S; Zhang C
Chinese Ophthalmic Research 2010; 28: 193-197 (IGR: 12-2)


25668 The use of mice in glaucoma research --to clarify the mechanism of intraocular pressure regulation and retinal ganglion cell damage
Aihara M
Nippon Ganka Gakkai Zasshi 2010; 114: 217-246 (IGR: 12-2)


25758 Hypoxia Inducible Factor-1(alpha) (HIF-1(alpha)) and Some HIF-1 Target Genes are Elevated in Experimental Glaucoma
Ergorul C; Ray A; Huang W; Wang DY; Ben Y; Cantuti-Castelvetri I; Grosskreutz CL
Journal of Molecular Neuroscience 2010; 1-9 (IGR: 12-2)


25757 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors modulate pro-inflammatory cytokine expression following acute retinal ischemia/reperfusion in the rat eye
Schmeer C; Walther F; Witte OW; Isenmann S
GLIA 2009; 57: S57-S58 (IGR: 12-2)


26097 Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer
Deschênes MC; Descovich D; Moreau M; Granger L; Kuchel GA; Mikkola TS; Fick GH; Chemtob S; Vaucher E; Lesk MR
Investigative Ophthalmology and Visual Science 2010; 51: 2587-2600 (IGR: 12-2)


26007 Alzheimer's disease and retinal neurodegeneration
Guo L; Duggan J; Cordeiro MF
Current Alzheimer Research 2010; 7: 3-14 (IGR: 12-2)


25750 Melatonin: A novel neuroprotectant for the treatment of glaucoma
Belforte NA; Moreno MC; de Zavalia N; Sande PH; Chianelli MS; Keller Sarmiento MI; Rosenstein RE
Journal of Pineal Research 2010; 48: 353-364 (IGR: 12-2)


26048 Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma
Chiu K; Yeung SC; So KF; Chang RC
Cellular and Molecular Immunology 2010; 7: 61-68 (IGR: 12-2)


25748 Up-regulation of crystallins is involved in the neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model
Chiu K; Zhou Y; Yeung S-C; Lok CK-M; Chan OO-C; Chang RC-C; So K-F; Chiu J-F
Journal of Cellular Biochemistry 2010; 110: 311-320 (IGR: 12-2)


25931 Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies
Dahlmann-Noor AH; Vijay S; Limb GA; Khaw PT
Drug Discovery Today 2010; 15: 7-8 287-299 (IGR: 12-2)


25948 Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage
Fang JH; Wang XH; Xu ZR; Jiang FG
BMC Neuroscience 2010; 11: 31 (IGR: 12-2)


26055 Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye
Hoyle CHV; Pintor JJ
Acta Physiologica 2010; 199: 205-210 (IGR: 12-2)


26163 Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma
Johnson TV; Bull ND; Hunt DP; Marina N; Tomarev SI; Martin KR
Investigative Ophthalmology and Visual Science 2010; 51: 2051-2059 (IGR: 12-2)


26305 Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex
Namekata K; Harada C; Taya C; Guo X; Kimura H; Parada LF; Harada T
Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 7586-7591 (IGR: 12-2)


26258 Effects of epigallocatechin-3-gallate on rat retinal ganglion cells after optic nerve axotomy
Peng PH; Chiou LF; Chao HM; Lin S; Chen CF; Liu JH; Ko ML
Experimental Eye Research 2010; 90: 528-534 (IGR: 12-2)


25928 Histological protection by donepezil against neurodegeneration induced by ischemia-reperfusion in the rat retina
Sakamoto K; Ohki K; Saito M; Nakahara T; Ishii K
Journal of Pharmacological Sciences 2010; 112: 327-335 (IGR: 12-2)


25942 Neuroprotection for treatment of glaucoma in adults
Sena DF; Ramchand K; Lindsley K
Cochrane Database of Systematic Reviews 2010; 2: CD006539 (IGR: 12-2)


25756 Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss
Son JL; Soto I; Oglesby E; Lopez-Roca T; Pease ME; Quigley HA; Marsh-Armstrong N
GLIA 2010; 58: 780-789 (IGR: 12-2)


25725 Glaucoma--neurodegenerative disease
Tataru LC; Bogdanici CM
Revista medico-chirurgical?? a Societ????ii de Medici ??i Naturali??ti din Ia??I 2009; 113: 1120-1125 (IGR: 12-2)


26257 Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent
Tsai RK; Chang CH; Sheu MM; Huang ZL
Experimental Eye Research 2010; 90: 537-545 (IGR: 12-2)


26113 Neuroprotective effect of upregulated sonic Hedgehog in retinal ganglion cells following chronic ocular hypertension
Wu J; Zhang S; Sun X
Investigative Ophthalmology and Visual Science 2010; 51: 2986-2992 (IGR: 12-2)


25830 Copolymer-1 immunization reduces damage in retinal ganglion cells under high intraocular pressure through altering the expression of retinal neurotrophins
Yang B; Shan L; Song W; Xiao Z; Shi L; Yuan H
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 11-19 (IGR: 12-2)


26030 Effects of bushenhuoxue on protecting the visual function of rat with chronic intraocular hypertension
Mao X; Li X
International Journal of Ophthalmology 2010; 10: 238-240 (IGR: 12-2)


25219 Neurotrophic Effect of a Novel TrkB Agonist on Retinal Ganglion Cells
Hu Y; Cho S; Goldberg JL
Investigative Ophthalmology and Visual Science 2010; 51: 1747-1754 (IGR: 12-1)


25369 Glutamate induces cell surface translocation of annexin A2 in retinal ganglion cells
Valapala M; Borejdo J; Vishwanatha J K
FASEB Journal 2009; 23: S1 (IGR: 12-1)


25159 RNA binding protein with multiple splicing: a new marker for retinal ganglion cells
Kwong JM; Caprioli J; Piri N
Investigative Ophthalmology and Visual Science 2010; 51: 1052-1058 (IGR: 12-1)


25584 Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma
Chiu K; Yeung S -C; So K -F; Chang R C -C
Cellular and Molecular Immunology 2010; 7: 61-68 (IGR: 12-1)


25331 Sensitivity of staurosporine-induced differentiated RGC-5 cells to homocysteine
Ganapathy P S; Dun Y; Ha Y; Duplantier J; Allen J B; Farooq A; Bozard B R; Smith S B
Current Eye Research 2010; 35: 80-90 (IGR: 12-1)


25348 Stimulation of Prostaglandin EP2 Receptors on RGC-5 Cells in Culture Blunts the Negative Effect of Serum Withdrawal
Kang K D; Andrade da Costa B L S; Osborne N N
Neurochemical Research 2010; 1-10 (IGR: 12-1)


25637 ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway
Lebrun-Julien F; Bertrand MJ; De Backer O; Stellwagen D; Morales CR; Di Polo A; Barker PA
Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 3817-3822 (IGR: 12-1)


25220 Expression and biophysical characterization of voltage-gated sodium channels in axons and growth cones of the regenerating optic nerve
Feigenspan A; Dedek K; Schlich K; Weiler R; Thanos S
Investigative Ophthalmology and Visual Science 2010; 51: 1789-1799 (IGR: 12-1)


25042 Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration
Salinas-Navarro M; Alarcón-Martínez L; Valiente-Soriano FJ; Jiménez-López M; Mayor-Torroglosa S; Avilés-Trigueros M; Villegas-Pérez MP; Vidal-Sanz M
Experimental Eye Research 2010; 90: 168-183 (IGR: 12-1)


25556 Retinal microglial cells and glaucoma
Yan X -X; Zhao P
International Journal of Ophthalmology 2009; 9: 1926-1929 (IGR: 12-1)


25222 Green Tea Catechins and Their Oxidative Protection in the Rat Eye
Chu KO; Chan KP; Wang CC; Chu CY; Li WY; Choy KW; Rogers MS; Pang CP
Journal of agricultural and food chemistry 2010; 58: 1523–1534 (IGR: 12-1)


25260 Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension
Zhang S; Wang H; Lu Q; Qing G; Wang N; Wang Y; Li S; Yang D; Yan F
Brain Research 2009; 1303: 131-143 (IGR: 12-1)


25259 Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model
Doh S H; Kim J H; Lee K M; Park H Y; Park C K
Brain Research 2010; 1308: 158-166 (IGR: 12-1)


25008 Head-up tilt lowers IOP and improves RGC dysfunction in glaucomatous DBA/2J mice
Porciatti V; Nagaraju M
Experimental Eye Research 2009; 90: 452-460 (IGR: 12-1)


25213 Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat
Chidlow G; Holman MC; Wood JP; Casson RJ
Investigative Ophthalmology and Visual Science 2010; 51: 1483-1497 (IGR: 12-1)


25180 Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury
Weber AJ; Viswanáthan S; Ramanathan C; Harman CD
Investigative Ophthalmology and Visual Science 2010; 51: 327-334 (IGR: 12-1)


25482 The effects of antiglaucomatous topical medications on retinal ganglion cell apoptosis
Karakucuk S; Yuce Y; Ulusal H; Oner A; Gumus K; Mirza E; Mujdeci M
Erciyes Tip Dergisi 2009; 31: 310-317 (IGR: 12-1)


25475 Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
Galanopoulos A; Goldberg I
Clinical Ophthalmology 2009; 3: 117-122 (IGR: 12-1)


25576 Advances of brain-derived neurotrophic factor on optic neuroprotection of glaucoma
Xie Z; Li X
International Journal of Ophthalmology 2010; 10: 100-101 (IGR: 12-1)


25315 Combination brain-derived neurotrophic factor and LINGO-1 fusion protein promote long-term survival to retinal ganglion cells after ocular hypertension
Fu Q -L; Yip H K; Li X; Shao Z; Wu W; Mi S; So K -F
Neuroscience Research 2009; 162: 375-382 (IGR: 12-1)


25541 Transcription factors as therapeutic targets in CNS disorders
Kane M J; Citron B A
Recent Patents on CNS Drug Discovery 2009; 4: 190-199 (IGR: 12-1)


25486 Neuroprotection for optic nerve disorders
Bessero A -C; Clarke P G H
Current Opinion in Neurology 2010; 23: 10-15 (IGR: 12-1)


25141 Retinal ganglion cell death postponed: giving apoptosis a break?
Kisiswa L; Dervan AG; Albon J; Morgan JE; Wride MA
Ophthalmic Research 2010; 3: 61-78 (IGR: 12-1)


25158 Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity
Seki M; Soussou W; Manabe S; Lipton SA
Investigative Ophthalmology and Visual Science 2010; 51: 1198-1207 (IGR: 12-1)


25026 Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load
Thaler S; Fiedorowicz M; Rejdak R; Choragiewicz TJ; Sulejczak D; Stopa P; Zarnowski T; Zrenner E; Grieb P; Schuettauf F
Experimental Eye Research 2010; 90: 254-260 (IGR: 12-1)


25024 Optimal parameters of transcorneal electrical stimulation (TES) to be neuroprotective of axotomized RGCs in adult rats
Morimoto T; Miyoshi T; Sawai H; Fujikado T
Experimental Eye Research 2010; 90: 285-291 (IGR: 12-1)


25022 Triamcinolone attenuates macrophage/microglia accumulation associated with NMDA-induced RGC death and facilitates survival of Müller stem cell grafts
Singhal S; Lawrence JM; Salt TE; Khaw PT; Limb GA
Experimental Eye Research 2010; 90: 308-315 (IGR: 12-1)


25168 Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the toll-like receptor 2 agonist Pam3Cys
Hauk TG; Leibinger M; Müller A; Andreadaki A; Knippschild U; Fischer D
Investigative Ophthalmology and Visual Science 2010; 51: 459-464 (IGR: 12-1)


25179 Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells
Biermann J; Grieshaber P; Goebel U; Martin G; Thanos S; Di Giovanni S; Lagrèze WA
Investigative Ophthalmology and Visual Science 2010; 51: 526-534 (IGR: 12-1)


25345 Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine
Selt M; Bartlett C A; Harvey A R; Dunlop S A; Fitzgerald M
Brain Research Bulletin 2010; 81: 467-471 (IGR: 12-1)


24766 Retinal cell apoptosis
Borrie SC; Duggan J; Cordeiro MF
Expert Review of Ophthalmology 2009; 4: 27-45 (IGR: 11-4)


24850 Acute energy reduction induces caspase-dependent apoptosis and activates p53 in retinal ganglion cells (RGC-5)
Li GY; Fan B; Su GF
Experimental Eye Research 2009; 89: 581-589 (IGR: 11-4)


24778 The two sides of cytokine signaling and glaucomatous optic neuropathy
Huang P; Zhang SS-M; Zhang C
Journal of Ocular Biology, Diseases, and Informatics 2009; 2: 78-83 (IGR: 11-4)


24694 Rapid and Noninvasive Imaging of Retinal Ganglion Cells in Live Mouse Models of Glaucoma
Tosi J; Wang N-K; Zhao J; Chou CL; Kasanuki JM; Tsang SH; Nagasaki T
Molecular Imaging and Biology 2009; 1-8 (IGR: 11-4)


24616 The neuroprotective effect of extact of ginko biloba on retinal ganglion cells after retinal ischemia-reperfusion
Li Y; Ma K; Xu L
Chinese Ophthalmic Research 2009; 27: 660-663 (IGR: 11-4)


24727 Effect of ferulic acid sodium on MDA, SOD of retina in rat models with chronic ocular hypertension
Zeng F; Li H
International Journal of Ophthalmology 2009; 9: 1668-1670 (IGR: 11-4)


24904 Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
Guo Y; Johnson E; Cepurna W; Jia L; Dyck J; Morrison JC
Experimental Eye Research 2009; 89: 921-933 (IGR: 11-4)


24941 Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma
Yang H; Hirooka K; Fukuda K; Shiraga F
Investigative Ophthalmology and Visual Science 2009; 50: 5800-5804 (IGR: 11-4)


24573 Pilocarpine Protects Cobalt Chloride-induced Apoptosis of RGC-5 Cells: Involvement of Muscarinic Receptors and HIF-1(alpha) Pathway
Zhu X; Zhou W; Cui Y; Zhu L; Li J; Feng X; Shao B; Qi H; Zheng J; Wang H
Cellular and molecular neurobiology 2009; 1-9 (IGR: 11-4)


24779 Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy
Goldenberg-Cohen N; Dadon-Bar-El S; Hasanreisoglu M; Avraham-Lubin BC; Dratviman-Storobinsky O; Cohen Y; Weinberger D
Clinical and Experimental Ophthalmology 2009; 37: 718-729 (IGR: 11-4)


24838 Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo
Kanamori A; Naka M; Fukuda M; Nakamura M; Negi A
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1353-1360 (IGR: 11-4)


24776 Modulation of microglia by Wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model
Chiu K; Chan H-C; Yeung S-C; Yuen W-H; Zee S-Y; Chang RC-C; So K-F
Journal of Ocular Biology, Diseases, and Informatics 2009; 2: 47-56 (IGR: 11-4)


24531 Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamate- and hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells
Harper MM; Adamson L; Blits B; Bunge MB; Grozdanic SD; Sakaguchi DS
Experimental Eye Research 2009; 89: 538-548 (IGR: 11-4)


24832 Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine
Fitzgerald M; Payne SC; Bartlett CA; Evill L; Harvey AR; Dunlop SA
Investigative Ophthalmology and Visual Science 2009; 50: 5456-5462 (IGR: 11-4)


24845 GM-CSF regulates the ERK1/2 pathways and protects injured retinal ganglion cells from induced death
Schallenberg M; Charalambous P; Thanos S
Experimental Eye Research 2009; 89: 665-677 (IGR: 11-4)


24775 Immune maintenance in glaucoma: Boosting the body's own neuroprotective potential
Schwartz M; London A
Journal of Ocular Biology, Diseases, and Informatics 2009; 2: 73-77 (IGR: 11-4)


24714 A neurotrophic rationale for the therapy of neurodegenerative disorders
Saragovi HU; Hamel E; Di Polo A
Current Alzheimer Research 2009; 6: 419-423 (IGR: 11-4)


24522 Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells
Koriyama Y; Ohno M; Kimura T; Kato S
Brain Research 2009; 1296: 187-195 (IGR: 11-4)


24582 Interleukin-1 attenuates normal tension glaucoma-like retinal degeneration in EAAC1-deficient mice
Namekata K; Harada C; Guo X; Kikushima K; Kimura A; Fuse N; Mitamura Y; Kohyama K; Matsumoto Y; Tanaka K
Neuroscience Letters 2009; 465: 160-164 (IGR: 11-4)


24822 Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells
Chen L; Sham CW; Chan AM; Francisco LM; Wu Y; Mareninov S; Sharpe AH; Freeman GJ; Yang XJ; Braun J
Investigative Ophthalmology and Visual Science 2009; 50: 4941-4948 (IGR: 11-4)


24669 Endocannabinoid system: Emerging role from neurodevelopment to neurodegeneration
Basavarajappa BS; Nixon RA; Arancio O
Mini Reviews in Medicinal Chemistry 2009; 9: 448-462 (IGR: 11-4)


24165 Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma
Bull ND; Irvine KA; Franklin RJ; Martin KR
Investigative Ophthalmology and Visual Science 2009; 50: 4244-4253 (IGR: 11-3)


24127 Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas
Nadal-Nicolás FM; Jiménez-López M; Sobrado-Calvo P; Nieto-López L; Cánovas-Martínez I; Salinas-Navarro M; Vidal-Sanz M; Agudo M
Investigative Ophthalmology and Visual Science 2009; 50: 3860-3868 (IGR: 11-3)


24198 Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction
Chen K; Zhang Q; Wang J; Liu F; Mi M; Xu H; Chen F; Zeng K
Brain Research 2009; 1279: 131-138 (IGR: 11-3)


24169 Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling
Liang KJ; Lee JE; Wang YD; Ma W; Fontainhas AM; Fariss RN; Wong WT
Investigative Ophthalmology and Visual Science 2009; 50: 4444-4451 (IGR: 11-3)


24167 Recharacterization of the RGC-5 retinal ganglion cell line
Van Bergen NJ; Wood JP; Chidlow G; Trounce IA; Casson RJ; Ju WK; Weinreb RN; Crowston JG
Investigative Ophthalmology and Visual Science 2009; 50: 4267-4272 (IGR: 11-3)


24243 Synaptic degeneration of retinal ganglion cells in a rat ocular hypertension glaucoma model
Fu Q-L; Li X; Shi J; Xu G; Wen W; Lee DHS; So K-F
Cellular and molecular neurobiology 2009; 29: 575-581 (IGR: 11-3)


24485 Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor
Baba K; Pozdeyev N; Mazzoni F; Contreras-Alcantara S; Liu C; Kasamatsu M; Martinez-Merlos T; Strettoi E; Iuvone PM; Tosini G
Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 15043-15048 (IGR: 11-3)


24019 Neuroprotection: extrapolating from neurologic diseases to the eye
Danesh-Meyer HV; Levin LA
American Journal of Ophthalmology 2009; 148: 186-191 (IGR: 11-3)


24156 Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram
Falsini B; Marangoni D; Salgarello T; Stifano G; Montrone L; Di Landro S; Guccione L; Balestrazzi E; Colotto A
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1223-1233 (IGR: 11-3)


24387 Both systemic and local application of Granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy
Frank T; Schlachetzki JCM; Goricke B; Meuer K; Rohde G; Dietz GPH; Bahr M; Schneider A; Weishaupt JH
BMC Neuroscience 2009; 10: 49 (IGR: 11-3)


24268 Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma
Fu Q-L; Li X; Yip HK; Shao Z; Wu W; Mi S; So K-F
Neuroscience 2009; 162: 375-382 (IGR: 11-3)


24116 Opioid receptor-activation: retina protected from ischemic injury
Husain S; Potter DE; Crosson CE
Investigative Ophthalmology and Visual Science 2009; 50: 3853-3859 (IGR: 11-3)


24388 Memantine: A comprehensive review of safety and efficacy
Kavirajan H
Expert Opinion on Drug Safety 2009; 8: 89-109 (IGR: 11-3)


24490 Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma
Lambiasea A; Aloe L; Centofanti M; Parisi V; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 13469-13474 (IGR: 11-3)


24057 Dosage dependence of the effect of Ginkgo biloba on the rat retinal ganglion cell survival after optic nerve crush
Ma K; Xu L; Zhan H; Zhang S; Pu M; Jonas JB
Eye 2009; 23: 1598-1604 (IGR: 11-3)


24201 The prostanoid EP(2) receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina
Mori A; Ishii T; Kuroki T; Shigeta N; Sakamoto K; Nakahara T; Ishii K
European Journal of Pharmacology 2009; 616: 64-67 (IGR: 11-3)


24117 The role of alphaA- and alphaB-crystallins in the survival of retinal ganglion cells after optic nerve axotomy
Munemasa Y; Kwong JM; Caprioli J; Piri N
Investigative Ophthalmology and Visual Science 2009; 50: 3869-3875 (IGR: 11-3)


24517 Pyroglutamic Acid Promotes Survival of Retinal Ganglion Cells after Optic Nerve Injury
Oono S; Kurimoto T; Nakazawa T; Miyoshi T; Okamoto N; Kashimoto R; Tagami Y; Ito Y; Mimura O
Current Eye Research 2009; 34: 598-605 (IGR: 11-3)


24080 Expression of prostaglandin PGE2 receptors under conditions of aging and stress and the protective effect of the EP2 agonist butaprost on retinal ischemia
Osborne NN; Li GY; Ji D; Andrade da Costa BL; Fawcett RJ; Kang KD; Rittenhouse KD
Investigative Ophthalmology and Visual Science 2009; 50: 3238-3248 (IGR: 11-3)


24223 Chapter 28 Identification of Novel Pharmacological Targets to Minimize Excitotoxic Retinal Damage
Russo R; Rotiroti D; Tassorelli C; Nucci C; Bagetta G; Bucci MG; Corasaniti MT; Morrone LA
International review of neurobiology 2009; 85: 407-423 (IGR: 11-3)


24155 A dietary combination of omega-3 and omega-6 polyunsaturated fatty acids is more efficient than single supplementations in the prevention of retinal damage induced by elevation of intraocular pressure in rats
Schnebelen C; Pasquis B; Salinas-Navarro M; Joffre C; Creuzot-Garcher CP; Vidal-Sanz M; Bron AM; Bretillon L; Acar N
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1191-1203 (IGR: 11-3)


24066 In vitro study of the effects of lens extract on rat retinal neuron survival and neurite outgrowth
Wang Y; Wang D; Wu N; Liu D; Yin Z; Zhu M
Ophthalmic Research 2009; 42: 29-35 (IGR: 11-3)


24203 Agmatine as retinal protection from ischemia-reperfusion injury in guinea pigs
Dastan A; Kocer I; Erdogan F; Ates O; KIzIltunc A
Japanese Journal of Ophthalmology 2009; 53: 219-224 (IGR: 11-3)


24185 A critical discussion of the rates of progression and causes of optic nerve damage in glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy
Caprioli J; Zeyen T
Journal of Glaucoma 2009; 18: S1-21 (IGR: 11-3)


23948 Reactivation of optic nerve head astrocytes by TGF-beta2 and H2O2 is accompanied by increased Hsp32 and Hsp47 expression
Yu AL; Moriniere J; Birke M; Neumann C; Fuchshofer R; Kampik A; Bloemendal H; Welge-Lussen U
Investigative Ophthalmology and Visual Science 2009; 50: 1707-1717 (IGR: 11-2)


23905 Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion
Li N; Li XR; Yuan JQ
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 503-514 (IGR: 11-2)


23427 Muscarinic activation attenuates abnormal processing of β-amyloid precursor protein induced by cobalt chloride-mimetic hypoxia in retinal ganglion cells
Zhu X; Zhou W; Cui Y; Zhu L; Li J; Xia Z; Shao B; Wang H; Chen H
Biochemical and Biophysical Research Communications 2009; 384: 110-113 (IGR: 11-2)


23713 Experimental detection of retinal ganglion cell damage in vivo
Leung CK; Weinreb RN
Experimental Eye Research 2009; 88: 831-836 (IGR: 11-2)


23617 Neuroprotection of recombinant human erythropoietin on chronic ocular hypertension induced retinal neuron injury in rats
Gao L-M; Duan X-C; Hu M-M
International Journal of Ophthalmology 2009; 9: 680-683 (IGR: 11-2)


23710 Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models
Johnson EC; Guo Y; Cepurna WO; Morrison JC
Experimental Eye Research 2009; 88: 808-815 (IGR: 11-2)


23881 alpha-Crystallin Downregulates the Expression of TNF-alpha and iNOS by Activated Rat Retinal Microglia in vitro and in vivo
Wu N; Wang YH; Zhao HS; Liu DN; Ying X; Yin ZQ; Wang Y
Ophthalmic Research 2009; 42: 21-28 (IGR: 11-2)


23664 Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo
Kanamori A; Naka M; Fukuda M; Nakamura M; Negi A
Experimental Eye Research 2009; 88: 535-541 (IGR: 11-2)


23848 Axonal regeneration induced by repetitive electrical stimulation of crushed optic nerve in adult rats
Tagami Y; Kurimoto T; Miyoshi T; Morimoto T; Sawai H; Mimura O
Japanese Journal of Ophthalmology 2009; 53: 257-266 (IGR: 11-2)


23941 Effect of CNTF on retinal ganglion cell survival in experimental glaucoma
Pease ME; Zack DJ; Berlinicke C; Bloom K; Cone F; Wang Y; Klein RL; Hauswirth WW; Quigley HA
Investigative Ophthalmology and Visual Science 2009; 50: 2194-2200 (IGR: 11-2)


23658 17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat
Russo R; Cavaliere F; Watanabe C; Nucci C; Bagetta G; Corasaniti MT; Sakurada S; Morrone LA
Progress in Brain Research 2008; 173:- 583-590 (IGR: 11-2)


23748 Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review
Saylor M; McLoon LK; Harrison AR; Lee MS
Archives of Ophthalmology 2009; 127: 402-406 (IGR: 11-2)


23716 Histological protection by cilnidipine, a dual L/N-type Ca(2+) channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina
Sakamoto K; Kawakami T; Shimada M; Yamaguchi A; Kuwagata M; Saito M; Nakahara T; Ishii K
Experimental Eye Research 2009; 88: 974-982 (IGR: 11-2)


23767 Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned
Osborne NN
Acta Ophthalmologica 2009; 87: 450-454 (IGR: 11-2)


23852 Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine
Hare WA; Wheeler L
Investigative Ophthalmology and Visual Science 2009; 50: 2940-2948 (IGR: 11-2)


23525 Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice
Zhou X; Li F; Kong L; Chodosh J; Cao W
Molecular Vision 2009; 15:- 438-450 (IGR: 11-2)


23429 Lithium chloride protects retinal neurocytes from nutrient deprivation by promoting DNA non-homologous end-joining
Zhuang J; Li F; Liu X; Liu Z; Lin J; Ge Y; Kaminski JM; Summers JB; Wang Z; Ge J
Biochemical and Biophysical Research Communications 2009; 380: 650-654 (IGR: 11-2)


23590 Safety of intravitreally administered recombinant erythropoietin (an AOS thesis)
Tsai JC
Transactions of the American Ophthalmological Society 2008; 106:- 459-472 (IGR: 11-2)


23629 Effect of tribulus terrestris L. on the retinal ganglion cells
Liao M-Y; Huang L-N; Zeng P; Liu J
International Journal of Ophthalmology 2009; 9: 282-283 (IGR: 11-2)


22952 The expressions of Fas and caspase-3 in human glaucomatous optic nerve axons
Zalewska R; Zalewski B; Reszec J; Mariak Z; Zimnoch L; Proniewska-Skretek E
Medical Science Monitor 2008; 14: BR274-BR278 (IGR: 11-1)


22857 The role of macrophages in optic nerve regeneration
Cui Q; Yin Y; Benowitz LI
Neuroscience 2009; 158: 1039-1048 (IGR: 11-1)


23368 Retinal ganglion cell death and optic nerve degeneration by genetic ablation in adult mice
Cho JH; Mu X; Wang SW; Klein WH
Experimental Eye Research 2009; 88: 542-552 (IGR: 11-1)


22615 Mechanical stretching elevates peptidyl arginine deiminase 2 expression in astrocytes
Algeciras ME; Takahara H; Bhattacharya SK
Current Eye Research 2008; 33: 994-1001 (IGR: 11-1)


22790 α2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma
Shi Z; Rudzinski M; Meerovitch K; Lebrun-Julien F; Birman E; Di Polo A; Saragovi HU
Journal of Biological Chemistry 2008; 283: 29156-29165 (IGR: 11-1)


22720 Glutamate-induced NFκB activation in the retina
Fan W; Cooper NG
Investigative Ophthalmology and Visual Science 2009; 50: 917-925 (IGR: 11-1)


22855 Microglial clearance function in health and disease
Napoli I; Neumann H
Neuroscience 2009; 158: 1030-1038 (IGR: 11-1)


22858 Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: The role of innate immunity
Schwartz M; London A; Shechter R
Neuroscience 2009; 158: 1133-1142 (IGR: 11-1)


22967 Haem oxygenase-1 gene transfer protects retinal ganglion cells from ischaemia/reperfusion injury
Peng PH; Ko ML; Chen CF; Juan SH
Clinical Science 2008; 115: 335-342 (IGR: 11-1)


22927 Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina
Ju W-K; Lindsey JD; Angert M; Patel A; Weinreb RN
Molecular Vision 2008; 14: 2629-2638 (IGR: 11-1)


22624 Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina
Ju WK; Kim KY; Angert M; Duong-Polk KX; Lindsey JD; Ellisman MH; Weinreb RN
Investigative Ophthalmology and Visual Science 2009; 50: 707-716 (IGR: 11-1)


23379 Neuroprotective effect of transpupillary thermotherapy in the optic nerve crush model of the rat
Kim SJ; Kim YJ; Park KH
Eye 2009; 23: 727-733 (IGR: 11-1)


22898 Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma
Munemasa Y; Ahn JH; Kwong JMK; Caprioli J; Piri N
Gene Therapy 2009; 16: 17-25 (IGR: 11-1)


22579 Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
American Journal of Ophthalmology 2009; 147: 326-331 (IGR: 11-1)


22709 Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion
Li SY; Fu ZJ; Ma H; Jang WC; So KF; Wong D; Lo AC
Investigative Ophthalmology and Visual Science 2009; 50: 836-843 (IGR: 11-1)


22738 Biomechanical effects of intraocular pressure elevation on optic nerve/lamina cribrosa before and after peripapillary scleral collagen cross-linking
Thornton IL; Dupps WJ; Roy AS; Krueger RR
Investigative Ophthalmology and Visual Science 2009; 50: 1227-1233 (IGR: 11-1)


22986 Ganglion cell loss and dysfunction: relationship to perimetric sensitivity
Drasdo N; Mortlock KE; North RV
Optometry and Vision Science 2008; 85: 1036-1042 (IGR: 11-1)


22936 Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: Critical role of p38 MAPK activation
El-Remessy AB; Tang Y; Zhu G; Matragoon S; Khalifa Y; Liu EK; Liu J-Y; Hanson E; Mian S; Fatteh N
Molecular Vision 2008; 14: 2190-2203 (IGR: 11-1)


22794 Axonal degeneration and regeneration: A mechanistic tug-of-war
Hilliard MA
Journal of Neurochemistry 2009; 108: 23-32 (IGR: 11-1)


22632 Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration
Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T
Journal of Glaucoma 2009; 18: 26-31 (IGR: 11-1)


22795 The complement cascade: Yin-Yang in neuroinflammation - Neuro-protection and -degeneration
Alexander JJ; Anderson AJ; Barnum SR; Stevens B; Tenner AJ
Journal of Neurochemistry 2008; 107: 1169-1187 (IGR: 11-1)


23023 Neuroprotective effect of erythropoietin and its derivatives
Cheng F; Yuan H-P
International Journal of Ophthalmology 2009; 9: 135-138 (IGR: 11-1)


23382 Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand
Wax MB; Tezel G; Yang J; Peng G; Patil RV; Agarwal N; Sappington RM; Calkins DJ
Journal of Neuroscience 2008; 12; 28: 12085-12096 (IGR: 11-1)


23362 GABA agonists fail to protect the retina from ischemia-reperfusion injury
Traustason S; Eysteinsson T; Agnarsson BA; Stefánsson E
Experimental Eye Research 2009; 88: 361-366 (IGR: 11-1)


23056 Retrograde labeling of retinal ganglion cells by application of fluoro-gold on the surface of superior colliculus
Chiu K; Lau WM; Yeung SC; Chang RC; So KF
Journal of Vision Exp 2008; 16: (IGR: 11-1)


22793 Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: Effects of NMDA receptor blockade
Russo R; Cavaliere F; Berliocchi L; Nucci C; Gliozzi M; Mazzei C; Tassorelli C; Corasaniti MT; Rotiroti D; Bagetta G
Journal of Neurochemistry 2008; 107: 1347-1357 (IGR: 11-1)


22710 Endogenous polysialylated neural cell adhesion molecule enhances the survival of retinal ganglion cells
Murphy JA; Hartwick AT; Rutishauser U; Clarke DB
Investigative Ophthalmology and Visual Science 2009; 50: 861-869 (IGR: 11-1)


23366 The role of Akt/protein kinase B subtypes in retinal ischemic preconditioning
Dreixler JC; Hemmert JW; Shenoy SK; Shen Y; Lee HT; Shaikh AR; Rosenbaum DM; Roth S
Experimental Eye Research 2009; 88: 512-521 (IGR: 11-1)


22844 Enhanced survival of melanopsin-expressing retinal ganglion cells after injury is associated with the PI3 K/Akt pathway
Li S-Y; Yau S-Y; Chen B-Y; Tay DK; Lee VWH; Pu M-L; Chan HHL; So K-F
Cellular and molecular neurobiology 2008; 28: 1095-1107 (IGR: 11-1)


22922 Intraocular pressure lowering, change of antiapoptotic molecule expression, and neuroretinal changes by dorzolamide 2%/timolol 0.5% combination in a chronic ocular hypertension rat model
Park HY; Lee NY; Kim JH; Park CK
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 563-571 (IGR: 11-1)


22884 Computer based vision restoration therapy in glaucoma patients: A small open pilot study
Gudlin J; Mueller I; Thanos S; Sabel BA
Restorative Neurology and Neuroscience 2008; 26: 403-412 (IGR: 11-1)


21436 Light affects mitochondria to cause apoptosis to cultured cells: Possible relevance to ganglion cell death in certain optic neuropathies
Osborne NN; Li G-Y; Ji D; Mortiboys HJ; Jackson S
Journal of Neurochemistry 2008; 105: 2013-2028 (IGR: 10-3)


21480 Soluble amyloid β oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma
Yin H; Chen L; Chen X; Liu X
Medical Hypotheses 2008; 71: 77-80 (IGR: 10-3)


21763 Engrafted chicken neural tube-derived stem cells support the innate propensity for axonal regeneration within the rat optic nerve
Charalambous P; Hurst LA; Thanos S
Investigative Ophthalmology and Visual Science 2008; 49: 3513-3524 (IGR: 10-3)


21508 Protection of Nimodipine on optic nerve in the patient with chronic intraocular hypertension
Zhang X; Geng Y; Zhang Z
Chinese Ophthalmic Research 2008; 26: 347-350 (IGR: 10-3)


21768 Human Müller stem cell (MIO-M1) transplantation in a rat model of glaucoma: Survival, differentiation, and integration
Bull ND; Limb GA; Martin KR
Investigative Ophthalmology and Visual Science 2008; 49: 3449-3456 (IGR: 10-3)


21532 Neuroprotection in glaucoma: drug-based approaches
Cheung W; Guo L; Cordeiro MF
Optometry and Vision Science 2008; 85: 406-416 (IGR: 10-3)


21564 Ginkgo biloba in glaucoma
Dumitrica DM; Stefan C
Oftalmologia 2007; 51: 30-33 (IGR: 10-3)


21668 Neuroprotection in glaucoma using calpain-1 inhibitors: Regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therepeutics
Govindarajan B; Laird J; Sherman R; Salomon RG; Bhattacharya SK
CNS and Neurological Disorders - Drug Targets 2008; 7: 295-304 (IGR: 10-3)


21775 The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush
Jehle T; Dimitriu C; Auer S; Knoth R; Vidal-Sanz M; Gozes I; Lagrèze WA
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 1255-1263 (IGR: 10-3)


21531 Molecular and cell-based approaches for neuroprotection in glaucoma
Lebrun-Julien F; Di Polo A
Optometry and Vision Science 2008; 85: 417-424 (IGR: 10-3)


21477 Transplanted olfactory ensheathing cells incorporated into the optic nerve head ensheathe retinal ganglion cell axons: possible relevance to glaucoma
Li Y; Li D; Khaw PT; Raisman G
Neuroscience Letters 2008; 440: 251-254 (IGR: 10-3)


21545 Estrogens and neuroprotection in retinal diseases
Maneesh Kumar D; Simpkins JW; Agarwal N
Molecular Vision 2008; 14: 1480-1486 (IGR: 10-3)


21776 Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress
Munemasa Y; Kim SH; Ahn JH; Kwong JM; Caprioli J; Piri N
Investigative Ophthalmology and Visual Science 2008; 49: 3535-3543 (IGR: 10-3)


21761 Dietary omega-3 fatty acids and ganglion cell function
Nguyen CT; Vingrys AJ; Bui BV
Investigative Ophthalmology and Visual Science 2008; 49: 3586-3594 (IGR: 10-3)


21599 PEDF promotes biosynthesis of a novel anti-inflammatory and anti-apoptotic mediator NPD1 in retinal pigment epithelial cells
Reinoso MA; Mukherjee P; Marcheselli V; Bergsma D; Hesse R; Bazan N
Ochsner Journal 2008; 8: 39-43 (IGR: 10-3)


21614 Neurodegenerative diseases of the retina and potential for protection and recovery
Schmidt K-G; Bergert H; Funk RHW
Current Neuropharmacology 2008; 6: 164-178 (IGR: 10-3)


21834 Bioenergetic-based neuroprotection and glaucoma
Schober MS; Chidlow G; Wood JP; Casson RJ
Clinical and Experimental Ophthalmology 2008; 36: 377-385 (IGR: 10-3)


21816 Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats
Tsai RK; Chang CH; Wang HZ
Experimental Eye Research 2008; 87: 242-250 (IGR: 10-3)


21650 Protective effect of adenovirus-mediated pigment epithelium-derived factor on retinal ischemia-reperfusion injury in rats
Xu X; Liu Z-L; Zhang H; Shao D; Cao J
International Journal of Ophthalmology 2008; 8: 899-902 (IGR: 10-3)


20996 Quantification of retinal transneuronal degeneration in human glaucoma: A novel multiphoton-DAPI approach
Lei Y; Garrahan N; Hermann B; Becker DL; Hernandez MR; Boulton ME; Morgan JE
Investigative Ophthalmology and Visual Science 2008; 49: 1940-1945 (IGR: 10-2)


21092 Efficient estimation of retinal ganglion cell number: A stereological approach
Fileta JB; Huang W; Kwon GP; Filippopoulos T; Ben Y; Dobberfuhl A; Grosskreutz CL
Journal of Neuroscience Methods 2008; 170: 1-8 (IGR: 10-2)


20864 GABAA receptors are associated with retinal ganglion cell death induced by oxidative stress
Okumichi H; Mizukami M; Kiuchi Y; Kanamoto T
Experimental Eye Research 2008; 86: 727-733 (IGR: 10-2)


21387 Real-time in vivo imaging of retinal cell apoptosis after laser exposure
Schmitz-Valckenberg S; Guo L; Maass A; Cheung W; Vugler A; Moss SE; Munro PM; Fitzke FW; Cordeiro MF
Investigative Ophthalmology and Visual Science 2008; 49: 2773-2780 (IGR: 10-2)


21355 STAT3 activation protects retinal ganglion cell layer neurons in response to stress
Zhang C; Li H; Liu MG; Kawasaki A; Fu XY; Barnstable CJ; Shao-Min Zhang S
Experimental Eye Research 2008; 86: 991-997 (IGR: 10-2)


21287 Effect of cannabinoid (WIN55, 212-2) on glutamic acid concentration in vitreous body of chronic glaucoma rabbit model
Zhao J-H; Wang W-H
International Journal of Ophthalmology 2008; 8: 726-728 (IGR: 10-2)


21146 Protection of endogenous CNTF on retina in rat with glaucoma
Zhang M; Wu Q; Song B; Lu B; Hu P
Chinese Ophthalmic Research 2008; 26: 96-99 (IGR: 10-2)


21158 Current management of glaucoma and the need for complete therapy
McKinnon SJ; Goldberg LD; Peeples P; Walt JG; Bramley TJ
American Journal of Managed Care 2008; 14: S20-S27 (IGR: 10-2)


21256 Evoluation on neuroprotection of memantine in acute elevated IOP
Li Y-L; Li J-M
Journal of Dalian Medical University 2008; 30: 87-89 (IGR: 10-2)


21254 Neuroprotection of progesterone on retinal ganglion cells in chronic ocular hypertension model rats
Xu S-L; Yin Y; Gu G-Z; Gao Z-Z
Journal of Jilin University Medicine Edition 2008; 34: 226-229 (IGR: 10-2)


21161 Disease progression and the need for neuroprotection in glaucoma management
Varma R; Peeples P; Walt JG; Bramley TJ
American Journal of Managed Care 2008; 14: S15-S19 (IGR: 10-2)


21384 σ-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation
Tchedre KT; Yorio T
Investigative Ophthalmology and Visual Science 2008; 49: 2577-2588 (IGR: 10-2)


21374 BDNF preserves the dendritic morphology of α- and β- ganglion cells in the cat retina after optic nerve injury
Weber AJ; Harman CD
Investigative Ophthalmology and Visual Science 2008; 49: 2456-2463 (IGR: 10-2)


21249 Pharmacodynamics of memantine: An update
Rammes G; Danysz W; Parsons CG
Current Neuropharmacology 2008; 6: 55-78 (IGR: 10-2)


20892 Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments
Hernández M; Urcola JH; Vecino E
Experimental Eye Research 2008; 86: 798-806 (IGR: 10-2)


21160 History of neuroprotection and rationale as a therapy for glaucoma
Levin LA; Peeples P
American Journal of Managed Care 2008; 14: S11-S14 (IGR: 10-2)


21142 Neuroprotection of retinal ganglion cells: Many candidates, a few mechanisms
Bonnet D; Hicks D
Current Topics in Pharmacology 2006; 10: 1-12 (IGR: 10-2)


21272 Expression of NF-κB affected by AG on retina of rats with chronic IOP elevation
Nie Q-Z; Wang Y-S; Sha Q; Gao D-W
International Journal of Ophthalmology 2008; 8: 280-283 (IGR: 10-2)


21276 Pharmacological neuroprotection on retinal ganglion cells
Lu S-H; Liu L
International Journal of Ophthalmology 2008; 8: 568-570 (IGR: 10-2)


21066 Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II
Rokicki W; Dorecka M; Romaniuk W
Klinika Oczna 2007; 109: 353-355 (IGR: 10-2)


21099 Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma
Buckingham BP; Inman DM; Lambert W; Oglesby E; Calkins DJ; Steele MR; Vetter ML; Marsh-Armstrong N; Horner PJ
Journal of Neuroscience 2008; 28: 2735-2744 (IGR: 10-2)


21065 Retinal ganglion cells death in glaucoma - mechanism and potential treatment. Part I
Rokicki W; Dorecka M; Romaniuk W
Klinika Oczna 2007; 109: 349-352 (IGR: 10-2)


21288 Protective effect of Buyanghuanwu decoction on experimental retinal ischemia-reperfusion injury in rats
Qi X-L; Zhang H-G; Zhang J; Gong H-Q
International Journal of Ophthalmology 2008; 8: 732-735 (IGR: 10-2)


21266 Protective effect of aminoguanidine and betaxolol on retinal ischemia-reperfusion injury in rats
Ma Y-P; Zhu C-H; Hang H
International Journal of Ophthalmology 2008; 8: 284-287 (IGR: 10-2)


21045 Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro
Zhang B; Rusciano D; Osborne NN
Brain Research 2008; 1198: 141-152 (IGR: 10-2)


21159 Managed care and the impact of glaucoma
Reeder CE; Franklin M; Bramley TJ
American Journal of Managed Care 2008; 14: S5-S10 (IGR: 10-2)


20787 Mechanisms regulating plasminogen activators in transformed retinal ganglion cells
Rock N; Chintala SK
Experimental Eye Research 2008; 86: 492-499 (IGR: 10-1)


20535 Expression of N-methyl-d-aspartate receptor 1 in rats with chronic ocular hypertension
Kim JH; Lee NY; Jung SW; Park CK
Neuroscience 2007; 149: 908-916 (IGR: 10-1)


20534 The expression of heat shock protein 27 in retinal ganglion and glial cells in a rat glaucoma model
Kalesnykas G; Niittykoski M; Rantala J; Miettinen R; Salminen A; Kaarniranta K; Uusitalo H
Neuroscience 2007; 150: 692-704 (IGR: 10-1)


20521 Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons
Zhou W; Zhu X; Zhu L; Cui YY; Wang H; Qi H; Ren QS; Chen HZ
Cellular and molecular neurobiology 2008; 28: 263-275 (IGR: 10-1)


20517 Effect of ocular hypertension on retinal GABAergic activity
Moreno MC; de Zavalia N; Sande P; Jaliffa CO; Fernandez DC; Keller Sarmiento MI; Rosenstein RE
Neurochemistry International 2008; 52: 675-682 (IGR: 10-1)


20472 Oxidative-induced apoptosis to an immortalized ganglion cell line is caspase independent but involves the activation of poly(ADP-ribose)polymerase and apoptosis-inducing factor
Li G-Y; Osborne NN
Brain Research 2008; 1188: 35-43 (IGR: 10-1)


20581 The neurobiology of cell death in glaucoma
Vrabec JP; Levin LA
Eye 2007; 21: S11-S14 (IGR: 10-1)


20508 In vivo imaging of murine retinal ganglion cells
Leung CKS; Lindsey JD; Crowston JG; Ju W-K; Liu Q; Bartsch D-U; Weinreb RN
Journal of Neuroscience Methods 2008; 168: 475-478 (IGR: 10-1)


20796 Blocking LINGO-1 Function Promotes Retinal Ganglion Cell Survival Following Ocular Hypertension and Optic Nerve Transection
Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
Investigative Ophthalmology and Visual Science 2008; 49: 975-985 (IGR: 10-1)


20573 Neuroprotection of retinal ganglion cell function and their central nervous system targets
Vidal-Sanz M; de la Villa P; Aviles-Trigueros M; Mayor-Torroglosa S; Salinas-Navarro M; Alarcon-Martinez L; Villegas-Perez MP
Eye 2007; 21: S42-S45 (IGR: 10-1)


20522 Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension
Fu Q-L; Wu W; Wang H; Li X; Lee VWH; So K-F
Cellular and molecular neurobiology 2008; 28: 317-329 (IGR: 10-1)


20572 A clinical trial studying neuroprotection in low-pressure glaucoma
Krupin T
Eye 2007; 21: S51-S54 (IGR: 10-1)


20588 Aloe-emodin suppressed NMDA-induced apoptosis of retinal ganglion cells through regulation of ERK phosphorylation
Lin H-J; Chao P-DL; Huang S-Y; Wan L; Wu C-J; Tsai F-J
Phytotherapy Research 2007; 21: 1007-1014 (IGR: 10-1)


20574 Detecting the effects of neuroprotection in living cells
Funk RHW; Kniep E-M; Rohlecke C
Eye 2007; 21: S38-S41 (IGR: 10-1)


20722 Research advances of optic neuroprotection of glaucoma
Zhou X-Q; Zhong Y-S
International Journal of Ophthalmology 2008; 8: 97-101 (IGR: 10-1)


20575 Neuroprotection: New pharmacological targets
Wheeler L; Lai R; Woldemussie E; Hare WA
Eye 2007; 21: S46-S50 (IGR: 10-1)


20756 Flavonoids protect retinal ganglion cells from ischemia in vitro
Maher P; Hanneken A
Experimental Eye Research 2008; 86: 366-374 (IGR: 10-1)


19941 JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions
Huang Y; Cen LP; Choy KW; van Rooijen N; Wang N; Pang CP; Cui Q
Experimental Eye Research 2007; 85: 684-695 (IGR: 9-4)


19756 Localization of α2 receptors in ocular tissues
Woldemussie E; Wijono M; Pow D
Visual Neuroscience 2007; 24: 745-756 (IGR: 9-4)


20069 Promotion of neurite outgrowth and protective effect of erythropoietin on the retinal neurons of rats
Zhong Y; Yao H; Deng L; Cheng Y; Zhou X
Graefe's Archive for Clinical and Experimental Ophthalmology 2007; 245: 1859-1867 (IGR: 9-4)


19702 Morphological and functional changes in experimental ocular hypertension and role of neuroprotective drugs
Garcia-Campos J; Villena A; Diaz F; Vidal L; Moreno M; Perez de Vargas I
Histology and Histopathology 2007; 22: 1399-1411 (IGR: 9-4)


19706 Pitavastatin: Protection against neuronal retinal damage induced by ischemia-reperfusion injury in rats
Kawaji T; Inomata Y; Takano A; Sagara N; Inatani M; Fukushima M; Tanihara H; Honjo M
Current Eye Research 2007; 32: 991-997 (IGR: 9-4)


20092 Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage
Liu Q; Ju WK; Crowston JG; Xie F; Perry G; Smith MA; Lindsey JD; Weinreb RN
Investigative Ophthalmology and Visual Science 2007; 48: 4580-4589 (IGR: 9-4)


19723 Expression of ciliary neurotrophic factor after induction of ocular hypertension in the retina of rats
Wu Q; Zhang M; Song B-W; Lu B; Hu P
Chinese Medical Journal 2007; 120: 1825-1829 (IGR: 9-4)


20074 Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes
Maass A; von Leithner PL; Luong V; Guo L; Salt TE; Fitzke FW; Cordeiro MF
Current Eye Research 2007; 32: 851-861 (IGR: 9-4)


20035 Is there more to glaucoma treatment than lowering IOP?
Mozaffarieh M; Flammer J
Survey of Ophthalmology 2007; 52: S174-179 (IGR: 9-4)


19770 Lig-8, a highly bioactive lignophenol derivative from bamboo lignin, exhibits multifaceted neuroprotective activity
Ito Y; Akao Y; Shimazawa M; Seki N; Nozawa Y; Hara H
CNS Drug Reviews 2007; 13: 296-307 (IGR: 9-4)


19775 Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Molecular Vision 2007; 13: 1783-1792 (IGR: 9-4)


19811 Pathologically activated therapeutics for neuroprotection
Lipton SA
Nature Reviews Neuroscience 2007; 8: 803-808 (IGR: 9-4)


19769 Reviews: On the hypes and falls in neuroprotection: Targeting the NMDA receptor
Villmann C; Becker C-M
Neuroscientist 2007; 13: 594-615 (IGR: 9-4)


19785 Characterization of the effects of anti-aging medicine Fructus lycii on β-amyloid peptide neurotoxicity
Yu MS; Lai CS; Ho YS; Zee SY; So KF; Yuen WH; Chang RC
International Journal of Molecular Medicine 2007; 20: 261-268 (IGR: 9-4)


19835 Hypericin's effects on retinal glutamate in acute ocular hypertension of rabbits
Li L-L; Jiang F-G; Li S
International Journal of Ophthalmology 2007; 7: 1308-1310 (IGR: 9-4)


19654 Targeting amyloid-β in glaucoma treatment
Guo L; Salt TE; Luong V; Wood N; Cheung W; Maass A; Ferrari G; Russo-Marie F; Sillito AM; Cheetham ME
Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 13444-13449 (IGR: 9-3)


19662 CaMKIIalphaB mediates a survival response in retinal ganglion cells subjected to a glutamate stimulus
Fan W; Cooper NG
Investigative Ophthalmology and Visual Science 2007; 48: 3854-3863 (IGR: 9-3)


19249 The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma
Harada T; Harada C; Nakamura K; Quah H-MA; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A
Journal of Clinical Investigation 2007; 117: 1763-1770 (IGR: 9-3)


19484 Regulation of cell death and survival pathways in experimental glaucoma
Levkovitch-Verbin H; Harizman N; Dardik R; Nisgav Y; Vander S; Melamed S
Experimental Eye Research 2007; 85: 250-258 (IGR: 9-3)


19295 Survival and axonal regeneration of off-center retinal ganglion cells of adult cats are promoted with an anti-glaucoma drug, nipradilol, but not BDNF and CNTF
Yata T; Nakamura M; Sagawa H; Tokita Y; Terasaki H; Watanabe M
Neuroscience 2007; 148: 53-64 (IGR: 9-3)


19483 Regeneration of retinal ganglion cell axons in organ culture is increased in rats with hereditary buphthalmos
Lasseck J; Schröer U; Koenig S; Thanos S
Experimental Eye Research 2007; 85: 90-104 (IGR: 9-3)


19437 Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model
Akta? Z; Gürelik G; Akyürek N; Onol M; Hasanreiso?lu B
Clinical and Experimental Ophthalmology 2007; 35: 527-34 (IGR: 9-3)


19637 Optic nerve restoration: New perspectives
Bull ND; Martin KR
Journal of Glaucoma 2007; 16: 506-511 (IGR: 9-3)


19608 Chemotactic effect of ciliary neurotrophic factor on macrophages in retinal ganglion cell survival and axonal regeneration
Cen LP; Luo JM; Zhang CW; Fan YM; Song Y; So KF; van Rooijen N; Pang CP; Lam DS; Cui Q
Investigative Ophthalmology and Visual Science 2007; 48: 4257-4266 (IGR: 9-3)


19476 Clinical evaluation of the neuroprotective effect of alpha-tocopherol against glaucomatous damage
Engin KN; Engin G; Kucuksahin H; Oncu M; Guvener B
European Journal of Ophthalmology 2007; 17: 528-533 (IGR: 9-3)


19343 Effect of nerve regeneration factor on expression of inducible-nitric oxide synthase in retina with experimental intraocular hypertension
Guan H; Huang Z; Ding F; Gu X
Chinese Ophthalmic Research 2007; 25: 325-328 (IGR: 9-3)


19330 Alteration of retinal intrinsic survival signal and effect of α2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat
Kim HS; Chang YI; Kim JH; Park CK
Visual Neuroscience 2007; 24: 127-139 (IGR: 9-3)


19383 Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation
Lipton SA
Current Drug Targets 2007; 8: 621-632 (IGR: 9-3)


19266 Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders
Lipton SA; Gu Z; Nakamura T
International review of neurobiology 2007; 82: 1-27 (IGR: 9-3)


19267 Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat
Nucci C; Tartaglione R; Cerulli A; Mancino R; Spano A; Cavaliere F; Rombola L; Bagetta G; Corasaniti MT; Morrone LA
International review of neurobiology 2007; 82: 397-406 (IGR: 9-3)


19436 Neurotrophic rationale in glaucoma: A TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo
Shi Z; Birman E; Saragovi HU
Developmental neurobiology 2007; 67: 884-894 (IGR: 9-3)


19557 Erythropoietin: A candidate neuroprotective agent in the treatment of glaucoma
Tsai JC; Song BJ; Wu L; Forbes M
Journal of Glaucoma 2007; 16: 567-571 (IGR: 9-3)


17965 Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina
Bretillon L; Diczfalusy U; Björkhem I; Maire MA; Martine L; Joffre C; Acar N; Bron A; Creuzot-Garcher C
Current Eye Research 2007; 32: 361-366 (IGR: 9-2)


17440 Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma
Zhou X; Li F; Ge J; Sarkisian Jr SR; Tomita H; Zaharia A; Chodosh J; Cao W
Developmental neurobiology 2007; 67: 603-616 (IGR: 9-2)


18108 Distribution and expression of RhoA in rat retina after optic nerve injury
Wang YH; Wang Y; Wang DW; Wu N; Liu DN; Yin ZQ
Ophthalmic Research 2007; 39: 174-178 (IGR: 9-2)


17963 Should we treat the brain in glaucoma?
Gupta N; Yücel YH
Canadian Journal of Ophthalmology 2007; 42: 409-413 (IGR: 9-2)


17471 Neuroglobin in normal retina and retina from eyes with advanced glaucoma
Rajendram R; Rao NA
British Journal of Ophthalmology 2007; 91: 663-666 (IGR: 9-2)


17451 Aloe-emodin metabolites protected N-methyl-D-aspartate-treated retinal ganglion cells by Cu-Zn superoxide dismutase
Lin H-J; Lai C-C; Chao P-DL; Fan S-S; Tsai Y; Huang S-Y; Wan L; Tsai F-J
Journal of Ocular Pharmacology and Therapeutics 2007; 23: 152-171 (IGR: 9-2)


17563 Neuronal death: where does the end begin?
Conforti L; Adalbert R; Coleman MP
Trends in Neurosciences 2007; 30: 159-166 (IGR: 9-2)


17615 Differential expression of heat shock protein mRNAs under in vivo glutathione depletion in the mouse retina
Park JW; Moon C; Yun S; Kim SY; Bae YC; Chun M-H; Moon J-I
Neuroscience Letters 2007; 413: 260-264 (IGR: 9-2)


17973 From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma
Nickells RW
Canadian Journal of Ophthalmology 2007; 42: 278-287 (IGR: 9-2)


17604 Glaucoma
Tezel G; Wax MB
Chemical immunology and allergy 2007; 92: 221-227 (IGR: 9-2)


17479 The histology observation on the protective effect of hypericin on retinal ganglion cell in chronic ocular hypertension rabbits
Li S; Jiang F-G; Li L-L
International Journal of Ophthalmology 2007; 7: 411-413 (IGR: 9-2)


17478 Protective effect of extract of ginkgo biloba leaves on retinal neuron injury in chronic high intraocular presure rats
Li H-L; Li H; Han H-Y
International Journal of Ophthalmology 2007; 7: 414-416 (IGR: 9-2)


17579 Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice
Li Y; Semaan SJ; Schlamp CL; Nickells RW
BMC Neuroscience 2007; 8: 19 (IGR: 9-2)


17546 Pharmacological neuroprotection for glaucoma
Chidlow G; Wood JPM; Casson RJ
Drugs 2007; 67: 725-759 (IGR: 9-2)


17662 Effects of nootropic agents on visual functions and lacrimal antioxidative activity in patients with primary open-angle glaucoma
Davydova NG; Kuznetsova TP; Borisova SA; Abdulkadyrova MZ
Vestnik Oftalmologii 2006; 122: 42-45 (IGR: 9-2)


18078 Is this neuroprotective drug good for my glaucoma patients? Some key factors in clinical decision-making
Goldberg I
Canadian Journal of Ophthalmology 2007; 42: 418-420 (IGR: 9-2)


18034 Axonal loss and neuroprotection in optic neuropathies
Levin LA
Canadian Journal of Ophthalmology 2007; 42: 403-408 (IGR: 9-2)


18077 Assessment of the optic disc to measure neuroprotection
Mikelberg FS
Canadian Journal of Ophthalmology 2007; 42: 421-424 (IGR: 9-2)


17570 Calpain activity in retinal degeneration
Paquet-Durand F; Johnson L; Ekstrom P
Journal of Neuroscience Research 2007; 85: 693-702 (IGR: 9-2)


18076 Natural compounds: Evidence for a protective role in eye disease
Ritch R
Canadian Journal of Ophthalmology 2007; 42: 425-438 (IGR: 9-2)


18075 Modulating the immune system: a vaccine for glaucoma?
Schwartz M
Canadian Journal of Ophthalmology 2007; 42: 439-441 (IGR: 9-2)


17562 Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres
Ward MS; Khoobehi A; Lavik EB; Langer R; Young MJ
Journal of Pharmaceutical Sciences 2007; 96: 558-568 (IGR: 9-2)


17975 Glaucoma neuroprotection: What is it? Why is it needed?
Weinreb RN
Canadian Journal of Ophthalmology 2007; 42: 396-398 (IGR: 9-2)


17608 Pigment epithelium-derived factor protects retinal ganglion cells
Pang I-H; Zeng H; Fleenor DL; Clark AF
BMC Neuroscience 2007; 8: 11 (IGR: 9-2)


17181 Tumor necrosis factor-(α) mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma
Nakazawa T; Nakazawa C; Matsubara A; Noda K; Hisatomi T; She H; Michaud N; Hafezi-Moghadam A; Miller JW; Benowitz LI
Journal of Neuroscience 2006; 26: 12633-12641 (IGR: 9-1)


16836 Role of extracellular signal-regulated kinase in glutamate-stimulated apoptosis of rat retinal ganglion cells
Zhou R-H; Yan H; Wang B-R; Kuang F; Duan X-L; Xu Z
Current Eye Research 2007; 32: 233-239 (IGR: 9-1)


16961 Chondroitin sulfate-derived disaccharide protects retinal cells from elevated intraocular pressure in aged and immunocompromised rats
Bakalash S; Rolls A; Lider O; Schwartz M
Investigative Ophthalmology and Visual Science 2007; 48: 1181-1190 (IGR: 9-1)


16809 Retinal ischemic injury rescued by sodium 4-phenylbutyrate in a rat model
Jeng YY; Lin NT; Chang PH; Huang YP; Pang VF; Liu CH; Lin CT
Experimental Eye Research 2007; 84: 486-492 (IGR: 9-1)


16811 A standardized method to create optic nerve crush: Yasargil aneurysm clip
Sarikcioglu L; Demir N; Demirtop A
Experimental Eye Research 2007; 84: 373-377 (IGR: 9-1)


17155 Brimonidine in the treatment of glaucoma and ocular hypertension
Cantor LB
Therapeutics and Clinical Risk Management 2006; 2: 337-346 (IGR: 9-1)


16813 Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy
Danylkova NO; Alcala SR; Pomeranz HD; McLoon LK
Experimental Eye Research 2007; 84: 293-301 (IGR: 9-1)


17026 Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma
Chan H-C; Chuen-Chung Chang R; Koon-Ching Ip A; Chiu K; Yuen W-H; Zee S-Y; So K-F
Experimental Neurology 2007; 203: 269-273 (IGR: 9-1)


17123 Advances in researches on the optic nerve protection
Fan X-R; Sun H
International Journal of Ophthalmology 2006; 6: 1267-1271 (IGR: 9-1)


17122 Effect of acathopanax senticosus on the level of glutamate and NO on the retina in high ocular pressure models
Gao D-W; Shao L; Yang Y
International Journal of Ophthalmology 2006; 6: 1294-1296 (IGR: 9-1)


17148 Influences of hyperbaric oxygenation therapy on cytochrome oxidase and nitric oxide synthase in retina of rats with experimentally elevated intraocular pressure
Yi J-H; Peng Z-R; Liu Q-L; Wu Z-Q
Chinese Journal of Clinical Rehabilitation 2006; 10: 114-116 (IGR: 9-1)


16945 Neuroprotective and intraocular pressure-lowering effects of (-)delta-tetrahydrocannabinol in a rat model of glaucoma
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Research 2007; 39: 69-75 (IGR: 9-1)


16958 Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Investigative Ophthalmology and Visual Science 2007; 48: 1212-1218 (IGR: 9-1)


14860 Gene therapy and transplantation in CNS repair: The visual system
Harvey AR; Hu Y; Leaver SG; Mellough CB; Park K; Verhaagen J; Plant GW; Cui Q
Progress in Retinal and Eye Research 2006; 25: 449-489 (IGR: 8-4)


15272 Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat
Schuettauf F; Rejdak R; Thaler S; Bolz S; Lehaci C; Mankowska A; Zarnowski T; Junemann A; Zagorski Z; Zrenner E
Experimental Eye Research 2006; 83: 1128-1134 (IGR: 8-4)


15264 Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells
Schlieve CR; Tam A; Nilsson BL; Lieven CJ; Raines RT; Levin LA
Experimental Eye Research 2006; 83: 1252-1259 (IGR: 8-4)


14473 Nitric oxide synthase in retina and optic nerve head of rat with increased intraocular pressure and effect of timolol
Vidal L; Diaz F; Villena A; Moreno M; Campos JG; Vargas IPd
Brain Research Bulletin 2006; 70: 406-413 (IGR: 8-4)


15262 Acetylcholine neuroprotection against glutamate-induced excitotoxicity in adult pig retinal ganglion cells is partially mediated through α4 nAChRs
Thompson SA; Smith O; Linn DM; Linn CL
Experimental Eye Research 2006; 83: 1135-1145 (IGR: 8-4)


14625 Neuroprotective properties of erythropoietin on neuro-retinopathy
Li D; Duan X-C
International Journal of Ophthalmology 2006; 6: 860-864 (IGR: 8-4)


14732 Rescula as an alternative therapy for beta-blockers with long-term drift effect in glaucoma patients
Chen C-L; Tseng H-Y; Wu K-Y
The Kaohsiung Journal of Medical Sciences 2006; 22: 266-270 (IGR: 8-4)


14519 Neuroprotection: Does it work for all neurological diseases?
Girkin CA
Clinical and Surgical Ophthalmology 2006; 24: 362-367 (IGR: 8-4)


15120 Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid
Heiduschka P; Thanos S
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1512-1521 (IGR: 8-4)


14503 Anti-apoptosis effect of bcl-xl on retinal ganglion cells by ultrasound-mediated microbubble destruction
Li W; Liu S; Wang Z-G
Chinese Journal of Medical Imaging Technology 2006; 22: 1147-1150 (IGR: 8-4)


14629 The analysis of hyperosmotic glucose combined with ferosemide to treat shallow anterior chamber after glaucoma filtering surgery
Zhao M; Yu B-K; Li G-F; Chen H-T; Chen X
International Journal of Ophthalmology 2006; 6: 935-936 (IGR: 8-4)


15067 Vaccine for glaucoma, myth or reality?
Baudouin C; Liang H
Journal Français d'Ophtalmologie 2006; 29: 9-12 (IGR: 8-4)


14595 AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells
Leaver SG; Cui Q; Plant GW; Arulpragasam A; Hisheh S; Verhaagen J; Harvey AR
Gene Therapy 2006; 13: 1328-1341 (IGR: 8-4)


14619 Protective effect of Erigeron Breviscapus (Vant.) Hangd-Mazz on the visual field of glaucoma with controlled intraocular pressure
Xiang M-H; Zhong Y-S; Zhang X-R
International Journal of Ophthalmology 2006; 6: 806-809 (IGR: 8-4)


14049 Nimodipine plasma concentration and retinal blood flow in healthy subjects
Michelson G; Warntges S; Leidig S; Lotsch J; Geisslinger G
Investigative Ophthalmology and Visual Science 2006; 47: 3479-3486 (IGR: 8-3)


14022 Neuroprotective effect of latanoprost on rat retinal ganglion cells
Kudo H; Nakazawa T; Shimura M; Takahashi H; Fuse N; Kashiwagi K; Tamai M
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1003-1009 (IGR: 8-3)


14209 Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx
Das A; Garner DP; Del Re AM; Woodward JJ; Kumar DM; Agarwal N; Banik NL; Ray SK
Brain Research 2006; 1084: 146-157 (IGR: 8-3)


14229 Understanding optic nerve degeneration: Key to neuroprotection in glaucoma
Ferrer E; Bozzo J
Drugs of the Future 2006; 31: 355-363 (IGR: 8-3)


13956 Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma
Hirooka K; Baba T; Fujimura T; Shiraga F
American Journal of Ophthalmology 2006; 142: 523-525 (IGR: 8-3)


14211 Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway
Nakazawa T; Takahashi H; Shimura M
Brain Research 2006; 1093: 141-149 (IGR: 8-3)


14058 Interleukin-6 protects retinal ganglion cells from pressure-induced death
Sappington RM; Chan M; Calkins DJ
Investigative Ophthalmology and Visual Science 2006; 47: 2932-2942 (IGR: 8-3)


14206 Effects of bone marrow stromal cell injection in an experimental glaucoma model
Yu S; Tanabe T; Dezawa M; Ishikawa H; Yoshimura N
Biochemical and Biophysical Research Communications 2006; 344: 1071-1079 (IGR: 8-3)


14167 Neuroprotective treatment of patients with normal tension glaucoma
Golovacheva MO
Georgian Medical News 2006; 131: 37-40 (IGR: 8-3)


13895 A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy
Ben Simon GJ; Bakalash S; Aloni E; Rosner M
American Journal of Ophthalmology 2006; 141: 1105-1111 (IGR: 8-2)


13896 Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection
Levkovitch-Verbin H; Kalev-Landoy M; Habot-Wilner Z; Melamed S
Archives of Ophthalmology 2006; 124: 520-526 (IGR: 8-2)


13603 Effects of EBHM on optic nerve head and peripapillary retinal blood flow in the glaucomatous patients with controlled intraocular pressure
Liu D-J; Bao J; Chen X-M; Pan R-G
International Journal of Ophthalmology 2006; 6: 107-109 (IGR: 8-2)


13623 Effect of oral donepezil on intraocular pressure in normotensive Alzheimer patients
Estermann S; Daepp G-C; Cattapan Ludewig K; Berkhoff M; Frueh BE; Goldblum D
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 62-67 (IGR: 8-2)


13627 Protective effects of melatonin in experimental free radical-related ocular diseases
Siu AW; Maldonado M; Sanchez Hidalgo M; Tan D-X; Reiter RJ
Journal of Pineal Research 2006; 40: 101-109 (IGR: 8-2)


13270 T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure
Bakalash S; Shlomo GB; Aloni E; Shaked I; Wheeler L; Ofri R; Schwartz M
Journal of Molecular Medicine 2005; 83: 904-916 (IGR: 8-1)


13521 Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo
Guo L; Salt TE; Maass A; Luong V; Moss SE; Fitzke FW; Cordeiro MF
Investigative Ophthalmology and Visual Science 2006; 47: 626-633 (IGR: 8-1)


13505 A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat
Karim Z; Sawada A; Kawakami H; Yamamoto T; Taniguchi T
Current Eye Research 2006; 31: 273-283 (IGR: 8-1)


13347 Neuroprotection and regeneration in glaucoma
Levin LA
Ophthalmology Clinics of North America 2005; 18: 585-596 (IGR: 8-1)


13371 Protective effect of donepezil on retinal ganglion cells in vitro and in vivo
Miki A; Otori Y; Morimoto T; Okada M; Tano Y
Current Eye Research 2006; 31: 69-77 (IGR: 8-1)


13334 Complementary therapy for the treatment of glaucoma: A perspective
Ritch R
Ophthalmology Clinics of North America 2005; 18: 597-609 (IGR: 8-1)


13262 Neuroprotective effects of Erigeron Breviscapus (vant) Hand-Mazz on NMDA-induced retinal neuron injury in the rats
Shi J-M; Jiang Y-Q; Liu X-Y
International Journal of Ophthalmology 2005; 5: 859-863 (IGR: 8-1)


13420 Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma
Yucel YH; Gupta N; Zhang Q; Mizisin AP; Kalichman MW; Weinreb RN
Archives of Ophthalmology 2006; 124: 217-225 (IGR: 8-1)


13003 Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up
Parisi V
Documenta Ophthalmologica 2005; 110: 91-102 (IGR: 7-3)


13227 Experimental modulation of optic nerve regeneration by reducing inhibitory effects of reactive astrocytes
Fan Z; Chen D; Ge J
Eye Science 2005; 21: 170-172 (IGR: 7-3)


13011 Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma
Hains BC; Waxman SG
Investigative Ophthalmology and Visual Science 2005; 46: 4164-4169 (IGR: 7-3)


12617 Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies
Kuehn MH; Fingert JH; Kwon YH
Ophthalmology Clinics of North America 2005; 18: 383-395 (IGR: 7-3)


13115 Study of effects of antiglaucoma eye drops on N-methyl-d: -aspartate-induced retinal damage
Metoki T; Ohguro H; Ohguro I; Mamiya K; Ito T; Nakazawa M
Japanese Journal of Ophthalmology 2005; 49: 453-461 (IGR: 7-3)


12995 Neuroprotective effect of citicoline against KA-induced neurotoxicity in the rat retina
Park CH; Kim YS; Noh HS; Cheon EW; Yang YA; Yoo JM; Choi WS; Cho GJ
Experimental Eye Research 2005; 81: 350-358 (IGR: 7-3)


13218 Heat shock protein 72 protects retinal ganglion cells in rat model of acute glaucoma
Qing G; Duan X; Jiang Y
Eye Science 2005; 21:163-168 (IGR: 7-3)


13097 Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells
Saito S; Ohashi M; Naito A; Fukaya Y; Suzuki Y; Araie M
Japanese Journal of Ophthalmology 2005; 49: 371-376 (IGR: 7-3)


13172 Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model
Swanson KI; Schlieve CR; Lieven CJ; Levin LA
Investigative Ophthalmology and Visual Science 2005; 46: 3737-3741 (IGR: 7-3)


13040 Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma
Tsai JC; Wu L; Worgul B; Forbes M; Cao J
Current Eye Research 2005; 30: 1025-1031 (IGR: 7-3)


13224 The effects of recombinant human erythropoeitin on electroretinogram after raising intraocular pressure in rabbits
Wang J; Hu H; Lu Y; Sun N; Feng H
Eye Science 2005; 21: 161-164 (IGR: 7-3)


12252 Invited review: Neuroprotective properties of certain beta-adrenoceptor antagonists used for the treatment of glaucoma
Osborne NN; Wood JP; Chidlow G
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 175-181 (IGR: 7-2)


11973 Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model
Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
British Journal of Ophthalmology 2005; 89: 504-507 (IGR: 7-1)


11768 Neuroprotection: Does it work for all neurological diseases?
Girkin CA
Clinical and Surgical Ophthalmology 2004; 22: 218-222 (IGR: 7-1)


12137 Protective effects of transplantation of hCNTF-transfected cell line on axotomy-induced degeneration of retinal ganglion cells
Li HM; Lu SD; Xia X; Xu P; Wang F; Huang Q
Chinese Journal of Ophthalmology 2005; 41: 119-122 (IGR: 7-1)


12104 Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer
Malik JMI; Shevtsova Z; Bahr M; Kugler S
Molecular Therapy 2005; 11: 373-381 (IGR: 7-1)


11929 Neuroprotective effect of subretinal implants in the RCS rat
Pardue MT; Phillips MJ; Yin H; Sippy BD; Webb-Wood S; Chow AY; Ball SL
Investigative Ophthalmology and Visual Science 2005; 46: 674-682 (IGR: 7-1)


11969 Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity
Schuettauf F; Vorwerk C; Naskar R; Orlin A; Quinto K; Zurakowski D; Dejneka NS; Klein RL; Meyer EM; Bennett J
Current Eye Research 2004; 29: 379-386 (IGR: 7-1)


12135 May glutathione S-transferase M1 positive genotype afford protection against primary open-angle glaucoma?
Yildirim O; Ates NA; Tamer L; Oz O; Yilmaz A; Atik U; Camdeviren H
Graefe's Archive for Clinical and Experimental Ophthalmology 2005; 243: 327-333 (IGR: 7-1)


11296 Metipranolol blunts nitric oxide-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs
Osborne NN; Wood JP
Investigative Ophthalmology and Visual Science 2004; 45: 3787-3795 (IGR: 6-3)


11261 Aquaporin-4 Gene Disruption in Mice Protects against Impaired Retinal Function and Cell Death after Ischemia
Da T; Verkman AS
Investigative Ophthalmology and Visual Science 2004; 45: 4477-4483 (IGR: 6-3)


11360 Optic nerve and neuroprotection strategies
Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
Eye 2004; 18: 1075-1084 (IGR: 6-3)


10588 Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats
Chen H; Weber AJ
Brain Research 2004; 1011: 99-106 (IGR: 6-2)


10663 Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: functional measures
Hare WA; Woldemussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
Investigative Ophthalmology and Visual Science 2004; 45: 2625-39 (IGR: 6-2)


10662 Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: structural measures
Hare WA; Woldemussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
Investigative Ophthalmology and Visual Science 2004; 45: 2640-51 (IGR: 6-2)


10761 The influence of the calcium channel blocker verapamil on experimental glaucoma
Mikheytseva IN; Kashintseva LT; Krizhanovsky GN; Kopp OP; Lipovetskaya EM
International Ophthalmology 2004; 25: 75-79 (IGR: 6-2)


10815 Induction of heat shock protein 72 in RGCs of rat acute glaucoma model after heat stress or zinc administration
Qing G; Duan X; Jiang Y
Eye Science 2004; 20: 30-3, 51 (IGR: 6-2)


10901 Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity
Wehrwein E; Thompson SA; Coulibaly SF; Linn DM; Linn CL
Investigative Ophthalmology and Visual Science 2004; 45: 1531-43 (IGR: 6-2)


10925 Protection by pyruvate of rat retinal cells against zinc toxicity in vitro, and pressure-induced ischemia in vivo
Yoo MH; Lee JY; Lee SE; Koh JY; Yoon YH
Investigative Ophthalmology and Visual Science 2004; 45: 1523-30 (IGR: 6-2)


10626 Acute effects of sildenafil on Humphrey visual field and intraocular pressure
Ermis SS; Inan UU; Samli M; Ozturk F
International Ophthalmology 2004; 25: 69-72 (IGR: 6-2)


10510 Effects of axonal injury on ganglion cell survival and glutamate homeostasis
Vorwerk CK; Zurakowski D; McDermott LM; Mawrin C; Dreyer EB
Brain Research Bulletin 2004; 62: 485-490 (IGR: 6-1)


10516 Expression of CNTF and CNTFRα mRNA in retina after optic nerve injury in rats
Zou Q; Ye J; Zhu P; Wang Z; Li Z
Chinese Ophthalmic Research 2004; 22: 54-56 (IGR: 6-1)


10498 Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension
Rudzinski M; Wong TP; Saragovi HU
Journal of Neurobiology 2004; 58: 341-354 (IGR: 6-1)


10485 Intraocular injection of dibutyryl cyclic AMP promotes axon regeneration in rat optic nerve
Monsul NT; Geisendorfer AR; Han PJ; Banik R; Pease ME; Skolasky Jr RL; Hoffman PN
Experimental Neurology 2004; 186: 124-133 (IGR: 6-1)


10459 Neuroprotection in ophthalmology: a review
Barkana Y; Belkin M
Brain Research Bulletin 2004; 62: 447-453 (IGR: 6-1)


10165 Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model
Caprioli J; Ishii Y; Kwong JMK; Gaasterland DE
Transactions of the American Ophthalmological Society 2003; 101: 39-51 (IGR: 6-1)


10162 The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma
Hirooka K; Tokuda M; Miyamoto O; Itano T; Baba T; Shiraga F
Current Eye Research 2004; 28: 153-157 (IGR: 6-1)


10164 A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat
Maeda K; Sawada A; Matsubara M; Nakai Y; Hara A; Yamamoto T
Investigative Ophthalmology and Visual Science 2004; 45: 851-856 (IGR: 6-1)


10489 Pharmacological neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma
Neufeld AH
Brain Research Bulletin 2004; 62: 455-459 (IGR: 6-1)


10492 Methylprednisolone treatment does not influence axonal regeneration or degeneration following optic nerve injury in the adult rat
Ohlsson M; Westerlund U; Langmoen MIA; Svensson M
Journal of Neuro-Ophthalmology 2004; 24: 11-18 (IGR: 6-1)


10163 Retinal ganglion cell survival is enhanced by gabapentin-lactam in vitro: evidence for involvement of mitochondrial K(ATP) channels
Pielen A; Kirsch M; Hofmann HD; Feuerstein TJ; Lagreze WA
Graefe's Archive for Clinical and Experimental Ophthalmology 2004; 242: 240-244 (IGR: 6-1)


10501 Optic nerve crush: protection and regeneration
Schwartz M
Brain Research Bulletin 2004; 62: 467-471 (IGR: 6-1)


10500 Vaccination for glaucoma: dream or reality?
Schwartz M
Brain Research Bulletin 2004; 62: 481-484 (IGR: 6-1)


10166 Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration
Guarneri P; Cascio C; Russo D; D'Agostino S; Drago G; Galizzi G; De Leo G; Piccoli F; Guarneri M; Guarneri R
Annals of the New York Academy of Science 2003; 1007: 117-128 (IGR: 6-1)


9694 Glaucomatous optic neuropathy: when glia misbehave
Neufeld AH; Liu B
Neuroscientist 2003; 9: 485-495 (IGR: 5-3)


9730 Time course of the change in optic nerve head circulation after an acute increase in intraocular pressure
Takayama J; Tomidokoro A; Ishii K; Tamaki Y; Fukaya Y; Hosokawa T; Araie M
Investigative Ophthalmology and Visual Science 2003; 44: 3977-3985 (IGR: 5-3)


9763 Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection
Evans DW; Hosking SL; Gherghel D; Bartlett JD
British Journal of Ophthalmology 2003; 87: 1463-1465 (IGR: 5-3)


9940 Neuroprotective effect of (-)δ9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite
El Remessy AB; Khalil IE; Matragoon S; Abou-Mohamed G; Tsai NJ; Roon P; Caldwell RB; Caldwell RW; Green K; Liou GI
American Journal of Pathology 2003; 163: 1997-2008 (IGR: 5-3)


10029 The neuroprotective effect of erigeron breviscapus (vant) hand-mazz on retinal ganglion cells after optic nerve crush injury
Jiang B; Jiang Y
Chinese Journal of Ophthalmology 2003; 39: 481-484 (IGR: 5-3)


9941 Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies
Marcic TS; Belyea DA; Katz B
Current Opinions in Ophthalmology 2003; 14: 353-356 (IGR: 5-3)


9122 Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model
Ishii Y; Kwong JM; Caprioli J
Investigative Ophthalmology and Visual Science 2003; 44: 1982-1992 (IGR: 5-2)


8996 Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells
Aoun P; Simpkins JW; Agarwal N
Investigative Ophthalmology and Visual Science 2003; 44: 2999-3004 (IGR: 5-2)


8877 Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma
Bakalash S; Kessler A; Mizrahi T; Nussenblatt R; Schwartz M
Investigative Ophthalmology and Visual Science 2003; 44: 3374-3381 (IGR: 5-2)


8998 The effect of compound pill salvia miltiorrhiza on red blood cell immunity function in closure angle glaucoma
Du N; Chen Q
Chinese Ophthalmic Research 2003; 21: 312-313 (IGR: 5-2)


8999 Delivery of ciliary neurotrophic factor via lentiviral mediated transfer protects axotomized retinal ganglion cells for an extended period of time
Van Adel BA; Kostic C; Deglon N; Ball AK; Arsenijevic Y
Human Genetics and Therapeutics 2003; 14: 103-115 (IGR: 5-2)


9000 Effects of head down tilt on intra-ocular pressure, near vision, and visual field and the protection effect of Chinese herbs
Xu X; Xu ZM; Liu GY; Xu LM; Wang BZ; He H
Space Med Med Eng (Beijing) 2002; 15: 419-422 (IGR: 5-2)


8997 A clinical study of the neuroprotection effect of erigeron breviscapus hand mazz on glaucomatous patient eyes
Ye C; Jiang Y
Chinese Ophthalmic Research 2003; 21: 307-311 (IGR: 5-2)


8852 The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol
Wood JPM; Schmidt KG; Melena J; Chidlow Gallmeier H; Osborne NN
Experimental Eye Research 2003; 76: 505-516 (IGR: 5-1)


8748 Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucoma
Melamed S
Drugs Under Experimental and Clinical Research 2002; 28: 63-73 (IGR: 5-1)


8520 Partial regeneration and long-term survival of rat retinal ganglion cells after optic nerve crush is accompanied by altered expression, phosphorylation and distribution of cytoskeletal proteins
Dieterich DC; Trivedi N; Engelmann R; Gundelfinger ED; Gordon-Weeks PR; Kreutz MR
European Journal of Neuroscience 2002; 15: 1433-1443 (IGR: 5-1)


8632 Vaccination stimulates retinal ganglion cell regeneration in the adult optic nerve
Ellezam B; Bertrand J; Dergham P; McKerracher L
Neurobiology of Disease 2003; 12: 1-10 (IGR: 5-1)


8522 Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia
Kim TW; Kim DM; Park KH; Kim H
Korean Journal of Ophthalmology 2002; 16: 1-7 (IGR: 5-1)


8729 The effects of ginkgo flavonoids on the generation of hydroxyl radicals in the retina of rabbits with high intraocular pressure
Li Y; Yang X; Gao M
Chinese Ophthalmic Research 2003; 21: 29-31 (IGR: 5-1)


8736 BMP receptor 1b is required for axon guidance and cell survival in the developing retina
Liu J; Wilson S; Reh T
Developmental Biology 2003; 256: 34-47 (IGR: 5-1)


8790 Oral citicoline treatment improves visual pathway function in glaucoma
Rejdak R; Toczolowski J; Krukowski J; Kaminski M; Rejdak K; Stelmasiak Z; Grieb P
Medical Science Monitor 2003; 9: PI24-PI28 (IGR: 5-1)


8805 Neuroprotection as a treatment for glaucoma: Pharmacological and immunological approaches
Schwartz M
European Journal of Ophthalmology 2003; 13 Suppl 3: S27-31 (IGR: 5-1)


8518 Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy
Shirvan A; Kimron M; Holdengreber V; Ziv I; Ben-Shaul Y; Melamed S; Melamed E; Barzilai A; Solomon AS
Journal of Biological Chemistry 2002; 277: 49799-49807 (IGR: 5-1)


8857 Macrophage-derived factors stimulate optic nerve regeneration
Yin Y; Cui Q; Li Y; Irwin N; Fischer D; Harvey AR; Benowitz LI
Journal of Neuroscience 2003; 23: 2284-2293 (IGR: 5-1)


8521 Effects of β-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells
Zhang J; Wu SM; Gross R
Brain Research 2003; 959: 111-119 (IGR: 5-1)


8775 Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy
Osborne NN; Chidlow G; Wood J; Casson R
European Journal of Ophthalmology 2003; 13 Suppl 3: S19-26 (IGR: 5-1)


8519 Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina
Oshitari T; Fujimoto N; Adachi-Usami E
Neuroreport 2002; 13: 2109-2111 (IGR: 5-1)


8314 Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model
Schuettauf F; Quinto K; Naskar R; Zurakowski D
Vision Research 2002; 42: 2333-2337 (IGR: 4-3)


8351 Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells
Nakazawa T; Tomita H; Yamaguchi K; Sato Y; Shimura M; Kuwahara S; Tamai M
Current Eye Research 2002; 24: 114-122 (IGR: 4-3)


8063 Protection of retinal ganglion cells against glaucomatous neuropathy by neurotrophin-producing, genetically modified neural progenitor cells in a rat model
Wang N; Zeng M; Ruan Y; Wu H; Chen J; Fan Z; Zhen H
Chinese Medical Journal 2002; 115: 1394-1400 (IGR: 4-3)


8238 Neuroprotective effect of memantine in different retinal injury models in rats
Woldemussie E; Yoles E; Schwartz M; Ruis G; Wheeler LA
Journal of Glaucoma 2002; 11: 474-480 (IGR: 4-3)


3445 Protective effect of arachidonic acid on glutamate neurotoxicity in rat retinal ganglion cells
Kawasaki A; Ming-Hu Han; Ji-Ye Wei; Hirata K; Otori Y; Barnstable CJ
Investigative Ophthalmology and Visual Science 2002; 43: 1835-1842 (IGR: 4-2)


3450 Use of memantine in progressive glaucoma - Case report
Schröder A; Erb C
Klinische Monatsblätter für Augenheilkunde 2002; 219: 533-536 (IGR: 4-2)


3606 Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells
Hua Gao; Xiaoxi Qiao; Cantor LB; WuDunn D
Archives of Ophthalmology 2002; 120: 797-803 (IGR: 4-2)


3613 Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina
Baptiste DC; Hartwick ATE; Jollimore CAB; Baldridge WH; Chauhan BC; Tremblay F; Kelly MEM
Investigative Ophthalmology and Visual Science 2002; 43: 2666-2676 (IGR: 4-2)


3582 Antagonists of protein kinase C inhibit rat retinal glutamate transport activity in situ
Bull ND; Barnett NL
Journal of Neurochemistry 2002; 81: 472-480 (IGR: 4-2)


3583 Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells
Kashiwagi K; Iizuka Y; Tsukahara S
Journal of Glaucoma 2002; 11: 231-238 (IGR: 4-2)


3584 Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice
Kilic E; Hermann DM; Isenmann S; Bahr M
Journal of Pineal Research 2002; 32: 106-111 (IGR: 4-2)


3585 Fish oil (polyunsaturated fatty acid) prevents ischemic-induced injury in the mammalian retina
Murayama K; Yoneya S; Miyauchi O; Adachi-Usami E; Nishikawa M
Experimental Eye Research 2002; 74: 671-676 (IGR: 4-2)


3586 Phenytoin blocks retinal ganglion cell death after partial optic nerve crush
Naskar R; Quinto K; Romann I; Schuettauf F; Zurakowski D
Experimental Eye Research 2002; 74: 747-752 (IGR: 4-2)


3587 A prodrug of a selective inhibitor of inducible mitric oxide synthase is neuroprotective in the rat model of glaucoma
Neufeld AH; Das S; Vora S; Gachie E; Kawai S; Manning PT; Connor JR
Journal of Glaucoma 2002; 11: 221-225 (IGR: 4-2)


3588 Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity
Osborne NN; Wood JPM; Cupido A; Melena J; Chidlow G
Investigative Ophthalmology and Visual Science 2002; 43: 1456-1464 (IGR: 4-2)


6661 Brain-derived neurotrophic factor enhances neurite regeneration from retinal ganglion cells in aged human retina in vitro
Takano M; Horie H; Iijima Y; Dezawa M; Sawada H; Ishikawa Y
Experimental Eye Research 2002; 74: 319-323 (IGR: 4-1)


6850 Pharmacodynamics of citicoline relevant to the treatment of glaucoma
Grieb P; Rejdak R
Journal of Neuroscience Research 2002; 67: 143-148 (IGR: 4-1)


6851 Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone
Kurysheva NI; Shpak AA; Ioileva EE; Galanter LI; Nagornova ND; Shubina NI; Shlyshalova NN
Vestnik Oftalmologii 2001; 117: 5-8 (IGR: 4-1)


6852 Current understanding of neuroprotection in glaucoma
Wein FB; Levin LA
Current Opinions in Ophthalmology 2002; 13: 61-67 (IGR: 4-1)


6853 The dawn of neuroprotective therapy for glaucomatous optic neuropathy
Yamamoto T
Nippon Ganka Gakkai Zasshi 2001; 105: 866-883 (IGR: 4-1)


6854 Preservation of retinal morphology and functions in Royal College Surgeons rat by nilvadipine, a Ca2+ antagonist
Yamazaki H; Ohguro H; Maeda T; Maruyama I; Takano Y; Metoki T; Nakazawa M; Sawada H; Dezawa M
Investigative Ophthalmology and Visual Science 2002; 43: 919-926 (IGR: 4-1)


6855 Experimental researches of ocular hypertension retinal injury and the NOS mechanism in the injury
Yang X; Li J
Chinese Ophthalmic Research 2002; 20: 39-42 (IGR: 4-1)


18340 Neuroprotection: does it work for any neurological diseases?
Girkin CA
Ophthalmic Practice 2001; 19: 298-302 (IGR: 3-3)


18339 The neuroprotective properties of gabapentin-lactam
Lagrèze WA; Müller-Velten R; Feuerstein TJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2001; 239: 845-849 (IGR: 3-3)


18338 Animal and culture models of glaucoma for studying neuroprotection
Levin LA
European Journal of Ophthalmology 2001; 11: Suppl 2 S23-S29 (IGR: 3-3)


18337 Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches
Schwartz M
European Journal of Ophthalmology 2001; 11: Suppl 2 S7-S11 (IGR: 3-3)


18336 Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits
Toriu N; Sasaoka M; Shimazawa M; Sugiyama T; Hara H
Journal of Ocular Pharmacology and Therapeutics 2001; 17: 131-149 (IGR: 3-3)


6365 Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats
Ko ML; Hu DN; Ritch R; Sharma SC; Chen CF
Neuroscience Letters 2001; 305: 139-142 (IGR: 3-2)


6511 Neuroprotection in glaucoma. Where is the clinical evidence?
Haefliger IO; Pellanda N; Fleischhauer JC; Gekkieva M; Flammer J
Ophthalmologe 2001; 98: 564-567 (IGR: 3-2)


6512 Simultaneous management of blood flow and IOP in glaucoma
Harris A; Jonescu-Cuypers C; Martin B; Kagemann L; Zalish M; Garzozi HJ
Acta Ophthalmologica Scandinavica 2001; 79: 336-341 (IGR: 3-2)


6513 Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels
Melena J; Stanton D; Osborne NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2001; 239: 522-530 (IGR: 3-2)


6514 Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model
Park KH; Cozier F; Ong OC; Caprioli J
Investigative Ophthalmology and Visual Science 2001; 42: 1522-1530 (IGR: 3-2)


6515 Topical verapamil in glaucoma filtration surgery
Shin DH; Kardasis CT; Kim C; Juzych MS; Hughes BA; Keole NS
Journal of Glaucoma 2001; 10: 211-214 (IGR: 3-2)


19147 Antioxidants valuation in glaucoma
Della Valle V; Ricci R; Scorolli LG; Scorolli L
Annali di Ottalmologia e Clinica Oculistica 2000; 126: 257-262 (IGR: 3-1)


19148 Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies
Fisher J; Levkovitch-Verbin H; Schori H; Yoles E; Butovsky O; Kaye JF; Ben-Nun A; Schwartz M
Journal of Neuroscience 2001; 21: 136-142 (IGR: 3-1)


19149 Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy
Hartwick ATE
Optometry and Vision Science 2001; 78: 85-94 (IGR: 3-1)


19150 Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma
Schori H; Kipnis J; Yoles E; Wolde Mussie E; Ruiz G; Wheeler LA; Schwartz M
Proceedings of the National Academy of Sciences of the United States of America 2001; 98: 3398-3403 (IGR: 3-1)


15663 Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured petinal ganglion cells
Tezel G; Wax MB
Journal of Neuroscience 2000; 20: 8693-8700 (IGR: 2-3)


15664 The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma
Ko ML; Hu DN; Ritch R; Sharma SC
Investigative Ophthalmology and Visual Science 2000; 41: 2967-2971 (IGR: 2-3)


15662 Protection of ganglion cells in experimental glaucoma by retinal laser photocoagulation
Nork TM; Poulsen GL; Nickells RW; Ver Hoeve JN; Cho NC; Levin LA; Lucarelli MJ
Archives of Ophthalmology 2000; 118: 1242-1250 (IGR: 2-3)


15950 Ganglion cell death in glaucoma: mechanisms and neuroprotective strategies
Kwon YH; Mansberger SL; Cioffi GA
Ophthalmology Clinics of North America 2000; 13: 465-479 (IGR: 2-3)


15998 The protective effect of ligustrazine on optic nerve axons in rabbit eyes with continuous elevated IOP
Li X; Uang L; Kang F
Chinese Journal of Ophthalmology 2000; 36: 442 (IGR: 2-3)


15757 Lesion-induced regulation of netrin receptors and modification of netrin-1 expression in the retina of fish and grafted rats
Petrausch B; Jung M; Leppert CA; Stürmer CA
Molecular and Cellular Neurosciences 2000; 16: 350-364 (IGR: 2-3)


16003 The effect of Erigon Breviscapus (Vant.) Hand-Mazz on axoplasmic transport of optic nerve in rats with experimentally elevated intraocular pressure
Zhu Y; Jiang Y; Liu Z
Chinese Journal of Ophthalmology 2000; 36: 289 (IGR: 2-3)


6033 The structure of the optic nerve in experimental glaucoma and in the means for its treatment
Ivanova VF; Mikheeva EA; Karelina VE; Alekseev VN
Morfologiia 2000; 117: 56-61 (IGR: 2-2)


6205 Basic fibroblast growth factor applied to the optic nerve after injury increases long-term cell survival in the frog retina
Blanco RE; Lopez-Roca A; Soto J; Blagburn JM
Journal of Comparative Neurology 2000; 423: 646-658 (IGR: 2-2)


6206 In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
Haefliger IO; Fleischhauer JC; Flammer J
Eye 2000; 14: 464-472 (IGR: 2-2)


6207 T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies
Kipnis J; Yoles E; Porat Z; Cohen A; Mor F; Sela M; Cohen IR; Schwartz M
Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 7446-7451 (IGR: 2-2)


6208 Autoimmune T cells retard the loss of function in injured rat optic nerves
Moalem G; Yoles E; Leibowitz-Amit R; Muller-Gilor S; Mor F; Cohen IR; Schwartz M
Journal of Neuroimmunology 2000; 106: 189-197 (IGR: 2-2)


6209 5-hydroxytryptamine(1A) agonists: potential use in glaucoma. Evidence from animal studies
Osborne NN; Wood JPM; Melena J; Chao HM; Nash MS; Bron AJ; Chidlow G
Eye 2000; 14: 454-463 (IGR: 2-2)


6210 Effects of tetramethylpyrazine on retina of rabbits with experimental glaucoma
Song Z; Cui S; Zhang D; Chen X; Wang Y
Journal of Xi'an Medical University, English Edition 2000; 12: 23-26+45 (IGR: 2-2)


6211 Injury-specific expression of activating transcription factor-3 in retinal ganglion cells and its colocalized expression with phosphorylated c-Jun
Takeda M; Kato H; Takamiya A; Yoshida A; Kiyama H
Investigative Ophthalmology and Visual Science 2000; 41: 2412-2421 (IGR: 2-2)


5684 Potential role for Ginkgo biloba extract in the treatment of glaucoma
Ritch R
Medical Hypotheses 2000; 54: 221-235 (IGR: 2-1)


5830 Tenascin-R inhibits regrowth of optic fibers in vitro and persists in the optic nerve of mice after injury
Becker T; Anliker B; Becker CG; Taylor J; Schachner M; Meyer RL; Bartsch U
GLIA 2000; 29: 330-346 (IGR: 2-1)


5831 The effects of FK506 on retinal ganglion cells after optic nerve crush
Freeman EE; Grosskreutz CL
Investigative Ophthalmology and Visual Science 2000; 41: 1111-1115 (IGR: 2-1)


5832 Neuroprotective effect of N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat
Gu Z; Yamamoto T; Kawase C; Matsubara M; Kawase K; Sawada A; Kitazawa Y
Nippon Ganka Gakkai Zasshi 2000; 104: 11-16 (IGR: 2-1)


5833 Attenuation of ganglion cell dysfunction: a goal for glaucoma treatment in the new millennium
Osborne NN; DeSantis L; Melena J; Chidlow G; Wood JPM
Ophthalmology Clinics of North America 2000; 13:123-130 (IGR: 2-1)


5834 Neuroprotection: is it already applicable to glaucoma therapy?
Ritch R
Current Opinions in Ophthalmology 2000; 11: 78-84 (IGR: 2-1)


5835 Neuroprotection: a new treatment modality for glaucoma?
Schwartz M; Yoles E
Current Opinions in Ophthalmology 2000; 11: 107-111 (IGR: 2-1)


5836 Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina
Toriu N; Akaike A; Yasuyoshi H; Zhang S; Kashii S; Honda Y; Shimazawa M; Hara H
Experimental Eye Research 2000; 70: 475-484 (IGR: 2-1)


15334 Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia
Morgan J; Caprioli J; Koseki Y
Archives of Ophthalmology 1999; 117: 1524-1529 (IGR: 1-3)


15513 Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
Osborne NN; DeSantis L; Bae JH; Ugarte M; Wood JPM; Nash MS; Chidlow G
Experimental Eye Research 1999; 69: 331-342 (IGR: 1-3)


15539 Glaucomatous neurodegeneration and the concept of neuroprotection
Bautista RD
International Ophthalmology Clinics 1999; 39: 57-70 (IGR: 1-3)


15540 Saving the nerve from glaucoma: memantine to caspaces
Naskar R; Vorwerkd CK; Dreyer EB
Seminars in Ophthalmology 1999; 14: 152-158 (IGR: 1-3)


15541 Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
Neufeld AH; Sawada A; Becker B
Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 9944-9948 (IGR: 1-3)


15542 Effects of nicergoline on the retinal and cortical electrophysiological responses in glaucoma patients: a preliminary open study
Parisi V; Colacino G; Milazzo G; Scuderi AC; Manni G
Pharmacological Research 1999; 40: 249-255 (IGR: 1-3)


15543 Is neuroprotection a viable therapy for glaucoma?
Weinreb RN; Levin LA
Archives of Ophthalmology 1999; 117: 1540-1544 (IGR: 1-3)


5176 Ganglion cell death in glaucoma: what do we really know?
Osborne NN; Wood JPM; Childlow G; Bae J-H; Melena J; Nash MS
British Journal of Ophthalmology 1999; 83: 980-986 (IGR: 1-2)


5443 Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.
Kapin MA; Doshi R; Scatton B; DeSantis LM; Chandler ML
Investigative Ophthalmology and Visual Science 1999; 40: 1177-1182 (IGR: 1-2)


5444 Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy
Levin LA
Survey of Ophthalmology 1999; 43 (S1): S98-S101 (IGR: 1-2)


5445 The potential of neuroprotection in glaucoma treatment
Osborne NN; Chidlow G; Nash MS; Wood JPM
Current Opinions in Ophthalmology 1999; 10: 82-92 (IGR: 1-2)


5446 Neuroprotection in relation to retinal ischemia and relevance to glaucoma
Osborne NN; Ugarte M; Chao M; Chidlow G; Bae JH; Wood JPM; Nash MS
Survey of Ophthalmology 1999; 43 (S1): S102-S128 (IGR: 1-2)


5447 Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells
Pang I-H; Wexler EM; Nawy S; DeSantis L; Kapin MA
Investigative Ophthalmology and Visual Science 1999; 40: 1170-1176 (IGR: 1-2)


5448 Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma.
Parisi V; Manni G; Colacino G; Bucci MG
Ophthalmology 1999; 106: 1126-1134 (IGR: 1-2)


5449 Optic nerve degeneration and potential neuroprotection: implications for glaucoma.
Schwartz M; Yoles E
European Journal of Ophthalmology 1999; 9 (S1): S9-11 (IGR: 1-2)


5450 Apoptotic mechanisms in neurodegeneration: possible relevance to glaucoma.
Tatton WG
European Journal of Ophthalmology 1999; 9 (S1): S22-29 (IGR: 1-2)


5451 Neuroprotektivny ucinok pilokarpinu a hladina kyseliny glutamovej v tkanivovych strukturach zadneho segmentu oka (Neuroprotective effect of pilocarpine and glutamic acid level in tissue structures of the posterior segment of the eye)
Veselovsky J; Olah Z
?eska a Slovenska Oftalmologie 1999; 55: 53-57 (IGR: 1-2)



6.20 Progression (2485 abstracts found)


94460 Clinically Verified Hybrid Deep Learning System for Retinal Ganglion Cells Aware Grading of Glaucomatous Progression
Raja H
IEEE Transactions on Bio-Medical Engineering 2021; 68: 2140-2151 (IGR: 22-2)


94742 Risk Factors for the Structural Progression of Myopic Glaucomatous Eyes with a History of Laser Refractive Surgery
Lee K
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94255 Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression
Aoki S
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Bak E
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94575 Synergic effect of corneal hysteresis and central corneal thickness in the risk of early-stage primary open-angle glaucoma progression
Jiménez-Santos MA
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2743-2751 (IGR: 22-2)


94942 Association of Optic Disc Tilt and Torsion with Open-Angle Glaucoma Progression Risk: Meta-Analysis and Meta-Regression Analysis
Ha A
American Journal of Ophthalmology 2021; 232: 30-39 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Bak E
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
David RCC
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Armstrong JJ
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Seo D
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Phillips MJ
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Bak E
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Proudfoot JA
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Seo D
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Bak E; Kim YK
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Moghimi S
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Zangwill LM
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Dinh-Dang D
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94255 Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression
Miki A
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Lee T
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Zhang R
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94460 Clinically Verified Hybrid Deep Learning System for Retinal Ganglion Cells Aware Grading of Glaucomatous Progression
Hassan T
IEEE Transactions on Bio-Medical Engineering 2021; 68: 2140-2151 (IGR: 22-2)


94575 Synergic effect of corneal hysteresis and central corneal thickness in the risk of early-stage primary open-angle glaucoma progression
Saénz-Francés F
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2743-2751 (IGR: 22-2)


94942 Association of Optic Disc Tilt and Torsion with Open-Angle Glaucoma Progression Risk: Meta-Analysis and Meta-Regression Analysis
Chung W
American Journal of Ophthalmology 2021; 232: 30-39 (IGR: 22-2)


94742 Risk Factors for the Structural Progression of Myopic Glaucomatous Eyes with a History of Laser Refractive Surgery
Kim BY
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Kim JY
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Fung M
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94575 Synergic effect of corneal hysteresis and central corneal thickness in the risk of early-stage primary open-angle glaucoma progression
Sánchez-Jean R
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2743-2751 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Moghimi S
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94460 Clinically Verified Hybrid Deep Learning System for Retinal Ganglion Cells Aware Grading of Glaucomatous Progression
Akram MU
IEEE Transactions on Bio-Medical Engineering 2021; 68: 2140-2151 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Do JL
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Ha A
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94742 Risk Factors for the Structural Progression of Myopic Glaucomatous Eyes with a History of Laser Refractive Surgery
Seong GJ
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94942 Association of Optic Disc Tilt and Torsion with Open-Angle Glaucoma Progression Risk: Meta-Analysis and Meta-Regression Analysis
Shim SR
American Journal of Ophthalmology 2021; 232: 30-39 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Bolo K
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94255 Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression
Omoto T
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94575 Synergic effect of corneal hysteresis and central corneal thickness in the risk of early-stage primary open-angle glaucoma progression
Martinez-de-la Casa JM
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2743-2751 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Bowd C
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94942 Association of Optic Disc Tilt and Torsion with Open-Angle Glaucoma Progression Risk: Meta-Analysis and Meta-Regression Analysis
Kim CY
American Journal of Ophthalmology 2021; 232: 30-39 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Hou H
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Zeman-Pocrnich C
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Han YS
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Burkemper B
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94742 Risk Factors for the Structural Progression of Myopic Glaucomatous Eyes with a History of Laser Refractive Surgery
Kim CY
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94460 Clinically Verified Hybrid Deep Learning System for Retinal Ganglion Cells Aware Grading of Glaucomatous Progression
Werghi N
IEEE Transactions on Bio-Medical Engineering 2021; 68: 2140-2151 (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Seong GJ
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Hou H
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94255 Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression
Fujino Y
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Hou H
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94942 Association of Optic Disc Tilt and Torsion with Open-Angle Glaucoma Progression Risk: Meta-Analysis and Meta-Regression Analysis
Chang IB
American Journal of Ophthalmology 2021; 232: 30-39 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Kim JS
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Lee JC
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Proudfoot J
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94742 Risk Factors for the Structural Progression of Myopic Glaucomatous Eyes with a History of Laser Refractive Surgery
Bae HW
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Saunders LJ
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Proudfoot J
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94575 Synergic effect of corneal hysteresis and central corneal thickness in the risk of early-stage primary open-angle glaucoma progression
García-Feijoo J
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2743-2751 (IGR: 22-2)


94255 Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression
Matsuura M
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Choi W
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Rotenberg B
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
LeTran VH
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94255 Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression
Murata H
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Zangwill LM
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Hou H
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Bae HW
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Bauman G
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Hou H
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Lee J
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94575 Synergic effect of corneal hysteresis and central corneal thickness in the risk of early-stage primary open-angle glaucoma progression
Jañez-Escalada L
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 2743-2751 (IGR: 22-2)


94942 Association of Optic Disc Tilt and Torsion with Open-Angle Glaucoma Progression Risk: Meta-Analysis and Meta-Regression Analysis
Kim YK
American Journal of Ophthalmology 2021; 232: 30-39 (IGR: 22-2)


94742 Risk Factors for the Structural Progression of Myopic Glaucomatous Eyes with a History of Laser Refractive Surgery
Lee SY
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
LeTran VH
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Hou H; Belghith A
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Chang BR
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94255 Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression
Asaoka R
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94386 Glaucoma Progression after Delivery in Patients with Open-Angle Glaucoma Who Discontinued Glaucoma Medication during Pregnancy
Kim CY
Journal of clinical medicine 2021; 10: (IGR: 22-2)


94942 Association of Optic Disc Tilt and Torsion with Open-Angle Glaucoma Progression Risk: Meta-Analysis and Meta-Regression Analysis
Park KH
American Journal of Ophthalmology 2021; 232: 30-39 (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Gilbert K
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Kamalipour A
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Kim YW
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Nishida T
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Baek SU
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94846 Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis
Hutnik CML
American journal of ophthalmology case reports 2021; 23: 101132 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Grisafe DJ
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Medeiros FA
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Baek SU
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Chu Z
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Jeoung JW
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Williams-Steppe E
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
De Moraes CG; Girkin CA
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Acera T
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94496 Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma
Park KH
Investigative Ophthalmology and Visual Science 2021; 62: 4 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Zhou X; Song BJ
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Liebmann JM
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Dirkes K
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Xu BY
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


94978 Characteristics of Central Visual Field Progression in Eyes with Optic Disc Hemorrhage
Weinreb RN
American Journal of Ophthalmology 2021; 231: 109-119 (IGR: 22-2)


94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Weinreb R
JAMA ophthalmology 2021; 139: 839-846 (IGR: 22-2)


94853 Steps to Measurement Floor of an Optical Microangiography Device in Glaucoma
Wong B; Wang RK; Richter GM
American Journal of Ophthalmology 2021; 231: 58-69 (IGR: 22-2)


92840 Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma
Lee J
British Journal of Ophthalmology 2021; 105: 653-660 (IGR: 22-1)


92213 Detecting Progression in Patients with Different Clinical Presentations of Primary Open-angle Glaucoma
Abu SL
Journal of Glaucoma 2021; 0: (IGR: 22-1)


91994 Ageing and glaucoma progression of the retinal nerve fibre layer using spectral-domain optical coherence tomography analysis
Öhnell HM
Acta Ophthalmologica 2021; 99: 260-268 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Mushtaq Y
Eye 2022; 36: 555-563 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Ratanawongphaibul K
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92617 Characterizing and quantifying the temporal relationship between structural and functional change in glaucoma
Chu FI
PLoS ONE 2021; 16: e0249212 (IGR: 22-1)


92241 Nocturnal Variability of Intraocular Pressure Monitored With Contact Lens Sensor Is Associated With Visual Field Loss in Glaucoma
Yang Z
Journal of Glaucoma 2021; 30: e56-e60 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Gupta S
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


92629 Baseline Choroidal Microvasculature Dropout as a Predictor of Subsequent Visual Field Progression in Open-Angle Glaucoma
Jo YH
Journal of Glaucoma 2021; 30: 672-681 (IGR: 22-1)


92450 Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Tsuchiya S
Eye 2021; 35: 919-928 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Aydın R
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Susanna FN
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Kim EW
Eye 2021; 35: 536-543 (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Li F
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92544 Detection of Primary Angle Closure Glaucoma Progression by Optical Coherence Tomography
Kurysheva NI
Journal of Glaucoma 2021; 30: 410-420 (IGR: 22-1)


92829 Did the OCT Show Progression Since the Last Visit?
Hood DC
Journal of Glaucoma 2021; 30: e134-e145 (IGR: 22-1)


92667 Progression of Visual Pathway Degeneration in Primary Open-Angle Glaucoma: A Longitudinal Study
Haykal S
Frontiers in human neuroscience 2021; 15: 630898 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Girkin CA
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


92621 Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
Realini T
British Journal of Ophthalmology 2022; 106: 1235-1239 (IGR: 22-1)


91971 An Increased Choroidal Microvasculature Dropout Size is Associated With Progressive Visual Field Loss in Open-Angle Glaucoma
Lee JY
American Journal of Ophthalmology 2021; 223: 205-219 (IGR: 22-1)


92011 Longitudinal Macular Ganglion Cell-Inner Plexiform Layer Measurements to Detect Glaucoma Progression in High Myopia
Shin JW
American Journal of Ophthalmology 2021; 223: 9-20 (IGR: 22-1)


92618 Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma
Swaminathan SS
American Journal of Ophthalmology 2021; 229: 100-107 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Thenappan A
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92533 Juxtapapillary Deep-Layer Microvasculature Dropout and Retinal Nerve Fiber Layer Thinning in Glaucoma
Kwon JM
American Journal of Ophthalmology 2021; 227: 154-165 (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Chan E
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Ye C
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Rao HL
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


91933 Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve
Mahmoudinezhad G
British Journal of Ophthalmology 2021; 105: 381-386 (IGR: 22-1)


92667 Progression of Visual Pathway Degeneration in Primary Open-Angle Glaucoma: A Longitudinal Study
Jansonius NM
Frontiers in human neuroscience 2021; 15: 630898 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Tsikata E
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Melchior B
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92629 Baseline Choroidal Microvasculature Dropout as a Predictor of Subsequent Visual Field Progression in Open-Angle Glaucoma
Shin JW
Journal of Glaucoma 2021; 30: 672-681 (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Srinivasan T
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Tsamis E
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92544 Detection of Primary Angle Closure Glaucoma Progression by Optical Coherence Tomography
Lepeshkina LV
Journal of Glaucoma 2021; 30: 410-420 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Belghith A
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


91971 An Increased Choroidal Microvasculature Dropout Size is Associated With Progressive Visual Field Loss in Open-Angle Glaucoma
Shin JW
American Journal of Ophthalmology 2021; 223: 205-219 (IGR: 22-1)


92533 Juxtapapillary Deep-Layer Microvasculature Dropout and Retinal Nerve Fiber Layer Thinning in Glaucoma
Weinreb RN
American Journal of Ophthalmology 2021; 227: 154-165 (IGR: 22-1)


92213 Detecting Progression in Patients with Different Clinical Presentations of Primary Open-angle Glaucoma
Marín-Franch I
Journal of Glaucoma 2021; 0: (IGR: 22-1)


91933 Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve
Lin M
British Journal of Ophthalmology 2021; 105: 381-386 (IGR: 22-1)


92011 Longitudinal Macular Ganglion Cell-Inner Plexiform Layer Measurements to Detect Glaucoma Progression in High Myopia
Song MK
American Journal of Ophthalmology 2021; 223: 9-20 (IGR: 22-1)


92618 Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma
Jammal AA
American Journal of Ophthalmology 2021; 229: 100-107 (IGR: 22-1)


91994 Ageing and glaucoma progression of the retinal nerve fibre layer using spectral-domain optical coherence tomography analysis
Heijl A
Acta Ophthalmologica 2021; 99: 260-268 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Tsamis E
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92617 Characterizing and quantifying the temporal relationship between structural and functional change in glaucoma
Racette L
PLoS ONE 2021; 16: e0249212 (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Lin F
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Barış M
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Wang X
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Park HS
Eye 2021; 35: 536-543 (IGR: 22-1)


92621 Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
Shillingford-Ricketts H
British Journal of Ophthalmology 2022; 106: 1235-1239 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Singh A
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


92829 Did the OCT Show Progression Since the Last Visit?
Melchior B
Journal of Glaucoma 2021; 30: e134-e145 (IGR: 22-1)


92840 Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma
Ahn EJ
British Journal of Ophthalmology 2021; 105: 653-660 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Panchasara B
Eye 2022; 36: 555-563 (IGR: 22-1)


92241 Nocturnal Variability of Intraocular Pressure Monitored With Contact Lens Sensor Is Associated With Visual Field Loss in Glaucoma
Mansouri K
Journal of Glaucoma 2021; 30: e56-e60 (IGR: 22-1)


92450 Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Higashide T
Eye 2021; 35: 919-928 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Tsamis E
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Yeh K
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


92621 Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
Burt D
British Journal of Ophthalmology 2022; 106: 1235-1239 (IGR: 22-1)


91971 An Increased Choroidal Microvasculature Dropout Size is Associated With Progressive Visual Field Loss in Open-Angle Glaucoma
Song MK
American Journal of Ophthalmology 2021; 223: 205-219 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Mahalingam K
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


92450 Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Udagawa S
Eye 2021; 35: 919-928 (IGR: 22-1)


92829 Did the OCT Show Progression Since the Last Visit?
Tsamis E
Journal of Glaucoma 2021; 30: e134-e145 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Durmaz-Engin C
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Nassehzadehtabriz N
Eye 2022; 36: 555-563 (IGR: 22-1)


92618 Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma
Berchuck SI
American Journal of Ophthalmology 2021; 229: 100-107 (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Choi W
Eye 2021; 35: 536-543 (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Pradhan ZS
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Moghimi S
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Gao K
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92829 Did the OCT Show Progression Since the Last Visit?
Tsamis E
Journal of Glaucoma 2021; 30: e134-e145 (IGR: 22-1)


92840 Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma
Kim YW
British Journal of Ophthalmology 2021; 105: 653-660 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Zemplenyi M
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


91933 Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve
Rabiolo A
British Journal of Ophthalmology 2021; 105: 381-386 (IGR: 22-1)


92533 Juxtapapillary Deep-Layer Microvasculature Dropout and Retinal Nerve Fiber Layer Thinning in Glaucoma
Zangwill LM
American Journal of Ophthalmology 2021; 227: 154-165 (IGR: 22-1)


92241 Nocturnal Variability of Intraocular Pressure Monitored With Contact Lens Sensor Is Associated With Visual Field Loss in Glaucoma
Moghimi S
Journal of Glaucoma 2021; 30: e56-e60 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Zemborain ZZ
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92213 Detecting Progression in Patients with Different Clinical Presentations of Primary Open-angle Glaucoma
Racette L
Journal of Glaucoma 2021; 0: (IGR: 22-1)


92629 Baseline Choroidal Microvasculature Dropout as a Predictor of Subsequent Visual Field Progression in Open-Angle Glaucoma
Song MK
Journal of Glaucoma 2021; 30: 672-681 (IGR: 22-1)


92829 Did the OCT Show Progression Since the Last Visit?
Tsamis E
Journal of Glaucoma 2021; 30: e134-e145 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Yu MC
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


91994 Ageing and glaucoma progression of the retinal nerve fibre layer using spectral-domain optical coherence tomography analysis
Bengtsson B
Acta Ophthalmologica 2021; 99: 260-268 (IGR: 22-1)


92667 Progression of Visual Pathway Degeneration in Primary Open-Angle Glaucoma: A Longitudinal Study
Cornelissen FW
Frontiers in human neuroscience 2021; 15: 630898 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Bowd C
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Paula JS
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92618 Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma
Berchuck SI
American Journal of Ophthalmology 2021; 229: 100-107 (IGR: 22-1)


92011 Longitudinal Macular Ganglion Cell-Inner Plexiform Layer Measurements to Detect Glaucoma Progression in High Myopia
Sung KR
American Journal of Ophthalmology 2021; 223: 9-20 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Shang X
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


92618 Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma
Medeiros FA
American Journal of Ophthalmology 2021; 229: 100-107 (IGR: 22-1)


92533 Juxtapapillary Deep-Layer Microvasculature Dropout and Retinal Nerve Fiber Layer Thinning in Glaucoma
Suh MH
American Journal of Ophthalmology 2021; 227: 154-165 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Al-Aswad LA
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


92840 Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma
Ha A
British Journal of Ophthalmology 2021; 105: 653-660 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Boland MV
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92241 Nocturnal Variability of Intraocular Pressure Monitored With Contact Lens Sensor Is Associated With Visual Field Loss in Glaucoma
Weinreb RN
Journal of Glaucoma 2021; 30: e56-e60 (IGR: 22-1)


92829 Did the OCT Show Progression Since the Last Visit?
Liebmann JM
Journal of Glaucoma 2021; 30: e134-e145 (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Proudfoot J
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


92621 Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
Balasubramani GK
British Journal of Ophthalmology 2022; 106: 1235-1239 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Medeiros FA
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
La Bruna S
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Lee H
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Sreenivasaiah S
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Selvan H
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Proudfoot J
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


92450 Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Sugiyama K
Eye 2021; 35: 919-928 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Lim HK
Eye 2022; 36: 555-563 (IGR: 22-1)


91933 Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve
Morales E
British Journal of Ophthalmology 2021; 105: 381-386 (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Lee K
Eye 2021; 35: 536-543 (IGR: 22-1)


91971 An Increased Choroidal Microvasculature Dropout Size is Associated With Progressive Visual Field Loss in Open-Angle Glaucoma
Hong JW
American Journal of Ophthalmology 2021; 223: 205-219 (IGR: 22-1)


92629 Baseline Choroidal Microvasculature Dropout as a Predictor of Subsequent Visual Field Progression in Open-Angle Glaucoma
Won HJ
Journal of Glaucoma 2021; 30: 672-681 (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Cheng W
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Eguia M
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


91971 An Increased Choroidal Microvasculature Dropout Size is Associated With Progressive Visual Field Loss in Open-Angle Glaucoma
Kook MS
American Journal of Ophthalmology 2021; 223: 205-219 (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Song Y
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Blumberg DM
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


91933 Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve
Hirunpatravong P
British Journal of Ophthalmology 2021; 105: 381-386 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Mushtaq M
Eye 2022; 36: 555-563 (IGR: 22-1)


92629 Baseline Choroidal Microvasculature Dropout as a Predictor of Subsequent Visual Field Progression in Open-Angle Glaucoma
Kook MS
Journal of Glaucoma 2021; 30: 672-681 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Gupta P
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Zhou K
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Lee SY
Eye 2021; 35: 536-543 (IGR: 22-1)


92840 Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma
Kim YK
British Journal of Ophthalmology 2021; 105: 653-660 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Myers JS
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Rao DAS
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Weinreb RN
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Margeta MA
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Liu X
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


92829 Did the OCT Show Progression Since the Last Visit?
De Moraes CG
Journal of Glaucoma 2021; 30: e134-e145 (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Zangwill L
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


91933 Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve
Sharifipour F
British Journal of Ophthalmology 2021; 105: 381-386 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Pandey S
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Tao Y
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Seong GJ
Eye 2021; 35: 536-543 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Liebmann JM
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Cioffi GA
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


92840 Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma
Jeoung JW
British Journal of Ophthalmology 2021; 105: 653-660 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Wellik SR
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Puttaiah NK
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Ondeck CL
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Liu Y
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Joiner D
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Kean J
Eye 2022; 36: 555-563 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Pandey S
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Farrell S
Eye 2022; 36: 555-563 (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Devi S
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
De Moraes CG
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Wang YM
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Kim CY
Eye 2021; 35: 536-543 (IGR: 22-1)


92840 Impact of myopia on the association of long-term intraocular pressure fluctuation with the rate of progression in normal-tension glaucoma
Park KH
British Journal of Ophthalmology 2021; 105: 653-660 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Lu F
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


92552 Changes in Corneal Biomechanics and Glaucomatous Visual Field Loss
Weinreb RN
Journal of Glaucoma 2021; 30: e246-e251 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Proudfoot JA
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


91933 Rate of visual field decay in glaucomatous eyes with acquired pits of the optic nerve
Caprioli J
British Journal of Ophthalmology 2021; 105: 381-386 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Kim J
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Elze T
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Somarajan BI
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Liebmann JM
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Pan BX
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Bae HW
Eye 2021; 35: 536-543 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Zangwill LM
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


92024 Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study
Gupta V
Ophthalmic and Physiological Optics 2021; 41: 475-485 (IGR: 22-1)


91945 Progression of Macular Vessel Density in Primary Open-Angle Glaucoma: A Longitudinal Study
Liang Y
American Journal of Ophthalmology 2021; 223: 259-266 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Pasquale LR
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Lam A
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92761 Detecting Progression in Advanced Glaucoma: Are Optical Coherence Tomography Global Metrics Viable Measures?
Hood DC
Optometry and Vision Science 2021; 98: 518-530 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Bourne RRA
Eye 2022; 36: 555-563 (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Moghimi S
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Tezel TH
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Shen LQ
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Tham CC
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Shahid H
Eye 2022; 36: 555-563 (IGR: 22-1)


92499 Early localized alterations of the retinal inner plexiform layer in association with visual field worsening in glaucoma patients
Tezel G
PLoS ONE 2021; 16: e0247401 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Petrakos P
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Mansouri K
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92466 Racial Differences in the Rate of Change in Anterior Lamina Cribrosa Surface Depth in the African Descent and Glaucoma Evaluation Study
Fazio MA
Investigative Ophthalmology and Visual Science 2021; 62: 12 (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Webers CAB
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Khatib TZ
Eye 2022; 36: 555-563 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Ritch R
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Coleman AL
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Cheung C
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92449 Optical Coherence Tomography Angiography and Visual Field Progression in Primary Angle Closure Glaucoma
Weinreb RN
Journal of Glaucoma 2021; 30: e61-e67 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Yu F
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Susanna R
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Zhang X
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Martin KR
Eye 2022; 36: 555-563 (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Hood DC
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92520 Association of foveal avascular zone area withstructural and functional progression in glaucoma patients
Zangwill LM
British Journal of Ophthalmology 2022; 106: 1245-1251 (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
de Boer JF
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
Liebmann JM
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92217 Earlier Detection of Glaucoma Progression Using High-Density 3-Dimensional Spectral-Domain OCT Optic Nerve Volume Scans
Chen TC
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


92519 Variability and Power to Detect Progression of Different Visual Field Patterns
De Moraes CG
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Jammal AA
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91400 Clinical Use of PanoMap for Glaucoma: Frequently Damaged Areas in Early Glaucoma
Lee WJ
Journal of Glaucoma 2021; 30: 10-16 (IGR: 21-4)


91547 Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma
Nouri-Mahdavi K
American Journal of Ophthalmology 2021; 226: 172-181 (IGR: 21-4)


91230 Evaluation of the external validity of a joint structure-function model for monitoring glaucoma progression
Abu SL
Scientific reports 2020; 10: 19701 (IGR: 21-4)


91533 Visual field progression in patients with severe glaucoma
Maul EJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1579-1586 (IGR: 21-4)


91333 Association Between Progressive Retinal Capillary Density Loss and Visual Field Progression in Open-Angle Glaucoma Patients According to Disease Stage
Shin JW
American Journal of Ophthalmology 2021; 226: 137-147 (IGR: 21-4)


91769 Time Lag Between Functional Change and Loss of Retinal Nerve Fiber Layer in Glaucoma
Gardiner SK
Investigative Ophthalmology and Visual Science 2020; 61: 5 (IGR: 21-4)


91164 The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)
Alghamdi A
PLoS ONE 2020; 15: e0241902 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Qassim A
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


91235 Relationship between nocturnal intraocular pressure-related peak recorded by contact lens sensor and disease progression in treated glaucomatous eyes
Dubey S
Indian Journal of Ophthalmology 2020; 68: 2427-2433 (IGR: 21-4)


91325 The Progression of Peripapillary Retinoschisis May Indicate the Progression of Glaucoma
Lee EJ
Investigative Ophthalmology and Visual Science 2021; 62: 16 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
Melchior B
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91381 The effect of anxiety and depression on progression of glaucoma
Shin DY
Scientific reports 2021; 11: 1769 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Yamagami A
Scientific reports 2020; 10: 21059 (IGR: 21-4)


91380 Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression
Hubens WHG
Experimental Eye Research 2021; 204: 108460 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Mursch-Edlmayr AS
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Founti P
Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Kim HM
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91286 Detection of functional deterioration in glaucoma by trend analysis using comprehensive overlapping clusters of locations
Gardiner SK
Scientific reports 2020; 10: 18470 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
De Moraes CG
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91547 Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma
Mohammadzadeh V
American Journal of Ophthalmology 2021; 226: 172-181 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Tomidokoro A
Scientific reports 2020; 10: 21059 (IGR: 21-4)


91286 Detection of functional deterioration in glaucoma by trend analysis using comprehensive overlapping clusters of locations
Mansberger SL
Scientific reports 2020; 10: 18470 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Thompson AC
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91380 Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression
Beckers HJM
Experimental Eye Research 2021; 204: 108460 (IGR: 21-4)


91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Bunce C
Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)


91235 Relationship between nocturnal intraocular pressure-related peak recorded by contact lens sensor and disease progression in treated glaucomatous eyes
Mittal D
Indian Journal of Ophthalmology 2020; 68: 2427-2433 (IGR: 21-4)


91533 Visual field progression in patients with severe glaucoma
Kastner A
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1579-1586 (IGR: 21-4)


91164 The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)
Aldossary W
PLoS ONE 2020; 15: e0241902 (IGR: 21-4)


91769 Time Lag Between Functional Change and Loss of Retinal Nerve Fiber Layer in Glaucoma
Mansberger SL
Investigative Ophthalmology and Visual Science 2020; 61: 5 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
McKee WE
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91381 The effect of anxiety and depression on progression of glaucoma
Jung KI
Scientific reports 2021; 11: 1769 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Mullany S
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


91325 The Progression of Peripapillary Retinoschisis May Indicate the Progression of Glaucoma
Kee HJ
Investigative Ophthalmology and Visual Science 2021; 62: 16 (IGR: 21-4)


91400 Clinical Use of PanoMap for Glaucoma: Frequently Damaged Areas in Early Glaucoma
Shin YU
Journal of Glaucoma 2021; 30: 10-16 (IGR: 21-4)


91230 Evaluation of the external validity of a joint structure-function model for monitoring glaucoma progression
KhalafAllah MT
Scientific reports 2020; 10: 19701 (IGR: 21-4)


91333 Association Between Progressive Retinal Capillary Density Loss and Visual Field Progression in Open-Angle Glaucoma Patients According to Disease Stage
Song MK
American Journal of Ophthalmology 2021; 226: 137-147 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Ng WS
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Matsumoto S
Scientific reports 2020; 10: 21059 (IGR: 21-4)


91533 Visual field progression in patients with severe glaucoma
Schmidt J
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1579-1586 (IGR: 21-4)


91325 The Progression of Peripapillary Retinoschisis May Indicate the Progression of Glaucoma
Han JC
Investigative Ophthalmology and Visual Science 2021; 62: 16 (IGR: 21-4)


91380 Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression
Gorgels TGMF
Experimental Eye Research 2021; 204: 108460 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Mariottoni EB
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Diniz-Filho A
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Khawaja AP
Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
Paula JS
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Mariottoni EB
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91547 Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma
Rabiolo A
American Journal of Ophthalmology 2021; 226: 172-181 (IGR: 21-4)


91400 Clinical Use of PanoMap for Glaucoma: Frequently Damaged Areas in Early Glaucoma
Lim HW
Journal of Glaucoma 2021; 30: 10-16 (IGR: 21-4)


91230 Evaluation of the external validity of a joint structure-function model for monitoring glaucoma progression
Racette L
Scientific reports 2020; 10: 19701 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Abedi F
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


91333 Association Between Progressive Retinal Capillary Density Loss and Visual Field Progression in Open-Angle Glaucoma Patients According to Disease Stage
Kook MS
American Journal of Ophthalmology 2021; 226: 137-147 (IGR: 21-4)


91235 Relationship between nocturnal intraocular pressure-related peak recorded by contact lens sensor and disease progression in treated glaucomatous eyes
Mukherjee S
Indian Journal of Ophthalmology 2020; 68: 2427-2433 (IGR: 21-4)


91380 Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression
Gorgels TGMF
Experimental Eye Research 2021; 204: 108460 (IGR: 21-4)


91164 The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)
Albahkali S
PLoS ONE 2020; 15: e0241902 (IGR: 21-4)


91769 Time Lag Between Functional Change and Loss of Retinal Nerve Fiber Layer in Glaucoma
Fortune B
Investigative Ophthalmology and Visual Science 2020; 61: 5 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Malendowicz KB
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91381 The effect of anxiety and depression on progression of glaucoma
Park HYL
Scientific reports 2021; 11: 1769 (IGR: 21-4)


91235 Relationship between nocturnal intraocular pressure-related peak recorded by contact lens sensor and disease progression in treated glaucomatous eyes
Bhoot M
Indian Journal of Ophthalmology 2020; 68: 2427-2433 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
A Cioffi G
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91381 The effect of anxiety and depression on progression of glaucoma
Park CK
Scientific reports 2021; 11: 1769 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Sousa DC
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Thenappan AA
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91400 Clinical Use of PanoMap for Glaucoma: Frequently Damaged Areas in Early Glaucoma
Cho H
Journal of Glaucoma 2021; 30: 10-16 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Marshall H
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Yamazaki Y
Scientific reports 2020; 10: 21059 (IGR: 21-4)


91325 The Progression of Peripapillary Retinoschisis May Indicate the Progression of Glaucoma
Kee C
Investigative Ophthalmology and Visual Science 2021; 62: 16 (IGR: 21-4)


91380 Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression
Webers CAB
Experimental Eye Research 2021; 204: 108460 (IGR: 21-4)


91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Doré CJ
Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Urata CN
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91547 Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma
Edalati K
American Journal of Ophthalmology 2021; 226: 172-181 (IGR: 21-4)


91533 Visual field progression in patients with severe glaucoma
Tapia JA
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1579-1586 (IGR: 21-4)


91164 The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)
Alotaibi B
PLoS ONE 2020; 15: e0241902 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Hassall MM
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Tsamis E
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91400 Clinical Use of PanoMap for Glaucoma: Frequently Damaged Areas in Early Glaucoma
Park KH
Journal of Glaucoma 2021; 30: 10-16 (IGR: 21-4)


91533 Visual field progression in patients with severe glaucoma
Morales C
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1579-1586 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Tsamis E
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Yoshikawa K
Scientific reports 2020; 10: 21059 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
Girkin CA
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Estrela T
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91164 The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)
Alrfaei BM
PLoS ONE 2020; 15: e0241902 (IGR: 21-4)


91235 Relationship between nocturnal intraocular pressure-related peak recorded by contact lens sensor and disease progression in treated glaucomatous eyes
Gupta YP
Indian Journal of Ophthalmology 2020; 68: 2427-2433 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Tsamis E
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91547 Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma
Caprioli J
American Journal of Ophthalmology 2021; 226: 172-181 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Estrela T
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Mohamed-Noriega J
Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Arnold L
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study
Garway-Heath DF
Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Berchuck SI
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Eguia MD
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Berchuck SI
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
Fazio MA
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91547 Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma
Yousefi S
American Journal of Ophthalmology 2021; 226: 172-181 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Kolovos A
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Yamagami J
Scientific reports 2020; 10: 21059 (IGR: 21-4)


91533 Visual field progression in patients with severe glaucoma
Maul EA
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1579-1586 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Schlenker MB
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91400 Clinical Use of PanoMap for Glaucoma: Frequently Damaged Areas in Early Glaucoma
Seong M
Journal of Glaucoma 2021; 30: 10-16 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Kolovos A; Knight LSW
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


91168 Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study

Ophthalmology 2020; 127: 1642-1651 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
De Moraes CG
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Tseng HC
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Duenas-Angeles K
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
N Weinreb R
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Tomita G
Scientific reports 2020; 10: 21059 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Ritch R
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Nguyen T
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


90984 Evaluation of the relationship between glaucomatous disc subtypes and occurrence of disc hemorrhage and glaucoma progression in open angle glaucoma
Araie M
Scientific reports 2020; 10: 21059 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Keane PA
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
M Zangwill L
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91108 Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study
Asrani S; Medeiros FA
American Journal of Ophthalmology 2021; 222: 238-247 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Crowston JG
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91165 Local Glaucomatous Defects of the Circumpapillary Retinal Nerve Fiber Layer Show a Variety of Patterns of Progression
Hood DC
Journal of Glaucoma 2020; 29: 857-863 (IGR: 21-4)


91539 Relationship between mean follow-up intraocular pressure, rates of visual field progression and current target intraocular pressure guidelines
M Liebmann J
British Journal of Ophthalmology 2022; 106: 229-233 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Awadalla MS; Chappell A
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


90900 Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
Jayaram H
Translational vision science & technology 2020; 9: 55 (IGR: 21-4)


91471 Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes
Chappell A; Schulz AM; Galanopoulos A; Agar A; Healey PR; Hewitt AW; Graham SL; Landers J; Casson RJ; Siggs OM; Craig JE
Ophthalmology 2021; 128: 993-1004 (IGR: 21-4)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Fujino Y
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90508 Impact of Artifacts From Optical Coherence Tomography Retinal Nerve Fiber Layer and Macula Scans on Detection of Glaucoma Progression
Li A
American Journal of Ophthalmology 2021; 221: 235-245 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Estrela T
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90422 Discovery and clinical translation of novel glaucoma biomarkers
Beykin G
Progress in Retinal and Eye Research 2020; 0: 100875 (IGR: 21-3)


90510 Lifetime visual outcomes of patients undergoing trabeculectomy
Chen R
British Journal of Ophthalmology 2021; 105: 1566-1570 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Thompson AC
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
de Gainza A
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Higashide T
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Nitta K
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90113 Glaucomatous Progression After Lens Extraction in Primary Angle Closure Disease Spectrum
Song MK
Journal of Glaucoma 2020; 29: 711-717 (IGR: 21-3)


90748 Effect of baseline test selection on glaucoma progression detection by optical coherence tomography-guided progression analysis
Kang DH
British Journal of Ophthalmology 2021; 105: 783-788 (IGR: 21-3)


90002 A framework for assessing glaucoma progression using structural and functional indices jointly
Abu SL
PLoS ONE 2020; 15: e0235255 (IGR: 21-3)


90636 Development of a nomogram using fundus photography to predict glaucoma progression in patients showing disc hemorrhage
Kim S
Scientific reports 2020; 10: 14650 (IGR: 21-3)


90299 Wide-field Trend-based Progression Analysis of Combined Retinal Nerve Fiber Layer and Ganglion Cell Inner Plexiform Layer Thickness: A New Paradigm to Improve Glaucoma Progression Detection
Wu K
Ophthalmology 2020; 127: 1322-1330 (IGR: 21-3)


89934 Impact of anxiety and depression on progression to glaucoma among glaucoma suspects
Berchuck S
British Journal of Ophthalmology 2020; 0: (IGR: 21-3)


90677 Clinical Predictors of the Region of First Structural Progression in Early Normal-tension Glaucoma
Lee JS
Korean Journal of Ophthalmology 2020; 34: 322-333 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Lin FB
Trials 2020; 21: 813 (IGR: 21-3)


90014 Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma
Li S
American Journal of Ophthalmology 2020; 217: 55-67 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Bommakanti NK
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90150 Compressive optic neuropathy. Not everything that progresses is glaucoma
Sotelo-Monge KG
Archivos de la Sociedad Española de Oftalmologia 2021; 96: 219-223 (IGR: 21-3)


89992 Improving the Detection of Glaucoma and Its Progression: A Topographical Approach
Hood DC
Journal of Glaucoma 2020; 29: 613-621 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Estrela T
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90269 Risk Factors Associated with Structural Progression in Normal-Tension Glaucoma: Intraocular Pressure, Systemic Blood Pressure, and Myopia
Lee K
Investigative Ophthalmology and Visual Science 2020; 61: 35 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
An D
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90134 Comparison of visual field progression in new-diagnosed primary open-angle and exfoliation glaucoma patients in Sweden
Ayala M
BMC Ophthalmology 2020; 20: 322 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Siesky B
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Jammal AA
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Tachibana G
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


89934 Impact of anxiety and depression on progression to glaucoma among glaucoma suspects
Jammal A
British Journal of Ophthalmology 2020; 0: (IGR: 21-3)


90113 Glaucomatous Progression After Lens Extraction in Primary Angle Closure Disease Spectrum
Sung KR
Journal of Glaucoma 2020; 29: 711-717 (IGR: 21-3)


89992 Improving the Detection of Glaucoma and Its Progression: A Topographical Approach
Zemborain ZZ
Journal of Glaucoma 2020; 29: 613-621 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Ohkubo S
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Jammal AA
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90636 Development of a nomogram using fundus photography to predict glaucoma progression in patients showing disc hemorrhage
Park CK
Scientific reports 2020; 10: 14650 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
House P
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90510 Lifetime visual outcomes of patients undergoing trabeculectomy
King AJ
British Journal of Ophthalmology 2021; 105: 1566-1570 (IGR: 21-3)


90150 Compressive optic neuropathy. Not everything that progresses is glaucoma
Espinosa-Barberi G
Archivos de la Sociedad Española de Oftalmologia 2021; 96: 219-223 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Zhou Y
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90508 Impact of Artifacts From Optical Coherence Tomography Retinal Nerve Fiber Layer and Macula Scans on Detection of Glaucoma Progression
Thompson AC
American Journal of Ophthalmology 2021; 221: 235-245 (IGR: 21-3)


90748 Effect of baseline test selection on glaucoma progression detection by optical coherence tomography-guided progression analysis
Hwang YH
British Journal of Ophthalmology 2021; 105: 783-788 (IGR: 21-3)


90002 A framework for assessing glaucoma progression using structural and functional indices jointly
Marín-Franch I
PLoS ONE 2020; 15: e0235255 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
Morales E
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Murata H
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Wentz SM
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90299 Wide-field Trend-based Progression Analysis of Combined Retinal Nerve Fiber Layer and Ganglion Cell Inner Plexiform Layer Thickness: A New Paradigm to Improve Glaucoma Progression Detection
Lin C
Ophthalmology 2020; 127: 1322-1330 (IGR: 21-3)


90150 Compressive optic neuropathy. Not everything that progresses is glaucoma
Espinosa-Barberi G
Archivos de la Sociedad Española de Oftalmologia 2021; 96: 219-223 (IGR: 21-3)


90677 Clinical Predictors of the Region of First Structural Progression in Early Normal-tension Glaucoma
Lee K
Korean Journal of Ophthalmology 2020; 34: 322-333 (IGR: 21-3)


90422 Discovery and clinical translation of novel glaucoma biomarkers
Norcia AM
Progress in Retinal and Eye Research 2020; 0: 100875 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Da Chen S
Trials 2020; 21: 813 (IGR: 21-3)


90269 Risk Factors Associated with Structural Progression in Normal-Tension Glaucoma: Intraocular Pressure, Systemic Blood Pressure, and Myopia
Yang H
Investigative Ophthalmology and Visual Science 2020; 61: 35 (IGR: 21-3)


90014 Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma
Zhang H
American Journal of Ophthalmology 2020; 217: 55-67 (IGR: 21-3)


90113 Glaucomatous Progression After Lens Extraction in Primary Angle Closure Disease Spectrum
Shin JW
Journal of Glaucoma 2020; 29: 711-717 (IGR: 21-3)


90002 A framework for assessing glaucoma progression using structural and functional indices jointly
Racette L
PLoS ONE 2020; 15: e0235255 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Song YH
Trials 2020; 21: 813 (IGR: 21-3)


90269 Risk Factors Associated with Structural Progression in Normal-Tension Glaucoma: Intraocular Pressure, Systemic Blood Pressure, and Myopia
Kim JY
Investigative Ophthalmology and Visual Science 2020; 61: 35 (IGR: 21-3)


90299 Wide-field Trend-based Progression Analysis of Combined Retinal Nerve Fiber Layer and Ganglion Cell Inner Plexiform Layer Thickness: A New Paradigm to Improve Glaucoma Progression Detection
Lam AK
Ophthalmology 2020; 127: 1322-1330 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
Barry C
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


89992 Improving the Detection of Glaucoma and Its Progression: A Topographical Approach
Tsamis E
Journal of Glaucoma 2020; 29: 613-621 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Mariottoni EB
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90150 Compressive optic neuropathy. Not everything that progresses is glaucoma
Pinilla Cortés LM
Archivos de la Sociedad Española de Oftalmologia 2021; 96: 219-223 (IGR: 21-3)


90508 Impact of Artifacts From Optical Coherence Tomography Retinal Nerve Fiber Layer and Macula Scans on Detection of Glaucoma Progression
Asrani S
American Journal of Ophthalmology 2021; 221: 235-245 (IGR: 21-3)


90677 Clinical Predictors of the Region of First Structural Progression in Early Normal-tension Glaucoma
Seong GJ
Korean Journal of Ophthalmology 2020; 34: 322-333 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Mariottoni EB
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90014 Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma
Shao M
American Journal of Ophthalmology 2020; 217: 55-67 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Berchuck SI
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


89992 Improving the Detection of Glaucoma and Its Progression: A Topographical Approach
Tsamis E
Journal of Glaucoma 2020; 29: 613-621 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Januleviciene I
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Matsuura M
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90636 Development of a nomogram using fundus photography to predict glaucoma progression in patients showing disc hemorrhage
Kim EW
Scientific reports 2020; 10: 14650 (IGR: 21-3)


90422 Discovery and clinical translation of novel glaucoma biomarkers
Srinivasan VJ
Progress in Retinal and Eye Research 2020; 0: 100875 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Udagawa S
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Berchuck SI
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


89934 Impact of anxiety and depression on progression to glaucoma among glaucoma suspects
Mukherjee S
British Journal of Ophthalmology 2020; 0: (IGR: 21-3)


89992 Improving the Detection of Glaucoma and Its Progression: A Topographical Approach
Tsamis E
Journal of Glaucoma 2020; 29: 613-621 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Wajima R
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
Salazar Vega DC
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Ehrlich JR
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
Turpin A
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90150 Compressive optic neuropathy. Not everything that progresses is glaucoma
Puntí Badosa A
Archivos de la Sociedad Española de Oftalmologia 2021; 96: 219-223 (IGR: 21-3)


89934 Impact of anxiety and depression on progression to glaucoma among glaucoma suspects
Somers T
British Journal of Ophthalmology 2020; 0: (IGR: 21-3)


90677 Clinical Predictors of the Region of First Structural Progression in Early Normal-tension Glaucoma
Kim CY
Korean Journal of Ophthalmology 2020; 34: 322-333 (IGR: 21-3)


90113 Glaucomatous Progression After Lens Extraction in Primary Angle Closure Disease Spectrum
Jo YH
Journal of Glaucoma 2020; 29: 711-717 (IGR: 21-3)


90014 Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma
Li Y
American Journal of Ophthalmology 2020; 217: 55-67 (IGR: 21-3)


90636 Development of a nomogram using fundus photography to predict glaucoma progression in patients showing disc hemorrhage
Lee SY
Scientific reports 2020; 10: 14650 (IGR: 21-3)


90299 Wide-field Trend-based Progression Analysis of Combined Retinal Nerve Fiber Layer and Ganglion Cell Inner Plexiform Layer Thickness: A New Paradigm to Improve Glaucoma Progression Detection
Chan L
Ophthalmology 2020; 127: 1322-1330 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Kim DH
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Mariottoni EB
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90422 Discovery and clinical translation of novel glaucoma biomarkers
Dubra A
Progress in Retinal and Eye Research 2020; 0: 100875 (IGR: 21-3)


89992 Improving the Detection of Glaucoma and Its Progression: A Topographical Approach
De Moraes CG
Journal of Glaucoma 2020; 29: 613-621 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
Mohammadzadeh V
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Wang W
Trials 2020; 21: 813 (IGR: 21-3)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Nakakura S
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90269 Risk Factors Associated with Structural Progression in Normal-Tension Glaucoma: Intraocular Pressure, Systemic Blood Pressure, and Myopia
Seong GJ
Investigative Ophthalmology and Visual Science 2020; 61: 35 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Mariottoni EB
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Inoue S
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Sugiyama K
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Urata CN
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Elam AR
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90422 Discovery and clinical translation of novel glaucoma biomarkers
Goldberg JL
Progress in Retinal and Eye Research 2020; 0: 100875 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
John D
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90636 Development of a nomogram using fundus photography to predict glaucoma progression in patients showing disc hemorrhage
Seong GJ
Scientific reports 2020; 10: 14650 (IGR: 21-3)


90150 Compressive optic neuropathy. Not everything that progresses is glaucoma
Anton A
Archivos de la Sociedad Española de Oftalmologia 2021; 96: 219-223 (IGR: 21-3)


89934 Impact of anxiety and depression on progression to glaucoma among glaucoma suspects
Medeiros FA
British Journal of Ophthalmology 2020; 0: (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
McKendrick AM
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90677 Clinical Predictors of the Region of First Structural Progression in Early Normal-tension Glaucoma
Lee SY
Korean Journal of Ophthalmology 2020; 34: 322-333 (IGR: 21-3)


90269 Risk Factors Associated with Structural Progression in Normal-Tension Glaucoma: Intraocular Pressure, Systemic Blood Pressure, and Myopia
Kim CY
Investigative Ophthalmology and Visual Science 2020; 61: 35 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Ogata NG
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Shoji N
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90299 Wide-field Trend-based Progression Analysis of Combined Retinal Nerve Fiber Layer and Ganglion Cell Inner Plexiform Layer Thickness: A New Paradigm to Improve Glaucoma Progression Detection
Leung CK
Ophthalmology 2020; 127: 1322-1330 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Wu Z
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Tanihara H
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Burgett KM
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
Yu F
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Ohigashi T
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Jin L
Trials 2020; 21: 813 (IGR: 21-3)


90113 Glaucomatous Progression After Lens Extraction in Primary Angle Closure Disease Spectrum
Won HJ
Journal of Glaucoma 2020; 29: 711-717 (IGR: 21-3)


90014 Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma
Song Y
American Journal of Ophthalmology 2020; 217: 55-67 (IGR: 21-3)


90677 Clinical Predictors of the Region of First Structural Progression in Early Normal-tension Glaucoma
Bae HW
Korean Journal of Ophthalmology 2020; 34: 322-333 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
Afifi A
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Araie M
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Liu BQ
Trials 2020; 21: 813 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Verticchio Vercellin AC
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Nakao Y
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
Chauhan BC
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Berchuck SI
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Otsuka N
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90014 Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma
Sun X
American Journal of Ophthalmology 2020; 217: 55-67 (IGR: 21-3)


90269 Risk Factors Associated with Structural Progression in Normal-Tension Glaucoma: Intraocular Pressure, Systemic Blood Pressure, and Myopia
Bae HW
Investigative Ophthalmology and Visual Science 2020; 61: 35 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Berchuck SI
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Kamat SS
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90636 Development of a nomogram using fundus photography to predict glaucoma progression in patients showing disc hemorrhage
Kim CY
Scientific reports 2020; 10: 14650 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Daga FB
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Rowe LW
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90636 Development of a nomogram using fundus photography to predict glaucoma progression in patients showing disc hemorrhage
Bae HW
Scientific reports 2020; 10: 14650 (IGR: 21-3)


90014 Association Between 17-β-Estradiol and Interleukin-8 and Visual Field Progression in Postmenopausal Women with Primary Angle Closure Glaucoma
Cao W
American Journal of Ophthalmology 2020; 217: 55-67 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Tomita G
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Rowe LW
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Kelstrom J
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Kurashima H
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
Manners S
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90232 The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients
Medeiros FA
Journal of Glaucoma 2020; 29: 872-877 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Ogata NG
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Kiuchi Y
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Liu YH
Trials 2020; 21: 813 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
Nouri-Mahdavi K
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Matsumoto C
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Santo K
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Urata CN
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90573 The Relationship Between Corneal Hysteresis and Progression of Glaucoma After Trabeculectomy
Asaoka R
Journal of Glaucoma 2020; 29: 912-917 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Newman-Casey PA
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90534 The Trajectory of Glaucoma Progression in 2-Dimensional Structural-Functional Space
Caprioli J
Ophthalmology. Glaucoma 2020; 3: 466-474 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Chen ML
Trials 2020; 21: 813 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Eckert GJ
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
Graham S
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Estrela T
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Shah MM
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Gao K
Trials 2020; 21: 813 (IGR: 21-3)


90285 Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma
Harris A
PLoS ONE 2020; 15: e0236819 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Estrela T
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
Yu DY
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Hashimoto M
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Fukuchi T
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Tomidokoro A
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Friedman DS
Trials 2020; 21: 813 (IGR: 21-3)


90775 Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT
Medeiros FA
Ophthalmology. Glaucoma 2020; 3: 414-420 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Weizer JS
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Shibahara H
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90811 Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma
Morgan WH
Ophthalmology. Glaucoma 2020; 3: 443-452 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Hirukawa M
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Hangai M
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Wood SD
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Jonas JB
Trials 2020; 21: 813 (IGR: 21-3)


90499 Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma
Sugiyama K
Clinical Ophthalmology 2020; 14: 1967-1978 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Aung T
Trials 2020; 21: 813 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Zhang AD
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Kawata H
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Lv L
Trials 2020; 21: 813 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Zhang J
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Inai M
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Lee PP
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Liu YZ
Trials 2020; 21: 813 (IGR: 21-3)


90854 Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study
Tanaka Y;
Ophthalmology. Glaucoma 2020; 0: (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial
Zhang XL
Trials 2020; 21: 813 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
Stein JD
JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


90762 Effect of medically lowering intraocular pressure in glaucoma suspects with high myopia (GSHM study): study protocol for a randomized controlled trial

Trials 2020; 21: 813 (IGR: 21-3)


90142 Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19

JAMA ophthalmology 2020; 138: 974-980 (IGR: 21-3)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
Shukla AG
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Kelly SR
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Bak E
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Yousefi S
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Shukla AG
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
De Moraes CG
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Bak E
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86602 Glaucomatous visual field loss in eyes undergoing first trabeculectomy in Iceland
Tryggvadottir EB
Laeknabladid 2020; 106: 187-192 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Mabuchi F
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Chua J
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86329 Nasalization of Central Retinal Vessel Trunk Predicts Rapid Progression of Central Visual Field in Open-Angle Glaucoma
Shon K
Scientific reports 2020; 10: 3789 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Bak E
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Shukla AG
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86848 Functional assessment of glaucoma: Uncovering progression
Hu R
Survey of Ophthalmology 2020; 65: 639-661 (IGR: 21-2)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
Shukla AG
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Bak E
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Gillmann K
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Ang BCH
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Normando EM
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Salazar D
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kiyota N
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Ha A
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Sirinek PE
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Shiga Y
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Kim YW
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86848 Functional assessment of glaucoma: Uncovering progression
Racette L
Survey of Ophthalmology 2020; 65: 639-661 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Young CC
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Seen S
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
De Moraes CG
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Yap TE
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Elze T
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Khawaja AP
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Kadziauskienė A
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Paula JS
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86329 Nasalization of Central Retinal Vessel Trunk Predicts Rapid Progression of Central Visual Field in Open-Angle Glaucoma
Hye Jo Y
Scientific reports 2020; 10: 3789 (IGR: 21-2)


86602 Glaucomatous visual field loss in eyes undergoing first trabeculectomy in Iceland
Hardarson SH
Laeknabladid 2020; 106: 187-192 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Mabuchi N
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Morales E
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Kim YW
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86602 Glaucomatous visual field loss in eyes undergoing first trabeculectomy in Iceland
Gottfredsdottir MS
Laeknabladid 2020; 106: 187-192 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Pasquale LR
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
De Moraes CG
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Wong D
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Bryan SR
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Sakurada Y
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86329 Nasalization of Central Retinal Vessel Trunk Predicts Rapid Progression of Central Visual Field in Open-Angle Glaucoma
Won Shin J
Scientific reports 2020; 10: 3789 (IGR: 21-2)


86848 Functional assessment of glaucoma: Uncovering progression
Chen KS
Survey of Ophthalmology 2020; 65: 639-661 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Rabiolo A
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
Cioffi GA
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Stanley J
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Kumaran A
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Yasuda M
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Ha A
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Lee J
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Maddison J
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Blumberg DM
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86848 Functional assessment of glaucoma: Uncovering progression
Johnson CA
Survey of Ophthalmology 2020; 65: 639-661 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Bak E
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Azuara-Blanco A
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Capistrano V
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Kim YK
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86329 Nasalization of Central Retinal Vessel Trunk Predicts Rapid Progression of Central Visual Field in Open-Angle Glaucoma
Kwon J
Scientific reports 2020; 10: 3789 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Yoneyama S
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Aizawa N
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Bak E
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Blumberg DM
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Cioffi GA
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Bak E
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
De Leon JMS
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Miodragovic S
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
Girkin CA
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Seibold LK
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Bak E
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Saeedi O
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Ašoklis R
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Omodaka K
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Al-Aswad LA
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
Weinreb RN
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Hoskens K
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Bonetti P
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Lin M
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Seah SKL
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Lesinskas E
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Park KH
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Han YS
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Cioffi GA
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Kashiwagi K
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Wang M
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Sparrow JM
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)


86329 Nasalization of Central Retinal Vessel Trunk Predicts Rapid Progression of Central Visual Field in Open-Angle Glaucoma
Jeong D
Scientific reports 2020; 10: 3789 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Almonte M
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Afifi AA
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Quang ND
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Foster PJ
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
Zangwill LM
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Midha N
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Shen LQ
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Girkin CA
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Crabb DP
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Kim YK
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Iijima H
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Tsuda S
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Jeoung JW
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)


86329 Nasalization of Central Retinal Vessel Trunk Predicts Rapid Progression of Central Visual Field in Open-Angle Glaucoma
Kook MS
Scientific reports 2020; 10: 3789 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Skaat A
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Kahook MY
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Gazzard G
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Wellik SR
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Yamagata Z
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Park KH
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Girkin CA
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Chong R
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Mohammad NG
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Pak K
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86625 The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression
Liebmann JM
Journal of Glaucoma 2020; 29: 435-440 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Yu F
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Weinreb RN
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Htoon HM
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Nouri-Mahdavi K
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Zangwill LM
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86577 Relationship Between Contact Lens Sensor Output Parameters and Visual Field Progression in Open-angle Glaucoma: Assessment of a Practical Tool to Guide Clinical Risk-assessment
Mansouri K
Journal of Glaucoma 2020; 29: 461-466 (IGR: 21-2)


86840 Morphological characteristics of parapapillary atrophy and subsequent visual field progression in primary open-angle glaucoma
Jeoung JW
British Journal of Ophthalmology 2021; 105: 361-366 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Ameen S
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kunikata H
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Takamoto M
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Weinreb RN
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
De Moraes CG
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Tan B
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Ameen S
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Aihara M
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Girard MJA
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Ritch R
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Myers JS
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Crawley L
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86606 Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma
Caprioli J
JAMA ophthalmology 2020; 138: 536-543 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Khaw PT
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Zangwill LM
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Nakazawa T
Acta Ophthalmologica 2020; 98: e747-e753 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Mari JM
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Aung T
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Ahmed F
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Susanna R
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Hood DC
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86766 Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard
Boland MV
Ophthalmology 2020; 127: 1170-1178 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Iwata T
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86696 Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects
Liebmann JM
Journal of Glaucoma 2020; 29: 429-434 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Crowston JG
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Hashimoto K
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Hood DC
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Bloom PA
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86350 Visual field progression 8 years after trabeculectomy in Asian eyes: results from The Singapore 5-Fluorouracil Study
Husain R
British Journal of Ophthalmology 2020; 104: 1690-1696 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Sato K
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Aung T
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86751 A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)
Cordeiro MF
Expert review of molecular diagnostics 2020; 20: 737-748 (IGR: 21-2)


86675 Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm
Liebmann JM
American Journal of Ophthalmology 2020; 216: 37-43 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Shiga Y
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


86204 One year structural and functional glaucoma progression after trabeculectomy
Schmetterer L
Scientific reports 2020; 10: 2808 (IGR: 21-2)


86550 Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma
Nishiguchi KM; Nakazawa T; Akiyama M; Kawase K; Ozaki M; Araie M;
American Journal of Ophthalmology 2020; 215: 135-140 (IGR: 21-2)


84935 Lamina cribrosa defect and progress of glaucoma
Liu XY
Chinese Journal of Ophthalmology 2020; 56: 17-20 (IGR: 21-1)


84659 Estimating Rates of Progression and Predicting Future Visual Fields in Glaucoma Using a Deep Variational Autoencoder
Berchuck SI
Scientific reports 2019; 9: 18113 (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Pan X
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84773 Machine learning classifiers-based prediction of normal-tension glaucoma progression in young myopic patients
Lee J
Japanese Journal of Ophthalmology 2020; 64: 68-76 (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Garcia GP
JAMA ophthalmology 2019; 0: (IGR: 21-1)


84659 Estimating Rates of Progression and Predicting Future Visual Fields in Glaucoma Using a Deep Variational Autoencoder
Berchuck SI
Scientific reports 2019; 9: 18113 (IGR: 21-1)


84443 Long-Term Follow-up on Glaucoma Patients With Initial Single-Hemifield Defect: Progression Patterns and Associated Factors
Baek SU
Journal of Glaucoma 2019; 28: 1041-1047 (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Bommakanti N
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Wang M
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Du J
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84443 Long-Term Follow-up on Glaucoma Patients With Initial Single-Hemifield Defect: Progression Patterns and Associated Factors
Baek SU
Journal of Glaucoma 2019; 28: 1041-1047 (IGR: 21-1)


84921 Selective Laser Trabeculoplasty Protects Glaucoma Progression in the Initial Primary Open-Angle Glaucoma and Angle-Closure Glaucoma after Laser Peripheral Iridotomy in the Long Term
Kurysheva NI
BioMed research international 2019; 2019: 4519412 (IGR: 21-1)


84545 Association of Retinal Blood Flow with Progression of Visual Field in Glaucoma
Jeon SJ
Scientific reports 2019; 9: 16813 (IGR: 21-1)


84773 Machine learning classifiers-based prediction of normal-tension glaucoma progression in young myopic patients
Kim YK
Japanese Journal of Ophthalmology 2020; 64: 68-76 (IGR: 21-1)


84443 Long-Term Follow-up on Glaucoma Patients With Initial Single-Hemifield Defect: Progression Patterns and Associated Factors
Kim YK
Journal of Glaucoma 2019; 28: 1041-1047 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Tichelaar J
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Patrie JT
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84935 Lamina cribrosa defect and progress of glaucoma
Fan N
Chinese Journal of Ophthalmology 2020; 56: 17-20 (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Lavieri MS
JAMA ophthalmology 2019; 0: (IGR: 21-1)


84545 Association of Retinal Blood Flow with Progression of Visual Field in Glaucoma
Shin DY
Scientific reports 2019; 9: 16813 (IGR: 21-1)


84921 Selective Laser Trabeculoplasty Protects Glaucoma Progression in the Initial Primary Open-Angle Glaucoma and Angle-Closure Glaucoma after Laser Peripheral Iridotomy in the Long Term
Lepeshkina LV
BioMed research international 2019; 2019: 4519412 (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
De Moraes CG
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Xu K
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84659 Estimating Rates of Progression and Predicting Future Visual Fields in Glaucoma Using a Deep Variational Autoencoder
Mukherjee S; Medeiros FA
Scientific reports 2019; 9: 18113 (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Boland MV
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Pasquale LR
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84443 Long-Term Follow-up on Glaucoma Patients With Initial Single-Hemifield Defect: Progression Patterns and Associated Factors
Park KH
Journal of Glaucoma 2019; 28: 1041-1047 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Prum BE
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84545 Association of Retinal Blood Flow with Progression of Visual Field in Glaucoma
Park HL
Scientific reports 2019; 9: 16813 (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Wang X
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Andrews C
JAMA ophthalmology 2019; 0: (IGR: 21-1)


84773 Machine learning classifiers-based prediction of normal-tension glaucoma progression in young myopic patients
Jeoung JW
Japanese Journal of Ophthalmology 2020; 64: 68-76 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Netland PA
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84545 Association of Retinal Blood Flow with Progression of Visual Field in Glaucoma
Park CK
Scientific reports 2019; 9: 16813 (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Myers JS
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Liu X
JAMA ophthalmology 2019; 0: (IGR: 21-1)


84773 Machine learning classifiers-based prediction of normal-tension glaucoma progression in young myopic patients
Ha A
Japanese Journal of Ophthalmology 2020; 64: 68-76 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Shen LQ
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84443 Long-Term Follow-up on Glaucoma Patients With Initial Single-Hemifield Defect: Progression Patterns and Associated Factors
Jeoung JW
Journal of Glaucoma 2019; 28: 1041-1047 (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Chen G
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Van Oyen MP
JAMA ophthalmology 2019; 0: (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Cheng H
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84773 Machine learning classifiers-based prediction of normal-tension glaucoma progression in young myopic patients
Kim YW
Japanese Journal of Ophthalmology 2020; 64: 68-76 (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Wellik SR
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Boland MV
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Shildkrot YE
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Elze T
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Kass MA
JAMA ophthalmology 2019; 0: (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Liu AJ
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Wellik SR
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84773 Machine learning classifiers-based prediction of normal-tension glaucoma progression in young myopic patients
Park KH
Japanese Journal of Ophthalmology 2020; 64: 68-76 (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Hou LT
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
De Moraes CG
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Gordon MO
JAMA ophthalmology 2019; 0: (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Pasquale LR
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Zhong L
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Myers JS
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Shen LQ
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


84541 Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension
Stein JD
JAMA ophthalmology 2019; 0: (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Ramulu P
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Ritch R
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


85169 Evening exercise is associated with lower odds of visual field progression in Chinese patients with primary open angle glaucoma
Chen J; Liang Y
Eye and vision (London, England) 2020; 7: 12 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Kwon M
JAMA ophthalmology 2020; 0: (IGR: 21-1)


84470 Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss
Liebmann JM
Journal of Glaucoma 2020; 29: 31-38 (IGR: 21-1)


84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Saeedi OJ; Wang H; Baniasadi N; Li D; Bex PJ; Elze T
JAMA ophthalmology 2020; 0: (IGR: 21-1)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Rabiolo A
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


82574 Relationship between sleep position and glaucoma progression
Kaplowitz K
Current Opinions in Ophthalmology 2019; 30: 484-490 (IGR: 20-4)


82211 Corneal deflection amplitude and visual field progression in primary open-angle glaucoma
Jung Y
PLoS ONE 2019; 14: e0220655 (IGR: 20-4)


82768 Changes on Confocal Scanning Laser Ophthalmoscopy with the Heidelberg Retinal Tomography after a Cardiac Catheterism in a Patient with Progressive Glaucoma
Valera-Cornejo DA
Case Reports in Ophthalmology 2019; 10: 256-266 (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Zhou K
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82714 Correlation between 24-h continuous intraocular pressure measurement with a contact lens sensor and visual field progression
Tojo N
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 175-182 (IGR: 20-4)


82371 Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications
Han JC
American Journal of Ophthalmology 2020; 209: 77-87 (IGR: 20-4)


82514 Making a Correct Diagnosis of Glaucoma: Data From the EMGT
Öhnell H
Journal of Glaucoma 2019; 28: 859-864 (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Lee EJ
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82161 Seeking a practical definition of stable glaucoma: a Delphi consensus survey of UK glaucoma consultants
Lakhani BK
Eye 2020; 34: 335-343 (IGR: 20-4)


82414 Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure
Susanna BN
Ophthalmology 2019; 126: 1640-1646 (IGR: 20-4)


81873 Optical Coherence Tomography Assessment of Risk Factors for Visual Acuity Decline After Trabeculectomy in Patients With Advanced Open-Angle Glaucoma
Asaoka K
Journal of Glaucoma 2019; 28: 780-784 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Asano S
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82190 Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study
Cheung CY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82768 Changes on Confocal Scanning Laser Ophthalmoscopy with the Heidelberg Retinal Tomography after a Cardiac Catheterism in a Patient with Progressive Glaucoma
Loayza-Gamboa W
Case Reports in Ophthalmology 2019; 10: 256-266 (IGR: 20-4)


82414 Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure
Ogata NG
Ophthalmology 2019; 126: 1640-1646 (IGR: 20-4)


82514 Making a Correct Diagnosis of Glaucoma: Data From the EMGT
Bengtsson B
Journal of Glaucoma 2019; 28: 859-864 (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Kim TW
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82371 Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications
Han SH
American Journal of Ophthalmology 2020; 209: 77-87 (IGR: 20-4)


81873 Optical Coherence Tomography Assessment of Risk Factors for Visual Acuity Decline After Trabeculectomy in Patients With Advanced Open-Angle Glaucoma
Kunimatsu-Sanuki S
Journal of Glaucoma 2019; 28: 780-784 (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Morales E
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


82161 Seeking a practical definition of stable glaucoma: a Delphi consensus survey of UK glaucoma consultants
Giannouladis K
Eye 2020; 34: 335-343 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Murata H
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Shang X
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82190 Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study
Li SL
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82211 Corneal deflection amplitude and visual field progression in primary open-angle glaucoma
Chun H
PLoS ONE 2019; 14: e0220655 (IGR: 20-4)


82714 Correlation between 24-h continuous intraocular pressure measurement with a contact lens sensor and visual field progression
Hayashi A
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 175-182 (IGR: 20-4)


82574 Relationship between sleep position and glaucoma progression
Dredge J
Current Opinions in Ophthalmology 2019; 30: 484-490 (IGR: 20-4)


82514 Making a Correct Diagnosis of Glaucoma: Data From the EMGT
Heijl A
Journal of Glaucoma 2019; 28: 859-864 (IGR: 20-4)


82161 Seeking a practical definition of stable glaucoma: a Delphi consensus survey of UK glaucoma consultants
Leighton P
Eye 2020; 34: 335-343 (IGR: 20-4)


81873 Optical Coherence Tomography Assessment of Risk Factors for Visual Acuity Decline After Trabeculectomy in Patients With Advanced Open-Angle Glaucoma
Kokubun T
Journal of Glaucoma 2019; 28: 780-784 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Matsuura M
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82714 Correlation between 24-h continuous intraocular pressure measurement with a contact lens sensor and visual field progression
Otsuka M
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 175-182 (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Wang XY
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82190 Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study
Chan PP
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82768 Changes on Confocal Scanning Laser Ophthalmoscopy with the Heidelberg Retinal Tomography after a Cardiac Catheterism in a Patient with Progressive Glaucoma
Herrera-Quiroz J
Case Reports in Ophthalmology 2019; 10: 256-266 (IGR: 20-4)


82574 Relationship between sleep position and glaucoma progression
Honkanen R
Current Opinions in Ophthalmology 2019; 30: 484-490 (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Kim JA
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Mohamed L
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


82371 Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications
Park DY
American Journal of Ophthalmology 2020; 209: 77-87 (IGR: 20-4)


82211 Corneal deflection amplitude and visual field progression in primary open-angle glaucoma
Moon JI
PLoS ONE 2019; 14: e0220655 (IGR: 20-4)


82414 Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure
Jammal AA
Ophthalmology 2019; 126: 1640-1646 (IGR: 20-4)


82371 Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications
Lee EJ
American Journal of Ophthalmology 2020; 209: 77-87 (IGR: 20-4)


82161 Seeking a practical definition of stable glaucoma: a Delphi consensus survey of UK glaucoma consultants
King AJ
Eye 2020; 34: 335-343 (IGR: 20-4)


81873 Optical Coherence Tomography Assessment of Risk Factors for Visual Acuity Decline After Trabeculectomy in Patients With Advanced Open-Angle Glaucoma
Nakazawa T
Journal of Glaucoma 2019; 28: 780-784 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Fujino Y
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82414 Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure
Susanna CN
Ophthalmology 2019; 126: 1640-1646 (IGR: 20-4)


82190 Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study
Chan NCY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Kim GN
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Wang XJ
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Capistrano V
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


82768 Changes on Confocal Scanning Laser Ophthalmoscopy with the Heidelberg Retinal Tomography after a Cardiac Catheterism in a Patient with Progressive Glaucoma
Alvarado-Villacorta R
Case Reports in Ophthalmology 2019; 10: 256-266 (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Cheng HH
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82371 Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications
Kee C
American Journal of Ophthalmology 2020; 209: 77-87 (IGR: 20-4)


82414 Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure
Berchuck SI
Ophthalmology 2019; 126: 1640-1646 (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Kim JM
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82768 Changes on Confocal Scanning Laser Ophthalmoscopy with the Heidelberg Retinal Tomography after a Cardiac Catheterism in a Patient with Progressive Glaucoma
Córdova-Crisanto L
Case Reports in Ophthalmology 2019; 10: 256-266 (IGR: 20-4)


82414 Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure
Berchuck SI
Ophthalmology 2019; 126: 1640-1646 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Miki A
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82190 Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study
Tan S
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Kim JH
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


82414 Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure
Medeiros FA
Ophthalmology 2019; 126: 1640-1646 (IGR: 20-4)


82190 Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study
Man X
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Hu HS
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82768 Changes on Confocal Scanning Laser Ophthalmoscopy with the Heidelberg Retinal Tomography after a Cardiac Catheterism in a Patient with Progressive Glaucoma
Valderrama-Albino V
Case Reports in Ophthalmology 2019; 10: 256-266 (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Afifi A
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Tanito M
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Girard MJA
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Huang QJ
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Mari JM
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82190 Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study
Tham CC
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Mizoue S
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Yu F
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


82768 Changes on Confocal Scanning Laser Ophthalmoscopy with the Heidelberg Retinal Tomography after a Cardiac Catheterism in a Patient with Progressive Glaucoma
Pantoja-Dávalos N
Case Reports in Ophthalmology 2019; 10: 256-266 (IGR: 20-4)


82134 Elucidation of the Strongest Factors Influencing Rapid Retinal Nerve Fiber Layer Thinning in Glaucoma
Kim H
Investigative Ophthalmology and Visual Science 2019; 60: 3343-3351 (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Coleman AL
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Mori K
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Pan XF; Xu X
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Nouri-Mahdavi K
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Suzuki K
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82488 Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression
Caprioli J
Translational vision science & technology 2019; 8: 2 (IGR: 20-4)


82602 Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Liang YB
Chinese Journal of Ophthalmology 2019; 55: 777-784 (IGR: 20-4)


81956 Validating the efficacy of the binomial pointwise linear regression method to detect glaucoma progression with multicentral database
Yamashita T; Kashiwagi K; Shoji N; Zangwill LM; Asaoka R
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


80633 Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method
Berchuck SI
Scientific reports 2019; 9: 4642 (IGR: 20-3)


80696 Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle Glaucoma
Shen T
Investigative Ophthalmology and Visual Science 2019; 60: 1069-1075 (IGR: 20-3)


80778 A spatially varying change points model for monitoring glaucoma progression using visual field data
Berchuck SI
Spatial statistics 2019; 30: 1-26 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Saeedi OJ
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


80563 Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma
Ballae Ganeshrao S
Investigative Ophthalmology and Visual Science 2019; 60: 889-900 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Zhang X
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


81248 Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial
Yokoyama Y
Journal of Glaucoma 2019; 28: 575-583 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Liu X
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


80990 Risk factors for disease progression in low-teens normal-tension glaucoma
Baek SU
British Journal of Ophthalmology 2020; 104: 81-86 (IGR: 20-3)


80825 Glaucoma progression analysis by Spectral-Domain Optical Coherence Tomography (SD-OCT)
Renard JP
Journal Français d'Ophtalmologie 2019; 42: 499-516 (IGR: 20-3)


81336 Risk Factors For Fast Visual Field Progression In Glaucoma
Kim JH
American Journal of Ophthalmology 2019; 207: 268-278 (IGR: 20-3)


80990 Risk factors for disease progression in low-teens normal-tension glaucoma
Baek SU
British Journal of Ophthalmology 2020; 104: 81-86 (IGR: 20-3)


81363 Prediction of Glaucoma Progression with Structural Parameters: Comparison of Optical Coherence Tomography and Clinical Disc Parameters
Daneshvar R
American Journal of Ophthalmology 2019; 208: 19-29 (IGR: 20-3)


81236 Spatial and Temporal Characteristics of Visual Field Progression in Glaucoma Assessed by Parallel Factor Analysis
Kim S
Korean Journal of Ophthalmology 2019; 33: 279-286 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Kiyota N
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


80633 Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method
Berchuck SI
Scientific reports 2019; 9: 4642 (IGR: 20-3)


80750 Association Between Parapapillary Choroidal Vessel Density Measured With Optical Coherence Tomography Angiography and Future Visual Field Progression in Patients With Glaucoma
Park HY
JAMA ophthalmology 2019; 137: 681-688 (IGR: 20-3)


80778 A spatially varying change points model for monitoring glaucoma progression using visual field data
Berchuck SI
Spatial statistics 2019; 30: 1-26 (IGR: 20-3)


81240 Visual Field Prediction using Recurrent Neural Network
Park K
Scientific reports 2019; 9: 8385 (IGR: 20-3)


80958 Optic Disc Microhemorrhage in Primary Open-Angle Glaucoma: Clinical Implications for Visual Field Progression
Ha A
Investigative Ophthalmology and Visual Science 2019; 60: 1824-1832 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Lee SY
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


81101 Contrast-to-Noise Ratios for Assessing the Detection of Progression in the Various Stages of Glaucoma
Majoor JEA
Translational vision science & technology 2019; 8: 8 (IGR: 20-3)


81253 Rapid Central Visual Field Progression Rate in Eyes with Open-Angle Glaucoma and Choroidal Microvasculature Dropout
Jo YH
Scientific reports 2019; 9: 8525 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Fan YY
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80602 Baseline Systolic versus Diastolic Blood Pressure Dip and Subsequent Visual Field Progression in Normal-Tension Glaucoma
Kwon J
Ophthalmology 2019; 126: 967-979 (IGR: 20-3)


81406 Classification and Statistical Trend Analysis in Detecting Glaucomatous Visual Field Progression
Valente C
Journal of Ophthalmology 2019; 2019: 1583260 (IGR: 20-3)


80829 Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression
Basu K
Cell biology international 2019; 43: 820-834 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Shiga Y
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


81363 Prediction of Glaucoma Progression with Structural Parameters: Comparison of Optical Coherence Tomography and Clinical Disc Parameters
Yarmohammadi A
American Journal of Ophthalmology 2019; 208: 19-29 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Kim EW
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


81236 Spatial and Temporal Characteristics of Visual Field Progression in Glaucoma Assessed by Parallel Factor Analysis
Shon K
Korean Journal of Ophthalmology 2019; 33: 279-286 (IGR: 20-3)


80958 Optic Disc Microhemorrhage in Primary Open-Angle Glaucoma: Clinical Implications for Visual Field Progression
Kim YK
Investigative Ophthalmology and Visual Science 2019; 60: 1824-1832 (IGR: 20-3)


80696 Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle Glaucoma
Gupta VK
Investigative Ophthalmology and Visual Science 2019; 60: 1069-1075 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Su WW
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80602 Baseline Systolic versus Diastolic Blood Pressure Dip and Subsequent Visual Field Progression in Normal-Tension Glaucoma
Jo YH
Ophthalmology 2019; 126: 967-979 (IGR: 20-3)


81253 Rapid Central Visual Field Progression Rate in Eyes with Open-Angle Glaucoma and Choroidal Microvasculature Dropout
Kwon J
Scientific reports 2019; 9: 8525 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Kelly SR
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


81240 Visual Field Prediction using Recurrent Neural Network
Kim J
Scientific reports 2019; 9: 8385 (IGR: 20-3)


80829 Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression
Maurya N
Cell biology international 2019; 43: 820-834 (IGR: 20-3)


80633 Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method
Mwanza JC
Scientific reports 2019; 9: 4642 (IGR: 20-3)


80778 A spatially varying change points model for monitoring glaucoma progression using visual field data
Mwanza JC
Spatial statistics 2019; 30: 1-26 (IGR: 20-3)


81406 Classification and Statistical Trend Analysis in Detecting Glaucomatous Visual Field Progression
D'Alessandro E
Journal of Ophthalmology 2019; 2019: 1583260 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Parrish RK
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


81336 Risk Factors For Fast Visual Field Progression In Glaucoma
Rabiolo A
American Journal of Ophthalmology 2019; 207: 268-278 (IGR: 20-3)


81101 Contrast-to-Noise Ratios for Assessing the Detection of Progression in the Various Stages of Glaucoma
Vermeer KA
Translational vision science & technology 2019; 8: 8 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Elze T
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


80990 Risk factors for disease progression in low-teens normal-tension glaucoma
Ha A
British Journal of Ophthalmology 2020; 104: 81-86 (IGR: 20-3)


80750 Association Between Parapapillary Choroidal Vessel Density Measured With Optical Coherence Tomography Angiography and Future Visual Field Progression in Patients With Glaucoma
Shin DY
JAMA ophthalmology 2019; 137: 681-688 (IGR: 20-3)


81248 Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial
Kawasaki R
Journal of Glaucoma 2019; 28: 575-583 (IGR: 20-3)


80563 Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma
Senthil S
Investigative Ophthalmology and Visual Science 2019; 60: 889-900 (IGR: 20-3)


80825 Glaucoma progression analysis by Spectral-Domain Optical Coherence Tomography (SD-OCT)
Fénolland JR
Journal Français d'Ophtalmologie 2019; 42: 499-516 (IGR: 20-3)


81336 Risk Factors For Fast Visual Field Progression In Glaucoma
Morales E
American Journal of Ophthalmology 2019; 207: 268-278 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Montesano G
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


80990 Risk factors for disease progression in low-teens normal-tension glaucoma
Kim DW
British Journal of Ophthalmology 2020; 104: 81-86 (IGR: 20-3)


80750 Association Between Parapapillary Choroidal Vessel Density Measured With Optical Coherence Tomography Angiography and Future Visual Field Progression in Patients With Glaucoma
Jeon SJ
JAMA ophthalmology 2019; 137: 681-688 (IGR: 20-3)


81101 Contrast-to-Noise Ratios for Assessing the Detection of Progression in the Various Stages of Glaucoma
Andrinopoulou ER
Translational vision science & technology 2019; 8: 8 (IGR: 20-3)


80825 Glaucoma progression analysis by Spectral-Domain Optical Coherence Tomography (SD-OCT)
Giraud JM
Journal Français d'Ophtalmologie 2019; 42: 499-516 (IGR: 20-3)


81253 Rapid Central Visual Field Progression Rate in Eyes with Open-Angle Glaucoma and Choroidal Microvasculature Dropout
Jeong D
Scientific reports 2019; 9: 8525 (IGR: 20-3)


81406 Classification and Statistical Trend Analysis in Detecting Glaucomatous Visual Field Progression
Iester M
Journal of Ophthalmology 2019; 2019: 1583260 (IGR: 20-3)


81240 Visual Field Prediction using Recurrent Neural Network
Lee J
Scientific reports 2019; 9: 8385 (IGR: 20-3)


80958 Optic Disc Microhemorrhage in Primary Open-Angle Glaucoma: Clinical Implications for Visual Field Progression
Baek SU
Investigative Ophthalmology and Visual Science 2019; 60: 1824-1832 (IGR: 20-3)


80778 A spatially varying change points model for monitoring glaucoma progression using visual field data
Warren JL
Spatial statistics 2019; 30: 1-26 (IGR: 20-3)


80563 Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma
Choudhari N
Investigative Ophthalmology and Visual Science 2019; 60: 889-900 (IGR: 20-3)


81236 Spatial and Temporal Characteristics of Visual Field Progression in Glaucoma Assessed by Parallel Factor Analysis
Sung KR
Korean Journal of Ophthalmology 2019; 33: 279-286 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Yasuda M
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Greenfield DS
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


80958 Optic Disc Microhemorrhage in Primary Open-Angle Glaucoma: Clinical Implications for Visual Field Progression
Baek SU
Investigative Ophthalmology and Visual Science 2019; 60: 1824-1832 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Choi W
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


80602 Baseline Systolic versus Diastolic Blood Pressure Dip and Subsequent Visual Field Progression in Normal-Tension Glaucoma
Jeong D
Ophthalmology 2019; 126: 967-979 (IGR: 20-3)


81248 Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial
Takahashi H
Journal of Glaucoma 2019; 28: 575-583 (IGR: 20-3)


81363 Prediction of Glaucoma Progression with Structural Parameters: Comparison of Optical Coherence Tomography and Clinical Disc Parameters
Alizadeh R
American Journal of Ophthalmology 2019; 208: 19-29 (IGR: 20-3)


80829 Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression
Kaur J
Cell biology international 2019; 43: 820-834 (IGR: 20-3)


80633 Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method
Tanna AP
Scientific reports 2019; 9: 4642 (IGR: 20-3)


80696 Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle Glaucoma
Klistorner A
Investigative Ophthalmology and Visual Science 2019; 60: 1069-1075 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Liu CH
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
D'Acunto L
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


80990 Risk factors for disease progression in low-teens normal-tension glaucoma
Jeoung JW
British Journal of Ophthalmology 2020; 104: 81-86 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Park CK
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


80829 Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression
Saxena R
Cell biology international 2019; 43: 820-834 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Aizawa N
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


80633 Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method
Budenz DL
Scientific reports 2019; 9: 4642 (IGR: 20-3)


81336 Risk Factors For Fast Visual Field Progression In Glaucoma
Yu F
American Journal of Ophthalmology 2019; 207: 268-278 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Chen HS
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80602 Baseline Systolic versus Diastolic Blood Pressure Dip and Subsequent Visual Field Progression in Normal-Tension Glaucoma
Shon K
Ophthalmology 2019; 126: 967-979 (IGR: 20-3)


80696 Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle Glaucoma
Chitranshi N
Investigative Ophthalmology and Visual Science 2019; 60: 1069-1075 (IGR: 20-3)


81363 Prediction of Glaucoma Progression with Structural Parameters: Comparison of Optical Coherence Tomography and Clinical Disc Parameters
Henry S
American Journal of Ophthalmology 2019; 208: 19-29 (IGR: 20-3)


81248 Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial
Maekawa S
Journal of Glaucoma 2019; 28: 575-583 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Bryan SR
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Francis BA
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


80958 Optic Disc Microhemorrhage in Primary Open-Angle Glaucoma: Clinical Implications for Visual Field Progression
Park KH
Investigative Ophthalmology and Visual Science 2019; 60: 1824-1832 (IGR: 20-3)


80750 Association Between Parapapillary Choroidal Vessel Density Measured With Optical Coherence Tomography Angiography and Future Visual Field Progression in Patients With Glaucoma
Park CK
JAMA ophthalmology 2019; 137: 681-688 (IGR: 20-3)


81101 Contrast-to-Noise Ratios for Assessing the Detection of Progression in the Various Stages of Glaucoma
Lemij HG
Translational vision science & technology 2019; 8: 8 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Swamy R
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


81253 Rapid Central Visual Field Progression Rate in Eyes with Open-Angle Glaucoma and Choroidal Microvasculature Dropout
Shon K
Scientific reports 2019; 9: 8525 (IGR: 20-3)


80563 Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma
Sri Durgam S
Investigative Ophthalmology and Visual Science 2019; 60: 889-900 (IGR: 20-3)


81253 Rapid Central Visual Field Progression Rate in Eyes with Open-Angle Glaucoma and Choroidal Microvasculature Dropout
Kook MS
Scientific reports 2019; 9: 8525 (IGR: 20-3)


81363 Prediction of Glaucoma Progression with Structural Parameters: Comparison of Optical Coherence Tomography and Clinical Disc Parameters
Law SK
American Journal of Ophthalmology 2019; 208: 19-29 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Kim S
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Varma R
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


80633 Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method
Warren JL
Scientific reports 2019; 9: 4642 (IGR: 20-3)


81336 Risk Factors For Fast Visual Field Progression In Glaucoma
Afifi AA
American Journal of Ophthalmology 2019; 207: 268-278 (IGR: 20-3)


80696 Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle Glaucoma
Graham SL
Investigative Ophthalmology and Visual Science 2019; 60: 1069-1075 (IGR: 20-3)


80602 Baseline Systolic versus Diastolic Blood Pressure Dip and Subsequent Visual Field Progression in Normal-Tension Glaucoma
Kook MS
Ophthalmology 2019; 126: 967-979 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Hegde V
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


81248 Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial
Tsuda S
Journal of Glaucoma 2019; 28: 575-583 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Wu SC
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80563 Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma
Garudadri CS
Investigative Ophthalmology and Visual Science 2019; 60: 889-900 (IGR: 20-3)


80829 Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression
Gupta V
Cell biology international 2019; 43: 820-834 (IGR: 20-3)


80958 Optic Disc Microhemorrhage in Primary Open-Angle Glaucoma: Clinical Implications for Visual Field Progression
Jeoung JW
Investigative Ophthalmology and Visual Science 2019; 60: 1824-1832 (IGR: 20-3)


80990 Risk factors for disease progression in low-teens normal-tension glaucoma
Park KH
British Journal of Ophthalmology 2020; 104: 81-86 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Barry RJ
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Omodaka K
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Bae HW
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Chang SHL
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80829 Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression
Sihota R
Cell biology international 2019; 43: 820-834 (IGR: 20-3)


81248 Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial
Omodaka K
Journal of Glaucoma 2019; 28: 575-583 (IGR: 20-3)


81336 Risk Factors For Fast Visual Field Progression In Glaucoma
Nouri-Mahdavi K
American Journal of Ophthalmology 2019; 207: 268-278 (IGR: 20-3)


80990 Risk factors for disease progression in low-teens normal-tension glaucoma
Kim YK
British Journal of Ophthalmology 2020; 104: 81-86 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Gupta S
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Tsuda S
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


80696 Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle Glaucoma
You Y
Investigative Ophthalmology and Visual Science 2019; 60: 1069-1075 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Schuman JS
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


81363 Prediction of Glaucoma Progression with Structural Parameters: Comparison of Optical Coherence Tomography and Clinical Disc Parameters
Caprioli J
American Journal of Ophthalmology 2019; 208: 19-29 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Keane PA
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


80829 Possible role of differentially expressing novel protein markers (ligatin and fibulin-7) in human aqueous humor and trabecular meshwork tissue in glaucoma progression
Ghosh I
Cell biology international 2019; 43: 820-834 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Kunikata H
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Tan O
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


81363 Prediction of Glaucoma Progression with Structural Parameters: Comparison of Optical Coherence Tomography and Clinical Disc Parameters
Nouri-Mahdavi K
American Journal of Ophthalmology 2019; 208: 19-29 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Denniston AK
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Venjara A
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Seong GJ
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Chen KJ
Eye 2019; 33: 1459-1465 (IGR: 20-3)


81336 Risk Factors For Fast Visual Field Progression In Glaucoma
Caprioli J
American Journal of Ophthalmology 2019; 207: 268-278 (IGR: 20-3)


81248 Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial
Nakazawa T
Journal of Glaucoma 2019; 28: 575-583 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Wu WC
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Tsai J
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


81039 Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery
Kim CY
British Journal of Ophthalmology 2020; 104: 276-281 (IGR: 20-3)


81369 Evaluating the Impact of Uveitis on Visual Field Progression Using Large Scale Real-World Data
Crabb DP
American Journal of Ophthalmology 2019; 207: 144-150 (IGR: 20-3)


81316 Sectoral Differences in the Association of Optic Nerve Head Blood Flow and Glaucomatous Visual Field Defect Severity and Progression
Nakazawa T
Investigative Ophthalmology and Visual Science 2019; 60: 2650-2658 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study
Huang D
American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Myers JS
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


80513 Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study

American Journal of Ophthalmology 2019; 202: 62-71 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Chen NH
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
Wellik SR
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


80837 Correlation between structural progression in glaucoma and obstructive sleep apnea
Li HY; Sun MH
Eye 2019; 33: 1459-1465 (IGR: 20-3)


80462 Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms
De Moraes CG; Pasquale LR; Shen LQ; Boland MV
Ophthalmology 2019; 126: 822-828 (IGR: 20-3)


79568 Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression
Matlach J
Clinical Ophthalmology 2019; 13: 9-16 (IGR: 20-2)


79599 Parapapillary Deep-Layer Microvasculature Dropout and Visual Field Progression in Glaucoma
Kwon JM
American Journal of Ophthalmology 2019; 200: 65-75 (IGR: 20-2)


79736 Relationship between Progressive Changes in Lamina Cribrosa Depth and Deterioration of Visual Field Loss in Glaucomatous Eyes
Kim YN
Korean Journal of Ophthalmology 2018; 32: 470-477 (IGR: 20-2)


79682 Intraocular Pressure Elevation during Lateral Body Posture in Side-sleeping Glaucoma Patients
Park JH
Optometry and Vision Science 2019; 96: 62-70 (IGR: 20-2)


79942 Intraocular pressure fluctuation and the risk of glaucomatous damage deterioration: a Meta-analysis
Guo ZZ
International Journal of Ophthalmology 2019; 12: 123-128 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Yousefi S
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Wang M
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Waisbourd M
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Kim JH
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Kiessling D
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


79390 Early Detection of Glaucomatous Visual Field Progression Using Pointwise Linear Regression With Binomial Test in the Central 10 Degrees
Asano S
American Journal of Ophthalmology 2019; 199: 140-149 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Sakata R
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


79990 Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes
Anderson AJ
Investigative Ophthalmology and Visual Science 2019; 60: 161-167 (IGR: 20-2)


79942 Intraocular pressure fluctuation and the risk of glaucomatous damage deterioration: a Meta-analysis
Chang K
International Journal of Ophthalmology 2019; 12: 123-128 (IGR: 20-2)


79990 Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes
Chaurasia AK
Investigative Ophthalmology and Visual Science 2019; 60: 161-167 (IGR: 20-2)


79568 Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression
Bender S
Clinical Ophthalmology 2019; 13: 9-16 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Yoshitomi T
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Christ H
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


79736 Relationship between Progressive Changes in Lamina Cribrosa Depth and Deterioration of Visual Field Loss in Glaucomatous Eyes
Shin JW
Korean Journal of Ophthalmology 2018; 32: 470-477 (IGR: 20-2)


79682 Intraocular Pressure Elevation during Lateral Body Posture in Side-sleeping Glaucoma Patients
Yoo C
Optometry and Vision Science 2019; 96: 62-70 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Shen LQ
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


79599 Parapapillary Deep-Layer Microvasculature Dropout and Visual Field Progression in Glaucoma
Weinreb RN
American Journal of Ophthalmology 2019; 200: 65-75 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Sanvicente CT
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Rabiolo A
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


79390 Early Detection of Glaucomatous Visual Field Progression Using Pointwise Linear Regression With Binomial Test in the Central 10 Degrees
Murata H
American Journal of Ophthalmology 2019; 199: 140-149 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Sakai H
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Sanvicente CT
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Pasquale LR
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


79390 Early Detection of Glaucomatous Visual Field Progression Using Pointwise Linear Regression With Binomial Test in the Central 10 Degrees
Matsuura M
American Journal of Ophthalmology 2019; 199: 140-149 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Murata H
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


79990 Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes
Sharma A
Investigative Ophthalmology and Visual Science 2019; 60: 161-167 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Coleman HM
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Gietzelt C
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


79942 Intraocular pressure fluctuation and the risk of glaucomatous damage deterioration: a Meta-analysis
Wei X
International Journal of Ophthalmology 2019; 12: 123-128 (IGR: 20-2)


79736 Relationship between Progressive Changes in Lamina Cribrosa Depth and Deterioration of Visual Field Loss in Glaucomatous Eyes
Sung KR
Korean Journal of Ophthalmology 2018; 32: 470-477 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Iwase A
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


79568 Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression
König J
Clinical Ophthalmology 2019; 13: 9-16 (IGR: 20-2)


79599 Parapapillary Deep-Layer Microvasculature Dropout and Visual Field Progression in Glaucoma
Zangwill LM
American Journal of Ophthalmology 2019; 200: 65-75 (IGR: 20-2)


79682 Intraocular Pressure Elevation during Lateral Body Posture in Side-sleeping Glaucoma Patients
Yoo E
Optometry and Vision Science 2019; 96: 62-70 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Morales E
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Schaub F
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Petrakos P
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Fujino Y
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


79990 Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes
Gupta A
Investigative Ophthalmology and Visual Science 2019; 60: 161-167 (IGR: 20-2)


79599 Parapapillary Deep-Layer Microvasculature Dropout and Visual Field Progression in Glaucoma
Suh MH
American Journal of Ophthalmology 2019; 200: 65-75 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Sieburth R
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Fatehi N
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


79390 Early Detection of Glaucomatous Visual Field Progression Using Pointwise Linear Regression With Binomial Test in the Central 10 Degrees
Fujino Y
American Journal of Ophthalmology 2019; 199: 140-149 (IGR: 20-2)


79568 Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression
Binder H
Clinical Ophthalmology 2019; 13: 9-16 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Matsumoto C
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


79682 Intraocular Pressure Elevation during Lateral Body Posture in Side-sleeping Glaucoma Patients
Kim YY
Optometry and Vision Science 2019; 96: 62-70 (IGR: 20-2)


79390 Early Detection of Glaucomatous Visual Field Progression Using Pointwise Linear Regression With Binomial Test in the Central 10 Degrees
Asaoka R
American Journal of Ophthalmology 2019; 199: 140-149 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Zhan T
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Dietlein TS
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


79568 Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression
Pfeiffer N
Clinical Ophthalmology 2019; 13: 9-16 (IGR: 20-2)


79990 Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes
Gupta S
Investigative Ophthalmology and Visual Science 2019; 60: 161-167 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Formica S
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Lee WS
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Higashide T
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Matsuura M
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Shirakashi M
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Yu F
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


79568 Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression
Hoffmann EM
Clinical Ophthalmology 2019; 13: 9-16 (IGR: 20-2)


79990 Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes
Khanna A
Investigative Ophthalmology and Visual Science 2019; 60: 161-167 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Boland MV
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Gogte P
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Garway-Heath D
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Cursiefen C
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Aihara M
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Wellik SR
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Muhire RSM
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Afifi AA
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Weinreb R
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Heindl LM
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


79990 Comparison of Rates of Fast and Catastrophic Visual Field Loss in Three Glaucoma Subtypes
Gupta V
Investigative Ophthalmology and Visual Science 2019; 60: 161-167 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Sugiyama K
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Wizov SS
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79343 Impact of ab-interno trabeculectomy on Bruch's membrane opening-based morphometry of the optic nerve head for glaucoma progression analysis
Enders P
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 339-347 (IGR: 20-2)


79823 Rates of Visual Field Loss in Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma: Asymmetric Patterns
Asaoka R
Investigative Ophthalmology and Visual Science 2018; 59: 5717-5725 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Nouri-Mahdavi K
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
De Moraes CG; Myers JS
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


79844 Cataract Surgery and Rate of Visual Field Progression in Primary Open-Angle Glaucoma
Caprioli J
American Journal of Ophthalmology 2019; 201: 19-30 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure
Araie M
Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Moster MR
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Saeedi O
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80071 Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure

Ophthalmology 2019; 126: 1107-1116 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Pro MJ
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Wang H
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Fudemberg SJ
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Baniasadi N
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Mantravadi AV
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Li D
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Myers JS; Katz LJ
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Tichelaar J
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Hark LA
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


79883 An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis
Bex PJ; Elze T
Investigative Ophthalmology and Visual Science 2019; 60: 365-375 (IGR: 20-2)


80034 Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression
Spaeth GL
Journal of Glaucoma 2019; 28: 216-222 (IGR: 20-2)


78497 Combined Use of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Event-based Progression Analysis
Lee WJ
American Journal of Ophthalmology 2018; 196: 65-71 (IGR: 20-1)


78876 Correlation between elastic energy stored in an eye and visual field progression in glaucoma
Aoki S
PLoS ONE 2018; 13: e0204451 (IGR: 20-1)


79225 Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma
Lee MJ
Ophthalmology 2019; 126: 958-964 (IGR: 20-1)


78474 Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers
Susanna BN
Ophthalmology 2019; 126: 49-54 (IGR: 20-1)


79110 Lack of Association of rs1192415 in With Visual Field Progression: A Cohort Study in Chinese Open Angle Glaucoma Patients
Chen Y
Frontiers in genetics 2018; 9: 488 (IGR: 20-1)


79264 Influence of glaucoma surgery on visual function: a clinical cohort study and meta-analysis
Junoy Montolio FG
Acta Ophthalmologica 2019; 97: 193-199 (IGR: 20-1)


79087 A Method to Measure the Rate of Glaucomatous Visual Field Change
Caprioli J
Translational vision science & technology 2018; 7: 14 (IGR: 20-1)


78357 Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model
Yoshikawa K
Clinical Ophthalmology 2018; 12: 1617-1624 (IGR: 20-1)


78876 Correlation between elastic energy stored in an eye and visual field progression in glaucoma
Murata H
PLoS ONE 2018; 13: e0204451 (IGR: 20-1)


78497 Combined Use of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Event-based Progression Analysis
Na KI
American Journal of Ophthalmology 2018; 196: 65-71 (IGR: 20-1)


79225 Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma
Wang J
Ophthalmology 2019; 126: 958-964 (IGR: 20-1)


79087 A Method to Measure the Rate of Glaucomatous Visual Field Change
Mohamed L
Translational vision science & technology 2018; 7: 14 (IGR: 20-1)


79264 Influence of glaucoma surgery on visual function: a clinical cohort study and meta-analysis
Müskens RPHM
Acta Ophthalmologica 2019; 97: 193-199 (IGR: 20-1)


78357 Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model
Santo K
Clinical Ophthalmology 2018; 12: 1617-1624 (IGR: 20-1)


79110 Lack of Association of rs1192415 in With Visual Field Progression: A Cohort Study in Chinese Open Angle Glaucoma Patients
Qiu C
Frontiers in genetics 2018; 9: 488 (IGR: 20-1)


78474 Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers
Ogata NG
Ophthalmology 2019; 126: 49-54 (IGR: 20-1)


79264 Influence of glaucoma surgery on visual function: a clinical cohort study and meta-analysis
Jansonius NM
Acta Ophthalmologica 2019; 97: 193-199 (IGR: 20-1)


79087 A Method to Measure the Rate of Glaucomatous Visual Field Change
Morales E
Translational vision science & technology 2018; 7: 14 (IGR: 20-1)


78357 Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model
Hizaki H
Clinical Ophthalmology 2018; 12: 1617-1624 (IGR: 20-1)


78497 Combined Use of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Event-based Progression Analysis
Ha A
American Journal of Ophthalmology 2018; 196: 65-71 (IGR: 20-1)


79225 Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma
Friedman DS
Ophthalmology 2019; 126: 958-964 (IGR: 20-1)


78876 Correlation between elastic energy stored in an eye and visual field progression in glaucoma
Nakakura S
PLoS ONE 2018; 13: e0204451 (IGR: 20-1)


79110 Lack of Association of rs1192415 in With Visual Field Progression: A Cohort Study in Chinese Open Angle Glaucoma Patients
Qian S
Frontiers in genetics 2018; 9: 488 (IGR: 20-1)


78474 Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers
Daga FB
Ophthalmology 2019; 126: 49-54 (IGR: 20-1)


79087 A Method to Measure the Rate of Glaucomatous Visual Field Change
Rabiolo A
Translational vision science & technology 2018; 7: 14 (IGR: 20-1)


78357 Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model
Hashimoto M
Clinical Ophthalmology 2018; 12: 1617-1624 (IGR: 20-1)


78474 Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers
Susanna CN
Ophthalmology 2019; 126: 49-54 (IGR: 20-1)


79110 Lack of Association of rs1192415 in With Visual Field Progression: A Cohort Study in Chinese Open Angle Glaucoma Patients
Chen J
Frontiers in genetics 2018; 9: 488 (IGR: 20-1)


78876 Correlation between elastic energy stored in an eye and visual field progression in glaucoma
Nakao Y
PLoS ONE 2018; 13: e0204451 (IGR: 20-1)


78497 Combined Use of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Event-based Progression Analysis
Kim YK
American Journal of Ophthalmology 2018; 196: 65-71 (IGR: 20-1)


79225 Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma
Boland MV
Ophthalmology 2019; 126: 958-964 (IGR: 20-1)


79110 Lack of Association of rs1192415 in With Visual Field Progression: A Cohort Study in Chinese Open Angle Glaucoma Patients
Chen X
Frontiers in genetics 2018; 9: 488 (IGR: 20-1)


78876 Correlation between elastic energy stored in an eye and visual field progression in glaucoma
Matsuura M
PLoS ONE 2018; 13: e0204451 (IGR: 20-1)


79225 Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma
De Moraes CG
Ophthalmology 2019; 126: 958-964 (IGR: 20-1)


78497 Combined Use of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Event-based Progression Analysis
Jeoung JW
American Journal of Ophthalmology 2018; 196: 65-71 (IGR: 20-1)


78474 Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers
Diniz-Filho A
Ophthalmology 2019; 126: 49-54 (IGR: 20-1)


79087 A Method to Measure the Rate of Glaucomatous Visual Field Change
Sears N
Translational vision science & technology 2018; 7: 14 (IGR: 20-1)


78474 Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers
Medeiros FA
Ophthalmology 2019; 126: 49-54 (IGR: 20-1)


78497 Combined Use of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Event-based Progression Analysis
Park KH
American Journal of Ophthalmology 2018; 196: 65-71 (IGR: 20-1)


79087 A Method to Measure the Rate of Glaucomatous Visual Field Change
Pradtana H
Translational vision science & technology 2018; 7: 14 (IGR: 20-1)


79225 Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma
Ramulu PY
Ophthalmology 2019; 126: 958-964 (IGR: 20-1)


78876 Correlation between elastic energy stored in an eye and visual field progression in glaucoma
Kiuchi Y
PLoS ONE 2018; 13: e0204451 (IGR: 20-1)


79110 Lack of Association of rs1192415 in With Visual Field Progression: A Cohort Study in Chinese Open Angle Glaucoma Patients
Wang L; Sun X
Frontiers in genetics 2018; 9: 488 (IGR: 20-1)


78876 Correlation between elastic energy stored in an eye and visual field progression in glaucoma
Asaoka R
PLoS ONE 2018; 13: e0204451 (IGR: 20-1)


79087 A Method to Measure the Rate of Glaucomatous Visual Field Change
Alizadeh R; Yu F; Afifi AA; Coleman AL; Nouri-Mahdavi K
Translational vision science & technology 2018; 7: 14 (IGR: 20-1)


77926 Iridotomy to slow progression of visual field loss in angle-closure glaucoma
Le JT
Cochrane Database of Systematic Reviews 2018; 6: CD012270 (IGR: 19-4)


78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Ha A
Ophthalmology 2018; 0: (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Shah SM
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


78287 Comparison of Visual Field Point-Wise Event-Based and Global Trend-Based Analysis for Detecting Glaucomatous Progression
Wu Z
Translational vision science & technology 2018; 7: 20 (IGR: 19-4)


77956 Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
Yousefi S; Kiwaki T
American Journal of Ophthalmology 2018; 193: 71-79 (IGR: 19-4)


78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Kim TJ
Ophthalmology 2018; 0: (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Choo C
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


77926 Iridotomy to slow progression of visual field loss in angle-closure glaucoma
Rouse B
Cochrane Database of Systematic Reviews 2018; 6: CD012270 (IGR: 19-4)


78287 Comparison of Visual Field Point-Wise Event-Based and Global Trend-Based Analysis for Detecting Glaucomatous Progression
Medeiros FA
Translational vision science & technology 2018; 7: 20 (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Odden J
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


77956 Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
Zheng Y
American Journal of Ophthalmology 2018; 193: 71-79 (IGR: 19-4)


77926 Iridotomy to slow progression of visual field loss in angle-closure glaucoma
Gazzard G
Cochrane Database of Systematic Reviews 2018; 6: CD012270 (IGR: 19-4)


78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Girard MJA
Ophthalmology 2018; 0: (IGR: 19-4)


77956 Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
Sugiura H
American Journal of Ophthalmology 2018; 193: 71-79 (IGR: 19-4)


78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Mari JM
Ophthalmology 2018; 0: (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Zhao B; Fang C
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Kim YK
Ophthalmology 2018; 0: (IGR: 19-4)


77956 Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
Asaoka R
American Journal of Ophthalmology 2018; 193: 71-79 (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Schornack M
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Park KH
Ophthalmology 2018; 0: (IGR: 19-4)


77956 Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
Murata H
American Journal of Ophthalmology 2018; 193: 71-79 (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Stalboerger G
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


78012 Baseline Lamina Cribrosa Curvature and Subsequent Visual Field Progression Rate in Primary Open-Angle Glaucoma
Jeoung JW
Ophthalmology 2018; 0: (IGR: 19-4)


77956 Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
Lemij H
American Journal of Ophthalmology 2018; 193: 71-79 (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Bennett JR; Bennett JR
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


77956 Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning
Yamanishi K
American Journal of Ophthalmology 2018; 193: 71-79 (IGR: 19-4)


77877 Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model
Khanna CL
Journal of Glaucoma 2018; 27: 691-698 (IGR: 19-4)


77000 Comparison of changes of macular ganglion cell-inner plexiform layer defect between stable group and progression group in primary open-angle glaucoma
Seol BR
Japanese Journal of Ophthalmology 2018; 62: 491-498 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Song Y
Ophthalmology 2018; 0: (IGR: 19-3)


77177 Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma
De Moraes CG
JAMA ophthalmology 2018; 136: 779-785 (IGR: 19-3)


77243 Association of Diopsys® Short-duration Transient Visual Evoked Potential Latency with Visual Field Progression in Chronic Glaucoma
Trevino R
Journal of Current Glaucoma Practice 2018; 12: 29-35 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Murata H
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76481 Integrating Macular Ganglion Cell Inner Plexiform Layer and Parapapillary Retinal Nerve Fiber Layer Measurements to Detect Glaucoma Progression
Hou HW
Ophthalmology 2018; 125: 822-831 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Wu Z
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


77103 Influence of Removing the Large Retinal Vessels-related Effect on Peripapillary Vessel Density Progression Analysis in Glaucoma
Holló G
Journal of Glaucoma 2018; 27: e137-e139 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Hou H
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76870 Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index
Zhang C
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1227-1234 (IGR: 19-3)


76259 Recent developments in visual field testing for glaucoma
Wu Z
Current Opinions in Ophthalmology 2018; 29: 141-146 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Hou H
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Christopher M
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Sihota R
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Gracitelli CPB
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Hashimoto S
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76741 Location of Disc Hemorrhage and Direction of Progression in Glaucomatous Retinal Nerve Fiber Layer Defects
Lee EJ
Journal of Glaucoma 2018; 27: 504-510 (IGR: 19-3)


77239 Peripapillary Retinoschisis in Glaucoma: Association With Progression and OCT Signs of Müller Cell Involvement
Fortune B
Investigative Ophthalmology and Visual Science 2018; 59: 2818-2827 (IGR: 19-3)


76650 The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma
Li BB
Chinese Journal of Ophthalmology 2018; 54: 171-176 (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Aoki S
Scientific reports 2018; 8: 2969 (IGR: 19-3)


76948 Glaucoma Progression and its Relationship with Corrected and Uncorrected Intraocular Pressure in Eyes with History of Refractive Corneal Surgery
Kwon J
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


76612 The relationship between increased oxidative stress and visual field defect progression in glaucoma patients with sleep apnoea syndrome
Yamada E
Acta Ophthalmologica 2018; 96: e479-e484 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Hou H
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76309 Comparison of Peripapillary OCT Angiography Vessel Density and Retinal Nerve Fiber Layer Thickness Measurements for Their Ability to Detect Progression in Glaucoma
Holló G
Journal of Glaucoma 2018; 27: 302-305 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Weng DSD
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Angmo D
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Zangwill LM
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


76948 Glaucoma Progression and its Relationship with Corrected and Uncorrected Intraocular Pressure in Eyes with History of Refractive Corneal Surgery
Sung KR
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


77239 Peripapillary Retinoschisis in Glaucoma: Association With Progression and OCT Signs of Müller Cell Involvement
Ma KN
Investigative Ophthalmology and Visual Science 2018; 59: 2818-2827 (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Murata H
Scientific reports 2018; 8: 2969 (IGR: 19-3)


77000 Comparison of changes of macular ganglion cell-inner plexiform layer defect between stable group and progression group in primary open-angle glaucoma
Yoo BW
Japanese Journal of Ophthalmology 2018; 62: 491-498 (IGR: 19-3)


76612 The relationship between increased oxidative stress and visual field defect progression in glaucoma patients with sleep apnoea syndrome
Himori N
Acta Ophthalmologica 2018; 96: e479-e484 (IGR: 19-3)


76481 Integrating Macular Ganglion Cell Inner Plexiform Layer and Parapapillary Retinal Nerve Fiber Layer Measurements to Detect Glaucoma Progression
Lin C
Ophthalmology 2018; 125: 822-831 (IGR: 19-3)


76741 Location of Disc Hemorrhage and Direction of Progression in Glaucomatous Retinal Nerve Fiber Layer Defects
Han JC
Journal of Glaucoma 2018; 27: 504-510 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Weng DSD
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


76650 The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma
Cai Y
Chinese Journal of Ophthalmology 2018; 54: 171-176 (IGR: 19-3)


76259 Recent developments in visual field testing for glaucoma
Medeiros FA
Current Opinions in Ophthalmology 2018; 29: 141-146 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Matsumoto C
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Ishikawa H
Ophthalmology 2018; 0: (IGR: 19-3)


77177 Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma
Mansouri K
JAMA ophthalmology 2018; 136: 779-785 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Shoji T
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Weng DSD
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Zangwill LM
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Belghith A
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


76870 Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index
Tatham AJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1227-1234 (IGR: 19-3)


77243 Association of Diopsys® Short-duration Transient Visual Evoked Potential Latency with Visual Field Progression in Chronic Glaucoma
Sponsel WE
Journal of Current Glaucoma Practice 2018; 12: 29-35 (IGR: 19-3)


76741 Location of Disc Hemorrhage and Direction of Progression in Glaucomatous Retinal Nerve Fiber Layer Defects
Kee C
Journal of Glaucoma 2018; 27: 504-510 (IGR: 19-3)


77239 Peripapillary Retinoschisis in Glaucoma: Association With Progression and OCT Signs of Müller Cell Involvement
Gardiner SK
Investigative Ophthalmology and Visual Science 2018; 59: 2818-2827 (IGR: 19-3)


76612 The relationship between increased oxidative stress and visual field defect progression in glaucoma patients with sleep apnoea syndrome
Kunikata H
Acta Ophthalmologica 2018; 96: e479-e484 (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Matsuura M
Scientific reports 2018; 8: 2969 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Rajshekhar R
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


77177 Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma
Liebmann JM
JAMA ophthalmology 2018; 136: 779-785 (IGR: 19-3)


77000 Comparison of changes of macular ganglion cell-inner plexiform layer defect between stable group and progression group in primary open-angle glaucoma
Kim YK
Japanese Journal of Ophthalmology 2018; 62: 491-498 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Eura M
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Zangwill LM
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Rajshekhar R
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


76948 Glaucoma Progression and its Relationship with Corrected and Uncorrected Intraocular Pressure in Eyes with History of Refractive Corneal Surgery
Jo J
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Weinreb RN
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


76870 Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index
Daga FB
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1227-1234 (IGR: 19-3)


76650 The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma
Pan YZ
Chinese Journal of Ophthalmology 2018; 54: 171-176 (IGR: 19-3)


76481 Integrating Macular Ganglion Cell Inner Plexiform Layer and Parapapillary Retinal Nerve Fiber Layer Measurements to Detect Glaucoma Progression
Leung CK
Ophthalmology 2018; 125: 822-831 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Fujino Y
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Wu M
Ophthalmology 2018; 0: (IGR: 19-3)


76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Ramaswamy D
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)


77243 Association of Diopsys® Short-duration Transient Visual Evoked Potential Latency with Visual Field Progression in Chronic Glaucoma
Majcher CE
Journal of Current Glaucoma Practice 2018; 12: 29-35 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Diniz-Filho A
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Okuyama S
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Moghimi S
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


77000 Comparison of changes of macular ganglion cell-inner plexiform layer defect between stable group and progression group in primary open-angle glaucoma
Jeoung JW
Japanese Journal of Ophthalmology 2018; 62: 491-498 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Abe RY
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


76650 The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma
Li M
Chinese Journal of Ophthalmology 2018; 54: 171-176 (IGR: 19-3)


76948 Glaucoma Progression and its Relationship with Corrected and Uncorrected Intraocular Pressure in Eyes with History of Refractive Corneal Surgery
Yang SH
Current Eye Research 2018; 0: 1-9 (IGR: 19-3)


76797 Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma
Dada T
Indian Journal of Ophthalmology 2018; 66: 495-505 (IGR: 19-3)


76870 Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index
Jammal AA
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1227-1234 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Matsuura M
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Fujino Y
Scientific reports 2018; 8: 2969 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Bowd C
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


77239 Peripapillary Retinoschisis in Glaucoma: Association With Progression and OCT Signs of Müller Cell Involvement
Demirel S
Investigative Ophthalmology and Visual Science 2018; 59: 2818-2827 (IGR: 19-3)


76612 The relationship between increased oxidative stress and visual field defect progression in glaucoma patients with sleep apnoea syndrome
Omodaka K
Acta Ophthalmologica 2018; 96: e479-e484 (IGR: 19-3)


77243 Association of Diopsys® Short-duration Transient Visual Evoked Potential Latency with Visual Field Progression in Chronic Glaucoma
Allen J
Journal of Current Glaucoma Practice 2018; 12: 29-35 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Thenappan A
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


77177 Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma
Ritch R
JAMA ophthalmology 2018; 136: 779-785 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Liu YY
Ophthalmology 2018; 0: (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Nakakura S
Scientific reports 2018; 8: 2969 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Nomoto H
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Saunders LJ
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76612 The relationship between increased oxidative stress and visual field defect progression in glaucoma patients with sleep apnoea syndrome
Ogawa H
Acta Ophthalmologica 2018; 96: e479-e484 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Lucy KA
Ophthalmology 2018; 0: (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Miki A
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


77239 Peripapillary Retinoschisis in Glaucoma: Association With Progression and OCT Signs of Müller Cell Involvement
Mansberger SL
Investigative Ophthalmology and Visual Science 2018; 59: 2818-2827 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Goldbaum MH
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


77243 Association of Diopsys® Short-duration Transient Visual Evoked Potential Latency with Visual Field Progression in Chronic Glaucoma
Rabin J
Journal of Current Glaucoma Practice 2018; 12: 29-35 (IGR: 19-3)


76650 The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma
Fang Y
Chinese Journal of Ophthalmology 2018; 54: 171-176 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Ritch R
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


76870 Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index
Medeiros FA
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1227-1234 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Girkin CA
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


77177 Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma

JAMA ophthalmology 2018; 136: 779-785 (IGR: 19-3)


77000 Comparison of changes of macular ganglion cell-inner plexiform layer defect between stable group and progression group in primary open-angle glaucoma
Park KH
Japanese Journal of Ophthalmology 2018; 62: 491-498 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Hirasawa K
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76650 The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma
Tian T
Chinese Journal of Ophthalmology 2018; 54: 171-176 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Saunders LJ
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Lavinsky F
Ophthalmology 2018; 0: (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Nakao Y
Scientific reports 2018; 8: 2969 (IGR: 19-3)


77051 Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans
Hood DC
Translational vision science & technology 2018; 7: 5 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Hasenstab K
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Weinreb RN
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


76612 The relationship between increased oxidative stress and visual field defect progression in glaucoma patients with sleep apnoea syndrome
Ichinose M
Acta Ophthalmologica 2018; 96: e479-e484 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Tanabe F
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Medeiros FA
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Kayazawa T
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Liu M
Ophthalmology 2018; 0: (IGR: 19-3)


76612 The relationship between increased oxidative stress and visual field defect progression in glaucoma patients with sleep apnoea syndrome
Nakazawa T
Acta Ophthalmologica 2018; 96: e479-e484 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Tanito M
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Liebmann JM
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Kiuchi Y
Scientific reports 2018; 8: 2969 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Ghahari E
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76650 The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma
Yan XM
Chinese Journal of Ophthalmology 2018; 54: 171-176 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Wollstein G
Ophthalmology 2018; 0: (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Iwase A
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Manalastas PIC
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76514 Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent
Medeiros FA
JAMA ophthalmology 2018; 136: 329-335 (IGR: 19-3)


76502 The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression
Asaoka R
Scientific reports 2018; 8: 2969 (IGR: 19-3)


77238 Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression
Zangwill LM
Investigative Ophthalmology and Visual Science 2018; 59: 2748-2756 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Mizoue S
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76735 Distribution and Progression of Visual Field Defects With Binocular Vision in Glaucoma
Shimomura Y
Journal of Glaucoma 2018; 27: 519-524 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Akagi T
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Mori K
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76768 Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements
Schuman JS
Ophthalmology 2018; 0: (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Suzuki K
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Christopher M; Penteado RC
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Yamashita T; Kashiwagi K
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


76505 Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients
Weinreb RN
American Journal of Ophthalmology 2018; 189: 1-9 (IGR: 19-3)


76967 Validating Variational Bayes Linear Regression Method With Multi-Central Datasets
Shoji N; Asaoka R
Investigative Ophthalmology and Visual Science 2018; 59: 1897-1904 (IGR: 19-3)


75398 Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?
Swaminathan SS
Journal of Glaucoma 2018; 27: 1-6 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Nitta K
Scientific reports 2017; 7: 15048 (IGR: 19-2)


75336 The Future of Imaging in Detecting Glaucoma Progression
Lavinsky F
Ophthalmology 2017; 124: S76-S82 (IGR: 19-2)


75334 Detecting Structural Progression in Glaucoma with Optical Coherence Tomography
Tatham AJ
Ophthalmology 2017; 124: S57-S65 (IGR: 19-2)


75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Diekmann T
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Garg A
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


75130 Risk Factors Associated With Glaucomatous Progression in Pseudoexfoliation Patients
Moon Y
Journal of Glaucoma 2017; 26: 1107-1113 (IGR: 19-2)


76017 A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Kitaoka Y
Journal of Ophthalmology 2018; 2018: 8941489 (IGR: 19-2)


75544 Impact of optic disc hemorrhage on subsequent glaucoma progression in mild-to-moderate myopia
Ha A
PLoS ONE 2017; 12: e0189706 (IGR: 19-2)


75333 Detecting Visual Field Progression
Aref AA
Ophthalmology 2017; 124: S51-S56 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Whigham B
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75451 Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods
Kazemian P
Ophthalmology 2018; 125: 569-577 (IGR: 19-2)


75703 SITA-Standard perimetry has better performance than FDT2 matrix perimetry for detecting glaucomatous progression
Wall M
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)


75544 Impact of optic disc hemorrhage on subsequent glaucoma progression in mild-to-moderate myopia
Kim YK
PLoS ONE 2017; 12: e0189706 (IGR: 19-2)


75333 Detecting Visual Field Progression
Budenz DL
Ophthalmology 2017; 124: S51-S56 (IGR: 19-2)


75703 SITA-Standard perimetry has better performance than FDT2 matrix perimetry for detecting glaucomatous progression
Johnson CA
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
De Moraes CG
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


75334 Detecting Structural Progression in Glaucoma with Optical Coherence Tomography
Medeiros FA
Ophthalmology 2017; 124: S57-S65 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Oddone EZ
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Schrems-Hoesl LM
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)


75451 Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods
Lavieri MS
Ophthalmology 2018; 125: 569-577 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Wajima R
Scientific reports 2017; 7: 15048 (IGR: 19-2)


75398 Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?
Bhakta AS
Journal of Glaucoma 2018; 27: 1-6 (IGR: 19-2)


75130 Risk Factors Associated With Glaucomatous Progression in Pseudoexfoliation Patients
Sung KR
Journal of Glaucoma 2017; 26: 1107-1113 (IGR: 19-2)


76017 A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Tanito M
Journal of Ophthalmology 2018; 2018: 8941489 (IGR: 19-2)


75336 The Future of Imaging in Detecting Glaucoma Progression
Wollstein G
Ophthalmology 2017; 124: S76-S82 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Tachibana G
Scientific reports 2017; 7: 15048 (IGR: 19-2)


75130 Risk Factors Associated With Glaucomatous Progression in Pseudoexfoliation Patients
Kim JM
Journal of Glaucoma 2017; 26: 1107-1113 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Woolson S
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75336 The Future of Imaging in Detecting Glaucoma Progression
Tauber J
Ophthalmology 2017; 124: S76-S82 (IGR: 19-2)


75398 Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?
Shi W
Journal of Glaucoma 2018; 27: 1-6 (IGR: 19-2)


75451 Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods
Van Oyen MP
Ophthalmology 2018; 125: 569-577 (IGR: 19-2)


75544 Impact of optic disc hemorrhage on subsequent glaucoma progression in mild-to-moderate myopia
Jeoung JW
PLoS ONE 2017; 12: e0189706 (IGR: 19-2)


75703 SITA-Standard perimetry has better performance than FDT2 matrix perimetry for detecting glaucomatous progression
Zamba KD
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)


75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Mardin CY
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Cioffi GA
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


76017 A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Yokoyama Y
Journal of Ophthalmology 2018; 2018: 8941489 (IGR: 19-2)


75451 Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods
Andrews C
Ophthalmology 2018; 125: 569-577 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Coffman C
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75544 Impact of optic disc hemorrhage on subsequent glaucoma progression in mild-to-moderate myopia
Park KH
PLoS ONE 2017; 12: e0189706 (IGR: 19-2)


76017 A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Nitta K
Journal of Ophthalmology 2018; 2018: 8941489 (IGR: 19-2)


75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Laemmer R
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Girkin CA
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Inoue S
Scientific reports 2017; 7: 15048 (IGR: 19-2)


75336 The Future of Imaging in Detecting Glaucoma Progression
Schuman JS
Ophthalmology 2017; 124: S76-S82 (IGR: 19-2)


75398 Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?
Feuer WJ
Journal of Glaucoma 2018; 27: 1-6 (IGR: 19-2)


75130 Risk Factors Associated With Glaucomatous Progression in Pseudoexfoliation Patients
Shim SH
Journal of Glaucoma 2017; 26: 1107-1113 (IGR: 19-2)


75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Horn FK
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)


75451 Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods
Stein JD
Ophthalmology 2018; 125: 569-577 (IGR: 19-2)


76017 A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Katai M
Journal of Ophthalmology 2018; 2018: 8941489 (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Medeiros FA
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


75130 Risk Factors Associated With Glaucomatous Progression in Pseudoexfoliation Patients
Yoo C
Journal of Glaucoma 2017; 26: 1107-1113 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Ohigashi T
Scientific reports 2017; 7: 15048 (IGR: 19-2)


75398 Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?
Abreu AR
Journal of Glaucoma 2018; 27: 1-6 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Allingham RR
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75130 Risk Factors Associated With Glaucomatous Progression in Pseudoexfoliation Patients
Park JH
Journal of Glaucoma 2017; 26: 1107-1113 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Shieh C
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Kruse FE
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Otsuka N
Scientific reports 2017; 7: 15048 (IGR: 19-2)


75398 Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?
Chediak AD
Journal of Glaucoma 2018; 27: 1-6 (IGR: 19-2)


76017 A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Omodaka K
Journal of Ophthalmology 2018; 2018: 8941489 (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Weinreb RN
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


76017 A Small Disc Area Is a Risk Factor for Visual Field Loss Progression in Primary Open-Angle Glaucoma: The Glaucoma Stereo Analysis Study
Nakazawa T
Journal of Ophthalmology 2018; 2018: 8941489 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Kurashima H
Scientific reports 2017; 7: 15048 (IGR: 19-2)


75358 The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis
Muir KW
Ophthalmic Epidemiology 2018; 25: 207-214 (IGR: 19-2)


75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Schrems WA
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Zangwill LM
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


75398 Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?
Greenfield DS
Journal of Glaucoma 2018; 27: 1-6 (IGR: 19-2)


75682 Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss
Liebmann JM
American Journal of Ophthalmology 2018; 187: 92-98 (IGR: 19-2)


75271 Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma
Santo K; Hashimoto M; Shibahara H; Hirukawa M; Sugiyama K
Scientific reports 2017; 7: 15048 (IGR: 19-2)


74720 Optic Disc Image Subtraction as an Aid to Detect Glaucoma Progression
Amini N
Translational vision science & technology 2017; 6: 14 (IGR: 19-1)


74061 Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?
Anderson AJ
Ophthalmology 2017; 124: 1735-1742 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Cirineo N
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Rukmini AV
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Zhang X
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Naito T
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74408 Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
Guo C
BMC Ophthalmology 2017; 17: 170 (IGR: 19-1)


74215 Change in Visual Field Progression Following Treatment Escalation in Primary Open-angle Glaucoma
Aptel F
Journal of Glaucoma 2017; 26: 875-880 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Salonikiou A
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74453 5-year disease progression of patients across the glaucoma spectrum assessed by structural and functional tools
Seth NG
British Journal of Ophthalmology 2018; 102: 802-807 (IGR: 19-1)


74219 Glaucoma progression detection with frequency doubling technology (FDT) compared to standard automated perimetry (SAP) in the Groningen Longitudinal Glaucoma Study
Wesselink C
Ophthalmic and Physiological Optics 2017; 37: 594-601 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Najjar RP
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74408 Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
Wu Y
BMC Ophthalmology 2017; 17: 170 (IGR: 19-1)


74219 Glaucoma progression detection with frequency doubling technology (FDT) compared to standard automated perimetry (SAP) in the Groningen Longitudinal Glaucoma Study
Jansonius NM
Ophthalmic and Physiological Optics 2017; 37: 594-601 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Founti P
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74061 Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?
Bedggood PA
Ophthalmology 2017; 124: 1735-1742 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Dastiridou A
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Fujiwara M
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74720 Optic Disc Image Subtraction as an Aid to Detect Glaucoma Progression
Alizadeh R
Translational vision science & technology 2017; 6: 14 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Morales E
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74453 5-year disease progression of patients across the glaucoma spectrum assessed by structural and functional tools
Kaushik S
British Journal of Ophthalmology 2018; 102: 802-807 (IGR: 19-1)


74215 Change in Visual Field Progression Following Treatment Escalation in Primary Open-angle Glaucoma
Bron AM; Lachkar Y
Journal of Glaucoma 2017; 26: 875-880 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Atalay E
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74453 5-year disease progression of patients across the glaucoma spectrum assessed by structural and functional tools
Kaur S
British Journal of Ophthalmology 2018; 102: 802-807 (IGR: 19-1)


74720 Optic Disc Image Subtraction as an Aid to Detect Glaucoma Progression
Parivisutt N
Translational vision science & technology 2017; 6: 14 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Francis BA
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74061 Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?
George Kong YX
Ophthalmology 2017; 124: 1735-1742 (IGR: 19-1)


74408 Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
Xu L
BMC Ophthalmology 2017; 17: 170 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Miki T
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Kilintzis V
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Lee JM
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74453 5-year disease progression of patients across the glaucoma spectrum assessed by structural and functional tools
Raj S
British Journal of Ophthalmology 2018; 102: 802-807 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Sharma S
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74720 Optic Disc Image Subtraction as an Aid to Detect Glaucoma Progression
Kim E
Translational vision science & technology 2017; 6: 14 (IGR: 19-1)


74215 Change in Visual Field Progression Following Treatment Escalation in Primary Open-angle Glaucoma
Schweitzer C
Journal of Glaucoma 2017; 26: 875-880 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Antoniadis A
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Ramanathan M
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74408 Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
Li M
BMC Ophthalmology 2017; 17: 170 (IGR: 19-1)


74061 Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?
Martin KR
Ophthalmology 2017; 124: 1735-1742 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Tan O
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Araki R; Fujiwara A
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74408 Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
Wang Z
BMC Ophthalmology 2017; 17: 170 (IGR: 19-1)


74061 Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?
Vingrys AJ
Ophthalmology 2017; 124: 1735-1742 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Varma R
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Lock JZ
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Anastasopoulos E
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Hirunpatravong P
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74453 5-year disease progression of patients across the glaucoma spectrum assessed by structural and functional tools
Pandav SS
British Journal of Ophthalmology 2018; 102: 802-807 (IGR: 19-1)


74720 Optic Disc Image Subtraction as an Aid to Detect Glaucoma Progression
Nouri-Mahdavi K
Translational vision science & technology 2017; 6: 14 (IGR: 19-1)


74408 Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
Ni N
BMC Ophthalmology 2017; 17: 170 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Shiode Y
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Baskaran M
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74720 Optic Disc Image Subtraction as an Aid to Detect Glaucoma Progression
Caprioli J
Translational vision science & technology 2017; 6: 14 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Greenfield DS
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Lin M
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Pappas T
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Capistrano V
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Raptou A
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Nongpiur M
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Morizane Y
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74408 Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
Guo W
BMC Ophthalmology 2017; 17: 170 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Schuman JS
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Topouzis F
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field
Huang D
American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Nagayama M
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Abdelmonen A
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Gooley JJ
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74487 Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field

American Journal of Ophthalmology 2017; 184: 63-74 (IGR: 19-1)


74241 Effect of trabeculectomy on visual field progression in Japanese progressive normal-tension glaucoma with intraocular pressure < 15 mmHg
Shiraga F
PLoS ONE 2017; 12: e0184096 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Yu F
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Aung T
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Nouri-Mahdavi K
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


74288 Pupillary responses to light are not affected by narrow irido-corneal angles
Milea D
Scientific reports 2017; 7: 10190 (IGR: 19-1)


74271 Expert Evaluation of Visual Field Decay in Glaucoma Correlates With the Fast Component of Visual Field Loss
Coleman AL; Caprioli J
Journal of Glaucoma 2017; 26: 902-910 (IGR: 19-1)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Aoki S
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Hood DC
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


72853 Trend-based Analysis of Ganglion Cell-Inner Plexiform Layer Thickness Changes on Optical Coherence Tomography in Glaucoma Progression
Lee WJ
Ophthalmology 2017; 124: 1383-1391 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
De Moraes CG
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


72597 Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients
Wu Z
Ophthalmology 2017; 124: 786-792 (IGR: 18-4)


72998 Using CorvisST tonometry to assess glaucoma progression
Matsuura M
PLoS ONE 2017; 12: e0176380 (IGR: 18-4)


72848 Factors Associated With Visual Field Progression in Cirrus Optical Coherence Tomography-guided Progression Analysis: A Topographic Approach
Shin JW
Journal of Glaucoma 2017; 26: 555-560 (IGR: 18-4)


72666 Visual Field Progression is Associated with Systemic Concentration of Macrophage Chemoattractant Protein-1 in Normal-Tension Glaucoma
Lee NY
Current Eye Research 2017; 42: 1002-1006 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Verma S
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


73162 Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma
Shin JW
Ophthalmology 2017; 124: 1466-1474 (IGR: 18-4)


72739 Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma
Wu Z
Investigative Ophthalmology and Visual Science 2017; 58: 1825-1833 (IGR: 18-4)


72912 Is high myopia a risk factor for visual field progression or disk hemorrhage in primary open-angle glaucoma?
Nitta K
Clinical Ophthalmology 2017; 11: 599-604 (IGR: 18-4)


72766 Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity
Germano RAS
Journal of Glaucoma 2017; 26: 586-591 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Murata H
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


72597 Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients
Saunders LJ
Ophthalmology 2017; 124: 786-792 (IGR: 18-4)


72848 Factors Associated With Visual Field Progression in Cirrus Optical Coherence Tomography-guided Progression Analysis: A Topographic Approach
Sung KR
Journal of Glaucoma 2017; 26: 555-560 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Murphy JT
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


73162 Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma
Sung KR
Ophthalmology 2017; 124: 1466-1474 (IGR: 18-4)


72766 Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity
De Moraes CG
Journal of Glaucoma 2017; 26: 586-591 (IGR: 18-4)


72853 Trend-based Analysis of Ganglion Cell-Inner Plexiform Layer Thickness Changes on Optical Coherence Tomography in Glaucoma Progression
Kim YK
Ophthalmology 2017; 124: 1383-1391 (IGR: 18-4)


72739 Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma
Lin C
Investigative Ophthalmology and Visual Science 2017; 58: 1825-1833 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Nongpiur ME
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Lee D
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


72912 Is high myopia a risk factor for visual field progression or disk hemorrhage in primary open-angle glaucoma?
Sugiyama K
Clinical Ophthalmology 2017; 11: 599-604 (IGR: 18-4)


72998 Using CorvisST tonometry to assess glaucoma progression
Hirasawa K
PLoS ONE 2017; 12: e0176380 (IGR: 18-4)


72666 Visual Field Progression is Associated with Systemic Concentration of Macrophage Chemoattractant Protein-1 in Normal-Tension Glaucoma
Kim MH
Current Eye Research 2017; 42: 1002-1006 (IGR: 18-4)


72912 Is high myopia a risk factor for visual field progression or disk hemorrhage in primary open-angle glaucoma?
Wajima R
Clinical Ophthalmology 2017; 11: 599-604 (IGR: 18-4)


72666 Visual Field Progression is Associated with Systemic Concentration of Macrophage Chemoattractant Protein-1 in Normal-Tension Glaucoma
Park CK
Current Eye Research 2017; 42: 1002-1006 (IGR: 18-4)


72998 Using CorvisST tonometry to assess glaucoma progression
Murata H
PLoS ONE 2017; 12: e0176380 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Kaplan CM
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Jarukasetphon R
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


72597 Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients
Daga FB
Ophthalmology 2017; 124: 786-792 (IGR: 18-4)


73162 Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma
Lee GC
Ophthalmology 2017; 124: 1466-1474 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Fujino Y
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


72766 Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity
Susanna R
Journal of Glaucoma 2017; 26: 586-591 (IGR: 18-4)


72853 Trend-based Analysis of Ganglion Cell-Inner Plexiform Layer Thickness Changes on Optical Coherence Tomography in Glaucoma Progression
Park KH
Ophthalmology 2017; 124: 1383-1391 (IGR: 18-4)


72848 Factors Associated With Visual Field Progression in Cirrus Optical Coherence Tomography-guided Progression Analysis: A Topographic Approach
Lee J
Journal of Glaucoma 2017; 26: 555-560 (IGR: 18-4)


72739 Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma
Crowther M
Investigative Ophthalmology and Visual Science 2017; 58: 1825-1833 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Atalay E
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


73162 Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma
Durbin MK
Ophthalmology 2017; 124: 1466-1474 (IGR: 18-4)


72853 Trend-based Analysis of Ganglion Cell-Inner Plexiform Layer Thickness Changes on Optical Coherence Tomography in Glaucoma Progression
Jeoung JW
Ophthalmology 2017; 124: 1383-1391 (IGR: 18-4)


72766 Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity
Dantas DO
Journal of Glaucoma 2017; 26: 586-591 (IGR: 18-4)


72739 Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma
Mak H
Investigative Ophthalmology and Visual Science 2017; 58: 1825-1833 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Wei X
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


72848 Factors Associated With Visual Field Progression in Cirrus Optical Coherence Tomography-guided Progression Analysis: A Topographic Approach
Kwon J
Journal of Glaucoma 2017; 26: 555-560 (IGR: 18-4)


72912 Is high myopia a risk factor for visual field progression or disk hemorrhage in primary open-angle glaucoma?
Tachibana G
Clinical Ophthalmology 2017; 11: 599-604 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Matsuura M
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


72597 Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients
Diniz-Filho A
Ophthalmology 2017; 124: 786-792 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Reimann JJ
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Nunez J
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


72998 Using CorvisST tonometry to assess glaucoma progression
Nakakura S
PLoS ONE 2017; 12: e0176380 (IGR: 18-4)


72739 Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma
Yu M
Investigative Ophthalmology and Visual Science 2017; 58: 1825-1833 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Husain R
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Miki A
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


73162 Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma
Cheng D
Ophthalmology 2017; 124: 1466-1474 (IGR: 18-4)


72597 Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients
Medeiros FA
Ophthalmology 2017; 124: 786-792 (IGR: 18-4)


72766 Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity
Neto EDS
Journal of Glaucoma 2017; 26: 586-591 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Mavrommatis MA
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


72998 Using CorvisST tonometry to assess glaucoma progression
Kiuchi Y
PLoS ONE 2017; 12: e0176380 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Skaat A
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Rosen RB
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Tanito M
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


72739 Impact of Rates of Change of Lamina Cribrosa and Optic Nerve Head Surface Depths on Visual Field Progression in Glaucoma
Leung CK
Investigative Ophthalmology and Visual Science 2017; 58: 1825-1833 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Goh D
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


72998 Using CorvisST tonometry to assess glaucoma progression
Asaoka R
PLoS ONE 2017; 12: e0176380 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Blumberg DM; Al-Aswad L
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Perera SA
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Ritch R
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Mizoue S
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Dubra A
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Cioffi GA
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


72776 Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis
Aung T
Ophthalmology 2017; 124: 1065-1071 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Mori K
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


73464 Progression of Local Glaucomatous Damage Near Fixation as Seen with Adaptive Optics Imaging
Chui TYP
Translational vision science & technology 2017; 6: 6 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Girkin CA
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Suzuki K; Yamashita T
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Medeiros FA; Weinreb RN
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Kashiwagi K
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Zangwill L
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Hirasawa K
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


73046 β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study
Liebmann JM
JAMA ophthalmology 2017; 135: 617-623 (IGR: 18-4)


72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma
Shoji N; Asaoka R
British Journal of Ophthalmology 2017; 101: 1658-1665 (IGR: 18-4)


71410 Trend-Based Progression Analysis for Examination of the Topography of Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma
Lin C
JAMA ophthalmology 2017; 135: 189-195 (IGR: 18-3)


71299 The usefulness of CorvisST Tonometry and the Ocular Response Analyzer to assess the progression of glaucoma
Matsuura M
Scientific reports 2017; 7: 40798 (IGR: 18-3)


71364 Detecting change using standard global perimetric indices in glaucoma
Gardiner SK
American Journal of Ophthalmology 2017; 176: 148-156 (IGR: 18-3)


71010 Progressive Retinal Nerve Fiber Layer Atrophy Associated With Enlarging Peripapillary Pit
Lee EJ
Journal of Glaucoma 2017; 26: e79-e81 (IGR: 18-3)


71569 Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
Bae HW
Canadian Journal of Ophthalmology 2017; 52: 107-113 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
Moreno-Montañés J
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


71411 Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach
Bryan SR
Statistics in Medicine 2017; 36: 1735-1753 (IGR: 18-3)


71539 Sustained Resolution of Macular Retinoschisis After Trabeculectomy in a Patient With Progressive Glaucoma
Woo R
Journal of Glaucoma 2017; 26: e180-e186 (IGR: 18-3)


71340 Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?
Schrems WA
Journal of Glaucoma 2017; 26: 373-382 (IGR: 18-3)


71113 Applying "Lasso" Regression to Predict Future Glaucomatous Visual Field Progression in the Central 10 Degrees
Fujino Y
Journal of Glaucoma 2017; 26: 113-118 (IGR: 18-3)


71651 Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness
Thenappan A
Journal of Glaucoma 2017; 26: 473-477 (IGR: 18-3)


71462 24-Hour Contact Lens Sensor Monitoring of Intraocular Pressure-Related Profiles in Normal-Tension Glaucoma and Rates of Disease Progression
Hoban K
Ophthalmic Research 2017; 57: 208-215 (IGR: 18-3)


71651 Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness
De Moraes CG
Journal of Glaucoma 2017; 26: 473-477 (IGR: 18-3)


71569 Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
Seo SJ
Canadian Journal of Ophthalmology 2017; 52: 107-113 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
Antón V
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


71411 Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach
Eilers PH
Statistics in Medicine 2017; 36: 1735-1753 (IGR: 18-3)


71113 Applying "Lasso" Regression to Predict Future Glaucomatous Visual Field Progression in the Central 10 Degrees
Murata H
Journal of Glaucoma 2017; 26: 113-118 (IGR: 18-3)


71299 The usefulness of CorvisST Tonometry and the Ocular Response Analyzer to assess the progression of glaucoma
Hirasawa K
Scientific reports 2017; 7: 40798 (IGR: 18-3)


71340 Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?
Schrems-Hoesl LM
Journal of Glaucoma 2017; 26: 373-382 (IGR: 18-3)


71010 Progressive Retinal Nerve Fiber Layer Atrophy Associated With Enlarging Peripapillary Pit
Kim TW
Journal of Glaucoma 2017; 26: e79-e81 (IGR: 18-3)


71462 24-Hour Contact Lens Sensor Monitoring of Intraocular Pressure-Related Profiles in Normal-Tension Glaucoma and Rates of Disease Progression
Peden R
Ophthalmic Research 2017; 57: 208-215 (IGR: 18-3)


71410 Trend-Based Progression Analysis for Examination of the Topography of Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma
Mak H
JAMA ophthalmology 2017; 135: 189-195 (IGR: 18-3)


71364 Detecting change using standard global perimetric indices in glaucoma
Demirel S
American Journal of Ophthalmology 2017; 176: 148-156 (IGR: 18-3)


71539 Sustained Resolution of Macular Retinoschisis After Trabeculectomy in a Patient With Progressive Glaucoma
Akil H
Journal of Glaucoma 2017; 26: e180-e186 (IGR: 18-3)


71299 The usefulness of CorvisST Tonometry and the Ocular Response Analyzer to assess the progression of glaucoma
Murata H
Scientific reports 2017; 7: 40798 (IGR: 18-3)


71113 Applying "Lasso" Regression to Predict Future Glaucomatous Visual Field Progression in the Central 10 Degrees
Mayama C
Journal of Glaucoma 2017; 26: 113-118 (IGR: 18-3)


71462 24-Hour Contact Lens Sensor Monitoring of Intraocular Pressure-Related Profiles in Normal-Tension Glaucoma and Rates of Disease Progression
Megaw R
Ophthalmic Research 2017; 57: 208-215 (IGR: 18-3)


71410 Trend-Based Progression Analysis for Examination of the Topography of Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma
Yu M
JAMA ophthalmology 2017; 135: 189-195 (IGR: 18-3)


71539 Sustained Resolution of Macular Retinoschisis After Trabeculectomy in a Patient With Progressive Glaucoma
Koulisis N
Journal of Glaucoma 2017; 26: e180-e186 (IGR: 18-3)


71651 Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness
Wang DL
Journal of Glaucoma 2017; 26: 473-477 (IGR: 18-3)


71340 Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?
Mardin CY
Journal of Glaucoma 2017; 26: 373-382 (IGR: 18-3)


71569 Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
Lee SY
Canadian Journal of Ophthalmology 2017; 52: 107-113 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
Antón A
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


71411 Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach
Rosmalen JV
Statistics in Medicine 2017; 36: 1735-1753 (IGR: 18-3)


71539 Sustained Resolution of Macular Retinoschisis After Trabeculectomy in a Patient With Progressive Glaucoma
Olmos de Koo LC
Journal of Glaucoma 2017; 26: e180-e186 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
Larrosa JM
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


71340 Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?
Laemmer R
Journal of Glaucoma 2017; 26: 373-382 (IGR: 18-3)


71462 24-Hour Contact Lens Sensor Monitoring of Intraocular Pressure-Related Profiles in Normal-Tension Glaucoma and Rates of Disease Progression
Halpin P
Ophthalmic Research 2017; 57: 208-215 (IGR: 18-3)


71410 Trend-Based Progression Analysis for Examination of the Topography of Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma
Leung CK
JAMA ophthalmology 2017; 135: 189-195 (IGR: 18-3)


71299 The usefulness of CorvisST Tonometry and the Ocular Response Analyzer to assess the progression of glaucoma
Nakakura S
Scientific reports 2017; 7: 40798 (IGR: 18-3)


71651 Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness
Xin D
Journal of Glaucoma 2017; 26: 473-477 (IGR: 18-3)


71569 Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
Lee YH
Canadian Journal of Ophthalmology 2017; 52: 107-113 (IGR: 18-3)


71411 Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach
Rizopoulos D
Statistics in Medicine 2017; 36: 1735-1753 (IGR: 18-3)


71113 Applying "Lasso" Regression to Predict Future Glaucomatous Visual Field Progression in the Central 10 Degrees
Matsuo H
Journal of Glaucoma 2017; 26: 113-118 (IGR: 18-3)


71340 Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?
Kruse FE
Journal of Glaucoma 2017; 26: 373-382 (IGR: 18-3)


71651 Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness
Jarukasetphon R
Journal of Glaucoma 2017; 26: 473-477 (IGR: 18-3)


71539 Sustained Resolution of Macular Retinoschisis After Trabeculectomy in a Patient With Progressive Glaucoma
Tan JC
Journal of Glaucoma 2017; 26: e180-e186 (IGR: 18-3)


71411 Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach
Vermeer KA
Statistics in Medicine 2017; 36: 1735-1753 (IGR: 18-3)


71462 24-Hour Contact Lens Sensor Monitoring of Intraocular Pressure-Related Profiles in Normal-Tension Glaucoma and Rates of Disease Progression
Tatham AJ
Ophthalmic Research 2017; 57: 208-215 (IGR: 18-3)


71569 Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
Hong S
Canadian Journal of Ophthalmology 2017; 52: 107-113 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
Martinez-de-la-Casa JM
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


71299 The usefulness of CorvisST Tonometry and the Ocular Response Analyzer to assess the progression of glaucoma
Kiuchi Y
Scientific reports 2017; 7: 40798 (IGR: 18-3)


71113 Applying "Lasso" Regression to Predict Future Glaucomatous Visual Field Progression in the Central 10 Degrees
Asaoka R
Journal of Glaucoma 2017; 26: 113-118 (IGR: 18-3)


71411 Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach
Lemij HG
Statistics in Medicine 2017; 36: 1735-1753 (IGR: 18-3)


71569 Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
Seong GJ
Canadian Journal of Ophthalmology 2017; 52: 107-113 (IGR: 18-3)


71299 The usefulness of CorvisST Tonometry and the Ocular Response Analyzer to assess the progression of glaucoma
Asaoka R
Scientific reports 2017; 7: 40798 (IGR: 18-3)


71651 Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness
Ritch R
Journal of Glaucoma 2017; 26: 473-477 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
Rebolleda G
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


71340 Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?
Horn FK
Journal of Glaucoma 2017; 26: 373-382 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
Ussa F
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


71411 Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach
Lesaffre EM
Statistics in Medicine 2017; 36: 1735-1753 (IGR: 18-3)


71651 Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness
Hood DC
Journal of Glaucoma 2017; 26: 473-477 (IGR: 18-3)


71569 Risk factors for visual field progression of normal-tension glaucoma in patients with myopia
Kim CY
Canadian Journal of Ophthalmology 2017; 52: 107-113 (IGR: 18-3)


71581 Intraobserver and Interobserver Agreement of Structural and Functional Software Programs for Measuring Glaucoma Progression
García-Granero M
JAMA ophthalmology 2017; 135: 313-319 (IGR: 18-3)


70716 Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression
Sharon Y
Ocular Immunology and Inflammation 2016; 0: 1-8 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Asaoka R
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70416 The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma
Kim SH
PLoS ONE 2016; 11: e0164876 (IGR: 18-2)


70122 The retest distribution of the visual field summary index mean deviation is close to normal
Anderson AJ
Ophthalmic and Physiological Optics 2016; 36: 558-565 (IGR: 18-2)


70478 Rates of glaucomatous visual field change after trabeculectomy
Baril C
British Journal of Ophthalmology 2017; 101: 874-878 (IGR: 18-2)


69949 Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucoma
Din NM
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2439-2448 (IGR: 18-2)


70077 The relationship between self-reported habitual exercise and visual field defect progression: a retrospective cohort study
Yokota S
BMC Ophthalmology 2016; 16: 147 (IGR: 18-2)


70670 Estimating OCT Structural Measurement Floors to Improve Detection of Progression In Advanced Glaucoma
Bowd C
American Journal of Ophthalmology 2017; 175: 37-44 (IGR: 18-2)


70412 Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma
De Moraes CG
Progress in Retinal and Eye Research 2017; 56: 107-147 (IGR: 18-2)


70404 Lack of Visual Field Improvement After Initiation of Intraocular Pressure Reducing Treatment in the Early Manifest Glaucoma Trial
Bengtsson B
Investigative Ophthalmology and Visual Science 2016; 57: 5611-5615 (IGR: 18-2)


70174 Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma
Perdicchi A
Clinical Ophthalmology 2016; 10: 1647-1651 (IGR: 18-2)


70456 Glaucoma Progression in the Unaffected Fellow Eye of Glaucoma Patients Who Developed Unilateral Branch Retinal Vein Occlusion
Lopilly Park HY
American Journal of Ophthalmology 2017; 175: 194-200 (IGR: 18-2)


70551 Significant Glaucomatous Visual Field Progression in the First Two Years: What Does It Mean?
Anderson AJ
Translational vision science & technology 2016; 5: 1 (IGR: 18-2)


70089 A novel method to predict visual field progression more accurately, using intraocular pressure measurements in glaucoma patients

Scientific reports 2016; 6: 31728 (IGR: 18-2)


70334 Optic disc tilt direction affects regional visual field progression rates in myopic eyes with open-angle glaucoma
Lee JR
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2267-2276 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Zhang X
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70899 Association of Myopic Deformation of Optic Disc with Visual Field Progression in Paired Eyes with Open-Angle Glaucoma
Sawada Y
PLoS ONE 2017; 12: e0170733 (IGR: 18-2)


70268 Developing new automated alternation flicker using optic disc photography for the detection of glaucoma progression
Ahn J
Eye 2017; 31: 119-126 (IGR: 18-2)


70174 Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma
Abdolrahimzadeh S
Clinical Ophthalmology 2016; 10: 1647-1651 (IGR: 18-2)


70404 Lack of Visual Field Improvement After Initiation of Intraocular Pressure Reducing Treatment in the Early Manifest Glaucoma Trial
Heijl A
Investigative Ophthalmology and Visual Science 2016; 57: 5611-5615 (IGR: 18-2)


70268 Developing new automated alternation flicker using optic disc photography for the detection of glaucoma progression
Yun IS
Eye 2017; 31: 119-126 (IGR: 18-2)


70899 Association of Myopic Deformation of Optic Disc with Visual Field Progression in Paired Eyes with Open-Angle Glaucoma
Hangai M
PLoS ONE 2017; 12: e0170733 (IGR: 18-2)


69949 Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucoma
Talat L
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2439-2448 (IGR: 18-2)


70122 The retest distribution of the visual field summary index mean deviation is close to normal
Cheng AC
Ophthalmic and Physiological Optics 2016; 36: 558-565 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Murata H
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70416 The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma
Lee EJ
PLoS ONE 2016; 11: e0164876 (IGR: 18-2)


70077 The relationship between self-reported habitual exercise and visual field defect progression: a retrospective cohort study
Takihara Y
BMC Ophthalmology 2016; 16: 147 (IGR: 18-2)


70412 Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma
Liebmann JM
Progress in Retinal and Eye Research 2017; 56: 107-147 (IGR: 18-2)


70670 Estimating OCT Structural Measurement Floors to Improve Detection of Progression In Advanced Glaucoma
Zangwill LM
American Journal of Ophthalmology 2017; 175: 37-44 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Dastiridou A
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70456 Glaucoma Progression in the Unaffected Fellow Eye of Glaucoma Patients Who Developed Unilateral Branch Retinal Vein Occlusion
Jeon S
American Journal of Ophthalmology 2017; 175: 194-200 (IGR: 18-2)


70478 Rates of glaucomatous visual field change after trabeculectomy
Vianna JR
British Journal of Ophthalmology 2017; 101: 874-878 (IGR: 18-2)


70716 Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression
Friling R
Ocular Immunology and Inflammation 2016; 0: 1-8 (IGR: 18-2)


70334 Optic disc tilt direction affects regional visual field progression rates in myopic eyes with open-angle glaucoma
Lee J
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2267-2276 (IGR: 18-2)


70268 Developing new automated alternation flicker using optic disc photography for the detection of glaucoma progression
Yoo HG
Eye 2017; 31: 119-126 (IGR: 18-2)


70899 Association of Myopic Deformation of Optic Disc with Visual Field Progression in Paired Eyes with Open-Angle Glaucoma
Ishikawa M
PLoS ONE 2017; 12: e0170733 (IGR: 18-2)


70456 Glaucoma Progression in the Unaffected Fellow Eye of Glaucoma Patients Who Developed Unilateral Branch Retinal Vein Occlusion
Lee MY
American Journal of Ophthalmology 2017; 175: 194-200 (IGR: 18-2)


70334 Optic disc tilt direction affects regional visual field progression rates in myopic eyes with open-angle glaucoma
Lee JE
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2267-2276 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Francis BA
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70716 Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression
Luski M
Ocular Immunology and Inflammation 2016; 0: 1-8 (IGR: 18-2)


70478 Rates of glaucomatous visual field change after trabeculectomy
Shuba LM
British Journal of Ophthalmology 2017; 101: 874-878 (IGR: 18-2)


70670 Estimating OCT Structural Measurement Floors to Improve Detection of Progression In Advanced Glaucoma
Weinreb RN
American Journal of Ophthalmology 2017; 175: 37-44 (IGR: 18-2)


70122 The retest distribution of the visual field summary index mean deviation is close to normal
Lau S
Ophthalmic and Physiological Optics 2016; 36: 558-565 (IGR: 18-2)


70174 Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma
Cutini A
Clinical Ophthalmology 2016; 10: 1647-1651 (IGR: 18-2)


70077 The relationship between self-reported habitual exercise and visual field defect progression: a retrospective cohort study
Kimura K
BMC Ophthalmology 2016; 16: 147 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Fujino Y
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70412 Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma
Levin LA
Progress in Retinal and Eye Research 2017; 56: 107-147 (IGR: 18-2)


69949 Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucoma
Isa H
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2439-2448 (IGR: 18-2)


70416 The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma
Han JC
PLoS ONE 2016; 11: e0164876 (IGR: 18-2)


70670 Estimating OCT Structural Measurement Floors to Improve Detection of Progression In Advanced Glaucoma
Medeiros FA
American Journal of Ophthalmology 2017; 175: 37-44 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Tan O
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Hirasawa K
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70416 The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma
Sohn SW
PLoS ONE 2016; 11: e0164876 (IGR: 18-2)


70122 The retest distribution of the visual field summary index mean deviation is close to normal
Le-Pham A
Ophthalmic and Physiological Optics 2016; 36: 558-565 (IGR: 18-2)


70456 Glaucoma Progression in the Unaffected Fellow Eye of Glaucoma Patients Who Developed Unilateral Branch Retinal Vein Occlusion
Park CK
American Journal of Ophthalmology 2017; 175: 194-200 (IGR: 18-2)


70716 Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression
Campoverde BQ
Ocular Immunology and Inflammation 2016; 0: 1-8 (IGR: 18-2)


70334 Optic disc tilt direction affects regional visual field progression rates in myopic eyes with open-angle glaucoma
Lee JY
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2267-2276 (IGR: 18-2)


70268 Developing new automated alternation flicker using optic disc photography for the detection of glaucoma progression
Choi JJ
Eye 2017; 31: 119-126 (IGR: 18-2)


70899 Association of Myopic Deformation of Optic Disc with Visual Field Progression in Paired Eyes with Open-Angle Glaucoma
Yoshitomi T
PLoS ONE 2017; 12: e0170733 (IGR: 18-2)


69949 Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucoma
Tomkins-Netzer O
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2439-2448 (IGR: 18-2)


70478 Rates of glaucomatous visual field change after trabeculectomy
Rafuse PE
British Journal of Ophthalmology 2017; 101: 874-878 (IGR: 18-2)


70174 Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma
Ciarnella A
Clinical Ophthalmology 2016; 10: 1647-1651 (IGR: 18-2)


70077 The relationship between self-reported habitual exercise and visual field defect progression: a retrospective cohort study
Takamura Y
BMC Ophthalmology 2016; 16: 147 (IGR: 18-2)


70122 The retest distribution of the visual field summary index mean deviation is close to normal
Liu V
Ophthalmic and Physiological Optics 2016; 36: 558-565 (IGR: 18-2)


70077 The relationship between self-reported habitual exercise and visual field defect progression: a retrospective cohort study
Inatani M
BMC Ophthalmology 2016; 16: 147 (IGR: 18-2)


70670 Estimating OCT Structural Measurement Floors to Improve Detection of Progression In Advanced Glaucoma
Belghith A
American Journal of Ophthalmology 2017; 175: 37-44 (IGR: 18-2)


70268 Developing new automated alternation flicker using optic disc photography for the detection of glaucoma progression
Lee M
Eye 2017; 31: 119-126 (IGR: 18-2)


70478 Rates of glaucomatous visual field change after trabeculectomy
Chauhan BC
British Journal of Ophthalmology 2017; 101: 874-878 (IGR: 18-2)


69949 Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucoma
Barton K
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2439-2448 (IGR: 18-2)


70416 The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma
Rhee T
PLoS ONE 2016; 11: e0164876 (IGR: 18-2)


70174 Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma
Scuderi GL
Clinical Ophthalmology 2016; 10: 1647-1651 (IGR: 18-2)


70716 Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression
Amer R
Ocular Immunology and Inflammation 2016; 0: 1-8 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Tanito M
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70334 Optic disc tilt direction affects regional visual field progression rates in myopic eyes with open-angle glaucoma
Kook MS
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2267-2276 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Varma R
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70478 Rates of glaucomatous visual field change after trabeculectomy
Nicolela MT
British Journal of Ophthalmology 2017; 101: 874-878 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Greenfield DS
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Mizoue S
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70716 Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression
Kramer M
Ocular Immunology and Inflammation 2016; 0: 1-8 (IGR: 18-2)


69949 Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucoma
Lightman S
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 2439-2448 (IGR: 18-2)


70416 The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma
Kee C
PLoS ONE 2016; 11: e0164876 (IGR: 18-2)


70122 The retest distribution of the visual field summary index mean deviation is close to normal
Rahman F
Ophthalmic and Physiological Optics 2016; 36: 558-565 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Mori K
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Schuman JS; Sehi M
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Suzuki K
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Chopra V
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Yamashita T; Kashiwagi K
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Huang D;
American Journal of Ophthalmology 2016; 172: 94-103 (IGR: 18-2)


70729 Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors
Miki A; Shoji N;
British Journal of Ophthalmology 2017; 101: 1071-1075 (IGR: 18-2)


69189 Visual Field Progression Pattern Associated With Optic Disc Tilt Morphology in Myopic Open-Angle Glaucoma
Han JC
American Journal of Ophthalmology 2016; 169: 33-45 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Pleet A
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69385 Integrating independent spatio-temporal replications to assess population trends in disease spread
VanBuren J
Statistics in Medicine 2016; 35: 5210-5221 (IGR: 18-1)


69337 Factors Associated with Loss of Visual Function in Medically Treated Advanced Normal Tension Glaucoma
Kim S
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)


69454 Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed
Hong Y
International Journal of Ophthalmology 2016; 9: 973-978 (IGR: 18-1)


69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Hirooka K
Medicine 2016; 95: e4209 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Moore NA
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Naito T
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


68923 Optic Disc Rotation as a Clue for Predicting Visual Field Progression in Myopic Normal-Tension Glaucoma
Sung MS
Ophthalmology 2016; 123: 1484-1493 (IGR: 18-1)


69470 Effect of Glaucoma Surgery on the Progression Rate and Pattern in Glaucoma Patients With Myopia
Park HY
Investigative Ophthalmology and Visual Science 2016; 57: 4170-4179 (IGR: 18-1)


69489 Maladaptive coping strategies and glaucoma progression
Freeman EE
Medicine 2016; 95: e4761 (IGR: 18-1)


69126 Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma
Baig S
JAMA ophthalmology 2016; 134: 880-886 (IGR: 18-1)


69493 A Statistical Model to Analyze Clinician Expert Consensus on Glaucoma Progression using Spatially Correlated Visual Field Data
Warren JL
Translational vision science & technology 2016; 5: 14 (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Abe RY
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69470 Effect of Glaucoma Surgery on the Progression Rate and Pattern in Glaucoma Patients With Myopia
Yi R
Investigative Ophthalmology and Visual Science 2016; 57: 4170-4179 (IGR: 18-1)


69454 Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed
Shoji N
International Journal of Ophthalmology 2016; 9: 973-978 (IGR: 18-1)


69489 Maladaptive coping strategies and glaucoma progression
Lesk MR
Medicine 2016; 95: e4761 (IGR: 18-1)


69126 Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma
Diniz-Filho A
JAMA ophthalmology 2016; 134: 880-886 (IGR: 18-1)


69493 A Statistical Model to Analyze Clinician Expert Consensus on Glaucoma Progression using Spatially Correlated Visual Field Data
Mwanza JC
Translational vision science & technology 2016; 5: 14 (IGR: 18-1)


69189 Visual Field Progression Pattern Associated With Optic Disc Tilt Morphology in Myopic Open-Angle Glaucoma
Lee EJ
American Journal of Ophthalmology 2016; 169: 33-45 (IGR: 18-1)


69385 Integrating independent spatio-temporal replications to assess population trends in disease spread
Oleson JJ
Statistics in Medicine 2016; 35: 5210-5221 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Harris A
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Izumibata S
Medicine 2016; 95: e4209 (IGR: 18-1)


68923 Optic Disc Rotation as a Clue for Predicting Visual Field Progression in Myopic Normal-Tension Glaucoma
Kang YS
Ophthalmology 2016; 123: 1484-1493 (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Diniz-Filho A
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Yoshikawa K
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Sulewski M
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69337 Factors Associated with Loss of Visual Function in Medically Treated Advanced Normal Tension Glaucoma
Sung KR
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Zangwill LM
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Wentz S
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Mizoue S
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Salowe RJ
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69470 Effect of Glaucoma Surgery on the Progression Rate and Pattern in Glaucoma Patients With Myopia
Jung Y
Investigative Ophthalmology and Visual Science 2016; 57: 4170-4179 (IGR: 18-1)


68923 Optic Disc Rotation as a Clue for Predicting Visual Field Progression in Myopic Normal-Tension Glaucoma
Heo H
Ophthalmology 2016; 123: 1484-1493 (IGR: 18-1)


69493 A Statistical Model to Analyze Clinician Expert Consensus on Glaucoma Progression using Spatially Correlated Visual Field Data
Tanna AP
Translational vision science & technology 2016; 5: 14 (IGR: 18-1)


69454 Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed
Morita T
International Journal of Ophthalmology 2016; 9: 973-978 (IGR: 18-1)


69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Ukegawa K
Medicine 2016; 95: e4209 (IGR: 18-1)


69489 Maladaptive coping strategies and glaucoma progression
Harasymowycz P
Medicine 2016; 95: e4761 (IGR: 18-1)


69385 Integrating independent spatio-temporal replications to assess population trends in disease spread
Zamba GK
Statistics in Medicine 2016; 35: 5210-5221 (IGR: 18-1)


69189 Visual Field Progression Pattern Associated With Optic Disc Tilt Morphology in Myopic Open-Angle Glaucoma
Kim SH
American Journal of Ophthalmology 2016; 169: 33-45 (IGR: 18-1)


69126 Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma
Wu Z
JAMA ophthalmology 2016; 134: 880-886 (IGR: 18-1)


69454 Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed
Hirasawa K
International Journal of Ophthalmology 2016; 9: 973-978 (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Nanno M
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


68923 Optic Disc Rotation as a Clue for Predicting Visual Field Progression in Myopic Normal-Tension Glaucoma
Park SW
Ophthalmology 2016; 123: 1484-1493 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Verticchio Vercellin AC
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69126 Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma
Abe RY
JAMA ophthalmology 2016; 134: 880-886 (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Gracitelli CP
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69189 Visual Field Progression Pattern Associated With Optic Disc Tilt Morphology in Myopic Open-Angle Glaucoma
Kee C
American Journal of Ophthalmology 2016; 169: 33-45 (IGR: 18-1)


69470 Effect of Glaucoma Surgery on the Progression Rate and Pattern in Glaucoma Patients With Myopia
Park CK
Investigative Ophthalmology and Visual Science 2016; 57: 4170-4179 (IGR: 18-1)


69489 Maladaptive coping strategies and glaucoma progression
Desjardins D
Medicine 2016; 95: e4761 (IGR: 18-1)


69385 Integrating independent spatio-temporal replications to assess population trends in disease spread
Wall M
Statistics in Medicine 2016; 35: 5210-5221 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Fertig R
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69493 A Statistical Model to Analyze Clinician Expert Consensus on Glaucoma Progression using Spatially Correlated Visual Field Data
Budenz DL
Translational vision science & technology 2016; 5: 14 (IGR: 18-1)


69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Nitta E
Medicine 2016; 95: e4209 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Parekh P
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Marvasti AH
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Tsujikawa A
Medicine 2016; 95: e4209 (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Kimura T
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


69489 Maladaptive coping strategies and glaucoma progression
Flores V
Medicine 2016; 95: e4761 (IGR: 18-1)


69454 Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed
Matsumura K
International Journal of Ophthalmology 2016; 9: 973-978 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Salinas J
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69126 Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma
Gracitelli CP
JAMA ophthalmology 2016; 134: 880-886 (IGR: 18-1)


69489 Maladaptive coping strategies and glaucoma progression
Kamga H
Medicine 2016; 95: e4761 (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Suzumura H
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Rhodes A
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69126 Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma
Cabezas E
JAMA ophthalmology 2016; 134: 880-886 (IGR: 18-1)


69454 Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed
Kasahara M
International Journal of Ophthalmology 2016; 9: 973-978 (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Weinreb RN
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Gross J
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Umeda Y
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


69126 Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma
Medeiros FA
JAMA ophthalmology 2016; 134: 880-886 (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Baig S
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69489 Maladaptive coping strategies and glaucoma progression
Li G
Medicine 2016; 95: e4761 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Hussain RM
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Merritt Iii W
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69454 Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed
Shimizu K
International Journal of Ophthalmology 2016; 9: 973-978 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Natesh V
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Medeiros FA
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Thieme C
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Shiraga F
Clinical Ophthalmology 2016; 10: 1397-1403 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Huang J
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69154 Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years
Siesky B
British Journal of Ophthalmology 2016; 0: (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Gudiseva HV; Collins DW; Chavali VR; Tapino P; Lehman A; Regina-Gigiliotti M; Miller-Ellis E; Sankar P; Ying GS; O'Brien JM
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


66730 Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma
Diniz-Filho A
Ophthalmology 2016; 123: 754-759 (IGR: 17-4)


66937 Optical coherence tomography platforms and parameters for glaucoma diagnosis and progression
Mwanza JC
Current Opinions in Ophthalmology 2016; 27: 102-110 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Otarola F
JAMA ophthalmology 2016; 0: (IGR: 17-4)


67306 Structural and Functional Progression in the Early Manifest Glaucoma Trial
Öhnell H
Ophthalmology 2016; 123: 1173-1180 (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Yousefi S
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67575 Progression of primary open angle glaucoma in asymmetrically myopic eyes
Song MK
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1331-1337 (IGR: 17-4)


67207 Management of advanced glaucoma: characterization and monitoring
De Moraes CG
Survey of Ophthalmology 2016; 61: 597-615 (IGR: 17-4)


67425 Impact of Age and Myopia on the Rate of Visual Field Progression in Glaucoma Patients
Park HY
Medicine 2016; 95: e3500 (IGR: 17-4)


66747 Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA)
Belghith A
Investigative Ophthalmology and Visual Science 2016; 57: 675-682 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Fujino Y
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


67229 Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study
Yu M
Ophthalmology 2016; 123: 1201-1210 (IGR: 17-4)


66689 Changes in Retinal Nerve Fiber Layer Reflectance Intensity as a Predictor of Functional Progression in Glaucoma
Gardiner SK
Investigative Ophthalmology and Visual Science 2016; 57: 1221-1227 (IGR: 17-4)


66696 Association Between Peripheral Vascular Endothelial Function and Progression of Open-Angle Glaucoma
Liu CH
Medicine 2016; 95: e3055 (IGR: 17-4)


67575 Progression of primary open angle glaucoma in asymmetrically myopic eyes
Sung KR
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1331-1337 (IGR: 17-4)


67425 Impact of Age and Myopia on the Rate of Visual Field Progression in Glaucoma Patients
Hong KE
Medicine 2016; 95: e3500 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Chen A
JAMA ophthalmology 2016; 0: (IGR: 17-4)


66730 Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma
Abe RY
Ophthalmology 2016; 123: 754-759 (IGR: 17-4)


66689 Changes in Retinal Nerve Fiber Layer Reflectance Intensity as a Predictor of Functional Progression in Glaucoma
Demirel S
Investigative Ophthalmology and Visual Science 2016; 57: 1221-1227 (IGR: 17-4)


66747 Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA)
Bowd C
Investigative Ophthalmology and Visual Science 2016; 57: 675-682 (IGR: 17-4)


66937 Optical coherence tomography platforms and parameters for glaucoma diagnosis and progression
Budenz DL
Current Opinions in Ophthalmology 2016; 27: 102-110 (IGR: 17-4)


67229 Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study
Lin C
Ophthalmology 2016; 123: 1201-1210 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Asaoka R
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


66696 Association Between Peripheral Vascular Endothelial Function and Progression of Open-Angle Glaucoma
Su WW
Medicine 2016; 95: e3055 (IGR: 17-4)


67306 Structural and Functional Progression in the Early Manifest Glaucoma Trial
Heijl A
Ophthalmology 2016; 123: 1173-1180 (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Balasubramanian M
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67207 Management of advanced glaucoma: characterization and monitoring
Liebmann JM
Survey of Ophthalmology 2016; 61: 597-615 (IGR: 17-4)


67306 Structural and Functional Progression in the Early Manifest Glaucoma Trial
Brenner L
Ophthalmology 2016; 123: 1173-1180 (IGR: 17-4)


66689 Changes in Retinal Nerve Fiber Layer Reflectance Intensity as a Predictor of Functional Progression in Glaucoma
Reynaud J
Investigative Ophthalmology and Visual Science 2016; 57: 1221-1227 (IGR: 17-4)


66747 Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA)
Medeiros FA
Investigative Ophthalmology and Visual Science 2016; 57: 675-682 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Murata H
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


67229 Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study
Weinreb RN
Ophthalmology 2016; 123: 1201-1210 (IGR: 17-4)


66696 Association Between Peripheral Vascular Endothelial Function and Progression of Open-Angle Glaucoma
Shie SS
Medicine 2016; 95: e3055 (IGR: 17-4)


67425 Impact of Age and Myopia on the Rate of Visual Field Progression in Glaucoma Patients
Park CK
Medicine 2016; 95: e3500 (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Goldbaum MH
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67207 Management of advanced glaucoma: characterization and monitoring
Medeiros FA
Survey of Ophthalmology 2016; 61: 597-615 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Morales E
JAMA ophthalmology 2016; 0: (IGR: 17-4)


66730 Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma
Cho HJ
Ophthalmology 2016; 123: 754-759 (IGR: 17-4)


67575 Progression of primary open angle glaucoma in asymmetrically myopic eyes
Han S
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1331-1337 (IGR: 17-4)


66747 Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA)
Hammel N
Investigative Ophthalmology and Visual Science 2016; 57: 675-682 (IGR: 17-4)


67229 Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study
Lai G
Ophthalmology 2016; 123: 1201-1210 (IGR: 17-4)


67207 Management of advanced glaucoma: characterization and monitoring
Weinreb RN
Survey of Ophthalmology 2016; 61: 597-615 (IGR: 17-4)


67306 Structural and Functional Progression in the Early Manifest Glaucoma Trial
Anderson H
Ophthalmology 2016; 123: 1173-1180 (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Medeiros FA
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Miki A
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


66696 Association Between Peripheral Vascular Endothelial Function and Progression of Open-Angle Glaucoma
Cheng ST
Medicine 2016; 95: e3055 (IGR: 17-4)


66689 Changes in Retinal Nerve Fiber Layer Reflectance Intensity as a Predictor of Functional Progression in Glaucoma
Fortune B
Investigative Ophthalmology and Visual Science 2016; 57: 1221-1227 (IGR: 17-4)


66730 Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma
Baig S
Ophthalmology 2016; 123: 754-759 (IGR: 17-4)


67575 Progression of primary open angle glaucoma in asymmetrically myopic eyes
Lee JE
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1331-1337 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Yu F
JAMA ophthalmology 2016; 0: (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Zangwill LM
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67306 Structural and Functional Progression in the Early Manifest Glaucoma Trial
Bengtsson B
Ophthalmology 2016; 123: 1173-1180 (IGR: 17-4)


66747 Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA)
Yang Z
Investigative Ophthalmology and Visual Science 2016; 57: 675-682 (IGR: 17-4)


67229 Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study
Chiu V
Ophthalmology 2016; 123: 1201-1210 (IGR: 17-4)


67575 Progression of primary open angle glaucoma in asymmetrically myopic eyes
Yoon JY
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1331-1337 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Tanito M
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


66730 Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma
Gracitelli CP
Ophthalmology 2016; 123: 754-759 (IGR: 17-4)


66696 Association Between Peripheral Vascular Endothelial Function and Progression of Open-Angle Glaucoma
Su CW
Medicine 2016; 95: e3055 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Afifi A
JAMA ophthalmology 2016; 0: (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Mizoue S
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


66730 Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma
Medeiros FA
Ophthalmology 2016; 123: 754-759 (IGR: 17-4)


67575 Progression of primary open angle glaucoma in asymmetrically myopic eyes
Park JM
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1331-1337 (IGR: 17-4)


66696 Association Between Peripheral Vascular Endothelial Function and Progression of Open-Angle Glaucoma
Ho WJ
Medicine 2016; 95: e3055 (IGR: 17-4)


67229 Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study
Leung CK
Ophthalmology 2016; 123: 1201-1210 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Caprioli J
JAMA ophthalmology 2016; 0: (IGR: 17-4)


66747 Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA)
Weinreb RN
Investigative Ophthalmology and Visual Science 2016; 57: 675-682 (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Weinreb RN; Liebmann JM
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67575 Progression of primary open angle glaucoma in asymmetrically myopic eyes
Lee JY
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1331-1337 (IGR: 17-4)


66747 Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA)
Zangwill LM
Investigative Ophthalmology and Visual Science 2016; 57: 675-682 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Mori K
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Girkin CA
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Suzuki K; Yamashita T
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


67454 Unsupervised Gaussian Mixture-Model With Expectation Maximization for Detecting Glaucomatous Progression in Standard Automated Perimetry Visual Fields
Bowd C
Translational vision science & technology 2016; 5: 2 (IGR: 17-4)


67129 Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG)
Kashiwagi K; Shoji N;
Investigative Ophthalmology and Visual Science 2016; 57: 2012-2020 (IGR: 17-4)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Hammel N
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


66511 Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia
Yoshino T
Japanese Journal of Ophthalmology 2016; 60: 78-85 (IGR: 17-3)


66238 The Effect of Limiting the Range of Perimetric Sensitivities on Pointwise Assessment of Visual Field Progression in Glaucoma
Gardiner SK
Investigative Ophthalmology and Visual Science 2016; 57: 288-294 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Kostanyan T
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66475 Comparison of Standard Automated Perimetry, Short-Wavelength Automated Perimetry, and Frequency-Doubling Technology Perimetry to Monitor Glaucoma Progression
Hu R
Medicine 2016; 95: e2618 (IGR: 17-3)


66353 Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series
Bleisch D
BMC Ophthalmology 2015; 15: 179 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Lee CK
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66301 The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma
Abe RY
Ophthalmology 2016; 123: 552-557 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Malik R
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


65972 Persistence of Glaucoma Therapy and Visual Field Progression
De Leon JM
Journal of Glaucoma 2016; 25: e336-e339 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Yamada H
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Lee NE
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66511 Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia
Fukuchi T
Japanese Journal of Ophthalmology 2016; 60: 78-85 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
O'Leary N
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


65972 Persistence of Glaucoma Therapy and Visual Field Progression
Quek DT
Journal of Glaucoma 2016; 25: e336-e339 (IGR: 17-3)


66301 The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma
Diniz-Filho A
Ophthalmology 2016; 123: 552-557 (IGR: 17-3)


66238 The Effect of Limiting the Range of Perimetric Sensitivities on Pointwise Assessment of Visual Field Progression in Glaucoma
Swanson WH
Investigative Ophthalmology and Visual Science 2016; 57: 288-294 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Sung KR
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Akagi T
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66475 Comparison of Standard Automated Perimetry, Short-Wavelength Automated Perimetry, and Frequency-Doubling Technology Perimetry to Monitor Glaucoma Progression
Wang C
Medicine 2016; 95: e2618 (IGR: 17-3)


66353 Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series
Furrer S
BMC Ophthalmology 2015; 15: 179 (IGR: 17-3)


66489 Comparison of the Progression of High- and Low-tension Glaucoma as Determined by Two Different Criteria
Sung KR
Korean Journal of Ophthalmology 2016; 30: 40-47 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Belghith A
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


65972 Persistence of Glaucoma Therapy and Visual Field Progression
Htoon HM
Journal of Glaucoma 2016; 25: e336-e339 (IGR: 17-3)


66475 Comparison of Standard Automated Perimetry, Short-Wavelength Automated Perimetry, and Frequency-Doubling Technology Perimetry to Monitor Glaucoma Progression
Gu Y
Medicine 2016; 95: e2618 (IGR: 17-3)


66238 The Effect of Limiting the Range of Perimetric Sensitivities on Pointwise Assessment of Visual Field Progression in Glaucoma
Demirel S
Investigative Ophthalmology and Visual Science 2016; 57: 288-294 (IGR: 17-3)


66353 Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series
Funk J
BMC Ophthalmology 2015; 15: 179 (IGR: 17-3)


66489 Comparison of the Progression of High- and Low-tension Glaucoma as Determined by Two Different Criteria
Lee JY
Korean Journal of Ophthalmology 2016; 30: 40-47 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Nakanishi H
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Schuman JS
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66301 The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma
Costa VP
Ophthalmology 2016; 123: 552-557 (IGR: 17-3)


66511 Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia
Togano T
Japanese Journal of Ophthalmology 2016; 60: 78-85 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Mikelberg FS
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Bowd C
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Hong S
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Ikeda HO
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66301 The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma
Gracitelli CP
Ophthalmology 2016; 123: 552-557 (IGR: 17-3)


65972 Persistence of Glaucoma Therapy and Visual Field Progression
Tun TA
Journal of Glaucoma 2016; 25: e336-e339 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Medeiros FA
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Balazsi AG
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


66475 Comparison of Standard Automated Perimetry, Short-Wavelength Automated Perimetry, and Frequency-Doubling Technology Perimetry to Monitor Glaucoma Progression
Racette L
Medicine 2016; 95: e2618 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Ling Y
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Kang E
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66511 Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia
Sakaue Y
Japanese Journal of Ophthalmology 2016; 60: 78-85 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Lucy KA
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66301 The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma
Baig S
Ophthalmology 2016; 123: 552-557 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Rho SS
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Sharpsten L
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


66511 Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia
Seki M
Japanese Journal of Ophthalmology 2016; 60: 78-85 (IGR: 17-3)


65972 Persistence of Glaucoma Therapy and Visual Field Progression
Perera SA
Journal of Glaucoma 2016; 25: e336-e339 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Kimura Y
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Leblanc RP
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


66511 Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia
Tanaka T
Japanese Journal of Ophthalmology 2016; 60: 78-85 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Suda K
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Bilonick RA
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


65972 Persistence of Glaucoma Therapy and Visual Field Progression
Lamoureux EL
Journal of Glaucoma 2016; 25: e336-e339 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Seong GJ
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Lesk MR
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Mendoza N
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


66301 The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma
Medeiros FA
Ophthalmology 2016; 123: 552-557 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Ishikawa H
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Nicolela MT
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


65972 Persistence of Glaucoma Therapy and Visual Field Progression
Aung T
Journal of Glaucoma 2016; 25: e336-e339 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Hasegawa T
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66511 Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia
Ueda J
Japanese Journal of Ophthalmology 2016; 60: 78-85 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Tatham AJ
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Hong YJ
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Khachatryan N
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


65969 Risk Factors of Disease Progression After Cataract Surgery in Chronic Angle-closure Glaucoma Patients
Kim CY
Journal of Glaucoma 2016; 25: e372-e376 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Trope GE
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Yoshikawa M
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Kagemann L
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Liebmann JM
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4
Chauhan BC
American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Iida Y
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Lee JY
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66313 Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma
Yoshimura N
Ophthalmology 2016; 123: 542-551 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Girkin CA
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


66559 Glaucoma Structural and Functional Progression in American and Korean Cohorts
Wollstein G
Ophthalmology 2016; 123: 783-788 (IGR: 17-3)


66300 Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4

American Journal of Ophthalmology 2016; 163: 140-147.e1 (IGR: 17-3)


66267 Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes
Weinreb RN; Zangwill LM
Ophthalmology 2016; 123: 760-770 (IGR: 17-3)


61677 A Study on the Central Corneal Thickness of Primary Angle Closure and Primary Angle Closure Glaucoma and Its Effect on Visual Field Progression
Tan HK
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2015; 4: 161-165 (IGR: 17-1)


61262 Circadian Intraocular Pressure Fluctuation and Disease Progression in Primary Angle Closure Glaucoma
Tan S
Investigative Ophthalmology and Visual Science 2015; 56: 4994-5005 (IGR: 17-1)


61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Inuzuka H
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)


61529 Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma
Qiu C
PLoS ONE 2015; 10: e0133189 (IGR: 17-1)


61734 Functional disorders in the chronological progression of glaucoma
Erb C
Ophthalmologe 2015; 112: 402-409 (IGR: 17-1)


61066 Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma
Banegas SA
Journal of Glaucoma 2016; 25: e229-e235 (IGR: 17-1)


61719 Learning from healthy and stable eyes: A new approach for detection of glaucomatous progression
Belghith A
Artificial Intelligence in Medicine 2015; 64: 105-115 (IGR: 17-1)


61750 Basic biochemical processes in glaucoma progression
von Thun Und Hohenstein-Blaul N
Ophthalmologe 2015; 112: 395-401 (IGR: 17-1)


61619 Visual and structural prognosis of the untreated fellow eyes of unilateral normal tension glaucoma patients
Cho HK
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1547-1555 (IGR: 17-1)


61259 Comparison of Three Parametric Models for Glaucomatous Visual Field Progression Rate Distributions
Anderson AJ
Translational vision science & technology 2015; 4: 2 (IGR: 17-1)


61723 Central retinal artery resistive index and optical coherence tomography in assessment of glaucoma progression
Ghany AF
International Journal of Ophthalmology 2015; 8: 305-309 (IGR: 17-1)


61388 Log-gamma linear-mixed effects models for multiple outcomes with application to a longitudinal glaucoma study
Zhang P
Biometrical journal. Biometrische Zeitschrift 2015; 57: 766-776 (IGR: 17-1)


61124 Comparing glaucoma progression on 24-2 and 10-2 visual field examinations
Rao HL
PLoS ONE 2015; 10: e0127233 (IGR: 17-1)


61821 Evaluation of Visual Field Progression in Glaucoma: Quasar Regression Program and Event Analysis
Díaz-Alemán VT
Current Eye Research 2015; 0: 1-8 (IGR: 17-1)


61417 Relationship Between Daytime Variability of Blood Pressure or Ocular Perfusion Pressure and Glaucomatous Visual Field Progression
Lee J
American Journal of Ophthalmology 2015; 160: 522-537.e1 (IGR: 17-1)


61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Naito T
Clinical Ophthalmology 2015; 9: 1373-1378 (IGR: 17-1)


61118 Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma
Erdem E
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-1)


61007 The Use of Spectral-Domain Optical Coherence Tomography to Detect Glaucoma Progression
Abe RY
Open Ophthalmology Journal 2015; 9: 78-88 (IGR: 17-1)


61294 Global Visit Effects in Point-Wise Longitudinal Modeling of Glaucomatous Visual Fields
Bryan SR
Investigative Ophthalmology and Visual Science 2015; 56: 4283-4289 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Aptel F
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


61723 Central retinal artery resistive index and optical coherence tomography in assessment of glaucoma progression
Botros SM
International Journal of Ophthalmology 2015; 8: 305-309 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Aryal-Charles N
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


61619 Visual and structural prognosis of the untreated fellow eyes of unilateral normal tension glaucoma patients
Suh W
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1547-1555 (IGR: 17-1)


61262 Circadian Intraocular Pressure Fluctuation and Disease Progression in Primary Angle Closure Glaucoma
Yu M
Investigative Ophthalmology and Visual Science 2015; 56: 4994-5005 (IGR: 17-1)


61750 Basic biochemical processes in glaucoma progression
Kunst S
Ophthalmologe 2015; 112: 395-401 (IGR: 17-1)


61066 Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma
Antón A
Journal of Glaucoma 2016; 25: e229-e235 (IGR: 17-1)


61529 Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma
Qian S
PLoS ONE 2015; 10: e0133189 (IGR: 17-1)


61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Kawase K
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)


61821 Evaluation of Visual Field Progression in Glaucoma: Quasar Regression Program and Event Analysis
González-Hernández M
Current Eye Research 2015; 0: 1-8 (IGR: 17-1)


61417 Relationship Between Daytime Variability of Blood Pressure or Ocular Perfusion Pressure and Glaucomatous Visual Field Progression
Choi J
American Journal of Ophthalmology 2015; 160: 522-537.e1 (IGR: 17-1)


61677 A Study on the Central Corneal Thickness of Primary Angle Closure and Primary Angle Closure Glaucoma and Its Effect on Visual Field Progression
Ahmad Tajuddin LS
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2015; 4: 161-165 (IGR: 17-1)


61294 Global Visit Effects in Point-Wise Longitudinal Modeling of Glaucomatous Visual Fields
Eilers PH
Investigative Ophthalmology and Visual Science 2015; 56: 4283-4289 (IGR: 17-1)


61124 Comparing glaucoma progression on 24-2 and 10-2 visual field examinations
Begum VU
PLoS ONE 2015; 10: e0127233 (IGR: 17-1)


61719 Learning from healthy and stable eyes: A new approach for detection of glaucomatous progression
Bowd C
Artificial Intelligence in Medicine 2015; 64: 105-115 (IGR: 17-1)


61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Yoshikawa K
Clinical Ophthalmology 2015; 9: 1373-1378 (IGR: 17-1)


61118 Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma
Williams A
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-1)


61388 Log-gamma linear-mixed effects models for multiple outcomes with application to a longitudinal glaucoma study
Luo D
Biometrical journal. Biometrische Zeitschrift 2015; 57: 766-776 (IGR: 17-1)


61007 The Use of Spectral-Domain Optical Coherence Tomography to Detect Glaucoma Progression
Gracitelli CP
Open Ophthalmology Journal 2015; 9: 78-88 (IGR: 17-1)


61124 Comparing glaucoma progression on 24-2 and 10-2 visual field examinations
Khadka D
PLoS ONE 2015; 10: e0127233 (IGR: 17-1)


61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Mizoue S
Clinical Ophthalmology 2015; 9: 1373-1378 (IGR: 17-1)


61821 Evaluation of Visual Field Progression in Glaucoma: Quasar Regression Program and Event Analysis
Perera-Sanz D
Current Eye Research 2015; 0: 1-8 (IGR: 17-1)


61388 Log-gamma linear-mixed effects models for multiple outcomes with application to a longitudinal glaucoma study
Li P
Biometrical journal. Biometrische Zeitschrift 2015; 57: 766-776 (IGR: 17-1)


61007 The Use of Spectral-Domain Optical Coherence Tomography to Detect Glaucoma Progression
Medeiros FA
Open Ophthalmology Journal 2015; 9: 78-88 (IGR: 17-1)


61294 Global Visit Effects in Point-Wise Longitudinal Modeling of Glaucomatous Visual Fields
Lesaffre EM
Investigative Ophthalmology and Visual Science 2015; 56: 4283-4289 (IGR: 17-1)


61417 Relationship Between Daytime Variability of Blood Pressure or Ocular Perfusion Pressure and Glaucomatous Visual Field Progression
Jeong D
American Journal of Ophthalmology 2015; 160: 522-537.e1 (IGR: 17-1)


61118 Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma
Kuchar SD
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-1)


61066 Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma
Morilla A
Journal of Glaucoma 2016; 25: e229-e235 (IGR: 17-1)


61719 Learning from healthy and stable eyes: A new approach for detection of glaucomatous progression
Medeiros FA
Artificial Intelligence in Medicine 2015; 64: 105-115 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Giraud JM
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


61262 Circadian Intraocular Pressure Fluctuation and Disease Progression in Primary Angle Closure Glaucoma
Baig N
Investigative Ophthalmology and Visual Science 2015; 56: 4994-5005 (IGR: 17-1)


61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Sawada A
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)


61750 Basic biochemical processes in glaucoma progression
Pfeiffer N
Ophthalmologe 2015; 112: 395-401 (IGR: 17-1)


61619 Visual and structural prognosis of the untreated fellow eyes of unilateral normal tension glaucoma patients
Kee C
Graefe's Archive for Clinical and Experimental Ophthalmology 2015; 253: 1547-1555 (IGR: 17-1)


61723 Central retinal artery resistive index and optical coherence tomography in assessment of glaucoma progression
El-Raggal TM
International Journal of Ophthalmology 2015; 8: 305-309 (IGR: 17-1)


61529 Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma
Sun X
PLoS ONE 2015; 10: e0133189 (IGR: 17-1)


61677 A Study on the Central Corneal Thickness of Primary Angle Closure and Primary Angle Closure Glaucoma and Its Effect on Visual Field Progression
Lee MY
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2015; 4: 161-165 (IGR: 17-1)


61529 Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma
Zhou C
PLoS ONE 2015; 10: e0133189 (IGR: 17-1)


61066 Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma
Bogado M
Journal of Glaucoma 2016; 25: e229-e235 (IGR: 17-1)


61124 Comparing glaucoma progression on 24-2 and 10-2 visual field examinations
Mandal AK
PLoS ONE 2015; 10: e0127233 (IGR: 17-1)


61294 Global Visit Effects in Point-Wise Longitudinal Modeling of Glaucomatous Visual Fields
Lemij HG
Investigative Ophthalmology and Visual Science 2015; 56: 4283-4289 (IGR: 17-1)


61118 Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma
Waisbourd M
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-1)


61677 A Study on the Central Corneal Thickness of Primary Angle Closure and Primary Angle Closure Glaucoma and Its Effect on Visual Field Progression
Ismail S
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2015; 4: 161-165 (IGR: 17-1)


61262 Circadian Intraocular Pressure Fluctuation and Disease Progression in Primary Angle Closure Glaucoma
Chan PP
Investigative Ophthalmology and Visual Science 2015; 56: 4994-5005 (IGR: 17-1)


61719 Learning from healthy and stable eyes: A new approach for detection of glaucomatous progression
Balasubramanian M
Artificial Intelligence in Medicine 2015; 64: 105-115 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
El Chehab H
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


61388 Log-gamma linear-mixed effects models for multiple outcomes with application to a longitudinal glaucoma study
Sharpsten L
Biometrical journal. Biometrische Zeitschrift 2015; 57: 766-776 (IGR: 17-1)


61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Kokuzawa S
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)


61821 Evaluation of Visual Field Progression in Glaucoma: Quasar Regression Program and Event Analysis
Armas-Domínguez K
Current Eye Research 2015; 0: 1-8 (IGR: 17-1)


61417 Relationship Between Daytime Variability of Blood Pressure or Ocular Perfusion Pressure and Glaucomatous Visual Field Progression
Kim S
American Journal of Ophthalmology 2015; 160: 522-537.e1 (IGR: 17-1)


61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Nanno M
Clinical Ophthalmology 2015; 9: 1373-1378 (IGR: 17-1)


61750 Basic biochemical processes in glaucoma progression
Grus FH
Ophthalmologe 2015; 112: 395-401 (IGR: 17-1)


61417 Relationship Between Daytime Variability of Blood Pressure or Ocular Perfusion Pressure and Glaucomatous Visual Field Progression
Kook MS
American Journal of Ophthalmology 2015; 160: 522-537.e1 (IGR: 17-1)


61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Kimura T
Clinical Ophthalmology 2015; 9: 1373-1378 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Delbarre M
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Ishida K
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)


61294 Global Visit Effects in Point-Wise Longitudinal Modeling of Glaucomatous Visual Fields
Vermeer KA
Investigative Ophthalmology and Visual Science 2015; 56: 4283-4289 (IGR: 17-1)


61118 Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma
Spaeth GL
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-1)


61529 Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma
Meng F
PLoS ONE 2015; 10: e0133189 (IGR: 17-1)


61066 Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma
Ayala EM
Journal of Glaucoma 2016; 25: e229-e235 (IGR: 17-1)


61677 A Study on the Central Corneal Thickness of Primary Angle Closure and Primary Angle Closure Glaucoma and Its Effect on Visual Field Progression
Wan-Hitam WH
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2015; 4: 161-165 (IGR: 17-1)


61262 Circadian Intraocular Pressure Fluctuation and Disease Progression in Primary Angle Closure Glaucoma
Tang FY
Investigative Ophthalmology and Visual Science 2015; 56: 4994-5005 (IGR: 17-1)


61388 Log-gamma linear-mixed effects models for multiple outcomes with application to a longitudinal glaucoma study
Medeiros FA
Biometrical journal. Biometrische Zeitschrift 2015; 57: 766-776 (IGR: 17-1)


61124 Comparing glaucoma progression on 24-2 and 10-2 visual field examinations
Senthil S
PLoS ONE 2015; 10: e0127233 (IGR: 17-1)


61719 Learning from healthy and stable eyes: A new approach for detection of glaucomatous progression
Weinreb RN
Artificial Intelligence in Medicine 2015; 64: 105-115 (IGR: 17-1)


61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Yamamoto T
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)


61719 Learning from healthy and stable eyes: A new approach for detection of glaucomatous progression
Zangwill LM
Artificial Intelligence in Medicine 2015; 64: 105-115 (IGR: 17-1)


61124 Comparing glaucoma progression on 24-2 and 10-2 visual field examinations
Garudadri CS
PLoS ONE 2015; 10: e0127233 (IGR: 17-1)


61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Suzumura H
Clinical Ophthalmology 2015; 9: 1373-1378 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Chiquet C
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


61066 Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma
Fernandez-Guardiola A
Journal of Glaucoma 2016; 25: e229-e235 (IGR: 17-1)


61262 Circadian Intraocular Pressure Fluctuation and Disease Progression in Primary Angle Closure Glaucoma
Tham CC
Investigative Ophthalmology and Visual Science 2015; 56: 4994-5005 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Romanet JP
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Shiraga F
Clinical Ophthalmology 2015; 9: 1373-1378 (IGR: 17-1)


61066 Evaluation of the Retinal Nerve Fiber Layer Thickness, the Mean Deviation, and the Visual Field Index in Progressive Glaucoma
Moreno-Montañes J
Journal of Glaucoma 2016; 25: e229-e235 (IGR: 17-1)


61352 Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Renard JP
Acta Ophthalmologica 2015; 93: e615-e620 (IGR: 17-1)


60552 Effectiveness of Single-Digit IOP Targets on Decreasing Global and Localized Visual Field Progression After Filtration Surgery in Eyes With Progressive Normal-Tension Glaucoma
Iverson SM
Journal of Glaucoma 2016; 25: 408-414 (IGR: 16-4)


60405 Comparison of clinical characteristics and progression rates of bilaterally and unilaterally progressing glaucoma
Jeong D
Korean Journal of Ophthalmology 2015; 29: 40-46 (IGR: 16-4)


60495 Effect of myopia on the progression of primary open-angle glaucoma
Lee JY
Investigative Ophthalmology and Visual Science 2015; 56: 1775-1781 (IGR: 16-4)


60497 Applying 'Lasso' regression to predict future visual field progression in glaucoma patients
Fujino Y
Investigative Ophthalmology and Visual Science 2015; 56: 2334-2339 (IGR: 16-4)


60567 Comparison of visual field progression between temporally tilted disc and nontilted disc, in patients with normal tension glaucoma
Choy YJ
Eye 2015; 29: 1308-1314 (IGR: 16-4)


60256 Is Myopic Optic Disc Appearance a Risk Factor for Rapid Progression in Medically Treated Glaucomatous Eyes With Confirmed Visual Field Progression?
Lee JR
Journal of Glaucoma 2016; 25: 330-337 (IGR: 16-4)


60353 Agreement among spectral-domain optical coherence tomography, standard automated perimetry, and stereophotography in the detection of glaucoma progression
Banegas SA
Investigative Ophthalmology and Visual Science 2015; 56: 1253-1260 (IGR: 16-4)


60115 Comparison of event-based analysis of glaucoma progression assessed subjectively on visual fields and retinal nerve fibre layer attenuation measured by optical coherence tomography
Kaushik S
International Ophthalmology 2014; 0: (IGR: 16-4)


60717 Risk factors for predicting visual field progression in Chinese patients with primary open-angle glaucoma: A retrospective study
Hung KH
Journal of the Chinese Medical Association 2015; 78: 418-423 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Khachatryan N
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60488 The relationship of TP53 and GRIN2B gene polymorphisms with risk of occurrence and progression of primary open-angle glaucoma in a Polish population
Nowak A
Polish journal of pathology : official journal of the Polish Society of Pathologists 2014; 65: 313-321 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Yu L
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60461 Estimating the true distribution of visual field progression rates in glaucoma
Anderson AJ
Investigative Ophthalmology and Visual Science 2015; 56: 1603-1608 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Xie L
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60353 Agreement among spectral-domain optical coherence tomography, standard automated perimetry, and stereophotography in the detection of glaucoma progression
Antón A
Investigative Ophthalmology and Visual Science 2015; 56: 1253-1260 (IGR: 16-4)


60115 Comparison of event-based analysis of glaucoma progression assessed subjectively on visual fields and retinal nerve fibre layer attenuation measured by optical coherence tomography
Mulkutkar S
International Ophthalmology 2014; 0: (IGR: 16-4)


60256 Is Myopic Optic Disc Appearance a Risk Factor for Rapid Progression in Medically Treated Glaucomatous Eyes With Confirmed Visual Field Progression?
Kim S
Journal of Glaucoma 2016; 25: 330-337 (IGR: 16-4)


60567 Comparison of visual field progression between temporally tilted disc and nontilted disc, in patients with normal tension glaucoma
Kwun Y
Eye 2015; 29: 1308-1314 (IGR: 16-4)


60405 Comparison of clinical characteristics and progression rates of bilaterally and unilaterally progressing glaucoma
Sung KR
Korean Journal of Ophthalmology 2015; 29: 40-46 (IGR: 16-4)


60497 Applying 'Lasso' regression to predict future visual field progression in glaucoma patients
Murata H
Investigative Ophthalmology and Visual Science 2015; 56: 2334-2339 (IGR: 16-4)


60552 Effectiveness of Single-Digit IOP Targets on Decreasing Global and Localized Visual Field Progression After Filtration Surgery in Eyes With Progressive Normal-Tension Glaucoma
Schultz SK
Journal of Glaucoma 2016; 25: 408-414 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Medeiros FA
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60717 Risk factors for predicting visual field progression in Chinese patients with primary open-angle glaucoma: A retrospective study
Cheng CY
Journal of the Chinese Medical Association 2015; 78: 418-423 (IGR: 16-4)


60495 Effect of myopia on the progression of primary open-angle glaucoma
Sung KR
Investigative Ophthalmology and Visual Science 2015; 56: 1775-1781 (IGR: 16-4)


60488 The relationship of TP53 and GRIN2B gene polymorphisms with risk of occurrence and progression of primary open-angle glaucoma in a Polish population
Przybylowska-Sygut K
Polish journal of pathology : official journal of the Polish Society of Pathologists 2014; 65: 313-321 (IGR: 16-4)


60717 Risk factors for predicting visual field progression in Chinese patients with primary open-angle glaucoma: A retrospective study
Liu CJ
Journal of the Chinese Medical Association 2015; 78: 418-423 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Dai C
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60552 Effectiveness of Single-Digit IOP Targets on Decreasing Global and Localized Visual Field Progression After Filtration Surgery in Eyes With Progressive Normal-Tension Glaucoma
Shi W
Journal of Glaucoma 2016; 25: 408-414 (IGR: 16-4)


60405 Comparison of clinical characteristics and progression rates of bilaterally and unilaterally progressing glaucoma
Na JH
Korean Journal of Ophthalmology 2015; 29: 40-46 (IGR: 16-4)


60488 The relationship of TP53 and GRIN2B gene polymorphisms with risk of occurrence and progression of primary open-angle glaucoma in a Polish population
Szymanek K
Polish journal of pathology : official journal of the Polish Society of Pathologists 2014; 65: 313-321 (IGR: 16-4)


60497 Applying 'Lasso' regression to predict future visual field progression in glaucoma patients
Mayama C
Investigative Ophthalmology and Visual Science 2015; 56: 2334-2339 (IGR: 16-4)


60495 Effect of myopia on the progression of primary open-angle glaucoma
Han S
Investigative Ophthalmology and Visual Science 2015; 56: 1775-1781 (IGR: 16-4)


60256 Is Myopic Optic Disc Appearance a Risk Factor for Rapid Progression in Medically Treated Glaucomatous Eyes With Confirmed Visual Field Progression?
Lee JY
Journal of Glaucoma 2016; 25: 330-337 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Sharpsten L
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60115 Comparison of event-based analysis of glaucoma progression assessed subjectively on visual fields and retinal nerve fibre layer attenuation measured by optical coherence tomography
Pandav SS
International Ophthalmology 2014; 0: (IGR: 16-4)


60567 Comparison of visual field progression between temporally tilted disc and nontilted disc, in patients with normal tension glaucoma
Han JC
Eye 2015; 29: 1308-1314 (IGR: 16-4)


60353 Agreement among spectral-domain optical coherence tomography, standard automated perimetry, and stereophotography in the detection of glaucoma progression
Morilla-Grasa A
Investigative Ophthalmology and Visual Science 2015; 56: 1253-1260 (IGR: 16-4)


60497 Applying 'Lasso' regression to predict future visual field progression in glaucoma patients
Asaoka R
Investigative Ophthalmology and Visual Science 2015; 56: 2334-2339 (IGR: 16-4)


60495 Effect of myopia on the progression of primary open-angle glaucoma
Na JH
Investigative Ophthalmology and Visual Science 2015; 56: 1775-1781 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Bowd C
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60567 Comparison of visual field progression between temporally tilted disc and nontilted disc, in patients with normal tension glaucoma
Kee C
Eye 2015; 29: 1308-1314 (IGR: 16-4)


60552 Effectiveness of Single-Digit IOP Targets on Decreasing Global and Localized Visual Field Progression After Filtration Surgery in Eyes With Progressive Normal-Tension Glaucoma
Feuer WJ
Journal of Glaucoma 2016; 25: 408-414 (IGR: 16-4)


60115 Comparison of event-based analysis of glaucoma progression assessed subjectively on visual fields and retinal nerve fibre layer attenuation measured by optical coherence tomography
Verma N
International Ophthalmology 2014; 0: (IGR: 16-4)


60256 Is Myopic Optic Disc Appearance a Risk Factor for Rapid Progression in Medically Treated Glaucomatous Eyes With Confirmed Visual Field Progression?
Back S
Journal of Glaucoma 2016; 25: 330-337 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Xie B
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60353 Agreement among spectral-domain optical coherence tomography, standard automated perimetry, and stereophotography in the detection of glaucoma progression
Bogado M
Investigative Ophthalmology and Visual Science 2015; 56: 1253-1260 (IGR: 16-4)


60115 Comparison of event-based analysis of glaucoma progression assessed subjectively on visual fields and retinal nerve fibre layer attenuation measured by optical coherence tomography
Gupta A
International Ophthalmology 2014; 0: (IGR: 16-4)


60353 Agreement among spectral-domain optical coherence tomography, standard automated perimetry, and stereophotography in the detection of glaucoma progression
Ayala EM
Investigative Ophthalmology and Visual Science 2015; 56: 1253-1260 (IGR: 16-4)


60488 The relationship of TP53 and GRIN2B gene polymorphisms with risk of occurrence and progression of primary open-angle glaucoma in a Polish population
Szaflik J
Polish journal of pathology : official journal of the Polish Society of Pathologists 2014; 65: 313-321 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Liang M
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60552 Effectiveness of Single-Digit IOP Targets on Decreasing Global and Localized Visual Field Progression After Filtration Surgery in Eyes With Progressive Normal-Tension Glaucoma
Greenfield DS
Journal of Glaucoma 2016; 25: 408-414 (IGR: 16-4)


60256 Is Myopic Optic Disc Appearance a Risk Factor for Rapid Progression in Medically Treated Glaucomatous Eyes With Confirmed Visual Field Progression?
Lee KS
Journal of Glaucoma 2016; 25: 330-337 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Sample PA
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60256 Is Myopic Optic Disc Appearance a Risk Factor for Rapid Progression in Medically Treated Glaucomatous Eyes With Confirmed Visual Field Progression?
Kook MS
Journal of Glaucoma 2016; 25: 330-337 (IGR: 16-4)


60488 The relationship of TP53 and GRIN2B gene polymorphisms with risk of occurrence and progression of primary open-angle glaucoma in a Polish population
Majsterek I
Polish journal of pathology : official journal of the Polish Society of Pathologists 2014; 65: 313-321 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Liebmann JM
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Zhao L
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60353 Agreement among spectral-domain optical coherence tomography, standard automated perimetry, and stereophotography in the detection of glaucoma progression
Moreno-Montañes J
Investigative Ophthalmology and Visual Science 2015; 56: 1253-1260 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Girkin CA
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Yin X
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Weinreb RN
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


60704 Progressive thinning of visual cortex in primary open-angle glaucoma of varying severity
Wang J
PLoS ONE 2015; 10: e0121960 (IGR: 16-4)


60293 The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects
Miki A; Hammel N; Zangwill LM
American Journal of Ophthalmology 2015; 159: 777-787.e1 (IGR: 16-4)


59596 Longitudinal Changes in Quality of Life and Rates of Progressive Visual Field Loss in Glaucoma Patients
Medeiros FA; Gracitelli CP; Boer ER; Weinreb RN; Zangwill LM; Rosen PN
Ophthalmology 2015; 122: 293-301 (IGR: 16-3)


59076 An examination of the hypothesis that intraocular pressure elevation episodes can have prognostic significance in glaucoma suspects
McMonnies C
Journal of optometry 2015; 8: 223-231 (IGR: 16-3)


59481 Models of glaucomatous visual field loss
Chen A; Nouri-Mahdavi K; Otarola FJ; Yu F; Afifi AA; Caprioli J
Investigative Ophthalmology and Visual Science 2014; 55: 7881-7887 (IGR: 16-3)


59579 Prevalence and spatial concordance of visual field deterioration in fellow eyes of glaucoma patients
Kim MK; Lee JM; Morales E; Caprioli J
Korean Journal of Ophthalmology 2014; 28: 436-443 (IGR: 16-3)


58857 Effect of cataract extraction on the visual field decay rate in patients with glaucoma
Lee JW; Morales E; Yu F; Afifi AA; Kim EA; Abdollahi N; Nouri-Mahdavi K; Caprioli J
JAMA ophthalmology 2014; 132: 1296-1302 (IGR: 16-3)


59012 Comparison of regression models for serial visual field analysis
Lee JM; Nouri-Mahdavi K; Morales E; Afifi A; Yu F; Caprioli J
Japanese Journal of Ophthalmology 2014; 58: 504-514 (IGR: 16-3)


59413 Clustering visual field test points based on rates of progression to improve the prediction of future damage
Hirasawa K; Murata H; Hirasawa H; Mayama C; Asaoka R
Investigative Ophthalmology and Visual Science 2014; 55: 7681-7685 (IGR: 16-3)


59323 Confocal Laser Scanning Tomography to Predict Visual Field Conversion in Patients With Ocular Hypertension and Early Glaucoma
Schrems-Hoesl LM; Schrems WA; Laemmer R; Horn FK; Juenemann AG; Kruse FE; Mardin CY
Journal of Glaucoma 2016; 25: 371-376 (IGR: 16-3)


59537 Inter-test reference height variability - a major error factor in Heidelberg Retina Tomography glaucoma progression analysis based on stereometric parameters changes
Dascalu A; Stana D; Duta S; Ardeleanu I; Savlovschi C; Serban D; Cherecheanu A
Journal of medicine and life 2014; 7: 408-411 (IGR: 16-3)


59615 Predictive Value of Heidelberg Retina Tomograph Parameters for the Development of Glaucoma in the European Glaucoma Prevention Study
Miglior S; Zeyen T; Hoffmann EM; Torri V; Rulli E; Floriani I; Poli D; Aliyeva S; Cunha-Vaz J; Pfeiffer N
American Journal of Ophthalmology 2015; 159: 265-76.e1 (IGR: 16-3)


59083 Misguided progression analysis by optical coherence tomography: a report of two cases
Kennedy JB; Soohoo JR; Seibold LK; Kahook MY
Case Reports in Ophthalmology 2014; 5: 217-221 (IGR: 16-3)


59276 Use of the structure-function relationship in detecting glaucoma progression in early glaucoma
Hirooka K; Manabe S; Tenkumo K; Nitta E; Sato S; Tsujikawa A
BMC Ophthalmology 2014; 14: 118 (IGR: 16-3)


58818 Structural glaucomatous progression before and after occurrence of an optic disc haemorrhage
Chung E; Demetriades AM; Christos PJ; Radcliffe NM
British Journal of Ophthalmology 2015; 99: 21-25 (IGR: 16-3)


59542 A new approach to measure visual field progression in glaucoma patients using Variational Bayes linear regression
Murata H; Araie M; Asaoka R
Investigative Ophthalmology and Visual Science 2014; 0: (IGR: 16-3)


59404 Agreement among graders on Heidelberg retina tomograph (HRT) topographic change analysis (TCA) glaucoma progression interpretation
Iester MM; Wollstein G; Bilonick RA; Xu J; Ishikawa H; Kagemann L; Schuman JS
British Journal of Ophthalmology 2015; 99: 519-523 (IGR: 16-3)


59524 Predictive Values of Optical Coherence Tomography (OCT) Parameters in Assessment of Glaucoma progression
Kasumovic SS; Kasumovic A; Pavljasevic S; Cabric E; Mavija M; Sesar I; Lepara SD; Jankov M
Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : časopis Društva za medicinsku informatiku BiH 2014; 22: 237-240 (IGR: 16-3)


58999 Estimated rates of retinal ganglion cell loss in glaucomatous eyes with and without optic disc hemorrhages
Gracitelli CP; Tatham AJ; Zangwill LM; Weinreb RN; Liu T; Medeiros FA
PLoS ONE 2014; 9: e105611 (IGR: 16-3)


59330 Combined assessment of early-stage primary open-angle glaucoma progression
Shpak AA; Sevost'ianova MK; Usol'tseva EA; Abdusadykova AK
Vestnik Oftalmologii 2014; 130: 14-17 (IGR: 16-3)


59296 Measuring rates of structural and functional change in glaucoma
Nouri-Mahdavi K; Caprioli J
British Journal of Ophthalmology 2015; 99: 893-898 (IGR: 16-3)


59610 Long-Term Follow-up in Preperimetric Open-Angle Glaucoma: Progression Rates and Associated Factors
Kim KE; Jeoung JW; Kim DM; Ahn SJ; Park KH; Kim SH
American Journal of Ophthalmology 2015; 159: 160-168.e2 (IGR: 16-3)


59042 Perimetric progression using the Visual Field Index and the Advanced Glaucoma Intervention Study score and its clinical correlations
Gros-Otero J; Castejón M; Paz-Moreno J; Mikropoulos D; Teus M
Journal of optometry 2015; 8: 232-238 (IGR: 16-3)


59578 Influence of Lamina Cribrosa Thickness and Depth on the Rate of Progressive Retinal Nerve Fiber Layer Thinning
Lee EJ; Kim TW; Kim M; Kim H
Ophthalmology 2015; 122: 721-729 (IGR: 16-3)


59444 Prediction Accuracy of a Novel Dynamic Structure-Function Model for Glaucoma Progression
Hu R; Marín-Franch I; Racette L
Investigative Ophthalmology and Visual Science 2014; 55: 8086-8094 (IGR: 16-3)


59433 Progression of Normal-Tension Glaucoma After Ventriculoperitoneal Shunt to Decrease Cerebrospinal Fluid Pressure
Chen BH; Drucker MD; Louis KM; Richards DW
Journal of Glaucoma 2016; 25: e50-e52 (IGR: 16-3)


59206 Safety And Efficacy Of Achieving Single-Digit Intraocular Pressure Targets With Filtration Surgery In Eyes With Progressive Normal-Tension Glaucoma
Schultz SK; Iverson SM; Shi W; Greenfield DS
Journal of Glaucoma 2016; 25: 217-222 (IGR: 16-3)


58920 Retinal vessel diameter in normal-tension glaucoma patients with asymmetric progression
Lee TE; Kim YY; Yoo C
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 1795-1801 (IGR: 16-3)


58728 Disc haemorrhage is associated with the fast component, but not the slow component, of visual field decay rate in glaucoma
Kim JM; Kyung H; Azarbod P; Lee JM; Caprioli J
British Journal of Ophthalmology 2014; 98: 1555-1559 (IGR: 16-3)


59209 Prediction of Glaucomatous Visual Field Progression Using Baseline Clinical Data
Ernest PJ; Schouten JS; Beckers HJ; Hendrikse F; Prins MH; Webers CA
Journal of Glaucoma 2016; 25: 228-235 (IGR: 16-3)


57407 Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration
Sponsel WE; Groth SL; Satsangi N; Maddess T; Reilly MA
Translational vision science & technology 2014; 3: 1 (IGR: 16-2)


57338 Prediction of glaucomatous visual field progression: pointwise analysis
Shon K; Wollstein G; Schuman JS; Sung KR
Current Eye Research 2014; 39: 705-710 (IGR: 16-2)


57477 Evaluation of Octopus Polar Trend Analysis for detection of glaucomatous progression
Holló G; Naghizadeh F
European Journal of Ophthalmology 2014; 24: 862-868 (IGR: 16-2)


57335 Detection of early glaucomatous progression with octopus cluster trend analysis
Naghizadeh F; Holló G
Journal of Glaucoma 2014; 23: 269-275 (IGR: 16-2)


57378 Rates of glaucomatous visual field change in a large clinical population
Chauhan BC; Malik R; Shuba LM; Rafuse PE; Nicolela MT; Artes PH
Investigative Ophthalmology and Visual Science 2014; 55: 4135-4143 (IGR: 16-2)


56900 Frequency doubling technology perimetry for detection of visual field progression in glaucoma: a pointwise linear regression analysis
Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
Investigative Ophthalmology and Visual Science 2014; 55: 2862-2869 (IGR: 16-2)


57001 Using filtered forecasting techniques to determine personalized monitoring schedules for patients with open-angle glaucoma
Schell GJ; Lavieri MS; Helm JE; Liu X; Musch DC; Van Oyen MP; Stein JD
Ophthalmology 2014; 121: 1539-1546 (IGR: 16-2)


57118 Hierarchical cluster analysis of progression patterns in open-angle glaucoma patients with medical treatment
Bae HW; Rho S; Lee HS; Lee N; Hong S; Seong GJ; Sung KR; Kim CY
Investigative Ophthalmology and Visual Science 2014; 55: 3231-3236 (IGR: 16-2)


57293 Visual Field Progression in Glaucoma: What Is the Specificity of the Guided Progression Analysis?
Artes PH; O'Leary N; Nicolela MT; Chauhan BC; Crabb DP
Ophthalmology 2014; 121: 2023-2027 (IGR: 16-2)


57286 Portsmouth visual field database: an audit of glaucoma progression
Kirwan JF; Hustler A; Bobat H; Toms L; Crabb DP; McNaught AI
Eye 2014; 28: 974-979 (IGR: 16-2)


57277 Nocturnal Systemic Hypotension Increases the Risk of Glaucoma Progression
Charlson ME; De Moraes CG; Link A; Wells MT; Harmon G; Peterson JC; Ritch R; Liebmann JM
Ophthalmology 2014; 121: 2004-2012 (IGR: 16-2)


56979 Central visual field progression in normal-tension glaucoma patients with autonomic dysfunction
Park HY; Park SH; Park CK
Investigative Ophthalmology and Visual Science 2014; 55: 2557-2563 (IGR: 16-2)


56987 The risk of newly developed visual impairment in treated normal-tension glaucoma: 10-year follow-up
Choi YJ; Kim M; Park KH; Kim DM; Kim SH
Acta Ophthalmologica 2014; 92: e644-e649 (IGR: 16-2)


57233 Rapidly Progressing Glaucoma Associated With Monoclonal Gammopathy
Jeang LJ; Chang PT; Frankfort BJ
Journal of Glaucoma 2015; 24: e139-e141 (IGR: 16-2)


57202 Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up
Costagliola C; Romano MR; dell'Omo R; Russo A; Mastropasqua R; Semeraro F
Journal of medicinal food 2014; 17: 949-954 (IGR: 16-2)


57294 A Control Experiment for Studies that Show Improved Visual Sensitivity with Intraocular Pressure Lowering in Glaucoma
Anderson AJ; Stainer MJ
Ophthalmology 2014; 121: 2028-2032 (IGR: 16-2)


56202 Anterior lamina cribrosa surface depth, age, and visual field sensitivity in the Portland Progression Project
Ren R; Yang H; Gardiner SK; Fortune B; Hardin C; Demirel S; Burgoyne CF
Investigative Ophthalmology and Visual Science 2014; 55: 1531-1539 (IGR: 16-1)


56436 Intraocular pressure fluctuation and glaucoma progression: what do we know?
Leidl MC; Choi CJ; Syed ZA; Melki SA
British Journal of Ophthalmology 2014; 98: 1315-1319 (IGR: 16-1)


56550 A unified framework for glaucoma progression detection using Heidelberg Retina Tomograph images
Belghith A; Balasubramanian M; Bowd C; Weinreb RN; Zangwill LM
Computerized Medical Imaging and Graphics 2014; 38: 411-420 (IGR: 16-1)


56072 Diagnosing glaucoma progression with optical coherence tomography
Leung CK
Current Opinions in Ophthalmology 2014; 25: 104-111 (IGR: 16-1)


56267 Detecting glaucoma progression from localized rates of retinal changes in parametric and nonparametric statistical framework with type I error control
Balasubramanian M; Arias-Castro E; Medeiros FA; Kriegman DJ; Bowd C; Weinreb RN; Holst M; Sample PA; Zangwill LM
Investigative Ophthalmology and Visual Science 2014; 55: 1684-1695 (IGR: 16-1)


56183 A novel optic nerve photograph alignment and subtraction technique for the detection of structural progression in glaucoma
Marlow ED; McGlynn MM; Radcliffe NM
Acta Ophthalmologica 2014; 92: e267-e272 (IGR: 16-1)


56552 Learning from data: Recognizing glaucomatous defect patterns and detecting progression from visual field measurements
Yousefi S; Goldbaum M; Balasubramanian M; Medeiros F; Zangwill L; Liebmann J; Girkin C; Weinreb R; Bowd C
IEEE Transactions on Bio-Medical Engineering 2014; 61: 2112-2124 (IGR: 16-1)


56588 Analysis of risk factors for long-term glaucomatous damage development
Gross S; Gugleta K; Turksever C; Ledolter A; Kochkorov A; Flammer J; Orgul S
Klinische Monatsblätter für Augenheilkunde 2014; 231: 335-339 (IGR: 16-1)


56539 Effect of Focal Lamina Cribrosa Defect on Glaucomatous Visual Field Progression
Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
Ophthalmology 2014; 121: 1524-1530 (IGR: 16-1)


55996 Estimation of retinal ganglion cell loss in glaucomatous eyes with a relative afferent pupillary defect
Tatham AJ; Meira-Freitas D; Weinreb RN; Marvasti AH; Zangwill LM; Medeiros FA
Investigative Ophthalmology and Visual Science 2014; 55: 513-522 (IGR: 16-1)


56294 Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis
Crnej A; Paschalis EI; Salvador-Culla B; Tauber A; Drnovsek-Olup B; Shen LQ; Dohlman CH
Cornea 2014; 33: 349-354 (IGR: 16-1)


56482 Glaucoma progression detection using structural retinal nerve fiber layer measurements and functional visual field points
Yousefi S; Goldbaum MH; Balasubramanian M; Jung TP; Weinreb RN; Medeiros FA; Zangwill LM; Liebmann JM; Girkin CA; Bowd C
IEEE Transactions on Bio-Medical Engineering 2014; 61: 1143-1154 (IGR: 16-1)


56171 Preperimetric normal tension glaucoma study: long-term clinical course and effect of therapeutic lowering of intraocular pressure
Jeong JH; Park KH; Jeoung JW; Kim DM
Acta Ophthalmologica 2014; 92: e185-e193 (IGR: 16-1)


55349 Structural diagnostics of course observation for glaucoma
Mardin CY
Ophthalmologe 2013; 110: 1036-1044 (IGR: 15-4)


55586 New insights into measurement variability in glaucomatous visual fields from computer modelling
Russell RA; Garway-Heath DF; Crabb DP
PLoS ONE 2013; 8: e83595 (IGR: 15-4)


55695 Current status of visual field examination in Andalusia, Spain: The SICVA Study
Benítez-Del-Castillo J; Regi T;
European Journal of Ophthalmology 2013; 0: 0 (IGR: 15-4)


55284 Visual field progression with frequency-doubling matrix perimetry and standard automated perimetry in patients with glaucoma and in healthy controls
Redmond T; O'Leary N; Hutchison DM; Nicolela MT; Artes PH; Chauhan BC
JAMA ophthalmology 2013; 131: 1565-1572 (IGR: 15-4)


55722 Clinical significance of optic disc progression by topographic change analysis maps in glaucoma: an 8-year follow-up study
Kourkoutas D; Buys YM; Flanagan JG; Karamaounas N; Georgopoulos G; Iliakis E; Moschos MM; Trope GE
Journal of Ophthalmology 2014; 2014: 987389 (IGR: 15-4)


55179 Cross-sectional study: Does combining optical coherence tomography measurements using the 'Random Forest' decision tree classifier improve the prediction of the presence of perimetric deterioration in glaucoma suspects?
Sugimoto K; Murata H; Hirasawa H; Aihara M; Mayama C; Asaoka R
BMJ open 2013; 3: e003114 (IGR: 15-4)


55540 OCT for glaucoma diagnosis, screening and detection of glaucoma progression
Bussel II; Wollstein G; Schuman JS
British Journal of Ophthalmology 2014; 98: ii15-9 (IGR: 15-4)


55706 Study of long term structural and functional changes in medically controlled glaucoma
Pandey AN; Sujata S
International Journal of Ophthalmology 2014; 7: 128-132 (IGR: 15-4)


55436 Predicting progression of glaucoma from rates of frequency doubling technology perimetry change
Meira-Freitas D; Tatham AJ; Lisboa R; Kuang TM; Zangwill LM; Weinreb RN; Girkin CA; Liebmann JM; Medeiros FA
Ophthalmology 2014; 121: 498-507 (IGR: 15-4)


55283 Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome
Johnson TV; Dekorver NW; Levasseur VA; Osborne A; Tassoni A; Lorber B; Heller JP; Villasmil R; Bull ND; Martin KR; Tomarev SI
Brain 2014; 137: 503-519 (IGR: 15-4)


55120 Robust and censored modeling and prediction of progression in glaucomatous visual fields
Bryan SR; Vermeer KA; Eilers PH; Lemij HG; Lesaffre EM
Investigative Ophthalmology and Visual Science 2013; 54: 6694-6700 (IGR: 15-4)


55439 Defining 10-2 visual field progression criteria: exploratory and confirmatory factor analysis using pointwise linear regression
De Moraes CG; Song C; Liebmann JM; Simonson JL; Furlanetto RL; Ritch R
Ophthalmology 2014; 121: 741-749 (IGR: 15-4)


55396 Baseline thickness of macular ganglion cell complex predicts progression of visual field loss
Anraku A; Enomoto N; Takeyama A; Ito H; Tomita G
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 109-115 (IGR: 15-4)


55320 Detection of progression of glaucomatous visual field damage using the point-wise method with the binomial test
Karakawa A; Murata H; Hirasawa H; Mayama C; Asaoka R
PLoS ONE 2013; 8: e78630 (IGR: 15-4)


55546 Filtering data from the collaborative initial glaucoma treatment study for improved identification of glaucoma progression
Schell GJ; Lavieri MS; Stein JD; Musch DC
BMC Medical Informatics and Decision Making 2013; 13: 137 (IGR: 15-4)


55517 Retinal blood vessel positional shifts and glaucoma progression
Radcliffe NM; Smith SD; Syed ZA; Park SC; Ehrlich JR; De Moraes CG; Liebmann JM; Ritch R
Ophthalmology 2014; 121: 842-848 (IGR: 15-4)


55171 Discrepancy between optic disc and nerve fiber layer assessment and optical coherence tomography in detecting glaucomatous progression
Lee JR; Sung KR; Na JH; Shon K; Lee KS
Japanese Journal of Ophthalmology 2013; 57: 546-552 (IGR: 15-4)


55513 Detecting an event of progression using glaucoma probability score and the stereometric parameters of Heidelberg Retina Tomograph 3
Saarela V; Falck A; Tuulonen A
European Journal of Ophthalmology 2013; 0: 0 (IGR: 15-4)


55523 Relationship between preferred sleeping position and asymmetric visual field loss in open-angle glaucoma patients
Kim KN; Jeoung JW; Park KH; Kim DM; Ritch R
American Journal of Ophthalmology 2014; 157: 739-745 (IGR: 15-4)


55426 Arteriovenous passage times and visual field progression in normal tension glaucoma
Koch EC; Arend KO; Bienert M; Remky A; Plange N
TheScientificWorldJournal 2013; 2013: 726912 (IGR: 15-4)


55201 The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics
Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
Ophthalmology 2013; 120: 2540-2545 (IGR: 15-4)


54602 Relationship between 24-hour mean ocular perfusion pressure fluctuation and rate of paracentral visual field progression in normal-tension glaucoma
Choi J; Lee JR; Lee Y; Lee KS; Na JH; Han S; Kook MS
Investigative Ophthalmology and Visual Science 2013; 54: 6150-6157 (IGR: 15-3)


54706 The significance of intraocular pressure elevation during sleep-related postures
McMonnies CW
Clinical and Experimental Optometry 2014; 97: 221-224 (IGR: 15-3)


54583 Measuring visual field progression in the central 10 degrees using additional information from central 24 degrees visual fields and 'lasso regression'
Asaoka R
PLoS ONE 2013; 8: e72199 (IGR: 15-3)


54456 Risk factors for progressive visual field loss in primary angle-closure glaucoma: a retrospective cohort study
Fan NW; Hwang DK; Ko YC; Tseng FC; Hung KH; Liu CJ
PLoS ONE 2013; 8: e69772 (IGR: 15-3)


54842 Role of color Doppler imaging in early diagnosis and prediction of progression in glaucoma
Jimenez-Aragon F; Garcia-Martin E; Larrosa-Lopez R; Artigas-Martí,n JM; Seral-Moral P; Pablo LE
BioMed research international 2013; 2013: 871689 (IGR: 15-3)


54522 Refinement of pointwise linear regression criteria for determining glaucoma progression
Kummet CM; Zamba KD; Doyle CK; Johnson CA; Wall M
Investigative Ophthalmology and Visual Science 2013; 54: 6234-6241 (IGR: 15-3)


54797 Detecting the Progression of Eye Disease: CUSUM Charts for Assessing the Visual Field and Retinal Nerve Fiber Layer Thickness
Ledolter J; Kardon R
Translational vision science & technology 2013; 2: 2 (IGR: 15-3)


54661 Impact of Age-related Change of Retinal Nerve Fiber Layer and Macular Thicknesses on Evaluation of Glaucoma Progression
Leung CK; Ye C; Weinreb RN; Yu M; Lai G; Lam DS
Ophthalmology 2013; 120: 2485-2492 (IGR: 15-3)


54857 Determinants of severity at presentation among young patients with early onset glaucoma
Gupta V; Srivastava RM; Sihota R; Kaur J; Kumar S; Singh D
Indian Journal of Ophthalmology 2013; 61: 546-551 (IGR: 15-3)


54675 An internal medicine perspective review of risk factors for assessing and progression of primary open angle glaucoma
Actis AG; Dall'Orto L; Penna R; Brogliatti B; Rolle T
Minerva Medica 2013; 104: 471-485 (IGR: 15-3)


54761 Effects of optic disc size on progression of visual field defects in normal-tension glaucoma
Hayamizu F; Yamazaki Y
Nippon Ganka Gakkai Zasshi 2013; 117: 609-615 (IGR: 15-3)


53687 Corneal Hysteresis as a Risk Factor for Glaucoma Progression: A Prospective Longitudinal Study
Medeiros FA; Meira-Freitas D; Lisboa R; Kuang TM; Zangwill LM; Weinreb RN
Ophthalmology 2013; 120: 1533-1540 (IGR: 15-2)


53773 Parafoveal Scotoma Progression in Glaucoma: Humphrey 10-2 versus 24-2 Visual Field Analysis
Park SC; Kung Y; Su D; Simonson JL; Furlanetto RL; Liebmann JM; Ritch R
Ophthalmology 2013; 120: 1546-1550 (IGR: 15-2)


53665 Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography
Wessel JM; Horn FK; Tornow RP; Schmid M; Mardin CY; Kruse FE; Juenemann AG; Laemmer R
Investigative Ophthalmology and Visual Science 2013; 54: 3613-3620 (IGR: 15-2)


53963 Evaluation of relationship between retinal nerve fiber layer thickness progression and visual field progression in patients with glaucoma
Tenkumo K; Hirooka K; Baba T; Nitta E; Sato S; Shiraga F
Japanese Journal of Ophthalmology 2013; 0: (IGR: 15-2)


53802 Features of optic disc progression in patients with ocular hypertension and early glaucoma
Lloyd MJ; Mansberger SL; Fortune BA; Nguyen H; Torres R; Demirel S; Gardiner SK; Johnson CA; Cioffi GA
Journal of Glaucoma 2013; 22: 343-348 (IGR: 15-2)


53570 Agreement between event-based and trend-based glaucoma progression analyses
Rao HL; Kumbar T; Kumar AU; Babu JG; Senthil S; Garudadri CS
Eye 2013; 27: 803-808 (IGR: 15-2)


53714 Predicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts
Meira-Freitas D; Lisboa R; Tatham A; Zangwill LM; Weinreb RN; Girkin CA; Liebmann JM; Medeiros FA
Investigative Ophthalmology and Visual Science 2013; 54: 4174-4183 (IGR: 15-2)


53909 Increased Urinary 8-Hydroxy-2'-deoxyguanosine (8-OHdG)/Creatinine Level is Associated with the Progression of Normal-Tension Glaucoma
Yuki K; Tsubota K
Current Eye Research 2013; 38: 983-988 (IGR: 15-2)


53888 Comparison of Visual Field Progression Between Relatively Low and High Intraocular Pressure Groups in Normal Tension Glaucoma Patients
Lee J; Kong M; Kim J; Kee C
Journal of Glaucoma 2014; 23: 553-560 (IGR: 15-2)


53254 Visual field progression outcomes in glaucoma subtypes
De Moraes CG; Liebmann JM; Liebmann CA; Susanna R; Tello C; Ritch R
Acta Ophthalmologica 2013; 91: 288-293 (IGR: 15-2)


53568 How should we follow end-stage glaucoma?
Paletta Guedes RA; Paletta Guedes VM
Journal Français d'Ophtalmologie 2013; 36: 442-448 (IGR: 15-2)


52654 Spatial modeling of visual field data for assessing glaucoma progression
Betz-Stablein BD; Morgan WH; House PH; Hazelton ML
Investigative Ophthalmology and Visual Science 2013; 54: 1544-1553 (IGR: 15-1)


52571 Global and pointwise rates of decay in glaucoma eyes deteriorating according to pointwise event analysis
Nassiri N; Moghimi S; Coleman AL; Law SK; Caprioli J; Nouri-Mahdavi K
Investigative Ophthalmology and Visual Science 2013; 54: 1208-1213 (IGR: 15-1)


52671 Relationship of change in central corneal thickness to visual field progression in eyes with glaucoma
Viswanathan D; Goldberg I; Graham SL
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 1593-1599 (IGR: 15-1)


53213 The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study
Zangwill LM; Jain S; Dirkes K; He F; Medeiros FA; Trick GL; Brandt JD; Cioffi GA; Coleman AL; Liebmann JM; Piltz-Seymour JR; Gordon MO; Kass MA; Weinreb RN;
American Journal of Ophthalmology 2013; 155: 971-982 (IGR: 15-1)


52730 Usefulness of macular thickness derived from spectral-domain optical coherence tomography in the detection of glaucoma progression
Lee KS; Lee JR; Na JH; Kook MS
Investigative Ophthalmology and Visual Science 2013; 54: 1941-1949 (IGR: 15-1)


52946 Progression of retinal nerve fiber layer thinning in glaucoma assessed by cirrus optical coherence tomography-guided progression analysis
Na JH; Sung KR; Baek S; Lee JY; Kim S
Current Eye Research 2013; 38: 386-395 (IGR: 15-1)


52648 Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography
Grewal DS; Tanna AP
Current Opinions in Ophthalmology 2013; 24: 150-161 (IGR: 15-1)


52411 Detection of Glaucomatous Progression by Spectral-Domain Optical Coherence Tomography
Na JH; Sung KR; Lee JR; Lee KS; Baek S; Kim HK; Sohn YH
Ophthalmology 2013; 120: 1388-1395 (IGR: 15-1)


53166 Current approach on various methods of detection glaucomatous visual field progression
Zhong H; Yuan YS
Chinese Journal of Ophthalmology 2013; 49: 84-87 (IGR: 15-1)


52765 How useful is population data for informing visual field progression rate estimation?
Anderson AJ; Johnson CA
Investigative Ophthalmology and Visual Science 2013; 54: 2198-2206 (IGR: 15-1)


52876 Behavior of visual field index in advanced glaucoma
Rao HL; Senthil S; Choudhari NS; Mandal AK; Garudadri CS
Investigative Ophthalmology and Visual Science 2013; 54: 307-312 (IGR: 15-1)


53252 Optic disc progression and rates of visual field change in treated glaucoma
De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
Acta Ophthalmologica 2013; 91: e86-e91 (IGR: 15-1)


52806 Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment
Sakata R; Aihara M; Murata H; Mayama C; Tomidokoro A; Iwase A; Araie M
Journal of Glaucoma 2013; 22: 250-254 (IGR: 15-1)


53150 Optic disc size and progression of visual field damage in patients with normal-tension glaucoma
Hayamizu F; Yamazaki Y; Nakagami T; Mizuki K
Clinical Ophthalmology 2013; 7: 807-813 (IGR: 15-1)


52763 Citicoline oral solution in glaucoma: is there a role in slowing disease progression?
Ottobelli L; Manni GL; Centofanti M; Iester M; Allevena F; Rossetti L
Ophthalmologica 2013; 229: 219-226 (IGR: 15-1)


51987 Effect of Lateral Decubitus Position on Intraocular Pressure in Glaucoma Patients with Asymmetric Visual Field Loss
Kim KN; Jeoung JW; Park KH; Lee DS; Kim DM
Ophthalmology 2013; 120: 731-735 (IGR: 14-4)


51818 Progression Pattern of Initial Parafoveal Scotomas in Glaucoma
Su D; Park SC; Simonson JL; Liebmann JM; Ritch R
Ophthalmology 2013; 120: 520-527 (IGR: 14-4)


51722 Rates of retinal nerve fibre layer thickness change in glaucoma patients and control subjects
O'Leary N; Artes PH; Hutchison DM; Nicolela MT; Chauhan BC
Eye 2012; 26: 1554-1562 (IGR: 14-4)


51704 Rates of visual field progression in clinical glaucoma care
Heijl A; Buchholz P; Norrgren G; Bengtsson B
Acta Ophthalmologica 2013; 91: 406-412 (IGR: 14-4)


51919 Combining structure and function to evaluate glaucomatous progression: implications for the design of clinical trials
Lisboa R; Weinreb RN; Medeiros FA
Current opinion in pharmacology 2013; 13: 115-122 (IGR: 14-4)


51899 An Evidence-Based Review of Prognostic Factors for Glaucomatous Visual Field Progression
Ernest PJ; Schouten JS; Beckers HJ; Hendrikse F; Prins MH; Webers CA
Ophthalmology 2013; 120: 512-519 (IGR: 14-4)


51885 Detection of glaucoma progression by population and individual derived variability criteria
Folio LS; Wollstein G; Kotowski J; Bilonick RA; Ling Y; Ishikawa H; Kagemann L; Schuman JS
British Journal of Ophthalmology 2013; 97: 403-407 (IGR: 14-4)


51881 Modelling and analysing the dynamics of disease progression from cross-sectional studies
Li Y; Swift S; Tucker A
Journal of biomedical informatics 2013; 46: 266-274 (IGR: 14-4)


51804 Retrospective study of glaucoma and closed-eyelid test: long-term outcomes in an Italian native population
Pescosolido N; Belcaro G; Rusciano D; Steigerwalt RD; Nebbioso M
Panminerva medica 2012; 0: (IGR: 14-4)


51911 Ocular risk factors for progression of primary open angle glaucoma in the Tunisian population
Loukil I; Korchène N; Hachicha F; Wathek C; Bouguerra C; Mallouch N; Bhiri R; Hijazi A; Zouari B; El Afrit MA
Journal Français d'Ophtalmologie 2013; 36: 324-330 (IGR: 14-4)


51693 Evaluation of baseline structural factors for predicting glaucomatous visual-field progression using optical coherence tomography, scanning laser polarimetry and confocal scanning laser ophthalmoscopy
Sehi M; Bhardwaj N; Chung YS; Greenfield DS;
Eye 2012; 26: 1527-1535 (IGR: 14-4)


51780 Relationship between intraocular pressure and glaucoma onset and progression
Miglior S; Bertuzzi F
Current opinion in pharmacology 2013; 13: 32-35 (IGR: 14-4)


51747 Posture-induced intraocular pressure changes in eyes with open-angle glaucoma, primary angle closure with or without glaucoma medications, and control eyes
Sawada A; Yamamoto T
Investigative Ophthalmology and Visual Science 2012; 53: 7631-7635 (IGR: 14-4)


51057 Persistence, spatial distribution and implications for progression detection of blind parts of the visual field in glaucoma: a clinical cohort study
Junoy Montolio FG; Wesselink C; Jansonius NM
PLoS ONE 2012; 7: e41211 (IGR: 14-3)


50957 Progression of patterns (POP): a machine classifier algorithm to identify glaucoma progression in visual fields
Goldbaum MH; Lee I; Jang G; Balasubramanian M; Sample PA; Weinreb RN; Liebmann JM; Girkin CA; Anderson DR; Zangwill LM; Fredette MJ; Jung TP; Medeiros FA; Bowd C
Investigative Ophthalmology and Visual Science 2012; 53: 6557-6567 (IGR: 14-3)


50941 Visual field progression in glaucoma: Cluster analysis
Bresson-Dumont H; Hatton J; Foucher J; Fonteneau M
Journal Français d'Ophtalmologie 2012; 35: 735-741 (IGR: 14-3)


50926 Validation of point-wise exponential regression to measure the decay rates of glaucomatous visual fields
Azarbod P; Mock D; Bitrian E; Afifi AA; Yu F; Nouri-Mahdavi K; Coleman AL; Caprioli J
Investigative Ophthalmology and Visual Science 2012; 53: 5403-5409 (IGR: 14-3)


51169 Detection of Early Glaucomatous Progression With Different Parameters of the RTVue Optical Coherence Tomograph
Naghizadeh F; Garas A; Vargha P; Holló G
Journal of Glaucoma 2014; 23: 195-198 (IGR: 14-3)


51039 Estimating the rate of retinal ganglion cell loss in glaucoma
Medeiros FA; Zangwill LM; Anderson DR; Liebmann JM; Girkin CA; Harwerth RS; Fredette MJ; Weinreb RN
American Journal of Ophthalmology 2012; 154: 814-824.e1 (IGR: 14-3)


51049 Comparison of Event-Based Methods Using Optical Coherence Tomography and Automated Perimetry to Detect the Progression of Glaucoma in Patients with Open-Angle Glaucoma
Lee M; Yang H; Kim J; Ahn J
Ophthalmologica 2013; 229: 106-112 (IGR: 14-3)


51288 Novel Fractal Feature-Based Multiclass Glaucoma Detection and Progression Prediction
Iftekharuddin K; Kim Y; Davey P; Essock E; Garas A; Hollo G
IEEE transactions on information technology in biomedicine: a publication of the IEEE Engineering in Medicine and Biology Society 2012; 0: (IGR: 14-3)


51118 The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change
Medeiros FA; Zangwill LM; Bowd C; Mansouri K; Weinreb RN
Investigative Ophthalmology and Visual Science 2012; 53: 6939-6946 (IGR: 14-3)


51347 Retinal Nerve Fiber Layer Atrophy Is Associated With Visual Field Loss Over Time in Glaucoma Suspect and Glaucomatous Eyes
Sehi M; Zhang X; Greenfield DS; Chung Y; Wollstein G; Francis BA; Schuman JS; Varma R; Huang D;
American Journal of Ophthalmology 2013; 155: 73-82.e1 (IGR: 14-3)


51362 Glaucoma progression detection: agreement, sensitivity, and specificity of expert visual field evaluation, event analysis, and trend analysis
Antón A; Pazos M; Martín B; Navero JM; Ayala ME; Castany M; Martínez P; Bardavío J
European Journal of Ophthalmology 2012; 0: 0 (IGR: 14-3)


50882 Glaucoma progression in eyes with a history of refractive corneal surgery
Kim YJ; Yun SC; Na JH; Tchah HW; Jung JJ; Sung KR
Investigative Ophthalmology and Visual Science 2012; 53: 4485-4489 (IGR: 14-3)


51216 Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR)
O'Leary N; Chauhan BC; Artes PH
Investigative Ophthalmology and Visual Science 2012; 53: 6776-6784 (IGR: 14-3)


51156 Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma
Ding QJ; Cook AC; Dumitrescu AV; Kuehn MH
Investigative Ophthalmology and Visual Science 2012; 53: 6370-6377 (IGR: 14-3)


51233 Comparison of the progression rates of the superior, inferior, and both hemifield defects in normal-tension glaucoma patients
Cho HK; Kee C
American Journal of Ophthalmology 2012; 154: 958-968.e1 (IGR: 14-3)


51027 Risk factors for visual field progression in the low-pressure glaucoma treatment study
De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
American Journal of Ophthalmology 2012; 154: 702-711 (IGR: 14-3)


50684 Glaucoma progression after the first-detected optic disc hemorrhage by optical coherence tomography
Suh MH; Park KH; Kim H; Kim TW; Kim SW; Kim SY; Kim DM
Journal of Glaucoma 2012; 21: 358-366 (IGR: 14-3)


51283 Glaucoma progression associated with Leber's hereditary optic neuropathy
Nucci C; Martucci A; Mancino R; Cerulli L
International Ophthalmology 2013; 33: 75-77 (IGR: 14-3)


51356 Effect of trabeculectomy on retrobulbar circulation and visual field progression in patients with primary open-angle glaucoma
Yamazaki Y; Hayamizu F
Clinical Ophthalmology 2012; 6: 1539-1545 (IGR: 14-3)


50204 Localized Glaucomatous Change Detection within the Proper Orthogonal Decomposition Framework
Balasubramanian M; Kriegman DJ; Bowd C; Holst M; Weinreb RN; Sample PA; Zangwill LM
Investigative Ophthalmology and Visual Science 2012; 53: 3615-3628 (IGR: 14-2)


50487 Glaucoma progression detection by retinal nerve fiber layer measurement using scanning laser polarimetry: event and trend analysis
Moon BG; Sung KR; Cho JW; Kang SY; Yun SC; Na JH; Lee Y; Kook MS
Korean Journal of Ophthalmology 2012; 26: 174-181 (IGR: 14-2)


50323 Detection of glaucoma progression by assessment of segmented macular thickness data obtained using spectral domain optical coherence tomography
Na JH; Sung KR; Baek S; Kim YJ; Durbin MK; Lee HJ; Kim HK; Sohn YH
Investigative Ophthalmology and Visual Science 2012; 53: 3817-3826 (IGR: 14-2)


50356 Factors predicting the rate of functional progression in early and suspected glaucoma
Gardiner SK; Johnson CA; Demirel S
Investigative Ophthalmology and Visual Science 2012; 53: 3598-3604 (IGR: 14-2)


50405 Relationship Between Intraocular Pressure and Rate of Visual Field Progression in Treated Glaucoma
Rao HL; Addepalli UK; Jonnadula GB; Kumbar T; Senthil S; Garudadri CS
Journal of Glaucoma 2013; 22: 719-724 (IGR: 14-2)


50467 Evaluating Objective and Subjective Quantitative Parameters at the Initial Visit to Predict Future Glaucomatous Visual Field Progression
Ungar AK; Wollstein G; Ishikawa H; Folio LS; Ling Y; Bilonick RA; Noecker RJ; Xu J; Kagemann L; Mattox C; Schuman JS
Ophthalmic Surgery Lasers and Imaging 2012; 0: 1-9 (IGR: 14-2)


50501 Retinal Nerve Fiber Layer Imaging with Spectral-domain Optical Coherence Tomography: Patterns of Retinal Nerve Fiber Layer Progression
Leung CK; Yu M; Weinreb RN; Lai G; Xu G; Lam DS
Ophthalmology 2012; 119: 1858-1866 (IGR: 14-2)


50265 The Impact of Surgical Intraocular Pressure Reduction on Visual Function Using Various Criteria to Define Visual Field Progression
Bhardwaj N; Niles PI; Greenfield DS; Hymowitz M; Sehi M; Feuer WJ; Budenz DL
Journal of Glaucoma 2013; 22: 632-637 (IGR: 14-2)


50316 Relationship between central corneal thickness and progression of visual field loss in patients with open-angle glaucoma
Cao KY; Kapasi M; Betchkal JA; Birt CM
Canadian Journal of Ophthalmology 2012; 47: 155-158 (IGR: 14-2)


50287 The Development of a Decision Analytic Model of Changes in Mean Deviation in People with Glaucoma: The COA Model
Kymes SM; Lambert DL; Lee PP; Musch DC; Siegfried CJ; Kotak SV; Stwalley DL; Fain J; Johnson C; Gordon MO
Ophthalmology 2012; 119: 1367-1374 (IGR: 14-2)


50302 Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy
Araie M; Shirato S; Yamazaki Y; Matsumoto C; Kitazawa Y; Ohashi Y;
Acta Ophthalmologica 2012; 90: e337-e343 (IGR: 14-2)


50406 Effect of Ginkgo biloba Extract on Visual Field Progression in Normal Tension Glaucoma
Lee J; Sohn SW; Kee C
Journal of Glaucoma 2013; 22: 780-784 (IGR: 14-2)


49167 Altered Stability of mRNAs Associated with Glaucoma Progression in Human Trabecular Meshwork Cells Following Oxidative Stress
Mochizuki H; Murphy CJ; Brandt JD; Kiuchi Y; Russell P
Investigative Ophthalmology and Visual Science 2012; 53: 1734-1741 (IGR: 14-1)


48628 Computer simulation of progressive retinal nerve fiber layer loss in glaucoma: performance of event and trend analyses
Yu M; Weinreb RN; Yiu C; Liu S; Or MK; Ye C; Lam DS; Leung CK
Investigative Ophthalmology and Visual Science 2011; 52: 9674-9683 (IGR: 14-1)


48630 Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma
Konstas AG; Quaranta L; Mikropoulos DG; Nasr MB; Russo A; Jaffee HA; Stewart JA; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 26-32 (IGR: 14-1)


48773 The rate of visual field change in the ocular hypertension treatment study
Demirel S; De Moraes CG; Gardiner SK; Liebmann JM; Cioffi GA; Ritch R; Gordon MO; Kass MA;
Investigative Ophthalmology and Visual Science 2012; 53: 224-227 (IGR: 14-1)


48738 Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma
Tanna AP; Budenz DL; Bandi J; Feuer WJ; Feldman RM; Herndon LW; Rhee DJ; Whiteside-De Vos J; Huang J; Anderson DR
Ophthalmology 2012; 119: 468-473 (IGR: 14-1)


48430 The influence of the assessment method on the incidence of visual field progression in glaucoma: a network meta-analysis
Ernest PJ; Viechtbauer W; Schouten JS; Beckers HJ; Hendrikse F; Prins MH; Webers CA
Acta Ophthalmologica 2012; 90: 10-19 (IGR: 14-1)


48936 Integrating event- and trend-based analyses to improve detection of glaucomatous visual field progression
Medeiros FA; Weinreb RN; Moore G; Liebmann JM; Girkin CA; Zangwill LM
Ophthalmology 2012; 119: 458-467 (IGR: 14-1)


48569 Cup size predicts subsequent functional change in early glaucoma
Gardiner SK; Johnson CA; Demirel S
Optometry and Vision Science 2011; 88: 1470-1476 (IGR: 14-1)


48819 Progression detection capability of macular thickness in advanced glaucomatous eyes
Sung KR; Sun JH; Na JH; Lee JY; Lee Y
Ophthalmology 2012; 119: 308-313 (IGR: 14-1)


48492 Detection of progressive retinal nerve fiber layer thickness loss with optical coherence tomography using 4 criteria for functional progression
Grewal DS; Sehi M; Paauw JD; Greenfield DS
Journal of Glaucoma 2012; 21: 214-220 (IGR: 14-1)


49263 A Validated Risk Calculator to Assess Risk and Rate of Visual Field Progression in Treated Glaucoma Patients
De Moraes CG; Sehi M; Greenfield DS; Chung YS; Ritch R; Liebmann JM
Investigative Ophthalmology and Visual Science 2012; 53: 2702-2707 (IGR: 14-1)


49288 Improved Estimates of Visual Field Progression Using Bayesian Linear Regression to Integrate Structural Information in Patients with Ocular Hypertension
Russell RA; Malik R; Chauhan BC; Crabb DP; Garway-Heath DF
Investigative Ophthalmology and Visual Science 2012; 53: 2760-2769 (IGR: 14-1)


49231 Predicting glaucomatous progression in glaucoma suspect eyes using relevance vector machine classifiers for combined structural and functional measurements
Bowd C; Lee I; Goldbaum MH; Balasubramanian M; Medeiros FA; Zangwill LM; Girkin CA; Liebmann JM; Weinreb RN
Investigative Ophthalmology and Visual Science 2012; 53: 2382-2389 (IGR: 14-1)


49240 Rates of visual field progression in distinct optic disc phenotypes
Schor KS; De Moraes CG; Teng CC; Tello C; Liebmann JM; Ritch R
Clinical and Experimental Ophthalmology 2012; 40: 706-712 (IGR: 14-1)


49193 Frequency and associated factors of structural progression of open-angle glaucoma in the Beijing Eye Study
Wang YX; Hu LN; Yang H; Jonas JB; Xu L
British Journal of Ophthalmology 2012; 96: 811-815 (IGR: 14-1)


49230 Pointwise Rates of Visual Field Progression Cluster according to Retinal Nerve Fiber Layer Bundles
Nouri-Mahdavi K; Mock D; Hosseini H; Bitrian E; Yu F; Afifi A; Coleman AL; Caprioli J
Investigative Ophthalmology and Visual Science 2012; 53: 2390-2394 (IGR: 14-1)


49013 Combining Structural and Functional Measurements to Improve Estimates of Rates of Glaucomatous Progression
Medeiros FA; Zangwill LM; Girkin CA; Liebmann JM; Weinreb RN
American Journal of Ophthalmology 2012; 153: 1197-1205 (IGR: 14-1)


48846 Progression detection in different stages of glaucoma: mean deviation versus visual field index
Cho JW; Sung KR; Yun SC; Na JH; Lee Y; Kook MS
Japanese Journal of Ophthalmology 2012; 56: 128-133 (IGR: 14-1)


49196 Incorporating risk factors to improve the assessment of rates of glaucomatous progression
Medeiros FA; Zangwill LM; Mansouri K; Lisboa R; Tafreshi A; Weinreb RN
Investigative Ophthalmology and Visual Science 2012; 53: 2199-2207 (IGR: 14-1)


49166 Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group
De Moraes CG; Demirel S; Gardiner SK; Liebmann JM; Cioffi GA; Ritch R; Gordon MO; Kass MA;
Investigative Ophthalmology and Visual Science 2012; 53: 1704-1709 (IGR: 14-1)


49010 Progression of Visual Field Defects in Eyes With Different Optic Disc Appearances in Patients With Normal Tension Glaucoma
Nakazawa T; Shimura M; Ryu M; Himori N; Nitta F; Omodaka K; Doi H; Yasui T; Fuse N; Nishida K
Journal of Glaucoma 2012; 21: 426-430 (IGR: 14-1)


49291 Short-term use of inhaled and intranasal corticosteroids is not associated with glaucoma progression on optical coherence tomography
Johnson LN; Soni CR; Johnson MA; Madsen RW
European Journal of Ophthalmology 2012; 0: 0 (IGR: 14-1)


48815 Risk factors associated with progression in exfoliative glaucoma patients
Holló G; Quaranta L; Cvenkel B; Astakhov YS; Teus MA; Kó thy P; Miglior S; Riva I; Akopov EL; Gros J; Stewart JA; Kristoffersen MS; Nelson LA; Stewart WC
Ophthalmic Research 2012; 47: 208-213 (IGR: 14-1)


48255 The Region of Largest ?-Zone Parapapillary Atrophy Area Predicts the Location of Most Rapid Visual Field Progression
Teng CC; De Moraes CG; Prata TS; Liebmann CA; Tello C; Ritch R; Liebmann JM
Ophthalmology 2011; 118: 2409-2413 (IGR: 13-4)


48331 Detection of retinal nerve fibre layer progression: comparison of the fast and extended modes of GDx guided progression analysis
Kjaergaard SM; Alencar LM; Nguyen B; Sassani P; Medeiros FA; Weinreb RN; Zangwill LM
British Journal of Ophthalmology 2011; 95: 1707-1712 (IGR: 13-4)


47629 Rates of Change in the Visual Field and Optic Disc in Patients with Distinct Patterns of Glaucomatous Optic Disc Damage
Reis ASC; Artes PH; Belliveau AC; Leblanc RP; Shuba LM; Chauhan BC; Nicolela MT
Ophthalmology 2011; (IGR: 13-4)


47699 Longitudinal relationship between retinal nerve fiber layer thickness parameters assessed by scanning laser polarimetry (GDxVCC) and visual field in glaucoma
Makabe K; Takei K; Oshika T
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; (IGR: 13-4)


47971 A method to measure and predict rates of regional visual field decay in glaucoma
Caprioli J; Mock D; Bitrian E; Afifi AA; Yu F; Nouri-Mahdavi K; Coleman AL
Investigative ophthalmology & visual science 2011; 52: 4765-4773 (IGR: 13-4)


47838 Visual field evolution in glaucoma patients presenting with different disease stages: Results from an observational study
Gerlier L; Shlaen R; Wolfram C; Lamotte M; Verboven Y
Value in Health 2011; 14: A502-A503 (IGR: 13-4)


46328 Risk factors of glaucoma progression: intraocular pressure fluctuations
Aptel F; Denis P
Journal Français d'Ophtalmologie 2011; 34: 400-402 (IGR: 13-3)


47084 The evidence base to select a method for assessing glaucomatous visual field progression
Ernest PJG; Schouten JSAG; Beckers HJM; Hendrikse F; Prins MH; Webers CAB
Acta Ophthalmologica 2011; (IGR: 13-3)


46932 Modern assessment of perimetric progression in glaucoma
Feraru CI; Pantalon A
Oftalmologia 2010; 54: 97-102 (IGR: 13-3)


46733 Detection of visual field progression in glaucoma with standard achromatic perimetry: A review and practical implications
Nouri-Mahdavi K; Nassiri N; Giangiacomo A; Caprioli J
Graefe's Archive for Clinical and Experimental Ophthalmology 2011; (IGR: 13-3)


46323 Influence of Visual Field Testing Frequency on Detection of Glaucoma Progression With Trend Analyses
Nouri-Mahdavi K; Zarei R; Caprioli J
Archives of Ophthalmology 2011; (IGR: 13-3)


46892 Agreement in detecting glaucomatous visual field progression by using guided progression analysis and Humphrey overview printout
Iester M; Corallo G; Capris E; Capris P
European Journal of Ophthalmology 2011; 21: 573-579 (IGR: 13-3)


46520 Event-based progression detection strategies using scanning laser polarimetry images of the human retina
Vermeer KA; Lo B; Zhou Q; Vos FM; Vossepoel AM; Lemij HG
Computers in Biology and Medicine 2011; 41: 857-864 (IGR: 13-3)


46511 Comparing rates of retinal nerve fibre layer loss with GDxECC using different methods of visual-field progression
Grewal DS; Sehi M; Greenfield DS; Quinn CD; Kishor K; Schuman JS; Noecker RJ; Ishikawa H; Wollstein G; Billonick RA
British Journal of Ophthalmology 2011; 95: 1122-1127 (IGR: 13-3)


46937 The use of optical coherence tomography for identifying retinal nerve fiber layer progressive damage
Danielescu C; Chiselita D
Oftalmologia 2010; 54: 109-114 (IGR: 13-3)


46825 Risk factors for visual field progression in the groningen longitudinal glaucoma study: A comparison of different statistical approaches
Wesselink C; Marcus MW; Jansonius NM
Journal of Glaucoma 2011; (IGR: 13-3)


46389 Combining Structural and Functional Measurements to Improve Detection of Glaucoma Progression using Bayesian Hierarchical Models
Medeiros FA; Leite MT; Zangwill LM; Weinreb RN
Investigative Ophthalmology and Visual Science 2011; 52: 5794-5803 (IGR: 13-3)


46514 Pressure-cornea-vascular index (PCVI) for predicting disease progression in normal tension glaucoma
Leung DYL; Iliev ME; Chan P; Baig N; Chi SCC; Tham CCY; Lam DSC
British Journal of Ophthalmology 2011; 95: 1106-1110 (IGR: 13-3)


46822 Detection of progressive retinal nerve fiber layer thicknessloss with optical coherence tomography using4 criteria for functional progression
Grewal DS; Sehi M; Paauw JD; Greenfield DS
Journal of Glaucoma 2011; (IGR: 13-3)


46629 Evaluation of retinal nerve fiber layer progression in glaucoma: A comparison between spectral-domain and time-domain optical coherence tomography
Leung CK-S; Chiu V; Weinreb RN; Liu S; Ye C; Yu M; Cheung CY-L; Lai G; Lam DS-C
Ophthalmology 2011; 118: 1558-1562 (IGR: 13-3)


46630 Evaluation of retinal nerve fiber layer progression in glaucoma: A prospective analysis with neuroretinal rim and visual field progression
Leung CKS; Liu S; Weinreb RN; Lai G; Ye C; Cheung CYL; Pang CP; Tse KK; Lam DSC
Ophthalmology 2011; 118: 1551-1557 (IGR: 13-3)


45693 The six keys of the monitoring of the glaucoma patient
Detry-Morel M
Bulletin de la Société Belge d'Ophtalmologie 2010; 316: 63-84 (IGR: 13-2)


45912 Baseline mean deviation and rates of visual field change in treated glaucoma patients
Forchheimer I; De Moraes CG; Teng CC; Folgar F; Tello C; Ritch R; Liebmann JM
Eye 2011; 25: 626-632 (IGR: 13-2)


46191 Perimetric indices as predictors of future glaucomatous functional change
Gardiner SK; Demirel S; Johnson CA
Optometry and Vision Science 2011; 88: 56-62 (IGR: 13-2)


45457 What reduction in standard automated perimetry variability would improve the detection of visual field progression?
Turpin A; McKendrick AM
Investigative Ophthalmology and Visual Science 2011; 52: 3237-3245 (IGR: 13-2)


45863 Ability of Heidelberg Retina Tomograph III to predict progression in patients with early glaucoma or suspected primary open-angle glaucoma
Garcia-Martin E; Pablo L; Ferreras A; Idoipe M; Perez S; Pueyo V
Archivos de la Sociedad Española de Oftalmologia 2010; 85: 138-143 (IGR: 13-2)


45606 Detecting glaucomatous progression using GDx with variable and enhanced corneal compensation using Guided Progression Analysis
Grewal DS; Sehi M; Greenfield DS
British Journal of Ophthalmology 2011; 95: 502-508 (IGR: 13-2)


45975 Perimetric progression in open angle glaucoma and the Visual Field Index (VFI)
Ang GS; Mustafa MS; Scott N; Diaz-Aleman VT; Azuara-Blanco A
Journal of Glaucoma 2011; 20: 223-227 (IGR: 13-2)


45589 Risk factors for visual field progression in treated glaucoma
De Moraes CGV; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna Jr R; Ritch R
Archives of Ophthalmology 2011; 129: 562-568 (IGR: 13-2)


46145 Lifetime visual prognosis of patients with glaucoma in Aberdeen, Scotland
Goh YW; Ang GS; Azuara-Blanco A
Clinical and Experimental Ophthalmology 2011; (IGR: 13-2)


45667 Clinical evaluation of a novel population-based regression analysis for detecting glaucomatous visual field progression
Kovalska MP; Burki E; Schoetzau A; Orguel SF; Jflammer Orguel S; Grieshaber MC
Klinische Monatsblätter für Augenheilkunde 2011; 228: 311-317 (IGR: 13-2)


45765 Evaluation of Retinal Nerve Fiber Layer Progression in Glaucoma. A Prospective Analysis with Neuroretinal Rim and Visual Field Progression
Leung CKS; Liu S; Weinreb RN; Lai G; Ye C; Cheung CYL; Pang CP; Tse KK; Lam DSC
Ophthalmology 2011; (IGR: 13-2)


45771 Evaluation of retinal nerve fiber layer progression in glaucoma: A comparison between the fast and the regular retinal nerve fiber layer scans
Leung CK-S; Cheung CY-L; Weinreb RN; Liu S; Ye C; Lai G; Liu N; Pang CP; Tse KK; Lam DSC
Ophthalmology 2011; 118: 763-767 (IGR: 13-2)


46031 Improved prediction of rates of visual field loss in glaucoma using empirical bayes estimates of slopes of change
Medeiros FA; Zangwill LM; Weinreb RN
Journal of Glaucoma 2011; (IGR: 13-2)


46308 Comparison of stereo disc photographs and alternation flicker using a novel matching technology for detecting glaucoma progression
Radcliffe NM; Sehi M; Wallace IB; Greenfield DS; Krupin T; Ritch R
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2010; 41: 629-634 (IGR: 13-2)


46013 Glaucoma progression after the first-detected optic disc hemorrhage by optical coherence tomography
Suh MH; Park KH; Kim H; Kim T-W; Kim SW; Kim S-Y; Kim DM
Journal of Glaucoma 2011; (IGR: 13-2)


46090 Do adherence rates and glaucomatous visual field progression correlate?
Rossi GCM; Pasinetti GM; Scudeller L; Radaelli R; Bianchi PE
European Journal of Ophthalmology 2011; 21: 410-414 (IGR: 13-2)


45673 Basic and clinical studies of pressure-independent damaging factors of open angle glaucoma
Araie M
Nippon Ganka Gakkai Zasshi 2011; 115: 213-236 (IGR: 13-2)


27919 Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma
Rao HL; Kumar AU; Babu JG; Senthil S; Garudadri CS
Ophthalmology 2011; 118: 249-253 (IGR: 13-1)


27784 Assessment of rates of structural change in glaucoma using imaging technologies
Mansouri K; Leite MT; Medeiros FA; Leung CK; Weinreb RN
Eye 2011; 25: 269-77 (IGR: 13-1)


28142 Progression rate of total, and upper and lower visual field defects in open-angle glaucoma patients
Fukuchi T; Yoshino T; Sawada H; Seki M; Togano T; Tanaka T; Ueda J; Abe H
Clinical Ophthalmology 2010; 4: 1315-1323 (IGR: 13-1)


27776 Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure
Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
Investigative Ophthalmology and Visual Science 2011; 52: 737-743 (IGR: 13-1)


27739 A Comparison of Functional and Structural Measures for Identifying Progression of Glaucoma
Xin D; Greenstein VC; Ritch R; Liebmann JM; De Moraes CG; Hood DC
Investigative Ophthalmology and Visual Science 2011; 52: 519-526 (IGR: 13-1)


27931 Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression
Tanna AP; Bandi JR; Budenz DL; Feuer WJ; Feldman RM; Herndon LW; Rhee DJ; Whiteside-De Vos J
Ophthalmology 2011; 118: 60-65 (IGR: 13-1)


27825 Medical decision, persistence of initial treatment, and glaucoma progression in a Brazilian reference hospital
Paula JS; Filho JAR; Cecchetti DFA; Nagatsuyu DT; Rodrigues MLV; Rocha EM
Arquivos Brasileiros de Oftalmologia 2010; 73: 141-145 (IGR: 13-1)


27059 An in silico model of scanning laser tomography image series: an alternative benchmark for the specificity of progression algorithms.
O'Leary N; Crabb DP; Garway-Heath DF
Investigative Ophthalmology and Visual Science 2010; 51: 6472-6482 (IGR: 12-4)


27199 The relationship between intraocular pressure reduction and rates of progressive visual field loss in eyes with optic disc hemorrhage
Medeiros FA; Alencar LM; Sample PA; Zangwill LM; Susanna Jr R; Weinreb RN
Ophthalmology 2010; 117: 2061-2066 (IGR: 12-4)


27338 Focusing on glaucoma progression and the clinical importance of progression rate measurement: A review
Rossetti L; Goni F; Denis P; Bengtsson B; Martinez A; Heijl A
Eye 2010; 24: S1-S7 (IGR: 12-4)


26940 Longitudinal and Cross-sectional Analyses of Visual Field Progression in Participants of the Ocular Hypertension Treatment Study
PH Artes; BC Chauhan; JL Keltner; KE Cello; CA Johnson; DR Anderson; MO Gordon; MA Kass
Archives of Ophthalmology 2010; 128: 1528-1532 (IGR: 12-4)


26992 Continued visual field progression in eyes with prior visual field progression in patients with open-angle glaucoma.
Chen PP; Cady RS; Mudumbai RC; Ngan R
Journal of Glaucoma 2010; 19: 598-603 (IGR: 12-4)


27011 Progression in primary angle closure eyes.
Sihota R; Rao A; Gupta V; Srinivasan G; Sharma A
Journal of Glaucoma 2010; 19: 632-636 (IGR: 12-4)


27634 Optic disc hemorrhages and progression in glaucoma
Niyadurupola N; Broadway DC
Expert Review of Ophthalmology 2010; 5: 637-643 (IGR: 12-4)


26792 A comparison of rates of change in neuroretinal rim area and retinal nerve fiber layer thickness in progressive glaucoma
Alencar LM; Zangwill LM; Weinreb RN; Bowd C; Sample PA; Girkin CA; Liebmann JM; Medeiros FA
Investigative Ophthalmology and Visual Science 2010; 51: 3531-3539 (IGR: 12-3)


26654 Modified visual field trend analysis
De Moraes CGV; Ritch R; Tello C; Liebmann JM
Journal of Glaucoma 2010; (IGR: 12-3)


26493 The challenges of monitoring glaucoma progression
Termote K; Zeyen T
Bulletin de la Société Belge d'Ophtalmologie 2010; 314: 25-32 (IGR: 12-3)


26788 Intraocular pressure and visual field damage as risk factors for visual field progression in filtering surgery
Cohen JS; Novack GD; Zink JM
Ophthalmic Surgery Lasers and Imaging 2010; 41: 452-458 (IGR: 12-3)


26890 Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma
Martinez A; Sanchez-Salorio M
Acta Ophthalmologica 2010; 88: 541-552 (IGR: 12-3)


26204 Four-year incidence and progression of visual impairment in Latinos: the Los Angeles Latino Eye Study
Varma R; Chung J; Foong AW; Torres M; Choudhury F; Azen SP; Los Angeles Latino Eye Study Group
American Journal of Ophthalmology 2010; 149: 713-727 (IGR: 12-2)


26149 Beta-Zone parapapillary atrophy and the velocity of glaucoma progression
Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
Ophthalmology 2010; 117: 909-915 (IGR: 12-2)


26212 Glaucomatous progression in series of stereoscopic photographs and Heidelberg retina tomograph images
O'Leary N; Crabb DP; Mansberger SL; Fortune B; Twa MD; Lloyd MJ; Kotecha A; Garway-Heath DF; Cioffi GA; Johnson CA
Archives of Ophthalmology 2010; 128: 560-568 (IGR: 12-2)


26248 Rates of progressive retinal nerve fiber layer loss in glaucoma measured by scanning laser polarimetry
Medeiros FA; Zangwill LM; Alencar LM; Sample PA; Weinreb RN
American Journal of Ophthalmology 2010; 149: 908-915 (IGR: 12-2)


26131 Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma
Aoyama A; Ishida K; Sawada A; Yamamoto T
Japanese Journal of Ophthalmology 2010; 54: 117-123 (IGR: 12-2)


26186 Detection of morphological and functional progression in initial glaucoma
Gonzalez de la Rosa M; Gonzalez-Hernandez M; Sanchez-Mendez M; Medina-Mesa E; Rodriguez de la Vega R
British Journal of Ophthalmology 2010; 94: 414-418 (IGR: 12-2)


26139 Predicting progression to glaucoma in ocular hypertensive patients
Strouthidis NG; Gardiner SK; Owen VM; Zuniga C; Garway-Heath DF
Journal of Glaucoma 2010; 19: 304-309 (IGR: 12-2)


26201 Influence of the extent of myopia on the progression of normal-tension glaucoma
Sohn SW; Song JS; Kee C
American Journal of Ophthalmology 2010; 149: 831-838 (IGR: 12-2)


26260 Patterns of progression of localized retinal nerve fibre layer defect on red-free fundus photographs in normal-tension glaucoma
Suh MH; Kim DM; Kim YK; Kim TW; Park KH
Eye 2010; 24: 857-863 (IGR: 12-2)


26234 Recurrent disc hemorrhage does not increase the rate of visual field progression
de Beaufort HC; De Moraes CG; Teng CC; Prata TS; Tello C; Ritch R; Liebmann JM
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 839-844 (IGR: 12-2)


25152 Evaluation of retinal nerve fiber layer progression in glaucoma: a study on optical coherence tomography guided progression analysis
Leung CK; Cheung CY; Weinreb RN; Qiu K; Liu S; Li H; Xu G; Fan N; Pang CP; Tse KK
Investigative Ophthalmology and Visual Science 2010; 51: 217-222 (IGR: 12-1)


25128 Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage
Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
Ophthalmology 2010; 117: 24-29 (IGR: 12-1)


25244 Agreement for Detecting Glaucoma Progression with the GDx Guided Progression Analysis, Automated Perimetry, and Optic Disc Photography
Alencar LM; Zangwill LM; Weinreb RN; Bowd C; Vizzeri G; Sample PA; Susanna R Jr; Medeiros FA
Ophthalmology 2010; 117: 462-470 (IGR: 12-1)


25221 Visual Field Progression Differences between Normal-Tension and Exfoliative High-Tension Glaucoma
Ahrlich KG; De Moraes CG; Teng CC; Prata TS; Tello C; Ritch R; Liebmann JM
Investigative Ophthalmology and Visual Science 2010; 51: 1458-1463 (IGR: 12-1)


24982 Specification of progression in glaucomatous visual field loss, applying locally condensed stimulus arrangements
Nevalainen J; Paetzold J; Papageorgiou E; Sample PA; Pascual JP; Krapp E; Selig B; Vonthein R; Schiefer U
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1659-1669 (IGR: 11-4)


24870 Prediction of functional loss in glaucoma from progressive optic disc damage
Medeiros FA; Alencar LM; Zangwill LM; Bowd C; Sample PA; Weinreb RN
Archives of Ophthalmology 2009; 127: 1250-1256 (IGR: 11-4)


24580 Unpredictability of glaucoma progression
Susanna Jr R
Current Medical Research and Opinion 2009; 25: 2167-2177 (IGR: 11-4)


24864 Progression of optic neuropathy after disc hemorrhage in primary angle-closure glaucoma
Hsieh JW; Lan YW
Japanese Journal of Ophthalmology 2009; 53: 380-383 (IGR: 11-4)


24965 Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma
Chauhan BC; Nicolela MT; Artes PH
Ophthalmology 2009; 116: 2110-2118 (IGR: 11-4)


25002 Natural history of open-angle glaucoma
Heijl A; Bengtsson B; Hyman L; Leske MC; Early Manifest Glaucoma Trial Group
Ophthalmology 2009; 116: 2271-2276 (IGR: 11-4)


24819 Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression
Sung KR; Lee S; Park SB; Choi J; Kim ST; Yun SC; Kang SY; Cho JW; Kook MS
Investigative Ophthalmology and Visual Science 2009; 50: 5266-5274 (IGR: 11-4)


24975 Prediction of glaucomatous visual field loss by extrapolation of linear trends
Bengtsson B; Patella VM; Heijl A
Archives of Ophthalmology 2009; 127: 1610-1615 (IGR: 11-4)


24493 Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression
De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
Archives of Ophthalmology 2009; 127: 1129-1134 (IGR: 11-3)


24491 Visual field progression after trabeculectomy in primary open-angle glaucoma: preliminary results
Dieng M; Wane A; Ba E; Roth PN; Demeideros M; Ndiaye M; Ndiaye P; Wade A
Journal Français d'Ophtalmologie 2009; 32: 474-480 (IGR: 11-3)


24494 The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data
Sample PA; Girkin CA; Zangwill LM; Jain S; Racette L; Becerra LM; Weinreb RN; Medeiros FA; Wilson MR; De León-Ortega J
Archives of Ophthalmology 2009; 127: 1136-1145 (IGR: 11-3)


23917 Evaluating a new disc staging scale for glaucomatous damage: the ability to detect change over time
Henderer J; Wang Y; Bayer A; Altangerel U; Schwartz L; Schmidt C
European Journal of Ophthalmology 2009; 19: 404-410 (IGR: 11-2)


23928 Linear regression analysis of the cumulative defect curve by sectors and other criteria of glaucomatous visual field progression
Gonzalez de la Rosa M; Gonzalez-Hernandez M; Diaz-Aleman T
European Journal of Ophthalmology 2009; 19: 416-424 (IGR: 11-2)


23955 Optic disc progression in glaucoma: comparison of confocal scanning laser tomography to optic disc photographs in a prospective study
Chauhan BC; Hutchison DM; Artes PH; Caprioli J; Jonas JB; Leblanc RP; Nicolela MT
Investigative Ophthalmology and Visual Science 2009; 50: 1682-1691 (IGR: 11-2)


23856 The Relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucoma
Medeiros FA; Alencar LM; Zangwill LM; Sample PA; Weinreb RN
Ophthalmology 2009; 116: 1125-1133 (IGR: 11-2)


23513 Mean target intraocular pressure and progression rates in chronic angle-closure glaucoma
Liza Sharmini AT; Yuen Shi Yin N; Shi-Huang Lee S; Jackson AL; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 71-75 (IGR: 11-2)


22536 Predicting progressive glaucomatous optic neuropathy using baseline standard automated perimetry data
Demirel S; Fortune B; Fan J; Levine RA; Torres R; Nguyen H; Mansberger SL; Gardiner SK; Cioffi GA; Johnson CA
Investigative Ophthalmology and Visual Science 2009; 50: 674-680 (IGR: 11-1)


22538 Performance of confocal scanning laser tomograph Topographic Change Analysis (TCA) for assessing glaucomatous progression
Bowd C; Balasubramanian M; Weinreb RN; Vizzeri G; Alencar LM; O'Leary N; Sample PA; Zangwill LM
Investigative Ophthalmology and Visual Science 2009; 50: 691-701 (IGR: 11-1)


22534 Ability of Stratus OCT to detect progressive retinal nerve fiber layer atrophy in glaucoma
Lee EJ; Kim TW; Park KH; Seong M; Kim H; Kim DM
Investigative Ophthalmology and Visual Science 2009; 50: 662-668 (IGR: 11-1)


22500 Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension
Konstas AG; Irkec MT; Teus MA; Cvenkel B; Astakhov YS; Sharpe ED; Hollo G; Mylopoulos N; Bozkurt B; Pizzamiglio C
Eye 2009; 23: 73-78 (IGR: 11-1)


22670 Clinicians agreement in establishing glaucomatous progression using the Heidelberg retina tomograph
Vizzeri G; Weinreb RN; Martinez De La Casa JM; Alencar LM; Bowd C; Balasubramanian M; Medeiros FA; Sample P; Zangwill LM
Ophthalmology 2009; 116: 14-24 (IGR: 11-1)


23353 Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study
Wesselink C; Heeg GP; Jansonius NM
Archives of Ophthalmology 2009; 127: 270-274 (IGR: 11-1)


22622 Detection of visual-field deterioration by Glaucoma Progression Analysis and Threshold Noiseless Trend programs
Diaz-Aleman VT; Anton A; de la Rosa MG; Johnson ZK; McLeod S; Azuara-Blanco A
British Journal of Ophthalmology 2009; 93: 322-328 (IGR: 11-1)


22528 Performance of glaucoma progression analysis software in a glaucoma population
Arnalich-Montiel F; Casas-Llera P; Muñoz-Negrete FJ; Rebolleda G
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 391-397 (IGR: 11-1)


22886 Association between high myopia and progression of visual field loss in primary open-angle glaucoma
Lee Y-A; Shih Y-F; Lin LL-K; Huang J-Y; Wang T-H
Journal of the Formosan Medical Association 2008; 107: 952-957 (IGR: 11-1)


21529 Charles F. Prentice Award Lecture 2006: A neuron doctrine for glaucoma
Harwerth RS
Optometry and Vision Science 2008; 85: 436-444 (IGR: 10-3)


21809 Reversal of optic disc cupping in glaucoma
Harju M; Saari J; Kurvinen L; Vesti E
British Journal of Ophthalmology 2008; 92: 901-905 (IGR: 10-3)


21720 Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study
Caprioli J; Coleman AL
Ophthalmology 2008; 115: 1123-1129 (IGR: 10-3)


21862 A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients
Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
Ophthalmology 2008; 115: 1557-1565 (IGR: 10-3)


21714 Long-term survival of central visual field in end-stage glaucoma
Much JW; Liu C; Piltz-Seymour JR
Ophthalmology 2008; 115: 1162-1166 (IGR: 10-3)


21533 Progression: Things we need to remember but often forget to think about
Artes PH
Optometry and Vision Science 2008; 85: 380-385 (IGR: 10-3)


21682 Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma
Inatani M; Iwao K; Inoue T; Awai M; Muto T; Koga T; Ogata-Iwao M; Hara R; Futa R; Tanihara H
Journal of Glaucoma 2008; 17: 275-279 (IGR: 10-3)


21855 Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma
Chauhan BC; Mikelberg FS; Balaszi AG; Leblanc RP; Lesk MR; Trope GE; Canadian Glaucoma Study Group
Archives of Ophthalmology 2008; 126: 1030-1036 (IGR: 10-3)


21401 Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma
Medeiros FA; Weinreb RN; Zangwill LM; Alencar LM; Sample PA; Vasile C; Bowd C
Ophthalmology 2008; 115: 934-940 (IGR: 10-2)


21102 Reduced choroidal blood flow can induce visual field defect in open angle glaucoma patients without intraocular pressure elevation following encircling scleral buckling
Sato EA; Shinoda K; Inoue M; Ohtake Y; Kimura I
Retina (Philadelphia, Pa.) 2008; 28: 493-497 (IGR: 10-2)


20967 Detection of visual field progression in glaucoma
Kovalska M; Grieshaber MC; Schötzau A; Katamay R; Hauenstein D; Flammer J; Orgül S
Klinische Monatsblätter für Augenheilkunde 2008; 225: 342-345 (IGR: 10-2)


21228 Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma
Pokroy R; Greenwald Y; Pollack A; Bukelman A; Zalish M
Ophthalmic Surgery Lasers and Imaging 2008; 39: 22-29 (IGR: 10-2)


20009 Monitoring glaucomatous progression using a novel Heidelberg Retina Tomograph event analysis
Fayers T; Strouthidis NG; Garway-Heath DF
Ophthalmology 2007; 114: 1973-1980 (IGR: 9-4)


16928 Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial
Bengtsson B; Leske MC; Hyman L; Heijl A; Early Manifest Glaucoma Trial Group
Ophthalmology 2007; 114: 205-209 (IGR: 9-1)


16845 Comparison of glaucoma progression evaluated with Heidelberg retina tomograph II versus optic nerve head stereophotographs
Kourkoutas D; Buys YM; Flanagan JG; Hatch WV; Balian C; Trope GE
Canadian Journal of Ophthalmology 2007; 42: 82-88 (IGR: 9-1)


16924 Nonprogressive glaucomatous cupping and visual field abnormalities in young Chinese males
Doshi A; Kreidl KO; Lombardi L; Sakamoto DK; Singh K
Ophthalmology 2007; 114: 472-479 (IGR: 9-1)


15258 Relative risk of progressive glaucomatous visual field loss in patients enrolled and not enrolled in a prospective longitudinal study
Henson DB; Shambhu S
Archives of Ophthalmology 2006; 124: 1405-1408 (IGR: 8-4)


14118 Iris colour, optic disc dimensions, degree and progression of glaucomatous optic nerve damage
Jonas JB; Budde WM; Stroux A; Oberacher-Velten IM
Clinical and Experimental Ophthalmology 2006; 34: 654-660 (IGR: 8-3)


14029 Glaucoma follow-up by the Heidelberg Retina Tomograph
Kalaboukhova L; Fridhammar V; Lindblom B
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 654-662 (IGR: 8-3)


14013 Estimating the clinical usefulness of optic disc biometry for detecting glaucomatous change over time
Tangelder GJ; Reus NJ; Lemij HG
Eye 2006; 20: 755-763 (IGR: 8-3)


14063 Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities
Manassakorn A; Nouri-Mahdavi K; Koucheki B; Law SK; Caprioli J
Investigative Ophthalmology and Visual Science 2006; 47: 2896-2903 (IGR: 8-3)


14062 Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement
Strouthidis NG; Scott A; Peter NM; Garway-Heath DF
Investigative Ophthalmology and Visual Science 2006; 47: 2904-2910 (IGR: 8-3)


13775 Central corneal thickness and corneal hysteresis associated with glaucoma damage
Congdon NG; Broman AT; Bandeen-Roche K; Grover D; Quigley HA
American Journal of Ophthalmology 2006; 141: 868-875 (IGR: 8-2)


13781 Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage
Jonas JB; Stroux A; Martus P; Budde W
Journal of Glaucoma 2006; 15: 206-212 (IGR: 8-2)


13674 Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma
Stewart WC; Day DG; Jenkins JN; Passmore CL; Stewart JA
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 26-33 (IGR: 8-2)


13612 Long-term changes in the shape of glaucomatous optic disc
Hiroishi G; Koike I; Ikeda Y; Yoshida S; Fujisawa K; Kubota T; Ishibashi T
Japanese Journal of Clinical Ophthalmology 2006; 60: 329-333 (IGR: 8-2)


13836 Ten-year RESULTS: detection of long-term progressive optic disc changes with confocal laser tomography
Philippin H; Unsoeld A; Maier P; Walter S; Bach M; Funk J
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 460-464 (IGR: 8-2)


13853 The relationship between recurrent optic disc hemorrhage and glaucoma progression
Kim SH; Park KH
Ophthalmology 2006; 113: 598-602 (IGR: 8-2)


13530 Diagnostic approaches for early detection of glaucoma progression
Arend KO; Plange N
Klinische Monatsblätter für Augenheilkunde 2006; 223: 194-216 (IGR: 8-1)


13497 Diagnosing glaucoma progression: current practice and promising technologies
Giangiacomo A; Garway-Heath D; Caprioli J
Current Opinions in Ophthalmology 2006; 17: 153-162 (IGR: 8-1)


13486 Towards an optimal perimetric strategy for progression detection in glaucoma: from fixed-space to adaptive inter-test intervals
Jansonius NM
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 390-393 (IGR: 8-1)


13330 Observer-based rather than population-based confidence limits for determining probability of change in visual fields
Turpin A; McKendrick AM
Vision Research 2005; 45: 3277-3289 (IGR: 8-1)


13394 Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial
Wilkins MR; Fitzke FW; Khaw PT
Eye 2006; 20: 98-106 (IGR: 8-1)


13374 Progression of visual field loss in open angle glaucoma in the Melbourne Visual Impairment Project
Zahari M; Mukesh BN; Rait JL; Taylor HR; McCarty CA
Clinical and Experimental Ophthalmology 2006; 34: 20-26 (IGR: 8-1)


13056 Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders
Parrish RK 2nd; Schiffman JC; Feuer WJ; Anderson DR; Budenz DL; Wells-Albornoz MC; Vandenbroucke R; Kass MA; Gordon MO; Ocular Hypertension Treatment Study Group
American Journal of Ophthalmology 2005; 140: 762-764 (IGR: 7-3)


13165 Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields
Sample PA; Boden C; Zhang Z; Pascual J; Lee TW; Zangwill LM; Weinreb RN; Crowston JG; Hoffmann EM; Medeiros FA
Investigative Ophthalmology and Visual Science 2005; 46: 3684-3692 (IGR: 7-3)


12719 Role and mechanism of endothelin-1 in the deterioration of visual function of glaucomatous eyes
Yan C-R; Liang X-W; Li R-Z; Liao H-L; Zheng B; Song H-N; Wang S-M
Chinese Journal of Clinical Rehabilitation 2005; 9: 156-157 (IGR: 7-3)


12415 Central corneal thickness and progression of the visual field and optic disc in glaucoma
Chauhan BC; Hutchison DM; Leblanc RP; Artes PH; Nicolela MT
British Journal of Ophthalmology 2005; 89: 1008-1012 (IGR: 7-2)


12173 Nomogram for ocular hypertension progression risk based on the ocular hypertension treatment study
Diaz Aleman VT; Fernandez Baca Vaca G; Lozano Lopez V; Garcia Somalo M; Perera Sanz D; Gonzalez de la Rosa M
Archivos de la Sociedad Española de Oftalmologia 2005; 80: 151-154 (IGR: 7-2)


12489 Bayes' theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value
Jansonius NM
Graefe's Archive for Clinical and Experimental Ophthalmology 2005; 243: 433-437 (IGR: 7-2)


12376 Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma
Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
American Journal of Ophthalmology 2005; 139: 999-1009 (IGR: 7-2)


12377 Use of progressive glaucomatous optic disk change as the reference standard for evaluation of diagnostic tests in glaucoma
Medeiros FA; Zangwill LM; Bowd C; Sample PA; Weinreb RN
American Journal of Ophthalmology 2005; 139: 1010-1018 (IGR: 7-2)


11818 Central corneal thickness correlated with glaucoma damage and rate of progression
Jonas JB; Stroux A; Velten I; Juenemann A; Martus P; Budde WM
Investigative Ophthalmology and Visual Science 2005; 46: 1269-1274 (IGR: 7-1)


11679 Longitudinal changes in the visual field and optic disc in glaucoma
Artes PH; Chauhan BC
Progress in Retinal and Eye Research 2005; 24: 333-354 (IGR: 7-1)


11748 Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma
Emre M; Orgul S; Haufschild T; Shaw SG; Flammer J
British Journal of Ophthalmology 2005; 89: 60-63 (IGR: 7-1)


11790 Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study
Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; Leblanc RP; Chauhan BC
Investigative Ophthalmology and Visual Science 2005; 46: 547-554 (IGR: 7-1)


11854 An evaluation of blebs after filtering surgery with the in vivo confocal microscope
Labbé A; Dupas B; Hamard P; Baudouin C
Journal Français d'Ophtalmologie 2004; 27: 1083-1089 (IGR: 7-1)


11857 Rate of visual field progression in primary open-angle glaucoma and primary angle-closure glaucoma
Lee YH; Kim CS; Hong SP
Korean Journal of Ophthalmology 2004; 18: 106-115 (IGR: 7-1)


11912 Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods
Nouri-Mahdavi K; Caprioli J; Coleman AL; Hoffman D; Gaasterland D
Archives of Ophthalmology 2005; 123: 193-199 (IGR: 7-1)


12082 Confocal microscopy used as the definitive, early diagnostic method in Chandler syndrome
Sheppard Jr JD; Lattanzio Jr FA; Williams PB; Mitrev PV; Allen RC
Cornea 2005; 24: 227-229 (IGR: 7-1)


12002 Is poor life expectancy a predictive factor in the progression of primary open angle glaucoma?
Tattersall CL; Vernon SA; Negi A
Eye 2005; 19: 387-391 (IGR: 7-1)


11239 Central corneal pachymetry and visual field progression in patients with open-angle glaucoma
Kim JW; Chen PP
Ophthalmology 2004; 111: 2126-2132 (IGR: 6-3)


11537 Blood flow studies and serological testing in the diagnostic evaluation of glaucoma: A pilot study
Greenfield DS; Bagga H
Ophthalmic Surgery Lasers and Imaging 2004; 35: 406-414 (IGR: 6-3)


11363 Patterns of glaucomatous visual field progression identified by three progression criteria
Boden C; Blumenthal EZ; Pascual J; McEwan G; Weinreb RN; Medeiros FA; Sample PA
American Journal of Ophthalmology 2004; 138: 1029-1036 (IGR: 6-3)


11349 The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations
Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A
Ophthalmology 2004; 111: 2109-2116 (IGR: 6-3)


11350 Statistical evaluation of the diagnostic accuracy of methods used to determine the progression of visual field defects in glaucoma
Mayama C; Araie M; Suzuki Y; Ishida K; Yamamoto T; Kitazawa Y; Shirakashi M; Abe H; Tsukamoto H; Mishima HK
Ophthalmology 2004; 111: 2117-2125 (IGR: 6-3)


11337 Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study
Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J; Advanced Glaucoma Intervention Study
Ophthalmology 2004; 111: 1627-1635 (IGR: 6-3)


10818 Central corneal thickness measurements with partial coherence interferometry, ultrasound, and the Orbscan system
Rainer G; Findl O; Petternel V; Kiss B; Drexler W; Skorpik C; Georgopoulos M; Schmetterer L
Ophthalmology 2004; 111: 875-9 (IGR: 6-2)


10736 Optic nerve head segmentation
Lowell J; Hunter A; Steel D; Basu A; Ryder R; Fletcher E; Kennedy L
IEEE Transactions on Medical Imaging 2004; 23: 256-64 (IGR: 6-2)


9111 Corneal thickness and endothelial cell density measured by non-contact specular microscopy and pachymetry in Rhesus macaques (Macaca mulatta) with laser-induced ocular hypertension
Ollivier FJ; Brooks DE; Komáromy AM; Källberg ME; Andrew SE; Sapp HL; Sherwood MB; Dawson WW
Experimental Eye Research 2003; 76: 671-677 (IGR: 5-2)


9187 Episcleral venous pressure in younger and older subjects in the sitting and supine positions
Sultan M; Blondeau P
Journal of Glaucoma 2003; 12: 370-373 (IGR: 5-2)


8131 Molecular imaging of perfusion disturbances in glaucoma
Golubnitschaja O; Wunderlich K; Decker C; Monkemann H; Schild HH; Flammer J
Amino Acids 2002; 23: 293-299 (IGR: 4-3)


6631 Two methods of lens opacity measurements in glaucomas
Horn FK; Junemann AG; Korth M
Documenta Ophthalmologica 2001; 103: 105-117 (IGR: 4-1)


6636 Functional magnetic resonance imaging of the retina
Duong TQ; Ngan SC; Ugurbil K; Kim SG
Investigative Ophthalmology and Visual Science 2002; 43: 1176-1181 (IGR: 4-1)


6718 In vivo confocal microscopy in primary congenital glaucoma with megalocornea
Mastropasqua L; Carpineto P; Ciancaglini M; Nubile M; Doronzo E
Journal of Glaucoma 2002; 11: 83-89 (IGR: 4-1)


6719 Simple and inexpensive software designed for the evaluation of color
Otaka I; Kumagai K; Inagaki Y; Shimoyama M; Saegusa K; Hara T
American Journal of Ophthalmology 2002; 133: 140-142 (IGR: 4-1)


19023 Management of the Pulfrich phenomenon secondary to pigmentary glaucoma
Tong DT; Borsting E; Ridder WH
Optometry 2001; 72: 86-93 (IGR: 3-1)


6086 Diagnosis of glaucoma using telemedicine: the effect of compression on the evaluation of optic nerve head cup-disc ratio
Beauregard D; Lewis J; Piccolo M; Bedell H
Journal of Telemedicine and Telecare 2000; 6: S123-125 (IGR: 2-2)


6087 The contribution of magnetic resonance imaging in the differential diagnosis of optic nerve damage
Gass A; Moseley IF
Journal of the Neurological Sciences 2000; 172: S17-22 (IGR: 2-2)


6088 Telemedicine in the control of intra-ocular pressure
Michelson G; Striebel W; Prihoda W; Schmidt V
Journal of Telemedicine and Telecare 2000; 6: S126-128 (IGR: 2-2)


6089 International transmission of tele-ophthalmology images
Yogesan K; Constable IJ; Morgan W; Soebadi DY
Journal of Telemedicine and Telecare 2000; 6: 41-44 (IGR: 2-2)


5692 Telemedicine screening of glaucoma
Li HK; Tang RA; Oschner K; Koplos C; Grady J; Crump WJ
Telemedicine Journal 1999; 5:283-290 (IGR: 2-1)


5693 Multivariate approach for quantification of morphologic and functional damage in glaucoma
Martus P; Jünemann A; Wisse M; Budde WM; Horn F; Korth M; Jonas JB
Investigative Ophthalmology and Visual Science 2000; 41: 1099-1110 (IGR: 2-1)


5694 Reflex lacrimation in patients with glaucoma and healthy control subjects by fluorophotometry
Tang NE; Zuure PL; Pardo RD; De Keizer RJ; Van Best JA
Investigative Ophthalmology and Visual Science 2000; 41:709-714 (IGR: 2-1)


15435 The application of teleophthalmology in examining patients with glaucoma: a pilot study
Tuulonen A; Ohinmaa A; Alanko H; Hyytinen P; Juutinen A; Toppinen E
Journal of Glaucoma 1999; 8: 367-373 (IGR: 1-3)


5304 A comparison of imaging techniques for diagnosing drusen of the optic nerve head
Kurz-Levin MM; Landau K
Archives of Ophthalmology 1999; 117: 1045-1049 (IGR: 1-2)


Issue 21-3

Change Issue


advertisement

Topcon